PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR				Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR			Bidirectional behavioral plasticity of memory reconsolidation depends on amygdalar protein kinase A	NATURE NEUROSCIENCE			English	Article							EXTINCTION; CONSOLIDATION; RETRIEVAL	Reconsolidation-the stabilization of a memory after retrieval is hypothesized to be a critical and distinct component of memory processing, the disruption of which results in memory impairment. In the rat, we found that activation of amygdalar protein kinase A ( PKA) was sufficient to enhance memory only when it was retrieved; in contrast, PKA inhibition impaired reconsolidation. This study demonstrates both a selective enhancement and an impairment of memory reconsolidation dependent on amygdalar PKA.	Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, New Haven, CT 06508 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University; Yale University	Taylor, JR (corresponding author), Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, 34 Pk St, New Haven, CT 06508 USA.	jane.taylor@yale.edu		Wiseman, Shari/0000-0001-7868-9723; Tronson, Natalie/0000-0001-5676-1579	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15222] Funding Source: Medline; NIMH NIH HHS [MH25642] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; GORDON WC, 1977, PHYSIOL BEHAV, V19, P95; Jentsch JD, 2002, BIOL PSYCHIAT, V52, P111, DOI 10.1016/S0006-3223(02)01358-6; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PAXINOS G, 1996, RAT BRAIN ATLAS STER; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004	11	204	206	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					167	169		10.1038/nn1628	http://dx.doi.org/10.1038/nn1628			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415868				2022-12-28	WOS:000234990100009
J	Daw, ND; Niv, Y; Dayan, P				Daw, ND; Niv, Y; Dayan, P			Uncertainty-based competition between prefrontal and dorsolateral striatal systems for behavioral control	NATURE NEUROSCIENCE			English	Article							LINKING BASAL GANGLIA; REINFORCER DEVALUATION; COMPUTATIONAL MODEL; CEREBRAL-CORTEX; HABIT FORMATION; LESIONS; REWARD; DOPAMINE; MEMORY; SENSITIVITY	A broad range of neural and behavioral data suggests that the brain contains multiple systems for behavioral choice, including one associated with prefrontal cortex and another with dorsolateral striatum. However, such a surfeit of control raises an additional choice problem: how to arbitrate between the systems when they disagree. Here, we consider dual-action choice systems from a normative perspective, using the computational theory of reinforcement learning. We identify a key trade-off pitting computational simplicity against the flexible and statistically efficient use of experience. The trade-off is realized in a competition between the dorsolateral striatal and prefrontal systems. We suggest a Bayesian principle of arbitration between them according to uncertainty, so each controller is deployed when it should be most accurate. This provides a unifying account of a wealth of experimental evidence about the factors favoring dominance by either system.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Daw, ND (corresponding author), UCL, Gatsby Computat Neurosci Unit, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	daw@gatsby.ucl.ac.uk		Dayan, Peter/0000-0003-3476-1839				ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; Baum EB, 1997, ARTIF INTELL, V97, P195, DOI 10.1016/S0004-3702(97)00059-3; Blundell P, 2003, J NEUROSCI, V23, P7702; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chavarriaga R, 2005, NEUROINFORMATICS, V3, P223, DOI 10.1385/NI:3:3:223; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P520, DOI 10.1037/0097-7403.11.4.520; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DAW ND, 2003, ADV NEURAL INFORM PR, V15, P99; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dearden R, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P761; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Hartley T, 2005, TRENDS NEUROSCI, V28, P169, DOI 10.1016/j.tins.2005.02.004; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Houk JC, 1995, MODELS INFORMATION P, P249; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kahneman D., 2011, THINKING FAST SLOW; Killcross A.S., 2002, EMOTIONAL COGNITION, P35; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Lieberman M.D., 2003, SOCIAL JUDGMENTS IMP, P44; LOEWENSTEIN G, 2004, 0414 CORN U CTR AN E; MANNOR S, 2004, P 21 INT C MACH LEAR, P568; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parkinson JA, 2005, Q J EXP PSYCHOL-B, V58, P19, DOI 10.1080/02724990444000023; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; Suri RE, 2001, EXP BRAIN RES, V140, P234, DOI 10.1007/s002210100814; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	1412	1427	1	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1704	1711		10.1038/nn1560	http://dx.doi.org/10.1038/nn1560			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286932				2022-12-28	WOS:000233576200019
J	Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F				Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F			Dissociation between physical and mental number line bisection in right hemisphere brain damage	NATURE NEUROSCIENCE			English	Article							UNILATERAL NEGLECT; SPACE; REPRESENTATION; HEMIANOPIA; MAGNITUDE; ANATOMY; CORTEX	To compare numeric quantities, humans make use of a 'mental number line' with smaller quantities located to the left of larger ones; it is unclear, however, whether orienting along the number line is like orienting along a physical line. We found that in brain-damaged subjects with defective leftward orienting, rightward deviation in the bisection of numeric and physical intervals is doubly dissociated. Deviation in numeric interval bisection was associated with prefrontal damage and spatial working memory deficit.	IRCCS, LENA, Fdn Santa Lucia, Rome, Italy; Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Sci Neurol Cattedra 5, Rome, Italy; Auxilium Vitae Volterra, Pisa, Italy	IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome	Doricchi, F (corresponding author), IRCCS, LENA, Fdn Santa Lucia, Rome, Italy.	Fabrizio.Doricchi@uniroma1.it	Tomaiuolo, Francesco/AAC-1534-2019	Tomaiuolo, Fancesco/0000-0003-1230-2770				Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Della Sala S, 2004, NEUROPSYCHOLOGIA, V42, P1358, DOI 10.1016/j.neuropsychologia.2004.02.011; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Malhotra P, 2005, BRAIN, V128, P424, DOI 10.1093/brain/awh372; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Rizzuto DS, 2005, NAT NEUROSCI, V8, P415, DOI 10.1038/nn1424; Rossetti Y, 2004, PSYCHOL SCI, V15, P426, DOI 10.1111/j.0956-7976.2004.00696.x; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	15	144	146	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1663	1665		10.1038/nn1563	http://dx.doi.org/10.1038/nn1563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261135				2022-12-28	WOS:000233576200013
J	Hefft, S; Jonas, P				Hefft, S; Jonas, P			Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; RAT HIPPOCAMPUS; NEUROMUSCULAR-JUNCTION; SHUNTING INHIBITION; NERVE-TERMINALS; GRANULE CELLS; TIME-COURSE; IN-VITRO; TRANSMISSION; PARVALBUMIN	Hippocampal GABAergic interneurons show diverse molecular and morphological properties. The functional significance of this diversity for information processing is poorly understood. Here we show that cholecystokinin (CCK)-expressing interneurons in rat dentate gyrus release GABA in a highly asynchronous manner, in contrast to parvalbumin (PV) interneurons. With a gamma-frequency burst of ten action potentials, the ratio of asynchronous to synchronous release is 3: 1 in CCK interneurons but is 1: 5 in parvalbumin interneurons. N-type channels trigger synchronous and asynchronous release in CCK interneuron synapses, whereas P/Q-type Ca2+ channels mediate release at PV interneuron synapses. Effects of Ca2+ chelators suggest that both a long-lasting presynaptic Ca2+ transient and a large distance between Ca2+ source and sensor of exocytosis contribute to the higher ratio of asynchronous to synchronous release in CCK interneuron synapses. Asynchronous release occurs at physiological temperature and with behaviorally relevant stimulation patterns, thus generating long-lasting inhibition in the brain.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804				Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brickley SG, 1999, J NEUROSCI, V19, P2960; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Morozov YM, 2003, NEUROSCIENCE, V120, P923, DOI 10.1016/S0306-4522(03)00409-3; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rumpel E, 1999, J PHYSIOL-LONDON, V514, P447, DOI 10.1111/j.1469-7793.1999.447ae.x; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu LG, 1999, J NEUROSCI, V19, P726; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	50	416	420	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1319	1328		10.1038/nn1542	http://dx.doi.org/10.1038/nn1542			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158066				2022-12-28	WOS:000232145900015
J	McDonald, JJ; Teder-Salejarvi, WA; Di Russo, F; Hillyard, SA				McDonald, JJ; Teder-Salejarvi, WA; Di Russo, F; Hillyard, SA			Neural basis of auditory-induced shifts in visual time-order perception	NATURE NEUROSCIENCE			English	Article							BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SELECTIVE ATTENTION; PRIOR ENTRY; TEMPORAL-ORDER; POTENTIALS; COMPONENTS; ERP	Attended objects are perceived to occur before unattended objects even when the two objects are presented simultaneously. This finding has led to the widespread view that attention modulates the speed of neural transmission in the various perceptual pathways. We recorded event-related potentials during a time-order judgment task to determine whether a reflexive shift of attention to a sudden sound modulates the speed of sensory processing in the human visual system. Attentional cueing influenced the perceived order of lateralized visual events but not the timing of event-related potentials in visual cortex. Attentional cueing did, however, enhance the amplitude of neural activity in visual cortex, which shows that attention-induced shifts in visual time-order perception can arise from modulations of signal strength rather than processing speed in the early visual-cortical pathways.	Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Human Movement, Dept Educ Sport & Human Movement, I-00194 Rome, Italy; Santa Lucia Fdn IRCCS, I-00179 Rome, Italy	Simon Fraser University; University of California System; University of California San Diego; IRCCS Santa Lucia	McDonald, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jmcd@sfu.ca	Di Russo, Francesco/N-6686-2015; McDonald, John/P-6966-2015	Di Russo, Francesco/0000-0002-3127-9433; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 25594] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Downing PE, 1997, J EXP PSYCHOL HUMAN, V23, P768; Dufour A, 1999, EXP BRAIN RES, V126, P215, DOI 10.1007/s002210050731; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; FREY RD, 1990, HUM MOVEMENT SCI, V9, P481, DOI 10.1016/0167-9457(90)90012-3; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; JASKOWSKI P, 1993, PERCEPTION, V22, P681, DOI 10.1068/p220681; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2003, J COGNITIVE NEUROSCI, V15, P10, DOI 10.1162/089892903321107783; Pashler HE, 1998, PSYCHOL ATTENTION; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; STELMACH LB, 1991, J EXP PSYCHOL HUMAN, V17, P539, DOI 10.1037/0096-1523.17.2.539; Stone SA, 1926, AM J PSYCHOL, V37, P284, DOI 10.2307/1413699; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	25	116	120	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1197	1202		10.1038/nn1512	http://dx.doi.org/10.1038/nn1512			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	958YJ	16056224				2022-12-28	WOS:000231483800019
J	Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M				Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M			GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOMAIN PROTEIN GRIP1; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; KINESIN; EPHRINS; MICROTUBULES	The function of the multi-PDZ domain scaffold protein GRIP1 (glutamate receptor interacting protein 1) in neurons is unclear. To explore the function of GRIP1 in hippocampal neurons, we used RNA interference (RNAi) to knock down the expression of GRIP1. Knockdown of GRIP1 by small interfering RNA (siRNA) in cultured hippocampal neurons caused a loss of dendrites, associated with mislocalization of the GRIP-interacting proteins GluR2 (AMPA receptor subunit), EphB2 (receptor tyrosine kinase) and KIF5 (also known as kinesin 1; microtubule motor). The loss of dendrites by GRIP1-siRNA was rescued by overexpression of the extracellular domain of EphB2, and was phenocopied by overexpression of the intracellular domain of EphB2 and extracellular application of ephrinB-Fc fusion proteins. Neurons from EphB1-EphB2-EphB3 triple knockout mice showed abnormal dendrite morphogenesis. Disruption of the KIF5-GRIP1 interaction inhibited EphB2 trafficking and strongly impaired dendritic growth. These results indicate an important role for GRIP1 in dendrite morphogenesis by serving as an adaptor protein for kinesin-dependent transport of EphB receptors to dendrites.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of California System; University of California Riverside; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.	msheng@mit.edu	Hoogenraad, Casper/B-8866-2011	Hoogenraad, Casper/0000-0002-2666-0758; Milstein, Aaron/0000-0002-7186-5779; Henkemeyer, Mark/0000-0002-7525-1061; Ethell, Iryna/0000-0002-1324-6611; Sheng, Morgan/0000-0002-8703-5366	NIMH NIH HHS [R01 MH067121-03, MH66332, R01 MH066332] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332, R01MH067121] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Burette A, 1999, J COMP NEUROL, V411, P601; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hering H, 2003, J NEUROSCI, V23, P11759; Horton AC, 2003, J NEUROSCI, V23, P6188; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	50	162	169	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					906	915		10.1038/nn1487	http://dx.doi.org/10.1038/nn1487			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965473				2022-12-28	WOS:000230137100018
J	Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ				Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ			Glutamate receptor dynamics organizing synapse formation in vivo	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; LATERAL MOVEMENTS; QUANTAL CONTENT; PLASTICITY; PROTEINS; LOCALIZATION	Insight into how glutamatergic synapses form in vivo is important for understanding developmental and experience-triggered changes of excitatory circuits. Here, we imaged postsynaptic densities (PSDs) expressing a functional, GFP-tagged glutamate receptor subunit (GluR-IIA(GFP)) at neuromuscular junctions of Drosophila melanogaster larvae for several days in vivo. New PSDs, associated with functional and structural presynaptic markers, formed independently of existing synapses and grew continuously until reaching a stable size within hours. Both in vivo photoactivation and photobleaching experiments showed that extrasynaptic receptors derived from diffuse, cell-wide pools preferentially entered growing PSDs. After entering PSDs, receptors were largely immobilized. In comparison, other postsynaptic proteins tested (PSD-95, NCAM and PAK homologs) exchanged faster and with no apparent preference for growing synapses. We show here that new glutamatergic synapses form de novo and not by partitioning processes from existing synapses, suggesting that the site-specific entry of particular glutamate receptor complexes directly controls the assembly of individual PSDs.	European Neurosci Inst Gottingen, Max Planck Soc, D-37073 Gottingen, Germany; IMB, Graz, Austria; Inst Physiol, D-79104 Freiburg, Germany	Max Planck Society	Sigrist, SJ (corresponding author), European Neurosci Inst Gottingen, Max Planck Soc, Waldweg 33, D-37073 Gottingen, Germany.	heckmann@physiologie.uni-freiburg.de; ssigris@gwdg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Schmidt, Manuela/0000-0003-1972-3519; Heckmann, Manfred/0000-0002-4874-1735; Madeo, Frank/0000-0002-5070-1329				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Renger JJ, 2000, J NEUROSCI, V20, P3980; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Sone M, 2000, DEVELOPMENT, V127, P4157; Stewart BA, 1996, J NEUROSCI, V16, P3877; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	138	141	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					898	905		10.1038/nn1484	http://dx.doi.org/10.1038/nn1484			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136672				2022-12-28	WOS:000230137100017
J	Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH				Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH			In vivo auditory brain mapping in mice with Mn-enhanced MRI	NATURE NEUROSCIENCE			English	Article							RESONANCE-IMAGING MEMRI; INFERIOR COLLICULUS; OTITIS-MEDIA; MOUSE-BRAIN; ACTIVATION; RESPONSES; NEURONS; HEARING; NUCLEI	There are currently no noninvasive imaging methods available for auditory brain mapping in mice, despite the increasing use of genetically engineered mice to study auditory brain development and hearing loss. We developed a manganese-enhanced MRI (MEMRI) method to map regions of accumulated sound-evoked activity in awake, normally behaving mice. To demonstrate its utility for high-resolution (100-mu m) brain mapping, we used MEMRI to show the tonotopic organization of the mouse inferior colliculus. To test its efficacy in an experimental setting, we acquired data from mice experiencing unilateral conductive hearing loss at different ages. Larger and persistent changes in auditory brainstem activity resulted when hearing loss occurred before the onset of hearing, showing that early hearing loss biases the response toward the functional ear. Thus, MEMRI provides a sensitive and effective method for mapping the mouse auditory brainstem and has great potential for a range of functional neuroimaging studies in normal and mutant mice.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Grad Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Turnbull, DH (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	turnbull@saturn.med.nyu.edu	Wadghiri, Youssef Zaim/Q-5110-2019; Wadghiri, Youssef/E-6848-2016	Wadghiri, Youssef Zaim/0000-0001-7175-9397; Wadghiri, Youssef/0000-0001-7175-9397; Turnbull, Daniel/0000-0003-0889-5155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006864, R21DC006892] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC006892, DC06892, R01 DC006864-03, R01 DC006864] Funding Source: Medline; NINDS NIH HHS [NS38461, R01 NS038461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Ehret G, 1976, J Am Audiol Soc, V1, P179; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; HALL JW, 1995, ARCH OTOLARYNGOL, V121, P847; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KENNEDY C, 1975, SCIENCE, V187, P850, DOI 10.1126/science.1114332; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; ROMAND R, 1990, DEV BRAIN RES, V54, P221, DOI 10.1016/0165-3806(90)90145-O; RYUGO DK, 1981, BRAIN RES, V210, P342, DOI 10.1016/0006-8993(81)90907-0; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SANES DH, 1985, J NEUROSCI, V5, P1152; SCHILDER AGM, 1993, CLIN OTOLARYNGOL, V18, P234; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Shnerson A, 1983, AUDITORY PSYCHOBIOLO, P395; Shukakidze A, 2003, Neurosci Behav Physiol, V33, P263; Sterbing SJ, 2003, HEARING RES, V177, P91, DOI 10.1016/S0378-5955(02)00805-5; Tai YC, 2003, PHYS MED BIOL, V48, P1519, DOI 10.1088/0031-9155/48/11/303; Tindemans I, 2003, EUR J NEUROSCI, V18, P3352, DOI 10.1111/j.1460-9568.2003.03056.x; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; WEBSTER DB, 1977, ARCH OTOLARYNGOL, V103, P392; WILLOTT JF, 1978, J COMP PHYSIOL, V127, P175, DOI 10.1007/BF01352302	30	231	236	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					961	968		10.1038/nn1477	http://dx.doi.org/10.1038/nn1477			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924136	Green Accepted			2022-12-28	WOS:000230137100025
J	Aton, SJ; Colwell, CS; Harmar, AJ; Waschek, J; Herzog, ED				Aton, SJ; Colwell, CS; Harmar, AJ; Waschek, J; Herzog, ED			Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons	NATURE NEUROSCIENCE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; MOUSE SUPRACHIASMATIC NUCLEUS; FREE-RUNNING RHYTHMS; VPAC(2) RECEPTOR; MESSENGER-RNA; EXPRESSION; PEPTIDE; CELLS; VIP; NEUROPEPTIDES	The mammalian suprachiasmatic nucleus (SCN) is a master circadian pacemaker. It is not known which SCN neurons are autonomous pacemakers or how they synchronize their daily firing rhythms to coordinate circadian behavior. Vasoactive intestinal polypeptide ( VIP) and the VIP receptor VPAC2 ( encoded by the gene Vipr2) may mediate rhythms in individual SCN neurons, synchrony between neurons, or both. We found that Vip(-/-) and Vipr2(-/-) mice showed two daily bouts of activity in a skeleton photoperiod and multiple circadian periods in constant darkness. Loss of VIP or VPAC2 also abolished circadian firing rhythms in approximately half of all SCN neurons and disrupted synchrony between rhythmic neurons. Critically, daily application of a VPAC2 agonist restored rhythmicity and synchrony to VIP-/- SCN neurons, but not to Vipr2(-/-) neurons. We conclude that VIP coordinates daily rhythms in the SCN and behavior by synchronizing a small population of pacemaking neurons and maintaining rhythmicity in a larger subset of neurons.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland	Washington University (WUSTL); University of California System; University of California Los Angeles; University of Edinburgh; University of Edinburgh	Herzog, ED (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	herzog@wustl.edu	Colwell, Chris/AAM-6111-2020	Aton, Sara/0000-0002-2921-0509; Colwell, Christopher/0000-0002-1059-184X; Herzog, Erik/0000-0001-7209-5174; Harmar, Anthony/0000-0002-3838-9264	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062517, R01MH063104, F31MH073302] Funding Source: NIH RePORTER; NIMH NIH HHS [MH62517, MH073302, R01 MH062517, MH63104, F31 MH073302, R01 MH063104] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; Ban Y, 1997, J NEUROSCI, V17, P3920; BANKER G, 1991, CULTURING NERVE CELL, P75; BATSCHELET E, 1981, MATH BIOL, P31; Cagampang FRA, 1998, MOL BRAIN RES, V54, P108, DOI 10.1016/S0169-328X(97)00327-6; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; DAIKOKU S, 1992, J COMP NEUROL, V325, P559, DOI 10.1002/cne.903250408; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Kallo I, 2004, EUR J NEUROSCI, V19, P2201, DOI 10.1111/j.0953-816X.2004.03335.x; Kalsbeek A, 2002, CELL TISSUE RES, V309, P109, DOI 10.1007/s00441-002-0577-0; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; MISTLBERGER RE, 1991, J BIOL RHYTHM, V6, P71, DOI 10.1177/074873049100600108; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; Nakamura W, 2001, EUR J NEUROSCI, V14, P666, DOI 10.1046/j.0953-816x.2001.01684.x; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Reed HE, 2002, J NEUROENDOCRINOL, V14, P639, DOI 10.1046/j.1365-2826.2002.00826.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shen SB, 2000, P NATL ACAD SCI USA, V97, P11575, DOI 10.1073/pnas.97.21.11575; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; VANDENPOL AN, 1986, J COMP NEUROL, V252, P507, DOI 10.1002/cne.902520407; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	553	567	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					476	483		10.1038/nn1419	http://dx.doi.org/10.1038/nn1419			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15750589	Green Accepted			2022-12-28	WOS:000228040400018
J	Rizzuto, DS; Mamelak, AN; Sutherling, WW; Fineman, I; Andersen, RA				Rizzuto, DS; Mamelak, AN; Sutherling, WW; Fineman, I; Andersen, RA			Spatial selectivity in human ventrolateral prefrontal cortex	NATURE NEUROSCIENCE			English	Article							VISUAL WORKING-MEMORY; NEURONAL-ACTIVITY; PARIETAL CORTEX; OBJECT	The functional organization of lateral prefrontal cortex is not well understood, and there is debate as to whether the dorsal and ventral aspects mediate distinct spatial and non-spatial functions, respectively. We show for the first time that recordings from human ventrolateral prefrontal cortex show spatial selectivity, supporting the idea that ventrolateral prefrontal cortex is involved in spatial processing. Our results also indicate that prefrontal cortex may be a source of control signals for neuroprosthetic applications.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Huntington Mem Hosp, Dept Neurosurg, Pasadena, CA 91105 USA; Huntington Mem Hosp, Epilepsy & Brain Mapping Program, Pasadena, CA 91105 USA	California Institute of Technology; University of Southern California; Huntington Memorial Hospital; University of Southern California; Huntington Memorial Hospital	Rizzuto, DS (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Mamelak, Adam/H-8347-2014	Mamelak, Adam/0000-0002-4245-6431				Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Deco G, 2004, J COGNITIVE NEUROSCI, V16, P683, DOI 10.1162/089892904323057380; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Sabes PN, 2002, J NEUROPHYSIOL, V88, P1815, DOI 10.1152/jn.2002.88.4.1815; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	15	33	36	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					415	417		10.1038/nn1424	http://dx.doi.org/10.1038/nn1424			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768035				2022-12-28	WOS:000228040400009
J	Watanabe, K; Kamiya, D; Nishiyama, A; Katayama, T; Nozaki, S; Kawasaki, H; Watanabe, Y; Mizuseki, K; Sasai, Y				Watanabe, K; Kamiya, D; Nishiyama, A; Katayama, T; Nozaki, S; Kawasaki, H; Watanabe, Y; Mizuseki, K; Sasai, Y			Directed differentiation of telencephalic precursors from embryonic stem cells	NATURE NEUROSCIENCE			English	Article							NEURAL DIFFERENTIATION; HEAD INDUCTION; MOUSE EMBRYOS; GENE; EXPRESSION; NEURONS; BRAIN; WNT; SPECIFICATION; GASTRULATION	We demonstrate directed differentiation of telencephalic precursors from mouse embryonic stem (ES) cells using optimized serum-free suspension culture (SFEB culture). Treatment with Wnt and Nodal antagonists (Dkk1 and LeftyA) during the first 5 d of SFEB culture causes nearly selective neural differentiation in ES cells (similar to90%). In the presence of Dkkl, with or without LeftyA, SFEB induces efficient generation (similar to35%) of cells expressing telencephalic marker Bf1. Wnt3a treatment during the late culture period increases the pallial telencephalic population (Pax6(+) cells yield up to 75% of Bf1(+) cells), whereas Shh promotes basal telencephalic differentiation (into Nkx2.1(+) and/or lslet1/2(+) cells) at the cost of pallial telencephalic differentiation. Thus, in the absence of caudalizing signals, floating aggregates of ES cells generate naive telencephalic precursors that acquire subregional identities by responding to extracellular patterning signals.	RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 5458585, Japan; Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo 1130033, Japan	RIKEN; Kyoto University; Osaka Metropolitan University; University of Tokyo	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	sasaicdb@mub.biglobe.ne.jp	Nozaki, Satoshi/E-3052-2010; KAWASAKI, Hiroshi/L-3736-2015; Mizuseki, Kenji/A-9214-2011; Kawasaki, Hiroshi/C-4404-2015; Watanabe, Kiichi/ABA-4854-2020	Nozaki, Satoshi/0000-0002-9526-1902; Mizuseki, Kenji/0000-0002-1456-2149; Kawasaki, Hiroshi/0000-0002-2514-1497				Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duncan SA, 1997, DEVELOPMENT, V124, P279; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Galceran J, 2000, DEVELOPMENT, V127, P469; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gunhaga L, 2003, NAT NEUROSCI, V6, P701, DOI 10.1038/nn1068; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee SMK, 2000, DEVELOPMENT, V127, P457; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Oliver G, 1995, DEVELOPMENT, V121, P4045; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rallu M, 2002, DEVELOPMENT, V129, P4963; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Wang HF, 2001, NEUROSCIENCE, V103, P999, DOI 10.1016/S0306-4522(00)00590-X; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	48	563	609	5	51	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					288	296		10.1038/nn1402	http://dx.doi.org/10.1038/nn1402			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696161	Green Submitted			2022-12-28	WOS:000227354600013
J	Winocur, G; Moscovitch, M; Fogel, S; Rosenbaum, RS; Sekeres, M				Winocur, G; Moscovitch, M; Fogel, S; Rosenbaum, RS; Sekeres, M			Preserved spatial memory after hippocampal lesions: effects of extensive experience in a complex environment	NATURE NEUROSCIENCE			English	Article								Damage to the hippocampus typically impairs spatial learning and memory in animals, but humans with hippocampal lesions retain spatial memories of premorbidly familiar environments. We showed that, like humans, normal rats reared in a complex environment and then given hippocampal lesions retained allocentric spatial memory for that environment. These results, which ruled out dependency on single cues, landmarks or specific routes, suggest that extensive premorbid experience leads to spatial representations that are independent of the hippocampus.	Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Trent University	Winocur, G (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada.	gwinocur@rotman-baycrest.on.ca	Fogel, Stuart/F-7179-2017	Fogel, Stuart/0000-0002-3227-5370; Sekeres, Melanie/0000-0002-7952-3175				Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; CLARK RE, IN PRESS HIPPOCAMPUS; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Moscovitch M, 2005, DYNAMIC COGNITIVE PROCESSES, P333, DOI 10.1007/4-431-27431-6_14; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	15	100	101	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					273	275		10.1038/nn1401	http://dx.doi.org/10.1038/nn1401			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723062				2022-12-28	WOS:000227354600010
J	Hickmott, PW; Steen, PA				Hickmott, PW; Steen, PA			Large-scale changes in dendritic structure during reorganization of adult somatosensory cortex	NATURE NEUROSCIENCE			English	Article							PLASTICITY; EXPERIENCE; BOUNDARY; NEURONS; MAPS	In adult rat somatosensory cortex (S1), neurons are biased and have less dendritic arbor close to the border between the forepaw and lower jaw representations. Changes in sensory experience cause changes in the functional organization of the neocortex. Therefore, we examined the morphology of neurons in the reorganized region of S1 after forepaw denervation. We found that during reorganization dendritic arbors changed to reflect the new location of the border.	Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Hickmott, PW (corresponding author), Univ Calif Riverside, Dept Psychol, Olmsted Hall 1344, Riverside, CA 92521 USA.	peter.hickmott@ucr.edu			NINDS NIH HHS [NS42241] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042241] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLACK JE, 1989, DEV PSYCHOBIOL, V22, P727, DOI 10.1002/dev.420220707; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Hickmott PW, 1999, J COMP NEUROL, V409, P385; Hickmott PW, 1998, J NEUROSCI, V18, P4403; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; STEFFEN H, 1980, EXP BRAIN RES, V40, P419, DOI 10.1007/BF00236150; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001	15	73	73	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					140	142		10.1038/nn1384	http://dx.doi.org/10.1038/nn1384			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657598				2022-12-28	WOS:000226638200009
J	Lu, L; Hope, BT; Dempsey, J; Liu, SY; Bossert, JM; Shaham, Y				Lu, L; Hope, BT; Dempsey, J; Liu, SY; Bossert, JM; Shaham, Y			Central amygdala ERK signaling pathway is critical to incubation of cocaine craving	NATURE NEUROSCIENCE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; MAP KINASE CASCADE; EXCITOTOXIC LESIONS; SEEKING BEHAVIOR; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; REGULATED KINASE; PROTEIN-KINASE	Using a rat model of craving and relapse, we have previously found time-dependent increases in cue-induced cocaine seeking over the first months of withdrawal from cocaine, suggesting that drug craving incubates over time. Here, we explored the role of the amygdala extracellular signal-regulated kinase (ERK) signaling pathway in this incubation. Cocaine seeking induced by exposure to cocaine cues was substantially higher after 30 withdrawal days than after 1 withdrawal day. Exposure to these cues increased ERK phosphorylation in the central, but not the basolateral, amygdala after 30 d, but not 1 d, of withdrawal. After 30 d of withdrawal from cocaine, inhibition of central, but not basolateral, amygdala ERK phosphorylation decreased cocaine seeking. After 1 d of withdrawal, stimulation of central amygdala ERK phosphorylation increased cocaine seeking. Results suggest that the incubation of cocaine craving is mediated by time-dependent increases in the responsiveness of the central amygdala ERK pathway to cocaine cues.	NIDA, NIH, Dept HHS, Intramural Res Program,Behav Neurosci Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shaham, Y (corresponding author), NIDA, NIH, Dept HHS, Intramural Res Program,Behav Neurosci Branch, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014; Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061	NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000434, ZIADA000434] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berhow MT, 1996, J NEUROSCI, V16, P4707; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis M, 2003, ANN NY ACAD SCI, V985, P218; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Everitt BJ, 2002, J NEUROSCI, V22, P3312; EYSENCK HJ, 1968, BEHAV RES THER, V6, P309, DOI 10.1016/0005-7967(68)90064-8; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Grimm JW, 2003, J NEUROSCI, V23, P742; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hayes RJ, 2003, PSYCHOPHARMACOLOGY, V168, P75, DOI 10.1007/s00213-002-1328-3; Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; OVERTON DA, 1974, FED PROC, V33, P1800; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robledo P, 1996, BEHAV NEUROSCI, V110, P981, DOI 10.1037/0735-7044.110.5.981; Schafe GE, 2000, J NEUROSCI, V20, P8177; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Stewart J, 2004, NEBR SYM MOTIV, V50, P197; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Valjent E, 2000, J NEUROSCI, V20, P8701; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006	50	334	340	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					212	219		10.1038/nn1383	http://dx.doi.org/10.1038/nn1383			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	892GN	15657599				2022-12-28	WOS:000226638200021
J	Amedi, A; Floel, A; Knecht, S; Zohary, E; Cohen, LG				Amedi, A; Floel, A; Knecht, S; Zohary, E; Cohen, LG			Transcranial magnetic stimulation of the occipital pole interferes with verbal processing in blind subjects	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; VISUAL-CORTEX; ACTIVATION; MEMORY; BRAIN; ORGANIZATION; CONNECTIONS; DEPRIVATION; CORTICES; PEOPLE	Recent neuroimaging studies in blind persons show that the occipital cortex, including the primary visual cortex (V1), is active during language-related and verbal-memory tasks. No studies, however, have identified a causal link between early visual cortex activity and successful performance on such tasks. We show here that repetitive transcranial magnetic stimulation (rTMS) of the occipital pole reduces accuracy on a verb-generation task in blind subjects, but not in sighted controls. An analysis of error types revealed that the most common error produced by rTMS was semantic; phonological errors and interference with motor execution or articulation were rare. Thus, in blind persons, a transient 'virtual lesion' of the left occipital cortex interferes with high-level verbal processing.	NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Munster, D-48148 Munster, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Munster	Cohen, LG (corresponding author), NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA.	udiz@lobster.ls.huji.ac.il; cohenl@ninds.nih.gov	Floel, Agnes/A-9426-2017	Amedi, Amir/0000-0001-5042-2533; Knecht, Stefan/0000-0003-1056-9228				Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Buchel C, 2003, NAT NEUROSCI, V6, P657, DOI 10.1038/nn0703-657; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Burton H, 2003, J NEUROSCI, V23, P4005; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DEHAY C, 1984, EXP BRAIN RES, V57, P208; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; KUCERA WN, 1967, COMPUTATIONAL ANAL P; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Noppeney U, 2003, BRAIN, V126, P1620, DOI 10.1093/brain/awg152; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PascualLeone A, 1995, ANN NEUROL, V38, P910, DOI 10.1002/ana.410380611; Paus T, 1999, NEUROPSYCHOLOGIA, V37, P219; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Stewart L, 2001, NEUROIMAGE, V13, P472, DOI 10.1006/nimg.2000.0701	35	196	199	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1266	1270		10.1038/nn1328	http://dx.doi.org/10.1038/nn1328			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15467719				2022-12-28	WOS:000224749400020
J	Kiecker, C; Lumsden, A				Kiecker, C; Lumsden, A			Hedgehog signaling from the ZLI regulates diencephalic regional identity	NATURE NEUROSCIENCE			English	Article							PROGENITOR-CELL IDENTITY; VENTRAL NEURAL-TUBE; SONIC-HEDGEHOG; DEVELOPING BRAIN; EXPRESSION PATTERNS; PROSOMERIC MODEL; NEURONAL FATE; ZONA LIMITANS; LONG-RANGE; FOREBRAIN	The zona limitans intrathalamica (ZLI), a narrow compartment in the vertebrate forebrain that bisects the diencephalon transversely, expresses the secreted factor sonic hedgehog (Shh). Because genetic disruption of Shh in mouse causes severe early developmental defects, this strategy has not been useful in identifying a ZLI-specific role for this gene. To modulate Shh signaling in a spatiotemporally restricted manner, we carried out gain- and loss-of-function experiments in chick embryos using in ovo electroporation and found that Shh signaling is required for region-specific gene expression in thalamus and prethalamus, the major diencephalic brain areas flanking the ZLI. We further show that differential competence of thalamic and prethalamic primordia in responding to Shh signaling is regulated by the transcription factor Irx3. We show that, through the release of Shh, the ZLI functions as a local signaling center that regulates the acquisition of identity for these important diencephalic regions.	Univ London Kings Coll, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Lumsden, A (corresponding author), Univ London Kings Coll, MRC, Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	andrew.lumsden@kcl.ac.uk	Kiecker, Clemens/C-7170-2009; Lumsden, Andrew/C-5146-2009					Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; Garcia-Lopez R, 2004, DEV BIOL, V268, P514, DOI 10.1016/j.ydbio.2003.12.038; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Larsen CW, 2001, J NEUROSCI, V21, P4699, DOI 10.1523/JNEUROSCI.21-13-04699.2001; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Nakamura H, 2000, DEV GROWTH DIFFER, V42, P199; Niss K, 1998, MECH DEVELOP, V76, P151, DOI 10.1016/S0925-4773(98)00103-8; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Shimamura K, 1995, DEVELOPMENT, V121, P3923; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455	50	171	171	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1242	1249		10.1038/nn1338	http://dx.doi.org/10.1038/nn1338			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494730				2022-12-28	WOS:000224749400017
J	Adams, WJ; Graf, EW; Ernst, MO				Adams, WJ; Graf, EW; Ernst, MO			Experience can change the 'light-from-above' prior	NATURE NEUROSCIENCE			English	Article								To interpret complex and ambiguous input, the human visual system uses prior knowledge or assumptions about the world. We show that the `light-from-above' prior, used to extract information about shape from shading is modified in response to active experience with the scene. The resultant adaptation is not specific to the learned scene but generalizes to a different task, demonstrating that priors are constantly adapted by interactive experience with the environment.	Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England; Max Planck Inst Biol Cybernet, Tubingen, Germany	University of Southampton; Max Planck Society	Adams, WJ (corresponding author), Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England.	w.adams@soton.ac.uk		Ernst, Marc/0000-0003-4197-8569; Graf, Erich/0000-0002-3162-4233				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Brewster D., 1826, EDINBURGH J SCI, V4, P99; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; HERSHBERGER W, 1970, J COMP PHYSIOL PSYCH, V73, P407, DOI 10.1037/h0030223; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Langer MS, 2001, PERCEPTION, V30, P403, DOI 10.1068/p3178; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	10	254	256	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1057	1058		10.1038/nn1312	http://dx.doi.org/10.1038/nn1312			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361877				2022-12-28	WOS:000224156900014
J	Shirley, RL; Walter, NAR; Reilly, MT; Fehr, C; Buck, KJ				Shirley, RL; Walter, NAR; Reilly, MT; Fehr, C; Buck, KJ			Mpdz is a quantitative trait gene for drug withdrawal seizures	NATURE NEUROSCIENCE			English	Article							ALCOHOL-WITHDRAWAL; LOCI; DEPENDENCE; RECEPTORS; MICE	Physiological dependence and associated withdrawal episodes can constitute a powerful motivational force that perpetuates drug use and abuse. Using robust behavioral models of drug physiological dependence in mice, positional cloning, and sequence and expression analyses, we identified an addiction-relevant quantitative trait gene, Mpdz. Our findings provide a framework to define the protein interactions and neural circuit by which this gene's product (multiple PDZ domain protein) affects drug dependence, withdrawal and relapse.	Oregon Hlth & Sci Univ, Portland Alcohol Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Dept Vet Affairs Med Ctr, Portland, OR 97239 USA; Univ Mainz, Dept Psychiat, D-55131 Mainz, Germany	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Johannes Gutenberg University of Mainz	Buck, KJ (corresponding author), Oregon Hlth & Sci Univ, Portland Alcohol Res Ctr, 3181 SW Sam Jackson Pk Rd,Mailcode L-470, Portland, OR 97239 USA.	buckk@ohsu.edu		Walter, Nicole/0000-0003-0431-8078	NIAAA NIH HHS [F31AA13865, R01AA11114, R01AA06243, P50AA10760, P60 AA010760] Funding Source: Medline; NIDA NIH HHS [R01DA05228] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011114, R01AA006243, P50AA010760, P60AA010760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005228] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Buck K, 1999, MAMM GENOME, V10, P431, DOI 10.1007/s003359901018; Buck KJ, 1997, J NEUROSCI, V17, P3946; Fehr C, 2004, GENES BRAIN BEHAV, V3, P8, DOI 10.1111/j.1601-183X.2004.00035.x; Fehr C, 2002, J NEUROSCI, V22, P3730; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; METTEN P, 1994, BEHAV PHARMACOL, V5, P533, DOI 10.1097/00008877-199408000-00014; Metten P., 1996, PHARM TOXIC, P269; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Reich T, 1999, AM J HUM GENET, V65, P599, DOI 10.1086/302561; Shen KZ, 1997, J PHYSIOL-LONDON, V505, P153, DOI 10.1111/j.1469-7793.1997.153bc.x	12	103	106	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					699	700		10.1038/nn1271	http://dx.doi.org/10.1038/nn1271			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208631				2022-12-28	WOS:000222274400008
J	Li, W; Piech, V; Gilbert, CD				Li, W; Piech, V; Gilbert, CD			Perceptual learning and top-down influences in primary visual cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ORIENTATION DISCRIMINATION; RECEPTIVE-FIELD; VERNIER ACUITY; ATTENTION; V1; IMPROVEMENT; NEURONS; REPRESENTATION; MECHANISMS	Neuronal responses at early stages in visual cortical processing, including those in primary visual cortex (V1), are subject to the influences of visual context, experience and attention. Here we show that for monkeys trained in a shape discrimination task, V1 neurons took on novel functional properties related to the attributes of the trained shapes. Furthermore, these properties depended on the perceptual task being performed; neurons responded very differently to an identical visual stimulus under different visual discrimination tasks. These top-down influences were seen from the very beginning and throughout the entire time course of the neural responses. Information theoretic analysis showed that neurons carried more information about a stimulus attribute when the animals were performing a task related to that attribute. Our findings suggest that the output from V1 reflects both sensory and behavioral context.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu	Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; 	NEI NIH HHS [R01 EY007968, EY07968] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; FENDICK M, 1983, VISION RES, V23, P145, DOI 10.1016/0042-6989(83)90137-2; Finney DJ, 1952, PROBIT ANAL STAT TRE; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787	43	340	348	4	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					651	657		10.1038/nn1255	http://dx.doi.org/10.1038/nn1255			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156149	Green Accepted			2022-12-28	WOS:000221640300020
J	Osu, R; Hirai, S; Yoshioka, T; Kawato, M				Osu, R; Hirai, S; Yoshioka, T; Kawato, M			Random presentation enables subjects to adapt to two opposing forces on the hand	NATURE NEUROSCIENCE			English	Article							MOTOR WORKING-MEMORY; INTERNAL-MODELS; DISPLACEMENT; INTERFERENCE; ENVIRONMENT; IMPEDANCE; DYNAMICS	Studies have shown that humans cannot simultaneously learn opposing force fields or opposing visuomotor rotations, even when provided with arbitrary contextual information, probably because of interference in their working memory(1-6). In contrast, we found that subjects can adapt to two opposing force fields when provided with contextual cues and can consolidate motor memories if random and frequent switching occurs. Because significant aftereffects were seen, this study suggests that multiple internal models can be acquired simultaneously during learning and predictively switched, depending only on contextual information.	ATR Computat Neurosci Labs, Seika, Kyoto 6190288, Japan; Nara Inst Sci & Technol, Nara 6300101, Japan	Nara Institute of Science & Technology	Osu, R (corresponding author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Seika, Kyoto 6190288, Japan.	osu@atr.jp						Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; CUNNINGHAM HA, 1994, J EXP PSYCHOL HUMAN, V20, P987, DOI 10.1037/0096-1523.20.5.987; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KRAVITZ JH, 1972, PERCEPT PSYCHOPHYS, V12, P305, DOI 10.3758/BF03207210; SHADMEHR R, IN PRESS MOTOR CORTE; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4; WELCH RB, 1993, PERCEPT PSYCHOPHYS, V54, P195, DOI 10.3758/BF03211756; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	15	143	144	0	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					111	112		10.1038/nn1184	http://dx.doi.org/10.1038/nn1184			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14745452				2022-12-28	WOS:000188468500007
J	Laurent, P; Becker, JAJ; Valverde, O; Ledent, C; d'Exaerde, AD; Schiffmann, SN; Maldonado, R; Vassart, G; Parmentier, M				Laurent, P; Becker, JAJ; Valverde, O; Ledent, C; d'Exaerde, AD; Schiffmann, SN; Maldonado, R; Vassart, G; Parmentier, M			The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROPEPTIDE FF; MORPHINE-WITHDRAWAL; FOOD-INTAKE; PAIN; MECHANISMS; NOCICEPTIN; MICE; PHARMACOLOGY; TOLERANCE	Prolactin-releasing peptide (PrRP) and its receptor G protein - coupled receptor 10 (GPR10) are expressed in brain areas involved in the processing of nociceptive signals. We investigated the role of this new neuropeptidergic system in GPR10-knockout mice. These mice had higher nociceptive thresholds and stronger stress-induced analgesia than wild-type mice, differences that were suppressed by naloxone treatment. In addition, potentiation of morphine-induced antinociception and reduction of morphine tolerance were observed in mutants. Intracerebroventricular administration of PrRP in wild-type mice promoted hyperalgesia and reversed morphine-induced antinociception. PrRP administration had no effect on GPR10-mutant mice, showing that its effects are mediated by GPR10. Anti-opioid effects of neuropeptide FF were found to require a functional PrRP-GPR10 system. Finally, GPR10 deficiency enhanced the acquisition of morphine-induced conditioned place preference and decreased the severity of naloxone-precipitated morphine withdrawal syndrome. Altogether, our data identify the PrRP-GPR10 system as a new and potent negative modulator of the opioid system.	Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; Univ Pompeu Fabra, Fac Ciences Salut & Vida, Lab Neurofarmacol, Barcelona, Spain; Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium	Universite Libre de Bruxelles; Pompeu Fabra University; Universite Libre de Bruxelles	Parmentier, M (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,Route Lennik 808, Brussels, Belgium.	mparment@ulb.ac.be	Becker, Jerome/I-7879-2016; Maldonado, Rafael/F-5657-2014; de Kerchove d'Exaerde, Alban/R-6984-2019; Valverde, Olga/D-8654-2012; laurent, patrick/ABD-9373-2021	Becker, Jerome/0000-0002-0039-0067; Maldonado, Rafael/0000-0002-4359-8773; Valverde, Olga/0000-0003-2264-7852; laurent, patrick/0000-0001-5360-5597; Schiffmann, Serge/0000-0002-0118-9816; de Kerchove d'Exaerde, Alban/0000-0002-0682-5877; Parmentier, Marc/0000-0001-8081-4685				ALLARD M, 1995, J PHARMACOL EXP THER, V274, P577; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Kalliomaki ML, 2004, NEUROPHARMACOLOGY, V46, P412, DOI 10.1016/j.neuropharm.2003.09.021; King MA, 1997, NEUROSCI LETT, V223, P113, DOI 10.1016/S0304-3940(97)13414-0; Langmead CJ, 2000, BRIT J PHARMACOL, V131, P683, DOI 10.1038/sj.bjp.0703617; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Lawrence CB, 2000, NAT NEUROSCI, V3, P645, DOI 10.1038/76597; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P360, DOI 10.1210/en.143.2.360; Lin SHS, 2002, BRAIN RES, V952, P15, DOI 10.1016/S0006-8993(02)03183-9; MALIN DH, 1990, PEPTIDES, V11, P277, DOI 10.1016/0196-9781(90)90082-G; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Maruyama M, 1999, NEUROSCI LETT, V276, P193, DOI 10.1016/S0304-3940(99)00831-9; Maruyama M, 2001, ENDOCRINOLOGY, V142, P2032, DOI 10.1210/en.142.5.2032; Meunier Jean-Claude, 2003, Am J Pharmacogenomics, V3, P117, DOI 10.2165/00129785-200303020-00005; Mogil Jefrey S., 1996, Physiology and Behavior, V59, P123, DOI 10.1016/0031-9384(95)02073-X; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Murphy NP, 1999, BRAIN RES, V832, P168, DOI 10.1016/S0006-8993(99)01425-0; Noble F, 2003, DRUGS TODAY, V39, P897, DOI 10.1358/dot.2003.39.11.799467; Noble F, 1999, PROG NEUROBIOL, V58, P349, DOI 10.1016/S0301-0082(98)00090-2; NOBLE F, 1993, BRIT J PHARMACOL, V109, P1064, DOI 10.1111/j.1476-5381.1993.tb13730.x; PACAK K, 1993, HYPERTENSION, V22, P467, DOI 10.1161/01.HYP.22.4.467; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Passik SD, 2000, ADV THER, V17, P70, DOI 10.1007/BF02854840; Pommier B, 2002, J NEUROSCI, V22, P2005, DOI 10.1523/JNEUROSCI.22-05-02005.2002; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; SEMENOVA S, 1995, PHARMACOL BIOCHEM BE, V50, P17, DOI 10.1016/0091-3057(94)00221-4; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sundblom DM, 1999, PEPTIDES, V20, P319, DOI 10.1016/S0196-9781(99)00038-8; Ueda H, 2003, LIFE SCI, V74, P313, DOI 10.1016/j.lfs.2003.09.018; Ueda H, 1997, NEUROSCI LETT, V237, P136, DOI 10.1016/S0304-3940(97)00832-X; Ueda H, 2000, J NEUROSCI, V20, P7640	38	39	42	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1735	1741		10.1038/nn1585	http://dx.doi.org/10.1038/nn1585			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299503				2022-12-28	WOS:000233576200023
J	Rodriguez, J; Esteve, P; Weinl, C; Ruiz, JM; Fermin, Y; Trousse, F; Dwivedy, A; Holt, C; Bovolenta, P				Rodriguez, J; Esteve, P; Weinl, C; Ruiz, JM; Fermin, Y; Trousse, F; Dwivedy, A; Holt, C; Bovolenta, P			SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor	NATURE NEUROSCIENCE			English	Article							NEGATIVE FEEDBACK REGULATOR; WNT; PROTEIN; GUIDANCE; PATHWAY; MODULATION; EXPRESSION; GENES; DIFFERENTIATION; IDENTIFICATION	Axon growth is governed by the ability of growth cones to interpret attractive and repulsive guidance cues. Recent studies have shown that secreted signaling molecules known as morphogens can also act as axon guidance cues. Of the large family of Wnt signaling components, only Wnt4 and Wnt5 seem to participate directly in axon guidance. Here we show that secreted Frizzled-related protein 1 (SFRP1), a proposed Wnt signaling inhibitor, can directly modify and reorient the growth of chick and Xenopus laevis retinal ganglion cell axons. This activity does not require Wnt inhibition and is modulated by extracellular matrix molecules. Intracellularly, SFRP1 function requires G(alpha) protein activation, protein synthesis and degradation, and it is modulated by cyclic nucleotide levels. Because SFRP1 interacts with Frizzled-2 (Fz2) and interference with Fz2 expression abolishes growth cone responses to SFRP1, we propose a previously unknown function for this molecule: the ability to guide growth cone movement via the Fz2 receptor.	CSIC, Inst Cajal, Dept Neurobiol Desarrollo, E-28002 Madrid, Spain; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of Cambridge	Bovolenta, P (corresponding author), CSIC, Inst Cajal, Dept Neurobiol Desarrollo, Dr Arce 37, E-28002 Madrid, Spain.	bovolenta@cajal.csic.es		Holt, Christine Elizabeth/0000-0003-2829-121X; , francoise/0000-0002-6354-3331	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Chuman Y, 2004, PEPTIDES, V25, P1831, DOI 10.1016/j.peptides.2004.07.010; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Deiner MS, 1999, J NEUROSCI, V19, P9900; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Esteve P, 2000, MECH DEVELOP, V97, P217, DOI 10.1016/S0925-4773(00)00421-4; Esteve P, 2004, MECH DEVELOP, V121, P687, DOI 10.1016/j.mod.2004.03.003; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Irie A, 2002, DEVELOPMENT, V129, P61; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lim YS, 2002, J NEUROSCI, V22, P7080; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Morissette N, 1995, J NEUROSCI, V15, P8067; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trousse F, 2001, DEVELOPMENT, V128, P3927; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; van Horck FPG, 2004, CURR OPIN NEUROBIOL, V14, P61, DOI 10.1016/j.conb.2004.01.002; Wang HY, 2004, CELL MOL LIFE SCI, V61, P69, DOI 10.1007/s00018-003-3165-x; Wang YS, 2002, J NEUROSCI, V22, P8563; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	50	119	121	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1301	1309		10.1038/nn1547	http://dx.doi.org/10.1038/nn1547			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172602				2022-12-28	WOS:000232145900013
J	Wadiche, JI; Jahr, CE				Wadiche, JI; Jahr, CE			Patterned expression of Purkinje cell glutamate transporters controls synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; GATED CHLORIDE CHANNEL; KAINATE RECEPTORS; MICE LACKING; RAT-BRAIN; CURRENTS; EAAT4; CEREBELLUM; ACTIVATION	Glutamate transporters are responsible for clearing synaptically released glutamate from the extracellular space. If expressed at high enough densities, transporters can prevent activation of extrasynaptic receptors by rapidly lowering glutamate concentrations to insignificant levels. We find that synaptic activation of metabotropic glutamate receptors expressed by Purkinje cells is prevented in regions of rat cerebellum where the density of the glutamate transporter EAAT4 is high. The consequences of metabotropic receptor stimulation, including activation of a depolarizing conductance, cannabinoid-mediated presynaptic inhibition and long-term depression, are also limited in Purkinje cells expressing high levels of EAAT4. We conclude that neuronal uptake sites must be overwhelmed by glutamate to activate perisynaptic metabotropic glutamate receptors. Regional differences in glutamate transporter expression affect the degree of metabotropic glutamate receptor activation and therefore regulate synaptic plasticity.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	jahr@ohsu.edu		Wadiche, Jacques/0000-0001-8180-2061	NINDS NIH HHS [NS40056] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040056, R01NS040056] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CASADO M, 1993, J BIOL CHEM, V268, P27313; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dzubay JA, 1999, J NEUROSCI, V19, P5265; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jinno S, 2003, J COMP NEUROL, V458, P412, DOI 10.1002/cne.10585; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Ozol K, 1999, J COMP NEUROL, V412, P95; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Welsh JP, 2002, ADV NEUROL, V89, P331	46	157	159	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1329	1334		10.1038/nn1539	http://dx.doi.org/10.1038/nn1539			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136036				2022-12-28	WOS:000232145900016
J	Di Marzo, V; Matias, I				Di Marzo, V; Matias, I			Endocannabinoid control of food intake and energy balance	NATURE NEUROSCIENCE			English	Review							CB1 RECEPTOR ANTAGONIST; MESSENGER-RNA EXPRESSION; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; SELECTIVE ANTAGONIST; BODY-WEIGHT; BRAIN; ANANDAMIDE; SR141716; DIET	Marijuana and its major psychotropic component, Delta(9)-tetrahydrocannabinol, stimulate appetite and increase body weight in wasting syndromes, suggesting that the CB1 cannabinoid receptor and its endogenous ligands, the endocannabinoids, are involved in controlling energy balance. The endocannabinoid system controls food intake via both central and peripheral mechanisms, and it may also stimulate lipogenesis and fat accumulation. Here we discuss the multifaceted regulation of energy homeostasis by endocannabinoids, together with its applications to the treatment of eating disorders and metabolic syndromes.	CNR, Endocannnabinoid Res Grp, Inst Biomol Chem, I-80078 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR)	Di Marzo, V (corresponding author), CNR, Endocannnabinoid Res Grp, Inst Biomol Chem, Via Campi Flegrei 34, I-80078 Naples, Italy.	vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070				Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Black Shawn C, 2004, Curr Opin Investig Drugs, V5, P389; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Carai MAM, 2004, EUR J PHARMACOL, V494, P221, DOI 10.1016/j.ejphar.2004.05.005; Chambers AP, 2004, PHYSIOL BEHAV, V82, P863, DOI [10.1016/S0031-9384(04)00302-6, 10.1016/j.physbeh.2004.07.004]; Chen RZ, 2004, BRAIN RES, V999, P227, DOI 10.1016/j.brainres.2003.12.004; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di S, 2003, J NEUROSCI, V23, P4850; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Duarte C, 2004, NEUROPSYCHOPHARMACOL, V29, P911, DOI 10.1038/sj.npp.1300370; Fride E, 2004, EUR J PHARMACOL, V500, P289, DOI 10.1016/j.ejphar.2004.07.033; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GOMEZOCANA J, 1912, ARXIUS I CIENCES, V1, P22; Hanus L, 2003, BRAIN RES, V983, P144, DOI 10.1016/S0006-8993(03)03046-4; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; Higgs S, 2003, PSYCHOPHARMACOLOGY, V165, P370, DOI 10.1007/s00213-002-1263-3; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; Horvath TL, 2003, J CLIN INVEST, V112, P323, DOI [10.1172/JCI19376, 10.1172/JCI200319376]; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kirkham TC, 2001, PSYCHOPHARMACOLOGY, V153, P267, DOI 10.1007/s002130000596; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; Matias I, 2003, CELL MOL LIFE SCI, V60, P382, DOI 10.1007/s000180300031; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MONTELEONE P, IN PRESS NEUROPSYCHO; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; OSEIHYIAMAN D, IN PRESS J CLIN INVE; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rinaldi-Carmona M, 2004, J PHARMACOL EXP THER, V310, P905, DOI 10.1124/jpet.104.067884; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rowland NE, 2001, PSYCHOPHARMACOLOGY, V159, P111, DOI 10.1007/s002130100910; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; THORNTONJONES ZD, 2005, PSYCHOPHARMACOLO JAN, DOI DOI 10.1007/S00213-004-2047-8; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Verty ANA, 2004, BRAIN RES, V1020, P188, DOI 10.1016/j.brainres.2004.06.033; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Verty ANA, 2003, PSYCHOPHARMACOLOGY, V168, P314, DOI 10.1007/s00213-003-1451-9; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Werner NA, 2003, BRAIN RES, V967, P290, DOI 10.1016/S0006-8993(02)04274-9; Williams CM, 1998, PHYSIOL BEHAV, V65, P343, DOI 10.1016/S0031-9384(98)00170-X; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143	65	570	586	0	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					585	589		10.1038/nn1457	http://dx.doi.org/10.1038/nn1457			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856067				2022-12-28	WOS:000228895100017
J	Hanchar, HJ; Dodson, PD; Olsen, RW; Otis, TS; Wallner, M				Hanchar, HJ; Dodson, PD; Olsen, RW; Otis, TS; Wallner, M			Alcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activity	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; TONIC INHIBITION; SUBUNIT GENE; NEURONAL EXCITABILITY; HIPPOCAMPAL-NEURONS; A RECEPTORS; RAT BRAIN; ETHANOL; EXPRESSION; MICE	Neuronal mechanisms underlying alcohol intoxication are unclear. We find that alcohol impairs motor coordination by enhancing tonic inhibition mediated by a specific subtype of extrasynaptic GABA(A) receptor (GABAR), alpha6beta3delta, expressed exclusively in cerebellar granule cells. In recombinant studies, we characterize a naturally occurring single-nucleotide polymorphism that causes a single amino acid change (R100Q) in alpha6 (encoded in rats by the Gabra6 gene). We show that this change selectively increases alcohol sensitivity of alpha6beta3delta GABARs. Behavioral and electrophysiological comparisons of Gabra6(100R/100R) and Gabra6(100Q/100Q) rats strongly suggest that alcohol impairs motor coordination by enhancing granule cell tonic inhibition. These findings identify extrasynaptic GABARs as critical targets underlying low-dose alcohol intoxication and demonstrate that subtle changes in tonic inhibition in one class of neurons can alter behavior.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Otis, TS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	otist@ucla.edu	Wallner, Martin/B-8322-2009	Wallner, Martin/0000-0003-4134-8946; Dodson, Paul/0000-0003-0858-6088	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA015460, R37AA007680, R01AA007680] Funding Source: NIH RePORTER; NIAAA NIH HHS [R37 AA007680-16, AA07680, R01 AA007680, AA015460, R37 AA007680, F31 AA015460, F31 AA015460-02] Funding Source: Medline; NINDS NIH HHS [NS41651, P01 NS035985-090004, P01 NS035985, P01 NS035985-05, NS35985] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Campos ML, 2001, NEUROSCIENCE, V102, P625, DOI 10.1016/S0306-4522(00)00525-X; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; FARRANT M, 1993, NATURE, V361, P302, DOI 10.1038/361302a0; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Jones A, 1997, J NEUROSCI, V17, P1350; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; KORPI ER, 1992, ALCOHOL, V9, P225, DOI 10.1016/0741-8329(92)90058-I; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mohler H, 2001, Curr Opin Pharmacol, V1, P22, DOI 10.1016/S1471-4892(01)00008-X; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Radcliffe RA, 2004, BEHAV GENET, V34, P453, DOI 10.1023/B:BEGE.0000023650.32243.39; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saba L, 2001, MOL BRAIN RES, V87, P263, DOI 10.1016/S0169-328X(01)00003-1; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundram FX, 2002, WORLD J NUCL MED, V1, P5; SUZDAK PD, 1986, SCIENCE, V234, P1243, DOI 10.1126/science.3022383; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; Vallee BL, 1998, SCI AM, V278, P80, DOI 10.1038/scientificamerican0698-80; Vekovischeva OY, 1999, BRAIN RES, V837, P184, DOI 10.1016/S0006-8993(99)01691-1; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7	48	236	241	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					339	345		10.1038/nn1398	http://dx.doi.org/10.1038/nn1398			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696164	Green Accepted			2022-12-28	WOS:000227354600019
J	Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C				Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C			Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter	NATURE NEUROSCIENCE			English	Article							POLYMORPHISM; PROJECTIONS; STIMULI	Major depression is conditionally linked to a polymorphism of the human serotonin transporter gene (SLC6A4). During the presentation of aversive, but not pleasant, pictures, healthy carriers of the SLC6A4 short (s) allele showed stronger activation of the amygdala on functional magnetic resonance imaging. s carriers also showed greater coupling between the amygdala and the ventromedial prefrontal cortex, which may contribute to the abnormally high activity in the amygdala and medial prefrontal cortex seen in major depression.	Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; Univ Med Ctr, Dept Psychiat, NeuroImage Nord, D-20246 Hamburg, Germany; Cent Inst Mental Hlth, D-68159 Mannheim, Germany; Charite Univ Med Berlin, Dept Med Psychol, D-10117 Berlin, Germany; Univ Med Ctr, Dept Neurol, NeuroImage Nord, D-20246 Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heinz, A (corresponding author), Charite Univ Med Berlin, Dept Psychiat, Campus Charite Mitte,Schumannstr 20-21, D-10117 Berlin, Germany.	andreas.heinz@charite.de	anand, amit/A-7222-2009; Heinz, Andreas/ABB-7736-2020; Smolka, Michael/B-4865-2011; Vollstädt-Klein, Sabine/C-6744-2012; Schumann, Gunter/H-1013-2013	Heinz, Andreas/0000-0001-5405-9065; Smolka, Michael/0000-0001-5398-5569; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Flor, Herta/0000-0003-4809-5398; Hermann, Derik/0000-0003-4434-1221				AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Irwin W, 2004, NEUROIMAGE, V21, P674, DOI 10.1016/j.neuroimage.2003.09.057; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; *NAT I MENT HLTH C, 1999, PHOT SLID; Pinto AO, 2003, ANN NY ACAD SCI, V985, P542; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3	14	554	573	0	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					20	21		10.1038/nn1366	http://dx.doi.org/10.1038/nn1366			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592465				2022-12-28	WOS:000225967600009
J	Nadler, JW; DeAngelis, GC				Nadler, JW; DeAngelis, GC			Precision pooling predicts primate perceptual performance	NATURE NEUROSCIENCE			English	Editorial Material							AREA-MT; VISUAL-MOTION; NEURONS; CHOICE; RESPONSES; MACAQUE; MONKEY		Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nadler, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	nadlerj@msnotes.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; GREEN DM, 1966, SIGNAL DETECTION THE; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2	14	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					12	13		10.1038/nn0105-12	http://dx.doi.org/10.1038/nn0105-12			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15622412				2022-12-28	WOS:000225967600006
J	McPeek, RM; Keller, EL				McPeek, RM; Keller, EL			Deficits in saccade target selection after inactivation of superior colliculus	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LATERAL INTRAPARIETAL AREA; REVERSIBLE INACTIVATION; EYE-MOVEMENTS; NEURONAL-ACTIVITY; MONKEY; FIELD; DISCRIMINATION; INVOLVEMENT; GENERATION	Saccades are rapid eye movements that orient gaze toward areas of interest in the visual scene. Neural activity correlated with saccade target selection has been identified in several brain regions, including the superior colliculus (SC), but it is not known whether the SC is directly involved in target selection, or whether the SC merely receives selection-related signals from cortex in preparation for the execution of eye movements. In monkeys, we used focal reversible inactivation to test the functional contributions of the SC to target selection during visual search, and found that inactivation resulted in clear deficits. When a target appeared in the inactivated field, saccades were often misdirected to distractor stimuli. Control tasks showed that this deficit was not caused by low-level visual or motor impairments. Our results indicate that, in addition to its well-established involvement in movement execution, the SC has an important functional role in target selection.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	The Smith-Kettlewell Eye Research Institute	McPeek, RM (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.	rmm@ski.org			NATIONAL EYE INSTITUTE [R01EY014885] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY08060, R01 EY014885-01, R01-EY014885, R01 EY014885] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266, DOI 10.1152/jn.1994.71.3.1266; Chen LTL, 2001, J NEUROSCI METH, V107, P81, DOI 10.1016/S0165-0270(01)00354-5; Chimoto S, 1996, J NEUROPHYSIOL, V75, P2658, DOI 10.1152/jn.1996.75.6.2658; Chou IH, 1999, VISION RES, V39, P4200, DOI 10.1016/S0042-6989(99)00133-9; Clark JJ, 1999, VISION RES, V39, P585, DOI 10.1016/S0042-6989(98)00190-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Green DM, 1966, SIGNAL DETECTION THE; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; HIKOSAKA O, 1986, EXP BRAIN RES, V61, P531; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Miyashita N, 1996, EXP BRAIN RES, V112, P187; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; Olson CR, 2000, J NEUROPHYSIOL, V84, P1369, DOI 10.1152/jn.2000.84.3.1369; OTTES FP, 1987, EXP BRAIN RES, V66, P465, DOI 10.1007/BF00270679; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Port NL, 2003, J NEUROPHYSIOL, V90, P1887, DOI 10.1152/jn.01151.2002; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RAYBOURN MS, 1977, J NEUROPHYSIOL, V40, P861, DOI 10.1152/jn.1977.40.4.861; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schiller PH, 2003, EUR J NEUROSCI, V18, P3127, DOI 10.1111/j.1460-9568.2003.03036.x; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SOLOMON SJ, 1981, EXP BRAIN RES, V44, P259; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPARKS DL, 1990, COLD SH Q B, V55, P805; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; VETTER RJ, 1975, INT J NEUROSCI, V6, P215, DOI 10.3109/00207457509149495; Wardak C, 2002, J NEUROSCI, V22, P9877; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; WURTZ RH, 1980, PROGR PSYCHOBIOLOGY, V9, P43	44	240	244	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					757	763		10.1038/nn1269	http://dx.doi.org/10.1038/nn1269			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195099				2022-12-28	WOS:000222274400018
J	Corfas, G; Roy, K; Buxbaum, J				Corfas, G; Roy, K; Buxbaum, J			Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER; PREFRONTAL CORTEX; OLIGODENDROCYTE DEVELOPMENT; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GABAERGIC INTERNEURONS; PSYCHIATRIC-DISORDERS; SELECTIVE ALTERATIONS; INTERSTITIAL NEURONS; NICOTINIC RECEPTORS	Schizophrenia is a devastating psychiatric disease that affects 0.5-1% of the world's adult population. The hypothesis that this disease is a developmental disorder of the nervous system with late onset of its characteristic symptoms has been gaining acceptance in past years. However, the anatomical, cellular and molecular bases of schizophrenia remain unclear. Numerous studies point to alterations in different aspects of brain development as possible causes of schizophrenia, including defects in neuronal migration, neurotransmitter receptor expression and myelination. Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients, suggesting that NRG1-erbB signaling is involved in the pathogenesis of schizophrenia. These findings open new approaches to defining the molecular and cellular basis of schizophrenia in more mechanistic terms.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Corfas, G (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@tch.harvard.edu	Corfas, Gabriel/AAH-2378-2020; Buxbaum, Joseph D/G-6001-2010	Corfas, Gabriel/0000-0001-5412-9473; Buxbaum, Joseph/0000-0001-8898-8313	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH066392] Funding Source: Medline; NINDS NIH HHS [R01 NS35884] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Akbarian S, 1996, J NEUROSCI, V16, P19; Anton ES, 1997, DEVELOPMENT, V124, P3501; Arnold SE, 1996, ACTA NEUROPATHOL, V92, P217, DOI 10.1007/s004010050512; Bartzokis G, 2003, BIOL PSYCHIAT, V53, P412, DOI 10.1016/S0006-3223(02)01835-8; Bartzokis G, 2002, NEUROPSYCHOPHARMACOL, V27, P672, DOI 10.1016/S0893-133X(02)00364-0; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Blum BP, 2002, INT J NEUROPSYCHOPH, V5, P159, DOI 10.1017/S1461145702002894; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Cannella B, 1999, J NEUROIMMUNOL, V100, P233, DOI 10.1016/S0165-5728(99)00201-5; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P1084, DOI 10.1001/archpsyc.55.12.1084; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fernandez PA, 2000, NEURON, V28, P81, DOI 10.1016/S0896-6273(00)00087-8; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Foong J, 2002, NEUROREPORT, V13, P333, DOI 10.1097/00001756-200203040-00017; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; HASHIMOTO R, 2003, MOL PSYCHIATR, V21, P21; Hof PR, 2003, BIOL PSYCHIAT, V53, P1075, DOI 10.1016/S0006-3223(03)00237-3; Hof PR, 2002, NEUROCHEM RES, V27, P1193, DOI 10.1023/A:1020981510759; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Iwata N, 2004, MOL PSYCHIATR, V9, P126, DOI 10.1038/sj.mp.4001456; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moises HW, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-8; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Prevot V, 2003, J NEUROSCI, V23, P230; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Rioux L, 2003, AM J PSYCHIAT, V160, P149, DOI 10.1176/appi.ajp.160.1.149; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Sklar P, 2002, ANNU REV GENOM HUM G, V3, P371, DOI 10.1146/annurev.genom.3.022502.103141; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; Tang JX, 2004, MOL PSYCHIATR, V9, P11, DOI 10.1038/sj.mp.4001436; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tsuang MT, 2001, BRIT J PSYCHIAT, V178, pS18, DOI 10.1192/bjp.178.40.s18; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Walker E, 2002, SCHIZOPHR RES, V54, P17, DOI 10.1016/S0920-9964(01)00347-4; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zavitsanou K, 2002, NEUROPSYCHOPHARMACOL, V27, P826, DOI 10.1016/S0893-133X(02)00347-0	65	314	332	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					575	580		10.1038/nn1258	http://dx.doi.org/10.1038/nn1258			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15162166				2022-12-28	WOS:000221640300007
J	Ito, R; Robbins, TW; Everitt, BJ				Ito, R; Robbins, TW; Everitt, BJ			Differential control over cocaine-seeking behavior by nucleus accumbens core and shell	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; KAINIC ACID LESIONS; EXCITOTOXIC LESIONS; EXTRACELLULAR DOPAMINE; BASOLATERAL AMYGDALA; INTRAVENOUS COCAINE; 2ND-ORDER SCHEDULE; CONDITIONED REINFORCEMENT; LOCOMOTOR-ACTIVITY; VENTRAL STRIATUM	Nucleus accumbens (NAc) dopamine is widely implicated in mediating the reinforcing effects of drugs of abuse. However, the precise function of the NAc itself in drug self-administration has been difficult to establish. Here we show a neural double-dissociation of the behavioral processes that underlie cocaine self-administration in rats. Whereas selective excitotoxic lesions of the NAc core had only a minor effect on the acquisition of responding for cocaine under a standard schedule of continuous reinforcement, these lesions profoundly impaired the acquisition of drug-seeking behavior that was maintained by drug-associated conditioned reinforcers and assessed using a second-order schedule of cocaine reinforcement. In contrast, selective excitotoxic lesions of the NAc shell did not impair drug self-administration or the acquisition of cocaine-seeking, but they did attenuate the psychostimulant effects of cocaine. These results further our understanding of how the NAc controls drug-seeking and drug-taking behavior.	Univ Cambridge, Dept Expt Psychol, Cambridge CB1 1BB, England	University of Cambridge	Everitt, BJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB1 1BB, England.	bje10@cam.ac.uk	Robbins, Trevor W/A-7551-2008; Ito, Rutsuko/E-7296-2013	Ito, Rutsuko/0000-0003-1769-5470; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderson HL, 2001, PSYCHOPHARMACOLOGY, V153, P455, DOI 10.1007/s002130000634; ANNETT LE, 1989, BEHAV BRAIN RES, V31, P231, DOI 10.1016/0166-4328(89)90005-3; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; CAINE SB, 1995, BRAIN RES, V692, P47; CAINE SB, 1992, BEHAV NEUROSCIENCE P, V2, P117; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Dalley JW, 2002, PSYCHOPHARMACOLOGY, V161, P425, DOI 10.1007/s00213-002-1078-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICHIARA G, 1993, PSYCHOPHARMACOLOGY, V112, P398, DOI 10.1007/BF02244939; DWORKIN SI, 1988, PHARMACOL BIOCHEM BE, V29, P175, DOI 10.1016/0091-3057(88)90292-4; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Haber SN, 2000, J NEUROSCI, V20, P2369; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; HURD YL, 1989, BRAIN RES, V498, P199, DOI 10.1016/0006-8993(89)90422-8; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Ito R, 2000, J NEUROSCI, V20, P7489; MALDONADOIRIZARRY CS, 1995, BRAIN RES BULL, V38, P551, DOI 10.1016/0361-9230(95)02030-2; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PULVIRENTI L, 1992, BRAIN RES, V594, P327, DOI 10.1016/0006-8993(92)91145-5; READING PJ, 1991, BEHAV BRAIN RES, V46, P17, DOI 10.1016/S0166-4328(05)80093-2; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBLEDO P, 1992, ANN NY ACAD SCI, V654, P509, DOI 10.1111/j.1749-6632.1992.tb26015.x; Rodd-Henricks ZA, 2002, J PHARMACOL EXP THER, V303, P1216, DOI 10.1124/jpet.102.038950; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; VOORN P, 1989, J COMP NEUROL, V289, P189, DOI 10.1002/cne.902890202; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wyvell CL, 2000, J NEUROSCI, V20, P8122; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	49	362	372	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					389	397		10.1038/nn1217	http://dx.doi.org/10.1038/nn1217			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034590				2022-12-28	WOS:000220482500018
J	Carrasco, M; Ling, S; Read, S				Carrasco, M; Ling, S; Read, S			Attention alters appearance	NATURE NEUROSCIENCE			English	Article							COVERT ATTENTION; CONTRAST; SENSITIVITY; BRIGHTNESS	Does attention alter appearance? This critical issue, debated for over a century, remains unsettled. From psychophysical evidence that covert attention affects early vision-it enhances contrast sensitivity and spatial resolution- and from neurophysiological evidence that attention increases the neuronal contrast sensitivity (contrast gain), one could infer that attention changes stimulus appearance. Surprisingly, few studies have directly investigated this issue. Here we developed a psychophysical method to directly assess the phenomenological correlates of attention in humans. We show that attention alters appearance; it boosts the apparent stimulus contrast. These behavioral results are consistent with neurophysiological findings suggesting that attention changes the strength of a stimulus by increasing its 'effective contrast' or salience.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Dept Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu			NEI NIH HHS [R01 EY016200] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baldassi S, 2000, VISION RES, V40, P1293, DOI 10.1016/S0042-6989(00)00029-8; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; CARRASCO M, IN PRESS VISION RES; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Helmholtz H., 1866, TREATISE PHYSL OPTIC, V2; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MACKEBEN M, 1993, VISION RES, V33, P85, DOI 10.1016/0042-6989(93)90061-Z; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mood A. M., 1974, INTRO THEORY STAT, P440; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pashler HE, 1998, PSYCHOL ATTENTION; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Princ FG, 1998, J PINEAL RES, V24, P1, DOI 10.1111/j.1600-079X.1998.tb00359.x; Prinzmetal W, 1997, CONSCIOUS COGN, V6, P372, DOI 10.1006/ccog.1997.0313; PRINZMETAL W, 1986, J EXP PSYCHOL HUMAN, V12, P361, DOI 10.1037/0096-1523.12.3.361; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; TALGAR C, 2004, J VIS, V41, P23; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TSAL Y, 1994, Q J EXP PSYCHOL-A, V47, P865, DOI 10.1080/14640749408401100; von Helmholtz H., 1866, TREATISE PHYSL OPTIC, VIII; Yeshurun Y, 2000, NAT NEUROSCI, V3, P622, DOI 10.1038/75804; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	46	667	673	17	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					308	313		10.1038/nn1194	http://dx.doi.org/10.1038/nn1194			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	777UU	14966522	Green Accepted			2022-12-28	WOS:000189197900022
J	Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD				Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD			Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage	NATURE NEUROSCIENCE			English	Article							ANTERIOR MEDULLARY VELUM; DORSAL SPINAL-CORD; SONIC-HEDGEHOG; NEURAL-TUBE; CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; BASAL FOREBRAIN; PRECURSOR CELLS; TRANSGENIC MICE	The developmental origin of oligodendrocyte progenitors ( OLPs) in the forebrain has been controversial. We now show, by Cre-lox fate mapping in transgenic mice, that the first OLPs originate in the medial ganglionic eminence ( MGE) and anterior entopeduncular area ( AEP) in the ventral forebrain. From there, they populate the entire embryonic telencephalon including the cerebral cortex before being joined by a second wave of OLPs from the lateral and/or caudal ganglionic eminences ( LGE and CGE). Finally, a third wave arises within the postnatal cortex. When any one population is destroyed at source by the targeted expression of diphtheria toxin, the remaining cells take over and the mice survive and behave normally, with a normal complement of oligodendrocytes and myelin. Thus, functionally redundant populations of OLPs compete for space in the developing brain. Notably, the embryonic MGE- and AEP-derived population is eliminated during postnatal life, raising questions about the nature and purpose of the competition.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of London; University College London; University of London; University College London; University of Erlangen Nuremberg	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	n.tekki-kessaris@ucl.ac.uk; w.richardson@ucl.ac.uk	Kessaris, Nicoletta/C-7249-2008; Messier, Claude/A-2322-2008; Richardson, William/C-1762-2008; Kessaris, Nicoletta/AAD-6774-2019	Kessaris, Nicoletta/0000-0003-1191-6009; Messier, Claude/0000-0002-4791-1763; Richardson, William/0000-0001-7261-2485; Kessaris, Nicoletta/0000-0003-1191-6009; Wegner, Michael/0000-0002-4586-3294	MRC [G9708005, G0501173] Funding Source: UKRI; Medical Research Council [G9708005, G0800575, G0501173] Funding Source: Medline; Wellcome Trust [066745] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BUTT AM, 1995, GLIA, V14, P185, DOI 10.1002/glia.440140304; Butt AM, 1997, J NEUROCYTOL, V26, P327, DOI 10.1023/A:1018556702353; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, DEVELOPMENT, V105, P595; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2002, J NEUROSCI, V22, P9821; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Orentas DM, 1999, DEVELOPMENT, V126, P2419; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2001, DEVELOPMENT, V128, P4993; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	747	758	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					173	179		10.1038/nn1620	http://dx.doi.org/10.1038/nn1620			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388308	Green Accepted			2022-12-28	WOS:000234990100011
J	Duff, MC; Hengst, J; Tranel, D; Cohen, NJ				Duff, MC; Hengst, J; Tranel, D; Cohen, NJ			Development of shared information in communication despite hippocampal amnesia	NATURE NEUROSCIENCE			English	Article							RELATIONAL MEMORY; SYSTEM; HM; REPRESENTATIONS; NEOCORTEX; DEFICITS; BINDING; RECALL	This study investigated the ability of individuals with amnesia to acquire referential labels across a series of collaborative, dynamic interactions with a communication partner. Despite their inability to learn arbitrary relations in paired-associate learning, the amnesic patients showed remarkably robust collaborative learning across trials, at a rate equal to that of normal comparison subjects. The amnesic participants' learning resulted in their arriving at labels for a set of abstract shapes (tangrams), thus facilitating rapid and efficient communication. The labels generated and used by the amnesics during interactions with their partners became simpler across trials, with most labels stabilizing long before the end of training and then being used consistently throughout; moreover, they endured long after the task had ended. These findings have important implications for understanding the memory systems involved in semantic learning and in acquiring shared knowledge ('common ground') among communication partners, and the nature of hippocampal-dependent versus hippocampal-independent learning.	Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Cohen, NJ (corresponding author), Univ Illinois, Beckman Inst, 405 N Mathews Ave, Urbana, IL 61801 USA.	njc@uiuc.edu		Tranel, Daniel/0000-0002-1338-1389				ALLEN JS, IN PRESS J CLIN EXP; Bayley PJ, 2002, J NEUROSCI, V22, P5741; Clark H.H., 1992, ARENAS LANGUAGE USE; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; COHEN NJ, 2003, LEARNING MEMORY; COHEN NJ, 1997, THEORIES ORGANIC AMN, P131; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum HE, 2001, CONDITIONING CONSCIO; ELFFERS J, 1997, TANGRAM 1600 ANCIENT; GABRIELI JDE, 1988, BRAIN COGNITION, V7, P157, DOI 10.1016/0278-2626(88)90027-9; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Hengst JA, 2003, J SPEECH LANG HEAR R, V46, P831, DOI 10.1044/1092-4388(2003/065); KOVNER R, 1983, J CLIN NEUROPSYCHOL, V5, P65, DOI 10.1080/01688638308401151; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; MacKay DG, 2001, LANG COGNITIVE PROC, V16, P419, DOI 10.1080/01690960042000102; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; O'Kane G, 2004, HIPPOCAMPUS, V14, P417, DOI 10.1002/hipo.20005; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Skotko BG, 2004, NEUROPSYCHOLOGY, V18, P756, DOI 10.1037/0894-4105.18.4.756; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TEYLER TJ, 1985, NEUROSCI BIOBEHAV R, V9, P377, DOI 10.1016/0149-7634(85)90016-8; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; Wilson B.A., 1995, Broken Memories: Case studies in Memory Impairment, P14	34	88	91	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					140	146		10.1038/nn1601	http://dx.doi.org/10.1038/nn1601			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	997ZQ	16341214				2022-12-28	WOS:000234288000028
J	Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB				Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB			Molecular taxonomy of major neuronal classes in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GABAERGIC INTERNEURONS; TRANSGENIC MICE; VISUAL-CORTEX; MESSENGER-RNA; DLX GENES; EXPRESSION; NEOCORTEX; PROTEIN; SUBTYPES	Identifying the neuronal cell types that comprise the mammalian forebrain is a central unsolved problem in neuroscience. Global gene expression profiles offer a potentially unbiased way to assess functional relationships between neurons. Here, we carried out microarray analysis of 12 populations of neurons in the adult mouse forebrain. Five of these populations were chosen from cingulate cortex and included several subtypes of GABAergic interneurons and pyramidal neurons. The remaining seven were derived from the somatosensory cortex, hippocampus, amygdala and thalamus. Using these expression profiles, we were able to construct a taxonomic tree that reflected the expected major relationships between these populations, such as the distinction between cortical interneurons and projection neurons. The taxonomic tree indicated highly heterogeneous gene expression even within a single region. This dataset should be useful for the classification of unknown neuronal subtypes, the investigation of specifically expressed genes and the genetic manipulation of specific neuronal circuit elements.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Brandeis University; Brandeis University; Cold Spring Harbor Laboratory	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Huang, Z. Josh/0000-0003-0592-028X	NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gewin V, 2005, PLOS BIOL, V3, P13, DOI 10.1371/journal.pbio.0030024; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jongen-Relo AL, 2000, J NEUROSCI METH, V101, P9, DOI 10.1016/S0165-0270(00)00240-5; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mott DD, 2003, TRENDS NEUROSCI, V26, P484, DOI 10.1016/S0166-2236(03)00200-5; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	50	421	426	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					99	107		10.1038/nn1618	http://dx.doi.org/10.1038/nn1618			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369481				2022-12-28	WOS:000234288000023
J	Kao, YC; Davis, ES; Gabrieli, JDE				Kao, YC; Davis, ES; Gabrieli, JDE			Neural correlates of actual and predicted memory formation	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; SUBSEQUENT MEMORY; TIME ALLOCATION; FRONTAL-CORTEX; BRAIN ACTIVITY; JUDGMENTS; RETRIEVAL; ACCURACY; LESIONS	We aimed to discover the neural correlates of subjective judgments of learning - whereby participants judge whether current experiences will be subsequently remembered or forgotten - and to compare these correlates to the neural correlates of actual memory formation. During event-related functional magnetic resonance imaging, participants viewed 350 scenes and predicted whether they would remember each scene in a later recognition-memory test. Activations in the medial temporal lobe were associated with actual encoding success ( greater activation for objectively remembered than forgotten scenes), but not with predicted encoding success (activations did not differ for scenes predicted to be remembered versus forgotten). Conversely, activations in the ventromedial prefrontal cortex were associated with predicted but not actual encoding success, and correlated with individual differences in the accuracy of judgments of learning. Activations in the lateral and dorsomedial prefrontal cortex were associated with both actual and predicted encoding success. These findings indicate specific dissociations and associations between the neural systems that mediate actual and predicted memory formation.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Kao, YC (corresponding author), Stanford Univ, Dept Psychol, 420 Jordan Hall, Stanford, CA 94305 USA.	ykao@psych.stanford.edu	Gabrieli, John/AAJ-2869-2020		NIMH NIH HHS [MH59940, MH073234] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940, F31MH073234] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Benjamin AS, 1998, J EXP PSYCHOL GEN, V127, P55, DOI 10.1037/0096-3445.127.1.55; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Chua EF, 2004, J COGNITIVE NEUROSCI, V16, P1131, DOI 10.1162/0898929041920568; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Dunlosky J, 2003, PSYCHOL AGING, V18, P340, DOI 10.1037/0882-7974.18.2.340; Dunlosky J, 1998, EXP CLIN PSYCHOPHARM, V6, P77, DOI 10.1037/1064-1297.6.1.77; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gomez-Beldarrain M, 2004, J COGNITIVE NEUROSCI, V16, P74, DOI 10.1162/089892904322755575; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hertzog C, 2003, J EXP PSYCHOL LEARN, V29, P22, DOI 10.1037/0278-7393.29.1.22; Izaute M, 2005, NEUROPSYCHOPHARMACOL, V30, P196, DOI 10.1038/sj.npp.1300564; Kelemen WL, 2000, MEM COGNITION, V28, P92, DOI 10.3758/BF03211579; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; KING JF, 1980, AM J PSYCHOL, V93, P329, DOI 10.2307/1422236; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; MAKI RH, 1984, J EXP PSYCHOL LEARN, V10, P663, DOI 10.1037/0278-7393.10.4.663; Maril A, 2003, NEUROIMAGE, V18, P827, DOI 10.1016/S1053-8119(03)00014-4; MAZZONI G, 1993, J EXP PSYCHOL GEN, V122, P47, DOI 10.1037/0096-3445.122.1.47; Moscovitch M., 2002, PRINCIPLES FRONTAL L, P188, DOI [10.1093/acprof:oso/9780195134971.003.0012, DOI 10.1093/ACPROF:OSO/9780195134971.003.0012]; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Nelson TO., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Reber PJ, 2002, J NEUROSCI, V22, P9541; SCHACTER DL, 1985, CAN J PSYCHOL, V39, P467, DOI 10.1037/h0080074; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; STERN CE, 1996, P NATL ACAD SCI USA, V93, P8600; Thiede KW, 2003, J EDUC PSYCHOL, V95, P66, DOI 10.1037/0022-0663.95.1.66; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler ME, 2003, J NEUROSCI, V23, P3869	43	78	81	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1776	1783		10.1038/nn1595	http://dx.doi.org/10.1038/nn1595			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	988FC	16286927				2022-12-28	WOS:000233576200028
J	Bengtsson, SL; Nagy, Z; Skare, S; Forsman, L; Forssberg, H; Ullen, F				Bengtsson, SL; Nagy, Z; Skare, S; Forsman, L; Forssberg, H; Ullen, F			Extensive piano practicing has regionally specific effects on white matter development	NATURE NEUROSCIENCE			English	Article							CORPUS-CALLOSUM; BRAIN; ADOLESCENTS; MATURATION; CHILDHOOD; CHILDREN; MRI	Using diffusion tensor imaging, we investigated effects of piano practicing in childhood, adolescence and adulthood on white matter, and found positive correlations between practicing and fiber tract organization in different regions for each age period. For childhood, practicing correlations were extensive and included the pyramidal tract, which was more structured in pianists than in non-musicians. Long-term training within critical developmental periods may thus induce regionally specific plasticity in myelinating tracts.	Karolinska Inst, Dept Woman & Child Hlth, SE-17177 Stockholm, Sweden; Karolinska Hosp, Karolinska MR Res Ctr, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ullen, F (corresponding author), Karolinska Inst, Dept Woman & Child Hlth, SE-17177 Stockholm, Sweden.	Fredrik.Ullen@neuro.ki.se	Forssberg, Hans/A-2944-2009; Nagy, Zoltan/AAI-2485-2019	Nagy, Zoltan/0000-0001-6611-6362; Forssberg, Hans/0000-0003-2069-6618; Bengtsson, Sara/0000-0003-0887-7344; Bengtsson, Sara/0000-0003-4567-102X				Armand J., 1996, P125, DOI 10.1016/B978-012759440-8/50010-4; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Gaser C, 2003, J NEUROSCI, V23, P9240; Giedd JN, 1996, DEV BRAIN RES, V91, P274; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	15	738	752	2	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1148	1150		10.1038/nn1516	http://dx.doi.org/10.1038/nn1516			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116456				2022-12-28	WOS:000231483800013
J	Gotz, R; Wiese, S; Takayama, S; Camarero, GC; Rossoll, W; Schweizer, U; Troppmair, J; Jablonka, S; Holtmann, B; Reed, JC; Rapp, UR; Sendtner, M				Gotz, R; Wiese, S; Takayama, S; Camarero, GC; Rossoll, W; Schweizer, U; Troppmair, J; Jablonka, S; Holtmann, B; Reed, JC; Rapp, UR; Sendtner, M			Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells	NATURE NEUROSCIENCE			English	Article							CHAPERONE ACTIVITY; BCL-2-BINDING PROTEIN; B-RAF; BCL-2; DEATH; BAD; PHOSPHORYLATION; DEGENERATION; MOTONEURONS; INHIBITION	Bag1 is a cochaperone for the heat-shock protein Hsp70 that interacts with C-Raf, B-Raf, Akt, Bcl-2, steroid hormone receptors and other proteins. Here we use targeted gene disruption in mice to show that Bag1 has an essential role in the survival of differentiating neurons and hematopoietic cells. Cells of the fetal liver and developing nervous system in Bag1(-/-) mice underwent massive apoptosis. Lack of Bag1 did not disturb the primary function of Akt or Raf, as phosphorylation of the forkhead transcription factor FKHR and activation of extracellular signal - regulated kinase (Erk)-1/2 were not affected. However, the defect was associated with the disturbance of a tripartite complex formed by Akt, B-Raf and Bag1, in addition to the absence of Bad phosphorylation at Ser136. We also observed reduced expression of members of the inhibitor of apoptosis (IAP) family. Our data show that Bag1 is a physiological mediator of extracellular survival signals linked to the cellular mechanisms that prevent apoptosis in hematopoietic and neuronal progenitor cells.	Univ Wurzburg, Inst Klin Neurobiol, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Burnham Inst, La Jolla, CA 92037 USA	University of Wurzburg; University of Wurzburg; Sanford Burnham Prebys Medical Discovery Institute	Sendtner, M (corresponding author), Univ Wurzburg, Inst Klin Neurobiol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	sendtner@mail.uni-wuerzburg.de	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014; Schweizer, Ulrich/E-8105-2013; Jablonka, Sibylle/S-1843-2018	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Jablonka, Sibylle/0000-0002-4517-3760; Rossoll, Wilfried/0000-0002-9622-541X; Troppmair, Jakob/0000-0002-0611-3837; Schweizer, Ulrich/0000-0003-1380-4780	NATIONAL CANCER INSTITUTE [R01CA067329] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA067329, CA67385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Crocoll A, 2000, MECH DEVELOP, V91, P355, DOI 10.1016/S0925-4773(99)00284-1; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Eversole-Cire P, 2000, INVEST OPHTH VIS SCI, V41, P1953; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kermer P, 2003, BRAIN PATHOL, V13, P495; Kermer P, 2002, CELL DEATH DIFFER, V9, P405, DOI 10.1038/sj.cdd.4400972; Laprise P, 2003, J CELL BIOCHEM, V89, P1115, DOI 10.1002/jcb.10581; Lee MY, 2002, EXP NEUROL, V175, P338, DOI 10.1006/exnr.2002.7903; LO AC, 1995, ARCH HISTOL CYTOL, V58, P139, DOI 10.1679/aohc.58.139; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miki K, 2002, MOL CELL BIOL, V22, P2536, DOI 10.1128/MCB.22.8.2536-2543.2002; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang HG, 1998, BIOFACTORS, V8, P13, DOI 10.1002/biof.5520080103; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3	40	100	105	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1169	1178		10.1038/nn1524	http://dx.doi.org/10.1038/nn1524			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116448	Green Accepted			2022-12-28	WOS:000231483800016
J	Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Ono, T				Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Ono, T			Auditory thalamus integrates visual inputs into behavioral gains	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS; MULTISENSORY INTEGRATION; EVOKED-POTENTIALS; SPATIAL ATTENTION; CORTEX; RAT; CONNECTIONS; MONKEY; PROJECTIONS; MECHANISMS	By binding multisensory signals, we get robust percepts and respond to our surroundings more correctly and quickly. How and where does the brain link cross-modal sensory information to produce such behavioral advantages? The classical role of sensory thalamus is to relay modality-specific information to the cortex. Here we find that, in the rat thalamus, visual cues influence auditory responses, which have two distinct components: an early phasic one followed by a late gradual buildup that peaks before reward. Although both bimodal presentation and reward value had similar effects on behavioral performance, the cross-modal effect on neural activity showed unique temporal dynamics: it affected the amplitude of the early component and starting level of the late component, whereas reward value affected only the slope of the late component. These results demonstrate that cross-modal cueing modulates gain in the sensory thalamus, potentially providing a priming influence on the choice of an optimal behavior.	Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Kawaguchi 3320012, Japan; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Physiol, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Grad Sch Med, Toyama 9300194, Japan	Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Toyama; University of Toyama	Ono, T (corresponding author), Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, 4-1-8 Honcho, Kawaguchi 3320012, Japan.	onotake@ms.toyama-mpu.ac.jp						Barth DS, 1996, NATURE, V383, P78, DOI 10.1038/383078a0; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bell AH, 2001, CAN J EXP PSYCHOL, V55, P123, DOI 10.1037/h0087359; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frens MA, 1998, BRAIN RES BULL, V46, P211, DOI 10.1016/S0361-9230(98)00007-0; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Harvey M, 2002, NEUROPSYCHOLOGIA, V40, P705, DOI 10.1016/S0028-3932(01)00189-0; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; HU B, 1994, J PHYSIOL-LONDON, V479, P217, DOI 10.1113/jphysiol.1994.sp020290; ITAYA SK, 1982, BRAIN RES, V233, P45, DOI 10.1016/0006-8993(82)90928-3; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KOBLER JB, 1987, SCIENCE, V236, P824, DOI 10.1126/science.2437655; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Linke R, 1999, J COMP NEUROL, V403, P158; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rektor I, 2001, NEUROPHYSIOL CLIN, V31, P253, DOI 10.1016/S0987-7053(01)00262-3; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; ShammahLagnado SJ, 1996, J COMP NEUROL, V376, P489, DOI 10.1002/(SICI)1096-9861(19961216)376:3<489::AID-CNE10>3.0.CO;2-H; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stein BE, 2001, PROG BRAIN RES, V134, P143; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; TAKADA M, 1985, EXP BRAIN RES, V60, P385; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Weeks R, 2000, J NEUROSCI, V20, P2664; Wilkinson LK, 1996, EXP BRAIN RES, V112, P1; Winer JA, 1999, HEARING RES, V130, P19, DOI 10.1016/S0378-5955(98)00216-0	50	86	88	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1203	1209		10.1038/nn1528	http://dx.doi.org/10.1038/nn1528			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116444				2022-12-28	WOS:000231483800020
J	Kim, CH; Takamiya, K; Petralia, RS; Sattler, R; Yu, S; Zhou, WG; Kalb, R; Wenthold, R; Huganir, R				Kim, CH; Takamiya, K; Petralia, RS; Sattler, R; Yu, S; Zhou, WG; Kalb, R; Wenthold, R; Huganir, R			Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; SYNAPSES; SUBUNIT	The C-terminal PDZ ligand of the AMPA receptor GluR1 subunit may be important for expression of CA1 hippocampal long-term potentiation. To test this directly in vivo, we generated a knock-in mouse lacking the last seven residues of GluR1, comprising the PDZ ligand. This deletion did not affect basal GluR1 synaptic localization, basal synaptic transmission, long-term potentiation or long-term depression, indicating that the ligand is not required for CA1 hippocampal synaptic plasticity.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Huganir, R (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Takamiya, Kogo/0000-0001-7240-6307	NINDS NIH HHS [R01 NS036715, NS36715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9	12	77	80	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					985	987		10.1038/nn1432	http://dx.doi.org/10.1038/nn1432			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007085				2022-12-28	WOS:000230760200007
J	Lisman, J; Spruston, N				Lisman, J; Spruston, N			Postsynaptic depolarization requirements for LTP and LTD: a critique of spike timing-dependent plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; BACKPROPAGATING ACTION-POTENTIALS; SYNAPTIC PLASTICITY; AREA CA1; HIPPOCAMPAL-NEURONS; DENDRITIC SPIKES; NMDA RECEPTORS; VISUAL-CORTEX; BARREL CORTEX	Long-term potentiation and long-term depression require postsynaptic depolarization, which many current models attribute to backpropagating action potentials. New experimental work suggests, however, that other mechanisms can lead to dendritic depolarization, and that backpropagating action potentials may be neither necessary nor sufficient for synaptic plasticity in vivo.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Northwestern Univ, Inst Neurosci, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Brandeis University; Northwestern University	Lisman, J (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, 415 South St, Waltham, MA 02454 USA.	Lisman@brandeis.edu		Spruston, Nelson/0000-0003-3118-1636				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Holscher C, 1997, J NEUROSCI, V17, P6470; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Staubli UV, 1996, BRAIN RES, V714, P169, DOI 10.1016/0006-8993(95)01523-X; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Vargas-Caballero M, 2003, J NEUROPHYSIOL, V89, P2778, DOI 10.1152/jn.01038.2002; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Waters J, 2005, PROG BIOPHYS MOL BIO, V87, P145, DOI 10.1016/j.pbiomolbio.2004.06.009; WESTPATAT V, 2004, J NEUROSCI, V24, P9067; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305	57	181	183	1	24	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					839	841		10.1038/nn0705-839	http://dx.doi.org/10.1038/nn0705-839			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136666				2022-12-28	WOS:000230137100002
J	Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS				Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS			Deficits in perceptual noise exclusion in developmental dyslexia	NATURE NEUROSCIENCE			English	Article							READING-DISABILITY; SENSITIVITY; INSIGHTS; CHILDREN	We evaluated signal-noise discrimination in children with and without dyslexia, using magnocellular and parvocellular visual stimuli presented either with or without high noise. Dyslexic children had elevated contrast thresholds when stimuli of either type were presented in high noise, but performed as well as non-dyslexic children when either type was displayed without noise. Our findings suggest that deficits in noise exclusion, not magnocellular processing, contribute to the etiology of dyslexia.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Wisconsin, Madison, WI 53706 USA	Georgetown University; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Sperling, AJ (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW,Bldg D,Room 207E, Washington, DC 20057 USA.	ajs76@georgetown.edu		Lu, Zhong-Lin/0000-0002-7295-727X	NICHD NIH HHS [HD29891] Funding Source: Medline; NIMH NIH HHS [P50-MH64445, KO2-MH01188] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445, K02MH001188] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Demb JB, 1998, J NEUROSCI, V18, P6939; Gottardo A, 1996, J EXP CHILD PSYCHOL, V63, P563, DOI 10.1006/jecp.1996.0062; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MANIS FR, 2004, CONNECTIONS LANGUAGE; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368	13	209	212	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					862	863		10.1038/nn1474	http://dx.doi.org/10.1038/nn1474			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	940IK	15924138				2022-12-28	WOS:000230137100012
J	Yoon, K; Gaiano, N				Yoon, K; Gaiano, N			Notch signaling in the mammalian central nervous system: insights from mouse mutants	NATURE NEUROSCIENCE			English	Review							NEURAL STEM-CELLS; SYNAPTIC PLASTICITY; DROSOPHILA HOMOLOG; PROGENITOR CELLS; DELTA HOMOLOG; MICE LACKING; RADIAL GLIA; NUMB; DIFFERENTIATION; DEFECTS	The Notch pathway, although originally identified in fruit flies, is now among the most heavily studied in mammalian biology. In mice, loss-of-function and gain-of-function work has demonstrated that Notch signaling is essential both during development and in the adult in a multitude of tissues. Prominent among these is the CNS, where Notch has been implicated in processes ranging from neural stem cell regulation to learning and memory. Here we review the role of Notch in the mammalian CNS by focusing specifically on mutations generated in mice. These mutations have provided critical insight into Notch function in the CNS and have led to the identification of promising new directions that are likely to generate important discoveries in the future.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gaiano, N (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gaiano@jhmi.edu		Yoon, Keejung/0000-0002-2361-9039				Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; FEDER JN, 1993, MOL CELL BIOL, V13, P105, DOI 10.1128/MCB.13.1.105; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Handler M, 2000, DEVELOPMENT, V127, P2593; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Kusumi K, 2004, GENESIS, V39, P115, DOI 10.1002/gene.20034; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lutolf S, 2002, DEVELOPMENT, V129, P373; McCright B, 2001, DEVELOPMENT, V128, P491; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OKA C, 1995, DEVELOPMENT, V121, P3291; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	87	466	488	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					709	715		10.1038/nn1475	http://dx.doi.org/10.1038/nn1475			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15917835				2022-12-28	WOS:000229345300008
J	Cone, RD				Cone, RD			Anatomy and regulation of the central melanocortin system	NATURE NEUROSCIENCE			English	Review							GROWTH-HORMONE SECRETAGOGUE; HYPOTHALAMIC ARCUATE NUCLEUS; RECEPTOR MESSENGER-RNA; FOOD-INTAKE; NEUROPEPTIDE-Y; PROOPIOMELANOCORTIN NEURONS; FRAMESHIFT MUTATION; TRACTUS-SOLITARIUS; BODY-WEIGHT; GUT HORMONE	The central melanocortin system is perhaps the best-characterized neuronal pathway involved in the regulation of energy homeostasis. This collection of circuits is unique in having the capability of sensing signals from a staggering array of hormones, nutrients and afferent neural inputs. It is likely to be involved in integrating long-term adipostatic signals from leptin and insulin, primarily received by the hypothalamus, with acute signals regulating hunger and satiety, primarily received by the brainstem. The system is also unique from a regulatory point of view in that it is composed of fibers expressing both agonists and antagonists of melanocortin receptors. Given that the central melanocortin system is an active target for development of drugs for the treatment of obesity, diabetes and cachexia, it is important to understand the system in its full complexity, including the likelihood that the system also regulates the cardiovascular and reproductive systems.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Ctr Study Weight Regulat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Cone, RD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	cone@ohsu.edu						Adan RAH, 2000, RECEPTORS, P109; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Andersson U, 2005, BIOCHEM BIOPH RES CO, V329, P719, DOI 10.1016/j.bbrc.2005.02.027; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; APPLEYARD SM, IN PRESS J NEUROSCI; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BLUM M, 1989, ENDOCRINOLOGY, V124, P2283, DOI 10.1210/endo-124-5-2283; Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cannon CM, 2003, AM J PHYSIOL-REG I, V284, pR1384, DOI 10.1152/ajpregu.00689.2002; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; DOURISH CT, 1989, EUR J PHARMACOL, V173, P233, DOI 10.1016/0014-2999(89)90528-1; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Farooqi I.S., 2003, NEW ENGL J MED, V348, P1160, DOI DOI 10.1056/NEJM0A002050; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; Grill HJ, 1998, J NEUROSCI, V18, P10128; Hakansson ML, 1996, NEUROREPORT, V7, P3087, DOI 10.1097/00001756-199611250-00059; Halatchev IG, 2004, ENDOCRINOLOGY, V145, P2585, DOI 10.1210/en.2003-1754; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Horvath TL, 1999, J NEUROSCI, V19, P1072; Humphreys MH, 2004, AM J PHYSIOL-REG I, V286, pR417, DOI 10.1152/ajpregu.00365.2003; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kelly MJ, 2003, ANN NY ACAD SCI, V1007, P6, DOI 10.1196/annals.1286.001; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Li SJ, 1996, J NEUROSCI, V16, P5182; Martin WJ, 2004, EUR UROL, V45, P706, DOI 10.1016/j.eururo.2003.03.001; Matson CA, 2000, AM J PHYSIOL-REG I, V278, pR882, DOI 10.1152/ajpregu.2000.278.4.R882; Matson CA, 1997, PEPTIDES, V18, P1275, DOI 10.1016/S0196-9781(97)00138-1; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ni XP, 2003, J CLIN INVEST, V111, P1251, DOI 10.1172/JCI200316993; Ni XP, 1998, AM J PHYSIOL-REG I, V274, pR931, DOI 10.1152/ajpregu.1998.274.4.R931; NILAVER G, 1979, J CELL BIOL, V81, P50; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PALKOVITS M, 1987, BRAIN RES, V436, P323, DOI 10.1016/0006-8993(87)91676-3; PILCHER WH, 1986, PEPTIDES, V7, P783, DOI 10.1016/0196-9781(86)90096-3; RAYBOULD HE, 1985, BRAIN RES, V342, P187, DOI 10.1016/0006-8993(85)91373-3; RIEDY CA, 1995, PHYSIOL BEHAV, V58, P755, DOI 10.1016/0031-9384(95)00108-U; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Rosen RC, 2004, INT J IMPOT RES, V16, P135, DOI 10.1038/sj.ijir.3901200; Saper Clifford B., 1995, P107; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tamura H, 2002, ENDOCRINOLOGY, V143, P3268, DOI 10.1210/en.2002-220268; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2002, ENDOCRINOLOGY, V143, P558, DOI 10.1210/en.143.2.558; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wang LX, 2002, NEUROSCI LETT, V325, P47; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG XG, 1995, J COMP NEUROL, V363, P37, DOI 10.1002/cne.903630105	100	1102	1142	4	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					571	578		10.1038/nn1455	http://dx.doi.org/10.1038/nn1455			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856065				2022-12-28	WOS:000228895100015
J	Schmitt, WB; Sprengel, R; Mack, V; Draft, RW; Seeburg, PH; Deacon, RMJ; Rawlins, JNP; Bannerman, DM				Schmitt, WB; Sprengel, R; Mack, V; Draft, RW; Seeburg, PH; Deacon, RMJ; Rawlins, JNP; Bannerman, DM			Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; TEST BATTERY; HIPPOCAMPUS; POTENTIATION; LESIONS; DORSAL	Gene-targeted mice lacking the AMPA receptor subunit GluR-A (also called GluR1 encoded by the gene Gria1 have deficits in hippocampal CA3-CA1 long-term potentiation (LTP) and have profoundly impaired hippocampus-dependent spatial working memory (SWM) tasks, although their spatial reference memory remains normal. Here we show that forebrain-localized expression of GFP-tagged GluR-A subunits in GluR-A-deficient mice rescues SWM, paralleling its rescue of CA3-CA1 LTR This provides powerful new evidence linking hippocampal GluR-A-dependent synaptic plasticity to rapid, flexible memory processing.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Oxford; Max Planck Society	Bannerman, DM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	david.bannerman@psy.ox.ac.uk		Bannerman, David/0000-0002-3024-7595	Wellcome Trust [087736] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Eichenbaum H, 2003, CURR DIR PSYCHOL SCI, V12, P53, DOI 10.1111/1467-8721.01225; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Schmitt WB, 2003, J NEUROSCI, V23, P3953	14	96	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					270	272		10.1038/nn1412	http://dx.doi.org/10.1038/nn1412			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723058				2022-12-28	WOS:000227354600009
J	Ronan, D; Gillespie, P				Ronan, D; Gillespie, P			Metazoan mechanotransduction mystery finally solved	NATURE NEUROSCIENCE			English	Editorial Material							C-ELEGANS; CAENORHABDITIS-ELEGANS; MECHANOSENSORY TRANSDUCTION; CHANNEL; DROSOPHILA; PROTEIN; FAMILY; LOCOMOTION; GENETICS; SUBUNIT		Oregon Hearing Res Ctr, Portland, OR 97239 USA; Vollum Inst, Portland, OR 97239 USA		Ronan, D (corresponding author), Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd L335A, Portland, OR 97239 USA.	gillespp@ohsu.edu		Barr-Gillespie, Peter/0000-0002-9787-5860				Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; COREY DP, 2004, NATURE          1013; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	15	2	9	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					7	8		10.1038/nn0105-7	http://dx.doi.org/10.1038/nn0105-7			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15622409				2022-12-28	WOS:000225967600003
J	Zhang, J; Lefebvre, JL; Zhao, SX; Granato, M				Zhang, J; Lefebvre, JL; Zhao, SX; Granato, M			Zebrafish unplugged reveals a role for muscle-specific kinase homologs in axonal pathway choice	NATURE NEUROSCIENCE			English	Article							IN-VIVO; IDENTIFIED MOTONEURONS; CHONDROITIN SULFATE; GENE CONTROLS; MOTOR AXONS; GUIDANCE; RECEPTOR; EMBRYOS; SELECTION; CELLS	En route to their target, pioneering motor growth cones repeatedly encounter choice points at which they make pathway decisions. In the zebrafish mutant unplugged, two of the three segmental motor axons make incorrect decisions at a somitic choice point. Using positional cloning, we show here that unplugged encodes a homolog of muscle-specific kinase ( MuSK) and that, unlike mammalian MuSK, unplugged has only a limited role in neuromuscular synaptogenesis. We demonstrate that unplugged is transiently expressed in cells adjacent to the choice point and that unplugged signaling before the arrival of growth cones induces changes in the extracellular environment. In addition, we find that the unplugged locus generates three different transcripts. The splice variant 1 (SV1) isoform lacks the extracellular modules essential for agrin responsiveness, and signaling through this isoform mediates axonal pathfinding, independent of the MuSK downstream component rapsyn. Our results demonstrate a new role for MuSK homologs in axonal pathway selection.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu						Beattie CE, 2000, BRAIN RES BULL, V53, P489, DOI 10.1016/S0361-9230(00)00382-8; Bernhardt RR, 1998, DEV DYNAM, V213, P334, DOI 10.1002/(SICI)1097-0177(199811)213:3<334::AID-AJA9>3.0.CO;2-4; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; Chung KY, 2000, DEVELOPMENT, V127, P2673; Coers C., 1967, International Review of Cytology, V22, P239, DOI 10.1016/S0074-7696(08)61837-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Du SJ, 2003, COMP BIOCHEM PHYS B, V134, P123, DOI 10.1016/S1096-4959(02)00194-X; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; FERNS MJ, 1993, J NEUROSCI, V13, P2463, DOI 10.1523/JNEUROSCI.13-06-02463.1993; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Giger RJ, 2001, CELL, V105, P1, DOI 10.1016/S0092-8674(01)00290-2; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hesser BA, 1999, FEBS LETT, V442, P133, DOI 10.1016/S0014-5793(98)01641-X; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; Landgraf M, 1999, CURR BIOL, V9, P589, DOI 10.1016/S0960-9822(99)80262-0; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Melancon E, 1997, J NEUROSCI, V17, P7796; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ono F, 2002, J NEUROSCI, V22, P6491; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; Walz A, 2002, J NEUROBIOL, V53, P330, DOI 10.1002/neu.10113; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhang J, 2001, DEV BIOL, V240, P560, DOI 10.1006/dbio.2001.0492; Zhang J, 2000, DEVELOPMENT, V127, P2099; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	48	72	72	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1303	1309		10.1038/nn1350	http://dx.doi.org/10.1038/nn1350			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543140				2022-12-28	WOS:000225353900010
J	Tsai, J; Grutzendler, J; Duff, K; Gan, WB				Tsai, J; Grutzendler, J; Duff, K; Gan, WB			Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; HYPOTHESIS; CALCIUM	Amyloid plaques are a hallmark of Alzheimer disease, but their importance in its pathogenesis is controversial. By neuronal labeling and transcranial two-photon imaging, we show in a transgenic mouse model of Alzheimer disease that dendrites passing through or near fibrillar amyloid deposits undergo spine loss and shaft atrophy, and nearby axons develop large varicosities, together leading to neurite breakage and large-scale, permanent disruption of neuronal connections. Thus, fibrillar amyloid deposition is more detrimental to neuronal circuitry than previously thought, underscoring the importance of prevention and early clearance of plaques.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Orangeburg, NY 10962 USA; Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA	New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Duff, Karen EK/C-2510-2009; Grutzendler, Jaime/F-3691-2010	Duff, Karen/0000-0002-6177-868X				Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; MASLIAH E, 1993, J NEUROPATH EXP NEUR, V52, P619, DOI 10.1097/00005072-199311000-00009; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Phinney AL, 1999, J NEUROSCI, V19, P8552; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001	15	418	435	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1181	1183		10.1038/nn1335	http://dx.doi.org/10.1038/nn1335			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475950				2022-12-28	WOS:000224749400007
J	Huang, FD; Matthies, HJG; Speese, SD; Smith, MA; Broadie, K				Huang, FD; Matthies, HJG; Speese, SD; Smith, MA; Broadie, K			Rolling blackout, a newly identified PIP2-DAG pathway lipase required for Drosophila phototransduction	NATURE NEUROSCIENCE			English	Article							SENSITIVE CHANNELS TRP; VISUAL TRANSDUCTION; CA2+ CHANNEL; IN-VIVO; PROTEIN; GENE; NORPA; RECEPTOR; MUTANTS; PHOTORECEPTORS	The rolling blackout (rbo) gene encodes an integral plasma membrane lipase required for Drosophila phototransduction. Photoreceptors are enriched for the RBO protein, and temperature-sensitive rbo mutants show reversible elimination of phototransduction within minutes, demonstrating an acute requirement for the protein. The block is activity dependent, indicating that the action of RBO is use dependent. Conditional rbo mutants show activity-dependent depletion of diacylglycerol and concomitant accumulation of phosphatidylinositol phosphate and phosphatidylinositol 4,5-bisphosphate within minutes of induction, suggesting rapid downregulation of phospholipase C (PLC) activity. The RBO requirement identifies an essential regulatory step in G-protein-coupled, PLC-dependent inositol lipid signaling mediating activation of TRP and TRPL channels during phototransduction.	Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Kennedy Ctr, Dept Biol Sci, Nashville, TN 37235 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Vanderbilt University; Utah System of Higher Education; University of Utah	Broadie, K (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Kennedy Ctr, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	kendal.broadie@vanderbilt.edu	Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Speese, Sean/0000-0002-3965-9828	NIGMS NIH HHS [GM54544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROADIE K, 2000, DROSOPHILA PROTOCOLS, P297; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Cygler M, 1997, METHOD ENZYMOL, V284, P3; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; INOUE H, 1989, J BIOL CHEM, V264, P5996; Kumar M, 2001, J GENET, V80, P83, DOI 10.1007/BF02728334; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MARTINEZ C, 1992, NATURE, V356, P615, DOI 10.1038/356615a0; MCKAY RR, 1994, NEUROSCIENCE, V61, P141, DOI 10.1016/0306-4522(94)90067-1; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; ORDWAY RW, 1994, P NATL ACAD SCI USA, V91, P5715, DOI 10.1073/pnas.91.12.5715; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Pearn MT, 1996, J BIOL CHEM, V271, P4937; PREISS J, 1986, J BIOL CHEM, V261, P8597; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHYNGLE J, 1985, INDIAN J EXP BIOL, V23, P235; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; YOSHIOKA T, 1984, BIOCHEM BIOPH RES CO, V119, P389, DOI 10.1016/0006-291X(84)91664-4; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171	43	52	54	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1070	1078		10.1038/nn1313	http://dx.doi.org/10.1038/nn1313			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361878				2022-12-28	WOS:000224156900016
J	Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y				Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y			Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; AMPA RECEPTORS; F-ACTIN; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; LTP	The synapse is a highly organized cellular specialization whose structure and composition are reorganized, both positively and negatively, depending on the strength of input signals. The mechanisms orchestrating these changes are not well understood. A plausible locus for the reorganization of synapse components and structure is actin, because it serves as both cytoskeleton and scaffold for synapses and exists in a dynamic equilibrium between F-actin and G-actin that is modulated bidirectionally by cellular signaling. Using a new FRET-based imaging technique to monitor F-actin/G-actin equilibrium, we show here that tetanic stimulation causes a rapid, persistent shift of actin equilibrium toward F-actin in the dendritic spines of rat hippocampal neurons. This enlarges the spines and increases postsynaptic binding capacity. In contrast, prolonged low-frequency stimulation shifts the equilibrium toward G-actin, resulting in a loss of postsynaptic actin and of structure. This bidirectional regulation of actin is actively involved in protein assembly and disassembly and provides a substrate for bidirectional synaptic plasticity.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Saitama 3510198, Japan	Massachusetts Institute of Technology (MIT); RIKEN; RIKEN	Hayashi, Y (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, E25-618, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Okamoto, Kenichi/E-4582-2013; Miyawaki, Atsushi/K-3569-2014; Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019	Miyawaki, Atsushi/0000-0002-2329-3235; Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Nagai, Takeharu/0000-0003-2650-9895; Okamoto, Kenichi/0000-0001-9527-2444				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allison DW, 1998, J NEUROSCI, V18, P2423; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hering H, 2003, J NEUROSCI, V23, P11759; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LISMAN J, 1988, J PHYSIOL-PARIS, V83, P187; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Piccini A, 2002, J NEUROSCI, V22, P5387; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; WANG YL, 1981, CELL, V27, P429, DOI 10.1016/0092-8674(81)90384-6; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	51	605	620	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1104	1112		10.1038/nn1311	http://dx.doi.org/10.1038/nn1311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361876				2022-12-28	WOS:000224156900020
J	Boutla, M; Supalla, T; Newport, EL; Bavelier, D				Boutla, M; Supalla, T; Newport, EL; Bavelier, D			Short-term memory span: insights from sign language	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; WORD-LENGTH; PHONOLOGICAL COMPLEXITY; DEAF SIGNERS; INFORMATION; RECALL; SIMILARITY; CHILDHOOD; DURATION; CAPACITY	Short-term memory (STM), or the ability to hold information in mind for a few seconds, is thought to be limited in its capacity to about 7 +/- 2 items. Notably, the average STM capacity when using American Sign Language (ASL) rather than English is only 5 +/- 1 items. Here we show that, contrary to previous interpretations, this difference cannot be attributed to phonological factors, item duration or reduced memory abilities in deaf people. We also show that, despite this difference in STM span, hearing speakers and deaf ASL users have comparable working memory resources during language use, indicating similar abilities to maintain and manipulate linguistic information. The shorter STM span in ASL users therefore confirms the view that the spoken span of 7 +/- 2 is an exception, probably owing to the reliance of speakers on auditory-based rather than visually based representations in linguistic STM, and calls for adjustments in the norms used with deaf individuals.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Bavelier, D (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	daphne@bcs.rochester.edu		Bavelier, Daphne/0000-0002-5904-1240	NIDCD NIH HHS [R01 DC000167-26, R01 DC000167, DC04418, R01 DC004418, R01 DC004418-08, DC00167] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000167, R01DC004418] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A.D., 1986, WORKING MEMORY THOUG; BELLUGI U, 1972, COGNITION, V1, P173, DOI 10.1016/0010-0277(72)90018-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAPLAN D, 1992, Q J EXP PSYCHOL-A, V45, P177, DOI 10.1080/14640749208401323; CAPLAN D, 1994, Q J EXP PSYCHOL-A, V47, P1055, DOI 10.1080/14640749408401108; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; CONRAD R, 1972, BRIT J PSYCHOL, V63, P173, DOI 10.1111/j.2044-8295.1972.tb02097.x; CONRAD R, 1970, BRIT J PSYCHOL, V61, P179, DOI 10.1111/j.2044-8295.1970.tb01236.x; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DANEMAN M, 1986, J MEM LANG, V25, P1, DOI 10.1016/0749-596X(86)90018-5; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DARWIN CJ, 1972, COGNITIVE PSYCHOL, V3, P255, DOI 10.1016/0010-0285(72)90007-2; ELLIOTT JM, 1992, PERCEPT MOTOR SKILL, V74, P291, DOI 10.2466/PMS.74.1.291-295; ELLIS NC, 1980, BRIT J PSYCHOL, V71, P43, DOI 10.1111/j.2044-8295.1980.tb02728.x; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Fortkamp M. B. M., 1999, COMMUN COGNITION, V32, P259; HANSON VL, 1990, MEM COGNITION, V18, P604, DOI 10.3758/BF03197103; HANSON VL, 1982, J EXP PSYCHOL LEARN, V8, P572, DOI 10.1037/0278-7393.8.6.572; Kanabus M, 2002, ACTA NEUROBIOL EXP, V62, P263; Keppel G, 1991, DESIGN ANAL RES HDB; Klima E., 1979, SIGNS LANGUAGE; Lau CW, 1999, PSYCHOLOGIA, V42, P139; LOSIEWICZ BL, 2000, SW J LINGUIST, V19, P63; Macsweeney M, 1996, J Deaf Stud Deaf Educ, V1, P249; Marschark M, 1998, SCAND J PSYCHOL, V39, P145, DOI 10.1111/1467-9450.393069; Martin RC, 2001, SCI CON SER, P331; MAYBERRY RI, 1993, J SPEECH HEAR RES, V36, P1258, DOI 10.1044/jshr.3606.1258; MAYBERRY RI, 1991, J MEM LANG, V30, P486, DOI 10.1016/0749-596X(91)90018-F; METCALFE J, 1981, MEM COGNITION, V9, P351, DOI 10.3758/BF03197559; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mueller ST, 2003, J EXP PSYCHOL LEARN, V29, P1353, DOI 10.1037/0278-7393.29.6.1353; NEATH I, 1990, J EXP PSYCHOL LEARN, V16, P316, DOI 10.1037/0278-7393.16.2.316; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perfetti C. A., 1977, COGNITIVE PROCESS, P141; Service E, 1998, Q J EXP PSYCHOL-A, V51, P283, DOI 10.1080/027249898391639; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; Wilson M, 2000, SIGNS OF LANGUAGE REVISITED, P135; Wilson M, 1997, J Deaf Stud Deaf Educ, V2, P150; Wilson M, 1998, MEM COGNITION, V26, P584, DOI 10.3758/BF03201164; Wilson M, 2001, PSYCHON B REV, V8, P44, DOI 10.3758/BF03196138; Wilson M, 1997, MEM COGNITION, V25, P313, DOI 10.3758/BF03211287	45	87	88	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					997	1002		10.1038/nn1298	http://dx.doi.org/10.1038/nn1298			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	849NX	15311279	Green Accepted			2022-12-28	WOS:000223546700020
J	Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A				Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A			Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate	NATURE NEUROSCIENCE			English	Article							CALCIUM OSCILLATIONS; SYNAPTIC VESICLES; RELEASE; TRANSPORTERS; MEMBRANE; CA2+; LOCALIZATION; EXPRESSION; RECEPTORS; SUGGESTS	Astrocytes establish rapid cell-to-cell communication through the release of chemical transmitters. The underlying mechanisms and functional significance of this release are, however, not well understood. Here we identify an astrocytic vesicular compartment that is competent for glutamate exocytosis. Using postembedding immunogold labeling of the rat hippocampus, we show that vesicular glutamate transporters (VGLUT1/2) and the vesicular SNARE protein, cellubrevin, are both expressed in small vesicular organelles that resemble synaptic vesicles of glutamatergic terminals. Astrocytic vesicles, which are not as densely packed as their neuronal counterparts, can be observed in small groups at sites adjacent to neuronal structures bearing glutamate receptors. Fluorescently tagged VGLUT-containing vesicles were studied dynamically in living astrocytes by total internal reflection fluorescence (TIRF) microscopy. After activation of metabotropic glutamate receptors, astrocytic vesicles underwent rapid (milliseconds) Ca2+- and SNARE-dependent exocytic fusion that was accompanied by glutamate release. These data document the existence of a Ca2+-dependent quantal glutamate release activity in glia that was previously considered to be specific to synapses.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; UNIL CHUV Technol Dev Unit, Cellular Imaging Facil, CH-1005 Lausanne, Switzerland; Univ Oslo, Inst Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Bonn, Dept Expt Neurobiol, D-53105 Bonn, Germany; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Oslo; University of Oslo; University of Bonn; University of Milan; University of Milan	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	Andrea.Volterra@ibcm.unil.ch	Bezzi, Paola/AAP-2440-2020	Volterra, Andrea/0000-0003-1069-1602				Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bergersen L, 2003, EUR J NEUROSCI, V18, P931, DOI 10.1046/j.1460-9568.2003.02828.x; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHILTON BJ, 1995, CIVIL ENG SYST, V12, P219, DOI 10.1080/02630259508970172; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Gundersen V, 1998, J NEUROSCI, V18, P6059; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matthias K, 2003, J NEUROSCI, V23, P1750; Muyderman H, 2001, J BIOL CHEM, V276, P46504, DOI 10.1074/jbc.M103849200; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schroder W, 1999, GLIA, V28, P166, DOI 10.1002/(SICI)1098-1136(199911)28:2<166::AID-GLIA8>3.0.CO;2-T; SEIFERT G, 2002, NEUROMETHODS PATCH C, V35, P301; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237; Tse FT, 1999, BIOESSAYS, V21, P861, DOI 10.1002/(SICI)1521-1878(199910)21:10<861::AID-BIES8>3.0.CO;2-9; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; VOLTERRA A, 2004, NEUROGLIA, P190; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	47	535	556	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					613	620		10.1038/nn1246	http://dx.doi.org/10.1038/nn1246			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156145				2022-12-28	WOS:000221640300015
J	Keller, A; Vosshall, LB				Keller, A; Vosshall, LB			A psychophysical test of the vibration theory of olfaction	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION ABILITY	At present, no satisfactory theory exists to explain how a given molecule results in the perception of a particular smell. One theory is that olfactory sensory neurons detect intramolecular vibrations of the odorous molecule. We used psychophysical methods in humans to test this vibration theory of olfaction and found no evidence to support it.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Rockefeller University	Keller, A (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10021 USA.	kellera@mail.rockefeller.edu		Keller, Andreas/0000-0001-5491-2214; Vosshall, Leslie/0000-0002-6060-8099				BURR C, 2002, EMPEROR SCENT; Dyson GM., 1938, CHEM IND, V57, P647, DOI [10.1002/jctb.5000572802, DOI 10.1002/JCTB.5000572802]; Gilbert AN, 2003, NAT NEUROSCI, V6, P335; GIVHAN R, 2003, WASHINGTON POST 0216; Haffenden LJW, 2001, FOOD CHEM, V73, P67, DOI 10.1016/S0308-8146(00)00287-9; Hummel T, 2002, INT ARCH OCC ENV HEA, V75, P305, DOI 10.1007/s00420-002-0315-7; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; MASLIN J, 2003, NY TIMES        0206, pE8; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Turin L, 2003, HDB OLFACTION GUSTAT, P275; Watson WL, 2001, DEV PSYCHOBIOL, V39, P137, DOI 10.1002/dev.1037; WRIGHT RH, 1977, J THEOR BIOL, V64, P473, DOI 10.1016/0022-5193(77)90283-1	14	78	82	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					337	338		10.1038/nn1215	http://dx.doi.org/10.1038/nn1215			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034588				2022-12-28	WOS:000220482500010
J	Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM				Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM			Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							EXTRACELLULAR-MATRIX; OLFACTORY-BULB; CELL-ADHESION; MICE DEFICIENT; NEURONS; MIGRATION; INDUCTION; BRAIN; GLYCOPROTEINS; LOCALIZATION	Neuroblasts arising in the adult forebrain that travel to the olfactory bulb use two modes of migration: tangentially, along the rostral migratory stream, and radially, in the core of the olfactory bulb where they start to ascend to the outer layers. Although the mechanisms of tangential migration have been extensively studied, the factors controlling radial migration remain unexplored. Here we report that the extracellular matrix glycoprotein tenascin-R, expressed in the adult mouse olfactory bulb, initiates both the detachment of neuroblasts from chains and their radial migration. Expression of tenascin-R is activity dependent, as it is markedly reduced by odor deprivation. Furthermore, grafting of tenascin-R-transfected cells into non-neurogenic regions reroutes migrating neuroblasts toward these regions. The identification of an extracellular microenvironment capable of directing migrating neuroblasts provides insights into the mechanisms regulating radial migration in the adult olfactory bulb and offers promising therapeutic venues for brain repair.	Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	; de Chevigny, Antoine/M-7477-2016	Saghatelyan, Armen/0000-0003-4962-0465; de Chevigny, Antoine/0000-0002-7413-0591				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chazal G, 2000, J NEUROSCI, V20, P1446; Cummings DM, 1997, J NEUROSCI, V17, P7433; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; HENEGAR JR, 1991, BRAIN RES, V568, P230, DOI 10.1016/0006-8993(91)91402-M; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Murase S, 2002, J NEUROSCI, V22, P3568; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Svendsen CN, 1996, PERSPECT DEV NEUROBI, V3, P133; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thomas LB, 1996, GLIA, V17, P1; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xiao ZC, 1998, J NEUROSCI RES, V52, P390, DOI 10.1002/(SICI)1097-4547(19980515)52:4<390::AID-JNR3>3.3.CO;2-6	41	166	182	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					347	356		10.1038/nn1211	http://dx.doi.org/10.1038/nn1211			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034584				2022-12-28	WOS:000220482500013
J	Jo, J; Ball, SM; Seok, H; Oh, SB; Massey, PV; Molnar, E; Bashir, ZI; Cho, K				Jo, J; Ball, SM; Seok, H; Oh, SB; Massey, PV; Molnar, E; Bashir, ZI; Cho, K			Experience-dependent modification of mechanisms of long-term depression	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; PERIRHINAL CORTEX; VISUAL-CORTEX; PLASTICITY; INDUCTION; LTP	Mechanisms of long-term potentiation and depression ( LTP and LTD) change considerably during development, but the importance of these changes and the factors that control them is not clear. We found that visual experience triggered a switch in mechanisms of LTD in rat perirhinal cortex, an area critical for visual recognition memory. Thus, changes in synaptic plasticity mechanisms were correlated with the changing physiological demands on the CNS.	Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Bristol, Dept Anat, MRC, Ctr Synapt Plastic, Bristol BS8 1TD, Avon, England; Seoul Natl Univ, Mol & Cellular Neurosci Program, Dept Physiol, Coll Dent, Seoul 110749, South Korea	University of Sheffield; University of Bristol; Seoul National University (SNU)	Cho, K (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Western Ban, Sheffield S10 2TN, S Yorkshire, England.	K.Cho@sheffield.ac.uk	Molnár, Elek/D-1427-2019; OH, Seog Bae/AAQ-2478-2020	Molnár, Elek/0000-0002-3525-4671; Bashir, Zafar/0000-0003-3650-2136; Cho, Kwangwook/0000-0001-6724-7073	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	10	38	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					170	172		10.1038/nn1637	http://dx.doi.org/10.1038/nn1637			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429132				2022-12-28	WOS:000234990100010
J	Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME				Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME			Calcium-dependent interaction of Lis1 with IQGAP1 and Cdc42 promotes neuronal motility	NATURE NEUROSCIENCE			English	Article							INTRACELLULAR CA2+ FLUCTUATIONS; RHO-GTPASES; NMDA RECEPTORS; ACTIN CYTOSKELETON; SPINE MORPHOLOGY; CELL-MIGRATION; RAT-BRAIN; MICROTUBULE; BINDING; CALMODULIN	Lis1 gene defects impair neuronal migration, causing the severe human brain malformation lissencephaly. Although much is known about its interactions with microtubules, microtubule-binding proteins such as CLIP-170, and with the dynein motor complex, the response of Lis1 to neuronal motility signals has not been elucidated. Lis1 deficiency is associated with deregulation of the Rho-family GTPases Cdc42, Rac1 and RhoA, and ensuing actin cytoskeletal defects, but the link between Lis1 and Rho GTPases remains unclear. We report here that calcium influx enhances neuronal motility through Lis1-dependent regulation of Rho GTPases. Lis1 promotes Cdc42 activation through interaction with the calcium sensitive GTPase scaffolding protein IQGAP1, maintaining the perimembrane localization of IQGAP1 and CLIP170 and thereby tethering microtubule ends to the cortical actin cytoskeleton. Lis1 thus is a key component of neuronal motility signal transduction that regulates the cytoskeleton by complexing with IQGAP1, active Cdc42 and CLIP-170 upon calcium influx.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Univ Calif San Diego, San Diego Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Wisconsin, Sch Med, Dept Neurosci, Madison, WI 53706 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	Cornell University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Ross, ME (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	mer2005@med.cornell.edu	Letourneau, Paul C/A-6764-2009	Gomez, Timothy/0000-0002-1515-8228	NICHD NIH HHS [R01HD19950] Funding Source: Medline; NINDS NIH HHS [R01NS35515, P01NS39404] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD019950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035515, P01NS039404] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GASSER UE, 1990, J NEUROSCI, V10, P1276; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Li QW, 2004, BIOCHEM BIOPH RES CO, V317, P787, DOI 10.1016/j.bbrc.2004.03.119; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; Schell MJ, 1997, J NEUROSCI, V17, P1604; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101	48	140	144	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					50	57		10.1038/nn1619	http://dx.doi.org/10.1038/nn1619			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369480				2022-12-28	WOS:000234288000017
J	Felsen, G; Dan, Y				Felsen, G; Dan, Y			A natural approach to studying vision	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; SPATIAL-FREQUENCY; V1 NEURONS; INDEPENDENT COMPONENTS; SIMPLE CELLS; SCENES; STATISTICS; RESPONSES	An ultimate goal of systems neuroscience is to understand how sensory stimuli encountered in the natural environment are processed by neural circuits. Achieving this goal requires knowledge of both the characteristics of natural stimuli and the response properties of sensory neurons under natural stimulation. Most of our current notions of sensory processing have come from experiments using simple, parametric stimulus sets. However, a growing number of researchers have begun to question whether this approach alone is sufficient for understanding the real-life sensory tasks performed by the organism. Here, focusing on the early visual pathway, we argue that the use of natural stimuli is vital for advancing our understanding of sensory processing.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Felsen, G (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY012561] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12561] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Hartline HK, 1940, AM J PHYSIOL, V130, P0690, DOI 10.1152/ajplegacy.1940.130.4.690; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; Hyvarinen A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-12; Karklin Y, 2003, NETWORK-COMP NEURAL, V14, P483, DOI 10.1088/0954-898X/14/3/306; Kayser C, 2003, NEUROCOMPUTING, V52-4, P117, DOI 10.1016/S0925-2312(02)00789-0; Lei YL, 2004, J NEUROSCI METH, V135, P35, DOI 10.1016/j.jneumeth.2003.11.014; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; Lipton P, 2005, SCIENCE, V307, P219, DOI 10.1126/science.1103024; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; Mechler F, 2002, J NEUROSCI, V22, P6129; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Passaglia C, 1997, P NATL ACAD SCI USA, V94, P12649, DOI 10.1073/pnas.94.23.12649; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smyth D, 2003, J NEUROSCI, V23, P4746; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; WANG Z, 2003, ADV NEURAL INFORM PR, V16; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	49	186	190	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1643	1646		10.1038/nn1608	http://dx.doi.org/10.1038/nn1608			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16306891				2022-12-28	WOS:000233576200008
J	Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U				Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U			Induction of sharp wave-ripple complexes in vitro and reorganization of hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY OSCILLATIONS; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; MEMORY CONSOLIDATION; NEURONS; SLICES; DEPRESSION; PLASTICITY; SLEEP	Hippocampal sharp wave-ripple complexes (SPW-Rs) occur during slow-wave sleep and behavioral immobility and are thought to represent stored information that is transferred to the neocortex during memory consolidation. Here we show that stimuli that induce long-term potentiation (LTP), a neurophysiological correlate of learning and memory, can lead to the generation of SPW-Rs in rat hippocampal slices. The induced SPW-Rs have properties that are identical to spontaneously generated SPW-Rs: they originate in CA3, propagate to CA1 and subiculum and require AMPA/kainate receptors. Their induction is dependent on NMDA receptors and involves changes in interactions between clusters of neurons in the CA3 network. Their expression is blocked by low-frequency stimulation but not by NMDA receptor antagonists. These data indicate that induction of LTP in the recurrent CA3 network may facilitate the generation of SPW-Rs.	Charite Univ Med Berlin, Inst Neurophysiol, D-10117 Berlin, Germany; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Heinemann, U (corresponding author), Charite Univ Med Berlin, Inst Neurophysiol, Tucholskystr 2, D-10117 Berlin, Germany.	uwe.heinemann@charite.de		de Hoz, Livia/0000-0002-5782-1120				Amaral David G., 1995, P443; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ASHTON D, 1989, BRAIN RES, V487, P368, DOI 10.1016/0006-8993(89)90842-1; Axmacher N, 2004, J PHYSIOL-LONDON, V555, P713, DOI 10.1113/jphysiol.2003.052225; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAGDON AC, 1986, BRAIN RES, V378, P169, DOI 10.1016/0006-8993(86)90300-8; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BUZSAKI G, 1984, BRAIN RES, V300, P179, DOI 10.1016/0006-8993(84)91356-8; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; BUZSAKI G, 1987, BRAIN RES, V435, P331, DOI 10.1016/0006-8993(87)91618-0; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dudek F E, 1986, Adv Neurol, V44, P593; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; Heinemann U., 1992, P206; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Moser MB, 2000, NEURON, V26, P559, DOI 10.1016/S0896-6273(00)81192-7; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Ponomarenko AA, 2003, NEUROSCIENCE, V121, P759, DOI 10.1016/S0306-4522(03)00524-4; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wong R K, 1986, Adv Neurol, V44, P583; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	49	183	187	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1560	1567		10.1038/nn1571	http://dx.doi.org/10.1038/nn1571			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222227				2022-12-28	WOS:000232966600031
J	Chanda, B; Blunck, R; Faria, LC; Schweizer, FE; Mody, I; Bezanilla, F				Chanda, B; Blunck, R; Faria, LC; Schweizer, FE; Mody, I; Bezanilla, F			A hybrid approach to measuring electrical activity in genetically specified neurons	NATURE NEUROSCIENCE			English	Article							FLUORESCENT PROTEIN; CORTICAL ACTIVITY; TRANSGENIC MICE; NEURAL CIRCUITS; REAL-TIME; VOLTAGE; DYES; CELL; DISPLACEMENT; POTENTIALS	The development of genetically encoded fluorescent voltage probes is essential to image electrical activity from neuronal populations. Previous green fluorescent protein (GFP)-based probes have had limited success in recording electrical activity of neurons because of their low sensitivity and poor temporal resolution. Here we describe a hybrid approach that combines a genetically encoded fluorescent probe (membrane-anchored enhanced GFP) with dipicrylamine, a synthetic voltage-sensing molecule that partitions into the plasma membrane. The movement of the synthetic voltage sensor is translated via fluorescence resonance energy transfer (FRET) into a large fluorescence signal (up to 34% change per 100 mV) with a fast response and recovery time (0.5 ms). Using this two-component approach, we were able to optically record action potentials from neuronal cell lines and trains of action potentials from primary cultured neurons. This hybrid approach may form the basis for a new generation of protein-based voltage probes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bezanilla, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	fbezanil@ucla.edu	Blunck, Rikard/AAM-3078-2020; Blunck, Rikard/L-4226-2013	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907; Chanda, Baron/0000-0003-4954-7034	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS041317, R01NS030549] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30376] Funding Source: Medline; NINDS NIH HHS [NS30549, NS41317] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Djurisic M, 2003, METHOD ENZYMOL, V361, P423; FERNANDEZ JM, 1983, J GEN PHYSIOL, V82, P331, DOI 10.1085/jgp.82.3.331; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; Gordey M, 2001, NEUROSCIENCE, V105, P987, DOI 10.1016/S0306-4522(01)00234-2; GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jiang W, 1998, BIOTECHNIQUES, V24, P349; KALYANARAMAN B, 1987, P NATL ACAD SCI USA, V84, P2999, DOI 10.1073/pnas.84.9.2999; Knopfel T, 2003, METHODS, V30, P42, DOI 10.1016/S1046-2023(03)00006-9; LIEKE EE, 1989, ANNU REV PHYSIOL, V51, P543, DOI 10.1146/annurev.physiol.51.1.543; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miyawaki A, 2003, CURR OPIN NEUROBIOL, V13, P591, DOI 10.1016/j.conb.2003.09.005; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Salter-Cid L, 1999, P NATL ACAD SCI USA, V96, P5434, DOI 10.1073/pnas.96.10.5434; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805	30	132	141	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1619	1626		10.1038/nn1558	http://dx.doi.org/10.1038/nn1558			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16205716				2022-12-28	WOS:000232966600038
J	Fan, Y; Fricker, D; Brager, DH; Chen, XX; Lu, HC; Chitwood, RA; Johnston, D				Fan, Y; Fricker, D; Brager, DH; Chen, XX; Lu, HC; Chitwood, RA; Johnston, D			Activity-dependent decrease of excitability in rat hippocampal neurons through increases in I-h	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; DENDRITIC K+ CHANNELS; INTRINSIC EXCITABILITY; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; CORTICAL-NEURONS; PROTEIN-KINASE; PLASTICITY; STIMULATION	Hippocampal long-term potentiation (LTP) induced by theta-burst pairing of Schaffer collateral inputs and postsynaptic firing is associated with localized increases in synaptic strength and dendritic excitability. Using the same protocol, we now demonstrate a decrease in cellular excitability that was blocked by the h-channel blocker ZD7288. This decrease was also induced by postsynaptic theta-burst firing alone, yet it was blocked by NMDA receptor antagonists, postsynaptic Ca2+ chelation, low concentrations of tetrodotoxin, omega-conotoxin MVIIC, calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitors and a protein synthesis inhibitor. Increasing network activity with high extracellular K+ caused a similar reduction of cellular excitability and an increase in h-channel HCN1 protein. We propose that backpropagating action potentials open glutamate-bound NMDA receptors, resulting in an increase in I-h and a decrease in overall excitability. The occurrence of such a reduction in cellular excitability in parallel with synaptic potentiation would be a negative feedback mechanism to normalize neuronal output firing and thus promote network stability.	Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA; Univ Paris 06, INSERM, U739, F-75013 Paris, France; Baylor Coll Med, Dept Pediat, Div Neurol & Dev Neurosci, Cain Fdn Labs, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Baylor College of Medicine	Johnston, D (corresponding author), Univ Texas, Ctr Learning & Memory, 1 Univ Stn,C7000, Austin, TX 78712 USA.	djohnston@mail.clm.utexas.edu	Fricker, Desdemona/ABD-2279-2020	Fricker, Desdemona/0000-0001-7328-9480; Brager, Darrin/0000-0002-3736-0515; Chitwood, Raymond/0000-0002-2016-5238	NIMH NIH HHS [MH44754, MH48432, R01 MH048432] Funding Source: Medline; NINDS NIH HHS [NS37444, F32 NS011034, NS48884] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048432, R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048884, P01NS037444, F32NS011034] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Berger T, 2004, EUR J NEUROSCI, V20, P1688, DOI 10.1111/j.1460-9568.2004.03617.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Frick A, 2003, J NEUROSCI, V23, P3243; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	50	280	281	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1542	1551		10.1038/nn1568	http://dx.doi.org/10.1038/nn1568			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234810				2022-12-28	WOS:000232966600029
J	Murphy, GJ; Darcy, DP; Isaacson, JS				Murphy, GJ; Darcy, DP; Isaacson, JS			Intraglomerular inhibition: signaling mechanisms of an olfactory microcircuit	NATURE NEUROSCIENCE			English	Article							CALCIUM CURRENT; GABA RELEASE; DENDRODENDRITIC INHIBITION; SYNAPTIC ORGANIZATION; ACTION-POTENTIALS; GLOMERULAR LAYER; NMDA RECEPTORS; CA2+ CHANNELS; T-TYPE; BULB	Microcircuits composed of principal neuron and interneuron dendrites have an important role in shaping the representation of sensory information in the olfactory bulb. Here we establish the physiological features governing synaptic signaling in dendrodendritic microcircuits of olfactory bulb glomeruli. We show that dendritic gamma-aminobutyric acid (GABA) release from periglomerular neurons mediates inhibition of principal tufted cells, retrograde inhibition of sensory input and lateral signaling onto neighboring periglomerular cells. We find that L-type dendritic Ca2+ spikes in periglomerular cells underlie dendrodendritic transmission by depolarizing periglomerular dendrites and activating P/Q type channels that trigger GABA release. Ca2+ spikes in periglomerular cells are evoked by powerful excitatory inputs from a single principal cell, and glutamate release from the dendrites of single principal neurons activates a large ensemble of periglomerular cells.	Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	jisaacson@ucsd.edu		Murphy, Gabe/0000-0002-9321-8556	NIDCD NIH HHS [DC005679, R01 DC04682] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005679, R01DC004682] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Avery RB, 1996, J NEUROSCI, V16, P5567; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cang JH, 2003, J NEUROSCI, V23, P4108; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2001, J NEUROPHYSIOL, V85, P169, DOI 10.1152/jn.2001.85.1.169; Egger V, 2003, J NEUROSCI, V23, P7551; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Halabisky B, 2000, J NEUROSCI, V20, P5124; Hausser M, 1997, J NEUROSCI, V17, P7606; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; Holderith NB, 2003, EUR J NEUROSCI, V18, P344, DOI 10.1046/j.1460-9568.2003.02756.x; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PINCHING AJ, 1971, J CELL SCI, V9, P347; Power JM, 2005, J PHYSIOL-LONDON, V562, P439, DOI 10.1113/jphysiol.2004.076711; PRICE JL, 1970, J CELL SCI, V7, P125; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schwindt P, 1996, J NEUROPHYSIOL, V76, P3731, DOI 10.1152/jn.1996.76.6.3731; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stengel W, 1998, EUR J PHARMACOL, V342, P339, DOI 10.1016/S0014-2999(97)01495-7; Toida K, 1998, J COMP NEUROL, V392, P179, DOI 10.1002/(SICI)1096-9861(19980309)392:2<179::AID-CNE3>3.0.CO;2-#; WHITE EL, 1972, BRAIN RES, V37, P69, DOI 10.1016/0006-8993(72)90346-0; WHITE EL, 1973, BRAIN RES, V60, P299, DOI 10.1016/0006-8993(73)90792-0; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	147	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					354	364		10.1038/nn1403	http://dx.doi.org/10.1038/nn1403			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696160				2022-12-28	WOS:000227354600021
J	Gandhi, SP; Cang, JH; Stryker, MP				Gandhi, SP; Cang, JH; Stryker, MP			An eye-opening experience	NATURE NEUROSCIENCE			English	Editorial Material							VISUAL-CORTEX; CRITICAL PERIODS; RETINA; DEPRIVATION; PLASTICITY; REFINEMENT; RAT		Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gandhi, SP (corresponding author), Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [R37EY002874] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY002874, R37 EY002874-24S2] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100	15	17	17	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					9	10		10.1038/nn0105-9	http://dx.doi.org/10.1038/nn0105-9			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15622410	Green Accepted			2022-12-28	WOS:000225967600004
J	Bao, JX; Lin, H; Ouyang, Y; Lei, DB; Osman, A; Kim, TW; Mei, L; Dai, PG; Ohlemiller, KK; Ambron, RT				Bao, JX; Lin, H; Ouyang, Y; Lei, DB; Osman, A; Kim, TW; Mei, L; Dai, PG; Ohlemiller, KK; Ambron, RT			Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; PLASTICITY; GENE; EXPRESSION; MECHANISMS; PROTEINS; CLEAVAGE; REQUIRES; RELEASE; FAMILY	Neuregulin-1 (Nrg-1) contains an intracellular domain (Nrg-ICD) that translocates into the nucleus, where it may regulate gene expression upon neuronal depolarization. However, the identity of its target promoters and the mechanisms by which it regulates transcription have been elusive. Here we report that, in the mouse cochlea, synaptic activity increases the level of nuclear Nrg-ICD and upregulates postsynaptic density protein-95 (PSD-95), a scaffolding protein that is enriched in post-synaptic structures. Nrg-ICD enhances the transcriptional activity of the PSD-95 promoter by binding to a zinc-finger transcription factor, Eos. The Nrg-ICD-Eos complex induces endogenous PSD-95 expression in vivo through a signaling pathway that is mostly independent of gamma-secretase regulation. This upregulation of PSD-95 expression by the Nrg-ICD- Eos complex provides a molecular basis for activity-dependent synaptic plasticity.	Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA; Washington Univ, Ctr Aging, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Augusta, GA 30912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Columbia University; Columbia University; University System of Georgia; Augusta University	Bao, JX (corresponding author), Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA.	jbao@wustl.edu	Mei, Lin/G-8755-2012		NATIONAL INSTITUTE ON AGING [P50AG005681, K01AG001016] Funding Source: NIH RePORTER; NIA NIH HHS [AG05681, AG01016] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Grimm S, 1998, J EXP MED, V188, P1535, DOI 10.1084/jem.188.8.1535; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Morley BJ, 1998, MOL BRAIN RES, V54, P170, DOI 10.1016/S0169-328X(97)00355-0; Muller T J, 2001, World J Biol Psychiatry, V2, P9; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Perdomo J, 2000, J BIOL CHEM, V275, P38347, DOI 10.1074/jbc.M005457200; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Quaranta A, 1998, SCAND AUDIOL, V27, P75; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Roysommuti S, 2003, NEUROSCIENCE, V121, P779, DOI 10.1016/S0306-4522(03)00503-7; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Wang CH, 1998, NEUROGENETICS, V1, P273; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zhang M, 2002, HEARING RES, V169, P56, DOI 10.1016/S0378-5955(02)00339-8; Zito K, 2003, NEURON, V37, P1, DOI 10.1016/S0896-6273(02)01182-0	50	123	133	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1250	1258		10.1038/nn1342	http://dx.doi.org/10.1038/nn1342			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494726				2022-12-28	WOS:000224749400018
J	Li, WQ; Lee, J; Vikis, HG; Lee, SH; Liu, GF; Aurandt, J; Shen, TL; Fearon, ER; Guan, JL; Han, M; Rao, Y; Hong, KS; Guan, KL				Li, WQ; Lee, J; Vikis, HG; Lee, SH; Liu, GF; Aurandt, J; Shen, TL; Fearon, ER; Guan, JL; Han, M; Rao, Y; Hong, KS; Guan, KL			Activation of FAK and Src are receptor-proximal events required for netrin signaling	NATURE NEUROSCIENCE			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; C-ELEGANS; TYROSINE PHOSPHORYLATION; FAMILY KINASES; TERMINAL DOMAIN; AXON GUIDANCE; DCC; CELL	The axon guidance cue netrin is importantly involved in neuronal development. DCC (deleted in colorectal cancer) is a functional receptor for netrin and mediates axon outgrowth and the steering response. Here we show that different regions of the intracellular domain of DCC directly interacted with the tyrosine kinases Src and focal adhesion kinase (FAK). Netrin activated both FAK and Src and stimulated tyrosine phosphorylation of DCC. Inhibition of Src family kinases reduced DCC tyrosine phosphorylation and blocked both axon attraction and outgrowth of neurons in response to netrin. Mutation of the tyrosine phosphorylation residue in DCC abolished its function of mediating netrin-induced axon attraction. On the basis of our observations, we suggest a model in which DCC functions as a kinase-coupled receptor, and FAK and Src act immediately downstream of DCC in netrin signaling.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular Dev Biol, Boulder, CO 80309 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; Washington University (WUSTL); Cornell University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; Lee, Seung-Hee/J-5971-2013; Li, Weiquan/B-4897-2011	Shen, Tang-Long/0000-0001-6264-3608	NCI NIH HHS [R01 CA107193, R01 CA107193-03] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOCKHOLT SM, 1995, CELL ADHES COMMUN, V3, P91, DOI 10.3109/15419069509081279; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CARY LA, 1999, FRONT BIOSCI, V4, P102; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tabti N., 1991, CULTURING NERVE CELL, P137; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200	42	176	187	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1213	1221		10.1038/nn1329	http://dx.doi.org/10.1038/nn1329			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494734	Green Accepted, Green Submitted			2022-12-28	WOS:000224749400014
J	Bult, C; Kibbe, WA; Snoddy, J; Vitaterna, M; Swanson, D; Pretel, S; Li, YX; Hohman, MM; Rinchik, E; Takahashi, JS; Frankel, WN; Goldowitz, D				Bult, C; Kibbe, WA; Snoddy, J; Vitaterna, M; Swanson, D; Pretel, S; Li, YX; Hohman, MM; Rinchik, E; Takahashi, JS; Frankel, WN; Goldowitz, D			A genome end-game: understanding gene function in the nervous system	NATURE NEUROSCIENCE			English	Article							MOUSE		Jackson Lab, Neurosci Mutagenesis Facil, Bar Harbor, ME 04609 USA; Northwestern Univ, Howard Hughes Med Inst, Ctr Funct Genome, Evanston, IL 60208 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Ctr Genom & Bioinformat, Memphis, TN 38163 USA	Jackson Laboratory; Howard Hughes Medical Institute; Northwestern University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Bult, C (corresponding author), Jackson Lab, Neurosci Mutagenesis Facil, 600 Main St, Bar Harbor, ME 04609 USA.	dgold@nb.utmem.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kibbe, Warren/B-2106-2010	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Goldowitz, Daniel/0000-0003-4756-4017; Kibbe, Warren/0000-0001-5622-7659	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [U01 MH061915] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Noveroske JK, 2000, MAMM GENOME, V11, P478, DOI 10.1007/s003350010093; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818	3	17	17	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					484	485		10.1038/nn0504-484	http://dx.doi.org/10.1038/nn0504-484			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114363	Green Accepted			2022-12-28	WOS:000221101300018
J	Barraclough, DJ; Conroy, ML; Lee, D				Barraclough, DJ; Conroy, ML; Lee, D			Prefrontal cortex and decision making in a mixed-strategy game	NATURE NEUROSCIENCE			English	Article							STRICTLY COMPETITIVE GAMES; SUPPLEMENTARY EYE FIELD; PEOPLE PLAY GAMES; MINIMAX HYPOTHESIS; ANTERIOR CINGULATE; REWARD EXPECTANCY; NEURONAL-ACTIVITY; SIGNALS; CHOICE; RANDOMIZATION	In a multi-agent environment, where the outcomes of one's actions change dynamically because they are related to the behavior of other beings, it becomes difficult to make an optimal decision about how to act. Although game theory provides normative solutions for decision making in groups, how such decision-making strategies are altered by experience is poorly understood. These adaptive processes might resemble reinforcement learning algorithms, which provide a general framework for finding optimal strategies in a dynamic environment. Here we investigated the role of prefrontal cortex (PFC) in dynamic decision making in monkeys. As in reinforcement learning, the animal's choice during a competitive game was biased by its choice and reward history, as well as by the strategies of its opponent. Furthermore, neurons in the dorsolateral prefrontal cortex (DLPFC) encoded the animal's past decisions and payoffs, as well as the conjunction between the two, providing signals necessary to update the estimates of expected reward. Thus, PFC might have a key role in optimizing decision-making strategies.	Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Lee, D (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	dlee@cvs.rochester.edu	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X	NEI NIH HHS [EY01319] Funding Source: Medline; NINDS NIH HHS [NS44270] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044270] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; [Anonymous], 1997, MACHIAVELLIAN INTELL; [Anonymous], 1998, THEORY LEARNING GAME; Binmore K, 2001, ECON J, V111, P445, DOI 10.1111/1468-0297.00645; BROWN JN, 1990, ECONOMETRICA, V58, P1065, DOI 10.2307/2938300; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BUDESCU DV, 1994, J BEHAV DECIS MAKING, V7, P261, DOI 10.1002/bdm.3960070404; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Byrne R., 1988, MACHIAVELLIAN INTELL; Camerer C, 2003, BEHAV GAME THEORY; Chen HC, 1997, GAME ECON BEHAV, V18, P32, DOI 10.1006/game.1997.0514; Christensen R, 1997, LOG LINEAR MODELS LO; Dixit A., 1999, GAMES STRATEGY; Erev I, 1998, AM ECON REV, V88, P848; Fudenberg D., 1991, GAME THEORY; Glimcher PW, 2003, BRADFORD BOOKS, P1; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LITTMAN ML, 1994, MACH LEARN, P157; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MOOKHERJEE D, 1994, GAME ECON BEHAV, V7, P62, DOI 10.1006/game.1994.1037; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; ONEILL B, 1987, P NATL ACAD SCI USA, V84, P2106, DOI 10.1073/pnas.84.7.2106; ONEILL B, 1991, ECONOMETRICA, V59, P503, DOI 10.2307/2938267; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RAPOPORT A, 1992, GAME ECON BEHAV, V4, P261, DOI 10.1016/0899-8256(92)90019-O; Rapoport A, 1997, PSYCHOL REV, V104, P603, DOI 10.1037/0033-295X.104.3.603; RAPOPORT A, 1992, J EXP PSYCHOL GEN, V121, P352, DOI 10.1037/0096-3445.121.3.352; ROBINSON J, 1951, ANN MATH, V54, P296, DOI 10.2307/1969530; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; ROLLS ET, 1999, BRAIN EMOTION; Rubinstein A., 1998, MODELING BOUNDED RAT; Sarin R, 2001, GAME ECON BEHAV, V34, P104, DOI 10.1006/game.1999.0783; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shachat JM, 2002, J ECON THEORY, V104, P189, DOI 10.1006/jeth.2001.2915; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simon H. A., 1957, MODELS MAN; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; TOUHEY JC, 1974, HUM RELAT, V27, P813, DOI 10.1177/001872677402700807; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	50	478	486	2	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					404	410		10.1038/nn1209	http://dx.doi.org/10.1038/nn1209			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	807DP	15004564				2022-12-28	WOS:000220482500020
J	Lengyel, M; Kwag, J; Paulsen, O; Dayan, P				Lengyel, M; Kwag, J; Paulsen, O; Dayan, P			Matching storage and recall: hippocampal spike timing-dependent plasticity and phase response curves	NATURE NEUROSCIENCE			English	Article							NEURAL NETWORKS; SYNAPTIC MODIFICATION; THETA-OSCILLATIONS; GRADED-RESPONSE; PYRAMIDAL CELLS; OLFACTORY-BULB; NEURONS; SLEEP; RETRIEVAL; MEMORY	Hippocampal area CA3 is widely considered to function as an autoassociative memory. However, it is insufficiently understood how it does so. In particular, the extensive experimental evidence for the importance of carefully regulated spiking times poses the question as to how spike timing - based dynamics may support memory functions. Here, we develop a normative theory of autoassociative memory encompassing such network dynamics. Our theory specifies the way that the synaptic plasticity rule of a memory constrains the form of neuronal interactions that will retrieve memories optimally. If memories are stored by spike timing dependent plasticity, neuronal interactions should be formalized in terms of a phase response curve, indicating the effect of presynaptic spikes on the timing of postsynaptic spikes. We show through simulation that such memories are competent analog autoassociators and demonstrate directly that the attributes of phase response curves of CA3 pyramidal cells recorded in vitro qualitatively conform with the theory.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of London; University College London; University of Oxford	Lengyel, M (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	lmate@gatsby.ucl.ac.uk	Paulsen, Ole/ABB-4843-2020; Lengyel, Mate/A-6665-2013	Paulsen, Ole/0000-0002-2258-5455; Lengyel, Mate/0000-0001-7266-0049; Dayan, Peter/0000-0003-3476-1839				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; [Anonymous], 1998, NEURAL NETWORKS BRAI; BAIRD B, 1990, PHYSICA D, V42, P365, DOI 10.1016/0167-2789(90)90089-8; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; ENGEL A, 1989, EUROPHYS LETT, V8, P393, DOI 10.1209/0295-5075/8/4/016; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P225, DOI 10.1162/neco.1994.6.2.225; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hendin O, 1998, J COMPUT NEUROSCI, V5, P157, DOI 10.1023/A:1008813915992; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huhn Z, 2005, HIPPOCAMPUS, V15, P950, DOI 10.1002/hipo.20112; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LI Z, 1995, MODELS NEURAL NETWOR, V2, P221; Li ZP, 2000, NETWORK-COMP NEURAL, V11, P83, DOI 10.1088/0954-898X/11/1/305; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MACKAY DJC, 1991, FUND THEOR, V43, P237; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Scarpetta S, 2002, NEURAL COMPUT, V14, P2371, DOI 10.1162/08997660260293265; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sommer FT, 1998, IEEE T NEURAL NETWOR, V9, P705, DOI 10.1109/72.701183; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TREVES A, 1990, PHYS REV A, V42, P2418, DOI 10.1103/PhysRevA.42.2418; Wang DL, 1990, NEURAL COMPUT, V2, P94, DOI 10.1162/neco.1990.2.1.94	50	90	92	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1677	1683		10.1038/nn1561	http://dx.doi.org/10.1038/nn1561			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261136				2022-12-28	WOS:000233576200015
J	Dani, JA; Harris, RA				Dani, JA; Harris, RA			Nicotine addiction and comorbidity with alcohol abuse and mental illness	NATURE NEUROSCIENCE			English	Review							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; BRAIN REWARD FUNCTION; ACETYLCHOLINE-RECEPTORS; DOPAMINE RELEASE; SYNAPTIC MECHANISMS; CHOLINERGIC MODULATION; MOLECULAR-MECHANISMS; CIGARETTE-SMOKING; DEPENDENCE	The World Health Organization estimates that one-third of the global adult population smokes. Because tobacco use is on the rise in developing countries, death resulting from tobacco use continues to rise. Nicotine, the main addictive component of tobacco, initiates synaptic and cellular changes that underlie the motivational and behavioral alterations that culminate in addiction. Nicotine addiction progresses rapidly in adolescents and is most highly expressed in vulnerable people who have psychiatric illness or other substance abuse problems.	Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Dept Neurosci, Houston, TX 77030 USA; Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	Baylor College of Medicine; University of Texas System; University of Texas Austin	Dani, JA (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Dept Neurosci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu			NINDS NIH HHS [R01 NS021229] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021229] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adriani W, 2003, J NEUROSCI, V23, P4712; Balfour DJK, 2000, PHARMACOL BIOCHEM BE, V66, P79, DOI 10.1016/S0091-3057(00)00205-7; Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Berrendero F, 2002, J NEUROSCI, V22, P10935; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Blomqvist O, 2002, ALCOHOL CLIN EXP RES, V26, P326, DOI 10.1097/00000374-200203000-00004; Borghese CM, 2003, J PHARMACOL EXP THER, V307, P42, DOI 10.1124/jpet.102.053710; Butt CM, 2004, J PHARMACOL EXP THER, V308, P591, DOI 10.1124/jpet.103.059758; Butt CM, 2003, ALCOHOL CLIN EXP RES, V27, P733, DOI 10.1097/01.ALC.0000067973.41153.BC; Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Clark A, 2001, NEUROPHARMACOLOGY, V41, P108, DOI 10.1016/S0028-3908(01)00037-5; Cohen C, 2005, PHARMACOL BIOCHEM BE, V81, P387, DOI 10.1016/j.pbb.2005.01.024; Corrigall W A, 1999, Nicotine Tob Res, V1, P11, DOI 10.1080/14622299050011121; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; de Fiebre N, 2002, ALCOHOL CLIN EXP RES, V26, P765, DOI 10.1097/00000374-200206000-00004; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; DEFIEBRE CM, 1987, ALCOHOL, V4, P493, DOI 10.1016/0741-8329(87)90092-9; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Fowler JS, 1996, P NATL ACAD SCI USA, V93, P14065, DOI 10.1073/pnas.93.24.14065; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.3.CO;2-3; Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; HENNINGFIELD JE, 2003, TOBACCO CONTROL S1, V12, P14; HUGHES JR, 1994, ADDICTION, V89, P1461, DOI 10.1111/j.1360-0443.1994.tb03744.x; Hughes JR, 2000, ALCOHOL CLIN EXP RES, V24, P1633, DOI 10.1097/00000374-200011000-00005; John U, 2003, ADDICTION, V98, P805, DOI 10.1046/j.1360-0443.2003.00381.x; Johnson BA, 2004, ADDICT BEHAV, V29, P1465, DOI 10.1016/j.addbeh.2004.06.014; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karan LD, 2003, PRINCIPLES ADDICTION, P225; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Lanca AJ, 2000, NEUROSCIENCE, V96, P735, DOI 10.1016/S0306-4522(99)00607-7; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Levin ED, 2003, PSYCHOPHARMACOLOGY, V169, P141, DOI 10.1007/s00213-003-1486-y; Lopez MF, 2001, ADDICT BIOL, V6, P119, DOI 10.1080/13556210020040190; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; MADDEN PAF, 1995, ALCOHOL CLIN EXP RES, V19, P1111, DOI 10.1111/j.1530-0277.1995.tb01588.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; McEvoy JP, 1999, AM J PSYCHIAT, V156, P1120; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Owens JC, 2003, ALCOHOL CLIN EXP RES, V27, P1867, DOI 10.1097/01.ALC.0000102700.72447.0F; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Picciotto MR, 2002, J NEUROSCI, V22, P3338; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Quattrocki E, 2000, HARVARD REV PSYCHIAT, V8, P99, DOI 10.1093/hrp/8.3.99; Riala K, 2004, J ADOLESCENT HEALTH, V35, P245, DOI 10.1016/j.jadohealth.2003.08.016; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Salas R, 2004, J NEUROSCI, V24, P10035, DOI 10.1523/JNEUROSCI.1939-04.2004; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Schilstrom B, 2003, INT J NEUROPSYCHOPH, V6, P1, DOI 10.1017/S1461145702003188; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; Schuckit MA, 2004, ALCOHOL ALCOHOLISM, V39, P433, DOI 10.1093/alcalc/agh081; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Staley JK, 2005, ARCH GEN PSYCHIAT, V62, P877, DOI 10.1001/archpsyc.62.8.877; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; Upadhyaya HP, 2002, J AM ACAD CHILD PSY, V41, P1294, DOI 10.1097/00004583-200211000-00010; Vastola BJ, 2002, PHYSIOL BEHAV, V77, P107, DOI 10.1016/S0031-9384(02)00818-1; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Wonnacott S, 2005, CURR OPIN PHARMACOL, V5, P53, DOI 10.1016/j.coph.2004.12.002; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; World Health Organization, 1997, TOB HLTH GLOB STAT R; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	92	283	289	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1465	1470		10.1038/nn1580	http://dx.doi.org/10.1038/nn1580			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251989				2022-12-28	WOS:000232966600017
J	Gazzaley, A; Cooney, JW; Rissman, J; D'Esposito, M				Gazzaley, A; Cooney, JW; Rissman, J; D'Esposito, M			Top-down suppression deficit underlies working memory impairment in normal aging	NATURE NEUROSCIENCE			English	Article							INHIBITORY CONTROL; ATTENTION; FMRI	In this study, we assess the impact of normal aging on top-down modulation, a cognitive control mechanism that supports both attention and memory by the suppression and enhancement of sensory processing in accordance with task goals. Using fMRI ( functional magnetic resonance imaging), we show that healthy older adults demonstrated a prominent deficit in the suppression of cortical activity associated with task-irrelevant representations, whereas enhancement of task-relevant activity was preserved. Moreover, this suppression-specific attention deficit correlated with impaired working memory performance.	Univ Calif Berkeley, Henry H Wheeler Jr Brain Imaging Ctr, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gazzaley, A (corresponding author), Univ Calif San Francisco, 1700 4th St,Room 102C, San Francisco, CA 94143 USA.	adamgazz@comewander.com	Rissman, Jesse/ABH-2217-2021	Rissman, Jesse/0000-0001-8889-5539; Cooney, Jeffrey/0000-0002-9903-5400				Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; CRAIK FI, 2000, HDB AGING COGNITION, V2; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; May CP, 1999, MEM COGNITION, V27, P759, DOI 10.3758/BF03198529; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Ploner CJ, 2001, EUR J NEUROSCI, V13, P357, DOI 10.1046/j.1460-9568.2001.01397.x; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; West R, 1999, MEM COGNITION, V27, P1064, DOI 10.3758/BF03201235; [No title captured]	15	655	663	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1298	1300		10.1038/nn1543	http://dx.doi.org/10.1038/nn1543			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	968EY	16158065				2022-12-28	WOS:000232145900012
J	Vishwanath, D; Girshick, AR; Banks, MS				Vishwanath, D; Girshick, AR; Banks, MS			Why pictures look right when viewed from the wrong place	NATURE NEUROSCIENCE			English	Article							PSYCHOMETRIC FUNCTION; SHAPE CONSTANCY; PERCEPTION; SURFACE; SLANT; COMPENSATION; ORIENTATION; DISPARITY; POINTS; FUSION	A picture viewed from its center of projection generates the same retinal image as the original scene, so the viewer perceives the scene correctly. When a picture is viewed from other locations, the retinal image specifies a different scene, but we normally do not notice the changes. We investigated the mechanism underlying this perceptual invariance by studying the perceived shapes of pictured objects viewed from various locations. We also manipulated information about the orientation of the picture surface. When binocular information for surface orientation was available, perceived shape was nearly invariant across a wide range of viewing angles. By varying the projection angle and the position of a stimulus in the picture, we found that invariance is achieved through an estimate of local surface orientation, not from geometric information in the picture. We present a model that explains invariance and other phenomena ( such as perceived distortions in wide-angle pictures).	Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Vishwanath, D (corresponding author), Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA.	dxvgss@rit.edu			NEI NIH HHS [R01 EY014194-03, R01 EY014194, F32 EY14514, F32 EY014514, R01 EY014194-02, R01-EY014194] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY014514, R01EY014194] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams KR., 1972, LEONARDO, V5, P209, DOI [10.2307/1572377, DOI 10.2307/1572377]; AGRAWALA M, 2000, P 11 EUR REND WORKSH, V11, P125; ALESSE C, 1989, BASIC 35MM PHOTO GUI; Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; Banks MS, 2004, J NEUROSCI, V24, P2077, DOI 10.1523/JNEUROSCI.3852-02.2004; BURT P, 1980, SCIENCE, V208, P615, DOI 10.1126/science.7367885; BUSEY TA, 1990, PERCEPT PSYCHOPHYS, V48, P1, DOI 10.3758/BF03205006; CAPRILE B, 1990, INT J COMPUT VISION, V4, P127, DOI 10.1007/BF00127813; CUTTING JE, 1987, J EXP PSYCHOL HUMAN, V13, P323, DOI 10.1037/0096-1523.13.3.323; da Vinci Leonardo, 1970, LIT WORKS L DAVINCI, V3rd; EPSTEIN W, 1963, PSYCHOL BULL, V60, P265, DOI 10.1037/h0040875; EVANS F, 2000, SPIE VISUAL DATA EXP, V7; GARDING J, 1992, J MATH IMAGING VIS, V2, P329; Gershun A., 1939, J MATH PHYS, V18, P51, DOI [10.1002/sapm193918151, DOI 10.1002/SAPM193918151]; GIANCOLI DC, 2000, PHYS PRINCIPLES APPL; Gibson JJ, 1950, PERCEPTION VISUAL WO; GOLDSTEIN EB, 1987, J EXP PSYCHOL HUMAN, V13, P256, DOI 10.1037/0096-1523.13.2.256; Gombrich EH., 1960, ART ILLUSION; GREENE R, 1983, LEONARDO, V16, P97, DOI 10.2307/1574793; HAGEN MA, 1976, DEV PSYCHOL, V12, P57; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Hillis JM, 2001, VISION RES, V41, P2457, DOI 10.1016/S0042-6989(01)00137-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kingslake R., 1951, LENSES PHOTOGRAPHY P; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Koenderink JJ, 2003, LOOKING INTO PICTURES, P239; Kubovy M., 1986, PSYCHOL PERSPECTIVE; LAGOURNERIE JD, 1959, TRAITE PERSPECTIVE L; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Mamassian P, 1997, EXP BRAIN RES, V114, P235, DOI 10.1007/PL00005632; MEISTER R, 1966, J SOC MOTION PICT T, V75, P179; OLMER P, 1949, TRACES PRATIQUES; PERKINS DN, 1973, PERCEPT PSYCHOPHYS, V14, P13, DOI 10.3758/BF03198608; Pirenne M. H., 1970, OPTICS PAINTING PHOT; REGAN D, 1992, VISION RES, V32, P1845, DOI 10.1016/0042-6989(92)90046-L; Rogers Sheena, 1995, PERCEPT SP MOTION, P119; ROSINSKI RR, 1980, PERCEPT PSYCHOPHYS, V28, P521, DOI 10.3758/BF03198820; Rosinski RR., 1980, PERCEPTION PICTURES, V1, P137; Sedgwick H.A., 1991, PICTORIAL COMMUNICAT, P460; STEVENS KA, 1983, BIOL CYBERN, V46, P183, DOI 10.1007/BF00336800; Thouless RH, 1931, B J PSYCHOL-GEN SECT, V21, P339, DOI 10.1111/j.2044-8295.1931.tb00597.x; Topper D, 2000, LEONARDO, V33, P115, DOI 10.1162/002409400552379; WALLACH H, 1986, PERCEPT PSYCHOPHYS, V39, P233, DOI 10.3758/BF03204929; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZORIN D, 1995, P SIGGRAPH 1995 ACM, V14, P257	46	114	118	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1401	1410		10.1038/nn1553	http://dx.doi.org/10.1038/nn1553			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	968EY	16172600	Green Accepted			2022-12-28	WOS:000232145900026
J	Wilent, WB; Contreras, D				Wilent, WB; Contreras, D			Dynamics of excitation and inhibition underlying stimulus selectivity in rat somatosensory cortex	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; BARREL CORTEX; RESPONSE TRANSFORMATION; NEOCORTICAL NEURONS; THALAMIC BARRELOIDS; WHISKER DEFLECTIONS; TRIGEMINAL GANGLION; RECEPTIVE-FIELDS; SYNAPSE LOCATION; AUDITORY-CORTEX	Neurons in sensory systems respond to stimuli within their receptive fields, but the magnitude of the response depends on specific stimulus features. In the rodent whisker system, the response magnitude to the deflection of a particular whisker is, in most cells, dependent on the direction of deflection. Here we use in vivo intracellular recordings from thalamorecipient neurons in layers 3 and 4 of the rat barrel cortex to elucidate the dynamics of the synaptic inputs underlying direction selectivity. We show that cells are direction selective despite a broadly tuned excitatory and inhibitory synaptic input. Selectivity emerges from a direction-dependent temporal shift of excitation relative to inhibition. For preferred direction deflections, excitation precedes inhibition, but as the direction diverges from the preferred, this separation decreases. Our results illustrate a mechanism by which the timing of the synaptic inputs, and not their relative peak amplitudes, primarily determine feature selectivity.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19106 USA	University of Pennsylvania	Contreras, D (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall, Philadelphia, PA 19106 USA.	diegoc@mail.med.upenn.edu						Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; Deschenes M, 2003, J NEUROSCI, V23, P6778; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Higley MJ, 2003, J NEUROSCI, V23, P10190; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Johnston D, 1996, FDN CELLULAR NEUROPH; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MILLER W, 1988, CABIOS, V4, P11; Minnery BS, 2003, J NEUROPHYSIOL, V90, P1556, DOI 10.1152/jn.00111.2003; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; MULLE C, 1985, BRAIN RES, V333, P350, DOI 10.1016/0006-8993(85)91591-4; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Veinante P, 1999, J NEUROSCI, V19, P5085; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; WILLIAMS MN, 1994, EUR J NEUROSCI, V6, P429, DOI 10.1111/j.1460-9568.1994.tb00286.x; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	47	224	230	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1364	1370		10.1038/nn1545	http://dx.doi.org/10.1038/nn1545			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158064				2022-12-28	WOS:000232145900021
J	Chen, XK; Wang, LC; Zhou, Y; Cai, Q; Prakriya, M; Duan, KL; Sheng, ZH; Lingle, C; Zhou, Z				Chen, XK; Wang, LC; Zhou, Y; Cai, Q; Prakriya, M; Duan, KL; Sheng, ZH; Lingle, C; Zhou, Z			Activation of GPCRs modulates quantal size in chromaffin cells through G(beta gamma) and PKC	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; FUSION PORE KINETICS; BETA-GAMMA-SUBUNITS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; SECRETORY GRANULES; VESICLE FUSION; EXOCYTOSIS; RECEPTOR	Exocytosis proceeds by either full fusion or 'kiss-and-run' between vesicle and plasma membrane. Switching between these two modes permits the cell to regulate the kinetics and amount of secretion. Here we show that ATP receptor activation reduces secretion downstream from cytosolic Ca2+ elevation in rat adrenal chromaffin cells. This reduction is mediated by activation of a pertussis toxin - sensitive G(i/o) protein, leading to activation of G(beta gamma) subunits, which promote the `kiss-and-run' mode by reducing the total open time of the fusion pore during a vesicle fusion event. Furthermore, parallel activation of the muscarinic acetylcholine receptor removes the inhibitory effects of ATP on secretion. This is mediated by a G(q) pathway through protein kinase C activation. The inhibitory effects of ATP and its reversal by protein kinase C activation are also shared by opioids and somatostatin. Thus, a variety of G protein pathways exist to modulate Ca2+-evoked secretion at specific steps in fusion pore formation.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; NINDS, Synapt Funct Unit, Bethesda, MD 20892 USA; Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; Peking Univ, Coll Life Sci, State Key Lab Biomembrane Engn, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Washington University (WUSTL); Peking University	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	zzhou@pku.edu.cn	chen, xiaoke/E-5385-2011; zhou, zhuan/A-8285-2011	Prakriya, Murali/0000-0003-0781-4480; Lingle, Christopher/0000-0002-9916-3795	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002946] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046564, DK46564] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARTALEJO AR, 1995, ELECTROPHYSIOLOGY NE, P259; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Carabelli V, 1998, NEURON, V20, P1255, DOI 10.1016/S0896-6273(00)80505-X; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Duan KL, 2003, J NEUROSCI, V23, P11235; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Ennion SJ, 2004, MOL PHARMACOL, V66, P601, DOI 10.1124/mol.104.000224; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Lim W, 1997, PFLUG ARCH EUR J PHY, V435, P34, DOI 10.1007/s004240050481; LIVETT BG, 1984, CAN J PHYSIOL PHARM, V62, P467, DOI 10.1139/y84-076; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Nagy G, 2002, J NEUROSCI, V22, P9278; NEELY A, 1992, J PHYSIOL-LONDON, V453, P133, DOI 10.1113/jphysiol.1992.sp019221; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Powell AD, 2000, J NEUROSCI, V20, P606, DOI 10.1523/JNEUROSCI.20-02-00606.2000; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Smith C, 1999, J NEUROSCI, V19, P589; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498	39	85	86	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1160	1168		10.1038/nn1529	http://dx.doi.org/10.1038/nn1529			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116443				2022-12-28	WOS:000231483800015
J	Tsuchiya, N; Koch, C				Tsuchiya, N; Koch, C			Continuous flash suppression reduces negative afterimages	NATURE NEUROSCIENCE			English	Article							MOTION-INDUCED BLINDNESS; PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; AFTER-IMAGES; COMPLEMENTARY AFTERIMAGES; INTEROCULAR SUPPRESSION; ADAPTATION; PERCEPTION; AWARENESS; ATTENTION	Illusions that produce perceptual suppression despite constant retinal input are used to manipulate visual consciousness. Here we report on a powerful variant of existing techniques, continuous flash suppression. Distinct images flashed successively at similar to 10 Hz into one eye reliably suppress an image presented to the other eye. The duration of perceptual suppression is at least ten times greater than that produced by binocular rivalry. Using this tool we show that the strength of the negative afterimage of an adaptor was reduced by half when it was perceptually suppressed by input from the other eye. The more completely the adaptor was suppressed, the more strongly the afterimage intensity was reduced. Paradoxically, trial-to-trial visibility of the adaptor did not correlate with the degree of reduction. Our results imply that formation of afterimages involves neuronal structures that access input from both eyes but that do not correspond directly to the neuronal correlates of perceptual awareness.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Computat & Neural Syst Program, M-S 139-74,1200 E Calif Blvd, Pasadena, CA 91125 USA.	naotsu@klab.caltech.edu	; Tsuchiya, Naotsugu/N-8153-2014	Koch, Christof/0000-0001-6482-8067; Tsuchiya, Naotsugu/0000-0003-4216-8701				ALPERN M, 1962, J OPT SOC AM, V52, P219, DOI 10.1364/JOSA.52.000219; ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Blake Randolph, 1995, P17; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BOSSINK CJH, 1993, VISION RES, V33, P1413, DOI 10.1016/0042-6989(93)90047-Z; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hofstoetter C, 2004, CONSCIOUS COGN, V13, P691, DOI 10.1016/j.concog.2004.06.007; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; Koch Christof, 2004, QUEST CONSCIOUSNESS; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LACK LC, 1978, SELECTIVE ATTENTION, P117; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BINOCULAR RIVALTY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; Lou L, 2001, PERCEPTION, V30, P1439, DOI 10.1068/p3127; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; SAKITT B, 1976, VISION RES, V16, P129, DOI 10.1016/0042-6989(76)90089-4; SCHILLER PH, 1994, VISUAL NEUROSCI, V11, P643, DOI 10.1017/S0952523800002960; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Suzuki S, 2003, J EXP PSYCHOL HUMAN, V29, P793, DOI 10.1037/0096-1523.29.4.793; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; Weiskrantz L, 1950, Q J EXP PSYCHOL, V2, P170, DOI 10.1080/17470215008416594; Weiskrantz L, 2002, CONSCIOUS COGN, V11, P568, DOI 10.1016/S1053-8100(02)00015-6; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	50	613	628	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1096	1101		10.1038/nn1500	http://dx.doi.org/10.1038/nn1500			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	15995700				2022-12-28	WOS:000230760200022
J	Thomas, P; Mortensen, M; Hosie, AM; Smart, TG				Thomas, P; Mortensen, M; Hosie, AM; Smart, TG			Dynamic mobility of functional GABA(A) receptors at inhibitory synapses	NATURE NEUROSCIENCE			English	Article							ADULT-RAT BRAIN; GAMMA-2 SUBUNIT; BENZODIAZEPINE-RECEPTORS; SYNAPTIC-TRANSMISSION; GLYCINE RECEPTORS; BREFELDIN-A; TRAFFICKING; EXPRESSION; SUBTYPES; LOCALIZATION	Importing functional GABA(A) receptors into synapses is fundamental for establishing and maintaining inhibitory transmission and for controlling neuronal excitability. By introducing a binding site for an irreversible inhibitor into the GABA(A) receptor alpha 1 subunit channel lining region that can be accessed only when the receptor is activated, we have determined the dynamics of receptor mobility between synaptic and extrasynaptic locations in hippocampal pyramidal neurons. We demonstrate that the cell surface GABA(A) receptor population shows no fast recovery after irreversible inhibition. In contrast, after selective inhibition, the synaptic receptor population rapidly recovers by the import of new functional entities within minutes. The trafficking pathways that promote rapid importation of synaptic receptors do not involve insertion from intracellular pools, but reflect receptor diffusion within the plane of the membrane. This process offers the synapse a rapid mechanism to replenish functional GABA(A) receptors at inhibitory synapses and a means to control synaptic efficacy.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Mortensen, Martin/0000-0002-5873-7107	Medical Research Council [G0601529] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnes EM, 1996, INT REV NEUROBIOL, V39, P53, DOI 10.1016/S0074-7742(08)60663-7; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Rasmussen H, 2002, MOL CELL NEUROSCI, V19, P201, DOI 10.1006/mcne.2001.1074; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TEHRANI MHJ, 1991, J NEUROCHEM, V57, P1307, DOI 10.1111/j.1471-4159.1991.tb08295.x; Tovar KR, 2002, NEURON, V34, P253; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; VELAZQUEZ JL, 1989, J NEUROSCI, V9, P2163; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	45	132	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					889	897		10.1038/nn1483	http://dx.doi.org/10.1038/nn1483			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951809				2022-12-28	WOS:000230137100016
J	He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE				He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE			A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; EPIDERMAL-GROWTH-FACTOR; ASTROCYTE DIFFERENTIATION; SERINE PHOSPHORYLATION; NEURONAL DIFFERENTIATION; MAXIMAL ACTIVATION; MAMMALIAN BRAIN; GLIAL IDENTITY	During development of the CNS, neurons and glia are generated in a sequential manner. The mechanism underlying the later onset of gliogenesis is poorly understood, although the cytokine-induced Jak-STAT pathway has been postulated to regulate astrogliogenesis. Here, we report that the overall activity of Jak-STAT signaling is dynamically regulated in mouse cortical germinal zone during development. As such, activated STAT1/3 and STAT-mediated transcription are negligible at early, neurogenic stages, when neurogenic factors are highly expressed. At later, gliogenic periods, decreased expression of neurogenic factors causes robust elevation of STAT activity. Our data demonstrate a positive autoregulatory loop whereby STAT1/3 directly induces the expression of various components of the Jak-STAT pathway to strengthen STAT signaling and trigger astrogliogenesis. Forced activation of Jak-STAT signaling leads to precocious astrogliogenesis, and inhibition of this pathway blocks astrocyte differentiation. These observations suggest that autoregulation of the Jak-STAT pathway controls the onset of astrogliogenesis.	Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; MRC National Institute for Medical Research	Sun, YE (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	ysun@mednet.ucla.edu	Martinowich, Keri/F-9841-2012; Castro, Diogo S/I-6217-2016; Wu, Hao/G-4145-2013	Castro, Diogo S/0000-0001-8178-9565; Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929; Fan, Guoping/0000-0001-5235-6410; Martinowich, Keri/0000-0002-5237-0789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405] Funding Source: NIH RePORTER; NICHD NIH HHS [HD006576, P01 HD006576] Funding Source: Medline; NIMH NIH HHS [R01 MH066196] Funding Source: Medline; NINDS NIH HHS [R01 NS044405, NS44405] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bayer S.A., 1991, NEOCORTICAL DEV; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Chambers CB, 2001, DEVELOPMENT, V128, P689; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Li WW, 1998, J NEUROSCI, V18, P8853; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Sun YE, 2003, SEMIN CELL DEV BIOL, V14, P161, DOI 10.1016/S1084-9521(03)00007-7; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Viti J, 2003, J NEUROSCI, V23, P3385; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	49	291	300	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					616	625		10.1038/nn1440	http://dx.doi.org/10.1038/nn1440			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852015	Green Accepted			2022-12-28	WOS:000228895100022
J	Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE				Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE			PI(4,5)P-2 regulates the activation and desensitization of TRPM8 channels through the TRP domain	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRUCTURAL DETERMINANTS; CAPSAICIN RECEPTOR; POTASSIUM CHANNELS; PIP2; INHIBITION; PHOSPHOINOSITIDES; IDENTIFICATION	The subjective feeling of cold is mediated by the activation of TRPM8 channels in thermoreceptive neurons by cold or by cooling agents such as menthol. Here, we demonstrate a central role for phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in the activation of recombinant TRPM8 channels by both cold and menthol. Moreover, we show that Ca2+ influx through these channels activates a Ca2+-sensitive phospholipase C and that the subsequent depletion of PI(4,5)P-2 limits channel activity, serving as a unique mechanism for desensitization of TRPM8 channels. Finally, we find that mutation of conserved positive residues in the highly conserved proximal C-terminal TRP domain of TRPM8 and two other family members, TRPM5 and TRPV5, reduces the sensitivity of the channels for PI(4,5)P-2 and increases inhibition by PI(4,5)P-2 depletion. These data suggest that the TRP domain of these channels may serve as a PI(4,5)P-2-interacting site and that regulation by PI(4,5)P-2 is a common feature of members of the TRP channel family.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			NHLBI NIH HHS [HL59949] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Dodier Y, 2004, J BIOL CHEM, V279, P6853, DOI 10.1074/jbc.M310534200; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luzzi V, 1998, J BIOL CHEM, V273, P28657, DOI 10.1074/jbc.273.44.28657; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Ridefelt P, 1998, ANTICANCER RES, V18, P1819; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; SCHAFER K, 1982, J NEUROPHYSIOL, V47, P1017, DOI 10.1152/jn.1982.47.6.1017; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	50	443	471	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					626	634		10.1038/nn1451	http://dx.doi.org/10.1038/nn1451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852009				2022-12-28	WOS:000228895100023
J	Irvine, EE; Vernon, J; Giese, KP				Irvine, EE; Vernon, J; Giese, KP			ACaMKII autophosphorylation contributes to rapid learning but is not necessary for memory	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; PHOSPHORYLATION; STORAGE	Autophosphorylation of a calcium - calmodulin-dependent kinase II (alpha CaMKII) has been proposed to be the key event in memory storage. We tested this hypothesis with autophosphorylation-deficient mutant mice in hippocampus- and amygdala-dependent learning and memory tasks and found that the autophosphorylation of aCaMKII was required for rapid learning but was not essential for memory. We conclude that aCaMKII autophosphorylation contributes to single-trial learning but is dispensable for memory.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Giese, KP (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	p.giese@ucl.ac.uk	Giese, Karl P/A-3112-2011	Giese, Karl P/0000-0003-4503-7344; Irvine, Elaine/0000-0001-5508-8140				Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520	15	98	102	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					411	412		10.1038/nn1431	http://dx.doi.org/10.1038/nn1431			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778710				2022-12-28	WOS:000228040400007
J	Prakash, S; Caldwell, JC; Eberl, DF; Clandinin, TR				Prakash, S; Caldwell, JC; Eberl, DF; Clandinin, TR			Drosophila N-cadherin mediates an attractive interaction between photoreceptor axons and their targets	NATURE NEUROSCIENCE			English	Article							NEURONAL PROCESS OUTGROWTH; DIFFERENTIAL EXPRESSION; CELL REARRANGEMENT; DN-CADHERIN; DIVERSITY; MORPHOGENESIS; COMPLEX; MELANOGASTER; ORGANIZATION; SPECIFICITY	Classical cadherins have been proposed to mediate interactions between pre- and postsynaptic cells that are necessary for synapse formation. We provide the first direct, genetic evidence in favor of this model by examining the role of N-cadherin in controlling the pattern of synaptic connections made by photoreceptor axons in Drosophila. N-cadherin is required in both individual photoreceptors and their target neurons for photoreceptor axon extension. Cell-by-cell reconstruction of wild-type photoreceptor axons extending within mosaic patches of mutant target cells shows that N-cadherin mediates attractive interactions between photoreceptors and their targets. This interaction is not limited to those cells that will become the synaptic partners of photoreceptors. Multiple N-cadherin isoforms are produced, but single isoforms can substitute for endogenous N-cadherin activity. We propose that N-cadherin mediates a homophilic, attractive interaction between photoreceptor growth cones and their targets that precedes synaptic partner choice.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, 299 W Campus Dr, Stanford, CA 94305 USA.	trc@stanford.edu	Eberl, Daniel F./AAN-3359-2020	Eberl, Daniel F./0000-0001-9982-9895	NATIONAL EYE INSTITUTE [R01EY015231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004848] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015231, R01 EY015231-01A1] Funding Source: Medline; NIDCD NIH HHS [R01 DC004848-05, R01 DC004848, R01 DC004848-03, R01 DC004848-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anand A, 2001, GENETICS, V158, P1569; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Dumstrei K, 2003, J NEUROSCI, V23, P3325; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hill E, 2001, J MOL BIOL, V305, P1011, DOI 10.1006/jmbi.2000.4361; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lele Z, 2002, DEVELOPMENT, V129, P3281; Malicki J, 2003, DEV BIOL, V259, P95, DOI 10.1016/S0012-1606(03)00181-7; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Meinertzhagen Ian A., 1993, P1363; Poskanzer K, 2003, J NEUROSCI, V23, P2294; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Ranscht B, 2000, INT J DEV NEUROSCI, V18, P643, DOI 10.1016/S0736-5748(00)00030-7; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Yagi T, 2000, GENE DEV, V14, P1169; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	36	92	94	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					443	450		10.1038/nn1415	http://dx.doi.org/10.1038/nn1415			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15735641	Green Accepted			2022-12-28	WOS:000228040400014
J	Tunik, E; Frey, SH; Grafton, ST				Tunik, E; Frey, SH; Grafton, ST			Virtual lesions of the anterior intraparietal area disrupt goal-dependent on-line adjustments of grasp	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; VISUAL GUIDANCE; HAND ACTION; NEURONS; ACTIVATION; PERTURBATION; MOVEMENTS; OBJECTS; DISCRIMINATION; MANIPULATION	Adaptive motor behavior requires efficient error detection and correction. The posterior parietal cortex is critical for on-line control of reach-to-grasp movements. Here we show a causal relationship between disruption of cortical activity within the anterior intraparietal sulcus (aIPS) by transcranial magnetic stimulation (TMS) and disruption of goal-directed prehensile actions ( either grip size or forearm rotation, depending on the task goal, with reaching preserved in either case). Deficits were elicited by applying TMS within 65 ms after object perturbation, which attributes a rapid control process on the basis of visual feedback to aIPS. No aperture deficits were produced when TMS was applied to a more caudal region within the intraparietal sulcus, to the parietooccipital complex ( putative V6, V6A) or to the hand area of primary motor cortex. We contend that aIPS is critical for dynamic error detection during goal-dependent reach-to-grasp action that is visually guided.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Univ Oregon, Dept Psychol 1227, Eugene, OR 97403 USA	Dartmouth College; University of Oregon	Grafton, ST (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, HB 6162 Moore Hall, Hanover, NH 03755 USA.	scott.t.grafton@dartmouth.edu	Tunik, Eugene/O-8327-2015	Tunik, Eugene/0000-0002-7497-1251	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393] Funding Source: NIH RePORTER; NINDS NIH HHS [NS044393] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen Richard A, 2003, Adv Neurol, V93, P159; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CLOWER DM, 2004, CEREB CORTEX    0930, DOI DOI 10.1039/CERCOR/BHH190; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; JEANNEROD M, 1992, ADV PSYCHOL, V87, P265; Johnson SH, 2003, PROG BRAIN RES, V142, P127; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; JOHNSONFREY S, IN PRESS BRAIN RES C; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MACKENZIE CL, 1994, ADV PSYCHOL, V104, P162; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Monzee J, 2004, J NEUROPHYSIOL, V91, P1230, DOI 10.1152/jn.01120.2002; Morand S, 2000, CEREB CORTEX, V10, P817, DOI 10.1093/cercor/10.8.817; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Saito DN, 2003, COGNITIVE BRAIN RES, V17, P14, DOI 10.1016/S0926-6410(03)00076-4; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tunik E, 2004, EXP BRAIN RES, V159, P23, DOI 10.1007/s00221-004-1929-7; Tunik E, 2004, MOVEMENT DISORD, V19, P897, DOI 10.1002/mds.20138; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	46	292	295	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					505	511		10.1038/nn1430	http://dx.doi.org/10.1038/nn1430			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778711				2022-12-28	WOS:000228040400022
J	Mevorach, C; Humphreys, GW; Shalev, L				Mevorach, C; Humphreys, GW; Shalev, L			Attending to local form while ignoring, global aspects depends on handedness: evidence from TMS	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; FOREST; TREES; LESIONS; HUMANS	Our perceptions of the whole and of the parts of a visual stimulus are mediated by different brain regions. We used low-frequency transcranial magnetic stimulation (tMS) to show for the first time that opposite, homologous regions in the two hemispheres are involved in attending to local parts for leftand right-handed individuals. The brain regions that focus on the 'trees' while ignoring the 'forest' are switched as a function of handedness.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England; Open Univ Israel, Dept Educ & Psychol, Raanana, Israel	University of Birmingham; Open University Israel	Mevorach, C (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.	c.mevorach@bham.ac.uk	Mevorach, Carmel/AAT-9229-2021; Shalev, Lilach/ABA-8783-2021	Mevorach, Carmel/0000-0003-1596-1026; 				Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; LAENG B, 1995, NEUROPSYCHOLOGIA, V33, P421, DOI 10.1016/0028-3932(94)00126-A; MARSHALL JC, 1995, NATURE, V373, P521, DOI 10.1038/373521a0; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; SHALEV L, IN PRESS COGN NEURO	12	33	34	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					276	277		10.1038/nn1400	http://dx.doi.org/10.1038/nn1400			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696162				2022-12-28	WOS:000227354600011
J	Chase, DL; Pepper, JS; Koelle, MR				Chase, DL; Pepper, JS; Koelle, MR			Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RELEASE; MULTIPLE ASPECTS; RAT STRIATUM; RECEPTORS; PROTEIN; G(Q)ALPHA	D1-like and D2-like dopamine receptors have synergistic and antagonistic effects on behavior. To understand the mechanisms underlying these effects, we studied dopamine signaling genetically in Caenorhabditis elegans. Knocking out a D2-like receptor, DOP-3, caused locomotion defects similar to those observed in animals lacking dopamine. Knocking out a D1-like receptor, DOP-1, reversed the defects of the DOP-3 knockout. DOP-3 and DOP-1 have their antagonistic effects on locomotion by acting in the same motor neurons, which coexpress the receptors and which are not postsynaptic to dopaminergic neurons. In a screen for mutants unable to respond to dopamine, we identified four genes that encode components of the antagonistic Galpha(o) and Galpha(q) signaling pathways, including Galpha(o) itself and two subunits of the regulator of G protein signaling (RGS) complex that inhibits Galpha(q). Our results indicate that extrasynaptic dopamine regulates C. elegans locomotion through D1- and D2-like receptors that activate the antagonistic Galpha(q) and Galpha(o) signaling pathways, respectively.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Chase, DL (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	daniel.chase@yale.edu						Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; AVERY L, 1993, GENETICS, V133, P897; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Eastman C, 1999, J NEUROSCI, V19, P6225; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1109, DOI 10.1016/0306-4522(86)90127-2; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Gonon F, 1997, J NEUROSCI, V17, P5972; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Ikarashi Y, 1997, BRAIN RES BULL, V43, P107, DOI 10.1016/S0361-9230(96)00351-6; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kelly MA, 1998, J NEUROSCI, V18, P3470; KIMURA K, 1995, J BIOL CHEM, V270, P14672, DOI 10.1074/jbc.270.24.14672; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Lints R, 1999, DEVELOPMENT, V126, P5819; LIU YF, 1994, J BIOL CHEM, V269, P13880; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; McNamara FN, 2003, NEUROPSYCHOPHARMACOL, V28, P86, DOI 10.1038/sj.npp.1300008; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; PLAZNIK A, 1989, PSYCHOPHARMACOLOGY, V99, P558, DOI 10.1007/BF00589908; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; van der Linden AM, 2001, GENETICS, V158, P221; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	50	192	224	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1096	1103		10.1038/nn1316	http://dx.doi.org/10.1038/nn1316			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378064				2022-12-28	WOS:000224156900019
J	Schwamborn, JC; Puschel, AW				Schwamborn, JC; Puschel, AW			The sequential activity of the GTPases Rap1B and Cdc42 determines neuronal polarity	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; CELL POLARITY; RHO-GTPASES; ESTABLISHMENT; GROWTH; AXON; RAC; NEURITOGENESIS; BREAKING; PROTEIN	The establishment of a polarized morphology is an essential step in the differentiation of neurons with a single axon and multiple dendrites. In cultured rat hippocampal neurons, one of several initially indistinguishable neurites is selected to become the axon. Both phosphatidylinositol 3,4,5-trisphosphate and the evolutionarily conserved Par complex ( comprising Par3, Par6 and an atypical PKC (aPKC) such as PKClambda or PKCzeta) are involved in axon specification. However, the initial signals that establish cellular asymmetry and the pathways that subsequently translate it into structural changes remain to be elucidated. Here we show that localization of the GTPase Rap1B to the tip of a single neurite is a decisive step in determining which neurite becomes the axon. Using GTPase mutants and RNA interference, we found that Rap1B is necessary and sufficient to initiate the development of axons upstream of Cdc42 and the Par complex.	Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de	Schwamborn, Jens C/F-9395-2011	Schwamborn, Jens C/0000-0003-4496-0559				Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Park HO, 2002, J BIOL CHEM, V277, P26721, DOI 10.1074/jbc.C200245200; Pruyne D, 2000, J CELL SCI, V113, P365; Rolls MM, 2003, NATURE, V421, P905, DOI 10.1038/421905a; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sohrmann M, 2003, TRENDS CELL BIOL, V13, P526, DOI 10.1016/j.tcb.2003.08.006; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	37	307	312	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					923	929		10.1038/nn1295	http://dx.doi.org/10.1038/nn1295			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286792				2022-12-28	WOS:000223546700010
J	Todorov, E				Todorov, E			Optimality principles in sensorimotor control	NATURE NEUROSCIENCE			English	Review							OPTIMAL FEEDBACK-CONTROL; OPTIMAL-CONTROL MODEL; ARM MOVEMENTS; DYNAMIC OPTIMIZATION; TRAJECTORY FORMATION; REACHING MOVEMENTS; MUSCLE RECRUITMENT; MOTOR-PERFORMANCE; INTERNAL-MODELS; FORCE CONTROL	The sensorimotor system is a product of evolution, development, learning and adaptation - which work on different time scales to improve behavioral performance. Consequently, many theories of motor function are based on 'optimal performance': they quantify task goals as cost functions, and apply the sophisticated tools of optimal control theory to obtain detailed behavioral predictions. The resulting models, although not without limitations, have explained more empirical phenomena than any other class. Traditional emphasis has been on optimizing desired movement trajectories while ignoring sensory feedback. Recent work has redefined optimality in terms of feedback control laws, and focused on the mechanisms that generate behavior online. This approach has allowed researchers to fit previously unrelated concepts and observations into what may become a unified theoretical framework for interpreting motor function. At the heart of the framework is the relationship between high-level goals, and the real-time sensorimotor control strategies most suitable for accomplishing those goals.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Todorov, E (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	todorov@cogsci.ucsd.edu			NINDS NIH HHS [R01-NS045915, R01 NS045915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bernstein N, 1967, COORDINATION REGULAT; Bernstein N.A., 1996, RES ECOL PS; Bernstein N.A., 1947, CONSTRUCTION MOVEMEN; BERTSEKAS D, 1997, NEURODYNAMIC PROGRAM; BIZZI E, 1984, J NEUROSCI, V4, P2738; BIZZI E, 1992, BEHAV BRAIN SCI, V15, P603, DOI 10.1017/S0140525X00072538; Bryson A.E, 1969, APPL OPTIMAL CONTROL; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Camacho EF, 1999, MODEL PREDICTIVE CON; CHOW C K, 1971, Mathematical Biosciences, V10, P239, DOI 10.1016/0025-5564(71)90062-9; Cisek P, 1998, J COGNITIVE NEUROSCI, V10, P425, DOI 10.1162/089892998562852; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; COLLINS JJ, 1995, J BIOMECH, V28, P251, DOI 10.1016/0021-9290(94)00072-C; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Davis M., 1985, STOCHASTIC MODELLING; DAVY DT, 1987, J BIOMECH, V20, P187, DOI 10.1016/0021-9290(87)90310-1; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fagg AH, 2002, J NEUROPHYSIOL, V88, P3348, DOI 10.1152/jn.00621.2002; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310, DOI 10.1152/jn.1999.82.5.2310; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harwood MR, 1999, J NEUROSCI, V19, P9098, DOI 10.1523/JNEUROSCI.19-20-09098.1999; HATZE H, 1977, BIOL CYBERN, V27, P9, DOI 10.1007/BF00357705; HINTON G, 1984, J MOTOR BEHAV, V16, P171; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hoff B., 1992, THESIS U SO CALIFORN; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HOGAN N, 1984, J NEUROSCI, V4, P2745; HUMPHREY DR, 1983, ADV NEUROLOGY MOTOR, P347; Ijspeert AJ, 2001, BIOL CYBERN, V84, P331, DOI 10.1007/s004220000211; Ivanchenko V, 2003, NEURAL COMPUT, V15, P2051, DOI 10.1162/089976603322297287; Ivanenko YP, 2003, J NEUROPHYSIOL, V90, P3555, DOI 10.1152/jn.00223.2003; Kalaska JF, 1998, NOVART FDN SYMP, V218, P176; Kalman R. E, 1964, T ASME             D, V86, P51, DOI DOI 10.1115/1.3653115; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso S., 1995, DYNAMIC PATTERNS SEL; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068; Kirk D.E., 1998, OPTIMAL CONTROL THEO; Knill DC, 1996, PERCEPTION BAYESIAN; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KORENBERG A, 2003, THESIS U COLL LONDON; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Latash M. L., 1999, MOTOR CONTROL TODAY, P181; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; LI W, IN PRESS P 26 ANN IN; LI W, IN PRESS P 1 INT C I; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; LOEB GE, 1990, COLD SH Q B, V55, P791; Marr D., 1982, VISION; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; MOYLAN PJ, 1973, IEEE T AUTOMAT CONTR, VAC18, P460, DOI 10.1109/TAC.1973.1100365; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Ng A. Y., 2000, INT C MACH LEARN ICM; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; PANDY MG, 1995, J BIOMECH ENG-T ASME, V117, P15, DOI 10.1115/1.2792265; PANDY MG, 1990, J BIOMECH, V23, P1185, DOI 10.1016/0021-9290(90)90376-E; PELLIONISZ AJ, 1984, J THEOR BIOL, V110, P353, DOI 10.1016/S0022-5193(84)80179-4; Popovic D, 1999, IEEE Trans Rehabil Eng, V7, P69, DOI 10.1109/86.750554; Pratt J, 2001, INT J ROBOT RES, V20, P129, DOI 10.1177/02783640122067309; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Robertson EM, 1997, EXP BRAIN RES, V117, P148, DOI 10.1007/s002210050208; Rosenbaum D. A., 1991, HUMAN MOTOR CONTROL; Sabes PN, 1998, J NEUROSCI, V18, P5948; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shimansky YP, 2004, BIOL CYBERN, V90, P133, DOI 10.1007/s00422-003-0452-4; Shimansky YP, 2000, BIOL CYBERN, V83, P379, DOI 10.1007/s004220000159; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; SUTTON GG, 1967, J PHYSIOL-LONDON, V191, P699, DOI 10.1113/jphysiol.1967.sp008276; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2003, P ANN INT IEEE EMBS, V25, P1750, DOI 10.1109/IEMBS.2003.1279744; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; TODOROV E, 2003, P 25 ANN INT C IEEE; Todorov E., 2002, ADV NEURAL INFORM PR, V15, P27; Torres EB, 2002, J NEUROPHYSIOL, V88, P2355, DOI 10.1152/jn.00030.2002; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WOODWORTH RS, 1899, PSYCHOL REV MONOGR, V3; Zhu G, 1997, SIAM J CONTROL OPTIM, V35, P341, DOI 10.1137/S0363012994263974	119	1085	1101	7	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					907	915		10.1038/nn1309	http://dx.doi.org/10.1038/nn1309			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15332089	Green Accepted			2022-12-28	WOS:000223546700006
J	Liu, GS				Liu, GS			Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; QUANTITATIVE DISTRIBUTION; DIRECTION SELECTIVITY; SYNAPTIC PLASTICITY; GABAERGIC SYNAPSES; ACTIVE DENDRITES; PYRAMIDAL CELLS; IN-VIVO; NEURONS; TRANSMISSION	Theoretical and experimental studies on the computation of neural networks suggest that neural computation results from a dynamic interplay of excitatory and inhibitory(E/I) synaptic inputs. Precisely how E/I synapses are organized structurally and functionally to facilitate meaningful interaction remains elusive. Here we show that E/I synapses are regulated across dendritic trees to maintain a constant ratio of inputs in cultured rat hippocampal neurons. This structural arrangement is accompanied by an E/I functional balance maintained by a 'push-pull' feedback regulatory mechanism that is capable of adjusting E/I efficacies in a coordinated fashion. We also found that during activity, inhibitory synapses can determine the impact of adjacent excitatory synapses only if they are colocalized on the same dendritic branch and are activated simultaneously. These fundamental relationships among E/I synapses provide organizational principles relevant to deciphering the structural and functional basis for neural computation within dendritic branches.	MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); RIKEN	Liu, GS (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	liu@mit.edu	babakinejad, babak/G-2674-2012					Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Morales B, 2002, J NEUROSCI, V22, P8084; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; RUMSEY CC, 2003, J NEUROPHYSIOL; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	40	219	224	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					373	379		10.1038/nn1206	http://dx.doi.org/10.1038/nn1206			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004561				2022-12-28	WOS:000220482500016
J	Li, RW; Levi, DM; Klein, SA				Li, RW; Levi, DM; Klein, SA			Perceptual learning improves efficiency by re-tuning the decision 'template' for position discrimination	NATURE NEUROSCIENCE			English	Article							ORIENTATION	Visual position discrimination improves with practice; however, the mechanism(s) underlying this improvement are not yet known. We used positional noise to explore the underlying neural mechanisms and found that position discrimination improved with practice over a range of noise levels. This improvement can be largely explained by an increasing efficiency with which observers used positional information in the stimulus. In a second experiment, we tested the hypothesis that the improved efficiency reflects a re-tuning of the observers' perceptual 'template'-the weightings of inputs from basic visual mechanisms to more closely match the ideal template required to perform the perceptual task. Using a new technique to measure which parts of the stimulus influenced the observer's performance, we were able to record the re-tuning of the decision template across training sessions; we found a robust and steady increase in template efficiency during learning.	Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Levi, DM (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	dlevi@uclink.berkeley.edu	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Li, Roger/0000-0002-1666-0543	NEI NIH HHS [R01EY01728] Funding Source: Medline; PHS HHS [R0104776] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001728] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3	2	119	123	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					178	183		10.1038/nn1183	http://dx.doi.org/10.1038/nn1183			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730311				2022-12-28	WOS:000188468500016
J	Liu, JX; Asuncion-Chin, M; Liu, PC; Dopico, AM				Liu, JX; Asuncion-Chin, M; Liu, PC; Dopico, AM			CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE; MOLECULAR MECHANISMS; GLYCINE RECEPTORS; LARGE-CONDUCTANCE; ALCOHOL ACTION; K CHANNEL; CELLS; SENSITIVITY	High-conductance, Ca2+-activated and voltage-gated (BK) channels set neuronal firing. They are almost universally activated by alcohol, leading to reduced neuronal excitability and neuropeptide release and to motor intoxication. However, several BK channels are inhibited by alcohol, and most other voltage-gated K+ channels are refractory to drug action. BK channels are homotetramers (encoded by Slo1) that possess a unique transmembrane segment (S0), leading to a cytosolic S0-S1 loop. We identified Thr107 of bovine slo (bslo) in this loop as a critical residue that determines BK channel responses to alcohol. In addition, the activity of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in the cell controlled channel activity and alcohol modulation. Incremental CaMKII-mediated phosphorylation of Thr107 in the BK tetramer progressively increased channel activity and gradually switched the channel alcohol responses from robust activation to inhibition. Thus, CaMKII phosphorylation of slo Thr107 works as a 'molecular dimmer switch' that could mediate tolerance to alcohol, a form of neuronal plasticity.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Dopico, AM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	adopico@utmem.edu			NHLBI NIH HHS [R01 HL077424-02, HL77424, R01 HL077424] Funding Source: Medline; NIAAA NIH HHS [AA11560, R01 AA011560-08, R29 AA011560, R01 AA011560, R37 AA011560] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011560, R37AA011560, R29AA011560] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Borghese CM, 2002, ALCOHOL CLIN EXP RES, V26, P1764, DOI 10.1097/01.ALC.0000042012.58231.D9; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Crowder CM, 2004, TRENDS NEUROSCI, V27, P579, DOI 10.1016/j.tins.2004.07.006; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Eshete F, 2001, J NEUROSCI, V21, P6694, DOI 10.1523/JNEUROSCI.21-17-06694.2001; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim I, 2000, J PHYSIOL-LONDON, V526, P367, DOI 10.1111/j.1469-7793.2000.00367.x; Knott TK, 2002, MOL PHARMACOL, V62, P135, DOI 10.1124/mol.62.1.135; Krnjevic K., 1972, CELLULAR BIOL TOXICI, P3; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liu PC, 2004, P NATL ACAD SCI USA, V101, P18217, DOI 10.1073/pnas.0406096102; Liu PC, 2003, ALCOHOL CLIN EXP RES, V27, P1640, DOI 10.1097/01.ALC.0000094756.41638.5D; MAMIYA N, 1993, BIOCHEM BIOPH RES CO, V195, P608, DOI 10.1006/bbrc.1993.2089; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Mascia MP, 1996, MOL PHARMACOL, V50, P402; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Muller M, 1996, NEUROPHARMACOLOGY, V35, P877, DOI 10.1016/0028-3908(96)00091-3; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Randby AT, 1999, J DAIRY SCI, V82, P420, DOI 10.3168/jds.S0022-0302(99)75248-3; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sessoms-Sikes JS, 2003, J PHARMACOL EXP THER, V306, P595, DOI 10.1124/jpet.103.050542; Smith TL, 1999, NEUROSCI LETT, V269, P145, DOI 10.1016/S0304-3940(99)00438-3; Solem M, 1997, J PHARMACOL EXP THER, V282, P1487; Stevens N, 2001, J BIOCHEM, V129, P551, DOI 10.1093/oxfordjournals.jbchem.a002890; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Valenzuela CF, 1998, ALCOHOL CLIN EXP RES, V22, P1292; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Weiger TM, 2002, J COMP PHYSIOL A, V188, P79, DOI 10.1007/s00359-002-0281-2; Zakhari S, 1997, ALCOHOL HEALTH RES W, V21, P21; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	47	57	60	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					41	49		10.1038/nn1602	http://dx.doi.org/10.1038/nn1602			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341213	Green Accepted			2022-12-28	WOS:000234288000016
J	Dean, I; Harper, NS; McAlpine, D				Dean, I; Harper, NS; McAlpine, D			Neural population coding of sound level adapts to stimulus statistics	NATURE NEUROSCIENCE			English	Article							AUDITORY-NERVE FIBERS; RATE-INTENSITY FUNCTIONS; SHORT-TERM ADAPTATION; CONTRAST GAIN-CONTROL; DYNAMIC-RANGE; GUINEA-PIG; INFERIOR COLLICULUS; CORTICAL-NEURONS; NOISE; CATS	Mammals can hear sounds extending over a vast range of sound levels with remarkable accuracy. How auditory neurons code sound level over such a range is unclear; firing rates of individual neurons increase with sound level over only a very limited portion of the full range of hearing. We show that neurons in the auditory midbrain of the guinea pig adjust their responses to the mean, variance and more complex statistics of sound level distributions. We demonstrate that these adjustments improve the accuracy of the neural population code close to the region of most commonly occurring sound levels. This extends the range of sound levels that can be accurately encoded, fine-tuning hearing to the local acoustic environment.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, Ear Inst, London WC1E 6BT, England; UCL, Ctr Math & Phys Life Sci & Expt Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Dean, I (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	i.dean@ucl.ac.uk		Harper, Nicol/0000-0002-7851-4840; McAlpine, David/0000-0001-5467-6725	Medical Research Council [G0300417] Funding Source: Medline; RNID [G16] Funding Source: Medline; MRC [G0300417] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; AVAN P, 1992, HEARING RES, V59, P59, DOI 10.1016/0378-5955(92)90102-S; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARMEL PW, 1963, J NEUROPHYSIOL, V26, P598, DOI 10.1152/jn.1963.26.4.598; Colburn HS, 2003, JARO, V4, P294, DOI 10.1007/s10162-002-1090-6; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Dayan P, 2001, COMPUTATIONAL NEUROS; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; EVANS EF, 1980, EXP BRAIN RES, V40, P115; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GIBSON DJ, 1985, J NEUROPHYSIOL, V53, P940, DOI 10.1152/jn.1985.53.4.940; HOUTSMA AJM, 1980, J ACOUST SOC AM, V68, P807, DOI 10.1121/1.384819; Ingham NJ, 2004, J NEUROPHYSIOL, V91, P632, DOI 10.1152/jn.00779.2003; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Kirk EC, 2003, JARO-J ASSOC RES OTO, V4, P445, DOI 10.1007/s10162-002-3013-y; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MAY BJ, 1992, J NEUROPHYSIOL, V68, P1589, DOI 10.1152/jn.1992.68.5.1589; NUTTALL AL, 1974, J ACOUST SOC AM, V56, P1239, DOI 10.1121/1.1903414; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1986, J ACOUST SOC AM, V80, P177, DOI 10.1121/1.394178; Popelar J, 2003, PHYSIOL RES, V52, P615; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; REES A, 1988, J ACOUST SOC AM, V83, P1488, DOI 10.1121/1.395904; SACHS MB, 1974, J ACOUST SOC AM, V56, P1835, DOI 10.1121/1.1903521; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; SIMMONS JA, 1971, SCIENCE, V171, P212, DOI 10.1126/science.171.3967.212; SMITH RL, 1980, HEARING RES, V2, P123, DOI 10.1016/0378-5955(80)90034-9; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; VIEMEISTER NF, 1974, J ACOUST SOC AM, V56, P1594, DOI 10.1121/1.1903483; VIEMEISTER NF, 1988, HEARING RES, V34, P267, DOI 10.1016/0378-5955(88)90007-X; VIEMEISTER NF, 1983, SCIENCE, V221, P1206, DOI 10.1126/science.6612337; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; WINTER IM, 1991, J ACOUST SOC AM, V90, P1958, DOI 10.1121/1.401675; YATES GK, 1985, HEARING RES, V17, P1, DOI 10.1016/0378-5955(85)90124-8	36	346	357	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1684	1689		10.1038/nn1541	http://dx.doi.org/10.1038/nn1541			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286934				2022-12-28	WOS:000233576200016
J	Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M				Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M			Independence of luminance and contrast in natural scenes and in the early visual system	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; LIGHT ADAPTATION; RECEPTIVE-FIELD; IMAGE-CONTRAST; SPATIAL SCALE; GAIN-CONTROL; CAT; NEURONS; STATISTICS	The early visual system is endowed with adaptive mechanisms that rapidly adjust gain and integration time based on the local luminance ( mean intensity) and contrast ( standard deviation of intensity relative to the mean). Here we show that these mechanisms are matched to the statistics of the environment. First, we measured the joint distribution of luminance and contrast in patches selected from natural images and found that luminance and contrast were statistically independent of each other. This independence did not hold for artificial images with matched spectral characteristics. Second, we characterized the effects of the adaptive mechanisms in lateral geniculate nucleus (LGN), the direct recipient of retinal outputs. We found that luminance gain control had the same effect at all contrasts and that contrast gain control had the same effect at all mean luminances. Thus, the adaptive mechanisms for luminance and contrast operate independently, reflecting the very independence encountered in natural images.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA	The Smith-Kettlewell Eye Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	matteo@ski.org	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008; Bonin, Vincent/AAQ-3833-2020	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Bonin, Vincent/0000-0002-9437-8092; Geisler, Wilson/0000-0003-4630-6614	NEI NIH HHS [R01EY11747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011747] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BONIN V, IN PRESS J NEUROSCI; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; DERRINGTON AM, 1982, J PHYSIOL-LONDON, V333, P343, DOI 10.1113/jphysiol.1982.sp014457; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; LANKHEET MJM, 1993, VISION RES, V33, P1153, DOI 10.1016/0042-6989(93)90205-B; LANKHEET MJM, 1991, VISION RES, V31, P1129, DOI 10.1016/0042-6989(91)90039-8; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LENNIE P, 1980, VISION RES, V20, P561, DOI 10.1016/0042-6989(80)90115-7; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; Rodieck R.W., 1998, 1 STEPS SEEING; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sahani M, 2003, ADV NEURAL INFORM PR, P125; SAITO H, 1986, VISION RES, V26, P391, DOI 10.1016/0042-6989(86)90182-3; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SHAPLEY R, 1986, VISION RES, V26, P45, DOI 10.1016/0042-6989(86)90070-2; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shapley RM, 1993, CONTRAST SENSITIVITY; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; TROY JB, 1993, EXP BRAIN RES, V93, P383; Troy JB, 1999, VISUAL NEUROSCI, V16, P1089, DOI 10.1017/S0952523899166094; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	42	267	268	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1690	1697		10.1038/nn1556	http://dx.doi.org/10.1038/nn1556			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286933				2022-12-28	WOS:000233576200017
J	Luna, R; Hernandez, A; Brody, CD; Romo, R				Luna, R; Hernandez, A; Brody, CD; Romo, R			Neural codes for perceptual discrimination in primary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; CORTICAL-NEURONS; DECISION-MAKING; PSYCHOPHYSICAL MEASUREMENTS; FLUTTER-VIBRATION; AREA MT; SENSE; FREQUENCY; PERIODICITY; PERFORMANCE	We sought to determine the neural code(s) for frequency discrimination of vibrotactile stimuli. We tested five possible candidate codes by analyzing the responses of single neurons recorded in primary somatosensory cortex of trained monkeys while they discriminated between two consecutive vibrotactile stimuli. Differences in the frequency of two stimuli could be discriminated using information from (i) time intervals between spikes, (ii) average spiking rate during each stimulus, (iii) absolute number of spikes elicited by each stimulus, (iv) average rate of bursts of spikes or ( v) absolute number of spike bursts elicited by each stimulus. However, only a spike count code, in which spikes are integrated over a time window that has most of its mass in the first 250 ms of each stimulus period, covaried with behavior on a trial-by-trial basis, was consistent with psychophysical biases induced by manipulation of stimulus duration, and produced neurometric discrimination thresholds similar to behavioral psychophysical thresholds.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Universidad Nacional Autonoma de Mexico; Cold Spring Harbor Laboratory	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx		romo, ranulfo/0000-0003-3529-3635; Luna, Rogelio/0000-0003-0711-7562	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067991] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; BAIR W, 1994, J NEUROSCI, V14, P2870; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Carandini M, 2000, CURR BIOL, V10, pR605, DOI 10.1016/S0960-9822(00)00637-0; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Gescheider GA, 1999, SOMATOSENS MOT RES, V16, P229; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POGGIO GF, 1964, J NEUROPHYSIOL, V27, P517, DOI 10.1152/jn.1964.27.4.517; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; [No title captured]	35	175	176	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1210	1219		10.1038/nn1513	http://dx.doi.org/10.1038/nn1513			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16056223				2022-12-28	WOS:000231483800021
J	Seymour, B; O'Doherty, JP; Koltzenburg, M; Wiech, K; Frackowiak, R; Friston, KJ; Dolan, R				Seymour, B; O'Doherty, JP; Koltzenburg, M; Wiech, K; Frackowiak, R; Friston, KJ; Dolan, R			Opponent appetitive-aversive neural processes underlie predictive learning of pain relief	NATURE NEUROSCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; ACQUIRED MOTIVATION; NUCLEUS-ACCUMBENS; OPIOID ANALGESIA; VENTRAL STRIATUM; HUMAN BRAIN; REWARD; DOPAMINE; AMYGDALA; ANTICIPATION	Termination of a painful or unpleasant event can be rewarding. However, whether the brain treats relief in a similar way as it treats natural reward is unclear, and the neural processes that underlie its representation as a motivational goal remain poorly understood. We used fMRI ( functional magnetic resonance imaging) to investigate how humans learn to generate expectations of pain relief. Using a pavlovian conditioning procedure, we show that subjects experiencing prolonged experimentally induced pain can be conditioned to predict pain relief. This proceeds in a manner consistent with contemporary reward-learning theory ( average reward/loss reinforcement learning), reflected by neural activity in the amygdala and midbrain. Furthermore, these reward-like learning signals are mirrored by opposite aversion-like signals in lateral orbitofrontal cortex and anterior cingulate cortex. This dual coding has parallels to 'opponent process' theories in psychology and promotes a formal account of prediction and expectation during pain.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; CALTECH, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA; UCL, Inst Child Hlth, London WC1N 1EH, England; Fdn Santa Lucia, Neuroimaging Lab, I-00179 Rome, Italy	University of London; University College London; California Institute of Technology; University of London; University College London; IRCCS Santa Lucia	Seymour, B (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	bseymour@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011; Frackowiak, Richard S/I-1809-2013; Koltzenburg, Martin/C-1349-2008; Frackowiak, Richard/H-4383-2011; O'Doherty, John P/F-1204-2013	Friston, Karl/0000-0001-7984-8909; Koltzenburg, Martin/0000-0001-9181-5966; Frackowiak, Richard/0000-0002-3151-822X; Dolan, Ray/0000-0001-9356-761X; Seymour, Ben/0000-0003-1724-5832	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Beiser, 1995, MODELS INFORM PROCES, P215; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CAMERER C, IN PRESS J EC LIT; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Daw ND, 2002, NEURAL COMPUT, V14, P2567, DOI 10.1162/089976602760407973; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2001, COMPUTATIONAL NEUROS; DICKENSON, 1979, MECH LEARNING MOTIVA, P203; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fields HL, 2000, PROG BRAIN RES, V122, P245; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Glascher J, 2005, NEURON, V47, P295, DOI 10.1016/j.neuron.2005.06.008; GROSSBERG S, 1984, BIOL PSYCHIAT, V19, P1075; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Konorski J., 1967, INTEGRATIVE ACTIVITY; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MAHADEVAN S, 1996, MACH LEARN, V22, P1; Markowitz H, 1952, J POLIT ECON, V60, P151, DOI 10.1086/257177; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price D. D., 1999, PSYCHOL MECH PAIN AN; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schull J., 1979, PSYCHOL LEARN MOTIV, V13, P57; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZ A, 1993, P 10 INT C MACH LEAR, P298; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; SOLOMON RL, 1980, ACTA NEUROBIOL EXP, V40, P271; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360	50	306	309	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1234	1240		10.1038/nn1527	http://dx.doi.org/10.1038/nn1527			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116445	Green Published			2022-12-28	WOS:000231483800024
J	Huberman, AD; Murray, KD; Warland, DK; Feldheim, DA; Chapman, B				Huberman, AD; Murray, KD; Warland, DK; Feldheim, DA; Chapman, B			Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PRENATAL DEVELOPMENT; OCULAR DOMINANCE; AXON GUIDANCE; OPTIC TRACT; IN-VITRO; RETINOGENICULATE; SEGREGATION; FERRET; LIGANDS	Axon guidance cues contributing to the development of eye-specific visual projections to the lateral geniculate nucleus (LGN) have not previously been identified. Here we show that gradients of ephrin-As and their receptors (EphAs) direct retinal ganglion cell (RGC) axons from the two eyes into their stereotyped pattern of layers in the LGN. Overexpression of EphAs in ferret RGCs using in vivo electroporation induced axons from both eyes to misproject within the LGN. The effects of EphA overexpression were competition-dependent and restricted to the early postnatal period. These findings represent the first demonstration of eye-specific pathfinding mediated by axon guidance cues and, taken with other reports, indicate that ephrin-As can mediate several mapping functions within individual target structures.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Sinsheimer Labs 225, Santa Cruz, CA 95064 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Santa Cruz	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95616 USA.	bxchapman@ucdavis.edu			NEI NIH HHS [EY11369, P30 EY012576, R01 EY011369-11, EY015387, EY14689-01, EY12576, R01 EY014689, T32 EY015387, R01 EY011369] Funding Source: Medline; NINDS NIH HHS [R01 NS039094, NS39094] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012576, R01EY014689, T32EY015387, R01EY011369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039094] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CUCCHIARO JB, 1991, J COMP NEUROL, V312, P193, DOI 10.1002/cne.903120203; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GUILLERY RW, 1971, J COMP NEUROL, V143, P73, DOI 10.1002/cne.901430106; GUILLERY RW, 1973, SCIENCE, V179, P1014, DOI 10.1126/science.179.4077.1014; GUILLERY RW, 1982, J NEUROSCI, V2, P714; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; Hayes SG, 2003, J COMP NEUROL, V463, P45, DOI 10.1002/cne.10749; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; JEFFERY G, 1985, NATURE, V313, P575, DOI 10.1038/313575a0; JEFFERY G, 1989, DEV BRAIN RES, V46, P187, DOI 10.1016/0165-3806(89)90282-4; JOHNSON JK, 1993, VISUAL NEUROSCI, V10, P117, DOI 10.1017/S0952523800003266; JONES EG, 2005, THALAMUS REVISITED; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, J NEUROBIOL, V21, P197, DOI 10.1002/neu.480210113; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; THOMPSON I, 1989, J COMP NEUROL, V282, P371; WALSH C, 1985, J NEUROSCI, V5, P3061; WILLIAMS RW, 1994, NATURE, V367, P637, DOI 10.1038/367637a0	50	78	81	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1013	1021		10.1038/nn1505	http://dx.doi.org/10.1038/nn1505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025110	Green Accepted			2022-12-28	WOS:000230760200012
J	Holton, KL; Loder, MK; Melikian, HE				Holton, KL; Loder, MK; Melikian, HE			Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization	NATURE NEUROSCIENCE			English	Article							HUMAN DOPAMINE TRANSPORTER; AMINOBUTYRIC-ACID TRANSPORTER; AMPA RECEPTOR TRAFFICKING; TYROSINE PHOSPHORYLATION; MEDIATED INTERNALIZATION; MONOAMINE TRANSPORTERS; RECYCLING COMPARTMENT; PHORBOL ESTERS; EXPRESSION; DRUGS	Neurotransmitter transporters are critical for synaptic neurotransmitter inactivation. Transporter inhibitors markedly increase the duration and magnitude of synaptic transmission, underscoring the importance of transporter activity in neurotransmission. Recent studies indicate that membrane trafficking dynamically governs neuronal transporter cell-surface presentation in a protein kinase C-regulated manner, suggesting that transporter trafficking profoundly affects synaptic signaling. However, the molecular architecture coupling neurotransmitter transporters to the endocytic machinery is not defined. Here, we identify nonclassical, distinct endocytic signals in the dopamine transporter (DAT) that are necessary and sufficient to drive constitutive and protein kinase C-regulated DAT internalization. The DAT internalization signal is conserved across SLC6 neurotransmitter carriers and is functional in the homologous norepinephrine transporter, suggesting that this region is likely to be the endocytic signal for all SLC6 neurotransmitter transporters. The DAT endocytic signal does not conform to classic internalization motifs, suggesting that SLC6 neurotransmitter transporters may have evolved unique endocytic mechanisms.	Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01604 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Melikian, Haley/S-8301-2016	Melikian, Haley/0000-0002-9694-5556	NIDA NIH HHS [R01 DA015169, R01 DA015169-04] Funding Source: Medline; PHS HHS [15169] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; ALI SA, 1995, BIOTECHNIQUES, V18, P746; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Deken SL, 2003, J NEUROSCI, V23, P1563; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Johnson AO, 1996, J CELL BIOL, V135, P1749, DOI 10.1083/jcb.135.6.1749; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; LaRosa FG, 1997, CANCER LETT, V113, P55, DOI 10.1016/S0304-3835(96)04595-8; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; MADSEN KL, 2005, J BIOL CHEM     0317; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Mena MA, 1997, J NEUROCHEM, V69, P1398; Moron JA, 2003, J NEUROSCI, V23, P8480; Quick MW, 2004, J BIOL CHEM, V279, P15961, DOI 10.1074/jbc.M306924200; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schenk James O, 2002, Prog Drug Res, V59, P111; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Whitworth TL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0003.2002; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	43	102	105	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					881	888		10.1038/nn1478	http://dx.doi.org/10.1038/nn1478			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924135	Green Accepted			2022-12-28	WOS:000230137100015
J	Le, N; Nagarajan, R; Wang, JYT; Svaren, J; LaPash, C; Araki, T; Schmidt, RE; Milbrandt, J				Le, N; Nagarajan, R; Wang, JYT; Svaren, J; LaPash, C; Araki, T; Schmidt, RE; Milbrandt, J			Nab proteins are essential for peripheral nervous system myelination	NATURE NEUROSCIENCE			English	Article							SCHWANN-CELL DIFFERENTIATION; MARIE-TOOTH DISEASE; NGFI-A; BONE-FORMATION; TRANSCRIPTION; KROX-20; GENE; COREPRESSOR; EXPRESSION; GROWTH	Mutations that disrupt Egr2 transcriptional activity cause severe demyelinating peripheral neuropathies. Here we provide evidence that Nab1 and Nab2 proteins are critical transcriptional modulators of Egr2 in myelinating Schwann cells. Like Egr2, these proteins are essential for Schwann cell differentiation into the myelinating state. Mice lacking both Nab1 and Nab2 show severe congenital hypomyelination of peripheral nerves, with Schwann cell development arresting at the promyelinating stage, despite elevated Egr2 expression. As observed for Egr2, Nab proteins are necessary for Schwann cells to exit the cell cycle, downregulate suppressed cAMP-inducible protein (SCIP) expression and upregulate expression of critical myelination genes. The mRNA expression signature of Schwann cells deficient in both Nab1 and Nab2 is highly similar to that of Egr2-deficient Schwann cells, further indicating that the Egr2/Nab protein complex is a key regulator of the Schwann cell myelination program and that disruption of this transcriptional complex is likely to result in Schwann cell dysfunction in patients with Egr2 mutations.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	jeff@pathbox.wustl.edu	Araki, Toshiyuki/H-4289-2019; Svaren, John/A-1605-2010; LaPash Daniels, Christine/D-3199-2012	Araki, Toshiyuki/0000-0003-3625-2042; Svaren, John/0000-0003-2963-7921; LaPash Daniels, Christine/0000-0001-6797-7551; Wang, James/0000-0003-2711-0827; Milbrandt, Jeffrey/0000-0002-5477-7689	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R37DK019645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010299] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG10299] Funding Source: Medline; NICHD NIH HHS [R01 HD041590] Funding Source: Medline; NIDDK NIH HHS [R37 DK19645, P60 DK20579] Funding Source: Medline; NINDS NIH HHS [NS4074] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; ANGRAND PO, 1999, NUCLEIC ACIDS RES, V27, P16; Bellone E, 1999, Hum Mutat, V14, P353, DOI 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.3.CO;2-W; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Bottomley SS., 1998, AM J HUM GENET, V63, pA352; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; Clements M, 2003, DEV DYNAM, V226, P67, DOI 10.1002/dvdy.10209; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Foley J, 1998, J INVEST DERMATOL, V111, P1122, DOI 10.1046/j.1523-1747.1998.00428.x; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gondre M, 1998, J CELL BIOL, V141, P493, DOI 10.1083/jcb.141.2.493; Grose R, 2002, DEV DYNAM, V223, P371, DOI 10.1002/dvdy.10064; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Kurihara S, 2002, NEUROEPIDEMIOLOGY, V21, P246, DOI 10.1159/000065643; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Levi G, 1996, DEVELOPMENT, V122, P113; LUPSKI JR, 1997, HOSP PRACT OFF ED, V32, P84; LUPSKI JR, 1997, HOSP PRACT, V32, P89; LUPSKI JR, 1997, HOSP PRACT, V32, P94; Magyar JP, 1996, J NEUROSCI, V16, P5351; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; Morocutti C, 2002, NEUROEPIDEMIOLOGY, V21, P241, DOI 10.1159/000065642; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nagasawa K, 2001, CURR DRUG METAB, V2, P355, DOI 10.2174/1389200013338243; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venken K, 2002, NEUROGENETICS, V4, P37, DOI 10.1007/s10048-001-0124-2; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Werner T, 2000, Methods Mol Biol, V132, P337; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	100	100	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					932	940		10.1038/nn1490	http://dx.doi.org/10.1038/nn1490			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136673				2022-12-28	WOS:000230137100021
J	Smith, MA; Majaj, NJ; Movshon, JA				Smith, MA; Majaj, NJ; Movshon, JA			Dynamics of motion signaling by neurons in macaque area MT	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SUPERIOR TEMPORAL SULCUS; ORIENTATION SELECTIVITY; 2-DIMENSIONAL PATTERNS; FUNCTIONAL-PROPERTIES; CORTICAL-NEURONS; SINGLE NEURONS; V1 NEURONS; PERCEPTION; DIRECTION	Most neurons in macaque area MT are selective for the direction of stimulus motion. By comparing direction selectivity for gratings and plaids, we classified MT neurons as pattern direction selective (PDS) or component direction selective (CDS). We compared the time course of responses in CDS and PDS neurons in opiate-anesthetized macaques, using a rapid pseudorandom sequence of gratings and plaids that moved in different directions. On average, responses began 6 ms earlier in CDS neurons than in PDS neurons. More importantly, the pattern-selective responses of PDS neurons did not reach their fully selective state until 50-75 ms after the responses of CDS neurons had stabilized. The population motion response of MT is therefore initially dominated by component motion signals, and does not completely represent pattern motion until substantially later. The circuits that compute pattern motion take more time to finish their work than those signaling component motion.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Movshon, JA (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave,115 Mellon Inst, Pittsburgh, PA 15232 USA.	movshon@nyu.edu		Smith, Matthew A/0000-0003-1192-9942	NEI NIH HHS [EY02017] Funding Source: Medline; PHS HHS [T32-7136] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2003, J NEUROSCI, V23, P7690; BAIR W, 1994, J NEUROSCI, V14, P2870; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bullier J, 2001, PROG BRAIN RES, V134, P193; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Gallyas F, 1979, Neurol Res, V1, P203; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOOI FL, 1992, PERCEPTION, V21, P583, DOI 10.1068/p210583; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li B, 2001, EUR J NEUROSCI, V14, P690, DOI 10.1046/j.0953-816x.2001.01689.x; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; Masson GS, 2002, J NEUROSCI, V22, P5149, DOI 10.1523/JNEUROSCI.22-12-05149.2002; Maunsell J. H., 1987, MATTERS INTELLIGENCE, P59, DOI DOI 10.1007/978-94-009-3833-5_3; MCCLURKIN JW, 1991, SCIENCE, V253, P675, DOI 10.1126/science.1908118; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Movshon A, 1985, PATTERN RECOGN, V54, P117; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Priebe NJ, 2003, J NEUROSCI, V23, P5650; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; YO C, 1992, VISION RES, V32, P135, DOI 10.1016/0042-6989(92)90121-X; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; Zipser K, 1996, J NEUROSCI, V16, P7376	49	143	143	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					220	228		10.1038/nn1382	http://dx.doi.org/10.1038/nn1382			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657600				2022-12-28	WOS:000226638200022
J	O'Hagan, R; Chalfie, M; Goodman, MB				O'Hagan, R; Chalfie, M; Goodman, MB			The MEC-4 DEG/ENaC channel of Caenorhabditis elegans touch receptor neurons transduces mechanical signals	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; MECHANOSENSORY TRANSDUCTION; SUBUNIT; PROTEIN; LOCALIZATION; MICROTUBULES; SENSITIVITY; LOCOMOTION; MUTATIONS; SENSATION	Transformation of mechanical energy into ionic currents is essential for touch, hearing and nociception. Although DEG/ENaC proteins are believed to form sensory mechanotransduction channels, the evidence for this role remains indirect. By recording from C. elegans touch receptor neurons in vivo, we found that external force evokes rapidly activating mechanoreceptor currents (MRCs) carried mostly by Na+ and blocked by amiloride-characteristics consistent with direct mechanical gating of a DEG/ENaC channel. Like mammalian Pacinian corpuscles, these neurons depolarized with both positive and negative changes in external force but not with sustained force. Null mutations in the DEG/ENaC gene mec-4 and in the accessory ion channel subunit genes mec-2 and mec-6 eliminated MRCs. In contrast, the genetic elimination of touch neuron-specific microtubules reduced, but did not abolish, MRCs. Our findings link the application of external force to the activation of a molecularly defined metazoan sensory transduction channel.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu; mbgoodman@stanford.edu	O'Hagan, Robert/AAE-9789-2020; Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030997, GM20997] Funding Source: Medline; NINDS NIH HHS [R01 NS047715, R01 NS047715-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; ALVAREZBUYLLA R, 1953, AM J PHYSIOL, V172, P237, DOI 10.1152/ajplegacy.1952.172.1.237; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; DIAMOND J, 1958, J PHYSIOL-LONDON, V142, P382, DOI 10.1113/jphysiol.1958.sp006024; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRAY JAB, 1953, J PHYSIOL-LONDON, V122, P610, DOI 10.1113/jphysiol.1953.sp005025; Hardie RC, 2001, J EXP BIOL, V204, P3403; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hoger U, 1997, J NEUROPHYSIOL, V78, P2079, DOI 10.1152/jn.1997.78.4.2079; Hong K, 2000, J NEUROSCI, V20, P2575; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Johnston D., 1995, FDN CELLULAR NEUROPH; JUUSOLA M, 1994, J NEUROPHYSIOL, V72, P3026, DOI 10.1152/jn.1994.72.6.3026; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Mello C, 1995, METHOD CELL BIOL, V48, P451; OTTOSON D, 1964, J PHYSIOL-LONDON, V171, P109, DOI 10.1113/jphysiol.1964.sp007365; PLASTERK RHA, 1995, CAENORHABDITIS ELEGA, P59; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Rankin CH, 2000, J NEUROSCI, V20, P4337; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAVAGE C, 1994, J CELL SCI, V107, P2165; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; ZHANG S, 2004, IN PRESS CURR BIOL; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	40	346	361	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					43	50		10.1038/nn1362	http://dx.doi.org/10.1038/nn1362			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580270				2022-12-28	WOS:000225967600014
J	Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ				Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ			A new chemotaxis assay shows the extreme sensitivity of axons to molecular gradients	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; GUIDANCE MOLECULES; CONE; CHEMOATTRACTANT; RECEPTORS; ORIENT; FIBRIN; TRK	Axonal chemotaxis is believed to be important in wiring up the developing and regenerating nervous system, but little is known about how axons actually respond to molecular gradients. We report a new quantitative assay that allows the long-term response of axons to gradients of known and controllable shape to be examined in a three-dimensional gel. Using this assay, we show that axons may be nature's most-sensitive gradient detectors, but this sensitivity exists only within a narrow range of ligand concentrations. This assay should also be applicable to other biological processes that are controlled by molecular gradients, such as cell migration and morphogenesis.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Georgetown Univ, Dept Phys, Washington, DC 20057 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Georgetown University; Georgetown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goodhill, GJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	geoff@georgetown.edu	Goodhill, Geoffrey J/D-9984-2013; Richards AO, Linda/P-6372-2014	Goodhill, Geoffrey/0000-0001-9789-9355; Urbach, Jeffrey/0000-0002-1593-520X; Richards AO, Linda/0000-0002-7590-7390				Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; Caton A, 2000, DEVELOPMENT, V127, P1751; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Crank J., 1975, MATH DIFFUSION; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gallo G, 1997, J NEUROSCI, V17, P5445; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1999, J NEUROBIOL, V41, P230, DOI 10.1002/(SICI)1097-4695(19991105)41:2<230::AID-NEU6>3.0.CO;2-9; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Phillips HS, 1996, PHILOS T ROY SOC B, V351, P413, DOI 10.1098/rstb.1996.0036; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Soeda H, 2002, NEUROSCI LETT, V325, P5, DOI 10.1016/S0304-3940(02)00215-X; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; TRANQUILLO RT, 1990, BIOL MOTION, P415; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	32	201	209	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					678	682		10.1038/nn1259	http://dx.doi.org/10.1038/nn1259			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15162167				2022-12-28	WOS:000221640300024
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M				Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M			Astrocyte-mediated control of cerebral blood flow	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL HYPEREMIA; PHOSPHOLIPASE A(2); BRAIN ACTIVATION; ARACHIDONIC-ACID; CALCIUM; RAT; CYCLOOXYGENASE-1; INDOMETHACIN; INHIBITION; METABOLISM	Local increase in blood flow during neural activity forms the basis for functional brain imaging, but its mechanism remains poorly defined. Here we show that cortical astrocytes in vivo possess a powerful mechanism for rapid vasodilation. We imaged the activity of astrocytes labeled with the calcium ( Ca2+)-sensitive indicator rhod-2 in somatosensory cortex of adult mice. Photolysis of caged Ca2+ in astrocytic endfeet ensheathing the vessel wall was associated with an 18% increase in arterial cross-section area that corresponded to a 37% increase in blood flow. Vasodilation occurred with a latency of only 1-2 s, and both indomethacin and the cyclooxygenase-1 inhibitor SC-560 blocked the photolysis-induced hyperemia. These observations implicate astrocytes in the control of local microcirculation and suggest that one of their physiological roles is to mediate vasodilation in response to increased neural activity.	Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Jagiellonian Univ, Dept Neurosurg, Krakow, Poland	University of Rochester; Jagiellonian University	Takano, T (corresponding author), Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Takahiro_Takano@URMC.Rochester.edu		Takano, Takahiro/0000-0002-6235-6673				Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Bakalova RA, 2002, PROSTAG LEUKOTR ESS, V67, P379, DOI 10.1054/plef.2002.0445; Bruhn H, 2001, J MAGN RESON IMAGING, V13, P325, DOI 10.1002/jmri.1047; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; DAVALOS D, 2005, NAT NEUROSCI; del Zoppo GJ, 2000, THROMB RES, V98, pV73; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; ELLIS EF, 1979, AM J PHYSIOL, V237, pH381, DOI 10.1152/ajpheart.1979.237.3.H381; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; GORDON EL, 1995, J NEUROSURG, V83, P875, DOI 10.3171/jns.1995.83.5.0875; Grossman M, 2003, NEUROPSYCHOLOGY, V17, P658, DOI 10.1037/0894-4105.17.4.658; Hademenos GJ, 1996, NEUROSURGERY, V38, P1005, DOI 10.1097/00006123-199605000-00030; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Hirase H, 2005, TRENDS NEUROSCI, V28, P217, DOI 10.1016/j.tins.2005.03.002; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Rombouts SARB, 2002, J NEUROL NEUROSUR PS, V73, P665, DOI 10.1136/jnnp.73.6.665; SAKABE T, 1979, ACTA PHYSIOL SCAND, V107, P283, DOI 10.1111/j.1748-1716.1979.tb06476.x; Simard M, 2003, J NEUROSCI, V23, P9254; Smith CD, 1999, NEUROLOGY, V53, P1391, DOI 10.1212/WNL.53.7.1391; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	45	794	820	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					260	267		10.1038/nn1623	http://dx.doi.org/10.1038/nn1623			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388306				2022-12-28	WOS:000234990100022
J	Delgado, MR; Frank, RH; Phelps, EA				Delgado, MR; Frank, RH; Phelps, EA			Perceptions of moral character modulate the neural systems of reward during the trust game	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; PREDICTION ERRORS; CAUDATE-NUCLEUS; MEMORY-SYSTEMS; BASAL GANGLIA; RESPONSES; STRIATUM; DECISION; COOPERATION; ACTIVATION	Studies of reward learning have implicated the striatum as part of a neural circuit that guides and adjusts future behavior on the basis of reward feedback. Here we investigate whether prior social and moral information about potential trading partners affects this neural circuitry. Participants made risky choices about whether to trust hypothetical trading partners after having read vivid descriptions of life events indicating praiseworthy, neutral or suspect moral character. Despite equivalent reinforcement rates for all partners, participants were persistently more likely to make risky choices with the 'good' partner. As expected from previous studies, activation of the caudate nucleus differentiated between positive and negative feedback, but only for the 'neutral' partner. Notably, it did not do so for the 'good' partner and did so only weakly for the 'bad' partner, suggesting that prior social and moral perceptions can diminish reliance on feedback mechanisms in the neural circuitry of trial-and-error reward learning.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Cornell Univ, Johnson Grad Sch Management, Ithaca, NY 14853 USA	New York University; New York University; Cornell University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu	sarinopoulos, isidoros/B-5453-2010					Beiser, 1995, MODELS INFORM PROCES, P215; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Coleman JS., 1990, FDN SOCIAL THEORY; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Davidson MC, 2004, NEUROIMAGE, V23, P1039, DOI 10.1016/j.neuroimage.2004.07.049; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Delgado MR, 2005, NEUROIMAGE, V24, P862, DOI 10.1016/j.neuroimage.2004.10.002; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Filoteo JV, 2005, NEUROREPORT, V16, P111, DOI 10.1097/00001756-200502080-00007; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frank R., 2004, WHAT PRICE MORAL HIG; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Talairach J., 1988, COPLANAR STEREOTAXIC; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	49	453	467	9	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1611	1618		10.1038/nn1575	http://dx.doi.org/10.1038/nn1575			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16222226				2022-12-28	WOS:000232966600037
J	Gropp, E; Shanabrough, M; Borok, E; Xu, AW; Janoschek, R; Buch, T; Plum, L; Balthasar, N; Hampel, B; Waisman, A; Barsh, GS; Horvath, TL; Bruning, JC				Gropp, E; Shanabrough, M; Borok, E; Xu, AW; Janoschek, R; Buch, T; Plum, L; Balthasar, N; Hampel, B; Waisman, A; Barsh, GS; Horvath, TL; Bruning, JC			Agouti-related peptide-expressing neurons are mandatory for feeding	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y; ARCUATE NUCLEUS; ENERGY HOMEOSTASIS; MELANOCORTIN; PROTEIN; OBESITY; INSULIN; RATS; MICE	Multiple hormones controlling energy homeostasis regulate the expression of neuropeptide Y (NPY) and agouti-related peptide ( AgRP) in the arcuate nucleus of the hypothalamus. Nevertheless, inactivation of the genes encoding NPY and/or AgRP has no impact on food intake in mice. Here we demonstrate that induced selective ablation of AgRP-expressing neurons in adult mice results in acute reduction of feeding, demonstrating direct evidence for a critical role of these neurons in the regulation of energy homeostasis.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med CMMC, Dept Mouse Genet & Metab, D-50674 Cologne, Germany; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; Stanford Univ, Sch Med, Dept Genet & Pediat, Stanford, CA 94305 USA; Univ Cologne, Dept Internal Med 2, D-50924 Cologne, Germany; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, Unit Pathophysiol, D-55131 Mainz, Germany	University of Cologne; University of Cologne; Yale University; Yale University; Yale University; Stanford University; University of Cologne; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johannes Gutenberg University of Mainz	Horvath, TL (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	tamas.horvath@yale.edu; jens.bruening@uni-koelin.de	Buch, Thorsten/P-1659-2019; Waisman, Ari/C-7383-2015; Plum-Mörschel, Leona/W-9413-2019	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Plum-Mörschel, Leona/0000-0002-1907-761X; Janoschek, Ruth/0000-0002-1332-9353	NIDDK NIH HHS [DK-060711, DK-07386] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711, T35DK007386] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Gardiner JV, 2005, BIOCHEM BIOPH RES CO, V327, P1088, DOI 10.1016/j.bbrc.2004.12.113; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	14	546	550	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1289	1291		10.1038/nn1548	http://dx.doi.org/10.1038/nn1548			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158063				2022-12-28	WOS:000232145900009
J	Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA				Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA			Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping	NATURE NEUROSCIENCE			English	Article							BETA-2 SUBUNIT; AXON GUIDANCE; SEGREGATION; PROJECTIONS; RECEPTORS; COMPETITION; REFINEMENT; EXPRESSION; INFUSION; COLUMNS	In mammals, retinal ganglion cell (RGC) projections initially intermingle and then segregate into a stereotyped pattern of eye-specific layers in the dorsal lateral geniculate nucleus (dLGN). Here we found that in mice deficient for ephrin-A2, ephrin-A3 and ephrin-A5, eye-specific inputs segregated but the shape and location of eye-specific layers were profoundly disrupted. In contrast, mice that lacked correlated retinal activity did not segregate eye-specific inputs. Inhibition of correlated neural activity in ephrin mutants led to overlapping retinal projections that were located in inappropriate regions of the dLGN. Thus, ephrin-As and neural activity act together to control patterning of eye-specific retinogeniculate layers.	Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Feldheim, DA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	feldheim@biology.ucsc.edu	Flanagan, John/AAM-2995-2020	Renteria, Rene/0000-0002-4490-0735	NCI NIH HHS [P01 CA23767, P01 CA023767] Funding Source: Medline; NEI NIH HHS [R01 EY014689, EY014689] Funding Source: Medline; NIDCD NIH HHS [R01 DC04209, R01 DC004209] Funding Source: Medline; NIGMS NIH HHS [GM08646, T32 GM008646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Demas J, 2003, J NEUROSCI, V23, P2851; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, CURR BIOL, V10, pR52, DOI 10.1016/S0960-9822(00)00293-1; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; METIN C, 1983, CR ACAD SCI III-VIE, V296, P157; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8	35	143	146	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1022	1027		10.1038/nn1508	http://dx.doi.org/10.1038/nn1508			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025107	Green Accepted			2022-12-28	WOS:000230760200013
J	Keleman, K; Ribeiro, C; Dickson, BJ				Keleman, K; Ribeiro, C; Dickson, BJ			Comm function in commissural axon guidance: cell-autonomous sorting of Robo in vivo	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; AMINO-ACID PERMEASE; CNS MIDLINE; ROUNDABOUT RECEPTOR; UBIQUITIN LIGASE; MEMBRANE-PROTEIN; TYROSINE KINASE; DROSOPHILA CNS; NEURONS; SLIT	Commissureless (Comm) controls axon guidance across the Drosophila melanogaster midline by regulating surface levels of Robo, the receptor for the midline repellent Slit. Two different models have been proposed for how Comm regulates Robo: a 'sorting' model and a 'clearance' model, both based on studies using heterologous cells in vitro. Here, we test these two models in vivo. We establish a genetic rescue assay for Comm, and use this assay to show that midline crossing does not require the presence of Comm in midline cells, as proposed by the clearance model. Moreover, by monitoring the trafficking of a Robo-green fluorescent protein (GFP) fusion in living embryos, we demonstrate that Comm prevents the delivery of Robo-GFP to the growth cone, as predicted by the sorting model. It has also been suggested that Comm must be ubiquitinated by the Nedd4 ubiquitin ligase. We show here, however, that ubiquitination of Comm is not required for its function in vitro or in vivo, and that Nedd4 is unlikely to function in axon guidance at the midline.	Austrian Acad Sci, IMBA, Inst Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, IMBA, Inst Biotechnol, Dr Bohr Gasse 305, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Ribeiro, Carlos/0000-0002-9542-7335				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Georgiou M, 2003, MECH DEVELOP, V120, P1009, DOI 10.1016/S0925-4773(03)00179-5; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; McGovern VL, 2003, DEV GENES EVOL, V213, P500, DOI 10.1007/s00427-003-0349-1; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Overly CC, 1996, J NEUROSCI, V16, P6056; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; WHARTON KA, 1994, DEVELOPMENT, V120, P3563	32	118	122	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					156	163		10.1038/nn1388	http://dx.doi.org/10.1038/nn1388			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657595				2022-12-28	WOS:000226638200014
J	Lee, SH; Blake, R; Heeger, DJ				Lee, SH; Blake, R; Heeger, DJ			Traveling waves of activity in primary visual cortex during binocular rivalry	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; PERCEPTION; DYNAMICS	When the two eyes view large, dissimilar patterns that induce binocular rivalry, alternating waves of visibility are experienced as one pattern sweeps the other out of conscious awareness. Here we combine psychophysics with functional magnetic resonance imaging to show tight linkage between dynamics of perceptual waves during rivalry and neural events in human primary visual cortex (V1).	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	New York University; New York University; Vanderbilt University	Heeger, DJ (corresponding author), NYU, Dept Psychol, 6 Washington Pl,8th Floor, New York, NY 10003 USA.	david.heeger@nyu.edu	Lee, Sang-Hun/B-9898-2008		NATIONAL EYE INSTITUTE [R01EY012741, R03EY014437] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY014437, EY14437, EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	15	179	181	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					22	23		10.1038/nn1365	http://dx.doi.org/10.1038/nn1365			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580269	Green Accepted			2022-12-28	WOS:000225967600010
J	Williams, ZM; Bush, G; Rauch, SL; Cosgrove, GR; Eskandar, EN				Williams, ZM; Bush, G; Rauch, SL; Cosgrove, GR; Eskandar, EN			Human anterior cingulate neurons and the integration of monetary reward with motor responses	NATURE NEUROSCIENCE			English	Article							CORTEX; CINGULOTOMY; SELECTION; STIMULUS	The human dorsal anterior cingulate cortex (dACC) has been implicated in cognitive processes that have been proposed to play a role in integrating contextual information needed to select or modify appropriate motor responses. In humans, however, there has been little direct evidence tying the dACC to the integration of contextual information and behavioral response. We used single-neuron recordings from human subjects to evaluate the role of the dACC in reward-based decision making. Subjects undergoing planned surgical cingulotomy performed a task where they were instructed to make specific movements in response to changing monetary rewards. In many neurons, activity increased in response to a diminished reward, and was also predictive of the movement ultimately made. After dACC ablation, subjects made selectively more errors when they were required to change movement based on reward reduction. These findings suggest that the dACC in humans plays an important role in linking reward-related information with alternative actions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Eskandar, EN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA.	eeskandar@partners.org						Ahlfors SP, 2004, NEUROIMAGE, V22, P323, DOI 10.1016/j.neuroimage.2003.12.044; Almeida R, 2002, NEUROIMAGE, V17, P1065, DOI 10.1006/nimg.2002.1234; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Paus T, 1996, CEREB CORTEX, V6, P207, DOI 10.1093/cercor/6.2.207; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Spangler WJ, 1996, NEUROSURGERY, V38, P1071, DOI 10.1227/00006123-199606000-00001; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Zhang HZH, 1999, COGNITIVE PSYCHOL, V38, P386, DOI 10.1006/cogp.1998.0703	31	246	247	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1370	1375		10.1038/nn1354	http://dx.doi.org/10.1038/nn1354			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558064				2022-12-28	WOS:000225353900018
J	Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD				Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD			Neural correlates of sensory and decision processes in auditory object identification	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE; REACTION-TIME; HUMAN-BRAIN; PREFRONTAL CORTEX; RHESUS-MONKEY; SPEECH; TASK; FMRI; ACTIVATION; SOUNDS	Physiological studies of auditory perception have not yet clearly distinguished sensory from decision processes. In this experiment, human participants identified speech sounds masked by varying levels of noise while blood oxygenation signals in the brain were recorded with functional magnetic resonance imaging (fMRI). Accuracy and response time were used to characterize the behavior of sensory and decision components of this perceptual system. Oxygenation signals in a cortical subregion just anterior and lateral to primary auditory cortex predicted accuracy of sound identification, whereas signals in an inferior frontal region predicted response time. Our findings provide neurophysiological evidence for a functional distinction between sensory and decision mechanisms underlying auditory object identification. The present results also indicate a link between inferior frontal lobe activation and response-selection processes during auditory perception tasks.	Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Binder, JR (corresponding author), Med Coll Wisconsin, Dept Neurol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jbinder@mcw.edu	Liebenthal, Einat/AAO-9781-2020; Binder, Jeff/CAJ-3303-2022	Binder, Jeffrey/0000-0002-2233-5640; Liebenthal, Einat/0000-0003-4917-8160	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006287] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00058] Funding Source: Medline; NIDCD NIH HHS [R01 DC006287] Funding Source: Medline; NIMH NIH HHS [P01 MH51358] Funding Source: Medline; NINDS NIH HHS [R01 NS33576] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Binder JR, 2001, HDB FUNCTIONAL NEURO, P187; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis MH, 2003, J NEUROSCI, V23, P3423; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Fant G., 1973, SPEECH SOUNDS FEATUR; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Grabowski TJ., 2000, BRAIN MAPPING SYSTEM, P425, DOI [10.1016/B978-012692545-6/50016-7, DOI 10.1016/B978-012692545-6/50016-7]; GREEN DM, 1966, SIGNAL DETECTION THE; GRICE GR, 1982, J EXP PSYCHOL GEN, V111, P135, DOI 10.1037/0096-3445.111.1.135; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Honey GD, 2000, NEUROIMAGE, V12, P495, DOI 10.1006/nimg.2000.0624; Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4; Ito SI, 2001, NEUROSCI RES, V41, P257, DOI 10.1016/S0168-0102(01)00287-5; Johnson PWM, 1997, ANN ONCOL, V8, P65, DOI 10.1023/A:1008234301024; Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783; Kleist K, 1962, SENSORY APHASIA AMUS; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Liebenthal E, 2003, J COGNITIVE NEUROSCI, V15, P549, DOI 10.1162/089892903321662930; MECKLINGER A, 1994, PSYCHOPHYSIOLOGY, V31, P23, DOI 10.1111/j.1469-8986.1994.tb01021.x; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Meyer A, 1908, J PSYCHOL NEUROL, V13, P203; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; NORRIS D, 2000, NEW COGNITIVE NEUROS, P867; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Warren JD, 2003, J NEUROSCI, V23, P5799; YELLOTT JI, 1971, J MATH PSYCHOL, V8, P159, DOI 10.1016/0022-2496(71)90011-3; Zatorre R. J., 2000, BRAIN MAPPING SYSTEM, P365; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	50	363	365	0	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					295	301		10.1038/nn1198	http://dx.doi.org/10.1038/nn1198			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966525				2022-12-28	WOS:000189197900020
J	Jarsky, T; Roxin, A; Kath, WL; Spruston, N				Jarsky, T; Roxin, A; Kath, WL; Spruston, N			Conditional dendritic spike propagation following distal synaptic activation of hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; CORTEX COMBINED SLICE; ENTORHINAL CORTEX; EXCITATORY SYNAPSES; IN-VITRO; AREA CA1; CELLS; RAT; BACKPROPAGATION; INPUTS	The perforant-path projection to the hippocampus forms synapses in the apical tuft of CA1 pyramidal neurons. We used computer modeling to examine the function of these distal synaptic inputs, which led to three predictions that we confirmed in experiments using rat hippocampal slices. First, activation of CA1 neurons by the perforant path is limited, a result of the long distance between these inputs and the soma. Second, activation of CA1 neurons by the perforant path depends on the generation of dendritic spikes. Third, the forward propagation of these spikes is unreliable, but can be facilitated by modest activation of Schaffer-collateral synapses in the upper apical dendrites. This 'gating' of dendritic spike propagation may be an important activation mode of CA1 pyramidal neurons, and its modulation by neurotransmitters or long-term, activity-dependent plasticity may be an important feature of dendritic integration during mnemonic processing in the hippocampus.	Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Univ Paris 05, CNRS, Unite Mixte Rech 8119, F-75270 Paris, France	Northwestern University; Northwestern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Spruston, N (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, 2205 Tech Dr, Evanston, IL 60208 USA.	spruston@northwestern.edu	Kath, William/B-6771-2009; Jarsky, Tim/S-1879-2019; Roxin, Alex/F-1742-2013	Roxin, Alex/0000-0003-1015-8138; Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783	NINDS NIH HHS [NS-35180, NS-045437, NS-46064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180, F31NS045437, R01NS046064] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1966, EXP BRAIN RES, V2, P247; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUZSAKI G, 1995, HIPPOCAMPUS, V5, P141, DOI 10.1002/hipo.450050210; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; Colbert CM, 1996, J NEUROSCI, V16, P6676; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DESMOND NL, 1994, HIPPOCAMPUS, V4, P594, DOI 10.1002/hipo.450040509; DOLLER HJ, 1982, BRAIN RES, V237, P1, DOI 10.1016/0006-8993(82)90553-4; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; PARE D, 1995, HIPPOCAMPUS, V5, P115, DOI 10.1002/hipo.450050205; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SOLTESZ I, 1995, HIPPOCAMPUS, V5, P120, DOI 10.1002/hipo.450050206; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	44	201	202	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1667	1676		10.1038/nn1599	http://dx.doi.org/10.1038/nn1599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299501				2022-12-28	WOS:000233576200014
J	Victor, JD				Victor, JD			Analyzing receptive fields, classification images and functional images: challenges with opportunities for synergy	NATURE NEUROSCIENCE			English	Article							WHITE-NOISE ANALYSIS; NEURONAL-ACTIVITY; STATISTICS; RESPONSES; FEATURES; CELLS; FMRI; SYSTEM	In neurophysiology, psychophysics, optical imaging and functional imaging studies, the investigator seeks a relationship between a high-dimensional variable, such as an image, and a categorical variable, such as the presence or absence of a spike or a behavior. The usual analysis strategy is fundamentally identical across these contexts - it amounts to calculating the average value of the high-dimensional variable for each value of the categorical variable and comparing these results by subtraction. Though intuitive and straightforward, this procedure may be inaccurate or inefficient and may overlook important details. Sophisticated approaches have been developed within these several experimental contexts, but they are rarely applied beyond the context in which they were developed. Recognition of the relationships among these contexts has the potential to accelerate improvements in analytic methods and to increase the amount of information that can be gleaned from experiments.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Victor, JD (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	jdvicto@med.cornell.edu	Victor, Jonathan D./D-2931-2009	Victor, Jonathan D./0000-0002-9293-0111	NEI NIH HHS [EY7977, R01 EY007977, EY9314, R01 EY009314] Funding Source: Medline; NIMH NIH HHS [R01 MH068012] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009314, R01EY007977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068012] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; CARMONA RA, 1995, IEEE T MED IMAGING, V14, P556, DOI 10.1109/42.414621; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Everson R, 1997, BIOL CYBERN, V77, P407, DOI 10.1007/s004220050400; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gabbay M, 2000, NEUROIMAGE, V11, P313, DOI 10.1006/nimg.2000.0547; Grinvald A., 1992, Brain Topography, V5, P71, DOI 10.1007/BF01129033; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KORENBERG MJ, 1988, ANN BIOMED ENG, V16, P201, DOI 10.1007/BF02364581; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEE YW, 1965, INT J CONTROL, V2, P237, DOI 10.1080/00207176508905543; Levi DM, 2002, J VISION, V2, P46, DOI 10.1167/2.1.4; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MARMARELIS PZ, 1972, SCIENCE, V175, P1276, DOI 10.1126/science.175.4027.1276; Neri P, 2004, J VISION, V4, P82, DOI 10.1167/4.2.2; Neri P, 2002, NAT NEUROSCI, V5, P812, DOI 10.1038/nn886; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pillow JW, 2003, NEUROCOMPUTING, V52-4, P109, DOI 10.1016/S0925-2312(02)00822-6; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smyth D, 2003, J NEUROSCI, V23, P4746; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Tikhonov A., 1977, SOLUTION ILL POSED P; Touryan J, 2002, J NEUROSCI, V22, P10811; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; Yokoo T, 2001, NEUROIMAGE, V14, P1309, DOI 10.1006/nimg.2001.0950	46	45	45	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1651	1656		10.1038/nn1607	http://dx.doi.org/10.1038/nn1607			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16306893	Green Accepted			2022-12-28	WOS:000233576200010
J	Sergent, C; Baillet, S; Dehaene, S				Sergent, C; Baillet, S; Dehaene, S			Timing of the brain events underlying access to consciousness during the attentional blink	NATURE NEUROSCIENCE			English	Article							SERIAL VISUAL PRESENTATION; INATTENTIONAL BLINDNESS; NEURONAL MODEL; NETWORK MODEL; NEURAL FATE; PERCEPTION; RECOGNITION; HUMANS; TASKS; IDENTIFICATION	In the phenomenon of attentional blink, identical visual stimuli are sometimes fully perceived and sometimes not detected at all. This phenomenon thus provides an optimal situation to study the fate of stimuli not consciously perceived and the differences between conscious and nonconscious processing. We correlated behavioral visibility ratings and recordings of event-related potentials to study the temporal dynamics of access to consciousness. Intact early potentials (P1 and N1) were evoked by unseen words, suggesting that these brain events are not the primary correlates of conscious perception. However, we observed a rapid divergence around 270 ms, after which several brain events were evoked solely by seen words. Thus, we suggest that the transition toward access to consciousness relates to the optional triggering of a late wave of activation that spreads through a distributed network of cortical association areas.	CEA, Serv Hosp Frederic Joliot, INSERM, U562, F-91401 Orsay, France; Hop La Pitie Salpetriere, CNRS, UPR LENA 640, Cognit Neurosci & Brain Imaging Lab, F-75651 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Sergent, C (corresponding author), CEA, Serv Hosp Frederic Joliot, INSERM, U562, 4 Pl Gen Leclerc, F-91401 Orsay, France.	sergent@shfj.cea.fr	Baillet, Sylvain/AAF-6512-2019	Baillet, Sylvain/0000-0002-6762-5713				Baars B.J., 1989, COGNITIVE THEORY CON; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Darvas F, 2006, HUM BRAIN MAPP, V27, P129, DOI 10.1002/hbm.20171; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; FRAGOPANAGOS NF, IN PRESS BRAIN RES C; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Pallaro Anabel N., 1997, Journal of Nutritional Immunology, V5, P29; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Pins D, 2003, CEREB CORTEX, V13, P461, DOI 10.1093/cercor/13.5.461; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Saunders P., 1980, INTRO CATASTROPHE TH; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Taylor JG, 1996, BIOL CYBERN, V75, P59, DOI 10.1007/BF00238740; Thom R., 1983, PARABOLES CATASTROPH; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207	47	588	599	2	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1391	1400		10.1038/nn1549	http://dx.doi.org/10.1038/nn1549			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	968EY	16158062				2022-12-28	WOS:000232145900025
J	Janssen, P; Shadlen, MN				Janssen, P; Shadlen, MN			A representation of the hazard rate of elapsed time in macaque area LIP	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; LATERAL INTRAPARIETAL AREA; SACCADIC EYE-MOVEMENTS; NEURONAL-ACTIVITY; NEURAL REPRESENTATION; SUPERIOR COLLICULUS; PREFRONTAL CORTEX; WORKING-MEMORY; MONKEY; ATTENTION	The capacity to anticipate the timing of environmental cues allows us to allocate sensory resources at the right time and prepare actions. Such anticipation requires knowledge of elapsed time and of the probability that an event will occur. Here we show that neurons in the parietal cortex represent the probability, as a function of time, that a salient event is likely to occur. Rhesus monkeys were trained to make eye movements to peripheral targets after a light dimmed. Within a block of trials, the 'go' times were drawn from either a bimodal or unimodal distribution of random numbers. Neurons in the lateral intraparietal area showed anticipatory activity that revealed an internal representation of both elapsed time and the probability that the 'go' signal was about to occur (termed the hazard rate). The results indicate that the parietal cortex contains circuitry for representing the time structure of environmental cues over a range of seconds.	Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), KU Leuven Med Sch, Lab Neuroen Psychofysiol, Herestr 49, B-3000 Louvain, Belgium.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLISTEL CR, 2000, PSYCHOL REV, V107, P289; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Anderson TW, 1984, INTRO MULTIVARIATE S; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; Durstewitz D, 2004, NEUROREPORT, V15, P745, DOI 10.1097/00001756-200404090-00001; Escobar, 1998, STAT METHODS RELIABI; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; KARLIN L, 1966, J EXP PSYCHOL, V72, P505, DOI 10.1037/h0023748; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; LUC RD, 1986, RESPONSE TIMES THEIR; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck W.H., 1988, QUANTITATIVE ANAL BE, P121; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roux S, 2003, EUR J NEUROSCI, V18, P1011, DOI 10.1046/j.1460-9568.2003.02792.x; SCHALL JD, 1993, BEHAV BRAIN SCI, V16, P588, DOI 10.1017/S0140525X00031812; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a	50	397	398	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					234	241		10.1038/nn1386	http://dx.doi.org/10.1038/nn1386			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657597	Green Published			2022-12-28	WOS:000226638200024
J	Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S				Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S			Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation	NATURE NEUROSCIENCE			English	Article							KINASE INHIBITOR P27(KIP1); MYELIN BASIC-PROTEIN; CELL-CYCLE; TRANSLATIONAL REGULATOR; SIGNAL-TRANSDUCTION; ECTOPIC EXPRESSION; STAR PROTEIN; MUTANT MICE; C-ELEGANS; GLD-1	The quaking (Qk) locus expresses a family of RNA binding proteins, and the expression of several alternatively spliced isoforms coincides with the development of oligodendrocytes and the onset of myelination. Quaking viable (Qk(v)) mice harboring an autosomal recessive mutation in this locus have uncompacted myelin in the central nervous system owing to the inability of oligodendrocytes to properly mature. Here we show that the expression of two QKI isoforms, absent from oligodendrocytes of Qk(v) mice, induces cell cycle arrest of primary rat oligodendrocyte progenitor cells and differentiation into oligodendrocytes. Injection of retroviruses expressing QKI into the telencephalon of mouse embryos induced differentiation and migration of multipotential neural progenitor cells into mature oligodendrocytes localized in the corpus callosum. The mRNA encoding the cyclin-dependent kinase (CDK)-inhibitor p27(Kip1) was bound and stabilized by QKI, leading to an increased accumulation of p27(Kip1) protein in oligodendrocytes. Our findings demonstrate that QKI is upstream of p27(Kip1) during oligodendrocyte differentiation.	Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca						ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; [Anonymous], MYELIN; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Colognato H, 2004, CURR OPIN NEUROBIOL, V14, P37, DOI 10.1016/j.conb.2004.01.009; Darnell RB, 2004, ARCH NEUROL-CHICAGO, V61, P30, DOI 10.1001/archneur.61.1.30; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lorenzetti D, 2004, MAMM GENOME, V15, P210, DOI 10.1007/s00335-003-2333-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nery S, 2001, DEVELOPMENT, V128, P527; Okano H, 2002, J CELL SCI, V115, P1355; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Song J, 2001, MOL CELL NEUROSCI, V17, P624, DOI 10.1006/mcne.2001.0974; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhang YY, 2001, J NEUROCHEM, V77, P165, DOI 10.1046/j.1471-4159.2001.00224.x	48	131	134	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					27	33		10.1038/nn1359	http://dx.doi.org/10.1038/nn1359			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568022				2022-12-28	WOS:000225967600012
J	Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P				Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P			Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LEUKEMIA INHIBITORY FACTOR; MOTOR-NEURON DEGENERATION; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PROLONGS SURVIVAL; GROWTH-FACTORS; MOUSE; MICE; GENE	Neurotrophin treatment has so far failed to prolong the survival of individuals affected with amyotrophic lateral sclerosis (ALS), an incurable motoneuron degenerative disorder. Here we show that intracerebroventricular (i.c.v.) delivery of recombinant vascular endothelial growth factor (Vegf) in a SOD1(G93A) rat model of ALS delays onset of paralysis by 17 d, improves motor performance and prolongs survival by 22 d, representing the largest effects in animal models of ALS achieved by protein delivery. By protecting cervical motoneurons, i.c.v. delivery of Vegf is particularly effective in rats with the most severe form of ALS with forelimb onset. Vegf has direct neuroprotective effects on motoneurons in vivo, because neuronal expression of a transgene expressing the Vegf receptor prolongs the survival of SOD1(G93A) mice. On i.c.v. delivery, Vegf is anterogradely transported and preserves neuromuscular junctions in SOD1(G93A) rats. Our findings in preclinical rodent models of ALS may have implications for treatment of neurodegenerative disease in general.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium; Katholieke Univ Leuven, Fac Med, Dept Neurol, B-3000 Leuven, Belgium; Maastricht Univ, Dept Psychiat & Neuropsychol, Div Cellular Neurosci, NL-6200 MD Maastricht, Netherlands; European Grad Sch Neurosci EURON, NL-6200 MD Maastricht, Netherlands; State Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Maastricht University; Maastricht University; Flanders Institute for Biotechnology (VIB); Ghent University	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Carmeliet, Peter/AAQ-5140-2020; Moreno-Murciano, Paz/D-7871-2018; Storkebaum, Erik/B-5389-2017; Lambrechts, Diether/AAJ-3167-2020; Van Den Bosch, Ludo/B-7258-2012; Moreno, Paz/K-6870-2012; Van Damme, Philip/A-6464-2009; Verdrengh, Evelien/H-4571-2012	Carmeliet, Peter/0000-0001-7961-1821; Storkebaum, Erik/0000-0002-9519-5642; Lambrechts, Diether/0000-0002-3429-302X; Van Damme, Philip/0000-0002-4010-2357; Van Den Bosch, Ludo/0000-0003-0104-4067; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Rutten, Bart/0000-0002-9834-6346; Conway, Edward/0000-0003-0081-0305				Aebischer P, 2004, GENE THER, V11, P429, DOI 10.1038/sj.gt.3302204; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Azari MF, 2003, BRAIN RES, V982, P92, DOI 10.1016/S0006-8993(03)02989-5; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Brown RH, 2001, SEMIN NEUROL, V21, P131; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Feeney SJ, 2003, CYTOKINE, V23, P108, DOI 10.1016/S1043-4666(03)00217-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; ORRELL RW, 1995, J NEUROL SCI, V132, P126, DOI 10.1016/0022-510X(95)00129-P; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Przedborski Serge, 2003, Curr Neurol Neurosci Rep, V3, P70, DOI 10.1007/s11910-003-0041-x; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Watson FL, 1999, J NEUROSCI, V19, P7889; WINDEBANK AJ, 1995, ADV NEUROL, V68, P229	33	390	437	1	26	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					85	92		10.1038/nn1360	http://dx.doi.org/10.1038/nn1360			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568021	Green Published			2022-12-28	WOS:000225967600020
J	Buzsaki, G				Buzsaki, G			Large-scale recording of neuronal ensembles	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; CENTRAL NERVOUS-SYSTEM; IN-VIVO; ACTION-POTENTIALS; BEHAVING RAT; SINGLE UNITS; CORTEX; CODE; BACKPROPAGATION; CLASSIFICATION	How does the brain orchestrate perceptions, thoughts and actions from the spiking activity of its neurons? Early single-neuron recording research treated spike pattern variability as noise that needed to be averaged out to reveal the brain's representation of invariant input. Another view is that variability of spikes is centrally coordinated and that this brain-generated ensemble pattern in cortical structures is itself a potential source of cognition. Large-scale recordings from neuronal ensembles now offer the opportunity to test these competing theoretical frameworks. Currently, wire and micro-machined silicon electrode arrays can record from large numbers of neurons and monitor local neural circuits at work. Achieving the full potential of massively parallel neuronal recordings, however, will require further development of the neuron-electrode interface, automated and efficient spike-sorting algorithms for effective isolation and identification of single neurons, and new mathematical insights for the analysis of network properties.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800	NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994, NS43157] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTHO P, IN PRESS J NEUROPHYS; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DEADWYLER SA, 1995, SCIENCE, V270, P1316, DOI 10.1126/science.270.5240.1316; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; DOUGLAS RJ, 1991, TRENDS NEUROSCI, V14, P286, DOI 10.1016/0166-2236(91)90139-L; EICHENBAUM H, 1988, NEURONAL ENSEMBLES S; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hampson R E, 2001, Prog Brain Res, V130, P345; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Letelier JC, 2000, J NEUROSCI METH, V101, P93, DOI 10.1016/S0165-0270(00)00250-8; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Musial PG, 2002, J NEUROSCI METH, V115, P29, DOI 10.1016/S0165-0270(01)00516-7; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0; Norlin P, 2002, J MICROMECH MICROENG, V12, P414, DOI 10.1088/0960-1317/12/4/312; OLSSON RH, 2003, IEEE ENG MED BIOL, V22, P1968; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; QUIROGA RQ, IN PRESS NEURAL COMP; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wise KD, 1998, SENSOR MATER, V10, P385; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192	65	1131	1163	8	240	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					446	451		10.1038/nn1233	http://dx.doi.org/10.1038/nn1233			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114356				2022-12-28	WOS:000221101300011
J	Ciccocioppo, R; Martin-Fardon, R; Weiss, F				Ciccocioppo, R; Martin-Fardon, R; Weiss, F			Stimuli associated with a single cocaine experience elicit longlasting cocaine-seeking	NATURE NEUROSCIENCE			English	Article							NEUROCHEMICAL SENSITIZATION; ADDICTION; EXPOSURE; WITHDRAWAL; COMPULSION; BRAIN; RATS	Epidemiological data suggest that cocaine dependence emerges rapidly, and most cocaine addicts meet criteria for dependence within 1-3 years after onset of drug use. Here we show that in rats, environmental stimuli associated with a single cocaine self-administration experience elicit strong cocaine-seeking that persists for up to one year. In contrast, conditioned stimuli that were associated with a highly palatable non-drug reinforcer elicited modest behavioral responses that extinguished within 3 months.	Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, MC, Italy; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	University of Camerino; Scripps Research Institute	Ciccocioppo, R (corresponding author), Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, MC, Italy.	roberto.ciccocioppo@unicam.it	Martin-Fardon, R/ABB-7865-2020		NIDA NIH HHS [DA08348, DA07348] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA008348, R37DA007348, R01DA007348] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; JACKSON HC, 1993, PHARMACOL BIOCHEM BE, V45, P733, DOI 10.1016/0091-3057(93)90533-Y; Meil WM, 1996, BEHAV PHARMACOL, V7, P754; Miller N S, 1994, Ann Clin Psychiatry, V6, P99, DOI 10.3109/10401239409148988; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x	13	87	90	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					495	496		10.1038/nn1219	http://dx.doi.org/10.1038/nn1219			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15048121				2022-12-28	WOS:000221101300024
J	Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ				Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ			Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DOPAMINE-RECEPTORS; DENDRITIC SPINES; STRIATAL NEURONS; CA2+ CHANNELS; SYNAPTIC-TRANSMISSION; NEOSTRIATAL NEURONS; RAT NEOSTRIATUM; GENE-EXPRESSION	Parkinson disease is a common neurodegenerative disorder that leads to difficulty in effectively translating thought into action. Although it is known that dopaminergic neurons that innervate the striatum die in Parkinson disease, it is not clear how this loss leads to symptoms. Recent work has implicated striatopallidal medium spiny neurons ( MSNs) in this process, but how and precisely why these neurons change is not clear. Using multiphoton imaging, we show that dopamine depletion leads to a rapid and profound loss of spines and glutamatergic synapses on striatopallidal MSNs but not on neighboring striatonigral MSNs. This loss of connectivity is triggered by a new mechanism-dysregulation of intraspine Cav1.3 L-type Ca2+ channels. The disconnection of striatopallidal neurons from motor command structures is likely to be a key step in the emergence of pathological activity that is responsible for symptoms in Parkinson disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Edinburgh, Div Neurosci & Vet Biomed Sci, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37212 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37212 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Sesack, Susan R/H-8013-2018; Arbuthnott, Gordon W/A-4606-2015; Tuluc, Petronel/C-2527-2011; Ding, Jun/B-2513-2009	Sesack, Susan R/0000-0002-2852-7440; Arbuthnott, Gordon W/0000-0002-3386-8362; Ding, Jun/0000-0003-0690-1312	NINDS NIH HHS [NS 047085, NS 19608, NS 34696, NS 44282] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, P50NS047085, P01NS019608, P50NS019608, P01NS044282, R01NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dunah AW, 2000, MOL PHARMACOL, V57, P342; GALARRAGA E, 1987, NEUROSCI LETT, V81, P351, DOI 10.1016/0304-3940(87)90409-5; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gross CE, 1999, PROG NEUROBIOL, V59, P509, DOI 10.1016/S0301-0082(99)00015-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; INGHAM CA, 1993, EXP BRAIN RES, V93, P17, DOI 10.1007/BF00227776; Ingham CA, 1998, J NEUROSCI, V18, P4732; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lovinger DM, 2003, ANN NY ACAD SCI, V1003, P226, DOI 10.1196/annals.1300.014; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NISENBAUM ES, 1986, BRAIN RES, V398, P221, DOI 10.1016/0006-8993(86)91481-2; Oertner TG, 2005, CELL CALCIUM, V37, P477, DOI 10.1016/j.ceca.2005.01.016; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pang ZP, 2001, NEUROSCI LETT, V308, P201, DOI 10.1016/S0304-3940(01)02031-6; Picconi B, 2004, BRAIN, V127, P1661, DOI 10.1093/brain/awh190; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; SHOLL DA, 1953, J ANAT, V87, P387; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wichmann T, 2003, ADV NEUROL, V91, P9; WILSON CJ, 1994, MICROSC RES TECHNIQ, V29, P368, DOI 10.1002/jemt.1070290507; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	572	589	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					251	259		10.1038/nn1632	http://dx.doi.org/10.1038/nn1632			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415865				2022-12-28	WOS:000234990100021
J	Wong, LF; Yip, PK; Battaglia, A; Grist, J; Corcoran, J; Maden, M; Azzouz, M; Kingsman, SM; Kingsman, AJ; Mazarakis, ND; McMahon, SB				Wong, LF; Yip, PK; Battaglia, A; Grist, J; Corcoran, J; Maden, M; Azzouz, M; Kingsman, SM; Kingsman, AJ; Mazarakis, ND; McMahon, SB			Retinoic acid receptor beta 2 promotes functional regeneration of sensory axons in the spinal cord	NATURE NEUROSCIENCE			English	Article							F9 TERATOCARCINOMA CELLS; NERVOUS-SYSTEM; LENTIVIRAL VECTORS; CYCLIC-AMP; ADULT RATS; NEURITE OUTGROWTH; IN-VITRO; NEURONS; EXPRESSION; INJURY	The embryonic CNS readily undergoes regeneration, unlike the adult CNS, which has limited axonal repair after injury. Here we tested the hypothesis that retinoic acid receptor beta 2 ( RAR beta 2), critical in development for neuronal growth, may enable adult neurons to grow in an inhibitory environment. Overexpression of RAR beta 2 in adult rat dorsal root ganglion cultures increased intracellular levels of cyclic AMP and stimulated neurite outgrowth. Stable RAR beta 2 expression in DRG neurons in vitro and in vivo enabled their axons to regenerate across the inhibitory dorsal root entry zone and project into the gray matter of the spinal cord. The regenerated neurons enhanced second-order neuronal activity in the spinal cord, and RAR beta 2-treated rats showed highly significant improvement in sensorimotor tasks. These findings show that RAR beta 2 induces axonal regeneration programs within injured neurons and may thus offer new therapeutic opportunities for CNS regeneration.	Oxford BioMed UK Ltd, Medawar Ctr, Oxford OX4 4GA, England; Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London SE1 1UL, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Oxford Biomedica (UK) Ltd; University of London; King's College London; University of London; King's College London	Wong, LF (corresponding author), Oxford BioMed UK Ltd, Medawar Ctr, Robert Robinson Ave,Oxford Sci Pk, Oxford OX4 4GA, England.	l.wong@oxfordbiomedica.co.uk; n.mazarakis@oxfordbiomedica.co.uk	Azzouz, Mimoun/B-3979-2009	Azzouz, Mimoun/0000-0001-6564-5967; McMahon, Stephen/0000-0003-4656-5536; Shaw, Pamela/0000-0002-8925-2567	Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Appel B, 2003, NEURON, V40, P461, DOI 10.1016/S0896-6273(03)00688-3; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Azzouz M, 2002, J NEUROSCI, V22, P10302; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cajal S., 1928, DEGENERATION REGENER; CARLSTEDT T, 1985, BRAIN RES, V347, P188, DOI 10.1016/0006-8993(85)90911-4; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAN SDH, 1990, J BIOL CHEM, V265, P20081; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Corcoran J, 2002, J CELL SCI, V115, P3779, DOI 10.1242/jcs.00046; Corcoran J, 2000, J CELL SCI, V113, P2567; DUBUISSON D, 1989, TXB PAIN, P544; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Golding JP, 1999, GLIA, V26, P309, DOI 10.1002/(SICI)1098-1136(199906)26:4<309::AID-GLIA5>3.3.CO;2-S; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lipskaia L, 1997, FEBS LETT, V415, P275, DOI 10.1016/S0014-5793(97)01001-6; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Maden M, 2001, INT REV CYTOL, V209, P1; Martin-Rendon E, 2002, MOL THER, V5, P566, DOI 10.1006/mthe.2002.0576; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; MONTOYA GP, 1991, J NEUROSCI METH, V36, P219; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; RATTRAY M, 1998, IN SITU HYBRIDISATIO, P23; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Werner EA, 2002, AM J PHYSIOL-ENDOC M, V282, pE672, DOI 10.1152/ajpendo.00280.2001; Wong LF, 2004, MOL THER, V9, P101, DOI 10.1016/j.ymthe.2003.09.017; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; Zhang Y, 1998, J NEUROSCI RES, V54, P554; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	41	102	111	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					243	250		10.1038/nn1622	http://dx.doi.org/10.1038/nn1622			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388307				2022-12-28	WOS:000234990100020
J	Kalivas, PW				Kalivas, PW			How do we determine which drug-induced neuroplastic changes are important?	NATURE NEUROSCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; DELTA-FOSB; ADDICTION; COCAINE; MOTIVATION; MECHANISMS; SENSITIZATION; PATHOLOGY; ABUSE	Although many drug-induced neural changes are known, progress has been slow in identifying the ones that actually mediate addiction. Identifying changes that are specific to particular elements of the transition from initial to habitual to relapsing drug use may be a fruitful strategy for pinpointing which forms of drug-induced plasticity are critical for addiction.	Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu						Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Canales JJ, 2005, NEUROBIOL LEARN MEM, V83, P93, DOI 10.1016/j.nlm.2004.10.006; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Keitz M., 2003, Neural Plasticity, V10, P121, DOI 10.1155/NP.2003.121; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; SZUMLINSKI KK, 2005, NEUROPSYCHOPHAR 0914; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	20	54	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1440	1441		10.1038/nn1105-1440	http://dx.doi.org/10.1038/nn1105-1440			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251984				2022-12-28	WOS:000232966600012
J	Volkow, N; Li, TK				Volkow, N; Li, TK			The neuroscience of addiction	NATURE NEUROSCIENCE			English	Editorial Material							DRUG-USE; DEPENDENCE; ALCOHOL; ASSOCIATION; DOPAMINE; SEEKING; CORTEX; ONSET; ABUSE; RISK								NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Baumeister SE, 2005, EUR ADDICT RES, V11, P92, DOI 10.1159/000083038; Belluzzi JD, 2004, PSYCHOPHARMACOLOGY, V174, P389, DOI 10.1007/s00213-003-1758-6; BREESE GR, ALCOHOL CLIN EXP RES, V29, P185; Brook DW, 2002, ARCH GEN PSYCHIAT, V59, P1039, DOI 10.1001/archpsyc.59.11.1039; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Hiroi N, 2005, MOL PSYCHIATR, V10, P336, DOI 10.1038/sj.mp.4001622; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Pistis M, 2004, BIOL PSYCHIAT, V56, P86, DOI 10.1016/j.biopsych.2004.05.006; Ranaldi R, 2001, BEHAV PHARMACOL, V12, P527, DOI 10.1097/00008877-200111000-00014; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; VOLKOW N, IN PRESS PHARM THER; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005	19	179	183	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1429	1430		10.1038/nn1105-1429	http://dx.doi.org/10.1038/nn1105-1429			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251981	Green Submitted			2022-12-28	WOS:000232966600009
J	Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF				Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF			Neural correlates of genetically abnormal social cognition in Williams syndrome	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; AMYGDALA RESPONSE; BEHAVIOR; STIMULI; ANXIETY	Williams-Beuren syndrome (WBS), caused by a microdeletion of approximately 21 genes on chromosome 7q11.23, is characterized by unique hypersociability combined with increased non-social anxiety. Using functional neuroimaging, we found reduced amygdala activation in individuals with WBS for threatening faces but increased activation for threatening scenes, relative to matched normal controls. Activation and interactions of prefrontal regions linked to amygdala, especially orbitofrontal cortex, were abnormal, suggesting a genetically controlled neural circuitry for regulating human social behavior.	NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Neuroimaging Core Facil, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,US Dept HHS, Bethesda, MD 20892 USA; Univ Louisville, Dept Psychol & Brain Sci, Neurodev Sci Lab, Louisville, KY 40292 USA; Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA.	andreasml@nih.gov	Hariri, Ahmad/D-5761-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002867, Z01MH002863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035102, NS35102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Dykens EM, 2003, DEV NEUROPSYCHOL, V23, P291, DOI 10.1207/S15326942DN231&2_13; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Klein-Tasman BP, 2003, DEV NEUROPSYCHOL, V23, P269, DOI 10.1207/S15326942DN231&2_12; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Wood JN, 2005, NEUROPSYCHOLOGIA, V43, P249, DOI 10.1016/j.neuropsychologia.2004.11.011	15	274	279	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					991	993		10.1038/nn1494	http://dx.doi.org/10.1038/nn1494			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007084				2022-12-28	WOS:000230760200009
J	Khan, AZ; Pisella, L; Vighetto, A; Cotton, F; Luaute, J; Boisson, D; Salemme, R; Crawford, JD; Rossetti, Y				Khan, AZ; Pisella, L; Vighetto, A; Cotton, F; Luaute, J; Boisson, D; Salemme, R; Crawford, JD; Rossetti, Y			Optic ataxia errors depend on remapped, not viewed, target location	NATURE NEUROSCIENCE			English	Article							HUMAN PARIETAL CORTEX; VISUAL SPACE; IMMEDIATE	Optic ataxia is a disorder associated with posterior parietal lobe lesions, in which visually guided reaching errors typically occur for peripheral targets. It has been assumed that these errors are related to a faulty sensorimotor transformation of inputs from the 'ataxic visual field'. However, we show here that the errors observed in the contralesional field in optic ataxia depend on a dynamic gaze-centered internal representation of reach space.	INSERM, U534, Inst Federat Neurosci Lyon, F-69676 Bron, France; York Univ, York Ctr Vis Res, Canadian Inst Hlth Res, Grp Act & Percept, N York, ON M3J 1P3, Canada; York Univ, Dept Psychol, N York, ON M3J 1P3, Canada; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada; Hop Henry Gabrielle, Hop Neurol Pierre Wertheimer, Hosp Civils Lyon, F-69002 Lyon, France; Ctr Hosp Lyon Sud Jules Courmont, F-69002 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institute for Work & Health; York University - Canada; York University - Canada; York University - Canada; York University - Canada; CHU Lyon; CHU Lyon	Rossetti, Y (corresponding author), INSERM, U534, Inst Federat Neurosci Lyon, 16 Ave Doyen Lepine, F-69676 Bron, France.	rossetti@lyon.inserm.fr	cotton, francois/F-4762-2013; Pisella, Laure/H-6072-2017; Rossetti, Yves/H-3693-2017; Luauté, jacques/H-4618-2017	cotton, francois/0000-0003-0046-2478; Pisella, Laure/0000-0001-6550-3774; Rossetti, Yves/0000-0001-8867-4496; Luauté, jacques/0000-0002-6387-9572; Crawford, Doug/0000-0003-2288-1286				Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; Henriques DYP, 1998, J NEUROSCI, V18, P1583; JEANNEROD M, 1993, VISUAL PERCEPTUAL DE; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 2004, NEUROSCI BIOBEHAV R, V28, P181, DOI 10.1016/j.neubiorev.2004.03.003; RATCLIFF G, 1990, BRAIN SPACE, P237; Revol P, 2003, SPATIAL VISION, V16, P347, DOI 10.1163/156856803322467572; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6	15	92	93	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					418	420		10.1038/nn1425	http://dx.doi.org/10.1038/nn1425			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768034				2022-12-28	WOS:000228040400010
J	Marino, J; Schummers, J; Lyon, DC; Schwabe, L; Beck, O; Wiesing, P; Obermayer, K; Sur, M				Marino, J; Schummers, J; Lyon, DC; Schwabe, L; Beck, O; Wiesing, P; Obermayer, K; Sur, M			Invariant computations in local cortical networks with balanced excitation and inhibition	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; SIMPLE CELLS; CONNECTIONS; DYNAMICS; NEURONS; TOPOGRAPHY; PLASTICITY; CONDUCTANCE	Cortical computations critically involve local neuronal circuits. The computations are often invariant across a cortical area yet are carried out by networks that can vary widely within an area according to its functional architecture. Here we demonstrate a mechanism by which orientation selectivity is computed invariantly in cat primary visual cortex across an orientation preference map that provides a wide diversity of local circuits. Visually evoked excitatory and inhibitory synaptic conductances are balanced exquisitely in cortical neurons and thus keep the spike response sharply tuned at all map locations. This functional balance derives from spatially isotropic local connectivity of both excitatory and inhibitory cells. Modeling results demonstrate that such covariation is a signature of recurrent rather than purely feed-forward processing and that the observed isotropic local circuit is sufficient to generate invariant spike tuning.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Berlin Univ Technol, Dept Comp Sci & Elect Engn, D-10587 Berlin, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Technical University of Berlin	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	msur@mit.edu		Lyon, David C./0000-0002-4367-5636; Schummers, James/0000-0002-1030-824X				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angelucci A, 2002, J NEUROSCI, V22, P8633; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; DRAGOI V, 2003, VISUAL NEUROSCIENCES, P1654; FAGIOLINI M, 2003, EXCITATORY INHIBITOR, P269; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Troyer TW, 1998, J NEUROSCI, V18, P5908; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Volgushev M, 2003, EUR J NEUROSCI, V17, P1768, DOI 10.1046/j.1460-9568.2003.02609.x; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yousef T, 2001, NEUROREPORT, V12, P1693, DOI 10.1097/00001756-200106130-00035; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	50	226	235	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					194	201		10.1038/nn1391	http://dx.doi.org/10.1038/nn1391			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665876				2022-12-28	WOS:000226638200019
J	Colwell, CS				Colwell, CS			Bridging the gap: coupling single-cell oscillators in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Editorial Material							RAT; SYNCHRONIZATION; COMMUNICATION; MODULATION; CLOCK		Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Colwell, Chris/AAM-6111-2020	Colwell, Christopher/0000-0002-1059-184X	NINDS NIH HHS [R01 NS043169-05, R01 NS043169] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043169] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Michel S, 2001, CHRONOBIOL INT, V18, P579, DOI 10.1081/CBI-100106074; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; REPPERT SM, 1984, J NEUROSCI, V4, P1677; Shinohara K, 2000, NEUROSCIENCE, V96, P591, DOI 10.1016/S0306-4522(99)00556-4; Shirakawa T, 2000, EUR J NEUROSCI, V12, P2833, DOI 10.1046/j.1460-9568.2000.00170.x; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	15	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					10	12		10.1038/nn0105-10	http://dx.doi.org/10.1038/nn0105-10			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15622411	Green Accepted			2022-12-28	WOS:000225967600005
J	Walton, ME; Devlin, JT; Rushworth, MFS				Walton, ME; Devlin, JT; Rushworth, MFS			Interactions between decision making and performance monitoring within prefrontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN FRONTAL-LOBE; ORBITOFRONTAL CORTEX; MOTOR AREAS; REWARD; OPTIMIZATION; SELECTION; FMRI; REGISTRATION; CONNECTIONS	Our ability to judge the consequences of our actions is central to rational decision making. A large body of evidence implicates primate prefrontal regions in the regulation of this ability. It has proven extremely difficult, however, to separate functional areas in the frontal lobes. Using functional magnetic resonance imaging, we demonstrate complementary and reciprocal roles for the human orbitofrontal (OFC) and dorsal anterior cingulate cortices (ACd) in monitoring the outcome of behavior. Activation levels in these regions were negatively correlated, with activation increasing in the ACd and decreasing in the OFC when the selected response was the result of the participant's own decision. The pattern was reversed when the selected response was guided by the experimenter rather than the participant. These results indicate that the neural mechanisms underlying the way we assess the consequences of choices differ depending on whether we are told what to do or are able to exercise our volition.	John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Walton, ME (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	mark.walton@psy.ox.ac.uk	Devlin, Joseph T/C-1525-2008	Rushworth, Matthew/0000-0002-5578-9884; Devlin, Joseph/0000-0001-9737-3070				BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chiavaras MM, 2000, J COMP NEUROL, V422, P35; DUM RP, 1991, J NEUROSCI, V11, P667; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kremer S, 2001, J NEUROL NEUROSUR PS, V70, P264, DOI 10.1136/jnnp.70.2.264; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; THALER D, 1995, EXP BRAIN RES, V102, P445; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wilson JL, 2002, NEUROIMAGE, V17, P967, DOI 10.1006/nimg.2002.1172; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	50	347	351	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1259	1265		10.1038/nn1339	http://dx.doi.org/10.1038/nn1339			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494729				2022-12-28	WOS:000224749400019
J	Wilson, SM; Saygin, AP; Sereno, MI; Iacoboni, M				Wilson, SM; Saygin, AP; Sereno, MI; Iacoboni, M			Listening to speech activates motor areas involved in speech production	NATURE NEUROSCIENCE			English	Article							PREMOTOR CORTEX; PERCEPTION	To examine the role of motor areas in speech perception, we carried out a functional magnetic resonance imaging (fMRI) study in which subjects listened passively to monosyllables and produced the same speech sounds. Listening to speech activated bilaterally a superior portion of ventral premotor cortex that largely overlapped a speech production motor area centered just posteriorly on the border of Brodmann areas 4a and 6, which we distinguished from a more ventral speech production area centered in area 4p. Our findings support the view that the motor system is recruited in mapping acoustic inputs to a phonetic code.	Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Wilson, SM (corresponding author), Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	stephenw@ucla.edu	Saygin, Ayse Pinar/B-1494-2010; Saygin, Ayse Pinar/A-7126-2009; Galantucci, Bruno/E-5770-2010; Sereno, Martin I/F-7657-2012	Saygin, Ayse Pinar/0000-0002-0859-9500; Sereno, Martin I/0000-0002-7598-7829; Wilson, Stephen/0000-0001-9884-2852				Benson RR, 2001, BRAIN LANG, V78, P364, DOI 10.1006/brln.2001.2484; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, MICROSTRUCTURAL BORD; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0	15	584	593	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					701	702		10.1038/nn1263	http://dx.doi.org/10.1038/nn1263			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184903				2022-12-28	WOS:000222274400009
J	Watt, AJ; Sjostrom, PJ; Hausser, M; Nelson, SB; Turrigiano, GG				Watt, AJ; Sjostrom, PJ; Hausser, M; Nelson, SB; Turrigiano, GG			A proportional but slower NMDA potentiation follows AMPA potentiation in LTP	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; PYRAMIDAL NEURONS; SYNAPTIC ACTIVITY; SILENT SYNAPSES; NEOCORTICAL SYNAPSES; SURFACE EXPRESSION; VISUAL-CORTEX; ACTIVATION	Most excitatory glutamatergic synapses contain both AMPA and NMDA receptors, but whether these receptors are regulated together or independently during synaptic plasticity has been controversial. Although long-term potentiation (LTP) is thought to selectively enhance AMPA currents and alter the NMDA-to-AMPA ratio, this ratio is well conserved across synapses onto the same neuron. This suggests that the NMDA-to-AMPA ratio is only transiently perturbed by LTP. To test this, we induced LTP at rat neocortical synapses and recorded mixed AMPA-NMDA currents. We observed rapid LTP of AMPA currents, as well as delayed potentiation of NMDA currents that required previous AMPA potentiation. The delayed potentiation of NMDA currents restored the original NMDA-to-AMPA ratio within 2 h of LTP induction. These data suggest that recruitment of AMPA receptors to synapses eventually induces a proportional increase in NMDA current. This may ensure that LTP does not alter the relative contributions of these two receptors to synaptic transmission and information processing.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Brandeis University; Brandeis University; University of London; University College London; University of London; University College London	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, MS 08,415 South St, Waltham, MA 02454 USA.	turrigiano@brandeis.edu	Hausser, Michael/AAW-6827-2020; Sjöström, Per Jesper/B-9696-2019	Hausser, Michael/0000-0002-2673-8957; Sjöström, Per Jesper/0000-0001-7085-2223; Nelson, Sacha/0000-0002-0108-8599; Watt, Alanna/0000-0002-6371-6220	NEI NIH HHS [EY11116] Funding Source: Medline; NINDS NIH HHS [NS36853] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, R56NS036853] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERRETTA N, 1991, EUR J NEUROSCI, V3, P850, DOI 10.1111/j.1460-9568.1991.tb00096.x; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; Groc L, 2002, J NEUROSCI, V22, P5552; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rivadulla C, 2001, J NEUROSCI, V21, P1710, DOI 10.1523/JNEUROSCI.21-05-01710.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; XIAO MY, 1995, NEUROSCIENCE, V68, P625, DOI 10.1016/0306-4522(95)00173-G	50	119	124	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					518	524		10.1038/nn1220	http://dx.doi.org/10.1038/nn1220			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15048122				2022-12-28	WOS:000221101300029
J	Abe, K; Chisaka, O; van Roy, F; Takeichi, M				Abe, K; Chisaka, O; van Roy, F; Takeichi, M			Stability of dendritic spines and synaptic contacts is controlled by alpha N-catenin	NATURE NEUROSCIENCE			English	Article							ACTIN-BASED PLASTICITY; CULTURED HIPPOCAMPAL-NEURONS; BETA-CATENIN; IN-VIVO; POSTSYNAPTIC DENSITIES; ADHESION COMPLEX; NERVOUS-SYSTEM; SMALL GTPASES; ADULT CORTEX; CADHERIN	Morphological plasticity of dendritic spines and synapses is thought to be crucial for their physiological functions. Here we show that alphaN-catenin, a linker between cadherin adhesion receptors and the actin cytoskeleton, is essential for stabilizing dendritic spines in rodent hippocampal neurons in culture. In the absence of alphaN-catenin, spine heads were abnormally motile, actively protruding filopodia from their synaptic contact sites. Conversely, alphaN-catenin overexpression in dendrites reduced spine turnover, causing an increase in spine and synapse density. Tetrodotoxin (TTX), a neural activity blocker, suppressed the synaptic accumulation of alphaN-catenin, whereas bicuculline, a GABA antagonist, promoted it. Furthermore, excess alphaN-catenin rendered spines resistant to the TTX treatment. These results suggest that alphaN-catenin is a key regulator for the stability of synaptic contacts.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; VIB Ghent Univ, Dept Mol Biomed Res, B-9000 Ghent, Belgium	RIKEN; Kyoto University; Flanders Institute for Biotechnology (VIB); Ghent University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Abe, Kentaro/A-6197-2008; van Roy, Frans M/C-6123-2009; Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/T-2247-2019	van Roy, Frans M/0000-0003-4358-1039; Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ebihara T, 2003, J NEUROSCI, V23, P2170; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Huntley GW, 1999, J COMP NEUROL, V407, P453; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	194	197	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					357	363		10.1038/nn1212	http://dx.doi.org/10.1038/nn1212			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034585				2022-12-28	WOS:000220482500014
J	Johansen, JP; Fields, HL				Johansen, JP; Fields, HL			Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; NOCICEPTIVE NEURONS; PAIN; RAT; RESPONSES; STIMULATION; AMYGDALA; BRAIN; PROJECTIONS; MODULATION	Noxious stimuli have motivational power and can support associative learning, but the neural circuitry mediating such avoidance learning is poorly understood. The anterior cingulate cortex (ACC) is implicated in the affective response to noxious stimuli and the motivational properties of conditioned stimuli that predict noxious stimulation. Using conditioned place aversion (CPA) in rats, we found that excitatory amino acid microinjection into the ACC during conditioning produces avoidance learning in the absence of a peripheral noxious stimulus. Furthermore, microinjection of an excitatory amino acid antagonist into the ACC during conditioning blocked learning elicited by a noxious stimulus. ACC lesions made after conditioning did not impair expression of CPA. Thus, ACC neuronal activity is necessary and sufficient for noxious stimuli to produce an aversive teaching signal. Our results support the idea that a shared ACC pathway mediates both pain-induced negative affect and a nociceptor-driven aversive teaching signal.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fields, HL (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave,S-784, San Francisco, CA 94143 USA.	hlf@itsa.ucsf.edu	Johansen, Joshua/N-8010-2015; Fields, Howard/ABG-9073-2020	Johansen, Joshua/0000-0003-4240-1550; 	NINDS NIH HHS [NS 21445] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021445, P50NS021445] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; Barros DM, 2000, BEHAV BRAIN RES, V114, P183, DOI 10.1016/S0166-4328(00)00226-6; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; BUCHANAN SL, 1982, J COMP PHYSIOL PSYCH, V96, P755, DOI 10.1037/h0077925; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Donahue RR, 2001, BRAIN RES, V897, P131, DOI 10.1016/S0006-8993(01)02103-5; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fields H. L., 1999, PAIN S, P61; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; GABRIEL M, 1991, EXP BRAIN RES, V86, P585; GIGG J, 1992, CEREB CORTEX, V2, P477, DOI 10.1093/cercor/2.6.477; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; Hurt R W, 1974, Clin Neurosurg, V21, P334; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Kandel E., 2000, PRINCIPLES NEURAL SC; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kung JC, 2003, BRAIN RES, V970, P58, DOI 10.1016/S0006-8993(02)04276-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; Manning BH, 1998, J NEUROSCI, V18, P9453; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; Pastoriza LN, 1996, PAIN, V64, P11, DOI 10.1016/0304-3959(95)00070-4; PERETZ E, 1960, J COMP PHYSIOL PSYCH, V53, P540, DOI 10.1037/h0040297; PESCHANSKI M, 1985, J COMP NEUROL, V236, P29, DOI 10.1002/cne.902360104; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; SALAS PJ, 1997, J CELL BIOL, V21, P359; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; VACCARINO AL, 1989, PAIN, V39, P213, DOI 10.1016/0304-3959(89)90008-0; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Yamamura H, 1996, BRAIN RES, V735, P83	50	264	274	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					398	403		10.1038/nn1207	http://dx.doi.org/10.1038/nn1207			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004562				2022-12-28	WOS:000220482500019
J	He, W; Lam, TKT; Obici, S; Rossetti, L				He, W; Lam, TKT; Obici, S; Rossetti, L			Molecular disruption of hypothalamic nutrient sensing induces obesity	NATURE NEUROSCIENCE			English	Article							HEPATIC GLUCOSE-PRODUCTION; FOOD-INTAKE; MALONYL-COA; LEPTIN RECEPTOR; BODY-WEIGHT; INSULIN-RESISTANCE; FATTY-ACIDS; AMP-KINASE; RATS; GENE	The sensing of circulating nutrients within the mediobasal hypothalamus may be critical for energy homeostasis. To induce a sustained impairment in hypothalamic nutrient sensing, adeno-associated viruses ( AAV) expressing malonyl-coenzyme A decarboxylase ( MCD; an enzyme involved in the degradation of malonyl coenzyme A) were injected bilaterally into the mediobasal hypothalamus of rats. MCD overexpression led to decreased abundance of long-chain fatty acyl-coenzyme A in the mediobasal hypothalamus and blunted the hypothalamic responses to increased lipid availability. The enhanced expression of MCD within this hypothalamic region induced a rapid increase in food intake and progressive weight gain. Obesity was sustained for at least 4 months and occurred despite increased plasma concentrations of leptin and insulin. These findings indicate that nutritional modulation of the hypothalamic abundance of malonyl-coenzyme A is required to restrain food intake and that a primary impairment in this central nutrient-sensing pathway is sufficient to disrupt energy homeostasis and induce obesity.	Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Diabet Res, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HOSOKAWA Y, 1986, ANAL BIOCHEM, V153, P45, DOI 10.1016/0003-2697(86)90058-8; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	31	178	183	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					227	233		10.1038/nn1626	http://dx.doi.org/10.1038/nn1626			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415870				2022-12-28	WOS:000234990100018
J	Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ				Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ			An essential role for Delta FosB in the nucleus accumbens in morphine action	NATURE NEUROSCIENCE			English	Article							KAPPA-OPIOID RECEPTORS; CHRONIC COCAINE; WITHDRAWAL SYNDROME; OPIATE WITHDRAWAL; TRANSGENIC MICE; BRAIN; ADDICTION; SYSTEMS; REWARD; EXPRESSION	The transcription factor Delta FosB is induced in the nucleus accumbens ( NAc) and dorsal striatum by the repeated administration of drugs of abuse. Here, we investigated the role of DFosB in the NAc in behavioral responses to opiates. We achieved overexpression of DFosB by using a bitransgenic mouse line that inducibly expresses the protein in the NAc and dorsal striatum and by using viral-mediated gene transfer to specifically express the protein in the NAc. DFosB overexpression in the NAc increased the sensitivity of the mice to the rewarding effects of morphine and led to exacerbated physical dependence, but also reduced their sensitivity to the analgesic effects of morphine and led to faster development of analgesic tolerance. The opioid peptide dynorphin seemed to be one target through which DFosB produced this behavioral phenotype. Together, these experiments demonstrated that DFosB in the NAc, partly through the repression of dynorphin expression, mediates several major features of opiate addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Crete, Fac Med, Dept Basic Sci, Iraklion 71003, Crete, Greece; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Penn, Sch Med, Dept Anesthesia, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Crete; Virginia Commonwealth University; University of Pennsylvania	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kelz, Max/E-4054-2010; Kumar, Arvind/B-6094-2009; Zachariou, Venetia/L-2726-2016	Kelz, Max/0000-0002-2803-6078; Kumar, Arvind/0000-0003-2879-3826; DiLeone, Ralph/0000-0002-4770-2590				AKIL H, 1994, PROG BRAIN RES, V100, P81; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chefer VI, 2005, J NEUROSCI, V25, P5029, DOI 10.1523/JNEUROSCI.0854-05.2005; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; FUNADA M, 1993, NEUROPHARMACOLOGY, V32, P1315; GEAR RW, 1995, J NEUROSCI, V15, P3154; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; HARRIS GC, 1994, NATURE, V371, P155, DOI 10.1038/371155a0; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; MALDONADO R, 1992, J PHARMACOL EXP THER, V261, P669; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nye HE, 1996, MOL PHARMACOL, V49, P636; NYLANDER I, 1995, PSYCHOPHARMACOLOGY, V118, P391, DOI 10.1007/BF02245939; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pich EM, 1997, SCIENCE, V275, P83; Robinson TE, 2000, ADDICTION, V95, pS91; Schmidt BL, 2002, J NEUROSCI, V22, P6773; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Shippenberg TS, 1996, EUR J PHARMACOL, V299, P33, DOI 10.1016/0014-2999(95)00852-7; Shippenberg TS, 1998, EUR J PHARMACOL, V345, P27, DOI 10.1016/S0014-2999(97)01614-2; Shippenberg TS, 2001, ANN NY ACAD SCI, V937, P50; SUZUKI T, 1992, EUR J PHARMACOL, V213, P91, DOI 10.1016/0014-2999(92)90237-X; Svingos AL, 1999, J NEUROSCI, V19, P1804; Wang XM, 1999, MOL BRAIN RES, V66, P184, DOI 10.1016/S0169-328X(99)00021-2; Werme M, 2002, J NEUROSCI, V22, P8133; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; YUKHANANOV RY, 1993, NEUROPHARMACOLOGY, V32, P703, DOI 10.1016/0028-3908(93)90084-G; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	50	202	209	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					205	211		10.1038/nn1636	http://dx.doi.org/10.1038/nn1636			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415864				2022-12-28	WOS:000234990100015
J	Mandiyan, VS; Coats, JK; Shah, NM				Mandiyan, VS; Coats, JK; Shah, NM			Deficits in sexual and aggressive behaviors in Cnga2 mutant mice	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; DISRUPTION; ODORANTS; DISTINCT; ANOSMIA	Odors detected by the vomeronasal organ or the main olfactory epithelium (MOE) trigger social behaviors in many animals. It is unknown whether MOE neurons detect cues that initiate mating or aggression. We demonstrate that mice lacking functional CNGA2 ( cyclic nucleotide - gated channel alpha 2), which is required for odor-evoked MOE signaling, fail to mate or fight, suggesting a broad and essential role for the MOE in regulating these behaviors.	Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, Box 2722, San Francisco, CA 94143 USA.	nms@itsa.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049488] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DEVOR M, 1973, BEHAV BIOL, V9, P31, DOI 10.1016/S0091-6773(73)80166-X; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	15	204	210	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1660	1662		10.1038/nn1589	http://dx.doi.org/10.1038/nn1589			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261133				2022-12-28	WOS:000233576200012
J	McCoy, AN; Platt, ML				McCoy, AN; Platt, ML			Risk-sensitive neurons in macaque posterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; PARIETAL; EXPECTATION; UNCERTAINTY; MONKEY; REPRESENTATION; ADOLESCENCE; MOTIVATION; NETWORKS	People and animals often demonstrate strong attraction or aversion to options with uncertain or risky rewards, yet the neural substrate of subjective risk preferences has rarely been investigated. Here we show that monkeys systematically preferred the risky target in a visual gambling task in which they chose between two targets offering the same mean reward but differing in reward uncertainty. Neuronal activity in posterior cingulate cortex (CGp), a brain area linked to visual orienting and reward processing, increased when monkeys made risky choices and scaled with the degree of risk. CGp activation was better predicted by the subjective salience of a chosen target than by its actual value. These data suggest that CGp signals the subjective preferences that guide visual orienting.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Cognit Neurosci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biol Anthropol & Anat, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	platt@neuro.duke.edu						Arnauld Antoine, 1662, ART THINKING PORT RO; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bateson M, 1997, ANIM BEHAV, V53, P1129, DOI 10.1006/anbe.1996.0388; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BERNOUILLI D, 1758, WORKS; Bickel WK, 2004, ADDICTION, V99, P855, DOI 10.1111/j.1360-0443.2004.00733.x; CARACO T, 1983, BEHAV ECOL SOCIOBIOL, V8, P820; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A, 1995, DESCARTES ERROR EMOT; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; Doremus TL, 2004, ANN NY ACAD SCI, V1021, P427, DOI 10.1196/annals.1308.057; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kacelnik A, 1997, Ciba Found Symp, V208, P51; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Ladouceur R, 2003, ADDICTION, V98, P733, DOI 10.1046/j.1360-0443.2003.00412.x; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McCoy A, 2005, J COMP PHYSIOL A, V191, P201, DOI 10.1007/s00359-004-0565-9; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MCGLOTHLIN WH, 1956, AM J PSYCHOL, V69, P604, DOI 10.2307/1419083; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Rode C, 1999, COGNITION, V72, P269, DOI 10.1016/S0010-0277(99)00041-4; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sharpe L, 2004, J GAMBL STUD, V20, P95, DOI 10.1023/B:JOGS.0000016706.96540.43; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430	50	278	281	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1220	1227		10.1038/nn1523	http://dx.doi.org/10.1038/nn1523			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116449				2022-12-28	WOS:000231483800022
J	Adelsberger, H; Garaschuk, O; Konnerth, A				Adelsberger, H; Garaschuk, O; Konnerth, A			Cortical calcium waves in resting newborn mice	NATURE NEUROSCIENCE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; NETWORKS; DIFFERENTIATION; PLASTICITY; SPIKES; CORTEX	Using a new optical fiber - based approach, we demonstrate the presence of recurrent Ca2+ transients in cortical neurons of non-anesthetized newborn mice in vivo. These Ca2+ waves reflect the correlated activity of thousands of cells and were detected only in resting, but not in moving pups. Our results suggest that Ca2+-dependent cortical maturation occurs predominantly during the intermittent sleep-like resting periods that are characteristic for the first days of postnatal life.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.	konnerth@lrz.uni-muenchen.de	Garaschuk, Olga/G-5633-2015					Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; DASZUTA A, 1985, BRAIN RES, V354, P39; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GU XN, 1994, J NEUROSCI, V14, P6325; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; UYLINGS HBM, 1990, CEREBRAL CORTEX RAT, P36; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	15	187	196	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					988	990		10.1038/nn1502	http://dx.doi.org/10.1038/nn1502			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007081				2022-12-28	WOS:000230760200008
J	Morishita, W; Marie, H; Malenka, RC				Morishita, W; Marie, H; Malenka, RC			Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CALCIUM-DEPENDENT INACTIVATION; ALPHA-ACTININ; RECEPTORS; CALMODULIN; TRANSMISSION; BINDING; ENDOCYTOSIS; CHANNEL; DYNAMIN	Although long-term depression (LTD) of AMPA receptor - mediated postsynaptic currents (AMPAR EPSCs) has been extensively examined, little is known about the mechanisms responsible for LTD of NMDA receptor ( NMDAR)- mediated EPSCs. Here we show differences in the intracellular signaling cascades that mediate LTD of AMPAR EPSCs versus NMDAR EPSCs in rat hippocampus. Both forms of LTD were blocked by inhibitors of protein phosphatase 1, but only LTD of AMPAR EPSCs was affected by inhibition of calcineurin. Notably, in contrast to LTD of AMPAR EPSCs, LTD of NMDAR EPSCs was unaffected by endocytosis inhibitors. A role for calcium-dependent actin depolymerization in LTD of NMDAR EPSCs was supported by the findings that the actin stabilizer phalloidin and a cofilin inhibitory peptide each blocked LTD of NMDAR EPSCs but not AMPAR EPSCs. These results suggest that the same pattern of afferent activity elicits depression of AMPAR- and NMDAR-mediated synaptic responses by means of distinct triggering and expression mechanisms.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011	Marie, Hélène/0000-0003-2310-6097	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Kim CH, 1999, J NEUROSCI, V19, P4314; Kotecha SA, 2003, INT REV NEUROBIOL, V54, P53; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Li B, 2003, J NEUROSCI, V23, P11244; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Tovar KR, 2002, NEURON, V34, P253; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	141	148	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1043	1050		10.1038/nn1506	http://dx.doi.org/10.1038/nn1506			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025109				2022-12-28	WOS:000230760200016
J	Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P				Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P			Regulation of NMDA receptor trafficking by amyloid-beta	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; FAMILY TRANSCRIPTION FACTOR; TYROSINE PHOSPHATASE STEP; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; GLUTAMATE RECEPTORS	Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta dependent endocytosis of NMDA receptors required the alpha- 7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cornell University; Yale University; Yale University	Snyder, EM (corresponding author), McKinsey & Co Inc, 600 Campus Dr, Florham Pk, NJ 07932 USA.	ericmaltesnyder@gmail.com	Gouras, Gunnar/B-3021-2010; de Almeida, Cláudia Guimas/AAN-8935-2020	Gouras, Gunnar/0000-0002-5500-6325; de Almeida, Cláudia Guimas/0000-0001-9384-2896; Nairn, Angus/0000-0002-7075-0195; Choi, Eun Young/0000-0003-3226-1486	NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NIA NIH HHS [AG09464] Funding Source: Medline; PHS HHS [52711, 01527] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim JH, 2001, J NEUROSCI, V21, P1327; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Levy RB, 2002, J NEUROSCI, V22, P5001, DOI 10.1523/JNEUROSCI.22-12-05001.2002; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mammen AL, 1997, J NEUROSCI, V17, P7351; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; PERDAHL E, 1984, NEUROBEH TOXICOL TER, V6, P425; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stevens TR, 2003, J NEUROSCI, V23, P10093; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	40	1232	1302	1	129	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1051	1058		10.1038/nn1503	http://dx.doi.org/10.1038/nn1503			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025111				2022-12-28	WOS:000230760200017
J	Taketomi, T; Yoshiga, D; Taniguchi, K; Kobayashi, T; Nonami, A; Kato, R; Sasaki, M; Sasaki, A; Ishibashi, H; Moriyama, M; Nakamura, K; Nishimura, J; Yoshimura, A				Taketomi, T; Yoshiga, D; Taniguchi, K; Kobayashi, T; Nonami, A; Kato, R; Sasaki, M; Sasaki, A; Ishibashi, H; Moriyama, M; Nakamura, K; Nishimura, J; Yoshimura, A			Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia	NATURE NEUROSCIENCE			English	Article							TYROSINE KINASE; RET; ACTIVATION; RECEPTOR; GENE	We report here that loss of the Sprouty2 gene (also known as Spry2) in mice resulted in enteric nerve hyperplasia, which led to esophageal achalasia and intestinal pseudo-obstruction. Glial cell line-derived neurotrophic factor (GDNF) induced hyperactivation of ERK and Akt in enteric nerve cells. Anti-GDNF antibody administration corrected nerve hyperplasia in Sprouty2-deficient mice. We show Sprouty2 to be a negative regulator of GDNF for the neonatal development or survival of enteric nerve cells.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Fac Dent Sci, Div Oral & Maxillofacial Oncol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Fac Med, Dept Physiol, Higashi Ku, Fukuoka 8128582, Japan; Kurume Univ, Sch Med, Dept Anat, Kurume, Fukuoka 8300011, Japan; Kyushu Univ, Grad Sch Med Sci, Res Inst Angiocardiol, Div Mol Cardiol, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University; Kurume University; Kyushu University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013; YOSHIGA, Daigo/GZM-9352-2022	YOSHIGA, Daigo/0000-0001-9603-3138; Sasaki, Atsuo/0000-0003-2963-4501				Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; GHOSH P, 1994, AM J GASTROENTEROL, V89, P1880; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Ieiri S, 2001, BRIT J PHARMACOL, V133, P529, DOI 10.1038/sj.bjp.0704122; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; MUNAKATA K, 1985, J PEDIATR SURG, V20, P231, DOI 10.1016/S0022-3468(85)80109-3; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	11	107	112	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					855	857		10.1038/nn1485	http://dx.doi.org/10.1038/nn1485			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937482				2022-12-28	WOS:000230137100009
J	Adolphs, R; Tranel, D; Buchanan, TW				Adolphs, R; Tranel, D; Buchanan, TW			Amygdala damage impairs emotional memory for gist but not details of complex stimuli	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; BASOLATERAL AMYGDALA; DECLARATIVE MEMORY; ENHANCED MEMORY; CONSOLIDATION; HIPPOCAMPUS; PERCEPTION; AROUSAL; EVENTS; STRESS	Neurobiological studies demonstrate the amygdala's role in emotional memory, and psychological studies suggest a particular pattern: enhanced memory for the gist but not the details of complex stimuli. We hypothesized that these two findings are related. Whereas normal ( n = 52) and brain- damaged ( n = 22) controls showed the expected enhancement of gist memory when the encoding context was emotional, persons with unilateral damage to the medial temporal lobe including the amygdala ( n = 16) did not show this pattern. Furthermore, amygdala volume showed a significant positive correlation with gist memory but not with overall memory. A further study in four subjects with selective medial temporal damage sparing the amygdala, and one with selective damage confined to the amygdala, confirmed the specificity of this effect to the amygdala. The data support a model whereby the amygdala focuses processing resources on gist, possibly accounting for features of traumatic memories and eyewitness testimony in real life.	CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Iowa, Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA	California Institute of Technology; University of Iowa	Adolphs, R (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	radolphs@hss.caltech.edu		Tranel, Daniel/0000-0002-1338-1389; Buchanan, Tony/0000-0002-9166-8457	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067681] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH67681] Funding Source: Medline; PHS HHS [P01 19632] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2001, BEHAV NEUROSCI, V115, P983, DOI 10.1037//0735-7044.115.5.983; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; Akirav I, 1999, J NEUROSCI, V19, P10530; ALLEN JS, IN PRESS J CLIN NEUR; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Brierley B, 2004, J NEUROL NEUROSUR PS, V75, P593, DOI 10.1136/jnnp.2002.006403; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P81, DOI 10.1016/S1074-7427(02)00019-9; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; CHRISTIANSON SA, 1991, COGNITION EMOTION, V5, P81, DOI 10.1080/02699939108411027; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Hamann SB, 1997, NEUROPSYCHOLOGY, V11, P104; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Ikegaya Y, 1996, EUR J NEUROSCI, V8, P1833, DOI 10.1111/j.1460-9568.1996.tb01327.x; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lang P.J., 1988, INT AFFECTIVE PICTUR; Loftus Elizabeth F, 1996, EYEWITNESS TESTIMONY; MAASS A, 1989, LAW HUMAN BEHAV, V13, P397, DOI 10.1007/BF01056411; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mori E, 1999, AM J PSYCHIAT, V156, P216; Packard MG, 1999, PSYCHOBIOLOGY, V27, P377; Parker A, 1998, J COGNITIVE NEUROSCI, V10, P691, DOI 10.1162/089892998563103; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; REISBERG D, 1992, EMORY S COG, V4, P162, DOI 10.1017/CBO9780511664069.009; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Smith APR, 2004, J COGNITIVE NEUROSCI, V16, P760, DOI 10.1162/089892904970816; Wessel I, 1998, COGNITION EMOTION, V12, P93, DOI 10.1080/026999398379790	39	171	180	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					512	518		10.1038/nn1413	http://dx.doi.org/10.1038/nn1413			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911XP	15735643				2022-12-28	WOS:000228040400023
J	Boemio, A; Fromm, S; Braun, A; Poeppel, D				Boemio, A; Fromm, S; Braun, A; Poeppel, D			Hierarchical and asymmetric temporal sensitivity in human auditory cortices	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; SPEECH-PERCEPTION; CORTEX; SOUNDS; FMRI; REPRESENTATIONS; INTEGRATION; TIME; IDENTIFICATION; ORGANIZATION	Lateralization of function in auditory cortex has remained a persistent puzzle. Previous studies using signals with differing spectrotemporal characteristics support a model in which the left hemisphere is more sensitive to temporal and the right more sensitive to spectral stimulus attributes. Here we use single-trial sparse-acquisition fMRI and a stimulus with parametrically varying segmental structure affecting primarily temporal properties. We show that both left and right auditory cortices are remarkably sensitive to temporal structure. Crucially, beyond bilateral sensitivity to timing information, we uncover two functionally significant interactions. First, local spectrotemporal signal structure is differentially processed in the superior temporal gyrus. Second, lateralized responses emerge in the higher-order superior temporal sulcus, where more slowly modulated signals preferentially drive the right hemisphere. The data support a model in which sounds are analyzed on two distinct timescales, 25-50 ms and 200-300 ms.	Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; NIMH, Brain & Cognit Lab, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Poeppel, D (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	dpoeppel@deans.umd.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000031, R01DC005660, Z01DC000031] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC05660] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; DIVENYI PL, 1989, BRAIN LANG, V37, P290, DOI 10.1016/0093-934X(89)90020-5; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Ivry RB, 1997, 2 SIDES PERCEPTION; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; MOORE BCJ, 1993, HUMAN PSYCHOPHYSICS; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Palva S, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0003.2002; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; SCHWARTZ J, 1980, SCIENCE, V207, P1380, DOI 10.1126/science.7355297; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Shamma S, 2001, TRENDS COGN SCI, V5, P340, DOI 10.1016/S1364-6613(00)01704-6; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Sussman E, 1999, NEUROSCI LETT, V264, P161, DOI 10.1016/S0304-3940(99)00214-1; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WINKLER I, 1993, PERCEPT PSYCHOPHYS, V53, P443, DOI 10.3758/BF03206788; Yabe H, 2001, BRAIN RES, V897, P222, DOI 10.1016/S0006-8993(01)02224-7; YOST WA, 1991, HEARING RES, V56, P8, DOI 10.1016/0378-5955(91)90148-3; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; ZWISLOCKI J, 1960, J ACOUST SOC AM, V32, P1046, DOI 10.1121/1.1908276	39	402	408	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					389	395		10.1038/nn1409	http://dx.doi.org/10.1038/nn1409			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723061				2022-12-28	WOS:000227354600025
J	Ohta, H; Yamazaki, S; McMahon, DG				Ohta, H; Yamazaki, S; McMahon, DG			Constant light desynchronizes mammalian clock neurons	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; INDIVIDUAL FIBROBLASTS; GENE-EXPRESSION; NUCLEUS; INVITRO	Circadian organization can be disrupted by constant light, resulting in behavioral arrhythmicity or 'splitting' of rhythms of activity and rest. By imaging molecular rhythms of individual clock neurons in explanted mouse clock nuclei, we now find that constant light desynchronizes clock neurons but does not compromise their ability to generate circadian rhythms. Cellular synchrony within clock nuclei is disrupted during arrhythmicity, whereas neurons in the left and right clock nuclei cycle in antiphase during 'splitting.'	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	McMahon, DG (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	douglas.g.mcmahon@vanderbilt.edu		Yamazaki, Shin/0000-0002-6691-1531	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063341] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH63341] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASCHOFF J, 1976, FED PROC, V35, P2326; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	10	281	289	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					267	269		10.1038/nn1395	http://dx.doi.org/10.1038/nn1395			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746913				2022-12-28	WOS:000227354600008
J	Putz, U; Harwell, C; Nedivi, E				Putz, U; Harwell, C; Nedivi, E			Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis	NATURE NEUROSCIENCE			English	Article							PROGRAMMED CELL-DEATH; DEVELOPING CEREBRAL-CORTEX; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; BAX-DEFICIENT MICE; NEOCORTICAL NEURONOGENESIS; POSTMITOTIC REGIONS; DECREASED APOPTOSIS; TRANSGENIC MICE; CASPASE 9	The balance between proliferation and apoptosis is critical for proper development of the nervous system. Yet, little is known about molecules that regulate apoptosis of proliferative neurons. Here we identify a soluble, secreted form of CPG15 expressed in embryonic rat brain regions undergoing rapid proliferation and apoptosis, and show that it protects cultured cortical neurons from apoptosis by preventing activation of caspase 3. Using a lentivirus-delivered small hairpin RNA, we demonstrate that endogenous CPG15 is essential for the survival of undifferentiated cortical progenitors in vitro and in vivo. We further show that CPG15 overexpression in vivo expands the progenitor pool by preventing apoptosis, resulting in an enlarged, indented cortical plate and cellular heterotopias within the ventricular zone, similar to the phenotypes of mutant mice with supernumerary forebrain progenitors. CPG15 expressed during mammalian forebrain morphogenesis may help balance neuronal number by countering apoptosis in specific neuroblasts subpopulations, thus influencing final brain size and shape.	MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Nedivi, E (corresponding author), MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021	/0000-0002-1710-0767	NATIONAL EYE INSTITUTE [R01EY011894] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011894, R01 EY011894-09] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Corbo JC, 2002, J NEUROSCI, V22, P7548; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Ghosh MM, 1995, BIOREMED SER, V3, P15; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gotz M, 2003, NAT NEUROSCI, V6, P1245, DOI 10.1038/nn1203-1245; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hooper NM, 2001, PROTEOMICS, V1, P748, DOI 10.1002/1615-9861(200106)1:6<748::AID-PROT748>3.3.CO;2-K; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee WCA, 2002, J NEUROSCI, V22, P1807, DOI 10.1523/JNEUROSCI.22-05-01807.2002; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Pompeiano M, 2000, J COMP NEUROL, V423, P1; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Roth KA, 2000, P NATL ACAD SCI USA, V97, P466, DOI 10.1073/pnas.97.1.466; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shindler KS, 1997, J NEUROSCI, V17, P3112; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Takahashi T, 1997, DEV NEUROSCI-BASEL, V19, P17, DOI 10.1159/000111179; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; White FA, 1998, J NEUROSCI, V18, P1428; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhou J, 2002, FEBS LETT, V526, P21, DOI 10.1016/S0014-5793(02)03107-1	50	86	101	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					322	331		10.1038/nn1407	http://dx.doi.org/10.1038/nn1407			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711540	Green Accepted			2022-12-28	WOS:000227354600017
J	Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N				Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N			Attentional modulation in human primary olfactory cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR PIRIFORM CORTEX; PRIMARY VISUAL-CORTEX; ORBITOFRONTAL CORTEX; FUNCTIONAL-HETEROGENEITY; SELECTIVE ATTENTION; SPATIAL ATTENTION; NEURONAL-ACTIVITY; CELL-ACTIVITY; BRAIN; FMRI	Central to the concept of attention is the fact that identical stimuli can be processed in different ways. In olfaction, attention may designate the identical flow of air through the nose as either respiration or olfactory exploration. Here we have used functional magnetic resonance imaging (fMRI) to probe this attentional mechanism in primary olfactory cortex (POC). We report a dissociation in POC that revealed attention-dependent and attention-independent subregions. Whereas a temporal subregion comprising temporal piriform cortex (PirT) responded equally across conditions, a frontal subregion comprising frontal piriform cortex (PirF) and the olfactory tubercle responded preferentially to attended sniffs as opposed to unattended sniffs. In addition, a task-specific anticipatory response occurred in the attention-dependent region only. This dissociation was consistent across two experimental designs: one focusing on sniffs of clean air, the other focusing on odor-laden sniffs. Our findings highlight the role of attention at the earliest cortical levels of olfactory processing.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Wheeler Brain Imaging Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelano, C (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	zelano@socrates.berkeley.edu; nsobel@socrates.berkeley.edu	Mainland, Joel/C-5171-2009; Bensafi, Moustafa/H-6618-2017	Mainland, Joel/0000-0002-5056-4598; Bensafi, Moustafa/0000-0002-2991-3036; Sobel, Noam/0000-0002-3232-9391	NIDCD NIH HHS [R01 DC005958] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005958] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRESSLER SL, 1987, BRAIN RES, V409, P294, DOI 10.1016/0006-8993(87)90714-1; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Effron B, 1993, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fontanini A, 2003, J NEUROSCI, V23, P7993; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Krauel K, 1998, CHEM SENSES, V23, P423, DOI 10.1093/chemse/23.4.423; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mai J.K., 1997, ATLAS HUMAN BRAIN; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; ODOHERTY J, 2000, NEUROREPORT, V11, P983; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2000, PERCEPT PSYCHOPHYS, V62, P1265, DOI 10.3758/BF03212128; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Wandell BA, 2003, NEUROL CLIN, V21, P417, DOI 10.1016/S0733-8619(03)00003-3; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson JL, 2002, MAGNET RESON MED, V48, P906, DOI 10.1002/mrm.10298; Yu YQ, 2004, J NEUROSCI, V24, P3060, DOI 10.1523/JNEUROSCI.4897-03.2004; Zinyuk LE, 2001, BEHAV BRAIN RES, V124, P29, DOI 10.1016/S0166-4328(01)00212-1	44	178	183	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					114	120		10.1038/nn1368	http://dx.doi.org/10.1038/nn1368			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608635				2022-12-28	WOS:000225967600024
J	Bianchi, L; Gerstbrein, B; Frokjaer-Jensen, C; Royal, DC; Mukherjee, G; Royal, MA; Xue, J; Schafer, WR; Driscoll, M				Bianchi, L; Gerstbrein, B; Frokjaer-Jensen, C; Royal, DC; Mukherjee, G; Royal, MA; Xue, J; Schafer, WR; Driscoll, M			The neurotoxic MEC-4(d) DEG/ENaC sodium channel conducts calcium: implications for necrosis initiation	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; MOLECULAR-BASIS; ION PERMEATION; CELL-DEATH; NEURODEGENERATION; SUBUNIT; GENETICS; NEURONS; MECHANOTRANSDUCTION; CALRETICULIN	Hyperactivation of the Caenorhabditis elegans MEC-4 Na+ channel of the DEG/ENaC superfamily (MEC-4(d)) induces neuronal necrosis through an increase in intracellular Ca2+ and calpain activation. How exacerbated Na+ channel activity elicits a toxic rise in cytoplasmic Ca2+, however, has remained unclear. We tested the hypothesis that MEC-4(d)-induced membrane depolarization activates voltage-gated Ca2+ channels (VGCCs) to initiate a toxic Ca2+ influx, and ruled out a critical requirement for VGCCs. Instead, we found that MEC-4(d) itself conducts Ca2+ both when heterologously expressed in Xenopus oocytes and in vivo in C. elegans touch neurons. Data generated using the Ca2+ sensor cameleon suggest that an induced release of endoplasmic reticulum (ER) Ca2+ is crucial for progression through necrosis. We propose a refined molecular model of necrosis initiation in which Ca2+ influx through the MEC-4(d) channel activates Ca2+- induced Ca2+ release from the ER to promote neuronal death, a mechanism that may apply to neurotoxicity associated with activation of the ASIC1a channel in mammalian ischemia.	Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, Piscataway, NJ 08854 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; University of California System; University of California San Diego	Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, 604 Allison Rd, Piscataway, NJ 08854 USA.	driscoll@mbcl.rutgers.edu	Frøkjær-Jensen, Christian/ABB-4637-2020	Frokjaer-Jensen, Christian/0000-0002-3178-0906; Schafer, William/0000-0002-6676-8034	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037955, R21NS049511, R01NS034435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER; NIDA NIH HHS [DA016445] Funding Source: Medline; NINDS NIH HHS [NS049511, NSF00139, NS034435, NS37955] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Amasheh S, 1999, J MEMBRANE BIOL, V172, P169, DOI 10.1007/s002329900594; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bianchi L, 2000, AM J PHYSIOL-HEART C, V279, pH3003, DOI 10.1152/ajpheart.2000.279.6.H3003; BIANCHI L, 2004, TRANSDUCTION CHANNEL, P1; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Jeziorski MC, 2000, J EXP BIOL, V203, P841; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P44091, DOI 10.1074/jbc.M108522200; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574	50	88	107	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1337	1344		10.1038/nn1347	http://dx.doi.org/10.1038/nn1347			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543143				2022-12-28	WOS:000225353900014
J	Liu, GF; Beggs, H; Jurgensen, C; Park, HT; Tang, H; Gorski, J; Jones, KR; Reichardt, LF; Wu, J; Rao, Y				Liu, GF; Beggs, H; Jurgensen, C; Park, HT; Tang, H; Gorski, J; Jones, KR; Reichardt, LF; Wu, J; Rao, Y			Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction	NATURE NEUROSCIENCE			English	Article							PROTEIN-TYROSINE KINASE; GROWTH CONE GUIDANCE; C-ELEGANS; COLORECTAL-CANCER; SPINAL-CORD; FLOOR PLATE; CAENORHABDITIS-ELEGANS; COMMISSURAL AXONS; RECEPTOR DCC; SIGNAL-TRANSDUCTION	Although netrins are an important family of neuronal guidance proteins, intracellular mechanisms that mediate netrin function are not well understood. Here we show that netrin-1 induces tyrosine phosphorylation of proteins including focal adhesion kinase (FAK) and the Src family kinase Fyn. Blockers of Src family kinases inhibited FAK phosphorylation and axon outgrowth and attraction by netrin. Dominant-negative FAK and Fyn mutants inhibited the attractive turning response to netrin. Axon outgrowth and attraction induced by netrin-1 were significantly reduced in neurons lacking the FAK gene. Our results show the biochemical and functional links between netrin, a prototypical neuronal guidance cue, and FAK, a central player in intracellular signaling that is crucial for cell migration.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Dong A Univ, Coll Med, Dept Physiol, Pusan 602714, South Korea; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Washington University (WUSTL); University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Dong A University; Vanderbilt University; University of Colorado System; University of Colorado Boulder	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	raoyi@pcg.wustl.edu	Tang, Hao/G-9841-2011	JONES, KEVIN/0000-0002-3802-7562	NATIONAL CANCER INSTITUTE [R01CA107193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107193, CA107193, R01 CA107193-03] Funding Source: Medline; NINDS NIH HHS [NS19090, R01 NS019090] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Merz DC, 2001, GENETICS, V158, P1071; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Richards LJ, 1997, J NEUROSCI, V17, P2445; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Wang H, 1999, J NEUROSCI, V19, P4938; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X	50	205	215	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1222	1232		10.1038/nn1331	http://dx.doi.org/10.1038/nn1331			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494732	Green Accepted			2022-12-28	WOS:000224749400015
J	Bibel, M; Richter, J; Schrenk, K; Tucker, KL; Staiger, V; Korte, M; Goetz, M; Barde, YA				Bibel, M; Richter, J; Schrenk, K; Tucker, KL; Staiger, V; Korte, M; Goetz, M; Barde, YA			Differentiation of mouse embryonic stem cells into a defined neuronal lineage	NATURE NEUROSCIENCE			English	Article							IN-VITRO DIFFERENTIATION; RADIAL GLIA; HIPPOCAMPAL-NEURONS; ES CELLS; DIRECTED DIFFERENTIATION; NEURAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; PRECURSOR CELLS; NERVOUS-SYSTEM; EXPRESSION	Although it has long been known that cultured embryonic stem cells can generate neurons, the lineage relationships with their immediate precursors remain unclear. We report here that selection of highly proliferative stem cells followed by treatment with retinoic acid generated essentially pure precursors that markers identified as Pax-6-positive radial glial cells. As they do in vivo, these cells went on to generate neurons with remarkably uniform biochemical and electrophysiological characteristics.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Friedrich Miescher Institute for Biomedical Research; Max Planck Society	Barde, YA (corresponding author), Novartis Pharma AG Nervous Syst Res, CH-4002 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				Abe Y, 2003, J NEUROSCI, V23, P8513; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Diez del Corral R, 2003, NEURON, V40, P65; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; KLEIN R, 1990, DEVELOPMENT, V109, P845; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li M, 2002, Methods Mol Biol, V185, P205; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liour SS, 2003, GLIA, V42, P109, DOI 10.1002/glia.10202; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MURRAY P, IN PRESS P R SOC M R; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; TRAPP BD, 1994, J NEUROSCI RES, V37, P538, DOI 10.1002/jnr.490370413; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	45	357	370	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					1003	1009		10.1038/nn1301	http://dx.doi.org/10.1038/nn1301			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15332090				2022-12-28	WOS:000223546700021
J	Heerssen, HM; Pazyra, MF; Segal, RA				Heerssen, HM; Pazyra, MF; Segal, RA			Dynein motors transport activated Trks to promote survival of target-dependent neurons	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; RETROGRADE AXONAL-TRANSPORT; RAT SYMPATHETIC NEURONS; INDUCED DIFFERENTIATION; NEUROTROPHIN RECEPTORS; COMPARTMENTED CULTURES; LOCAL-CONTROL; NGF; COMPLEX; DYNACTIN	Mutations that alter dynein function are associated with neurodegenerative diseases, but it is not known why defects in dynein-dependent transport impair neuronal survival. Here we show that dynein function in axons is selectively required for the survival of neurons that depend on target-derived neurotrophins. Stimulation of axon terminals with neurotrophins causes internalization of neurotrophin receptors (Trks). Using real-time imaging of fluorescently tagged Trks, we show that dynein is required for rapid transport of internalized, activated receptors from axon terminals to remote cell bodies. When dynein-based transport is inhibited, neurotrophin stimulation of axon terminals does not support survival. These studies indicate that defects in dynein-based transport reduce trafficking of activated Trks and thereby obstruct the prosurvival effect of target-derived trophic factors, leading to degeneration of target-dependent neurons.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Segal, RA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 44 Binney St, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049381] Funding Source: NIH RePORTER; NINDS NIH HHS [NS49381, NS65148] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 2002, J NEUROBIOL, V51, P302, DOI 10.1002/neu.10062; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; CLAUDE P, 1982, J NEUROSCI, V2, P431; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Ferhat L, 1998, J NEUROSCI, V18, P7822; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HENDRY IA, 1974, BRAIN RES, V82, P117, DOI 10.1016/0006-8993(74)90897-X; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KRANENBURG O, 1999, J BIOL CHEM, V274, P24575; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Muresan V, 2000, J NEUROCYTOL, V29, P799, DOI 10.1023/A:1010943424272; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	50	166	170	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					596	604		10.1038/nn1242	http://dx.doi.org/10.1038/nn1242			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15122257				2022-12-28	WOS:000221640300013
J	Chapin, JK				Chapin, JK			Using multi-neuron population recordings for neural prosthetics	NATURE NEUROSCIENCE			English	Article							REAL-TIME CONTROL; ENSEMBLE ACTIVITY; OLIVOCEREBELLAR CIRCUIT; SENSORY RESPONSIVENESS; CORTICAL-NEURONS; ESTROUS-CYCLE; BEHAVIOR; CORTEX; MODULATION; MOVEMENT	Classical single-neuron recording methods led to 'neuron-centric' concepts of neural coding, whereas more recent multi-neuron population recordings have inspired 'population-centric' concepts of distributed processing in neural systems. Because most neocortical neurons code information coarsely, sensory or motor processing tends to be widely distributed across neuronal populations. Dynamic fluctuations in neural population functions thus involve subtle changes in the overall pattern of neural activity. Mathematical analysis of neural population codes allows extraction of 'motor signals' from neuronal population recordings in the motor cortices, which can then be used in real-time to directly control movement of a robot arm. This technique holds promise for the development of neurally controlled prosthetic devices and provides insights into how information is distributed across several brain regions.	SUNY Downstate Med Ctr, Ctr Neurorobot & Neuroengn, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Chapin, JK (corresponding author), SUNY Downstate Med Ctr, Ctr Neurorobot & Neuroengn, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	john_chapin@downstate.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040543, P01NS024707, R01NS026722, P50NS024707] Funding Source: NIH RePORTER; NINDS NIH HHS [NS2672213, NS4054303, NS24707] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1995, SCALE IN CONSCIOUS EXPERIENCE: IS THE BRAIN TOO IMPORTANT TO BE LEFT TO SPECIALISTS TO STUDY?, P133; CHAPIN JK, 1981, EXP NEUROL, V72, P164, DOI 10.1016/0014-4886(81)90135-7; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHAPIN JK, 1989, ALCOHOL CLIN EXP RES, V13, P8, DOI 10.1111/j.1530-0277.1989.tb00275.x; CHAPIN JK, 1986, EXP BRAIN RES, V62, P549; CHAPIN JK, 1982, EXP NEUROL, V78, P670, DOI 10.1016/0014-4886(82)90083-8; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CHAPIN JK, 1998, MANY NEURON RECORDIN; DEADWYLER SA, 1995, SCIENCE, V270, P1316, DOI 10.1126/science.270.5240.1316; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; KRUGER J, 1983, REV PHYSIOL BIOCH P, V98, P177, DOI 10.1007/BFb0033868; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; LILLY JC, 1958, BIOL BIOCH BASES BEH; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 2002, SCI AM, V287, P46, DOI 10.1038/scientificamerican1002-46; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; PATEL IM, 1990, ANESTH ANALG, V70, P635; PATIL PG, IN PRESS NEUROSURGER; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; SHIN HC, 1993, KOR J PHYSL, V27, P79; Smith SS, 1996, EXP BRAIN RES, V111, P371, DOI 10.1007/BF00228726; Smith SS, 1996, EXP BRAIN RES, V111, P385, DOI 10.1007/BF00228727; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	33	95	96	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					452	455		10.1038/nn1234	http://dx.doi.org/10.1038/nn1234			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114357				2022-12-28	WOS:000221101300012
J	Gardner, D				Gardner, D			Neurodatabase.org: networking the microelectrode	NATURE NEUROSCIENCE			English	Database Review									Cornell Univ, Weill Med Coll, Dept Physiol, Lab Neuroinformat, New York, NY 10021 USA	Cornell University	Gardner, D (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, Lab Neuroinformat, New York, NY 10021 USA.	dan@aplysia.med.cornell.edu			NIMH NIH HHS [MH57153, MH60538, MH68012] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH060538, R01MH068012, R01MH057153, R44MH060538] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Gardner D, 2003, BIOPHYS J, V84, p305A; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Gardner D, 2001, PHILOS T ROY SOC B, V356, P1229, DOI 10.1098/rstb.2001.0911; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229	5	16	17	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					486	487		10.1038/nn0504-486	http://dx.doi.org/10.1038/nn0504-486			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114365				2022-12-28	WOS:000221101300020
J	Samson, D; Apperly, IA; Chiavarino, C; Humphreys, GW				Samson, D; Apperly, IA; Chiavarino, C; Humphreys, GW			Left temporoparietal junction is necessary for representing someone else's belief	NATURE NEUROSCIENCE			English	Article							ASPERGER-SYNDROME; NORMAL ADULTS; FALSE BELIEF; MIND; AUTISM; TASKS; EYES	A standard view in the neuroscience literature is that the frontal lobes sustain our ability to process others' mental states such as beliefs, intentions and desires (this ability is often referred to as having 'theory of mind'). Here we report evidence from brain-damaged patients showing that, in addition to involvement of the frontal lobes, the left temporoparietal junction is necessary for reasoning about the beliefs of others.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Samson, D (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Hills Bldg, Birmingham B15 2TT, W Midlands, England.	d.samson@bham.ac.uk	Chiavarino, Claudia/T-6784-2019; Samson, Dana/A-8692-2008; Apperly, Ian/N-9165-2018	Chiavarino, Claudia/0000-0001-9475-3764; Samson, Dana/0000-0001-7428-0031; Apperly, Ian/0000-0001-9485-563X				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carlson SM, 1998, CHILD DEV, V69, P672, DOI 10.2307/1132197; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Kay J., 1992, PSYCHOLINGUISTIC ASS; Peterson DM, 1999, MIND LANG, V14, P80, DOI 10.1111/1468-0017.00104; Riggs KJ, 1998, COGNITIVE DEV, V13, P73, DOI 10.1016/S0885-2014(98)90021-1; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942	14	362	370	2	51	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					499	500		10.1038/nn1223	http://dx.doi.org/10.1038/nn1223			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	816HP	15077111				2022-12-28	WOS:000221101300026
J	Tanaka, M				Tanaka, M			Inactivation of the central thalamus delays self-timed saccades	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NEURONAL-ACTIVITY; PERIOD ACTIVITY; EYE-MOVEMENTS; MONKEY; MOTOR; REPRESENTATION; RESPONSES	The central thalamus transmits corollary discharge signals for eye movement control, but its role in eye movement generation remains uncertain. Inactivation of the paralaminar part of the ventrolateral thalamus delayed the initiation of contraversive saccades, particularly during a new memory-guided saccade task that required self-triggering of the movement. The results suggest that signals through the thalamus regulate the timing of self-initiated saccades.	Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Tanaka, M (corresponding author), Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan.	masaki@med.hokudai.ac.jp	Tanaka, Masaki/D-9199-2011	Tanaka, Masaki/0000-0002-6177-1314				HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McFarland NR, 2002, J NEUROSCI, V22, P8117; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; SCHLAGREY M, 1984, J NEUROPHYSIOL, V51, P1149, DOI 10.1152/jn.1984.51.6.1149; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tanaka M, 2005, J NEUROSCI, V25, P5866, DOI 10.1523/JNEUROSCI.0676-05.2005; Tanibuchi I, 2005, J NEUROPHYSIOL, V93, P614, DOI 10.1152/jn.00969.2003; van Donkelaar P, 2000, J NEUROPHYSIOL, V83, P2780, DOI 10.1152/jn.2000.83.5.2780; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Wyder MT, 2004, J NEUROPHYSIOL, V91, P2628, DOI 10.1152/jn.01221.2003; Wyder MT, 2003, J NEUROPHYSIOL, V90, P2029, DOI 10.1152/jn.00064.2003	15	36	37	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					20	22		10.1038/nn1617	http://dx.doi.org/10.1038/nn1617			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341209	Green Submitted			2022-12-28	WOS:000234288000011
J	Kreek, MJ; Nielsen, DA; Butelman, ER; LaForge, KS				Kreek, MJ; Nielsen, DA; Butelman, ER; LaForge, KS			Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PARANOIA; PITUITARY-ADRENAL AXIS; RECEPTOR GENE; OPIOID RECEPTOR; SUBSTANCE-ABUSE; ALCOHOL DEPENDENCE; ASSOCIATION ANALYSIS; MOLECULAR-GENETICS; OPIATE ADDICTION; NOVELTY SEEKING	Genetic variation may partially underlie complex personality and physiological traits-such as impulsivity, risk taking and stress responsivity-as well as a substantial proportion of vulnerability to addictive diseases. Furthermore, personality and physiological traits themselves may differentially affect the various stages of addiction, defined chronologically as initiation of drug use, regular drug use, addiction/dependence and potentially relapse. Here we focus on recent approaches to the study of genetic variation in these personality and physiological traits, and their influence on and interaction with addictive diseases.	Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA	Rockefeller University	Kreek, MJ (corresponding author), Rockefeller Univ, Lab Biol Addict Dis, 1230 York Ave, New York, NY 10021 USA.	kreek@rockefeller.edu	Nielsen, David A/B-4655-2009		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA005130, K05DA000049] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00102] Funding Source: Medline; NIDA NIH HHS [K05-DA00049, P60-DA05130] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P417, DOI 10.1038/sj.npp.1300598; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; COCCARO EF, 1994, ARCH GEN PSYCHIAT, V51, P318; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cubells JF, 2000, MOL PSYCHIATR, V5, P56, DOI 10.1038/sj.mp.4000657; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Gelernter J, 2005, AM J MED GENET B, V136B, P45, DOI 10.1002/ajmg.b.30189; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Horowitz R, 2000, AM J MED GENET, V96, P599, DOI 10.1002/1096-8628(20001009)96:5<599::AID-AJMG4>3.3.CO;2-F; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Kreek MJ, 2002, NAT REV DRUG DISCOV, V1, P710, DOI 10.1038/nrd897; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kreek MJ, 2004, NEUROMOL MED, V5, P85, DOI 10.1385/NMM:5:1:085; Kreek MJ, 1996, MOL PSYCHIATR, V1, P232; KREEK MJ, 1972, P 4 NAT C METH TREAT, P171, DOI DOI 10.1001/JAMA.223.6.665; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; LEVIN FR, 1995, HARVARD REV PSYCHIAT, V2, P246, DOI 10.3109/10673229509017144; Li T, 2004, AM J MED GENET B, V129B, P120, DOI 10.1002/ajmg.b.30024; Limosin F, 2005, EUR PSYCHIAT, V20, P304, DOI 10.1016/j.eurpsy.2005.02.004; Lusher JM, 2001, MOL PSYCHIATR, V6, P497, DOI 10.1038/sj.mp.4000918; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nielsen DA, 1998, ARCH GEN PSYCHIAT, V55, P593, DOI 10.1001/archpsyc.55.7.593; NIELSEN DA, 1994, ARCH GEN PSYCHIAT, V51, P34; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; Oswald LM, 2004, BIOL PSYCHIAT, V55, P102, DOI 10.1016/j.biopsych.2003.07.003; Ott J, 2004, HUM HERED, V58, P171, DOI 10.1159/000083544; Primus RJ, 1997, J PHARMACOL EXP THER, V282, P1020; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schluger JH, 2001, NEUROPSYCHOPHARMACOL, V24, P568, DOI 10.1016/S0893-133X(00)00222-0; Schmidt LG, 2002, DRUG ALCOHOL DEPEN, V65, P221, DOI 10.1016/S0376-8716(01)00164-8; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Sipe JC, 2002, P NATL ACAD SCI USA, V99, P8394, DOI 10.1073/pnas.082235799; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Tsuang MT, 1999, BEHAV GENET, V29, P473, DOI 10.1023/A:1021635223370; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; Yuferov V, 2004, PHARMACOGENETICS, V14, P793, DOI 10.1097/00008571-200412000-00002; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zhou Y, 1996, J PHARMACOL EXP THER, V279, P351	50	703	728	6	228	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1450	1457		10.1038/nn1583	http://dx.doi.org/10.1038/nn1583			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251987				2022-12-28	WOS:000232966600015
J	Wu, Q; Zhao, ZW; Shen, P				Wu, Q; Zhao, ZW; Shen, P			Regulation of aversion to noxious food by Drosophila neuropeptide Y- and insulin-like systems	NATURE NEUROSCIENCE			English	Article							SIGNALING PATHWAY; GROWTH-CONTROL; CELL-GROWTH; S6 KINASE; RECEPTOR; EXPRESSION; TRANSPORT; BEHAVIOR; DYNAMIN; PROTEIN	Omnivores, including humans, have an inborn tendency to avoid noxious or unfamiliar foods. Such defensive foraging behaviors are modifiable, however, in response to physiological needs. Here we describe a method for assessing risk-sensitive food acquisition in Drosophila melanogaster. Food-deprived fly larvae become more likely to feed on noxious foods ( adulterated with quinine) as the duration of deprivation increases. The neuropeptide F receptor NPFR1, a mammalian neuropeptide Y (NPY) receptor homolog, centrally regulates the response to noxious food in D. melanogaster. Overexpression of NPFR1 was sufficient to cause nondeprived larvae to more readily take in noxious food, whereas loss of NPFR1 signaling led to the opposite phenotype. Moreover, NPFR1 neuronal activity may be directly regulated by the insulin-like signaling pathway. Upregulation of insulin-like receptor signaling in NPFR1 cells suppressed the feeding response to noxious food. Our results suggest that the coordinated activities of the conserved NPY- and insulin-like receptor signaling systems are essential for the dynamic regulation of noxious food intake according to the animal's energy state.	Univ Georgia, Dept Cellular Biol & Biomed, Athens, GA 30602 USA; Univ Georgia, Hlth Sci Inst, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Shen, P (corresponding author), Univ Georgia, Dept Cellular Biol & Biomed, 724 Biol Sci Bldg, Athens, GA 30602 USA.	pshen@cellmate.cb.uga.edu		Shen, Ping/0000-0001-5024-3893	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058348] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-58348] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cao H, 2000, J CELL SCI, V113, P1993; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; HAASS M, 1989, N-S ARCH PHARMACOL, V340, P509; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kimball SR, 2001, CURR OPIN CLIN NUTR, V4, P39, DOI 10.1097/00075197-200101000-00008; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Larhammar D, 1996, REGUL PEPTIDES, V62, P1, DOI 10.1016/0167-0115(95)00169-7; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Levine AS, 2004, PEPTIDES, V25, P505, DOI 10.1016/j.peptides.2004.01.005; Levine AS, 2003, J NUTR, V133, p831S, DOI 10.1093/jn/133.3.831S; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; MOORE P, 2003, J BIOL, V2; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Segal-Lieberman G, 2003, AM J PHYSIOL-ENDOC M, V284, pE1131, DOI 10.1152/ajpendo.00491.2002; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Stricker E. M., 1990, NEUROBIOLOGY FOOD FL; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	41	192	197	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1350	1355		10.1038/nn1540	http://dx.doi.org/10.1038/nn1540			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172603				2022-12-28	WOS:000232145900019
J	Cox, DD; Meier, P; Oertelt, N; DiCarlo, JJ				Cox, DD; Meier, P; Oertelt, N; DiCarlo, JJ			'Breaking' position-invariant object recognition	NATURE NEUROSCIENCE			English	Article							PERCEPTION; TRANSLATION; SACCADES; TIME	While it is often assumed that objects can be recognized irrespective of where they fall on the retina, little is known about the mechanisms underlying this ability. By exposing human subjects to an altered world where some objects systematically changed identity during the transient blindness that accompanies eye movements, we induced predictable object confusions across retinal positions, effectively 'breaking' position invariance. Thus, position invariance is not a rigid property of vision but is constantly adapting to the statistics of the environment.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DiCarlo, JJ (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dicarlo@mit.edu	Cox, David/C-4888-2008	Cox, David/0000-0002-2189-9743; Oertelt, Nadja/0000-0002-9030-8863	NEI NIH HHS [R01-EY014970] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bedford FL, 1999, TRENDS COGN SCI, V3, P4, DOI 10.1016/S1364-6613(98)01266-2; Biederman I, 1999, VISION RES, V39, P2885, DOI 10.1016/S0042-6989(98)00309-5; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; Dill M, 2001, PERCEPTION, V30, P707, DOI 10.1068/p2953; Edelman S, 2003, COGNITIVE SCI, V27, P73, DOI 10.1207/s15516709cog2701_3; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; NAZIR T A, 1990, Spatial Vision, V5, P81, DOI 10.1163/156856890X00011; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938	15	108	108	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1145	1147		10.1038/nn1519	http://dx.doi.org/10.1038/nn1519			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	958YJ	16116453				2022-12-28	WOS:000231483800012
J	Lai, MZ; Wang, FS; Rohan, JG; Maeno-Hikichi, Y; Chen, Y; Zhou, Y; Gao, GP; Sather, WA; Zhang, JF				Lai, MZ; Wang, FS; Rohan, JG; Maeno-Hikichi, Y; Chen, Y; Zhou, Y; Gao, GP; Sather, WA; Zhang, JF			A tctex1-Ca2+ channel complex for selective surface expression of Ca2+ channels in neurons	NATURE NEUROSCIENCE			English	Article							DYNEIN LIGHT-CHAIN; N-TYPE; CYTOPLASMIC DYNEIN; CALCIUM-CHANNELS; SUBCELLULAR-DISTRIBUTION; HIPPOCAMPAL-NEURONS; TCTEX-1; MECHANISMS; PROTEINS; RECEPTOR	Voltage-gated Ca2+ channels (VGCCs) are important in regulating a variety of cellular functions in neurons. It remains poorly understood how VGCCs with different functions are sorted within neurons. Here we show that the t-complex testis-expressed 1 (tctex1) protein, a light-chain subunit of the dynein motor complex, interacts directly and selectively with N- and P/Q-type Ca2+ channels, but not L-type Ca2+ channels. The interaction is insensitive to Ca2+. Overexpression in hippocampal neurons of a channel fragment containing the binding domain for tctex1 significantly decreases the surface expression of endogenous N- and P/Q- type Ca2+ channels but not L-type Ca2+ channels, as determined by immunostaining. Furthermore, disruption of the tctex1 Ca2+ channel interaction significantly reduces the Ca2+ current density in hippocampal neurons. These results underscore the importance of the specific tctex1-channel interaction in determining sorting and trafficking of neuronal Ca2+ channels with different functionalities.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Penn, Sch Med, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania	Zhang, JF (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Physiol, 1020 Locust St, Philadelphia, PA 19107 USA.	Ji-fang.Zhang@Jefferson.edu	Chen, Yuan/D-1462-2011	Chen, Yuan/0000-0002-9412-4623; Rohan, Joyce/0000-0001-5102-6639; Sather, William/0000-0003-1482-8055				Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bahls FH, 1998, J NEUROBIOL, V35, P198, DOI 10.1002/(SICI)1097-4695(199805)35:2<198::AID-NEU6>3.0.CO;2-#; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; Campbell KS, 1998, J IMMUNOL, V161, P1728; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023/B:JOBB.0000008027.19384.c0; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jones OT, 1997, J NEUROSCI, V17, P6152; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Maximov A, 2002, J NEUROSCI, V22, P6939; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; SIEGEL RM, 2000, SCI STKE, pPL1; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WESTON JE, 1981, SOLID STATE IONICS, V2, P347, DOI 10.1016/0167-2738(81)90038-2; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	50	22	23	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					435	442		10.1038/nn1418	http://dx.doi.org/10.1038/nn1418			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768038				2022-12-28	WOS:000228040400013
J	Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D				Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D			Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; K+ CHANNEL; FREQUENCY PREFERENCES; NEONATAL CONVULSIONS; THETA-OSCILLATIONS; MAMMALIAN-CELLS; KCNQ2 SUBUNITS; WORKING-MEMORY	In humans, mutations in the KCNQ2 or KCNQ3 potassium-channel genes are associated with an inherited epilepsy syndrome. We have studied the contribution of KCNQ/M-channels to the control of neuronal excitability by using transgenic mice that conditionally express dominant-negative KCNQ2 subunits in brain. We show that suppression of the neuronal M current in mice is associated with spontaneous seizures, behavioral hyperactivity and morphological changes in the hippocampus. Restriction of transgene expression to defined developmental periods revealed that M-channel activity is critical to the development of normal hippocampal morphology during the first postnatal weeks. Suppression of the M current after this critical period resulted in mice with signs of increased neuronal excitability and deficits in hippocampus-dependent spatial memory. M-current-deficient hippocampal CA1 pyramidal neurons showed increased excitability, reduced spike-frequency adaptation, attenuated medium afterhyperpolarization and reduced intrinsic subthreshold theta resonance. M channels are thus critical determinants of cellular and neuronal network excitability, postnatal brain development and cognitive performance.	Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, D-20246 Hamburg, Germany; Univ Oslo, Dept Physiol, Inst Basic Med Sci, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oslo; University of Oslo	Storm, JF (corresponding author), Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, Martinistr 52, D-20246 Hamburg, Germany.	j.f.storm@medisin.uio.no; isbrandt@uni-hamburg.de		Hu, Hua/0000-0001-8187-4735; Isbrandt, Dirk/0000-0002-4720-1016				Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; Dedek K, 2001, P NATL ACAD SCI USA, V98, P12272, DOI 10.1073/pnas.211431298; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hadley JK, 2003, J NEUROSCI, V23, P5012; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Lechner SG, 2003, J PHYSIOL-LONDON, V553, P789, DOI 10.1113/jphysiol.2003.052449; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MALENKA RC, 1986, J NEUROSCI, V6, P475; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; SCHRETER RK, 1996, PSYCHIAT PRACTICE MA, V2, P3; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; WILLIAMSON A, 1990, J NEUROPHYSIOL, V63, P72, DOI 10.1152/jn.1990.63.1.72; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118	50	304	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					51	60		10.1038/nn1375	http://dx.doi.org/10.1038/nn1375			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608631				2022-12-28	WOS:000225967600015
J	Di Cristo, G; Wu, CZ; Chattopadhyaya, B; Ango, F; Enott, G; Welker, E; Svoboda, K; Huang, ZJ				Di Cristo, G; Wu, CZ; Chattopadhyaya, B; Ango, F; Enott, G; Welker, E; Svoboda, K; Huang, ZJ			Subcellular domain-restricted GABAergic innervation in primary visual cortex in the absence of sensory and thalamic inputs	NATURE NEUROSCIENCE			English	Article							INTERNEURONS; HIPPOCAMPUS; INHIBITION; EXPERIENCE; SUBTYPES; NEURONS	Distinct classes of GABAergic synapses target restricted subcellular domains, thereby differentially regulating the input, integration and output of principal neurons, but the underlying mechanism for such synapse segregation is unclear. Here we show that the distributions of two major classes of GABAergic synapses along the perisomatic and dendritic domains of pyramidal neurons were indistinguishable between primary visual cortex in vivo and cortical organotypic cultures. Therefore, subcellular synapse targeting is independent of thalamic input and probably involves molecular labels and experience-independent forms of activity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Stony Brook, NY 11790 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Lausanne	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Knott, Graham W/0000-0002-2956-9052; Ango, Fabrice/0000-0002-5548-209X; Huang, Z. Josh/0000-0003-0592-028X	NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 13564-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHATTOPADHYAYA B, IN PRESS J NEUROSCI; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123	15	119	119	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1184	1186		10.1038/nn1334	http://dx.doi.org/10.1038/nn1334			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475951				2022-12-28	WOS:000224749400008
J	Roelfsema, PR; Lamme, VAF; Spekreijse, H				Roelfsema, PR; Lamme, VAF; Spekreijse, H			Synchrony and covariation of firing rates in the primary visual cortex during contour grouping	NATURE NEUROSCIENCE			English	Article							STRIATE CORTICAL ACTIVITY; SELECTIVE ATTENTION; FEATURE-INTEGRATION; NEURONAL SYNCHRONY; FAST OSCILLATIONS; ALERT MACAQUE; RESPONSES; REPRESENTATION; CONNECTIONS; COHERENCE	The visual system imposes structure onto incoming information, by grouping image elements of a single object together, and by segregating them from elements that belong to other objects and the background. One influential theory holds that the code for grouping and segmentation is carried by the synchrony of neuronal discharges on a millisecond time scale. We tested this theory by recording neuronal activity in the primary visual cortex ( area V1) of monkeys engaged in a contour-grouping task. We found that synchrony was unrelated to contour grouping. The firing rates of V1 neurons are also correlated across trials. We demonstrate that this rate covariation is mainly determined by fluctuations in visual attention. Moreover, we show that rate covariation depends on perceptual grouping, as it is strongest between neurons that respond to features of the same object.	Netherlands Ophthalm Res Inst, Dept Vis & Cognit, NL-1105 BA Amsterdam, Netherlands; Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, NL-1018 WB Amsterdam, Netherlands; UvA, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci Amsterdam, NL-1100 AA Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Roelfsema, PR (corresponding author), Netherlands Ophthalm Res Inst, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.roelfsema@ioi.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				Angelucci A, 2002, J NEUROSCI, V22, P8633; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brosch M, 1997, CEREB CORTEX, V7, P70, DOI 10.1093/cercor/7.1.70; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Frien A, 2000, EUR J NEUROSCI, V12, P1466, DOI 10.1046/j.1460-9568.2000.00026.x; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Lee D, 1998, J NEUROSCI, V18, P1161; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roelfsema PR, 2000, VISION RES, V40, P1385, DOI 10.1016/S0042-6989(00)00004-3; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roelfsema PR, 2001, NEURON, V31, P853, DOI 10.1016/S0896-6273(01)00408-1; Roelfsema PR, 1998, CEREB CORTEX, V8, P385, DOI 10.1093/cercor/8.5.385; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Scholte HS, 2001, VISION RES, V41, P2569, DOI 10.1016/S0042-6989(01)00148-1; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SPORNS O, 1989, P NATL ACAD SCI USA, V86, P7265, DOI 10.1073/pnas.86.18.7265; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Super H, 2003, J NEUROSCI, V23, P3407; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Worden MS, 2000, J NEUROSCI, V20	50	142	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					982	991		10.1038/nn1304	http://dx.doi.org/10.1038/nn1304			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322549				2022-12-28	WOS:000223546700018
J	Dissel, S; Codd, V; Fedic, R; Garner, KJ; Costa, R; Kyriacou, CP; Rosato, E				Dissel, S; Codd, V; Fedic, R; Garner, KJ; Costa, R; Kyriacou, CP; Rosato, E			A constitutively active cryptochrome in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK; BEHAVIORAL RHYTHMS; LIGHT; ENTRAINMENT; TIMELESS; GENE; PROTEIN; PERIOD; PHOTORECEPTOR; NEURONS	Light-activated cryptochrome (CRY) regulates circadian photoresponses in Drosophila melanogaster. Removing the carboxy (C) terminus to create CRYDelta produces, in yeast, a light-independent, constitutively active form. Here we show that flies overexpressing CRYDelta have a longer free-running period of locomotor activity, as well as altered cycling kinetics of the clock proteins timeless (TIM) and period (PER). Moreover, at the cellular level, they show a reduction in the level of TIM and in the nuclear localization of TIM and PER in two significant clusters of behavioral pacemaker cells: the large and the small ventral lateral neurons (LN(v)s). These effects are similar to those seen in wild-type flies under continuous light and suggest a regulatory role for the C terminus of CRY on the photosensitive, photolyase-like part of the protein.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Leicester; University of Leicester; University of Padua	Rosato, E (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	er6@le.ac.uk		Rosato, Ezio/0000-0001-7297-4697; Dissel, Stephane/0000-0002-4486-5052; Codd, Veryan/0000-0002-9430-8254				Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Shafer OT, 2002, J NEUROSCI, V22, P5946; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, J NEUROSCI, V17, P676; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	34	93	96	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					834	840		10.1038/nn1285	http://dx.doi.org/10.1038/nn1285			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258584				2022-12-28	WOS:000222930800013
J	Komiyama, T; Carlson, JR; Luo, LQ				Komiyama, T; Carlson, JR; Luo, LQ			Olfactory receptor neuron axon targeting: intrinsic transcriptional control and hierarchical interactions	NATURE NEUROSCIENCE			English	Article							SENSORY MAP; PROJECTION NEURONS; DROSOPHILA-ANTENNA; WIRING SPECIFICITY; ODORANT RECEPTORS; N-CADHERIN; FLY BRAIN; SYSTEM; GLOMERULI; GUIDANCE	From insects to mammals, olfactory receptor neurons (ORNs) expressing a common olfactory receptor target their axons to specific glomeruli with high precision. Here we show in Drosophila that the POU transcription factor Acj6 controls the axon targeting specificity of a subset of ORN classes, as defined by the olfactory receptors that they express. Of these classes, some require Acj6 cell-autonomously, whereas others require Acj6 cell-nonautonomously. Mosaic analyses show that cooperative targeting occurs between axon terminals of the same ORN classes and that there are hierarchical interactions among different ORN classes. We propose that the precision of ORN axon targeting derives from both intrinsic transcriptional control and extensive axon-axon interactions.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Stanford University; Stanford University; Yale University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Komiyama, Takaki/0000-0001-9609-4600				Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	35	83	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					819	825		10.1038/nn1284	http://dx.doi.org/10.1038/nn1284			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15247920				2022-12-28	WOS:000222930800011
J	Ren, TY				Ren, TY			Reverse propagation of sound in the gerbil cochlea	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE; OTOACOUSTIC EMISSIONS; 2-TONE DISTORTION; MECHANISMS; VIBRATION; WAVES	It is commonly believed that the cochlea emits sounds through backward-traveling waves. In the present experiment using a scanning-laser interferometer, I detected forward-traveling but not backward-traveling waves and found that the stapes vibrates earlier than the basilar membrane. These results contradict the current theory and show that the ear emits sounds through the cochlear fluids as compression waves rather than along the basilar membrane as backward-traveling waves.	Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Ren, TY (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd,NRC 04, Portland, OR 97239 USA.	rent@ohsu.edu			NIDCD NIH HHS [R21 DC006695-01, R21 DC006695, R01 DC004554, R01 DC004554-02] Funding Source: Medline; NIDDK NIH HHS [DK55819, DK62179] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062179, P01DK055819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006695, R01DC004554] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; KEMP DT, 1986, HEARING RES, V22, P95, DOI 10.1016/0378-5955(86)90087-0; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Knight RD, 2001, J ACOUST SOC AM, V109, P1513, DOI 10.1121/1.1354197; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; vonBekesy G., 1960, EXPT HEARING; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P986, DOI 10.1121/1.1907231	14	121	130	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					333	334		10.1038/nn1216	http://dx.doi.org/10.1038/nn1216			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034589				2022-12-28	WOS:000220482500008
J	Paterlini, M; Zakharenko, SS; Lai, WS; Qin, J; Zhang, H; Mukai, J; Westphal, KGC; Olivier, B; Sulzer, D; Pavlidis, P; Siegelbaum, SA; Karayiorgou, M; Gogos, JA				Paterlini, M; Zakharenko, SS; Lai, WS; Qin, J; Zhang, H; Mukai, J; Westphal, KGC; Olivier, B; Sulzer, D; Pavlidis, P; Siegelbaum, SA; Karayiorgou, M; Gogos, JA			Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice	NATURE NEUROSCIENCE			English	Article							GENETIC-VARIATION; NEUROBIOLOGICAL BASIS; DOPAMINE-RECEPTOR; LEARNING-DEFICITS; WORKING-MEMORY; PROLINE; PHENCYCLIDINE; EXPRESSION; GLUTAMATE; ASSOCIATION	Microdeletions of 22q11.2 represent one of the highest known genetic risk factors for schizophrenia. It is likely that more than one gene contributes to the marked risk associated with this locus. Two of the candidate risk genes encode the enzymes proline dehydrogenase (PRODH) and catechol-O-methyltransferase (COMT), which modulate the levels of a putative neuromodulator (L-proline) and the neurotransmitter dopamine, respectively. Mice that model the state of PRODH deficiency observed in humans with schizophrenia show increased neurotransmitter release at glutamatergic synapses as well as deficits in associative learning and response to psychomimetic drugs. Transcriptional profiling and pharmacological manipulations identified a transcriptional and behavioral interaction between the Prodh and Comt genes that is likely to represent a homeostatic response to enhanced dopaminergic signaling in the frontal cortex. This interaction modulates a number of schizophrenia-related phenotypes, providing a framework for understanding the high disease risk associated with this locus, the expression of the phenotype, or both.	Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Genome Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Univ Utrecht, Dept Pharmacol, NL-3584 CA Utrecht, Netherlands; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Utrecht University; Columbia University; Howard Hughes Medical Institute; Columbia University	Karayiorgou, M (corresponding author), Rockefeller Univ, Human Neurogenet Lab, 1230 York Ave, New York, NY 10021 USA.	karayim@rockefeller.edu; jag90@columbia.edu	Zakharenko, Stanislav/D-3287-2013; Pavlidis, Paul/H-8406-2013; Olivier, Berend/AAX-4412-2021	Zakharenko, Stanislav/0000-0001-8115-202X; Pavlidis, Paul/0000-0002-0426-5028; Lai, Wen-Sung/0000-0001-6918-5531; Mukai, Jun/0000-0003-2065-4784	NIDA NIH HHS [DA07418] Funding Source: Medline; NIMH NIH HHS [MH67068] Funding Source: Medline; Telethon [GFP02011] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R55DA007418, R29DA007418, R01DA007418] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Balla A, 2003, NEUROPSYCHOPHARMACOL, V28, P34, DOI 10.1038/sj.npp.1300019; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Castner SA, 2004, PSYCHOPHARMACOLOGY, V174, P111, DOI 10.1007/s00213-003-1710-9; Cohen SM, 1997, DEV BRAIN RES, V100, P230, DOI 10.1016/S0165-3806(97)00045-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Healy DJ, 1996, BRAIN RES, V708, P38, DOI 10.1016/0006-8993(95)01241-9; HENZI V, 1992, MOL PHARMACOL, V41, P793; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V17, P92, DOI 10.1016/S0893-133X(97)00034-1; KAAKKOLA S, 1994, GEN PHARMACOL-VASC S, V25, P813, DOI 10.1016/0306-3623(94)90082-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laruelle M, 2000, BRAIN RES REV, V31, P371, DOI 10.1016/S0165-0173(99)00054-5; Latysheva NV, 2003, PROG NEURO-PSYCHOPH, V27, P787, DOI 10.1016/S0278-5846(03)00110-6; Li T, 2004, AM J MED GENET B, V129B, P13, DOI 10.1002/ajmg.b.30049; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; O'Donnell J, 2003, SYNAPSE, V50, P171, DOI 10.1002/syn.10258; Pavlidis Paul, 2002, Pac Symp Biocomput, P474; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stefani MR, 2002, BEHAV BRAIN RES, V134, P267, DOI 10.1016/S0166-4328(02)00040-2; Szeszko PR, 1999, BIOL PSYCHIAT, V45, P680, DOI 10.1016/S0006-3223(98)00258-3; VEZINA P, 1991, EUR J NEUROSCI, V3, P1001, DOI 10.1111/j.1460-9568.1991.tb00036.x; Yui K, 1999, MOL PSYCHIATR, V4, P512, DOI 10.1038/sj.mp.4000575; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	45	197	206	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1586	1594		10.1038/nn1562	http://dx.doi.org/10.1038/nn1562			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234811				2022-12-28	WOS:000232966600034
J	Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS				Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS			Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; MOLECULAR PHYSIOLOGY; SUPRAOPTIC NEURONS; ASTROCYTES; GLUTAMATE; HYPOTHALAMUS; VASOPRESSIN	Glial cells actively participate in synaptic transmission. They clear molecules from the synaptic cleft, receive signals from neurons and, in turn, release molecules that can modulate signaling between neuronal elements. Whether glial-derived transmitters can contribute to enduring changes in postsynaptic efficacy, however, remains to be established. In rat hypothalamic paraventricular nucleus, we demonstrate an increase in the amplitude of miniature excitatory postsynaptic currents in response to norepinephrine that requires the release of ATP from glial cells. The increase in quantal efficacy, which likely results from an insertion of AMPA receptors, is secondary to the activation of P2X7 receptors, an increase in postsynaptic calcium and the activation of phosphatidylinositol 3-kinase. The gliotransmitter ATP, therefore, contributes directly to the regulation of postsynaptic efficacy at glutamatergic synapses in the CNS.	Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 5E5, Canada	University of Calgary; University of Calgary; University of Saskatchewan	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jsbains@ucalgary.ca		Fisher, Thomas/0000-0003-3890-2774; Bains, Jaideep/0000-0002-3634-6463				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Armstrong JN, 2002, J NEUROSCI, V22, P5938; ARMSTRONG WE, 1986, BRAIN RES, V365, P192, DOI 10.1016/0006-8993(86)90739-0; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bekar LK, 2005, J NEUROPHYSIOL, V93, P1699, DOI 10.1152/jn.00850.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Daftary SS, 1998, J NEUROSCI, V18, P10619; DAY TA, 1993, BRAIN RES, V607, P341, DOI 10.1016/0006-8993(93)91528-Z; Di S, 2003, J NEUROSCI, V23, P4850; DUFFY S, 1995, J NEUROSCI, V15, P5535; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kapoor JR, 2000, J NEUROSCI, V20, P8868; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kombian SB, 2000, J NEUROPHYSIOL, V83, P2542, DOI 10.1152/jn.2000.83.5.2542; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; RANDLE JCR, 1986, AM J PHYSIOL, V251, pR569, DOI 10.1152/ajpregu.1986.251.3.R569; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanna PP, 2002, J NEUROSCI, V22, P3359; SAWYER CH, 1980, FED PROC, V39, P2889; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shibuya I, 1999, J PHYSIOL-LONDON, V514, P351, DOI 10.1111/j.1469-7793.1999.351ae.x; Shigetomi E, 2004, J NEUROSCI, V24, P3125, DOI 10.1523/JNEUROSCI.0090-04.2004; Stern JE, 1999, J NEUROSCI, V19, P3367; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; TWEEDLE CD, 1987, NEUROSCIENCE, V20, P241, DOI 10.1016/0306-4522(87)90016-9; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zucker RS, 2003, NEURON, V38, P845, DOI 10.1016/S0896-6273(03)00363-5	50	247	257	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1078	1086		10.1038/nn1498	http://dx.doi.org/10.1038/nn1498			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995701				2022-12-28	WOS:000230760200020
J	Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M				Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M			Neuronal fate determinants of adult olfactory bulb neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; SUBVENTRICULAR ZONE; MOUSE FOREBRAIN; MAMMALIAN BRAIN; MIGRATION; PAX6; SPECIFICATION; OLIG2; PROGENITORS	Adult neurogenesis in mammals is restricted to two small regions, including the olfactory bulb, where GABAergic and dopaminergic interneurons are newly generated throughout the entire lifespan. However, the mechanisms directing them towards a specific neuronal phenotype are not yet understood. Here, we demonstrate the dual role of the transcription factor Pax6 in generating neuronal progenitors and also in directing them towards a dopaminergic periglomerular phenotype in adult mice. We present further evidence that dopaminergic periglomerular neurons originate in a distinct niche, the rostral migratory stream, and are fewer derived from precursors in the zone lining the ventricle. This regionalization of the adult precursor cells is further supported by the restricted expression of the transcription factor Olig2, which specifies transit-amplifying precursor fate and opposes the neurogenic role of Pax6. Together, these data explain both extrinsic and intrinsic mechanisms controlling neuronal identity in adult neurogenesis.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; Inst Pasteur, CNRS, Unite Rech Associee 2182, Lab Percept & Memory, F-75724 Paris, France; Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany; Sackler Fac Med, Dept Human Genet & Mol Med, IL-69987 Tel Aviv, Israel; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Munich; Tel Aviv University; Sackler Faculty of Medicine; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	pmlledo@pasteur.fr; magdalena.goetz@gsf.de	Messier, Claude/A-2322-2008; de Chevigny, Antoine/M-7477-2016	Messier, Claude/0000-0002-4791-1763; Gotz, Magdalena/0000-0003-1551-9203; de Chevigny, Antoine/0000-0002-7413-0591; Saghatelyan, Armen/0000-0003-4962-0465				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Beech RD, 2004, J COMP NEUROL, V475, P128, DOI 10.1002/cne.20179; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	41	467	488	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					865	872		10.1038/nn1479	http://dx.doi.org/10.1038/nn1479			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951811				2022-12-28	WOS:000230137100013
J	Amat, J; Baratta, MV; Paul, E; Bland, ST; Watkins, LR; Maier, SF				Amat, J; Baratta, MV; Paul, E; Bland, ST; Watkins, LR; Maier, SF			Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus	NATURE NEUROSCIENCE			English	Article							CONDITIONED FEAR; EXTRACELLULAR LEVELS; INDUCED SEROTONIN; PRELIMBIC CORTEX; AMYGDALA; EXPOSURE; PROJECTIONS; EXTINCTION; ANXIETY; 5-HT	The degree of behavioral control that an organism has over a stressor is a potent modulator of the stressor's impact; uncontrollable stressors produce numerous outcomes that do not occur if the stressor is controllable. Research on controllability has focused on brainstem nuclei such as the dorsal raphe nucleus (DRN). Here we find that the infralimbic and prelimbic regions of the ventral medial prefrontal cortex (mPFCv) in rats detect whether a stressor is under the organism's control. When a stressor is controllable, stress-induced activation of the DRN is inhibited by the mPFCv, and the behavioral sequelae of uncontrollable stress are blocked. This suggests a new function for the mPFCv and implies that the presence of control inhibits stress-induced neural activity in brainstem nuclei, in contrast to the prevalent view that such activity is induced by a lack of control.	Univ Colorado, Dept Psychol, Boulder, CO 80903 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80903 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Maier, SF (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80903 USA.	smaier@psych.colorado.edu		Paul, Evan/0000-0002-7011-8050; Bland, Sondra/0000-0002-5790-089X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH050479, F31MH075213, R01MH050479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013159] Funding Source: NIH RePORTER; NIDA NIH HHS [DA13159] Funding Source: Medline; NIMH NIH HHS [MH50479, F31 MH075213] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Amat J, 1998, BRAIN RES, V812, P113, DOI 10.1016/S0006-8993(98)00960-3; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Basoglu M., 1992, TORTURE ITS CONSEQUE, P182; Bland ST, 2003, NEUROPSYCHOPHARMACOL, V28, P1589, DOI 10.1038/sj.npp.1300206; Bland ST, 2003, SYNAPSE, V49, P206, DOI 10.1002/syn.10229; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; FANSELOW MS, 1988, J EXP ANAL BEHAV, V50, P361, DOI 10.1901/jeab.1988.50-361; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; Grahn RE, 2002, BEHAV BRAIN RES, V134, P387, DOI 10.1016/S0166-4328(02)00061-X; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/0278-5846(84)90120-9; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; MAIER SF, 1993, BEHAV NEUROSCI, V107, P377, DOI 10.1037/0735-7044.107.2.377; Maswood S, 1998, BRAIN RES, V783, P115, DOI 10.1016/S0006-8993(97)01313-9; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Mesulam M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morgan MA, 2003, BEHAV BRAIN RES, V146, P121, DOI 10.1016/j.bbr.2003.09.021; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 1998, NEUROSCIENCE, V82, P443; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Robbins TW, 2000, PROG BRAIN RES, V126, P469; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Tao R, 2000, J PHARMACOL EXP THER, V294, P571; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; WEISS JM, 1980, NEUROCHEM RES, V5, P9, DOI 10.1007/BF00964456; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; WEISS JM, 1986, CIBA F SYMP, V123, P191; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	41	691	707	0	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					365	371		10.1038/nn1399	http://dx.doi.org/10.1038/nn1399			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696163				2022-12-28	WOS:000227354600022
J	Mejat, A; Ramond, F; Bassel-Duby, R; Khochbin, S; Olson, EN; Schaeffer, L				Mejat, A; Ramond, F; Bassel-Duby, R; Khochbin, S; Olson, EN; Schaeffer, L			Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MEF2 TRANSCRIPTION FACTOR; ALPHA-SUBUNIT GENE; ELECTRICAL-ACTIVITY; SKELETAL-MUSCLE; NUCLEAR-ORGANIZATION; MOUSE EMBRYOGENESIS; MYOGENIC FACTORS; DIFFERENTIATION; MYOD	Electrical activity arising from motor innervation influences skeletal muscle physiology by controlling the expression of many muscle genes, including those encoding acetylcholine receptor (AChR) subunits. How electrical activity is converted into a transcriptional response remains largely unknown. We show that motor innervation controls chromatin acetylation in skeletal muscle and that histone deacetylase 9 (HDAC9) is a signal-responsive transcriptional repressor which is downregulated upon denervation, with consequent upregulation of chromatin acetylation and AChR expression. Forced expression of Hdac9 in denervated muscle prevents upregulation of activity-dependent genes and chromatin acetylation by linking myocyte enhancer factor 2 (MEF2) and class I HDACs. By contrast, Hdac9-null mice are supersensitive to denervation-induced changes in gene expression and show chromatin hyperacetylation and delayed perinatal downregulation of myogenin, an activator of AChR genes. These findings show a molecular mechanism to account for the control of chromatin acetylation by presynaptic neurons and the activity-dependent regulation of skeletal muscle genes by motor innervation.	Ecole Normale Super, CNRS, UMR 5161,Inst Federat Rech 128, Equipe Differenciat Neuromusculaire, F-69364 Lyon 07, France; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; INSERM, U309, Inst Albert Bonniot, F-38706 La Tronche, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Schaeffer, L (corresponding author), Ecole Normale Super, CNRS, UMR 5161,Inst Federat Rech 128, Equipe Differenciat Neuromusculaire, 46 Allee Italie, F-69364 Lyon 07, France.	lschaeff@ens-lyon.fr	MEJAT, Alexandre/G-8635-2013; Ramond, Francis/GVS-2149-2022; Khochbin, Saadi/M-8090-2013	Khochbin, Saadi/0000-0002-0455-0857; schaeffer, laurent/0000-0001-6600-503X				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; Bessereau JL, 1998, J BIOL CHEM, V273, P12786, DOI 10.1074/jbc.273.21.12786; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; DUCLERT A, 1991, NEUROREPORT, V2, P25, DOI 10.1097/00001756-199101000-00006; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; GUNDERSEN K, 1995, MOL CELL BIOL, V15, P7127; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; TANG JC, 1994, DEVELOPMENT, V120, P1799; Walke W, 1996, J NEUROSCI, V16, P3641; WITZEMANN V, 1991, FEBS LETT, V282, P259, DOI 10.1016/0014-5793(91)80490-T; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	136	143	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					313	321		10.1038/nn1408	http://dx.doi.org/10.1038/nn1408			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711539				2022-12-28	WOS:000227354600016
J	Reuter, J; Raedler, T; Rose, M; Hand, I; Glascher, J; Buchel, C				Reuter, J; Raedler, T; Rose, M; Hand, I; Glascher, J; Buchel, C			Pathological gambling is linked to reduced activation of the mesolimbic reward system	NATURE NEUROSCIENCE			English	Article							DRUG-ADDICTION; RESPONSES; STRIATUM; CORTEX; TASK; FMRI	By analogy to drug dependence, it has been speculated that the underlying pathology in pathological gambling is a reduction in the sensitivity of the reward system. Studying pathological gamblers and controls during a guessing game using functional magnetic resonance imaging, we observed a reduction of ventral striatal and ventromedial prefrontal activation in the pathological gamblers that was negatively correlated with gambling severity, linking hypoactivation of these areas to disease severity.	Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Neurol, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Psychiat, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Psychiat, Behav Therapy Univ, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg	Buchel, C (corresponding author), Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Neurol, Martinistr 52, D-20246 Hamburg, Germany.	buechel@uke.uni-hamburg.de	Jansen, Heiko T./A-5770-2008; Gläscher, Jan/H-2930-2019; Winwood, Peter/A-6363-2008	Jansen, Heiko T./0000-0003-0178-396X; Gläscher, Jan/0000-0002-1020-7115; 				Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Blum K, 1996, AM SCI, V84, P132; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	15	492	508	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					147	148		10.1038/nn1378	http://dx.doi.org/10.1038/nn1378			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643429				2022-12-28	WOS:000226638200012
J	Janzen, G; van Turennout, M				Janzen, G; van Turennout, M			Selective neural representation of objects relevant for navigation	NATURE NEUROSCIENCE			English	Article							ATTENTION; MEMORY; BRAIN; NETWORKS; HIPPOCAMPUS; ACTIVATION	As people find their way through their environment, objects at navigationally relevant locations can serve as crucial landmarks. The parahippocampal gyrus has previously been shown to be involved in object and scene recognition. In the present study, we investigated the neural representation of navigationally relevant locations. Healthy human adults viewed a route through a virtual museum with objects placed at intersections (decision points) or at simple turns (non-decision points). Event-related functional magnetic resonance imaging (fMRI) data were acquired during subsequent recognition of the objects in isolation. Neural activity in the parahippocampal gyrus reflected the navigational relevance of an object's location in the museum. Parahippocampal responses were selectively increased for objects that occurred at decision points, independent of attentional demands. This increase occurred for forgotten as well as remembered objects, showing implicit retrieval of navigational information. The automatic storage of relevant object location in the parahippocampal gyrus provides a part of the neural mechanism underlying successful navigation.	Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Max Planck Society	Janzen, G (corresponding author), Max Planck Inst Psycholinguist, Postbus 310, NL-6500 AH Nijmegen, Netherlands.	gabriele.janzen@mpi.nl	Janzen, Gabriele/G-2058-2012					Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; BLADES M, 1992, J ENVIRON PSYCHOL, V12, P175, DOI 10.1016/S0272-4944(05)80069-6; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; BURGESS N, 1999, HIPPOCAMPAL PARIETAL; Caldwell JI, 2001, MEM COGNITION, V29, P285, DOI 10.3758/BF03194922; DANIEL MP, 1998, KOGNITIONSWISSENSCHA, V7, P45, DOI DOI 10.1007/S001970050050; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Duzel E, 2003, J NEUROSCI, V23, P9439; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Golledge R, 1999, WAYFINDING BEHAV; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; HYDE JS, 1981, AM PSYCHOL, V36, P892, DOI 10.1037/0003-066X.36.8.892; Johnsrude IS, 1999, NEUROPSYCHOLOGIA, V37, P829, DOI 10.1016/S0028-3932(98)00136-5; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Owen AM, 1996, J COGNITIVE NEUROSCI, V8, P588, DOI 10.1162/jocn.1996.8.6.588; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	36	273	276	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					673	677		10.1038/nn1257	http://dx.doi.org/10.1038/nn1257			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146191	Green Published			2022-12-28	WOS:000221640300023
J	Mato, S; Chevaleyre, V; Robbe, D; Pazos, A; Castillo, PE; Manzoni, OJ				Mato, S; Chevaleyre, V; Robbe, D; Pazos, A; Castillo, PE; Manzoni, OJ			A single in-vivo exposure to Delta 9THC blocks endocannabinoid-mediated synaptic plasticity	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS; RAT-BRAIN; GABAERGIC SYNAPSES; NUCLEUS-ACCUMBENS; DELTA(9)-TETRAHYDROCANNABINOL; POTENTIATION; DEPRESSION	Endogenous cannabinoids (eCB) mediate synaptic plasticity in brain regions involved in learning and reward. Here we show that in mice, a single in-vivo exposure to Delta9-tetrahydrocannabinol (THC) abolishes the retrograde signaling that underlies eCB-mediated synaptic plasticity in both nucleus accumbens (NAc) and hippocampus in vitro. This effect is reversible within 3 days and is associated with a transient modification in the functional properties of cannabinoid receptors.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Inst Magendie Neurosci, Equipe INSERM Avenir, F-33077 Bordeaux, France; Univ Cantabria, Dept Physiol & Pharmacol, Santander 39011, Cantabria, Spain	Yeshiva University; Albert Einstein College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Cantabria	Castillo, PE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	pcastill@aecom.yu.edu; manzoni@bordeaux.inserm.fr	Manzoni, Olivier/M-7899-2016; robbe, david/O-5439-2016; Mato, Susana/AAU-3129-2020	Manzoni, Olivier/0000-0002-5579-6208; robbe, david/0000-0002-9450-0553; Mato, Susana/0000-0002-2005-9793; Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856; Pazos, Angel/0000-0001-8047-8802				Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Hutcheson DM, 1998, BRIT J PHARMACOL, V125, P1567, DOI 10.1038/sj.bjp.0702228; Maldonado R, 2002, PHARMACOL THERAPEUT, V95, P153, DOI 10.1016/S0163-7258(02)00254-1; Mato S, 2003, EUR J NEUROSCI, V17, P1747, DOI 10.1046/j.1460-9568.2003.02599.x; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sim LJ, 1996, J NEUROSCI, V16, P8057; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	15	169	175	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					585	586		10.1038/nn1251	http://dx.doi.org/10.1038/nn1251			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146190				2022-12-28	WOS:000221640300010
J	Himanen, JP; Chumley, MJ; Lackmann, M; Li, C; Barton, WA; Jeffrey, PD; Vearing, C; Geleick, D; Feldheim, DA; Boyd, AW; Henkemeyer, M; Nikolov, DB				Himanen, JP; Chumley, MJ; Lackmann, M; Li, C; Barton, WA; Jeffrey, PD; Vearing, C; Geleick, D; Feldheim, DA; Boyd, AW; Henkemeyer, M; Nikolov, DB			Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling	NATURE NEUROSCIENCE			English	Article							CRYSTAL-STRUCTURE; TYROSINE RESIDUES; LIGAND-BINDING; FAMILY; DOMAIN; NUK; PHOSPHORYLATION; ENDOCYTOSIS; KINASES	The interactions between Eph receptor tyrosine kinases and their ephrin ligands regulate cell migration and axon pathfinding. The EphA receptors are generally thought to become activated by ephrin-A ligands, whereas the EphB receptors interact with ephrin-B ligands. Here we show that two of the most widely studied of these molecules, EphB2 and ephrin-A5, which have never been described to interact with each other, do in fact bind one another with high affinity. Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling. Ephrin-A5 induces EphB2-mediated growth cone collapse and neurite retraction in a model system. We further show, using X-ray crystallography, that the ephrin-A5-EphB2 complex is a heterodimer and is architecturally distinct from the tetrameric EphB2-ephrin-B2 structure. The structural data reveal the molecular basis for EphB2-ephrin-A5 signaling and provide a framework for understanding the complexities of functional interactions and crosstalk between A- and B-subclass Eph receptors and ephrins.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ludwig Institute for Cancer Research; University of California System; University of California Santa Cruz; QIMR Berghofer Medical Research Institute	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	dimitar@ximpact3.ski.mskcc.org	Boyd, Andrew/G-2083-2010	Henkemeyer, Mark/0000-0002-7525-1061; Jeffrey, Philip/0000-0002-4351-5341	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066332, R01-MH66332] Funding Source: Medline; NINDS NIH HHS [R01-NS38486] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1997, Cell, V90, P403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, ONCOGENE, V13, P1343; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knoll B, 2001, DEVELOPMENT, V128, P895; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2000, METH MOL B, V124, P335; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Okada T, 2001, EUR J NEUROSCI, V13, P1635, DOI 10.1046/j.0953-816x.2001.01523.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; St John JA, 2001, DEV BRAIN RES, V126, P43, DOI 10.1016/S0165-3806(00)00136-X; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	42	357	373	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					501	509		10.1038/nn1237	http://dx.doi.org/10.1038/nn1237			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15107857				2022-12-28	WOS:000221101300027
J	Corbetta, M; Kincade, MJ; Lewis, C; Snyder, AZ; Sapir, A				Corbetta, M; Kincade, MJ; Lewis, C; Snyder, AZ; Sapir, A			Neural basis and recovery of spatial attention deficits in spatial neglect	NATURE NEUROSCIENCE			English	Article							HEMISPATIAL NEGLECT; SUBCORTICAL STROKE; UNILATERAL NEGLECT; VISUAL-ATTENTION; PARIETAL CORTEX; APHASIA; ANATOMY; MECHANISMS; HUMANS; VOLUNTARY	The syndrome of spatial neglect is typically associated with focal injury to the temporoparietal or ventral frontal cortex. This syndrome shows spontaneous partial recovery, but the neural basis of both spatial neglect and its recovery is largely unknown. We show that spatial attention deficits in neglect (rightward bias and reorienting) after right frontal damage correlate with abnormal activation of structurally intact dorsal and ventral parietal regions that mediate related attentional operations in the normal brain. Furthermore, recovery of these attention deficits correlates with the restoration and rebalancing of activity within these regions. These results support a model of recovery based on the re-weighting of activity within a distributed neuronal architecture, and they show that behavioral deficits depend not only on structural changes at the locus of injury, but also on physiological changes in distant but functionally related brain areas.	Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Rehabil Inst St Louis, St Louis, MO 63108 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Lewis, Chris M/F-6665-2010; Lewis, Christopher/AAP-5035-2021	Lewis, Christopher/0000-0001-8362-1248; CORBETTA, MAURIZIO/0000-0001-8295-3304				Appelros P, 2002, J REHABIL MED, V34, P215, DOI 10.1080/165019702760279206; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; CARAMAZZA A, 1988, ANNU REV NEUROSCI, V11, P395, DOI 10.1146/annurev.neuro.11.1.395; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEUEL RK, 1984, ANN NEUROL, V15, P521, DOI 10.1002/ana.410150603; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman K. M., 1987, NEUROPHYSIOLOGICAL N, V45, P115, DOI [DOI 10.1016/S0166-4115(08)61711-2, 10.1016/S0166-4115(08)61711-2]; Heiss WD, 1999, ANN NEUROL, V45, P430, DOI 10.1002/1531-8249(199904)45:4<430::AID-ANA3>3.0.CO;2-P; Hillis AE, 2005, J NEUROSCI, V25, P3161, DOI 10.1523/JNEUROSCI.4468-04.2005; HORNAK J, 1992, NEUROPSYCHOLOGIA, V30, P547, DOI 10.1016/0028-3932(92)90057-S; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Jackson J H, 1884, Br Med J, V1, P591; Jackson J. H., 1884, BMJ-BRIT MED J, V1, P660, DOI [DOI 10.1136/BMJ.1.1214.660, 10.1136/bmj.1.1214.660]; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; KINSBOURNE M, 1977, HEMIINATTENTION HEMI, P41; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; LYNCH JC, 1989, J NEUROPHYSIOL, V61, P74, DOI 10.1152/jn.1989.61.1.74; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Pedersen PM, 1997, AM J PHYS MED REHAB, V76, P122, DOI 10.1097/00002060-199703000-00007; PEERS PV, 2005, CEREB CORTEX; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Pizzamiglio L, 1998, ARCH NEUROL-CHICAGO, V55, P561, DOI 10.1001/archneur.55.4.561; POSNER MI, 1984, J NEUROSCI, V4, P1863; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; VALLAR G, 1988, J NEUROL NEUROSUR PS, V51, P1269, DOI 10.1136/jnnp.51.10.1269; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Von Monakov C., 1911, J PSYCHOL NEUROL, V17, P185	46	605	616	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1603	1610		10.1038/nn1574	http://dx.doi.org/10.1038/nn1574			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234807				2022-12-28	WOS:000232966600036
J	Loffler, G; Yourganov, G; Wilkinson, F; Wilson, HR				Loffler, G; Yourganov, G; Wilkinson, F; Wilson, HR			fMRI evidence for the neural representation of faces	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; STRIATE CORTEX; RECOGNITION; PERCEPTION; CONTRAST; MONKEY; AREA; IDENTIFICATION; POTENTIALS; RESPONSES	fMRI ( functional magnetic resonance imaging) studies on humans have shown a cortical area, the fusiform face area, that is specialized for face processing. An important question is how faces are represented within this area. This study provides direct evidence for a representation in which individual faces are encoded by their direction ( facial identity) and distance ( distinctiveness) from a prototypical ( mean) face. When facial geometry ( head shape, hair line, internal feature size and placement) was varied, the fMRI signal increased with increasing distance from the mean face. Furthermore, adaptation of the fMRI signal showed that the same neural population responds to faces falling along single identity axes within this space.	Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland; York Univ, Ctr Vis Res, N York, ON M3J 1P3, Canada	Glasgow Caledonian University; York University - Canada	Loffler, G (corresponding author), Glasgow Caledonian Univ, Dept Vis Sci, Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.	gloe@gcal.ac.uk		Loffler, Gunter/0000-0002-8359-9033	NEI NIH HHS [EY002158] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002158] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; BRUCE V, 1991, COGNITION, V38, P109, DOI 10.1016/0010-0277(91)90049-A; Bruce V., 1998, EYE BEHOLDER SCI FAC; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayaert G, 2003, J NEUROSCI, V23, P3016; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wilson HR, 2002, VISION RES, V42, P2909, DOI 10.1016/S0042-6989(02)00362-0	25	268	271	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1386	1390		10.1038/nn1538	http://dx.doi.org/10.1038/nn1538			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136037				2022-12-28	WOS:000232145900024
J	Liu, XX; Wang, Q; Haydar, TF; Bordey, A				Liu, XX; Wang, Q; Haydar, TF; Bordey, A			Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors	NATURE NEUROSCIENCE			English	Article							ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; NEURONAL PROGENITORS; VENTRICULAR ZONE; PRECURSOR CELLS; RAT FOREBRAIN; RADIAL GLIA; STEM-CELLS; IN-SITU	In the postnatal subventricular zone ( SVZ), local cues or signaling molecules released from neuroblasts limit the proliferation of glial fibrillary acidic protein (GFAP)-expressing progenitors thought to be stem cells. However, signals between SVZ cells have not been identified. We show that depolarization of neuroblasts induces nonsynaptic SNARE-independent GABA(A) receptor currents in GFAP-expressing cells, the time course of which depends on GABA uptake in acute mouse slices. We found that GABA(A) receptors are tonically activated in GFAP-expressing cells, consistent with the presence of spontaneous depolarizations in neuroblasts that are sufficient to induce GABA release. These data demonstrate the existence of nonsynaptic GABAergic signaling between neuroblasts and GFAP-expressing cells. Furthermore, we show that GABA(A) receptor activation in GFAP-expressing cells limits their progression through the cell cycle. Thus, as GFAP-expressing cells generate neuroblasts, GABA released from neuroblasts provides a feedback mechanism to control the proliferation of GFAP-expressing progenitors by activating GABA(A) receptors.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20010 USA; George Washington Univ, Sch Med, Dept Pharmacol, Washington, DC 20010 USA	Yale University; Yale University; George Washington University; George Washington University	Bordey, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	angelique.bordey@yale.edu		Haydar, Tarik/0000-0001-6772-3076	NINDS NIH HHS [R01 NS042189, R01 NS048256, NS042189, NS048256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042189, R01NS048256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCIA AD, 2004, NAT NEUROSCI, V7, P1233; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Bordey A, 2000, GLIA, V30, P27, DOI 10.1002/(SICI)1098-1136(200003)30:1<27::AID-GLIA4>3.0.CO;2-#; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fueshko SM, 1998, J NEUROSCI, V18, P2560; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Nguyen L, 2003, J NEUROSCI, V23, P3278; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pieribone VA, 2002, J COMP NEUROL, V454, P105, DOI 10.1002/cne.10417; Smith AJ, 2004, J PHARMACOL EXP THER, V311, P601, DOI 10.1124/jpet.104.070342; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	45	318	333	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1179	1187		10.1038/nn1522	http://dx.doi.org/10.1038/nn1522			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116450	Green Accepted			2022-12-28	WOS:000231483800017
J	Blackmer, T; Larsen, EC; Bartleson, C; Kowalchyk, JA; Yoon, EJ; Preininger, AM; Alford, S; Hamm, HE; Martin, TFJ				Blackmer, T; Larsen, EC; Bartleson, C; Kowalchyk, JA; Yoon, EJ; Preininger, AM; Alford, S; Hamm, HE; Martin, TFJ			G protein beta gamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis	NATURE NEUROSCIENCE			English	Article							GTP-BINDING PROTEIN; PHOSPHOLIPASE-C; MEMBRANE-FUSION; SUBUNITS; CELLS; SYNAPTOTAGMIN; ACTS; MODULATION; ACTIVATION; RESOLUTION	The activation of G protein - coupled receptors (GPCRs) can result in an inhibition of Ca2+-dependent hormone and neurotransmitter secretion. This has been attributed in part to G protein inhibition of Ca2+ influx. However, a frequently dominant inhibitory effect, of unknown mechanism, also occurs distal to Ca2+ entry. Here we characterize direct inhibitory actions of G protein beta gamma (G beta gamma) on Ca2+-triggered vesicle exocytosis in permeable PC12 cells. G beta gamma inhibition was rapid (<1 s) and was attenuated by cleavage of synaptosome-associated protein of 25 kD (SNAP25). G beta gamma bound soluble N-ethylmaleimide-sensitive factor attachment protein receptor ( SNARE) complexes, and binding was reduced to SNARE complexes containing cleaved SNAP25 or by Ca2+-dependent synaptotagmin binding. Here we show inhibitory coupling between GPCRs and vesicle exocytosis mediated directly by G beta gamma interactions with the Ca2+-dependent fusion machinery.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	heidi.hamm@mcmail.vanderbilt.edu; tfmartin@facstaff.wisc.edu	Hamm, Heidi E/G-2374-2014	Preininger, Anita/0000-0001-8011-9391; Alford, Simon/0000-0002-0454-4246				AHNERTHILGER G, 1987, BIOCHEMISTRY-US, V26, P7842, DOI 10.1021/bi00398a046; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; BLANK JL, 1992, J BIOL CHEM, V267, P23069; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KNIGHT DE, 1985, FEBS LETT, V189, P345, DOI 10.1016/0014-5793(85)81053-X; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; LUINI A, 1990, J NEUROCHEM, V54, P30, DOI 10.1111/j.1471-4159.1990.tb13279.x; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; OHARAIMAIZUMI M, 1992, J NEUROCHEM, V58, P2275, DOI 10.1111/j.1471-4159.1992.tb10974.x; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; UEDA N, 1994, J BIOL CHEM, V269, P4388; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	31	125	128	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					421	425		10.1038/nn1423	http://dx.doi.org/10.1038/nn1423			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778713				2022-12-28	WOS:000228040400011
J	Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ				Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ			Morphing Marilyn into Maggie dissociates physical and identity face representations in the brain	NATURE NEUROSCIENCE			English	Article							FAMOUS FACES; PERCEPTION; RECOGNITION; FMRI; RESPONSES; NEURONS; ACCOUNT; AREA; ACTIVATION; EXPRESSION	How the brain represents different aspects of faces remains controversial. Here we presented subjects with stimuli drawn from morph continua between pairs of famous faces. In the paired presentations, a second face could be identical to the first, could share perceived identity but differ physically (30% along the morph continuum), or could differ physically by the same distance along the continuum (30%) but in the other direction. We show that, behaviorally, subjects are more likely to classify face pairs in the third paired presentation as different and that this effect is more pronounced for subjects who are more familiar with the faces. In functional magnetic resonance imaging (fMRI), inferior occipital gyrus (IOG) shows sensitivity to physical rather than to identity changes, whereas right fusiform gyrus (FFG) shows sensitivity to identity rather than to physical changes. Bilateral anterior temporal regions show sensitivity to identity change that varies with the subjects' pre-experimental familiarity with the faces. These findings provide neurobiological support for a hierarchical model of face perception.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England; UCL, Dept Psychol, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3BG, England; SISSA, Program Neurosci, I-34013 Trieste, Italy	University of London; University College London; University of London; University College London; University of London; University College London; International School for Advanced Studies (SISSA)	Rotshtein, P (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London, England.	p.rotshtein@fil.ion.ucl.ac.uk	Henson, Richard/H-8822-2019; Driver, Jon/A-4779-2010; Treves, Alessandro/B-2318-2009	Henson, Richard/0000-0002-0712-2639; Dolan, Ray/0000-0001-9356-761X; TREVES, Alessandro/0000-0001-7246-5673; Rotshtein, Pia/0000-0002-0301-9511				Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Harnad S., 1987, CATEGORICAL PERCEPTI, P29; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Josephs O., 2000, NEUROIMAGE, V11, pS543; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mundel T, 2003, J CLIN NEUROPHYSIOL, V20, P102, DOI 10.1097/00004691-200304000-00003; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; PENNY W, 2003, HUMAN BRAIN FUNCTION, V2, P851; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Rajah MN, 1999, COGNITIVE BRAIN RES, V8, P259, DOI 10.1016/S0926-6410(99)00030-0; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	50	413	417	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					107	113		10.1038/nn1370	http://dx.doi.org/10.1038/nn1370			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592463	Green Published			2022-12-28	WOS:000225967600023
J	Denise, A; Garcia, R; Doan, NB; Imura, T; Bush, TG; Sofroniew, MV				Denise, A; Garcia, R; Doan, NB; Imura, T; Bush, TG; Sofroniew, MV			GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; INTERMEDIATE-FILAMENT PROTEIN; SITE-SPECIFIC RECOMBINATION; TRANSGENIC MICE; IN-VIVO; MAMMALIAN FOREBRAIN; SUBVENTRICULAR ZONE	Establishing the cellular identity in vivo of adult multipotent neural progenitors is fundamental to understanding their biology. We used two transgenic strategies to determine the relative contribution of glial fibrillary acidic protein (GFAP)-expressing progenitors to constitutive neurogenesis in the adult forebrain. Transgenically targeted ablation of dividing GFAP-expressing cells in the adult mouse subependymal and subgranular zones stopped the generation of immunohistochemically identified neuroblasts and new neurons in the olfactory bulb and the hippocampal dentate gyrus. Transgenically targeted cell fate mapping showed that essentially all neuroblasts and neurons newly generated in the adult mouse forebrain in vivo, and in adult multipotent neurospheres in vitro, derived from progenitors that expressed GFAP. Constitutively dividing GFAP-expressing progenitors showed predominantly bipolar or unipolar morphologies with significantly fewer processes than non-neurogenic multipolar astrocytes. These findings identify morphologically distinctive GFAP-expressing progenitor cells as the predominant sources of constitutive adult neurogenesis, and provide new methods for manipulating and investigating these cells.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020; Garcia, Anna Denise/G-5884-2013		NINDS NIH HHS [NS042693, NS47386] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047386, R21NS042693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Balzarini J, 1998, GENE THER, V5, P419, DOI 10.1038/sj.gt.3300586; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Buniatian G, 1998, BIOL CELL, V90, P53, DOI 10.1016/S0248-4900(98)80232-3; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Imura T, 2003, J NEUROSCI, V23, P2824; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JOHNSON WB, 1995, GLIA, V13, P174, DOI 10.1002/glia.440130304; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mathis C, 2000, J NEUROSCI, V20, P7698; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	50	721	758	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1233	1241		10.1038/nn1340	http://dx.doi.org/10.1038/nn1340			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494728				2022-12-28	WOS:000224749400016
J	Wolpe, PR				Wolpe, PR			Ethics and social policy in research on the neuroscience of human sexuality	NATURE NEUROSCIENCE			English	Article							BRAIN; ENHANCEMENT	The potential benefits of neuroscientific research into sexuality are great, but neuroscientists must participate in debates over the social, forensic and therapeutic implications of their findings. If serious research in sexuality is to be supported by the public, researchers must continue to earn society's trust with responsible and thoughtful presentation of their work.	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wolpe, PR (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	wolpep@mail.med.upenn.edu	Wolpe, Paul/A-1032-2007					Bing Janet, 1999, WOMEN LANGUAGE, V22, P4; BROWN DW, 1995, MED HYPOTHESES, V45, P383, DOI 10.1016/0306-9877(95)90099-3; BYNE W, 1999, SAME SEX DEBATING ET, P107; CACIOPPO JT, 2002, SOCIAL NEUROSCIENCE; Farah MJ, 2004, HASTINGS CENT REP, V34, P35, DOI 10.2307/3528418; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Feldman RP, 2001, NEUROSURGERY, V48, P647, DOI 10.1097/00006123-200103000-00041; Harmon-Jones E, 2003, J PERS SOC PSYCHOL, V85, P589, DOI 10.1037/0022-3514.85.4.589; Hines M, 2003, ANN NY ACAD SCI, V1007, P272, DOI 10.1196/annals.1286.026; Katz Jonathan., 1995, INVENTION HETEROSEXU; LANCASTER RN, 1988, ETHNOLOGY, V27, P111, DOI 10.2307/3773623; Raichle ME, 2003, POLIT PSYCHOL, V24, P759, DOI 10.1046/j.1467-9221.2003.00351.x; Richards TL, 2001, LEARN DISABILITY Q, V24, P189, DOI 10.2307/1511243; Tracy J, 2003, CEREB CORTEX, V13, P904, DOI 10.1093/cercor/13.9.904; Wolpe PR, 2002, BRAIN COGNITION, V50, P387, DOI 10.1016/S0278-2626(02)00534-1	15	8	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1031	1033		10.1038/nn1324	http://dx.doi.org/10.1038/nn1324			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	857YQ	15452573				2022-12-28	WOS:000224156900009
J	Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG				Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG			PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NEURITE GROWTH-INHIBITORS; NOGO RECEPTOR; GLYCOPROTEIN INTERACTS; CONE COLLAPSE; CELL-ADHESION; RHO-GTPASES; CYCLIC-AMP; OUTGROWTH	Successful axon regeneration in the mammalian central nervous system (CNS) is at least partially compromised due to the inhibitors associated with myelin and glial scar. However, the intracellular signaling mechanisms underlying these inhibitory activities are largely unknown. Here we provide biochemical and functional evidence that conventional isoforms of protein kinase C (PKC) are key components in the signaling pathways that mediate the inhibitory activities of myelin components and chondroitin sulfate proteoglycans (CSPGs), the major class of inhibitors in the glial scar. Both the myelin inhibitors and CSPGs induce PKC activation. Blocking PKC activity pharmacologically and genetically attenuates the ability of CNS myelin and CSPGs to activate Rho and inhibit neurite outgrowth. Intrathecal infusion of a PKC inhibitor, Go6976, into the site of dorsal hemisection promotes regeneration of dorsal column axons across and beyond the lesion site in adult rats. Thus, perturbing PKC activity could represent a therapeutic approach to stimulating axon regeneration after brain and spinal cord injuries.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Louisville; Harvard University; Harvard Medical School	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 320 Longwood Ave, Boston, MA 02115 USA.	xmxu0001@louisville.edu; zhigang.he@tch.harvard.edu		Xu, Xiao-ming/0000-0002-7229-0081; Wang, Kevin/0000-0002-5305-6791	NINDS NIH HHS [NS36350] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036350] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Prang P, 2001, EXP NEUROL, V169, P135, DOI 10.1006/exnr.2001.7648; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; SAVIO T, 1989, J NEUROSCI, V9, P1126; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Ughrin YM, 2003, J NEUROSCI, V23, P175; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006	50	250	261	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					261	268		10.1038/nn1193	http://dx.doi.org/10.1038/nn1193			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770187				2022-12-28	WOS:000189197900016
J	Kirik, D; Georgievska, B; Bjorklund, A				Kirik, D; Georgievska, B; Bjorklund, A			Localized striatal delivery of GDNF as a treatment for Parkinson disease	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR GDNF; AGED RHESUS-MONKEYS; PARTIAL LESION MODEL; SUBSTANTIA-NIGRA; IN-VIVO; GENE-TRANSFER; FUNCTIONAL RECOVERY; GROWTH-FACTOR; INTRAPUTAMENAL INFUSION		Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden	Lund University	Kirik, D (corresponding author), Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, BMC A11, S-22184 Lund, Sweden.	Deniz.Kirik@mphy.lu.se	Björklund, Anders/ABA-1326-2020; Kirik, Deniz/E-5156-2011	Bjorklund, Anders/0000-0002-5676-6203				Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Costa S, 2001, EUR J PHARMACOL, V412, P45, DOI 10.1016/S0014-2999(00)00933-X; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Gash DM, 1995, J COMP NEUROL, V363, P345, DOI 10.1002/cne.903630302; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gerhardt GA, 1999, BRAIN RES, V817, P163, DOI 10.1016/S0006-8993(98)01244-X; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Grondin R, 2003, J NEUROSCI, V23, P1974; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hebert MA, 1996, J PHARMACOL EXP THER, V279, P1181; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1997, EXP NEUROL, V147, P130, DOI 10.1006/exnr.1997.6571; Horger BA, 1998, J NEUROSCI, V18, P4929; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Iravani MM, 2001, EUR J NEUROSCI, V13, P597, DOI 10.1046/j.1460-9568.2001.01408.x; Kearns CM, 1997, J NEUROSCI, V17, P7111; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kobayashi S, 1998, EXP NEUROL, V154, P302, DOI 10.1006/exnr.1998.6952; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lapchak PA, 1997, NEUROSCIENCE, V78, P61, DOI 10.1016/S0306-4522(97)83045-X; Mandel RJ, 1997, P NATL ACAD SCI USA, V94, P14083, DOI 10.1073/pnas.94.25.14083; Martin D, 1996, EUR J PHARMACOL, V317, P247, DOI 10.1016/S0014-2999(96)00756-X; Martin D, 1996, EUR J NEUROSCI, V8, P1249, DOI 10.1111/j.1460-9568.1996.tb01293.x; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; Miyoshi Y, 1997, ANN NEUROL, V42, P208, DOI 10.1002/ana.410420212; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Sullivan AM, 1998, EUR J NEUROSCI, V10, P57; Tuszynski MH, 2002, LANCET NEUROL, V1, P51, DOI 10.1016/S1474-4422(02)00006-6; Wang J, 2003, NEUROSIGNALS, V12, P78, DOI 10.1159/000071817; Winkler C, 1996, J NEUROSCI, V16, P7206; Yang F, 2001, NAT NEUROSCI, V4, P1071, DOI 10.1038/nn734; Zhang ZM, 1997, J PHARMACOL EXP THER, V282, P1396	49	226	247	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					105	110		10.1038/nn1175	http://dx.doi.org/10.1038/nn1175			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14747832				2022-12-28	WOS:000188468500006
J	Kerjan, G; Dolan, J; Haumaitre, C; Schneider-Maunoury, S; Fujisawa, H; Mitchell, KJ; Chedotal, A				Kerjan, G; Dolan, J; Haumaitre, C; Schneider-Maunoury, S; Fujisawa, H; Mitchell, KJ; Chedotal, A			The transmembrane semaphorin Sema6A controls cerebellar granule cell migration	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; MOUSE CEREBELLUM; GENE; PROLIFERATION; MECHANISMS; EXPRESSION; RECEPTORS; PATTERNS; CLONING; PROTEIN	The transmembrane semaphorin protein Sema6A is broadly expressed in the developing nervous system. Sema6A repels several classes of developing axons in vitro and contributes to thalamocortical axon guidance in vivo. Here we show that during cerebellum development, Sema6A is selectively expressed by postmitotic granule cells during their tangential migration in the deep external granule cell layer, but not during their radial migration. In Sema6A-deficient mice, many granule cells remain ectopic in the molecular layer where they differentiate and are contacted by mossy fibers. The analysis of ectopic granule cell morphology in Sema6a(-/-) mice, and of granule cell migration and neurite outgrowth in cerebellar explants, suggests that Sema6A controls the initiation of granule cell radial migration, probably through a modulation of nuclear and/or soma translocation. Finally, the analysis of mouse chimeras suggests that this function of Sema6A is primarily non-cell-autonomous.	Univ Paris 06, CNRS, UMR7102, F-75005 Paris, France; Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; Univ Paris 06, CNRS, UMR7622, F-75005 Paris, France; Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century Ctr Excellence Program,Chikusa Ku, Nagoya, Aichi 4648602, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Trinity College Dublin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Nagoya University	Chedotal, A (corresponding author), Univ Paris 06, CNRS, UMR7102, Case 12,9 Quai St Bernard, F-75005 Paris, France.	chedotal@infobiogen.fr	Haumaitre, Cecile/E-5455-2017; Schneider-Maunoury, Sylvie/K-6795-2017; Chedotal, Alain/F-2750-2017	Haumaitre, Cecile/0000-0003-3526-7832; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Chedotal, Alain/0000-0001-7577-3794; Mitchell, Kevin/0000-0002-3433-4530				AHN AH, 1994, DEVELOPMENT, V120, P2081; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; BERCIANO MT, 1988, BRAIN RES, V439, P169, DOI 10.1016/0006-8993(88)91473-4; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V139, P11; Fiore R, 2003, FRONT BIOSCI-LANDMRK, V8, pS484, DOI 10.2741/1080; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Hogan B, 1994, MANIPULATING MOUSE E; Jensen P, 2004, J NEUROSCI, V24, P2202, DOI 10.1523/JNEUROSCI.3427-03.2004; Kikuchi K, 1999, MOL CELL NEUROSCI, V13, P9, DOI 10.1006/mcne.1998.0732; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kyriakopoulou K, 2002, DEVELOPMENT, V129, P287; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; NUNES MLA, 1985, J COMP NEUROL, V237, P291, DOI 10.1002/cne.902370302; Nusser Z, 1998, J NEUROSCI, V18, P1693; Qu XH, 2002, J BIOL CHEM, V277, P35574, DOI 10.1074/jbc.M206451200; Rabacchi SA, 1999, J NEUROSCI, V19, P4437; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Sakagami H, 1999, EUR J NEUROSCI, V11, P2531, DOI 10.1046/j.1460-9568.1999.00675.x; SIEVERS J, 1985, J COMP NEUROL, V232, P319, DOI 10.1002/cne.902320305; Soha JM, 1997, J COMP NEUROL, V389, P642, DOI 10.1002/(SICI)1096-9861(19971229)389:4<642::AID-CNE7>3.0.CO;2-0; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; TOYOFUKU T, 2004, NAT CELL BIOL; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; Yacubova E, 2003, CELL BIOCHEM BIOPHYS, V37, P213; Yacubova E, 2002, J NEUROSCI, V22, P5966; Yu HH, 2000, GENETICS, V156, P723; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	50	104	108	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1516	1524		10.1038/nn1555	http://dx.doi.org/10.1038/nn1555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16205717				2022-12-28	WOS:000232966600026
J	Cathala, L; Holderith, NB; Nusser, Z; DiGregorio, DA; Cull-Candy, SG				Cathala, L; Holderith, NB; Nusser, Z; DiGregorio, DA; Cull-Candy, SG			Changes in synaptic structure underlie the developmental speeding of AMPA receptor-mediated EPSCs	NATURE NEUROSCIENCE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; CEREBELLAR PURKINJE-CELLS; MULTIPLE RELEASE SITES; TIME-COURSE; DENDRITIC SPINES; ADULT FORMS; MOSSY FIBER; DESENSITIZATION; RAT; CHANNELS	At many excitatory and inhibitory synapses throughout the nervous system, postsynaptic currents become faster as the synapse matures, primarily owing to changes in receptor subunit composition. The origin of the developmental acceleration of AMPA receptor (AMPAR)-mediated excitatory postsynaptic currents (EPSCs) remains elusive. We used patch-clamp recordings, electron microscopic immunogold localization of AMPARs, partial three-dimensional reconstruction of the neuropil and numerical simulations of glutamate diffusion and AMPAR activation to examine the factors underlying the developmental speeding of miniature EPSCs in mouse cerebellar granule cells. We found that the main developmental change that permits submillisecond transmission at mature synapses is an alteration in the glutamate concentration waveform as experienced by AMPARs. This can be accounted for by changes in the synaptic structure and surrounding neuropil, rather than by a change in AMPAR properties. Our findings raise the possibility that structural alterations could be a general mechanism underlying the change in the time course of AMPAR-mediated synaptic transmission.	UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Paris 05, CNRS, UMR 8118, F-75006 Paris, France; Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Cull-Candy, SG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	s.cull-candy@ucl.ac.uk	Nusser, Zoltan/K-8587-2014	Nusser, Zoltan/0000-0001-7004-4111; Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Koike M, 2000, J NEUROSCI, V20, P2166; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lawrence JJ, 2000, J NEUROSCI, V20, P4864; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Saftenku EE, 2005, J THEOR BIOL, V234, P363, DOI 10.1016/j.jtbi.2004.11.036; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Smith TC, 2000, J NEUROSCI, V20, P2073; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tia S, 1996, J NEUROSCI, V16, P3630; Wall MJ, 2002, EUR J NEUROSCI, V15, P785, DOI 10.1046/j.1460-9568.2002.01910.x; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Yamashita T, 2003, J NEUROSCI, V23, P3633	50	94	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1310	1318		10.1038/nn1534	http://dx.doi.org/10.1038/nn1534			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172604				2022-12-28	WOS:000232145900014
J	Guerrero, G; Reiff, DF; Agarwal, G; Ball, RW; Borst, A; Goodman, CS; Isacoff, EY				Guerrero, G; Reiff, DF; Agarwal, G; Ball, RW; Borst, A; Goodman, CS; Isacoff, EY			Heterogeneity in synaptic transmission along a Drosophila larval motor axon	NATURE NEUROSCIENCE			English	Article							RETROGRADE SIGNAL; QUANTAL SIZE; TRANSMITTER RELEASE; NERVE-TERMINALS; PYRAMIDAL CELLS; NEURAL ACTIVITY; FASCICLIN-II; RECEPTOR; SECRETION; SYNAPSES	At the Drosophila melanogaster larval neuromuscular junction (NMJ), a motor neuron releases glutamate from 30 - 100 boutons onto the muscle it innervates. How transmission strength is distributed among the boutons of the NMJ is unknown. To address this, we created synapcam, a version of the Ca2+ reporter Cameleon. Synapcam localizes to the postsynaptic terminal and selectively reports Ca2+ influx through glutamate receptors (GluRs) with single-impulse and single-bouton resolution. GluR-based Ca2+ signals were uniform within a given connection ( that is, a given bouton/postsynaptic terminal pair) but differed considerably among connections of an NMJ. A steep gradient of transmission strength was observed along axonal branches, from weak proximal connections to strong distal ones. Presynaptic imaging showed a matching axonal gradient, with higher Ca2+ influx and exocytosis at distal boutons. The results suggest that transmission strength is mainly determined presynaptically at the level of individual boutons, possibly by one or more factors existing in a gradient.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Max Planck Society; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 279 Life Sci Addit, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359; Guerrero, Giovanna/0000-0003-4931-8530; Agarwal, Gautam/0000-0001-7300-7586	NIMH NIH HHS [R01 MH060711] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ATWOOD HL, 1967, NATURE, V215, P57, DOI 10.1038/215057a0; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BENNETT MR, 1986, J PHYSIOL-LONDON, V379, P257, DOI 10.1113/jphysiol.1986.sp016252; BITTNER GD, 1968, J GEN PHYSIOL, V51, P731, DOI 10.1085/jgp.51.6.731; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Cooper RL, 1996, J COMP NEUROL, V375, P583; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Fetcho JR, 1997, CURR OPIN NEUROBIOL, V7, P832, DOI 10.1016/S0959-4388(97)80143-2; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; LAVIDIS NA, 1992, J PHYSIOL-LONDON, V454, P9, DOI 10.1113/jphysiol.1992.sp019252; Liu GS, 2003, CURR OPIN NEUROBIOL, V13, P324, DOI 10.1016/S0959-4388(03)00078-3; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Murthy VN, 1999, CURR OPIN NEUROBIOL, V9, P314, DOI 10.1016/S0959-4388(99)80046-4; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oertner TG, 2002, EXP PHYSIOL, V87, P733, DOI 10.1113/eph8702482; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Quigley PA, 1999, J NEUROPHYSIOL, V81, P356, DOI 10.1152/jn.1999.81.1.356; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Reiff DF, 2002, J NEUROSCI, V22, P9399; ROBITAILLE R, 1991, NEUROSCIENCE, V40, P571, DOI 10.1016/0306-4522(91)90142-B; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	49	77	78	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1188	1196		10.1038/nn1526	http://dx.doi.org/10.1038/nn1526			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116446	Green Accepted			2022-12-28	WOS:000231483800018
J	Wig, GS; Grafton, ST; Demos, KE; Kelley, WM				Wig, GS; Grafton, ST; Demos, KE; Kelley, WM			Reductions in neural activity underlie behavioral components of repetition priming	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; FUNCTIONAL MRI EVIDENCE; IMPLICIT MEMORY; CORTICAL ACTIVITY; TEMPORAL CORTEX; HUMAN BRAIN; FMRI; PET; SPECIFICITY; RETRIEVAL	Repetition priming is a nonconscious form of memory that is accompanied by reductions in neural activity when an experience is repeated. To date, however, there is no direct evidence that these neural reductions underlie the behavioral advantage afforded to repeated material. Here we demonstrate a causal linkage between neural and behavioral priming in humans. fMRI ( functional magnetic resonance imaging) was used in combination with transcranial magnetic stimulation (TMS) to target and disrupt activity in the left frontal cortex during repeated classification of objects. Left-frontal TMS disrupted both the neural and behavioral markers of priming. Neural priming in early sensory regions was unaffected by left-frontal TMS - a finding that provides evidence for separable conceptual and perceptual components of priming.	Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Wig, GS (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	gagan.wig@dartmouth.edu		Demos, Kathryn/0000-0002-8578-4312	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH064667] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64667] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; DEMB JB, 1995, J NEUROSCI, V15, P5870; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; FRISTON KJ, 1992, P ROY SOC B-BIOL SCI, V248, P223, DOI 10.1098/rspb.1992.0065; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Grafton ST, 1998, J NEUROSCI, V18, P9420; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; KARNI A, 1995, NATURE, V377, P155; KEANE MM, 1991, BEHAV NEUROSCI, V105, P326, DOI 10.1037/0735-7044.105.2.326; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; Maccotta L, 2004, J COGNITIVE NEUROSCI, V16, P1625, DOI 10.1162/0898929042568451; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Mier H, 1998, J NEUROPHYSIOL, V80, P2177, DOI 10.1152/jn.1998.80.4.2177; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	37	135	137	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1228	1233		10.1038/nn1515	http://dx.doi.org/10.1038/nn1515			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16056222				2022-12-28	WOS:000231483800023
J	Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA				Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA			Visual field maps and stimulus selectivity in human ventral occipital cortex	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; HUMAN OBJECT AREAS; HUMAN COLOR-CENTER; FUNCTIONAL MRI; ORGANIZATION; BRAIN; TOPOGRAPHY; PERCEPTION; FMRI	Human visual cortex is organized into distinct visual field maps whose locations and properties provide important information about visual computations. There are two conflicting models of the organization and computational role of ventral occipital visual field maps. We report new functional MRI measurements that test these models. We also present the first coordinated measurements of visual field maps and stimulus responsivity to color, objects and faces in ventral occipital cortex. These measurements support a model that includes a hemifield map, hV4, adjacent to the central field representation of ventral V3. In addition, the measurements demonstrate a cluster of visual field maps in ventral occipital cortex ( VO cluster) anterior to hV4. We describe the organization and stimulus responsivity of two new hemifield maps, VO-1 and VO-2, within this cluster. The maps and stimulus responsivity support a general organization of visual cortex based on clusters of maps that serve distinct computational functions.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Stanford University; Stanford University; The Smith-Kettlewell Eye Research Institute	Brewer, AA (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	alyssa.brewer@stanford.edu	Wade, Alex/B-5473-2010	Brewer, Alyssa/0000-0001-8820-1525; Wade, Alexander Robert/0000-0003-4871-2747; Liu, Junjie/0000-0001-5820-4266	NATIONAL EYE INSTITUTE [R01EY003164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY03164] Funding Source: Medline; NINDS NIH HHS [F30 NS044759, 5 F30 NS44759] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIZER JS, 1991, J NEUROSCI, V11, P168; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRAINARD DH, 1995, HDB OPTICAL SOC, V1; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Ejima Y, 2003, NEUROREPORT, V14, P1579, DOI 10.1097/00001756-200308260-00008; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Levy I, 2004, HUM BRAIN MAPP, V22, P15, DOI 10.1002/hbm.20010; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; MEADOWS JC, 1974, BRAIN, V97, P615, DOI 10.1093/brain/97.1.615; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Van Essen DC, 2003, VISUAL NEUROSCIENCES, V1, P507; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wandell B., 1995, FDN VISION; Wandell BA, 2002, P IEEE, V90, P5, DOI 10.1109/5.982401; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1999, PHILOS T R SOC B, V354, P1371, DOI 10.1098/rstb.1999.0485; Zeki S, 1998, NAT NEUROSCI, V1, P335, DOI 10.1038/1537	50	304	305	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1102	1109		10.1038/nn1507	http://dx.doi.org/10.1038/nn1507			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025108				2022-12-28	WOS:000230760200023
J	Dumont, EC; Mark, GP; Mader, S; Williams, JT				Dumont, EC; Mark, GP; Mader, S; Williams, JT			Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; DOPAMINE NEURONS; RATS; NORADRENALINE; PROJECTIONS; BEHAVIOR	Understanding the neurobiology of motivation might help in reducing compulsive behaviors such as drug addiction or eating disorders. This study shows that excitatory synaptic transmission was enhanced in the bed nucleus of the stria terminalis of rats that performed an operant task to obtain cocaine or palatable food. There was no effect when cocaine or food was delivered passively, suggesting that synaptic plasticity in this area is involved in reward-seeking behaviors.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Williams, JT (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	williamj@ohsu.edu			Canadian Institutes of Health Research [49878-1] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; PHILLIPSON OT, 1979, J COMP NEUROL, V187, P117, DOI 10.1002/cne.901870108; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Walker JR, 2000, BRAIN RES, V854, P85, DOI 10.1016/S0006-8993(99)02288-X	13	89	90	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					413	414		10.1038/nn1414	http://dx.doi.org/10.1038/nn1414			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15735642	Green Accepted			2022-12-28	WOS:000228040400008
J	Hofstetter, CP; Holmstrom, NAV; Lilja, JA; Schweinhardt, P; Hao, JX; Spenger, C; Wiesenfeld-Hallin, Z; Kurpad, SN; Frisen, J; Olson, L				Hofstetter, CP; Holmstrom, NAV; Lilja, JA; Schweinhardt, P; Hao, JX; Spenger, C; Wiesenfeld-Hallin, Z; Kurpad, SN; Frisen, J; Olson, L			Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; NERVE GROWTH-FACTOR; FUNCTIONAL RECOVERY; INTRACEREBROVENTRICULAR INFUSION; AXONAL GROWTH; BHLH GENES; RAT; TRANSPLANTATION; MYELIN; REPAIR	Several studies have reported functional improvement after transplantation of neural stem cells into injured spinal cord. We now provide evidence that grafting of adult neural stem cells into a rat thoracic spinal cord weight-drop injury improves motor recovery but also causes aberrant axonal sprouting associated with allodynia-like hypersensitivity of forepaws. Transduction of neural stem cells with neurogenin-2 before transplantation suppressed astrocytic differentiation of engrafted cells and prevented graft-induced sprouting and allodynia. Transcluction with neurogenin-2 also improved the positive effects of engrafted stem cells, including increased amounts of myelin in the injured area, recovery of hindlimb locomotor function and hindlimb sensory responses, as determined by functional magnetic resonance imaging. These findings show that stem cell transplantation into injured spinal cord can cause severe side effects and call for caution in the consideration of clinical trials.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Div Clin Neurophysiol, S-17177 Stockholm, Sweden; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 1QX, England; Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Oxford; Medical College of Wisconsin	Hofstetter, CP (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	christoph.hofstetter@neuro.ki.se	Kurpad, Shekar/V-2188-2019; Schweinhardt, Petra/AAC-6797-2021	Schweinhardt, Petra/0000-0003-4837-6595				Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bennett AD, 2000, PAIN, V86, P163, DOI 10.1016/S0304-3959(00)00242-6; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brown A, 2004, EXP NEUROL, V188, P115, DOI 10.1016/j.expneurol.2004.03.017; Bunge R P, 1997, Adv Neurol, V72, P305; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Cajal S., 1928, DEGENERATION REGENER; Christensen MD, 1997, EXP NEUROL, V147, P463, DOI 10.1006/exnr.1997.6608; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hao JX, 2000, NEUROSCI LETT, V286, P208, DOI 10.1016/S0304-3940(00)01107-1; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hofstetter CP, 2003, EUR J NEUROSCI, V18, P3061, DOI 10.1111/j.1460-9568.2003.03062.x; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Jubran M, 2003, EXP NEUROL, V181, P204, DOI 10.1016/S0014-4886(03)00041-4; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Spenger C, 2000, EXP NEUROL, V166, P246, DOI 10.1006/exnr.2000.7524; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; UTZSCHNEIDER DA, 1994, P NATL ACAD SCI USA, V91, P53, DOI 10.1073/pnas.91.1.53; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	48	489	509	4	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					346	353		10.1038/nn1405	http://dx.doi.org/10.1038/nn1405			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711542				2022-12-28	WOS:000227354600020
J	Pegan, S; Arrabit, C; Zhou, W; Kwiatkowski, W; Collins, A; Slesinger, PA; Choe, S				Pegan, S; Arrabit, C; Zhou, W; Kwiatkowski, W; Collins, A; Slesinger, PA; Choe, S			Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification	NATURE NEUROSCIENCE			English	Article							RECTIFIER K+ CHANNELS; INWARD-RECTIFIER; POTASSIUM CHANNEL; ANDERSENS-SYNDROME; INTRACELLULAR VESTIBULE; SELECTIVITY FILTER; C-TERMINUS; PORE; PERMEATION; MECHANISM	N- and C-terminal cytoplasmic domains of inwardly rectifying K (Kir) channels control the ion-permeation pathway through diverse interactions with small molecules and protein ligands in the cytoplasm. Two new crystal structures of the cytoplasmic domains of Kir2.1 (Kir2.1(L)) and the G protein-sensitive Kir3.1 (Kir3.1(S)) channels in the absence of PIP2 show the cytoplasmic ion-permeation pathways occluded by four cytoplasmic loops that form a girdle around the central pore (G-loop). Significant flexibility of the pore-facing G-loop of Kir2.1(L) and Kir3.1(S) suggests a possible role as a diffusion barrier between cytoplasmic and transmembrane pores. Consistent with this, mutations of the G-loop disrupted gating or inward rectification. Structural comparison shows a di-aspartate cluster on the distal end of the cytoplasmic pore of Kir2.1(L) that is important for modulating inward rectification. Taken together, these results suggest the cytoplasmic domains of Kir channels undergo structural changes to modulate gating and inward rectification.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	Salk Institute; Salk Institute; Oregon State University	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu; choe@salk.edu						Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Chang HK, 2005, BIOPHYS J, V88, P243, DOI 10.1529/biophysj.104.052217; Chen L, 2002, P NATL ACAD SCI USA, V99, P8430, DOI 10.1073/pnas.122682899; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; Doring F, 1998, J NEUROSCI, V18, P8625; Fakler B, 1996, PFLUG ARCH EUR J PHY, V433, P77, DOI 10.1007/s004240050251; Garneau L, 2003, BIOPHYS J, V84, P3717, DOI 10.1016/S0006-3495(03)75100-5; Guo Y, 2002, J BIOL CHEM, V277, P48289, DOI 10.1074/jbc.M207987200; Hilgemann Donald W., 1995, P307; Hosaka Y, 2003, J MOL CELL CARDIOL, V35, P409, DOI 10.1016/S0022-2828(03)00046-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 1999, J NEUROSCI, V19, P1006; Ishihara K, 2004, J PHYSIOL-LONDON, V556, P61, DOI 10.1113/jphysiol.2003.055434; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; John SA, 2004, J GEN PHYSIOL, V123, P623, DOI 10.1085/jgp.200409017; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; SIESINGER PA, 1996, NEURON, V16, P321; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	50	225	234	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					279	287		10.1038/nn1411	http://dx.doi.org/10.1038/nn1411			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723059				2022-12-28	WOS:000227354600012
J	Harris, JM; Drga, VF				Harris, JM; Drga, VF			Using visual direction in three-dimensional motion perception	NATURE NEUROSCIENCE			English	Article							IN-DEPTH; OPTIC FLOW; LOCOMOTION; PRECISION; GUIDANCE; TARGET; FOOT	The eyes receive slightly different views of the world, and the differences between their images (binocular disparity) are used to see depth. Several authors have suggested how the brain could exploit this information for three-dimensional (3D) motion perception, but here we consider a simpler strategy. Visual direction is the angle between the direction of an object and the direction that an observer faces. Here we describe human behavioral experiments in which observers use visual direction, rather than binocular information, to estimate an object's 3D motion even though this causes them to make systematic errors. This suggests that recent models of binocular 3D motion perception may not reflect the strategies that human observers actually use.	Univ St Andrews, St Marys Coll, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland; Newcastle Univ, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of St Andrews; Newcastle University - UK	Harris, JM (corresponding author), Univ St Andrews, St Marys Coll, Sch Psychol, South St, St Andrews KY16 9JP, Fife, Scotland.	Julie.Harris@st-andrews.ac.uk		Harris, Julie/0000-0002-3497-4503	Engineering and Physical Sciences Research Council [GR/S62697/01, GR/A10734/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BEVERLEY KI, 1975, J PHYSIOL-LONDON, V249, P387, DOI 10.1113/jphysiol.1975.sp011021; Brooks KR, 2002, J VISION, V2, DOI 10.1167/2.3.2; Chardenon A, 2004, EXP BRAIN RES, V158, P100, DOI 10.1007/s00221-004-1880-7; CUMMING BG, 1994, VISION RES, V34, P483, DOI 10.1016/0042-6989(94)90162-7; Fajen BR, 2004, PERCEPTION, V33, P689, DOI 10.1068/p5236; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Harris JM, 2002, VISION RES, V42, P1619, DOI 10.1016/S0042-6989(02)00066-4; Harris JM, 2003, J EXP PSYCHOL HUMAN, V29, P869, DOI 10.1037/0096-1523.29.5.869; HOWARD IP, 2002, DEPTH PERCEPTION SEE, V2; MCKEE SP, 1992, VISION RES, V32, P1447, DOI 10.1016/0042-6989(92)90201-S; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1993, VISION RES, V33, P2359, DOI 10.1016/0042-6989(93)90114-C; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Welchman AE, 2004, VISION RES, V44, P2027, DOI 10.1016/j.visres.2004.03.014; WESTHEIMER G, 1979, INVEST OPHTH VIS SCI, V18, P893; Wilkie RM, 2002, CURR BIOL, V12, P2014, DOI 10.1016/S0960-9822(02)01337-4	18	38	39	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					229	233		10.1038/nn1389	http://dx.doi.org/10.1038/nn1389			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	892GN	15665878				2022-12-28	WOS:000226638200023
J	Corl, AB; Rodan, AR; Heberlein, U				Corl, AB; Rodan, AR; Heberlein, U			Insulin signaling in the nervous system regulates ethanol intoxication in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							PHENOTYPES; RECEPTOR; GROWTH; CELL; SENSITIVITY; HOMOLOG; SIZE	The insulin signaling pathway regulates multiple physiological processes, including energy metabolism, organismal growth, aging and reproduction. Here we show that genetic manipulations in Drosophila melanogaster that impair the function of insulin-producing cells or of the insulin-receptor signaling pathway in the nervous system lead to increased sensitivity to the intoxicating effects of ethanol. These findings suggest a previously unknown role for this highly conserved pathway in regulating the behavioral responses to an addictive drug.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Heberlein, U (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	ulrike@itsa.ucsf.edu		Rodan, Aylin/0000-0001-9202-2378	NIAAA NIH HHS [AA10035, AA13105] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013105, R01AA010035] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Figlewicz Dianne P, 2003, Semin Clin Neuropsychiatry, V8, P82, DOI 10.1053/scnp.2003.50012; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	14	72	73	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					18	19		10.1038/nn1363	http://dx.doi.org/10.1038/nn1363			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592467				2022-12-28	WOS:000225967600008
J	Yeo, GSH; Hung, CCC; Rochford, J; Keogh, J; Gray, J; Sivaramakrishnan, S; O'Rahilly, S; Farooqi, IS				Yeo, GSH; Hung, CCC; Rochford, J; Keogh, J; Gray, J; Sivaramakrishnan, S; O'Rahilly, S; Farooqi, IS			A de novo mutation affecting human TrkB associated with severe obesity and developmental delay	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; RECEPTOR GENE; MELANOCORTIN-4 RECEPTOR; AUTOPHOSPHORYLATION; ROLES; MICE; BDNF	An 8-year-old male with a complex developmental syndrome and severe obesity was heterozygous for a de novo missense mutation resulting in a Y722C substitution in the neurotrophin receptor TrkB. This mutation markedly impaired receptor autophosphorylation and signaling to MAP kinase. Mutation of NTRK2, which encodes TrkB, seems to result in a unique human syndrome of hyperphagic obesity. The associated impairment in memory, learning and nociception seen in the proband reflects the crucial role of TrkB in the human nervous system.	Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2XY, England; Castleford & Normanton Dist Hosp, Castleford WF10 5LT, Yorks, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2XY, England.	sorahill@hgmp.mrc.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Yeo, Giles See How/0000-0001-8823-3615; Farooqi, Sadaf/0000-0001-7609-3504; Rochford, Justin/0000-0002-5020-4939	Wellcome Trust [068086] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elliot C. D., 1996, BRIT ABILITY SCALES, V2; Erickson JT, 1996, J NEUROSCI, V16, P5361; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GUITON M, 1994, J BIOL CHEM, V269, P30370; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; McCarty JH, 1998, ONCOGENE, V16, P1691, DOI 10.1038/sj.onc.1201688; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	15	387	402	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1187	1189		10.1038/nn1336	http://dx.doi.org/10.1038/nn1336			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494731				2022-12-28	WOS:000224749400009
J	Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO				Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO			The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED MOTOR INCOORDINATION; ADENOSINE A(2A) RECEPTORS; RAT NUCLEUS-ACCUMBENS; EXTRACELLULAR ADENOSINE; PRESYNAPTIC INHIBITION; SEEKING BEHAVIOR; PROTEIN-KINASE; CALCIUM INFLUX; A(1) RECEPTORS	Adenosine is an important mediator of ethanol intoxication. In vitro, ethanol stimulates adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chronic ethanol exposure downregulates ENT1. It is not known, however, whether ENT1 is important for ethanol intoxication or consumption in vivo. Here we report that ENT1-null mice show reduced hypnotic and ataxic responses to ethanol and greater consumption of alcohol as compared with their wild-type littermates. These features are associated with a decrease in adenosine tone, as measured indirectly as a reduction in A(1)receptor- mediated inhibition of glutamate excitatory postsynaptic currents (EPSCs) in the nucleus accumbens, leading to increased phosphorylation of CRE-binding protein (CREB) in the striatum. Treatment with an A(1) receptor agonist decreases EPSC amplitude and reduces ethanol consumption in ENT1-null mice. Our results indicate that ENT1 has a physiological role in ethanol-mediated behaviors and suggest that decreased A(1) adenosine receptor function promotes alcohol consumption.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	romes@itsa.ucsf.edu	Messing, Robert/D-3642-2015; Choi, Doo-Sup/G-9474-2012	Messing, Robert/0000-0002-5345-4431; Choi, Doo-Sup/0000-0002-6796-9938	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013588, R37AA013588] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA013588] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anderson CM, 1999, J NEUROCHEM, V73, P867, DOI 10.1046/j.1471-4159.1999.0730867.x; Backstrom P, 2004, ALCOHOL CLIN EXP RES, V28, P558, DOI 10.1097/01.ALC.0000122101.13164.21; Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bowers BJ, 2000, ALCOHOL RES HEALTH, V24, P175; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Choi DS, 2002, J NEUROSCI, V22, P9905; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Dar MS, 2001, BRAIN RES BULL, V55, P513, DOI 10.1016/S0361-9230(01)00552-4; Dar MS, 1997, BRAIN RES, V749, P263, DOI 10.1016/S0006-8993(96)01263-2; Diao LH, 1996, J PHARMACOL EXP THER, V278, P542; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; El Yacoubi M, 2000, PSYCHOPHARMACOLOGY, V148, P153; Florio C, 1998, PSYCHOPHARMACOLOGY, V136, P311, DOI 10.1007/s002130050572; GEIGER JD, 1984, BRAIN RES BULL, V13, P657, DOI 10.1016/0361-9230(84)90198-9; Harvey J, 1997, J NEUROSCI, V17, P5271; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Jennings LL, 2001, NEUROPHARMACOLOGY, V40, P722, DOI 10.1016/S0028-3908(00)00207-0; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marston HM, 1998, J PHARMACOL EXP THER, V285, P1023; Naassila M, 2002, J NEUROSCI, V22, P10487; Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; SANDERSON G, 1986, PFLUG ARCH EUR J PHY, V406, P25, DOI 10.1007/BF00582948; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; Schuckit MA, 1998, J STUD ALCOHOL, V59, P485, DOI 10.15288/jsa.1998.59.485; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2	39	191	197	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					855	861		10.1038/nn1288	http://dx.doi.org/10.1038/nn1288			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258586				2022-12-28	WOS:000222930800016
J	Karnezis, T; Mandemakers, W; McQualter, JL; Zheng, BH; Ho, PP; Jordan, KA; Murray, BM; Barres, B; Tessier-Lavigne, M; Bernard, CCA				Karnezis, T; Mandemakers, W; McQualter, JL; Zheng, BH; Ho, PP; Jordan, KA; Murray, BM; Barres, B; Tessier-Lavigne, M; Bernard, CCA			The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ADULT-RAT; AXON REGENERATION; FUNCTIONAL RECOVERY; BRAIN-LESIONS; T-CELLS	Inhibitors associated with CNS myelin are thought to be important in the failure of axons to regenerate after spinal cord injury and in other neurodegenerative disorders. Here we show that targeting the CNS-specific inhibitor of neurite outgrowth Nogo A by active immunization blunts clinical signs, demyelination and axonal damage associated with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS). Mice vaccinated against Nogo A produce Nogo-specific antibodies that block the neurite outgrowth inhibitory activity associated with CNS myelin in vitro. Passive immunization with anti-Nogo IgGs also suppresses EAE. Our results identify Nogo A as an important determinant of the development of EAE and suggest that its blockade may help to maintain and/or to restore the neuronal integrity of the CNS after autoimmune insult in diseases such as MS. Our finding that Nogo A is involved in CNS autoimmune demyelination indicates that this molecule may have a far more complex role than has been previously anticipated.	La Trobe Univ, Sch Mol Sci, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3086, Australia; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	La Trobe University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Bernard, CCA (corresponding author), La Trobe Univ, Sch Mol Sci, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3086, Australia.	c.bernard@latrobe.edu.au	Murray, Belinda/B-9426-2008	Mandemakers, Wim/0000-0003-2673-5972; McQualter, Jonathan/0000-0002-3844-8009; /0000-0002-6848-318X	NEI NIH HHS [R01 EY10257] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; ACHIRON A, 1994, J CLIN INVEST, V93, P600, DOI 10.1172/JCI117012; Ahmed Z, 2001, AM J PATHOL, V158, P2127, DOI 10.1016/S0002-9440(10)64684-6; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; Baranzini SE, 1999, J IMMUNOL, V163, P5133; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buffo A, 2000, J NEUROSCI, V20, P2275; Buffo A, 2003, EUR J NEUROSCI, V18, P2146, DOI 10.1046/j.1460-9568.2003.02940.x; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; LININGTON C, 1992, J NEUROIMMUNOL, V40, P219, DOI 10.1016/0165-5728(92)90136-9; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Merkler D, 2003, FASEB J, V17, P2275, DOI 10.1096/fj.02-1203fje; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Miller DJ, 1997, J NEUROIMMUNOL, V75, P204, DOI 10.1016/S0165-5728(97)00027-1; MISTUNAGA Y, 2002, FASEB J, V16, P1325; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Okuda Y, 2002, J NEUROIMMUNOL, V131, P115, DOI 10.1016/S0165-5728(02)00267-9; Onuki I, 2001, MICROSC RES TECHNIQ, V52, P731; Reindl M, 2003, J NEUROIMMUNOL, V145, P139, DOI 10.1016/j.jneuroim.2003.09.010; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	50	190	222	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					736	744		10.1038/nn1261	http://dx.doi.org/10.1038/nn1261			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184901				2022-12-28	WOS:000222274400015
J	Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME				Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME			The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; C3-C5 PROPRIOSPINAL NEURONS; PSEUDORABIES VIRUS; MOTOR CORTEX; CAT; PLASTICITY; RECOVERY; ORGANIZATION; LESIONS; AXONS	In contrast to peripheral nerves, central axons do not regenerate. Partial injuries to the spinal cord, however, are followed by functional recovery. We investigated the anatomical basis of this recovery and found that after incomplete spinal cord injury in rats, transected hindlimb corticospinal tract (CST) axons sprouted into the cervical gray matter to contact short and long propriospinal neurons (PSNs). Over 12 weeks, contacts with long PSNs that bridged the lesion were maintained, whereas contacts with short PSNs that did not bridge the lesion were lost. In turn, long PSNs arborize on lumbar motor neurons, creating a new intraspinal circuit relaying cortical input to its original spinal targets. We confirmed the functionality of this circuit by electrophysiological and behavioral testing before and after CST re-lesion. Retrograde transynaptic tracing confirmed its integrity, and revealed changes of cortical representation. Hence, after incomplete spinal cord injury, spontaneous extensive remodeling occurs, based on axonal sprout formation and removal. Such remodeling may be crucial for rehabilitation in humans.	Univ Zurich, Inst Brain Res, Dept Neuromorphol, CH-8057 Zurich, Switzerland; ETH, Dept Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Brain Res, Dept Neurophysiol, CH-8057 Zurich, Switzerland; Fed Res Ctr Virus Dis Anim, Friedrich Loeffler Inst, Inst Mol & Cellular Virol, D-17498 Insel Riems, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Friedrich Loeffler Institute	Bareyre, FM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Box 8108, St Louis, MO USA.	florence@pcg.wustl.edu	Raineteau, Olivier/I-1190-2014; Schwab, Martin E/B-6818-2016; Mettenleiter, h. c. Thomas C./U-1016-2019	Raineteau, Olivier/0000-0003-4294-2496; 				ALSTERMARK B, 1987, BRAIN RES, V404, P382, DOI 10.1016/0006-8993(87)91400-4; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1990, NEUROSCI RES, V8, P131, DOI 10.1016/0168-0102(90)90065-M; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P291, DOI 10.1016/0304-3940(87)90312-0; AOKI M, 1986, Neuroscience Research, V3, P617, DOI 10.1016/0168-0102(86)90058-1; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; CARD JP, 1990, J NEUROSCI, V10, P1974; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen R, 1998, J NEUROSCI, V18, P3443; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; DERYCK M, 1992, BRAIN RES, V573, P44; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GIOVANELLIBARIL.M, 1969, BRAIN RES, V14, P321; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Holaday J W, 1983, Adv Shock Res, V10, P95; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JANKOWSKA E, 1973, BRAIN RES, V53, P227, DOI 10.1016/0006-8993(73)90786-5; JANKOWSKA E, 1974, EXP BRAIN RES, V21, P169; Jankowska E, 2002, BRAIN RES REV, V40, P19, DOI 10.1016/S0165-0173(02)00185-6; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LI WWY, 1994, NEUROSCIENCE, V61, P133, DOI 10.1016/0306-4522(94)90066-3; MARIANI J, 1983, PROG BRAIN RES, V58, P383, DOI 10.1016/S0079-6123(08)60041-2; MASSON RL, 1991, J COMP NEUROL, V307, P120, DOI 10.1002/cne.903070111; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MILLER S, 1973, J PHYSIOL-LONDON, V230, pP30; MURRAY M, 1974, J COMP NEUROL, V158, P19, DOI 10.1002/cne.901580103; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Pettersson LG, 1997, NEUROSCI RES, V29, P241, DOI 10.1016/S0168-0102(97)00093-X; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rossignol S, 1999, PROG BRAIN RES, V123, P349, DOI 10.1016/S0079-6123(08)62870-8; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; STRACK AM, 1989, BRAIN RES, V491, P274, DOI 10.1016/0006-8993(89)90063-2; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	50	818	840	3	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					269	277		10.1038/nn1195	http://dx.doi.org/10.1038/nn1195			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966523				2022-12-28	WOS:000189197900017
J	Richardson, MP; Strange, BA; Dolan, RJ				Richardson, MP; Strange, BA; Dolan, RJ			Encoding of emotional memories depends on amygdala and hippocampus and their interactions	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; DECLARATIVE MEMORY; FUNCTIONAL MRI; T2 RELAXATION; FREE-RECALL; LONG-TERM; RAT; PROJECTIONS; SCLEROSIS; NEUROPATHOLOGY	We have studied patients with variable degrees of left hippocampal and amygdala pathology who performed a verbal encoding task during functional magnetic resonance imaging (fMRI) to assess the impact of pathology on emotional-memory performance and encoding-evoked activity. The severity of left hippocampal pathology predicted memory performance for neutral and emotional items alike, whereas the severity of amygdala pathology predicted memory performance for emotional items alone. Encoding-related hippocampal activity for successfully remembered emotional items correlated with the degree of left amygdala pathology. Conversely, amygdala-evoked activity with respect to subsequently remembered emotional items correlated with the degree of left hippocampal pathology. Our data indicate a reciprocal dependence between amygdala and hippocampus during the encoding of emotional memories.	Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Richardson, MP (corresponding author), Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	m.richardson@ion.ucl.ac.uk	Strange, Bryan A/L-9466-2014; Richardson, Mark P/E-5385-2010; Strange, Bryan/AAF-3805-2019	Strange, Bryan A/0000-0001-6476-4091; Richardson, Mark P/0000-0001-8925-3140; Strange, Bryan/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartlett PA, 2002, J NEUROL NEUROSUR PS, V73, P753, DOI 10.1136/jnnp.73.6.753; Bellgowan PSF, 1998, NEUROLOGY, V51, P479, DOI 10.1212/WNL.51.2.479; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; DUNCAN JS, 1997, BRAIN, V120, P376; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Helmstaedter C, 2001, CURR OPIN NEUROL, V14, P211, DOI 10.1097/00019052-200104000-00013; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; Kalviainen R, 1997, NEUROLOGY, V48, P286, DOI 10.1212/WNL.48.1.286; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; KRETTEK JE, 1977, J COMP NEUROL, V172, P723, DOI 10.1002/cne.901720409; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; MAREN S, 1995, J NEUROSCI, V15, P7548; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VanPaesschen W, 1995, NEUROLOGY, V45, P2233; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656	44	354	369	1	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					278	285		10.1038/nn1190	http://dx.doi.org/10.1038/nn1190			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758364	Green Published			2022-12-28	WOS:000189197900018
J	Dapretto, M; Davies, MS; Pfeifer, JH; Scott, AA; Sigman, M; Bookheimer, SY; Iacoboni, M				Dapretto, M; Davies, MS; Pfeifer, JH; Scott, AA; Sigman, M; Bookheimer, SY; Iacoboni, M			Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders	NATURE NEUROSCIENCE			English	Article							IMITATION; INDIVIDUALS; ACTIVATION; MECHANISMS; EMPATHY; FACES	To examine mirror neuron abnormalities in autism, high-functioning children with autism and matched controls underwent fMRI while imitating and observing emotional expressions. Although both groups performed the tasks equally well, children with autism showed no mirror neuron activity in the inferior frontal gyrus (pars opercularis). Notably, activity in this area was inversely related to symptom severity in the social domain, suggesting that a dysfunctional 'mirror neuron system' may underlie the social deficits observed in autism.	Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Dapretto, M (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	mirella@loni.ucla.edu		Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [RR13642, P41 RR013642, RR08655, C06 RR012169] Funding Source: Medline; NICHD NIH HHS [P01 HD035470, P50 HD055784] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, P41RR013642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	15	1019	1057	11	615	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					28	30		10.1038/nn1611	http://dx.doi.org/10.1038/nn1611			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327784	Green Accepted			2022-12-28	WOS:000234288000014
J	Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J				Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J			K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons	NATURE NEUROSCIENCE			English	Article							SENSITIVE POTASSIUM CHANNELS; PARKINSONS-DISEASE; MOUSE MODEL; UNCOUPLING PROTEIN-2; SUBSTANTIA-NIGRA; GENE-EXPRESSION; PROTECTIVE ROLE; DEFICIENT MICE; MECHANISMS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	The selective degeneration of dopaminergic (DA) midbrain neurons in the substantia nigra (SN) is a hallmark of Parkinson disease. DA neurons in the neighboring ventral tegmental area (VTA) are significantly less affected. The mechanisms for this differential vulnerability of DA neurons are unknown. We identified selective activation of ATP-sensitive potassium (K-ATP) channels as a potential mechanism. We show that in response to parkinsonism-inducing toxins, electrophysiological activity of SN DA neurons, but not VTA DA neurons, is lost owing to activation of K-ATP channels. This selective K-ATP channel activation is controlled by differences in mitochondrial uncoupling between SN and VTA DA neurons. Genetic inactivation of the K-ATP channel pore-forming subunit Kir6.2 resulted in a selective rescue of SN but not VTA DA neurons in two mechanistically distinct mouse models of dopaminergic degeneration, the neurotoxicological 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine ( MPTP) model and the mutant weaver mouse. Thus, K-ATP channel activation has an unexpected role in promoting death of DA neurons in chronic disease.	Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England; Univ Grad Sch Med, Kobe, Hyogo 6500017, Japan	Philipps University Marburg; University of Oxford; University of Oxford	Liss, B (corresponding author), Univ Marburg, Dept Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	birgit.liss@staff.uni-marburg.de	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Roeper, Jochen/0000-0003-2145-8742; liss, Birgit/0000-0002-6733-9207				ALBURGES ME, 1993, SYNAPSE, V14, P314, DOI 10.1002/syn.890140409; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; Avshalumov MV, 2005, J NEUROSCI, V25, P4222, DOI 10.1523/JNEUROSCI.4701-04.2005; Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Hernandez-Sanchez C, 2001, P NATL ACAD SCI USA, V98, P3549, DOI 10.1073/pnas.051012898; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; JIANG C, 1994, J NEUROSCI, V14, P5590; Keuker JIH, 2001, BRAIN RES PROTOC, V7, P211, DOI 10.1016/S1385-299X(01)00064-2; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liss B, 2001, MOL MEMBR BIOL, V18, P117; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 2004, TRENDS NEUROSCI, V27, P475, DOI 10.1016/j.tins.2004.06.007; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; MERCURI NB, 1994, J NEUROPHYSIOL, V71, P1165, DOI 10.1152/jn.1994.71.3.1165; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; MORATALLA R, 1992, P NATL ACAD SCI USA, V89, P3859, DOI 10.1073/pnas.89.9.3859; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schapira AHV, 2001, ADV NEUROL, V86, P155; Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	49	219	233	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1742	1751		10.1038/nn1570	http://dx.doi.org/10.1038/nn1570			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299504				2022-12-28	WOS:000233576200024
J	Singer, O; Marr, RA; Rockenstein, E; Crews, L; Coufal, NG; Gage, FH; Verma, IM; Masliah, E				Singer, O; Marr, RA; Rockenstein, E; Crews, L; Coufal, NG; Gage, FH; Verma, IM; Masliah, E			Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; BETA-SECRETASE ACTIVITY; IN-VIVO; RNA INTERFERENCE; LENTIVIRAL VECTOR; CLEAVING ENZYME; MICE; BRAIN; EXPRESSION	In Alzheimer disease, increased beta-secretase (BACE1) activity has been associated with neurodegeneration and accumulation of amyloid precursor protein (APP) products. Thus, inactivation of BACE1 could be important in the treatment of Alzheimer disease. In this study, we found that lowering BACE1 levels using lentiviral vectors expressing siRNAs targeting BACE1 reduced amyloid production and the neurodegenerative and behavioral deficits in APP transgenic mice, a model of Alzheimer disease. Our results suggest that lentiviral vector delivery of BACE1 siRNA can specifically reduce the cleavage of APP and neurodegeneration in vivo and indicate that this approach could have potential therapeutic value for treatment of Alzheimer disease.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	verma@salk.edu; emasliah@ucsd.edu	Coufal, Nicole/ABA-9471-2021; Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Coufal, Nicole/0000-0001-6547-1733	NATIONAL INSTITUTE ON AGING [R37AG008514, R01AG008514, P01AG010435, R01AG018440, R37AG018440, P50AG005131] Funding Source: NIH RePORTER; NIA NIH HHS [AG18440, AG10435, AG08514, AG5131] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Citron M, 2002, NEUROBIOL AGING, V23, P1017, DOI 10.1016/S0197-4580(02)00122-7; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Dingwall C, 2001, J CLIN INVEST, V108, P1243, DOI 10.1172/JCI200114402; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HS, 1998, NEUROREPORT, V9, P3875, DOI 10.1097/00001756-199812010-00020; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2003, NEUROLOGY, V61, P206, DOI 10.1212/01.WNL.0000073987.79060.4B; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; ROCKENSTEIN E, 2005, J BIOL CHEM     0715; Rossner S, 2001, J NEUROSCI RES, V64, P437; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 2000, ANN NY ACAD SCI, V920, P206; Song DK, 1998, J NEUROCHEM, V71, P875; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tuszynski MH, 2003, EXPERT OPIN BIOL TH, V3, P815, DOI 10.1517/eobt.3.5.815.21228; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076	49	318	416	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1343	1349		10.1038/nn1531	http://dx.doi.org/10.1038/nn1531			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136043				2022-12-28	WOS:000232145900018
J	Meng, M; Remus, DA; Tong, F				Meng, M; Remus, DA; Tong, F			Filling-in of visual phantoms in the human brain	NATURE NEUROSCIENCE			English	Article							BLIND-SPOT; BINOCULAR-RIVALRY; PERCEPTUAL COMPLETION; FUNCTIONAL MRI; CORTEX; RESPONSES; REPRESENTATION; AWARENESS; V1; REORGANIZATION	The constructive nature of perception can be demonstrated under viewing conditions that lead to vivid subjective impressions in the absence of direct input. When a low-contrast moving grating is divided by a large gap, observers report seeing a 'visual phantom' of the real grating extending through the blank gap region. Here, we report fMRI evidence showing that visual phantoms lead to enhanced activity in early visual areas that specifically represent the blank gap region. We found that neural filling-in effects occurred automatically in areas V1 and V2, regardless of where the subject attended. Moreover, when phantom-inducing gratings were paired with competing stimuli in a binocular rivalry display, subjects reported spontaneous fluctuations in conscious perception of the phantom accompanied by tightly coupled changes in early visual activity. Our results indicate that phantom visual experiences are closely linked to automatic filling-in of activity at the earliest stages of cortical processing.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Princeton University; Vanderbilt University	Meng, M (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	mmeng@mit.edu	Meng, Ming/A-5829-2008		NEI NIH HHS [R01 EY014202, R01 EY14202] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014202] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angelucci A, 2002, J NEUROSCI, V22, P8633; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DURGIN FH, 1995, PERCEPTION, V24, P827, DOI 10.1068/p240827; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GYOBA J, 1994, VISION RES, V34, P1001, DOI 10.1016/0042-6989(94)90004-3; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Komatsu H, 2000, J NEUROSCI, V20, P9310; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Levelt WJM, 1965, BINOCULAR RIVALRY; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; RAMACHANDRAN VS, 1992, NATURE, V356, P115, DOI 10.1038/356115a0; RAMACHANDRAN VS, 1995, PERCEPTION, V24, P841, DOI 10.1068/p240841; Rauschenberger R, 2001, NATURE, V410, P369, DOI 10.1038/35066577; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; TYNAN P, 1975, SCIENCE, V188, P951, DOI 10.1126/science.1138365; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WEISSTEIN N, 1977, SCIENCE, V198, P955, DOI 10.1126/science.929181	43	95	95	1	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1248	1254		10.1038/nn1518	http://dx.doi.org/10.1038/nn1518			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116454	Green Accepted			2022-12-28	WOS:000231483800026
J	Schneider, P; Sluming, V; Roberts, N; Scherg, M; Goebel, R; Specht, HJ; Dosch, HG; Bleeck, S; Stippich, C; Rupp, A				Schneider, P; Sluming, V; Roberts, N; Scherg, M; Goebel, R; Specht, HJ; Dosch, HG; Bleeck, S; Stippich, C; Rupp, A			Structural and functional asymmetry of lateral Heschl's gyrus reflects pitch perception preference	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; HUMAN BRAIN; TEMPORAL REGULARITY; VOLUME MEASUREMENT; MUSICIANS; RESONANCE; REPRESENTATION; ORGANIZATION; SOUND; MORPHOMETRY	The relative pitch of harmonic complex sounds, such as instrumental sounds, may be perceived by decoding either the fundamental pitch (f(0)) or the spectral pitch (f(SP)) of the stimuli. We classified a large cohort of 420 subjects including symphony orchestra musicians to be either f(0) or fSP listeners, depending on the dominant perceptual mode. In a subgroup of 87 subjects, MRI ( magnetic resonance imaging) and magnetoencephalography studies demonstrated a strong neural basis for both types of pitch perception irrespective of musical aptitude. Compared with f(0) listeners, fSP listeners possessed a pronounced rightward, rather than leftward, asymmetry of gray matter volume and P50m activity within the pitch-sensitive lateral Heschl's gyrus. Our data link relative hemispheric lateralization with perceptual stimulus properties, whereas the absolute size of the Heschl's gyrus depends on musical aptitude.	Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany; Univ Liverpool, Sch Hlth Sci, Div Med Imaging, Liverpool L69 3GB, Merseyside, England; Univ Liverpool, MARIARC, Liverpool L69 3BX, Merseyside, England; Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Heidelberg, Dept Phys, D-69120 Heidelberg, Germany; Univ Southampton, Inst Sound & Vibrat Res, Southampton SO17 1BJ, Hants, England	Ruprecht Karls University Heidelberg; University of Liverpool; University of Liverpool; Maastricht University; Ruprecht Karls University Heidelberg; University of Southampton	Schneider, P (corresponding author), Univ Heidelberg Hosp, Dept Neurol, INF 400, D-69120 Heidelberg, Germany.	Peter.Schneider@med.uni-heidelberg.de	Sluming, Vanessa/P-2986-2015; Specht, Karsten/C-3762-2009	Sluming, Vanessa/0000-0001-5130-2090; Specht, Karsten/0000-0002-9946-3704; Goebel, Rainer/0000-0003-1780-2467; Schneider, Peter/0000-0002-1920-0438; Bleeck, Stefan/0000-0003-4378-3394; Stippich, Christoph/0000-0001-8815-7018				Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Devlin JT, 2003, J NEUROSCI, V23, P11516; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Gaser C, 2003, J NEUROSCI, V23, P9240; Gordon Edwin E., 1998, INTRO RES PSYCHOL MU; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2003, ANN NY ACAD SCI, V999, P40, DOI 10.1196/annals.1284.004; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Gutschalk A, 2002, NEUROIMAGE, V15, P207, DOI 10.1006/nimg.2001.0949; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Laguitton V, 1998, NEUROPSYCHOLOGIA, V36, P201, DOI 10.1016/S0028-3932(97)00122-X; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; MEYER A, 1977, MUSIC BRAIN, P225; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Penhune VB, 2003, NEUROIMAGE, V20, P1215, DOI 10.1016/S1053-8119(03)00373-2; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PFEIFER RA, 1936, HDB NEUROLOGIE, V6, P533; Plomp R., 1976, ASPECTS TONE SENSATI; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RITTER S, IN PRESS NEUROIMAGE; Rupp A, 2004, J NEUROPHYSIOL, V92, P2239, DOI 10.1152/jn.00163.2004; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; SMOORENBURG GF, 1970, J ACOUST SOC AM, V48, P924, DOI 10.1121/1.1912232; Talairach J, 1988, CO PLANAR STEREOTAXI; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; VONHELMHOLTZ HLF, 1985, SENSATIONS TONE; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	50	198	201	1	43	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1241	1247		10.1038/nn1530	http://dx.doi.org/10.1038/nn1530			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116442				2022-12-28	WOS:000231483800025
J	Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL				Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL			XTRPC1-dependent chemotropic guidance of neuronal growth cones	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; INTRACELLULAR CALCIUM; COMMISSURAL AXONS; TRP CHANNELS; MYELIN; REGENERATION; NETRINS; NOGO; CNS; ACTIVATION	Calcium arising through release from intracellular stores and from influx across the plasma membrane is essential for signalling by specific guidance cues and by factors that inhibit axon regeneration. The mediators of calcium influx in these cases are largely unknown. Transient receptor potential channels (TRPCs) belong to a superfamily of Ca2+-permeable, receptor-operated channels that have important roles in sensing and responding to changes in the local environment. Here we report that XTRPC1, a Xenopus homolog of mammalian TRPC1, is required for proper growth cone turning responses of Xenopus spinal neurons to microscopic gradients of netrin-1, brain-derived neurotrophic factor and myelin-associated glycoprotein, but not to semaphorin 3A. Furthermore, XTRPC1 is required for midline guidance of axons of commissural interneurons in the developing Xenopus spinal cord. Thus, members of the TRPC family may serve as a key mediator for the Ca2+ influx that regulates axon guidance during development and inhibits axon regeneration in adulthood.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	gming1@bs.jhmi.edu	Sailor, Kurt/GSO-2237-2022; Bootman, Martin/AAB-3330-2019; Goh, Eyleen/A-8006-2013; Ming, Guo-li/J-7880-2013; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Bootman, Martin/0000-0002-6447-3451; Sailor, Kurt Andrew/0000-0002-9574-6838; Roderick, Hywel/0000-0001-7065-3523; Ming, Guo-li/0000-0002-2517-6075; Goh, Eyleen/0000-0002-8244-6959	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R37NS047344, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C116, BBS/E/B/00001116] Funding Source: Medline; NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NICHD NIH HHS [R01 HD069184] Funding Source: Medline; NINDS NIH HHS [R01 NS047344, R01 NS048271, R56 NS047344, R37 NS047344] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; GORDON XW, 2005, NATURE, V434, P898; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Phelps PE, 1999, J COMP NEUROL, V409, P285; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; ROBERTS A, 1988, DEVELOPMENT, V103, P447; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	139	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					730	735		10.1038/nn1459	http://dx.doi.org/10.1038/nn1459			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880110	Green Accepted, Green Published			2022-12-28	WOS:000229345300012
J	Itri, JN; Michel, S; Vansteensel, MJ; Meijer, JH; Colwell, CS				Itri, JN; Michel, S; Vansteensel, MJ; Meijer, JH; Colwell, CS			Fast delayed rectifier potassium current is required for circadian neural activity	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS NEURONS; GATED K+ CHANNELS; MEMBRANE-PROPERTIES; GENE-EXPRESSION; SCN NEURONS; PACEMAKER; MOUSE; MECHANISMS; RHYTHMS; CAMP	In mammals, the precise circadian timing of many biological processes depends on the generation of oscillations in neural activity of pacemaker cells in the suprachiasmatic nucleus (SCN). The ionic mechanisms that underlie these rhythms are largely unknown. Using the mouse brain slice preparation, we show that the magnitude of fast delayed rectifier (FDR) potassium currents has a diurnal rhythm that peaks during the day. Notably, this rhythm continues in constant darkness, providing the first demonstration of the circadian regulation of an intrinsic voltage-gated current in mammalian cells. Blocking this current prevented the daily rhythm in firing rate in SCN neurons. Kv3.1b and Kv3.2 potassium channels were widely distributed within the SCN, with higher expression during the day. We conclude that the FDR is necessary for the circadian modulation of electrical activity in SCN neurons and represents an important part of the ionic basis for the generation of rhythmic output.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2300 RC Leiden, Netherlands	University of California System; University of California Los Angeles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Vansteensel, Mariska/K-8015-2019; Colwell, Chris/AAM-6111-2020	Vansteensel, Mariska/0000-0002-9252-5116; Colwell, Christopher/0000-0002-1059-184X	NHLBI NIH HHS [HL64582, R01 HL064582] Funding Source: Medline; NIMH NIH HHS [F30 MH068087, MH68087] Funding Source: Medline; NINDS NIH HHS [R01 NS043169, NS043169] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH068087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; BOUSKILA Y, 1995, J PHYSIOL-LONDON, V488, P339, DOI 10.1113/jphysiol.1995.sp020970; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; de Jeu M, 2002, J NEUROPHYSIOL, V88, P869, DOI 10.1152/jn.2002.88.2.869; deJeu MTG, 1997, BRAIN RES, V767, P72, DOI 10.1016/S0006-8993(97)00632-X; Gan L, 1998, J NEUROBIOL, V37, P69, DOI 10.1002/(SICI)1097-4695(199810)37:1<69::AID-NEU6>3.0.CO;2-6; Gillette MU, 1997, CURR OPIN NEUROBIOL, V7, P797, DOI 10.1016/S0959-4388(97)80138-9; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Kononenko NI, 2004, J NEUROPHYSIOL, V91, P710, DOI 10.1152/jn.00770.2003; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Martina M, 1998, J NEUROSCI, V18, P8111; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Michel S, 2002, J NEUROPHYSIOL, V88, P817, DOI 10.1152/jn.2002.88.2.817; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Schaap J, 2003, CHRONOBIOL INT, V20, P171, DOI 10.1081/CBI-120019311; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; Teshima K, 2003, NEUROSCIENCE, V120, P65, DOI 10.1016/S0306-4522(03)00270-7; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	40	99	100	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					650	656		10.1038/nn1448	http://dx.doi.org/10.1038/nn1448			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852012	Green Accepted			2022-12-28	WOS:000228895100026
J	Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP				Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP			SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; SYNAPTIC PLASTICITY; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; TIME COURSE; AREA CA1; CA2+	Small-conductance Ca2+-activated K+ channels (SK channels) influence the induction of synaptic plasticity at hippocampal CA3-CA1 synapses. We find that in mice, SK channels are localized to dendritic spines, and their activity reduces the amplitude of evoked synaptic potentials in an NMDA receptor (NMDAR)-dependent manner. Using combined two-photon laser scanning microscopy and two-photon laser uncaging of glutamate, we show that SK channels regulate NMDAR-dependent Ca2+ influx within individual spines. SK channels are tightly coupled to synaptically activated Ca2+ sources, and their activity reduces the amplitude of NMDAR-dependent Ca2+ transients. These effects are mediated by a feedback loop within the spine head; during an excitatory postsynaptic potential (EPSP), Ca2+ influx opens SK channels that provide a local shunting current to reduce the EPSP and promote rapid Mg2+ block of the NMDAR. Thus, blocking SK channels facilitates the induction of long-term potentiation by enhancing NMDAR-dependent Ca2+ signals within dendritic spines.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	adelman@ohsu.edu		Bloodgood, Brenda/0000-0002-4797-9119				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Goslin K., 1998, CULTURING NERVE CELL, P339; HABERMANN E, 1984, PHARMACOL THERAPEUT, V25, P255, DOI 10.1016/0163-7258(84)90046-9; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hirschberg B, 1999, BIOPHYS J, V77, P1905, DOI 10.1016/S0006-3495(99)77032-3; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LORENZON NM, 1992, J NEUROPHYSIOL, V67, P350, DOI 10.1152/jn.1992.67.2.350; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Naraghi M, 1997, J NEUROSCI, V17, P6961; Paul K, 2003, NEUROSCI LETT, V348, P180, DOI 10.1016/S0304-3940(03)00747-X; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; ZORUMSKI CF, 1989, NEUROSCI LETT, V99, P293, DOI 10.1016/0304-3940(89)90462-X	43	348	354	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					642	649		10.1038/nn1449	http://dx.doi.org/10.1038/nn1449			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852011				2022-12-28	WOS:000228895100025
J	Bollmann, JH; Sakmann, B				Bollmann, JH; Sakmann, B			Control of synaptic strength and timing by the release-site Ca2+ signal	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; PRESYNAPTIC WAVE-FORM; PURKINJE-CELL SYNAPSE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; TIME-COURSE; ACETYLCHOLINE-RELEASE; CALCIUM SENSITIVITY; NERVE-TERMINALS; GRANULE CELL	Transmitter release is triggered by highly localized, transient increases in the presynaptic Ca2+ concentration ([Ca2+]). Rapidly decaying [Ca2+] elevations were generated using Ca2+ uncaging techniques, and [Ca2+] was measured with a low-affinity Ca2+ indicator in a giant presynaptic terminal, the calyx of Held, in rat brain slices. The rise time and amplitude of evoked excitatory postsynaptic currents (EPSCs) depended on the half-width of the fluorescence transient, which was predicted by a five - binding site model of a Ca2+ sensor having relatively high affinity (K-d similar to 13 mu M). Very fast [Ca2+] transients (half- width < 0.5 ms) evoked EPSCs similar to those elicited by a single action potential (AP) in the same synapse. Triggering release with dual [Ca2+] transients of variable amplitudes demonstrated the supralinear transfer function of the sensor. The sensitivity of release to the time course of the [Ca2+] transient may contribute to mechanisms by which the presynaptic AP waveform controls synaptic strength.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Max Planck Society	Bollmann, JH (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	johann@mcb.harvard.edu						Atluri PP, 1996, J NEUROSCI, V16, P5661; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Byrne JH, 1996, J NEUROSCI, V16, P425; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Felmy F, 2003, P NATL ACAD SCI USA, V100, P15200, DOI 10.1073/pnas.2433276100; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Lin JW, 2002, TRENDS NEUROSCI, V25, P449, DOI 10.1016/S0166-2236(02)02212-9; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Millet O, 2002, FEBS LETT, V516, P93, DOI 10.1016/S0014-5793(02)02508-5; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Pattillo JM, 1999, J PHYSIOL-LONDON, V514, P719, DOI 10.1111/j.1469-7793.1999.719ad.x; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Slutsky I, 2003, J NEUROPHYSIOL, V89, P1954, DOI 10.1152/jn.00668.2002; Taschenberger H, 2000, J NEUROSCI, V20, P9162; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P605, DOI 10.1113/jphysiol.1988.sp017225; Wheeler DB, 1996, J NEUROSCI, V16, P2226; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	50	98	101	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					426	434		10.1038/nn1417	http://dx.doi.org/10.1038/nn1417			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15750590				2022-12-28	WOS:000228040400012
J	Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH				Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH			Natural oligomers of the amyloid-protein specifically disrupt cognitive function	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; MEMORY DEFICITS; TRANSGENIC MICE; NEURONAL LOSS; MOUSE MODEL; BRAIN; PLAQUES; DEPOSITS	A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia. Here we provide the first direct experimental evidence that a defined molecular species of the amyloid-protein interferes with cognitive function. Soluble oligomeric forms of amyloid-beta, including trimers and dimers, were both necessary and sufficient to disrupt learned behavior in a manner that was rapid, potent and transient; they produced impaired cognitive function without inducing permanent neurological deficits. Although beta-amyloidosis has long been hypothesized to affect cognition, the abnormally folded protein species associated with this or any other neurodegenerative disease has not previously been isolated, defined biochemically and then specifically characterized with regard to its effects on cognitive function. The biochemical isolation of discrete amyloid-moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.	Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Coll Dublin, Conway Inst Biomed & Biomol Res, Lab Neurodegenerat Res, Dublin 4, Ireland; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University College Dublin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ashe, KH (corresponding author), Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA.	hsiao005@umn.edu						Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CLEARY J, 1995, BRAIN RES, V682, P69, DOI 10.1016/0006-8993(95)00323-I; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dudai Y., 2002, MEMORY KEYWORDS CONC; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Johnson D, 1997, EDN, V42, P94; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; Mishima K, 2000, JPN J PHARMACOL, V84, P163, DOI 10.1254/jjp.84.163; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Hare E, 1999, BRAIN RES, V815, P1, DOI 10.1016/S0006-8993(98)01002-6; OHare E, 1996, BEHAV PHARMACOL, V7, P742; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pederson ES, 2001, REGUL PEPTIDES, V102, P147, DOI 10.1016/S0167-0115(01)00312-3; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Sweeney WA, 1997, NEUROBIOL LEARN MEM, V68, P97, DOI 10.1006/nlme.1997.3770; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Weldon DT, 1996, PHARMACOL BIOCHEM BE, V54, P753, DOI 10.1016/0091-3057(96)00014-7; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	46	1409	1499	1	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					79	84		10.1038/nn1372	http://dx.doi.org/10.1038/nn1372			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608634				2022-12-28	WOS:000225967600019
J	Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ				Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ			Epigenetic programming by maternal behavior	NATURE NEUROSCIENCE			English	Article							EARLY ENVIRONMENTAL-REGULATION; RECEPTOR GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARE; METHYLATION; RESPONSES; RAT; 5-METHYLCYTOSINE; TRANSMISSION; SENSITIVITY	Here we report that increased pup licking and grooming (LG) and arched-back nursing (ABN) by rat mothers altered the offspring epigenome at a glucocorticoid receptor (GR) gene promoter in the hippocampus. Offspring of mothers that showed high levels of LG and ABN were found to have differences in DNA methylation, as compared to offspring of 'low-LG-ABN' mothers. These differences emerged over the first week of life, were reversed with cross-fostering, persisted into adulthood and were associated with altered histone acetylation and transcription factor (NGFI-A) binding to the GR promoter. Central infusion of a histone deacetylase inhibitor removed the group differences in histone acetylation, DNA methylation, NGFI-A binding, GR expression and hypothalamic-pituitary- adrenal (HPA) responses to stress, suggesting a causal relation among epigenomic state, GR expression and the maternal effect on stress responses in the offspring. Thus we show that an epigenomic state of a gene can be established through behavioral programming, and it is potentially reversible.	Douglas Hosp, Res Ctr, Montreal, PQ H4H 1R3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Western Gen Hosp, Mol Med Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; McGill Univ, McGill Program Study Behav Genes & Environm, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Edinburgh; McGill University	Szyf, M (corresponding author), Douglas Hosp, Res Ctr, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	moshe.szyf@mcgill.ca; michael.meaney@mcgill.ca	Seckl, Jonathan R/C-3555-2013; Meaney, Michael/N-5931-2019; Weaver, Ian/AAH-6671-2020; Champagne, Frances Anne/Q-1220-2018	Weaver, Ian/0000-0001-8709-8941; Champagne, Frances Anne/0000-0002-3922-084X				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Brinton RD, 1998, MOL BRAIN RES, V57, P73; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CINTRA A, 1994, ANN NY ACAD SCI, V746, P42; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P55, DOI 10.1002/dev.420220105; RAZIN A, 1977, P NATL ACAD SCI USA, V74, P2725, DOI 10.1073/pnas.74.7.2725; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rossiter M.C., 1999, MATERNAL EFFECTS ADA; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SAPIENZA C, 1990, SCI AM, V263, P52, DOI 10.1038/scientificamerican1090-52; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Weaver ICG, 2001, MOL CELL ENDOCRINOL, V185, P205, DOI 10.1016/S0303-7207(01)00635-9	33	4021	4133	6	926	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					847	854		10.1038/nn1276	http://dx.doi.org/10.1038/nn1276			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15220929				2022-12-28	WOS:000222930800015
J	Zhang, H; Sulzer, D				Zhang, H; Sulzer, D			Frequency-dependent modulation of dopamine release by nicotine	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC MODULATION; RAT; RECEPTORS; STRIATUM; ADDICTION; NEURONS	Although nicotine activation of dopamine release is implicated in addiction, it also desensitizes nicotinic acetylcholine receptors (nAChRs), leading to a prolonged depression of evoked dopamine release. Here we show that nicotine's effects depend on the firing pattern of dopamine neurons, so that while desensitization of nAChRs indeed curbs dopamine released by stimuli emulating tonic firing, it allows a rapid rise in dopamine from stimuli emulating phasic firing patterns associated with incentive/salience paradigms. Nicotine may thus enhance the contrast of dopamine signals associated with behavioral cues.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, 650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu						Cragg SJ, 2003, J NEUROSCI, V23, P4378; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; Kulak JM, 2001, J NEUROCHEM, V77, P1581, DOI 10.1046/j.1471-4159.2001.00357.x; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Zhang H, 2003, J NEUROSCI, V23, P10585; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	15	256	262	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					581	582		10.1038/nn1243	http://dx.doi.org/10.1038/nn1243			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146187				2022-12-28	WOS:000221640300008
J	Kali, S; Dayan, P				Kali, S; Dayan, P			Off-line replay maintains declarative memories in a model of hippocampal-neocortical interactions	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; GRADED RETROGRADE-AMNESIA; SEMANTIC MEMORY; SLEEP; RATS; CONSOLIDATION; REACTIVATION; INFORMATION; ACQUISITION; STORAGE	During sleep, neural activity in the hippocampus and neocortex seems to recapitulate aspects of its earlier, awake form. This replay may be a substrate for the consolidation of long-term declarative memories, whereby they become independent of the hippocampus and are stored in neocortex. In contrast to storage, other crucial facets of competent long-term memory, such as maintenance of access to stored traces and preservation of their correct interpretation, have received little attention. We investigate long-term episodic and semantic memory in a theoretical model of neocortical-hippocampal interaction. We find that, in the absence of regular hippocampal reactivation, even supposedly consolidated episodic memories are fragile in the face of cortical semantic plasticity. Replay allows access to episodes stored in the hippocampus to be maintained, by keeping them in appropriate register with changing neocortical representations. Hippocampal storage and replay also has a constructive role in the recall of structured, semantic information.	Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary; UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of London; University College London	Kali, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.	kali@koki.hu	Káli, Szabolcs/AAW-1138-2020	Káli, Szabolcs/0000-0002-2740-6057; Dayan, Peter/0000-0003-3476-1839				Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; Bayley PJ, 2002, J NEUROSCI, V22, P5741; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freud S, 1966, INTRO LECT PSYCHOANA, P199; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Hamann SB, 1995, BEHAV NEUROSCI, V109, P1027, DOI 10.1037/0735-7044.109.6.1027; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; Hinton G. E., 1999, UNSUPERVISED LEARNIN; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Holdstock JS, 2002, NEUROPSYCHOLOGIA, V40, P748, DOI 10.1016/S0028-3932(01)00192-0; Kali S, 2003, ADV NEURAL INFORMATI, V15, P19; Kitchener EG, 1998, BRAIN, V121, P1313, DOI 10.1093/brain/121.7.1313; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCloskey M., 1989, PSYCHOL LEARN MOTIV, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; PLAUT DC, 1991, CMUCS91185; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rao R. P., 2002, PROBABILISTIC MODELS; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shen B, 1996, HIPPOCAMPUS, V6, P685; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 1995, J Int Neuropsychol Soc, V1, P443; Wiig KA, 1996, LEARN MEMORY, V3, P313, DOI 10.1101/lm.3.4.313; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	100	109	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					286	294		10.1038/nn1202	http://dx.doi.org/10.1038/nn1202			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	777UU	14983183				2022-12-28	WOS:000189197900019
J	Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A				Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A			Serum response factor controls neuronal circuit assembly in the hippocampus	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCIUM INFLUX; MICE LACKING; RHO-GTPASES; EPHRIN-AS; SRF; ACTIVATION; DYNAMICS; FAMILY	Higher organisms rely on multiple modes of memory storage using the hippocampal network, which is built by precisely orchestrated mechanisms of axonal outgrowth, guidance and synaptic targeting. We demonstrate essential roles of the transcription factor serum response factor ( SRF), a sensor of cytoskeletal actin dynamics, in all these processes. Conditional deletion of the mouse Srf gene reduced neurite outgrowth and abolished mossy fiber segregation, resulting in ectopic fiber growth inside the pyramidal layer. SRF-deficient mossy fibers aberrantly targeted CA3 somata for synapse formation. Axon guidance assays showed that SRF was a key mediator of ephrin-A and semaphorin guidance cues; in SRF-deficient neurons, these resulted in the formation of F-actin-microtubule rings rather than complete growth cone collapse. Dominant-negative variants of the SRF cofactor megakaryocytic acute leukemia ( MAL) severely impeded neurite outgrowth and guidance. These data highlight essential links between SRF-mediated transcription and axon guidance and circuit formation in the hippocampus.	Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, D-72076 Tubingen, Germany; Univ Freiburg, Inst Anat & Zellbiol, D-79104 Freiburg, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	Eberhard Karls University of Tubingen; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Nordheim, A (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, Morgenstelle 15, D-72076 Tubingen, Germany.	alfred.nordheim@uni-tuebingen.de		Kretz, Oliver/0000-0003-1152-5956				Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brownlee H, 2000, J COMP NEUROL, V425, P315, DOI 10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen B, 2001, SPECTROSC SPECT ANAL, V21, P263; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Goetze B, 2004, J NEUROBIOL, V60, P517, DOI 10.1002/neu.20073; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; LIPP HP, 1988, J NEUROSCI, V8, P1905; LIPP HP, 1989, EXPERIENTIA, V45, P845, DOI 10.1007/BF01954059; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599	50	128	131	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					195	204		10.1038/nn1627	http://dx.doi.org/10.1038/nn1627			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415869				2022-12-28	WOS:000234990100014
J	Arumugam, H; Liu, XH; Colombo, PJ; Corriveau, RA; Belousov, AB				Arumugam, H; Liu, XH; Colombo, PJ; Corriveau, RA; Belousov, AB			NMDA receptors regulate developmental gap junction uncoupling via CREB signaling	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMUS IN-VITRO; RAT-BRAIN; ELECTRICAL SYNAPSES; NERVOUS-SYSTEM; CONNEXIN EXPRESSION; MAMMALIAN BRAIN; VISUAL-CORTEX; MESSENGER-RNA; RETINAL WAVES; SPINAL-CORD	Signaling through gap junctions ( electrical synapses) is important in the development of the mammalian central nervous system. Abundant between neurons during postnatal development, gap junction coupling subsequently decreases and remains low in the adult, confined to specific subsets of neurons. Here we report that developmental uncoupling of gap junctions in the rat hypothalamus in vivo and in vitro is associated with a decrease in connexin 36 (Cx36) protein expression. Both developmental gap junction uncoupling and Cx36 downregulation are prevented by the blockade of NMDA glutamate receptors, action potentials and the calcium - cyclic AMP response element binding protein ( CREB), and are accelerated by CREB overexpression. Developmental gap junction uncoupling and Cx36 downregulation are not affected by blockade of non-NMDA glutamate receptors, and do not occur in hypothalamic neurons from NMDA receptor subunit 1 (NMDAR1) knockout mice. These results demonstrate that NMDA receptor activity contributes to the developmental uncoupling of gap junctions via CREB-dependent downregulation of Cx36.	Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Belousov, AB (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	belousov@tulane.edu		Liu, Xinhuai/0000-0002-4096-6913	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015088] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015088-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aberg ND, 1999, DEV BRAIN RES, V115, P97, DOI 10.1016/S0165-3806(99)00052-8; ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; Bani-Yaghoub M, 1999, DEV GENET, V24, P69, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M; Becker DL, 1999, EXP NEUROL, V156, P326, DOI 10.1006/exnr.1999.7027; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Belousov AB, 2002, J NEUROPHYSIOL, V88, P1352, DOI 10.1152/jn.2002.88.3.1352; Belousov AB, 1997, J PHYSIOL-LONDON, V499, P747, DOI 10.1113/jphysiol.1997.sp021966; Belousov AB, 2001, J NEUROSCI, V21, P2015, DOI 10.1523/JNEUROSCI.21-06-02015.2001; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; FACCHINETTI F, 1993, DEV BRAIN RES, V74, P219, DOI 10.1016/0165-3806(93)90007-W; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Greenberg ME, 2001, SYNAPSES, P357; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hatton GI, 1998, CELL BIOL INT, V22, P765, DOI 10.1006/cbir.1998.0386; Kandler K, 1998, DEV NEUROSCI-BASEL, V20, P59, DOI 10.1159/000017299; Kandler K, 1998, J NEUROSCI, V18, P1419; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Mentis GZ, 2002, J PHYSIOL-LONDON, V544, P757, DOI 10.1113/jphysiol.2002.028159; MEYER T, 1991, CELL, V64, P675, DOI 10.1016/0092-8674(91)90496-L; Milner LD, 1999, J NEUROSCI, V19, P3007; Naus CCG, 1998, CELL BIOL INT, V22, P751, DOI 10.1006/cbir.1998.0391; PEINADO A, 1993, CEREB CORTEX, V3, P488, DOI 10.1093/cercor/3.5.488; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Personius K, 2001, CELL COMMUN ADHES, V8, P329, DOI 10.3109/15419060109080748; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Srinivas M, 1999, J NEUROSCI, V19, P9848; Strata F, 1997, J NEUROSCI, V17, P1435; Sugiura N, 2001, J BIOL CHEM, V276, P14257, DOI 10.1074/jbc.M100011200; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; XIA Z, 1996, REGULATORY PROPERTIE, P105	50	77	79	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1720	1726		10.1038/nn1588	http://dx.doi.org/10.1038/nn1588			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299502				2022-12-28	WOS:000233576200021
J	Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW				Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW			BK channel beta 4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; SPIKE FREQUENCY ADAPTATION; RAT LATERAL AMYGDALA; LARGE-CONDUCTANCE; GRANULE CELLS; PYRAMIDAL CELLS; MOSSY CELLS; NEURONS; INHIBITION	Synaptic inhibition within the hippocampus dentate gyrus serves a 'low-pass filtering' function that protects against hyperexcitability that leads to temporal lobe seizures. Here we demonstrate that calcium-activated potassium (BK) channel accessory beta 4 subunits serve as key regulators of intrinsic firing properties that contribute to the low-pass filtering function of dentate granule cells. Notably, a critical b4 subunit function is to preclude BK channels from contributing to membrane repolarization and thereby broaden action potentials. Longer-duration action potentials secondarily recruit SK channels, leading to greater spike frequency adaptation and reduced firing rates. In contrast, granule cells from beta 4 knockout mice show a gain-of-function for BK channels that sharpens action potentials and supports higher firing rates. Consistent with breakdown of the dentate filter, beta 4 knockouts show distinctive seizures emanating from the temporal cortex, demonstrating a unique nonsynaptic mechanism for gate control of hippocampal synchronization leading to temporal lobe epilepsy.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Howard Hughes Medical Institute; Stanford University	Brenner, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu; raldrich@leland.stanford.edu		Brenner, Robert/0000-0002-1036-8031; Noebels, Jeffrey/0000-0002-2887-0839	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071645] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS29709] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; Blank T, 2004, CNS NEUROL DISORD-DR, V3, P161, DOI 10.2174/1568007043337472; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Coulter DA, 2000, EPILEPSIA, V41, pS96, DOI 10.1111/j.1528-1157.2000.tb01565.x; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Engel J, 1999, BIOPHYS J, V76, P1310, DOI 10.1016/S0006-3495(99)77293-0; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; Greffrath W, 2004, J NEUROENDOCRINOL, V16, P577, DOI 10.1111/j.1365-2826.2004.01204.x; Ha TS, 2004, BIOPHYS J, V86, P2871, DOI 10.1016/S0006-3495(04)74339-8; HEINEMANN U, 1992, EPILEPSY RES, P273; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Juhng KN, 1999, EPILEPSY RES, V34, P177, DOI 10.1016/S0920-1211(98)00111-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Lau D, 2000, J NEUROSCI, V20, P9071; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MODY I, 1992, EPILEPSY RES, P159; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; MOTT DD, 1993, J NEUROPHYSIOL, V69, P674, DOI 10.1152/jn.1993.69.3.674; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2004, TOXICON, V43, P933, DOI 10.1016/j.toxicon.2003.12.009; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Swensen AM, 2003, J NEUROSCI, V23, P9650; Teshima K, 2003, NEUROSCIENCE, V120, P65, DOI 10.1016/S0306-4522(03)00270-7; Tian LJ, 1998, J BIOL CHEM, V273, P13531, DOI 10.1074/jbc.273.22.13531; WANG G, 1992, PFLUG ARCH EUR J PHY, V421, P558, DOI 10.1007/BF00375051; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Williamson PD, 1997, EPILEPSY COMPREHENSI, P557; Yen JC, 1999, J BIOMED SCI, V6, P418, DOI 10.1159/000025417	49	277	286	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1752	1759		10.1038/nn1573	http://dx.doi.org/10.1038/nn1573			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261134				2022-12-28	WOS:000233576200025
J	Coricelli, G; Critchley, HD; Joffily, M; O'Doherty, JP; Sirigu, A; Dolan, RJ				Coricelli, G; Critchley, HD; Joffily, M; O'Doherty, JP; Sirigu, A; Dolan, RJ			Regret and its avoidance: a neuroimaging study of choice behavior	NATURE NEUROSCIENCE			English	Article							ROSTRAL ANTERIOR CINGULATE; ORBITOFRONTAL CORTEX; DECISION-MAKING; NEURAL RESPONSES; REWARD VALUE; ERROR; EMOTION; FMRI; DISAPPOINTMENT; PREDICTION	Human decisions can be shaped by predictions of emotions that ensue after choosing advantageously or disadvantageously. Indeed, anticipating regret is a powerful predictor of future choices. We measured brain activity using functional magnetic resonance imaging ( fMRI) while subjects selected between two gambles wherein regret was induced by providing information about the outcome of the unchosen gamble. Increasing regret enhanced activity in the medial orbitofrontal region, the anterior cingulate cortex and the hippocampus. Notably, across the experiment, subjects became increasingly regret-aversive, a cumulative effect reflected in enhanced activity within medial orbitofrontal cortex and amygdala. This pattern of activity reoccurred just before making a choice, suggesting that the same neural circuitry mediates direct experience of regret and its anticipation. These results demonstrate that medial orbitofrontal cortex modulates the gain of adaptive emotions in a manner that may provide a substrate for the influence of high-level emotions on decision making.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; CNRS, Inst Cognit Sci, Neuropsychol Grp, F-69675 Bron, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS)	Sirigu, A (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	sirigu@isc.cnrs.fr; rdolan@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011; Sirigu, Angela/L-4683-2017; Joffily, Mateus/H-7457-2017; O'Doherty, John P/F-1204-2013	critchley, hugo d/0000-0002-2445-9284; Joffily, Mateus/0000-0003-4073-4562; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BELL DE, 1985, OPER RES, V33, P1, DOI 10.1287/opre.33.1.1; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cartei G, 1999, ANN ONCOL, V10, P57, DOI 10.1023/A:1008368624555; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; DREHER JC, IN PRESS CEREB CORTE; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1982, SCI AM, V246, P160, DOI 10.1038/scientificamerican0182-160; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Miceli M, 2002, THEOR PSYCHOL, V12, P335, DOI 10.1177/0959354302012003015; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; ROESE NJ, 1995, WHAT MIGHT BEEN SOCI; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Zeelenberg M, 1996, ORGAN BEHAV HUM DEC, V65, P148, DOI 10.1006/obhd.1996.0013; ZEELENBERG M, 2005, PSYCHOL COUNTERFACTU, P147	46	409	423	4	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1255	1262		10.1038/nn1514	http://dx.doi.org/10.1038/nn1514			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116457				2022-12-28	WOS:000231483800027
J	Liu, SQJ; Cull-Candy, SG				Liu, SQJ; Cull-Candy, SG			Subunit interaction with PICK and GRIP controls Ca2+ permeability of AMPARs at cerebellar synapses	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR CHANNELS; DOMAIN-CONTAINING PROTEINS; LONG-TERM DEPRESSION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; FOREBRAIN ISCHEMIA; C-TERMINUS; GLUR-B; EXPRESSION; NSF	At many excitatory central synapses, activity produces a lasting change in the synaptic response by modifying postsynaptic AMPA receptors (AMPARs). Although much is known about proteins involved in the trafficking of Ca2+-impermeable (GluR2-containing) AMPARs, little is known about protein partners that regulate subunit trafficking and plasticity of Ca2+-permeable (GluR2-lacking) AMPARs. At cerebellar parallel fiber - stellate cell synapses, activity triggers a novel type of plasticity: Ca2+ influx through GluR2-lacking synaptic AMPARs drives incorporation of GluR2-containing AMPARs, generating rapid, lasting changes in excitatory postsynaptic current properties. Here we examine how glutamate receptor interacting protein ( GRIP, also known as AMPAR binding protein or ABP) and protein interacting with C-kinase-1 ( PICK) regulate subunit trafficking and plasticity. We find that repetitive synaptic activity triggers loss of synaptic GluR2-lacking AMPARs by selectively disrupting their interaction with GRIP and that PICK drives activity-dependent delivery of GluR2-containing receptors. This dynamic regulation of AMPARs provides a feedback mechanism for controlling Ca2+ permeability of synaptic receptors.	UCL, Dept Pharmacol, London WC1E 6BT, England; Penn State Univ, Dept Biol, State Coll, PA 16801 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Liu, SQJ (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	sjl16@psu.edu; s.cull-candy@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1997, J NEUROSCI, V17, P9393; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	50	132	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					768	775		10.1038/nn1468	http://dx.doi.org/10.1038/nn1468			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895086				2022-12-28	WOS:000229345300017
J	Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD				Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD			SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability	NATURE NEUROSCIENCE			English	Article							SERUM RESPONSE FACTOR; NMDA RECEPTOR ACTIVATION; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENES; C-FOS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; CRE RECOMBINASE; NERVOUS-SYSTEM	Synaptic activity-dependent gene expression is critical for certain forms of neuronal plasticity and survival in the mammalian nervous system, yet the mechanisms by which coordinated regulation of activity-induced genes supports neuronal function is unclear. Here, we show that deletion of serum response factor (SRF) in specific neuronal populations in adult mice results in profound deficits in activity-dependent immediate early gene expression, but components of upstream signaling pathways and cyclic AMP - response element binding protein ( CREB)- dependent transactivation remain intact. Moreover, SRF-deficient CA1 pyramidal neurons show attenuation of long-term synaptic potentiation, a model for neuronal information storage. Furthermore, in contrast to the massive neurodegeneration seen in adult mice lacking CREB family members, SRF-deficient adult neurons show normal morphologies and basal excitatory synaptic transmission. These findings indicate that the transcriptional events underlying neuronal survival and plasticity are dissociable and that SRF plays a prominent role in use-dependent modification of synaptic strength in the adult brain.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,Preclin Teaching Bldg Room 1015, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Sarsfield, Sarah/Y-5113-2019; RAMANAN, NARENDRAKUMAR/L-7487-2018; Lemberger, Thomas/A-7301-2008	Lemberger, Thomas/0000-0002-2499-4025				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Balschun D, 2003, J NEUROSCI, V23, P6304; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Gass P, 1998, LEARN MEMORY, V5, P274; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Treisman R, 1990, Semin Cancer Biol, V1, P47; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	46	169	169	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					759	767		10.1038/nn1462	http://dx.doi.org/10.1038/nn1462			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880109				2022-12-28	WOS:000229345300016
J	Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J				Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J			Asymmetric membrane ganglioside sialidase activity specifies axonal fate	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; CULTURED HIPPOCAMPAL-NEURONS; GM1 GANGLIOSIDE; CELL POLARITY; ACTIN FLOW; RHOA; 3-KINASE; GTPASES; RAC1; CONE	Axon specification triggers the polarization of neurons and requires the localized destabilization of filamentous actin. Here we show that plasma membrane ganglioside sialidase (PMGS) asymmetrically accumulates at the tip of one neurite of the unpolarized rat neuron, inducing actin instability. Suppressing PMGS activity blocks axonal generation, whereas stimulating it accelerates the formation of a single (not several) axon. PMGS induces axon specification by enhancing TrkA activity locally, which triggers phosphatidylinositol-3-kinase (PI3K)- and Rac1-dependent inhibition of RhoA signaling and the consequent actin depolymerization in one neurite only. Thus, spatial restriction of an actin-regulating molecular machinery, in this case a membrane enzymatic activity, before polarization is enough to determine axonal fate.	Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy; Miyagi Prefectural Canc Ctr, Div Biochem, Natori, Miyagi 9811293, Japan; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	University of Turin; Universite Catholique Louvain	Abad-Rodriguez, J (corresponding author), Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy.	carlos.dotti@unito.it; jose.abad@unito.it	Abad-Rodríguez, José/L-8274-2014; Dotti, Carlos G/I-5533-2015; Hasegawa, Takafumi/I-6668-2017	Abad-Rodríguez, José/0000-0002-0350-500X; Dotti, Carlos G/0000-0003-4052-1719; 				Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Banker G., 1991, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Da Silva JS, 2004, MOL CELL NEUROSCI, V27, P1, DOI 10.1016/j.men.2004.03.008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Duchemin AM, 1998, ANN NY ACAD SCI, V845, P406, DOI 10.1111/j.1749-6632.1998.tb09696.x; Hasegawa T, 2000, J BIOL CHEM, V275, P14778; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kalka D, 2001, BIOCHEM BIOPH RES CO, V283, P989, DOI 10.1006/bbrc.2001.4864; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1997, J CELL SCI, V110, P2417; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; RABIN SJ, 1995, J NEUROCHEM, V65, P347; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P371; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	183	187	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					606	615		10.1038/nn1442	http://dx.doi.org/10.1038/nn1442			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834419				2022-12-28	WOS:000228895100021
J	Gillespie, DC; Kim, G; Kandler, K				Gillespie, DC; Kim, G; Kandler, K			Inhibitory synapses in the developing auditory system are glutamatergic	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; GAMMA-AMINOBUTYRIC-ACID; GABAERGIC SYNAPSES; CALCIUM RESPONSES; SYNAPTIC ACTIVITY; BRAIN-STEM; GUINEA-PIG; GLYCINE; RECEPTORS; NEURONS	Activity-dependent synapse refinement is crucial for the formation of precise excitatory and inhibitory neuronal circuits. Whereas the mechanisms that guide refinement of excitatory circuits are becoming increasingly clear, the mechanisms guiding inhibitory circuits have remained obscure. In the lateral superior olive (LSO), a nucleus in the mammalian sound localization system that receives inhibitory input from the medial nucleus of the trapezoid body (MNTB), specific elimination and strengthening of synapses that are both GABAergic and glycinergic (GABA/glycinergic synapses) is essential for the formation of a precise tonotopic map. We provide evidence that immature GABA/glycinergic synapses in the rat LSO also release the excitatory neurotransmitter glutamate, which activates postsynaptic NMDA receptors (NMDARs). Immunohistochemical studies demonstrate synaptic colocalization of the vesicular glutamate transporter 3 with the vesicular GABA transporter, indicating that GABA, glycine and glutamate are released from single MNTB terminals. Glutamatergic transmission at MNTB-LSO synapses is most prominent during the period of synapse elimination. Synapse-specific activation of NMDARs by glutamate release at GABAergic and glycinergic synapses could be important in activity-dependent refinement of inhibitory circuits.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neurol Basis Cognit, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, W1412 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	kkarl@pitt.edu		Kim, Gunsoo/0000-0001-9318-8329; Kandler, Karl/0000-0002-6053-6400; Gillespie, Deda/0000-0002-3736-9886	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004199] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BLEDSOE SC, 1990, BRAIN RES, V517, P189, DOI 10.1016/0006-8993(90)91025-C; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Dickson KS, 2003, CURR BIOL, V13, pR920, DOI 10.1016/j.cub.2003.11.015; DOCHERTY M, 1987, NATURE, V330, P64, DOI 10.1038/330064a0; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Ene FA, 2003, J NEUROPHYSIOL, V90, P2581, DOI 10.1152/jn.00238.2003; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Furuta A, 1997, J NEUROSCI, V17, P8363; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Givens R S, 1998, Methods Enzymol, V291, P1; GLENDENNING KK, 1991, J COMP NEUROL, V310, P377, DOI 10.1002/cne.903100308; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; HELFERT RH, 1989, BRAIN RES, V501, P269, DOI 10.1016/0006-8993(89)90644-6; HELFERT RH, 1992, J COMP NEUROL, V323, P305, DOI 10.1002/cne.903230302; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; KANDLER K, 1995, J NEUROSCI, V15, P6890; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Kullmann PHM, 2001, DEV BRAIN RES, V131, P143, DOI 10.1016/S0165-3806(01)00271-1; Lehmann E D, 1999, Diabetes Technol Ther, V1, P41, DOI 10.1089/152091599317567; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; MOORE MJ, 1983, J NEUROSCI, V3, P237; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Schwartz I.R., 1992, MAMMALIAN AUDITORY P, P117; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	49	162	175	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					332	338		10.1038/nn1397	http://dx.doi.org/10.1038/nn1397			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746915				2022-12-28	WOS:000227354600018
J	Banghart, M; Borges, K; Isacoff, E; Trauner, D; Kramer, RH				Banghart, M; Borges, K; Isacoff, E; Trauner, D; Kramer, RH			Light-activated ion channels for remote control of neuronal firing	NATURE NEUROSCIENCE			English	Article							GATED POTASSIUM CHANNELS; K+-CHANNELS; MAMMALIAN NEURONS; INACTIVATION; MUTATIONS; PHOTOSTIMULATION; MECHANISMS; EXPRESSION; CIRCUITS; BLOCKADE	Neurons have ion channels that are directly gated by voltage, ligands and temperature but not by light. Using structure-based design, we have developed a new chemical gate that confers light sensitivity to an ion channel. The gate includes a functional group for selective conjugation to an engineered K+ channel, a pore blocker and a photoisomerizable azobenzene. Long-wavelength light drives the azobenzene moiety into its extended trans configuration, allowing the blocker to reach the pore. Short-wavelength light generates the shorter cis configuration, retracting the blocker and allowing conduction. Exogenous expression of these channels in rat hippocampal neurons, followed by chemical modification with the photoswitchable gate, enables different wavelengths of light to switch action potential firing on and off. These synthetic photoisomerizable azobenzene-regulated K+ (SPARK) channels allow rapid, precise and reversible control over neuronal firing, with potential applications for dissecting neural circuits and controlling activity downstream from sites of neural damage or degeneration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Trauner, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	trauner@cchem.berkeley.edu; rhkramer@berkeley.edu	isacoff, ehud/AAP-1459-2020	Banghart, Matthew/0000-0001-7248-2932; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; Blaustein RO, 2002, J GEN PHYSIOL, V120, P203, DOI 10.1085/jgp.20028613; CALLAWAY EM, 1994, CURR BIOL, V4, P1010, DOI 10.1016/S0960-9822(00)00228-1; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Djurisic M, 2003, METHOD ENZYMOL, V361, P423; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flint DG, 2002, CHEM BIOL, V9, P391, DOI 10.1016/S1074-5521(02)00109-6; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; James DA, 2001, PROTEIN ENG, V14, P983, DOI 10.1093/protein/14.12.983; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Johns DC, 1999, J NEUROSCI, V19, P1691; KARSCHIN A, 1991, FEBS LETT, V278, P229, DOI 10.1016/0014-5793(91)80123-K; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KNOLL H, 2004, CRC HDB ORGANIC PHOT, V2; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Slimko EM, 2002, J NEUROSCI, V22, P7373; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	31	536	615	7	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1381	1386		10.1038/nn1356	http://dx.doi.org/10.1038/nn1356			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558062	Green Accepted			2022-12-28	WOS:000225353900020
J	Friedrich, RW; Habermann, CJ; Laurent, G				Friedrich, RW; Habermann, CJ; Laurent, G			Multiplexing using synchrony in the zebrafish olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT REPRESENTATIONS; NEURONAL SYNCHRONY; OSCILLATIONS; DYNAMICS; SYSTEM; CORTEX; BRAIN; DISCRIMINATION; ORGANIZATION; RAT	In the olfactory bulb (OB) of zebrafish and other species, odors evoke fast oscillatory population activity and specific firing rate patterns across mitral cells (MCs). This activity evolves over a few hundred milliseconds from the onset of the odor stimulus. Action potentials of odor-specific MC subsets phase-lock to the oscillation, defining small and distributed ensembles within the MC population output. We found that oscillatory field potentials in the zebrafish OB propagate across the OB in waves. Phase-locked MC action potentials, however, were synchronized without a time lag. Firing rate patterns across MCs analyzed with low temporal resolution were informative about odor identity. When the sensitivity for phase-locked spiking was increased, activity patterns became progressively more informative about odor category. Hence, information about complementary stimulus features is conveyed simultaneously by the same population of neurons and can be retrieved selectively by biologically plausible mechanisms, indicating that seemingly alternative coding strategies operating on different time scales may coexist.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA	Max Planck Society; California Institute of Technology	Friedrich, RW (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.	Rainer.Friedrich@mpimf-heidelberg.mpg.de	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Friedrich, Rainer/0000-0001-9107-0482				BAIER H, 1994, J NEUROSCI, V14, P219; BYRD CA, 1995, J COMP NEUROL, V358, P247, DOI 10.1002/cne.903580207; Carr W.E.S., 1988, P3; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; Edwards JG, 2002, J COMP NEUROL, V454, P294, DOI 10.1002/cne.10445; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GOLDBERG SJ, 1987, EXP NEUROL, V96, P430, DOI 10.1016/0014-4886(87)90060-4; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; HASEGAWA T, 1994, COMP BIOCHEM PHYS A, V108, P17, DOI 10.1016/0300-9629(94)90048-5; Jvreskog, 1996, APPL FACTOR ANAL NAT; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kuhn B, 2003, J PHYS CHEM B, V107, P7903, DOI 10.1021/jp0345811; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; LAURENT G, 1994, J NEUROSCI; LEVINE RL, 1985, J COMP NEUROL, V237, P427, DOI 10.1002/cne.902370402; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Valentincic T, 2000, CHEM SENSES, V25, P21, DOI 10.1093/chemse/25.1.21; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; [No title captured]	50	191	191	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					862	871		10.1038/nn1292	http://dx.doi.org/10.1038/nn1292			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273692				2022-12-28	WOS:000222930800017
J	Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M				Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M			Abnormal cortical voice processing in autism	NATURE NEUROSCIENCE			English	Article							ASPERGER-SYNDROME; AUDITORY-CORTEX; INDIVIDUALS; CHILDREN; SPEECH; MIND	Impairments in social interaction are a key feature of autism and are associated with atypical social information processing. Here we report functional magnetic resonance imaging (fMRI) results showing that individuals with autism failed to activate superior temporal sulcus (STS) voice-selective regions in response to vocal sounds, whereas they showed a normal activation pattern in response to nonvocal sounds. These findings suggest abnormal cortical processing of socially relevant auditory information in autism.	CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, F-91406 Orsay, France; Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; Univ Montreal, Ctr Rech, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; AP HP, Serv Radiol Pediat, F-75015 Paris, France; Hop Henri Mondor, Psychiat Serv, AP HP, F-94000 Creteil, France; CHU Bretonneau, INSERM, Unite 619, F-37000 Tours, France; Grp Hosp Pitie Salpetriere, Serv Urgences Cerevrovasc, AP HP, F-75013 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Zilbovicius, M (corresponding author), CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, 4 Pl Gen Leclerc, F-91406 Orsay, France.	zilbo@shfj.cea.fr	boddaert, nathalie/GWV-2865-2022; Leboyer, Marion/AAW-3648-2021; samson, yves/C-5647-2013; Belin, Pascal/C-6247-2009	Leboyer, Marion/0000-0001-5473-3697; Belin, Pascal/0000-0002-7578-6365; samson, yves/0000-0002-8080-1427; boddaert, nathalie/0000-0003-0991-7774				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 2000, DIAGN STAT MAN; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331	15	311	316	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					801	802		10.1038/nn1291	http://dx.doi.org/10.1038/nn1291			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258587				2022-12-28	WOS:000222930800008
J	Slotnick, SD; Schacter, DL				Slotnick, SD; Schacter, DL			A sensory signature that distinguishes true from false memories	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ILLUSORY RECOGNITION MEMORY; EVENT-RELATED FMRI; EXPLICIT MEMORY; EPISODIC RETRIEVAL; PREFRONTAL CORTEX; IMPLICIT MEMORY; OLDER-ADULTS; BRAIN-AREAS; REACTIVATION	Human behavioral studies show that there is greater sensory/perceptual detail associated with true memories than false memories. We therefore hypothesized that true recognition of abstract shapes would elicit greater visual cortical activation than would false recognition. During functional magnetic resonance imaging (fMRI), participants studied exemplar shapes and later made recognition memory decisions ("old" or "new") concerning studied exemplars (old shapes), nonstudied lures (related shapes) and new shapes. Within visual processing regions, direct contrasts between true recognition ("old" response to an old shape; old-hit) and false recognition ("old" response to a related shape; related-false alarm) revealed preferential true recognition-related activity in early visual processing regions (Brodmann area (BA) 17, BA18). By comparison, both true and false recognition were associated with activity in early and late (BA19, BA37) visual processing regions, the late regions potentially supporting "old" responses, independent of accuracy. Further analyses suggested that the differential early visual processing activity reflected repetition priming, a type of implicit memory. Thus, the sensory signature that distinguishes true from false recognition may not be accessible to conscious awareness.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Slotnick, SD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	slotnick@wjh.harvard.edu		Schacter, Daniel/0000-0002-2460-6061	NIA NIH HHS [AG08441] Funding Source: Medline; NIMH NIH HHS [MH-NS60941] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008441, R37AG008441] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1973, STAT METHODS RES WOR; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 1996, J NEUROSCI, V16, P6219; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Dodson CS, 2002, PSYCHOL AGING, V17, P405, DOI 10.1037//0882-7974.17.3.405; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Koutstaal W, 1999, COGNITIVE NEUROPSYCH, V16, P317, DOI 10.1080/026432999380816; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Mather M, 1997, MEM COGNITION, V25, P826, DOI 10.3758/BF03211327; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 1996, J MEM LANG, V35, P76, DOI 10.1006/jmla.1996.0005; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1999, J MEM LANG, V40, P1, DOI 10.1006/jmla.1998.2611; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SCHOOLER JW, 1986, J EXP PSYCHOL LEARN, V12, P171, DOI 10.1037/0278-7393.12.2.171; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Uecker A, 1997, LEARN MEMORY, V4, P337, DOI 10.1101/lm.4.4.337; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; Velanova K, 2003, J NEUROSCI, V23, P8460; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Walla P, 1999, NEUROSCI LETT, V269, P129, DOI 10.1016/S0304-3940(99)00430-9; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	50	332	336	2	68	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					664	672		10.1038/nn1252	http://dx.doi.org/10.1038/nn1252			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	823VA	15156146				2022-12-28	WOS:000221640300022
J	Boguski, MS; Jones, AR				Boguski, MS; Jones, AR			Neurogenomics: at the intersection of neurobiology and genome sciences	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE; BRAIN; DNA; IDENTIFICATION; INFORMATICS; COMPLEXITY; EVOLUTION; ATLAS	Neurogenomics is the study of how the genome as a whole contributes to the evolution, development, structure and function of the nervous system. It includes investigations of how genome products (transcriptomes and proteomes) vary in time and space. Neurogenomics differs markedly from the application of genome sciences to other systems, particularly in the spatial category, because anatomy and connectivity are paramount to our understanding of function in the nervous system. We focus here on some of the influences of genomics and its associated technologies on neuroscience. We discuss comparative genomics, gene expression atlases of the brain, network genetics and applications to behavioral phenotypes, and consider the culture, organization and funding of genome-scale projects.	Allen Inst Brain Sci, Seattle, WA 98103 USA	Allen Institute for Brain Science	Boguski, MS (corresponding author), Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98103 USA.	markbo@alleninstitute.org						ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BANTLE JA, 1976, CELL, V8, P139, DOI 10.1016/0092-8674(76)90195-1; BASSET DE, 1995, TRENDS GENET, V11, P372, DOI 10.1016/S0168-9525(00)89109-X; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Boguski MS, 1999, SCIENCE, V286, P453, DOI 10.1126/science.286.5439.453; Boguski MS, 2003, NATURE, V422, P233, DOI 10.1038/nature01515; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Boguski MS, 2002, NATURE, V420, P515, DOI 10.1038/420515a; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOGUSKI MS, 1995, NEW ENGL J MED, V333, P645, DOI 10.1056/NEJM199509073331008; BOGUSKI MS, 2003, GENOMICS, V82, P253; Carson JP, 2002, CURR OPIN NEUROBIOL, V12, P562, DOI 10.1016/S0959-4388(02)00356-2; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; CHIKARAISHI DM, 1979, BIOCHEMISTRY-US, V18, P3249, DOI 10.1021/bi00582a009; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; Duyk GM, 2002, NAT GENET, V32, P465, DOI 10.1038/ng1027; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Ermolaeva O, 1998, NAT GENET, V20, P19, DOI 10.1038/1670; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gu ZJ, 1998, HUM MUTAT, V12, P221, DOI 10.1002/(SICI)1098-1004(1998)12:4<221::AID-HUMU1>3.0.CO;2-I; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Holden AL, 2002, BIOTECHNIQUES, P22; Insel TR, 2003, PLOS BIOL, V1, P9, DOI 10.1371/journal.pbio.0000017; Jessell T, 1998, NEURON, V20, P367, DOI 10.1016/S0896-6273(00)80980-0; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kohane I. S., 2002, MICROARRAYS INTEGRAT; Koslow SH, 2002, NAT REV NEUROSCI, V3, P311, DOI 10.1038/nrn787; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang M, 2004, J PHYSIOL-LONDON, V554, P22, DOI 10.1113/jphysiol.2003.049395; Lockhart DJ, 2001, NAT REV NEUROSCI, V2, P63, DOI 10.1038/35049070; Marcus G., 2004, BIRTH MIND TINY NUMB; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Moldin SO, 2001, MAMM GENOME, V12, P575, DOI 10.1007/s00335-001-4005-7; Nass S.J., 2003, LARGE SCALE BIOMEDIC; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Picoult-Newberg L, 1999, GENOME RES, V9, P167; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schadt EE, 2003, BIOCHEM SOC T, V31, P437, DOI 10.1042/BST0310437; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Singh RP, 2003, J NEUROSCI METH, V125, P93, DOI 10.1016/S0165-0270(03)00045-1; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Tecott LH, 2003, AM J PSYCHIAT, V160, P646, DOI 10.1176/appi.ajp.160.4.646; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tilghman SM, 1996, GENOME RES, V6, P773, DOI 10.1101/gr.6.9.773; TUGENDREICH S, 1994, HUM MOL GENET, V3, P1509, DOI 10.1093/hmg/3.suppl_1.1509; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van Horn JD, 2004, NAT NEUROSCI, V7, P473, DOI 10.1038/nn1231; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williamson AR, 1999, DRUG DISCOV TODAY, V4, P115, DOI 10.1016/S1359-6446(99)01303-3; Winslow RL, 2003, CIRC RES, V92, P953, DOI 10.1161/01.RES.0000072475.04373.07; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zweiger G., 2001, TRANSDUCING GENOME I; 2002, NAT GENET, V32, P461; 1995, NATURE, V373, P549; 2003, NAT NEUROSCI, V6, P1113	64	41	41	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					429	433		10.1038/nn1232	http://dx.doi.org/10.1038/nn1232			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114353				2022-12-28	WOS:000221101300008
J	Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC				Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC			Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM; MEMBRANE; SPINES; GLUR2; RAT	Regulation of AMPA receptor (AMPAR) trafficking is important for neural plasticity. Here we examined the trafficking and synthesis of the GluR1 and GluR2 subunits using ReAsH-EDT2 and FlAsH-EDT2 staining. Activity blockade of rat cultured neurons increased dendritic GluR1, but not GluR2, levels. Examination of transected dendrites revealed that both AMPAR subunits were synthesized in dendrites and that activity blockade enhanced dendritic synthesis of GluR1 but not GluR2. In contrast, acute pharmacological manipulations increased dendritic synthesis of both subunits. AMPARs synthesized in dendrites were inserted into synaptic plasma membranes and, after activity blockade, the electrophysiological properties of native synaptic AMPARs changed in the manner predicted by the imaging experiments. In addition to providing a novel mechanism for synaptic modifications, these results point out the advantages of using FlAsH-EDT2 and ReAsH-EDT2 for studying the trafficking of newly synthesized proteins in local cellular compartments such as dendrites.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci 0608, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Pharmacol, La Jolla, CA 92093 USA	Stanford University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Garner, Craig/0000-0003-1970-5417	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR04050] Funding Source: Medline; NIMH NIH HHS [MH63394] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Horton AC, 2003, J NEUROSCI, V23, P6188; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Martone ME, 1996, J NEUROSCI, V16, P7437; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Washburn MS, 1997, J NEUROSCI, V17, P9393; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	37	389	406	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					244	253		10.1038/nn1189	http://dx.doi.org/10.1038/nn1189			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770185				2022-12-28	WOS:000189197900014
J	Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX				Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX			Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds	NATURE NEUROSCIENCE			English	Article							FEMALE PRAIRIE VOLES; COCAINE-SEEKING BEHAVIOR; MICROTUS-OCHROGASTER; PARTNER PREFERENCES; SOCIAL-ORGANIZATION; MOLECULAR-MECHANISMS; DRUG-ADDICTION; D-2 RECEPTORS; MALE-RATS; VASOPRESSIN	The involvement of dopamine within the nucleus accumbens in the formation and maintenance of pair bonds was assessed in a series of experiments using the monogamous prairie vole. We show that dopamine transmission that promotes pair bond formation occurs within the rostral shell of the nucleus accumbens, but not in its core or caudal shell. Within this specific brain region, D1- and D2-like receptor activation produced opposite effects: D1-like activation prevented pair bond formation, whereas D2-like activation facilitated it. After extended cohabitation with a female, male voles showed behavior indicative of pair bond maintenance-namely, selective aggression towards unfamiliar females. These voles also showed a significant upregulation in nucleus accumbens D1- like receptors, and blockade of these receptors abolished selective aggression. Thus, neuroplastic reorganization of the nucleus accumbens dopamine system is responsible for the enduring nature of monogamous pair bonding. Finally, we show that this system may also contribute to species-specific social organization.	Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; NIMH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Aragona, BJ (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	aragona@unc.edu	Curtis, J. Thomas/J-4193-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD040722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066734, F31MH067396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019627] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-40722] Funding Source: Medline; NIDA NIH HHS [DA-19627] Funding Source: Medline; NIMH NIH HHS [MH-67396, MH-58616, MH-66734] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; DEWSBURY DA, 1988, NEBR SYM MOTIV, V35, P1; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Eyny YS, 2003, J NEUROSCI, V23, P1584; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 1997, J NEUROSCI, V17, P8580; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2002, J NEUROSCI, V22, P3306; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Panksepp J, 2002, ADDICTION, V97, P459, DOI 10.1046/j.1360-0443.2002.00025.x; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pizzuto T, 1998, BEHAV PROCESS, V43, P79, DOI 10.1016/S0376-6357(97)00091-0; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schuiling GA, 2003, J PSYCHOSOM OBST GYN, V24, P55, DOI 10.3109/01674820309042802; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Wang ZX, 1997, J COMP NEUROL, V378, P535; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	50	323	333	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					133	139		10.1038/nn1613	http://dx.doi.org/10.1038/nn1613			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327783				2022-12-28	WOS:000234288000027
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M			Prior experience enhances plasticity in adult visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; DEPENDENT PLASTICITY; AUDITORY-SYSTEM; MOUSE; RECOVERY; CATS; ADAPTATION; RESPONSES	The brain has a remarkable capacity to adapt to alterations in its sensory environment, which is normally much more pronounced in juvenile animals. Here we show that in adult mice, the ability to adapt to changes can be improved profoundly if the mouse has already experienced a similar change in its sensory environment earlier in life. Using the standard model for sensory plasticity in mouse visual cortex-ocular dominance (OD) plasticity-we found that a transient shift in OD, induced by monocular deprivation (MD) earlier in life, renders the adult visual cortex highly susceptible to subsequent MD many weeks later. Irrespective of whether the first MD was experienced during the critical period (around postnatal day 28) or in adulthood, OD shifts induced by a second MD were faster, more persistent and specific to repeated deprivation of the same eye. The capacity for plasticity in the mammalian cortex can therefore be conditioned by past experience.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X				Antonini A, 1999, J NEUROSCI, V19, P4388; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MCGONIGLE BO, 1978, NATURE, V272, P364, DOI 10.1038/272364a0; MITCHELL DE, 1977, J COMP NEUROL, V176, P53, DOI 10.1002/cne.901760104; MUIR DW, 1973, SCIENCE, V180, P420, DOI 10.1126/science.180.4084.420; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yang YP, 2005, NAT NEUROSCI, V8, P791, DOI 10.1038/nn1464	32	167	171	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					127	132		10.1038/nn1610	http://dx.doi.org/10.1038/nn1610			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327785				2022-12-28	WOS:000234288000026
J	Egner, T; Hirsch, J				Egner, T; Hirsch, J			Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN VISUAL-CORTEX; SELECTIVE ATTENTION; NEURAL MECHANISMS; SIMON TASK; AREAS; FMRI; INTEGRATION; PERCEPTION; MODULATION	A prominent model of how the brain regulates attention proposes that the anterior cingulate cortex monitors the occurrence of conflict between incompatible response tendencies and signals this information to a cognitive control system in dorsolateral prefrontal cortex. Cognitive control is thought to resolve conflict through the attentional biasing of perceptual processing, emphasizing task-relevant stimulus information. It is not known, however, whether conflict resolution is mediated by amplifying neural representations of task-relevant information, inhibiting representations of task-irrelevant information, or both. Here we manipulated trial-by-trial levels of conflict and control during a Stroop task using face stimuli, while recording hemodynamic responses from human visual cortex specialized for face processing. We show that, in response to high conflict, cognitive control mechanisms enhance performance by transiently amplifying cortical responses to task-relevant information rather than by inhibiting responses to task-irrelevant information. These results implicate attentional target-feature amplification as the primary mechanism for conflict resolution through cognitive control.	Columbia Univ, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA	Columbia University	Egner, T (corresponding author), Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Box 108,710 W 168th St, New York, NY 10032 USA.	te2111@columbia.edu	Egner, Tobias/A-5237-2009; Egner, Tobias/AAD-5864-2022	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cho IH, 2002, WA SCI TECHNOL, V2, P299, DOI 10.2166/ws.2002.0035; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ., 2004, HUMAN BRAIN FUNCTION, P971, DOI DOI 10.1016/B978-012264841-0/50050-0; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NIEUWENHUIS S, IN PRESS MEM COGNIT; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; SUMMERFIELD C, 2005, CEREB CORTEX    0713; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003	44	774	785	3	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1784	1790		10.1038/nn1594	http://dx.doi.org/10.1038/nn1594			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	988FC	16286928				2022-12-28	WOS:000233576200029
J	Rust, NC; Movshon, JA				Rust, NC; Movshon, JA			In praise of artifice	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD STRUCTURE; PRIMARY VISUAL-CORTEX; SIMPLE CELLS; SPATIAL STRUCTURE; NATURAL SCENES; CORTICAL-NEURONS; RESPONSES; ADAPTATION; CONTRAST; SIGNALS	The visual system evolved to process natural images, and the goal of visual neuroscience is to understand the computations it uses to do this. Indeed the goal of any theory of visual function is a model that will predict responses to any stimulus, including natural scenes. It has, however, recently become common to take this fundamental principle one step further: trying to use photographic or cinematographic representations of natural scenes ( natural stimuli) as primary probes to explore visual computations. This approach is both challenging and controversial, and we argue that this use of natural images is so fraught with difficulty that it is not useful. Traditional methods for exploring visual computations that use artificial stimuli with carefully selected properties have been and continue to be the most effective tools for visual neuroscience. The proper use of natural stimuli is to test models based on responses to these synthetic stimuli, not to replace them.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Rust, NC (corresponding author), NYU, Howard Hughes Med Inst, New York, NY 10003 USA.	rust@cns.nyu.edu						ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Angelucci A, 2002, PROG BRAIN RES, V136, P373; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CREUTZFELDT OD, 1978, NATURWISSENSCHAFTEN, V65, P307, DOI 10.1007/BF00368371; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smyth D, 2003, J NEUROSCI, V23, P4746; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1266, DOI 10.1152/jn.1985.53.5.1266; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Touryan J, 2002, J NEUROSCI, V22, P10811; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303	49	149	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1647	1650		10.1038/nn1606	http://dx.doi.org/10.1038/nn1606			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16306892				2022-12-28	WOS:000233576200009
J	Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL				Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL			Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM DEPRESSION; DENDRITIC SPINE MORPHOGENESIS; LHERMITTE-DUCLOS-DISEASE; CELL-GROWTH; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; PRODUCT TUBERIN; ACTIN DYNAMICS; KNOCKOUT MICE	Mutations in the TSC1 or TSC2 tumor suppressor genes lead to tuberous sclerosis complex (TSC), a dominant hamartomatous disorder that often presents with mental retardation, epilepsy and autism. The etiology of these neurological symptoms is unclear and the function of the TSC pathway in neurons is unknown. We found that in post-mitotic, hippocampal pyramidal neurons of mice and rats, loss of Tsc1 or Tsc2 triggered enlargement of somas and dendritic spines and altered the properties of glutamatergic synapses. Furthermore, loss of a single copy of the Tsc1 gene was sufficient to perturb dendritic spine structure. Morphological changes required regulation of the actin-depolymerization factor cofilin at a conserved LIM-kinase phosphorylation site, the phosphorylation of which was increased by loss of Tsc2. Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675	NINDS NIH HHS [5T32 NS07484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; CARTER AG, 2004, NEURON; Chang HI, 1996, BIOCHEM BIOPH RES CO, V223, P324, DOI 10.1006/bbrc.1996.0893; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hengstschlager M, 2003, BIOCHEM BIOPH RES CO, V312, P676, DOI 10.1016/j.bbrc.2003.10.170; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramesh V, 2003, BIOCHEM SOC T, V31, P579, DOI 10.1042/bst0310579; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SHEPHERD CW, 1995, AM J NEURORADIOL, V16, P149; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	363	376	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1727	1734		10.1038/nn1566	http://dx.doi.org/10.1038/nn1566			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286931				2022-12-28	WOS:000233576200022
J	Kuai, SG; Zhang, JY; Klein, SA; Levi, DM; Yu, C				Kuai, SG; Zhang, JY; Klein, SA; Levi, DM; Yu, C			The essential role of stimulus temporal patterning in enabling perceptual learning	NATURE NEUROSCIENCE			English	Article							CONTRAST DISCRIMINATION; ORIENTATION; TEMPLATE	Little is known about how temporal stimulus factors influence perceptual learning. Here we demonstrate an essential role of stimulus temporal patterning in enabling perceptual learning by showing that 'unlearnable' contrast and motion-direction discrimination (resulting from random interleaving of stimuli) can be readily learned when stimuli are practiced in a fixed temporal pattern. This temporal patterning does not facilitate learning by reducing stimulus uncertainty; further, learning enabled by temporal patterning can later generalize to randomly presented stimuli.	Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yu, C (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yucong@ion.ac.cn	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639	PHS HHS [R01-04776, R01-01728] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lu ZL, 2004, J VISION, V4, P44, DOI 10.1167/4.1.5; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; Tsodyks M, 2004, NEURAL NETWORKS, V17, P823, DOI 10.1016/j.neunet.2004.03.004; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4	9	47	48	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1497	1499		10.1038/nn1546	http://dx.doi.org/10.1038/nn1546			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222233				2022-12-28	WOS:000232966600022
J	Turney, SG; Bridgman, PC				Turney, SG; Bridgman, PC			Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity	NATURE NEUROSCIENCE			English	Article							CYTOSKELETAL DYNAMICS; GUIDANCE; MOTILITY; INTEGRINS; INHIBITOR	Guidance cues and signal transduction mechanisms acting at the nerve growth cone are fairly well understood, but the intracellular mechanisms operating to change the direction of axon outgrowth remain unknown. We now show that growth cones integrate myosin II - dependent contraction for rapid, coordinated turning at borders of laminin stripes in response to signals from laminin-activated integrin receptors; in the absence of myosin II activity, outgrowth continues across the borders.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bridgman, PC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	bridgmap@pcg.wustl.edu			NINDS NIH HHS [NS26150] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026150] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bridgman PC, 2003, METHOD CELL BIOL, V71, P353, DOI 10.1016/S0091-679X(03)01017-3; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Nakamoto T, 2004, CURR BIOL, V14, pR121, DOI 10.1016/j.cub.2004.01.020; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Schmucker D, 2003, NEURON, V40, P4, DOI 10.1016/S0896-6273(03)00603-2; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U	15	93	96	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					717	719		10.1038/nn1466	http://dx.doi.org/10.1038/nn1466			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880105				2022-12-28	WOS:000229345300009
J	Volkow, ND; Wise, RA				Volkow, ND; Wise, RA			How can drug addiction help us understand obesity?	NATURE NEUROSCIENCE			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; BRAIN DOPAMINE; FOOD-STIMULI; COCAINE; RISK; DEPENDENCE; REWARD; ABUSE; REINSTATEMENT; VULNERABILITY		Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Wise, Roy A/A-6465-2012		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000471, ZIADA000471] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adriani W, 2003, J NEUROSCI, V23, P4712; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Barrett E, 2004, OBES RES, V12, P362; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Carroll ME, 1999, PHARM TOXIC, P286; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; DALLMAN MF, IN PRESS BRAIN BEHAV; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Geary N, 2004, PHYSIOL BEHAV, V83, P659, DOI 10.1016/j.physbeh.2004.08.041; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Hu M, 2004, NEUROPSYCHOPHARMACOL, V29, P81, DOI 10.1038/sj.npp.1300301; JOHANSON CE, 1976, PHARMACOL BIOCHEM BE, V4, P45, DOI 10.1016/0091-3057(76)90174-X; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; JOSEFSSON JO, 1979, NATURE, V282, P78, DOI 10.1038/282078a0; KAVALIERS M, 1987, FASEB J, V46, P168; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; MacDonald AF, 2004, BRAIN RES, V1018, P78, DOI 10.1016/j.brainres.2004.05.043; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; *NAT CTR HLTH STAT, 2004, FASTATS A Z; Pijl H, 2003, EUR J PHARMACOL, V480, P125, DOI 10.1016/j.ejphar.2003.08.100; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Ranaldi R, 2001, BEHAV PHARMACOL, V12, P527, DOI 10.1097/00008877-200111000-00014; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; Richard D, 2002, EUR J PHARMACOL, V440, P189, DOI 10.1016/S0014-2999(02)01428-0; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; ROZIN P, 1969, J COMP PHYSIOL PSYCH, V69, P126, DOI 10.1037/h0027940; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shalev U, 2001, J NEUROSCI, V21; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Toschke AM, 2003, J PERINAT MED, V31, P251, DOI 10.1515/JPM.2003.034; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Volkow ND, 2000, LIFE SCI, V67, pPL1507; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1986, BRAIN RES, V368, P62, DOI 10.1016/0006-8993(86)91042-5; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zubieta JK, 1996, NAT MED, V2, P1225, DOI 10.1038/nm1196-1225	60	748	763	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					555	560		10.1038/nn1452	http://dx.doi.org/10.1038/nn1452			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	923FM	15856062				2022-12-28	WOS:000228895100012
J	Tissir, F; Bar, I; Jossin, Y; Goffinet, AM				Tissir, F; Bar, I; Jossin, Y; Goffinet, AM			Protocadherin Celsr3 is crucial in axonal tract development	NATURE NEUROSCIENCE			English	Article							7-PASS TRANSMEMBRANE CADHERIN; DROSOPHILA VISUAL-SYSTEM; NEURAL-TUBE DEFECTS; PLANAR POLARITY; MUTANT MICE; THALAMOCORTICAL DEVELOPMENT; LOOP-TAIL; MOUSE; FLAMINGO; GUIDANCE	In the embryonic CNS, the development of axonal tracts is required for the formation of connections and is regulated by multiple genetic and microenvironmental factors. Here we show that mice with inactivation of Celsr3, an ortholog of Drosophila melanogaster flamingo (fmi; also known as starry night, stan) that encodes a seven-pass protocadherin, have marked, selective anomalies of several major axonal fascicles, implicating protocadherins in axonal development in the mammalian CNS for the first time. In flies, fmi controls planar cell polarity (PCP) in a frizzled-dependent but wingless-independent manner. The neural phenotype in Celsr3 mutant mice is similar to that caused by inactivation of Fzd3, a member of the frizzled family. Celsr3 and Fzd3 are expressed together during brain development and may act in synergy. Thus, a genetic pathway analogous to the one that controls PCP is key in the development of the axonal blueprint.	Univ Louvain, Sch Med, Dev Neurobiol Unit, B-1200 Brussels, Belgium; Univ Namur, Sch Med, Mol Physiol Res Unit, B-5000 Namur, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Namur	Goffinet, AM (corresponding author), Univ Louvain, Sch Med, Dev Neurobiol Unit, 73 Ave Mounier,Box DENE7382, B-1200 Brussels, Belgium.	andre.goffinet@dene.ucl.ac.be	bar, isabelle/AAQ-7795-2020	Tissir, Fadel/0000-0002-9292-6622; Jossin, Yves/0000-0001-8466-7432				Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Chae J, 1999, DEVELOPMENT, V126, P5421; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Finger JH, 2002, J NEUROSCI, V22, P10346; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hadjantonakis AK, 1997, GENOMICS, V45, P97, DOI 10.1006/geno.1997.4892; Hadjantonakis AK, 1998, MECH DEVELOP, V78, P91, DOI 10.1016/S0925-4773(98)00153-1; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Jones L, 2002, DEVELOPMENT, V129, P5041; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 2003, CEREB CORTEX, V13, P661, DOI 10.1093/cercor/13.6.661; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Pratt T, 2002, J NEUROSCI, V22, P8523; RETHELYI M, 1972, BRAIN RES, V46, P203, DOI 10.1016/0006-8993(72)90016-9; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; SHOLL DA, 1953, J ANAT, V87, P387; Stoykova A, 2000, J NEUROSCI, V20, P8042; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Uemura T, 2003, J BIOCHEM, V134, P625, DOI 10.1093/jb/mvg186; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Wang YS, 2002, J NEUROSCI, V22, P8563; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	50	198	204	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					451	457		10.1038/nn1428	http://dx.doi.org/10.1038/nn1428			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778712				2022-12-28	WOS:000228040400015
J	Martinez, LM; Wang, QB; Reid, RC; Pillai, C; Alonso, JM; Sommer, FT; Hirsch, JA				Martinez, LM; Wang, QB; Reid, RC; Pillai, C; Alonso, JM; Sommer, FT; Hirsch, JA			Receptive field structure varies with layer in the primary visual cortex	NATURE NEUROSCIENCE			English	Article							COMPLEX CELLS; ORIENTATION SELECTIVITY; ORDINAL POSITION; CORTICAL SIMPLE; STRIATE CORTEX; LOCAL CIRCUITS; CAT; NEURONS; ORGANIZATION; PROJECTIONS	Here we ask whether visual response pattern varies with position in the cortical microcircuit by comparing the structure of receptive fields recorded from the different layers of the cat's primary visual cortex. We used whole-cell recording in vivo to show the spatial distribution of visually evoked excitatory and inhibitory inputs and to stain individual neurons. We quantified the distribution of 'On' and 'Off' responses and the presence of spatially opponent excitation and inhibition within the receptive field. The thalamorecipient layers (4 and upper 6) were dominated by simple cells, as defined by two criteria: they had separated On and Off subregions, and they had push-pull responses (in a given subregion, stimuli of the opposite contrast evoked responses of the opposite sign). Other types of response profile correlated with laminar location as well. Thus, connections unique to each visual cortical layer are likely to serve distinct functions.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ A Coruna, Dept Med, La Coruna 15006, Spain; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; Redwood Neurosci Inst, Menlo Pk, CA 94025 USA	University of Southern California; Universidade da Coruna; Harvard University; Harvard Medical School; State University of New York (SUNY) System; SUNY Optometry	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013	Pillai, Cinthi/0000-0002-7662-443X	NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER; NEI NIH HHS [EY09593, R01 EY009593] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Contreras D, 2003, J NEUROSCI, V23, P6936; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; HENRY GH, 1977, BRAIN RES, V133, P1, DOI 10.1016/0006-8993(77)90045-2; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Hirsch JA, 1998, J NEUROSCI, V18, P8086; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MATA ML, IN PRESS J NEUROPHYS; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rivadulla C, 2001, J NEUROSCI, V21, P1710, DOI 10.1523/JNEUROSCI.21-05-01710.2001; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Swadlow HA, 1996, J NEUROPHYSIOL, V75, P1753, DOI 10.1152/jn.1996.75.4.1753; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; Troyer TW, 1998, J NEUROSCI, V18, P5908; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002	50	150	151	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					372	379		10.1038/nn1404	http://dx.doi.org/10.1038/nn1404			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711543	Green Accepted			2022-12-28	WOS:000227354600023
J	Mulkey, DK; Stornetta, RL; Weston, MC; Simmons, JR; Parker, A; Bayliss, DA; Guyenet, PG				Mulkey, DK; Stornetta, RL; Weston, MC; Simmons, JR; Parker, A; Bayliss, DA; Guyenet, PG			Respiratory control by ventral surface chemoreceptor neurons in rats	NATURE NEUROSCIENCE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; CENTRAL CHEMOSENSITIVITY; SYMPATHOEXCITATORY NEURONS; NEUROKININ-1 RECEPTORS; SEROTONERGIC NEURONS; RAPHE NEURONS; K+ CHANNEL; MODULATION; CO2; PROJECTIONS	A long-standing theory posits that central chemoreception, the CNS mechanism for CO2 detection and regulation of breathing, involves neurons located at the ventral surface of the medulla oblongata (VMS). Using in vivo and in vitro electrophysiological recordings, we identify VMS neurons within the rat retrotrapezoid nucleus (RTN) that have characteristics befitting these elusive chemoreceptors. These glutamatergic neurons are vigorously activated by CO2 in vivo, whereas serotonergic neurons are not. Their CO2 sensitivity is unaffected by pharmacological blockade of the respiratory pattern generator and persists without carotid body input. RTN CO2-sensitive neurons have extensive dendrites along the VMS and they innervate key pontomedullary respiratory centers. In brainstem slices, a subset of RTN neurons with markedly similar morphology is robustly activated by acidification and CO2. Their pH sensitivity is intrinsic and involves a background K+ current. In short, the CO2-sensitive neurons of the RTN are good candidates for the long sought-after VMS chemoreceptors.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Guyenet, PG (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	pgg@virginia.edu		Mulkey, Daniel/0000-0002-7040-3927; Stornetta, Ruth/0000-0001-7278-8923; parker, anson/0000-0002-1206-8817	NHLBI NIH HHS [R01 HL028785, R01 HL074011, HL074011] Funding Source: Medline; NIDDK NIH HHS [5T32DK007646] Funding Source: Medline; NINDS NIH HHS [R01 NS033583, NS33583] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028785, R01HL074011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033583, R01NS033583] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballantyne D, 2001, RESP PHYSIOL, V129, P5, DOI 10.1016/S0034-5687(01)00297-3; Bayliss DA, 2001, RESP PHYSIOL, V129, P159, DOI 10.1016/S0034-5687(01)00288-2; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BOHN MC, 1987, DEV BRAIN RES, V37, P257, DOI 10.1016/0165-3806(87)90247-1; BROWN DL, 1985, CIRC RES, V56, P359; CONNELLY CA, 1989, NEUROSCI LETT, V105, P34, DOI 10.1016/0304-3940(89)90007-4; Cream C, 2002, RESP PHYSIOL NEUROBI, V130, P121, DOI 10.1016/S0034-5687(01)00338-3; ELDRIDGE FL, 1985, J PHYSIOL-LONDON, V358, P285, DOI 10.1113/jphysiol.1985.sp015551; ELLENBERGER HH, 1990, BRAIN RES, V513, P35, DOI 10.1016/0006-8993(90)91086-V; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FELDMAN JL, 1999, FUNDAMENTAL NEUROSCI, P1063; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; FUKUDA Y, 1993, NEUROSCI LETT, V153, P177, DOI 10.1016/0304-3940(93)90316-D; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; HASELTON JR, 1989, AM J PHYSIOL, V256, pR739, DOI 10.1152/ajpregu.1989.256.3.R739; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Li AH, 2002, RESP PHYSIOL NEUROBI, V133, P11, DOI 10.1016/S1569-9048(02)00134-9; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nattie EE, 2001, RESP PHYSIOL, V129, P257, DOI 10.1016/S0034-5687(01)00295-X; Okada Y, 2002, J APPL PHYSIOL, V93, P427, DOI 10.1152/japplphysiol.00620.2000; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; OREM J, 1983, J NEUROPHYSIOL, V50, P1098, DOI 10.1152/jn.1983.50.5.1098; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; RICHERSON GB, 1995, J NEUROPHYSIOL, V73, P933, DOI 10.1152/jn.1995.73.3.933; SATO M, 1992, J APPL PHYSIOL, V73, P96, DOI 10.1152/jappl.1992.73.1.96; Schreihofer AM, 1997, J COMP NEUROL, V387, P524, DOI 10.1002/(SICI)1096-9861(19971103)387:4<524::AID-CNE4>3.0.CO;2-4; Shigetomi E, 2004, J NEUROSCI, V24, P3125, DOI 10.1523/JNEUROSCI.0090-04.2004; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; Spyer KM, 2004, EXP PHYSIOL, V89, P53, DOI 10.1113/expphysiol.2003.002659; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Stornetta RL, 2003, J COMP NEUROL, V455, P113, DOI 10.1002/cne.10486; Sun MK, 1996, PHARMACOL REV, V48, P465; SUN MK, 1988, BRAIN RES, V438, P23, DOI 10.1016/0006-8993(88)91320-0; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Wellner-Kienitz MC, 1998, J NEUROPHYSIOL, V79, P2885, DOI 10.1152/jn.1998.79.6.2885; Weston MC, 2004, J COMP NEUROL, V473, P73, DOI 10.1002/cne.20076; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x	49	420	427	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1360	1369		10.1038/nn1357	http://dx.doi.org/10.1038/nn1357			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558061				2022-12-28	WOS:000225353900017
J	Beauchamp, MS; Argall, BD; Bodurka, J; Duyn, JH; Martin, A				Beauchamp, MS; Argall, BD; Bodurka, J; Duyn, JH; Martin, A			Unraveling multisensory integration: patchy organization within human STS multisensory cortex	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; OCULAR DOMINANCE; MACAQUE MONKEY; RHESUS-MONKEY; HUMAN BRAIN; PROJECTIONS; OBJECTS; SIGNAL; TRACER; SPEECH	Although early sensory cortex is organized along dimensions encoded by receptor organs, little is known about the organization of higher areas in which different modalities are integrated. We investigated multisensory integration in human superior temporal sulcus using recent advances in parallel imaging to perform functional magnetic resonance imaging (fMRI) at very high resolution. These studies suggest a functional architecture in which information from different modalities is brought into close proximity via a patchy distribution of inputs, followed by integration in the intervening cortex.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; NINDS, Sect Adv MRI, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	mbeauchamp@nih.gov	Duyn, Jozef H/F-2483-2010; Argall, Brenna/G-2543-2011; martin, alex/B-6176-2009; Beauchamp, Michael/AAK-9813-2020	Beauchamp, Michael/0000-0002-7599-9934	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002990, Z01NS002990] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	15	391	391	4	45	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1190	1192		10.1038/nn1333	http://dx.doi.org/10.1038/nn1333			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475952				2022-12-28	WOS:000224749400010
J	Ren, XR; Ming, GL; Xie, Y; Hong, Y; Sun, DM; Zhao, ZQ; Feng, Z; Wang, Q; Shim, S; Chen, ZF; Song, HJ; Mei, L; Xiong, WC				Ren, XR; Ming, GL; Xie, Y; Hong, Y; Sun, DM; Zhao, ZQ; Feng, Z; Wang, Q; Shim, S; Chen, ZF; Song, HJ; Mei, L; Xiong, WC			Focal adhesion kinase in netrin-1 signaling	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE ATTRACTION; PHOSPHOLIPASE C-GAMMA; COLORECTAL-CANCER; TYROSINE PHOSPHORYLATION; AXON OUTGROWTH; DCC; GUIDANCE; RECEPTOR; PROTEIN; SRC	Netrins are a family of secreted molecules that are important for axonal outgrowth and guidance in the developing nervous system. However, the signaling mechanisms that lie immediately downstream of netrin receptors remain poorly understood. Here we report that the netrin receptor DCC (deleted in colorectal cancer) interacts with the focal adhesion kinase (FAK), a kinase implicated in regulating cell adhesion and migration. FAK was expressed in developing brains and was localized with DCC in cultured neurons. Netrin-1 induced FAK and DCC tyrosine phosphorylation. Disruption of FAK signaling abolished netrin-1-induced neurite outgrowth and attractive growth cone turning. Taken together, these results indicate a new signaling mechanism for DCC, in which FAK is activated upon netrin-1 stimulation and mediates netrin-1 function; they also identify a critical role for FAK in axon navigation.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Washington Univ, Sch Med Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Xiong, WC (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	wxiong@mcg.edu	Ming, Guo-li/J-7880-2013; Mei, Lin/G-8755-2012	Ming, Guo-li/0000-0002-2517-6075	NIGMS NIH HHS [R01 GM063861] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Cary LA, 1996, J CELL SCI, V109, P1787; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rodriguez-Fernandez JL, 1999, BIOESSAYS, V21, P1069, DOI 10.1002/(SICI)1521-1878(199912)22:1<1069::AID-BIES13>3.0.CO;2-C; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	50	178	186	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1204	1212		10.1038/nn1330	http://dx.doi.org/10.1038/nn1330			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494733				2022-12-28	WOS:000224749400013
J	Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C				Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C			Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVE MULTIPLE-SCLEROSIS; HERV-W; CEREBROSPINAL-FLUID; PRIMATE EVOLUTION; EXPRESSION; PROTEIN; ACTIVATION; VIRUS; BRAIN	Human endogenous retroviruses (HERVs) constitute 8% of the human genome and have been implicated in both health and disease. Increased HERV gene activity occurs in immunologically activated glia, although the consequences of HERV expression in the nervous system remain uncertain. Here, we report that the HERV-W encoded glycoprotein syncytin is upregulated in glial cells within acute demyelinating lesions of multiple sclerosis patients. Syncytin expression in astrocytes induced the release of redox reactants, which were cytotoxic to oligodendrocytes. Syncytin-mediated neuroinflammation and death of oligodendrocytes, with the ensuing neurobehavioral deficits, were prevented by the antioxidant ferulic acid in a mouse model of multiple sclerosis. Thus, syncytin's proinflammatory properties in the nervous system demonstrate a novel role for an endogenous retrovirus protein, which may be a target for therapeutic intervention.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA; Ecole Normale Super Lyon, IFR BioSci Lyon Gerland 128, UMR CNRS bioMerieux, F-69364 Lyon, France; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	University of Calgary; University of Kentucky; University of Kentucky; Ecole Normale Superieure de Lyon (ENS de LYON); University of Calgary; University of Oxford; University of Alberta	Power, C (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	power@ucalgary.ca	Antony, Joseph Mathew/W-7552-2019; Mallet, Francois/G-4812-2014; Wallace, John/AAL-3763-2021; Power, Christopher/C-7181-2013	Antony, Joseph Mathew/0000-0002-5700-7719; van Marle, Guido/0000-0002-5148-6229; MALLET, Francois/0000-0002-1331-096X; Yong, V. Wee/0000-0002-2600-3563; Power, Christopher/0000-0002-5131-9711				Anlar O, 2003, Electromyogr Clin Neurophysiol, V43, P349; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Calabrese V, 2003, NEUROCHEM RES, V28, P1321, DOI 10.1023/A:1024984013069; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hua LWL, 2002, J NEUROCHEM, V83, P1120, DOI 10.1046/j.1471-4159.2002.01226.x; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Lynch WP, 2000, J VIROL, V74, P1558, DOI 10.1128/JVI.74.3.1558-1565.2000; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Ogiwara T, 2003, ANTICANCER RES, V23, P1317; PATY DW, 1998, MULT SCLER, P68; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ravikumar A., 2000, Indian Journal of Experimental Biology, V38, P438; ROSEN CL, 1989, J NEUROSCI, V9, P3371; Scott GS, 2003, GLIA, V41, P105, DOI 10.1002/glia.10137; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; TAKACS S, 1988, SUPERCOND SCI TECH, V1, P53, DOI 10.1088/0953-2048/1/1/011; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van Marle G, 2003, VIROLOGY, V309, P61, DOI 10.1016/S0042-6822(02)00139-3; Wesselingh SL, 2001, CURR OPIN NEUROL, V14, P375, DOI 10.1097/00019052-200106000-00018; West MJ, 1996, J COMP NEUROL, V370, P11; YONG VW, 1997, PROTOCOLS NEURAL CEL, P81; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	43	287	306	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1088	1095		10.1038/nn1319	http://dx.doi.org/10.1038/nn1319			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452578				2022-12-28	WOS:000224156900018
J	Hawkey, DJC; Amitay, S; Moore, DR				Hawkey, DJC; Amitay, S; Moore, DR			Early and rapid perceptual learning	NATURE NEUROSCIENCE			English	Article							FREQUENCY DISCRIMINATION; IMPAIRED CHILDREN; PLASTICITY; PATTERNS	Major, rapid performance improvements in perceptual training are often dismissed as `task' or `procedural' learning because they are fast and generalize within a task. We assessed the contributions of perceptual and procedural learning to improvement in an auditory tone frequency learning task in humans and found that perceptual learning accounted for between 76% and 98% of the rapid early performance improvement.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England		Amitay, S (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.	sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottselig JM, 2004, LEARN MEMORY, V11, P162, DOI 10.1101/lm.63304; Irvine DRF, 2000, J ACOUST SOC AM, V108, P2964, DOI 10.1121/1.1323465; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; LEEK MR, 1988, PERCEPT PSYCHOPHYS, V43, P389, DOI 10.3758/BF03208810; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBINSON K, 1996, EAR HEARING, V17, P51; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	15	124	132	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1055	1056		10.1038/nn1315	http://dx.doi.org/10.1038/nn1315			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361880				2022-12-28	WOS:000224156900013
J	Logothetis, NK				Logothetis, NK			Francis Crick - 1916-2004 - Obituary	NATURE NEUROSCIENCE			English	Biographical-Item									Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019					CRICK FH, PUBLICATION LIST	1	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1027	1028		10.1038/nn1004-1027	http://dx.doi.org/10.1038/nn1004-1027			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452571	Bronze, Green Published			2022-12-28	WOS:000224156900007
J	Schaal, S; Sternad, D; Osu, R; Kawato, M				Schaal, S; Sternad, D; Osu, R; Kawato, M			Rhythmic arm movement is not discrete	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; CENTRAL PATTERN GENERATOR; REACHING MOVEMENTS; SEGMENTED-CONTROL; MOTOR AREAS; POWER-LAW; COORDINATION; HUMANS; MODEL; SPACE	Rhythmic movements, such as walking, chewing or scratching, are phylogenetically old motor behaviors found in many organisms, ranging from insects to primates. In contrast, discrete movements, such as reaching, grasping or kicking, are behaviors that have reached sophistication primarily in younger species, particularly primates. Neurophysiological and computational research on arm motor control has focused almost exclusively on discrete movements, essentially assuming similar neural circuitry for rhythmic tasks. In contrast, many behavioral studies have focused on rhythmic models, subsuming discrete movement as a special case. Here, using a human functional neuroimaging experiment, we show that in addition to areas activated in rhythmic movement, discrete movement involves several higher cortical planning areas, even when both movement conditions are confined to the same single wrist joint. These results provide neuroscientific evidence that rhythmic arm movement cannot be part of a more general discrete movement system and may require separate neurophysiological and theoretical treatment.	Univ So Calif, Los Angeles, CA 90089 USA; Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; ATR Computat Neurosci Labs, Seika, Kyoto 6190288, Japan	University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schaal, S (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	sschaal@usc.edu	Sternad, Dagmar/D-8341-2013					ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Brett M, 2001, NEUROIMAGE, V13, pS85; Brett M., 2002, 8 INT C FUNC MAPP HU; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; de Rugy A, 2003, BRAIN RES, V994, P160, DOI 10.1016/j.brainres.2003.09.031; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FELDMAN AG, 1980, NEUROSCIENCE, V5, P81, DOI 10.1016/0306-4522(80)90073-1; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Ijspeert AJ, 2003, ADV NEURAL INFORM PR, V2003, P1547; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; Kugler P.N., 1987, INFORM NATURAL LAW S; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Latash M., 1993, CONTROL HUMAN MOVEME; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pinter MM, 1999, SPINAL CORD, V37, P531, DOI 10.1038/sj.sc.3100886; Richardson MJE, 2002, J NEUROSCI, V22, P8201; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; Seitz RJ, 2000, EXP BRAIN RES, V133, P71, DOI 10.1007/s002210000402; Smits-Engelsman BCM, 2002, EXP BRAIN RES, V145, P222, DOI 10.1007/s00221-002-1115-8; SOECHTING JF, 1987, NEUROSCIENCE, V23, P53, DOI 10.1016/0306-4522(87)90270-3; Sternad D, 2003, BRAIN RES, V989, P152, DOI 10.1016/S0006-8993(03)03292-X; Sternad D, 2002, EXP BRAIN RES, V147, P162, DOI 10.1007/s00221-002-1219-1; Sternad D, 2000, HUM MOVEMENT SCI, V19, P627, DOI 10.1016/S0167-9457(00)00028-2; Sternad D, 1999, EXP BRAIN RES, V124, P118, DOI 10.1007/s002210050606; Talairach J., 1988, COPLANAR STEREOTAXIC; Thickbroom GW, 1999, EXP BRAIN RES, V126, P431, DOI 10.1007/s002210050749; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wei KL, 2003, MOTOR CONTROL, V7, P134, DOI 10.1123/mcj.7.2.134	46	265	265	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1137	1144		10.1038/nn1322	http://dx.doi.org/10.1038/nn1322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452580				2022-12-28	WOS:000224156900024
J	Moqrich, A; Earley, TJ; Watson, J; Andahazy, M; Backus, C; Martin-Zanca, D; Wright, DE; Reichardt, LF; Patapoutian, A				Moqrich, A; Earley, TJ; Watson, J; Andahazy, M; Backus, C; Martin-Zanca, D; Wright, DE; Reichardt, LF; Patapoutian, A			Expressing TrkC from the TrkA locus causes a subset of dorsal root ganglia neurons to switch fate	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; SENSORY AFFERENTS; GENE; NEUROTROPHIN-3; RECEPTOR; CHANNEL; IDENTIFICATION; PROJECTION; AXONS	Tactile information is perceived by a heterogeneous population of specialized neurons. Neurotrophin receptors (the receptor tyrosine kinases, Trks) mark the major classes of these sensory neurons: TrkA is expressed in neurons that sense temperature and noxious stimuli, and TrkC is expressed in proprioceptive neurons that sense body position. Neurotrophin signaling through these receptors is required for cell survival. To test whether neurotrophins have an instructive role in sensory specification, we expressed rat TrkC from the TrkA (also known as Ntrk1) locus in mice. The surviving presumptive TrkA-expressing neurons adopted a proprioceptive phenotype, indicating that neurotrophin signaling can specify sensory neuron subtypes.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Calif San Francisco, Program Neurosci, Dept Physiol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94141 USA; Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca 37007, Spain; Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Scripps Research Institute; Novartis; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Kansas; University of Kansas Medical Center	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		moqrich, aziz/0000-0002-1937-1675	NINDS NIH HHS [R01 NS042822, R29NS37910, P01 NS016033, P01 NS016033-22, 5R01NS42822, R01 NS043314] Funding Source: Medline; PHS HHS [P01-16033] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037910, R01NS043314, R01NS042822, P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Scott SA, 1992, SENSORY NEURONS DIVE; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Song HJ, 1997, NATURE, V389, P412, DOI 10.1038/38788; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0	25	54	57	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					812	818		10.1038/nn1283	http://dx.doi.org/10.1038/nn1283			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15247919	Green Accepted, Green Published			2022-12-28	WOS:000222930800010
J	Haag, J; Borst, A				Haag, J; Borst, A			Neural mechanism underlying complex receptive field properties of motion-sensitive interneurons	NATURE NEUROSCIENCE			English	Article							ACCESSORY OPTIC-SYSTEM; SUPERIOR TEMPORAL AREA; RESPONSE SELECTIVITY; NETWORK INTERACTIONS; VISUAL INTERNEURONS; PRETECTAL NEURONS; MACAQUE MONKEY; FLOW STIMULI; LOBULA PLATE; MST NEURONS	In many species, neurons responding to visual motion at higher processing stages are often specifically tuned to particular flow fields; however, the neural circuitry that leads to this selectivity is not yet understood. Here we have studied this problem in 'vertical system' (VS) cells of the blowfly lobula plate. These neurons possess distinctive local preferred directions in different parts of their receptive field. Dual recordings from pairs of VS cells show that they are electrically coupled. This coupling is responsible for the elongated horizontal extent of their receptive fields. VS cells with a lateral receptive field have additional connections to a VS cell with a frontal receptive field and to the horizontal system, tuning these cells to rotational flow fields. In summary, the receptive field of these cells consists of two components: one that they receive from local motion detectors on their dendrite, and one that they import from other large-field neurons.	Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Haag, J (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	haag@neuro.mpg.de						BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; BORST A, 2004, IMAGING LIVING CELLS, pCH44; BUCHNER E, 1980, CELL TISSUE RES, V211, P51; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1829, DOI 10.1152/jn.00654.2002; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1140, DOI 10.1152/jn.00653.2002; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Duffy CJ, 1997, J NEUROSCI, V17, P2839; Farrow K, 2003, J NEUROSCI, V23, P9805; Gu Y, 2001, NEUROSCIENCE, V104, P153, DOI 10.1016/S0306-4522(01)00056-2; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Hausen K., 1981, Verhandlungen der Deutschen Zoologischen Gesellschaft, V74, P49; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; HOFFMANN KP, 1989, J NEUROPHYSIOL, V62, P416, DOI 10.1152/jn.1989.62.2.416; Hoffmann KP, 2002, J NEUROPHYSIOL, V87, P2113, DOI 10.1152/jn.00488.2001; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Lappe M, 1996, J NEUROSCI, V16, P6265; Mamiya A, 2003, J NEUROSCI, V23, P9557; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; STRAUSFELD NJ, 1984, PHOTORECEPTION VISIO, P483; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Wylie DRW, 1999, J NEUROPHYSIOL, V81, P267, DOI 10.1152/jn.1999.81.1.267	34	79	79	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					628	634		10.1038/nn1245	http://dx.doi.org/10.1038/nn1245			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133514				2022-12-28	WOS:000221640300017
J	Polsky, A; Mel, BW; Schiller, J				Polsky, A; Mel, BW; Schiller, J			Computational subunits in thin dendrites of pyramidal cells	NATURE NEUROSCIENCE			English	Article							SYNAPTIC INPUT; POSTSYNAPTIC POTENTIALS; SUPRALINEAR SUMMATION; BASAL DENDRITES; NEURONS; INTEGRATION; LOCATION; SPIKES; RAT; DISTRIBUTIONS	The thin basal and oblique dendrites of cortical pyramidal neurons receive most of the synaptic inputs from other cells, but their integrative properties remain uncertain. Previous studies have most often reported global linear or sublinear summation. An alternative view, supported by biophysical modeling studies, holds that thin dendrites provide a layer of independent computational `subunits' that sigmoidally modulate their inputs prior to global summation. To distinguish these possibilities, we combined confocal imaging and dual-site focal synaptic stimulation of identified thin dendrites in rat neocortical pyramidal neurons. We found that nearby inputs on the same branch summed sigmoidally, whereas widely separated inputs or inputs to different branches summed linearly. This strong spatial compartmentalization effect is incompatible with a global summation rule and provides the first experimental support for a two-layer 'neural network' model of pyramidal neuron thin-branch integration. Our findings could have important implications for the computing and memory-related functions of cortical tissue.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	Technion Israel Institute of Technology; University of Southern California	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Ariav G, 2003, J NEUROSCI, V23, P7750; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jones EG, 1999, CEREB CORTEX, V13, P139; Kepecs A, 2002, J NEUROSCI, V22, P9053; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1992, ADV NEUR IN, V4, P35; Mel BW, 1998, J NEUROSCI, V18, P4325; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Oakley JC, 2001, J NEUROPHYSIOL, V86, P503, DOI 10.1152/jn.2001.86.1.503; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	44	498	502	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					621	627		10.1038/nn1253	http://dx.doi.org/10.1038/nn1253			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156147	Green Accepted			2022-12-28	WOS:000221640300016
J	Holroyd, CB; Nieuwenhuis, S; Yeung, N; Nystrom, L; Mars, RB; Coles, MGH; Cohen, JD				Holroyd, CB; Nieuwenhuis, S; Yeung, N; Nystrom, L; Mars, RB; Coles, MGH; Cohen, JD			Dorsal anterior cingulate cortex shows fMRI response to internal and external error signals	NATURE NEUROSCIENCE			English	Article							REWARD; COGNITION; INTERFACE; DOPAMINE	In our event-related functional magnetic resonance imaging (fMRI) experiment, participants learned to select between two response options by trial-and-error, using feedback stimuli that indicated monetary gains and losses. The results of the experiment indicate that error responses and error feedback activate the same region of dorsal anterior cingulate cortex, suggesting that this region is sensitive to both internal and external sources of error information.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Free Univ Amsterdam, Dept Cognit Psychol, NL-1081 BT Amsterdam, Netherlands; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Univ Nijmegen, Nijmegen Inst Cognit & & Informat, NL-6500 HE Nijmegen, Netherlands	Princeton University; Vrije Universiteit Amsterdam; Princeton University; Radboud University Nijmegen	Holroyd, CB (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	cholroyd@princeton.edu	Mars, Rogier/G-2312-2018; Mars, Rogier/GWZ-9665-2022	Mars, Rogier/0000-0001-6302-8631; Holroyd, Clay/0000-0003-3084-8574; Yeung, Nick/0000-0003-1905-2129	NIMH NIH HHS [MH63550, MH064445] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445, F32MH063550] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; HOLROYD CB, COGNITIVE NEUROSCIEN; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003	14	367	387	0	32	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					497	498		10.1038/nn1238	http://dx.doi.org/10.1038/nn1238			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097995	Green Published			2022-12-28	WOS:000221101300025
J	Fan, W; Ellacott, KLJ; Halatchev, IG; Takahashi, K; Yu, PX; Cone, RD				Fan, W; Ellacott, KLJ; Halatchev, IG; Takahashi, K; Yu, PX; Cone, RD			Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system	NATURE NEUROSCIENCE			English	Article							POMC NEURONS; LEPTIN; OBESITY; NUCLEUS; MICE; RAT	Hypothalamic pro-opiomelanocortin (POMC) neurons help regulate long-term energy stores. POMC neurons are also found in the nucleus tractus solitarius (NTS), a region regulating satiety. We show here that mouse brainstem NTS POMC neurons are activated by cholecystokinin (CCK) and feeding-induced satiety and that activation of the neuronal melanocortin-4 receptor (MC4-R) is required for CCK-induced suppression of feeding; the melanocortin system thus provides a potential substrate for integration of long-term adipostatic and short-term satiety signals.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Cone, RD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	fanw@ohsu.edu; cone@ohsu.edu		Ellacott, Kate/0000-0001-5261-7465	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055819, R01DK062179] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55819, DK62179] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azzara AV, 2002, PHYSIOL BEHAV, V77, P411, DOI 10.1016/S0031-9384(02)00883-1; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi I.S., 2003, NEW ENGL J MED, V348, P1160, DOI DOI 10.1056/NEJM0A002050; Grill HJ, 1998, J NEUROSCI, V18, P10128; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; LUCKMAN SM, 1992, J NEUROENDOCRINOL, V4, P149, DOI 10.1111/j.1365-2826.1992.tb00152.x; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; Williams DL, 2002, PSYCHOPHARMACOLOGY, V161, P47, DOI 10.1007/s00213-002-1022-5	15	227	236	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					335	336		10.1038/nn1214	http://dx.doi.org/10.1038/nn1214			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034587				2022-12-28	WOS:000220482500009
J	Bartoletti, A; Medini, P; Berardi, N; Maffei, L				Bartoletti, A; Medini, P; Berardi, N; Maffei, L			Environmental enrichment prevents effects of dark-rearing in the rat visual cortex	NATURE NEUROSCIENCE			English	Article							PLASTICITY; EXERCISE; BDNF	Environmental enrichment potentiates neural plasticity, enhancing acquisition and consolidation of memory traces(1). In the sensory cortices, after cortical circuit maturation and sensory function acquisition are completed, neural plasticity declines and the critical period 'closes'(2). In the visual cortex, this process can be prevented by dark-rearing, and here we show that environmental enrichment can promote physiological maturation and consolidation of visual cortical connections in dark-reared rats, leading to critical period closure.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Scuola Normale Super Pisa, Pisa, Italy; Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Florence	Berardi, N (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	berardi@in.pi.cnr.it	Medini, Paolo/GWC-1936-2022; Medini, Paolo/R-7504-2018		Telethon [GGP030428] Funding Source: Medline	Telethon(Fondazione Telethon)		BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699	12	75	76	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					215	216		10.1038/nn1201	http://dx.doi.org/10.1038/nn1201			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966527				2022-12-28	WOS:000189197900008
J	Niell, CM; Meyer, MP; Smith, SJ				Niell, CM; Meyer, MP; Smith, SJ			In vivo imaging of synapse formation on a growing dendritic arbor	NATURE NEUROSCIENCE			English	Article							POSTSYNAPTIC SPECIALIZATION; HIPPOCAMPAL-NEURONS; ZEBRAFISH EMBRYOS; NMDA RECEPTOR; SYNAPTOGENESIS; DYNAMICS; GROWTH; RECRUITMENT; PLASTICITY; FILOPODIA	The form of a neuron's dendritic arbor determines the set of axons with which it may form synaptic contacts, thus establishing connectivity within neural circuits. However, the dynamic relationship between dendrite growth and synaptogenesis is not well understood. To observe both processes simultaneously, we performed long-term imaging of non-spiny dendritic arbors expressing a fluorescent postsynaptic marker protein as they arborized within the optic tectum of live zebrafish larvae. Our results indicate that almost all synapses form initially on newly extended dendritic filopodia. A fraction of these nascent synapses are maintained, which in turn stabilizes the subset of filopodia on which they form. Stabilized filopodia mature into dendritic branches, and successive iterations of this process result in growth and branching of the arbor. These findings support a `synaptotropic model' in which synapse formation can direct dendrite arborization.	Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA.	sjsmith@stanford.edu	Meyer, Martin/C-5472-2009	Meyer, Martin/0000-0001-8337-630X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043461] Funding Source: NIH RePORTER; NINDS NIH HHS [NS043461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; BANKER G, 1998, CULTURING NERVE CELL; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Douglas R., 1990, VISUAL SYSTEM FISH, DOI [10.1007/978-94-009-0411-8, DOI 10.1007/978-94-009-0411-8]; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Ebihara T, 2003, J NEUROSCI, V23, P2170; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gleason MR, 2003, NAT NEUROSCI, V6, P217, DOI 10.1038/nn1011; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; MEEK J, 1981, J COMP NEUROL, V199, P175, DOI 10.1002/cne.901990203; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Westerfield M, 1993, ZEBRAFISH BOOK; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	311	319	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					254	260		10.1038/nn1191	http://dx.doi.org/10.1038/nn1191			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758365				2022-12-28	WOS:000189197900015
J	Wilson, SJ; Sayette, MA; Fiez, JA				Wilson, SJ; Sayette, MA; Fiez, JA			Prefrontal responses to drug cues: a neurocognitive analysis	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; CIGARETTE AVAILABILITY; SMOKING OPPORTUNITY; ENVIRONMENTAL CUES; BRAIN ACTIVATION; ALCOHOL STIMULI; REACTIVITY; ADDICTION; URGE; INVOLVEMENT	The construct of craving has been central to addiction research for more than 50 years. Only recently have investigators begun to apply functional neuroimaging techniques to the study of drug cue reactivity, and a small but growing number of studies implicate a distributed system of brain regions in the pathogenesis of craving. The internal consistency of this burgeoning literature has thus far been disappointing, however, leaving open the question of which brain regions contribute to craving. Here we review neuroimaging studies of cue-elicited craving in the context of a framework drawn from behavioral research indicating that perceived drug use opportunity significantly affects responses to the presentation of drug cues. Using this framework provides a way to reconcile discrepant findings among brain-imaging studies of cue-elicited craving.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Ctr Neural Basis Cognit, Pittsburgh, PA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wilson, SJ (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	sjwilson@pitt.edu			NCI NIH HHS [R01 CA159463] Funding Source: Medline; NIDA NIH HHS [R01 DA010605, R01DA10605, R01DA14103, R01 DA014103, R01 DA010605-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA159463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010605, R01DA014103] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anton RF, 1999, ALCOHOL RES HEALTH, V23, P165; BAKER TB, 1987, NEBR SYM MOTIV, V34, P257; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Carter BL, 2001, EXP CLIN PSYCHOPHARM, V9, P183, DOI 10.1037//1064-1297.9.2.183; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; Dols M, 2000, ADDICT BEHAV, V25, P103, DOI 10.1016/S0306-4603(98)00115-4; DROUNGAS A, 1995, ADDICT BEHAV, V20, P657, DOI 10.1016/0306-4603(95)00029-C; Drummond DC, 2000, ADDICTION, V95, pS129, DOI 10.1046/j.1360-0443.95.8s2.2.x; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Field M, 2002, PSYCHOPHARMACOLOGY, V159, P325, DOI 10.1007/s00213-001-0923-z; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Hommer DW, 1999, ALCOHOL RES HEALTH, V23, P187; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lazev AB, 1999, EXP CLIN PSYCHOPHARM, V7, P56, DOI 10.1037/1064-1297.7.1.56; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Meyer RE, 2000, ADDICTION, V95, pS219; MODELL JG, 1995, J NEUROPSYCH CLIN N, V7, P15; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Sayette MA, 2003, EXP CLIN PSYCHOPHARM, V11, P218, DOI 10.1037/1064-1297.11.3.218; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Tapert SF, 2004, ADDICT BEHAV, V29, P33, DOI 10.1016/j.addbeh.2003.07.003; Tapert SF, 2003, ARCH GEN PSYCHIAT, V60, P727, DOI 10.1001/archpsyc.60.7.727; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Wertz JM, 2001, EXP CLIN PSYCHOPHARM, V9, P3, DOI 10.1037//1064-1297.9.1.3; Wertz JM, 2001, PSYCHOL ADDICT BEHAV, V15, P268, DOI 10.1037/0893-164X.15.3.268; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; WILLIAMS SM, 2000, SYLVIUS FUNDAMENTALS; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Zinser MC, 1999, J ABNORM PSYCHOL, V108, P240, DOI 10.1037/0021-843X.108.2.240; 2002, PHARMACOL BIOCHEM BE, V71, P517	50	301	310	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					211	214		10.1038/nn1200	http://dx.doi.org/10.1038/nn1200			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	15001989	Green Accepted			2022-12-28	WOS:000189197900024
J	Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M				Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M			Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELLS; PROTECTIVE AUTOIMMUNITY; SYNAPTIC PLASTICITY; NEUROPROTECTIVE AUTOIMMUNITY; THERAPEUTIC VACCINATION; ENRICHED ENVIRONMENT; NEUROTROPHIC FACTOR; GRANULE CELLS; BRAIN	Neurogenesis is known to take place in the adult brain. This work identifies T lymphocytes and microglia as being important to the maintenance of hippocampal neurogenesis and spatial learning abilities in adulthood. Hippocampal neurogenesis induced by an enriched environment was associated with the recruitment of T cells and the activation of microglia. In immune-deficient mice, hippocampal neurogenesis was markedly impaired and could not be enhanced by environmental enrichment, but was restored and boosted by T cells recognizing a specific CNS antigen. CNS-specific T cells were also found to be required for spatial learning and memory and for the expression of brain-derived neurotrophic factor in the dentate gyrus, implying that a common immune-associated mechanism underlies different aspects of hippocampal plasticity and cell renewal in the adult brain.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Minist Hlth, Mental Hlth Ctr,Anxiety & Stress Res Unit, IL-84105 Beer Sheva, Israel	Weizmann Institute of Science; Ben Gurion University	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	jkipnis@unmc.edu; michal.schwartz@weizmann.ac.il	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Butovsky, Oleg/0000-0003-0186-8867				Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; BUTOVSKY O, 2005, MOL CELL NEUROSCI; Butovsky Oleg, 2001, FASEB Journal, V15, P1065; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; COHEN H, IN PRESS J NEUROBIOL; Diesing Thomas S, 2002, AIDS Read, V12, P358; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Gaillard RC, 1998, ANN NY ACAD SCI, V840, P480, DOI 10.1111/j.1749-6632.1998.tb09586.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Muhallab S, 2002, SCAND J IMMUNOL, V55, P264, DOI 10.1046/j.0300-9475.2002.01038.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schwartz M, 2002, TRENDS IMMUNOL, V23, P530, DOI 10.1016/S1471-4906(02)02322-0; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wekerle H, 2005, P NATL ACAD SCI USA, V102, P3, DOI 10.1073/pnas.0408495101; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	48	844	880	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					268	275		10.1038/nn1629	http://dx.doi.org/10.1038/nn1629			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415867				2022-12-28	WOS:000234990100023
J	Fox, MD; Snyder, AZ; Zacks, JM; Raichle, ME				Fox, MD; Snyder, AZ; Zacks, JM; Raichle, ME			Coherent spontaneous activity accounts for trial-to-trial variability in human evoked brain responses	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; DYNAMICS; CORTEX	Trial-to-trial variability in the blood oxygen level-dependent (BOLD) response of functional magnetic resonance imaging has been shown to be relevant to human perception and behavior, but the sources of this variability remain unknown. We demonstrate that coherent spontaneous fluctuations in human brain activity account for a significant fraction of the variability in measured event-related BOLD responses and that spontaneous and task-related activity are linearly superimposed in the human brain.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fox, MD (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	foxm@npg.wustl.edu	Zacks, Jeffrey M/E-9099-2011; Fox, Michael D./AAZ-3928-2020; Bullmore, Ed/C-1706-2012; anand, amit/A-7222-2009	Zacks, Jeffrey M/0000-0003-1171-3690; Fox, Michael D./0000-0001-8848-6399; Bullmore, Ed/0000-0002-8955-8283; 	NINDS NIH HHS [NS06833] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, P01NS006833] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Olshausen B.A., 2003, VISUAL NEUROSCI, V2, P1603; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	15	507	512	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					23	25		10.1038/nn1616	http://dx.doi.org/10.1038/nn1616			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341210				2022-12-28	WOS:000234288000012
J	Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H				Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H			FARP2 triggers signals for Sema3A-mediated axonal repulsion	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE COLLAPSE; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RECEPTOR PLEXIN-B1; CELL-ADHESION; FERM DOMAIN; RHO-GTPASES; FAMILY; BETA-1-INTEGRIN; MORPHOGENESIS	Sema3A, a prototypical semaphorin, acts as a chemorepellent or a chemoattractant for axons by activating a receptor complex comprising neuropilin-1 as the ligand-binding subunit and plexin-A1 as the signal-transducing subunit. How the signals downstream of plexin-A1 are triggered upon Sema3A stimulation, however, is unknown. Here we show that, in the presence of neuropilin-1, the FERM domain - containing guanine nucleotide exchange factor (GEF) FARP2 associates directly with plexin-A1. Sema3A binding to neuropilin-1 induces the dissociation of FARP2 from plexin-A1, resulting in activation of FARP2' s Rac GEF activity, Rnd1 recruitment to plexin-A1, and downregulation of R-Ras. Simultaneously, the FERM domain of FARP2 sequesters phosphatidylinositol phosphate kinase type I isoform PIPKI gamma 661 from talin, thereby inhibiting its kinase activity. These activities are required for Sema3A-mediated repulsion of outgrowing axons and suppression of neuronal adhesion. We therefore conclude that FARP2 is a key molecule involved in the response of neuronal growth cones to class-3 semaphorins.	Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Saitama 3326612, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Toyofuku, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	toyofuku@medone.med.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009					Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grabham PW, 2000, J CELL SCI, V113, P3003; Jin Z, 1997, J NEUROSCI, V17, P6256; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Koyano Y, 1997, BIOCHEM BIOPH RES CO, V241, P369, DOI 10.1006/bbrc.1997.7826; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kubo T, 2002, J NEUROSCI, V22, P8504; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77	43	171	184	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1712	1719		10.1038/nn1596	http://dx.doi.org/10.1038/nn1596			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286926				2022-12-28	WOS:000233576200020
J	Gothelf, D; Eliez, S; Thompson, T; Hinard, C; Penniman, L; Feinstein, C; Kwon, H; Jin, ST; Jo, B; Antonarakis, SE; Morris, MA; Reiss, AL				Gothelf, D; Eliez, S; Thompson, T; Hinard, C; Penniman, L; Feinstein, C; Kwon, H; Jin, ST; Jo, B; Antonarakis, SE; Morris, MA; Reiss, AL			COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome	NATURE NEUROSCIENCE			English	Article							CARDIO-FACIAL SYNDROME; GENETIC-VARIATION; SCHIZOPHRENIA; BRAIN	Although schizophrenia is strongly hereditary, there are limited data regarding biological risk factors and pathophysiological processes. In this longitudinal study of adolescents with 22q11.2 deletion syndrome, we identified the catechol-O-methyltransferase low-activity allele (COMTL) as a risk factor for decline in prefrontal cortical volume and cognition, as well as for the consequent development of psychotic symptoms during adolescence. The 22q11.2 deletion syndrome is a promising model for identifying biomarkers related to the development of schizophrenia.	Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; Univ Geneva, Sch Med, Dept Psychiat, CH-1206 Geneva, Switzerland; Univ Hosp Geneva, Med Genet Serv, CH-1211 Geneva, Switzerland; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; Ctr Med Univ Geneva, Univ Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	Stanford University; Tel Aviv University; Sackler Faculty of Medicine; University of Geneva; University of Geneva; University of Washington; University of Washington Seattle; University of Geneva	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, 401 Quarry Rd, Stanford, CA 94305 USA.	reiss@stanford.edu	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	NICHD NIH HHS [HD31715] Funding Source: Medline; NIMH NIH HHS [MH50047, MH19908] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050047] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; KARYIORGOU M, 1995, P NATL ACAD SCI USA, V92, P7612; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6	15	258	265	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1500	1502		10.1038/nn1572	http://dx.doi.org/10.1038/nn1572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234808				2022-12-28	WOS:000232966600023
J	Rouach, N; Byrd, K; Petralia, RS; Elias, GM; Adesnik, H; Tomita, S; Karimzadegan, S; Kealey, C; Bredt, DS; Nicoll, RA				Rouach, N; Byrd, K; Petralia, RS; Elias, GM; Adesnik, H; Tomita, S; Karimzadegan, S; Kealey, C; Bredt, DS; Nicoll, RA			TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL SUBUNITS; LONG-TERM POTENTIATION; EXCITATORY SYNAPSES; ENDOPLASMIC-RETICULUM; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; MOUSE STARGAZER; CA2+ CHANNELS; MUTANT MOUSE; GENE FAMILY	Synaptic plasticity involves activity-dependent trafficking of AMPA-type glutamate receptors. Numerous cytoplasmic scaffolding proteins are postulated to control AMPA receptor trafficking, but the detailed mechanisms remain unclear. Here, we show that the transmembrane AMPA receptor regulatory protein (TARP) gamma-8, which is preferentially expressed in the mouse hippocampus, is important for AMPA receptor protein levels and extrasynaptic surface expression. By controlling the number of AMPA receptors, gamma-8 is also important in long-term potentiation, but not long-term depression. This study establishes gamma-8 as a critical protein for basal AMPA receptor expression and localization at extrasynaptic sites in the hippocampus and raises the possibility that TARP-dependent control of AMPA receptors during synapse development and plasticity may be widespread.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Rouach, Nathalie/L-4767-2017	Rouach, Nathalie/0000-0002-5574-888X	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andrianopoli L, 2003, J HIGH ENERGY PHYS; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bogdanov Y, 2000, EUR J NEUROSCI, V12, P894, DOI 10.1046/j.1460-9568.2000.00981.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	42	199	205	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1525	1533		10.1038/nn1551	http://dx.doi.org/10.1038/nn1551			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222232				2022-12-28	WOS:000232966600027
J	Bosbach, S; Cole, J; Prinz, W; Knoblich, G				Bosbach, S; Cole, J; Prinz, W; Knoblich, G			Inferring another's expectation from action: the role of peripheral sensation	NATURE NEUROSCIENCE			English	Article								It is unclear how knowledge of one's actions and one's body contribute to the understanding of others' actions. Here we show that two subjects lacking cutaneous touch and sense of movement and position show a selective deficit in interpreting another person's anticipation of weight when seeing him lifting boxes. We suggest that this ability occurs through mental simulation of action dependent on internal motor representations, which require peripheral sensation for their maintenance.	Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, D-80799 Munich, Germany; Bournemouth Univ, Poole BH15 2JB, Dorset, England; Poole Hosp, Poole BH15 2JB, Dorset, England; Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA	Max Planck Society; Bournemouth University; Poole Hospital; Rutgers State University Newark; Rutgers State University New Brunswick	Bosbach, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Amalienstr 33, D-80799 Munich, Germany.	bosbach@cbs.mpg.de	Knoblich, Günther/C-9465-2012	Schutz-Bosbach, Simone/0000-0002-0937-9454; Knoblich, Gunther/0000-0003-4463-5318				COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DAMASIO AR, 1994, DESCARTES ERROR; FLEURY M, 1995, BRAIN, V118, P1149, DOI 10.1093/brain/118.5.1149; FORGET R, 1987, HUM NEUROBIOL, V6, P27; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hamilton A, 2004, CURR BIOL, V14, P493, DOI 10.1016/j.cub.2004.03.007; Head H., 1920, STUDIES NEUROLOGY; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Miall RC, 1995, EXP BRAIN RES, V107, P267; RUNESON S, 1981, J EXP PSYCHOL HUMAN, V7, P733, DOI 10.1037/0096-1523.7.4.733; WILSON M, PSYCHOL B, V131, P460	15	83	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1295	1297		10.1038/nn1535	http://dx.doi.org/10.1038/nn1535			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136040				2022-12-28	WOS:000232145900011
J	Beck, DM; Kastner, S				Beck, DM; Kastner, S			Stimulus context modulates competition in human extrastriate cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; AREA V4; MACAQUE; SEARCH; V1; SEGREGATION	When multiple stimuli appear simultaneously in the visual field, they are not processed independently, but rather interact in a mutually suppressive way, suggesting that they compete for neural representation in visual cortex. The biased competition model of selective attention predicts that the competition can be influenced by both top-down and bottom-up mechanisms. Directed attention has been shown to bias competition in favor of the attended stimulus in extrastriate cortex. Here, we show that suppressive interactions among multiple stimuli are eliminated in extrastriate cortex when they are presented in the context of pop-out displays, in which a single item differs from the others, but not in heterogeneous displays, in which all items differ from each other. The pop-out effects seemed to originate in early visual cortex and were independent of attentional top-down control, suggesting that stimulus context may provide a powerful influence on neural competition in human visual cortex.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University; Princeton University	Beck, DM (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	dbeck@princeton.edu	Beck, Diane M/F-7536-2010	Beck, Diane M/0000-0001-9802-5828; Kastner, Sabine/0000-0002-9742-965X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043, P50MH062196] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH062196, P50 MH-62196, R01 MH064043, R01 MH-64043] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BANKS WP, 1976, PERCEPT PSYCHOPHYS, V19, P361, DOI 10.3758/BF03204244; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; BUNDESEN C, 1983, PERCEPT PSYCHOPHYS, V33, P487, DOI 10.3758/BF03202901; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kahneman D., 1981, PERCEPTUAL ORG, P181; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 1999, VISUAL NEUROSCI, V16, P587, DOI 10.1017/S095252389916317X; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Neisser U., 1967, COGNITIVE PSYCHOL; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1993, VISION RES, V33, P1937, DOI 10.1016/0042-6989(93)90020-W; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	49	137	140	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1110	1116		10.1038/nn1501	http://dx.doi.org/10.1038/nn1501			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007082	Green Accepted			2022-12-28	WOS:000230760200024
J	Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O				Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O			Adenosine A2(A), but not A(1), receptors mediate the arousal effect of caffeine	NATURE NEUROSCIENCE			English	Article							HOMEOSTATIC REGULATION; SLEEP; RATS	Caffeine, a component of tea, coffee and cola, induces wakefulness. It binds to adenosine A(1) and A(2A) receptors as an antagonist, but the receptor subtype mediating caffeine-induced wakefulness remains unclear. Here we report that caffeine at 5, 10 and 15 mg kg(-1) increased wakefulness in both wild-type mice and A(1) receptor knockout mice, but not in A(2A) receptor knockout mice. Thus, caffeine-induced wakefulness depends on adenosine A(2A) receptors.	Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Massachusetts Gen Hosp, Mol Neurobiol Lab, Boston, MA 02129 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Boston University; Harvard University; Massachusetts General Hospital; Karolinska Institutet	Hayaishi, O (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan.	hayaishi@obi.or.jp		Chen, Jiang-Fan/0000-0002-0446-3956; Huang, Zhi-Li/0000-0001-9359-1150				Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; El Yacoubi M, 2003, NEUROPHARMACOLOGY, V45, P977, DOI 10.1016/S0028-3908(03)00254-5; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Hayaishi O, 2004, ARCH ITAL BIOL, V142, P533; Hong ZY, 2005, J NEUROCHEM, V92, P1542, DOI 10.1111/j.1471-4159.2004.02991.x; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Porkka-Heiskanen T, 2002, SLEEP MED REV, V6, P321, DOI 10.1053/smrv.2001.0201; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; RAINNIE DG, 1994, SCIENCE, V263, P689, DOI 10.1126/science.8303279; Satoh S, 1996, P NATL ACAD SCI USA, V93, P5980, DOI 10.1073/pnas.93.12.5980; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Stenberg D, 2003, J SLEEP RES, V12, P283, DOI 10.1046/j.0962-1105.2003.00367.x	15	390	422	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					858	859		10.1038/nn1491	http://dx.doi.org/10.1038/nn1491			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965471				2022-12-28	WOS:000230137100010
J	Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV				Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV			The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids	NATURE NEUROSCIENCE			English	Article							EARLY GENE ZIF268; RECOGNITION MEMORY; NERVOUS-SYSTEM; KINASE CASCADE; SPATIAL MEMORY; FEAR MEMORY; DNA-BINDING; RECEPTOR; EXPRESSION; HIPPOCAMPUS	Many of the behavioral consequences of stress are mediated by the activation of the glucocorticoid receptor by stress-induced high levels of glucocorticoid hormones. To explore the molecular mechanisms of these effects, we combined in vivo and in vitro approaches. We analyzed mice carrying a brain-specific mutation (GR(NesCre)) in the glucocorticoid receptor gene (GR, also called Nr3c1) and cell lines that either express endogenous glucocorticoid receptor or carry a constitutively active form of the receptor (Delta GR) that can be transiently induced. In the hippocampus of the mutant mice after stress, as well as in the cell lines, activation of glucocorticoid receptors greatly increased the expression and enzymatic activity of proteins in the MAPK signaling pathway and led to an increase in the levels of both Egr-1 mRNA and protein. In parallel, inhibition of the MAPK pathway within the hippocampus abolished the increase in contextual fear conditioning induced by glucocorticoids. The present results provide a molecular mechanism for the stress-related effects of glucocorticoids on fear memories.	Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, F-33077 Bordeaux, France; Cognit Neurosci Lab, CNRS, UMR5106, F-33405 Talence, France; Coll France, Inst Biol, CNRS, FRE2401, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Piazza, PV (corresponding author), Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, Domaine Carreire,146 Rue Leo Saignat, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	TRONCHE, François/F-3895-2011	Desmedt, aline/0000-0002-1179-7161; Di Blasi, Francesco/0000-0001-8085-7538				Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blum S, 1999, J NEUROSCI, V19, P3535; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; de Kloet E Ronald, 2003, Endocr Regul, V37, P51; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Desmedt A, 1998, J NEUROSCI, V18, P480; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUNDER JW, 1992, J STEROID BIOCHEM, V43, P389, DOI 10.1016/0960-0760(92)90074-S; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jouvert P, 2002, NEUROMOL MED, V1, P137, DOI 10.1385/NMM:1:2:137; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Lee JE, 1996, ONCOGENE, V12, P1669; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Marais R, 1996, CANCER SURV, V27, P101; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MORATALLA R, 1992, J NEUROSCI, V12, P2609; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; STORM SM, 1990, ONCOGENE, V5, P345; STRAWHECKER JM, 1989, ONCOGENE, V4, P1317; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Widen C, 2000, J BIOL CHEM, V275, P39296, DOI 10.1074/jbc.M006943200; Yuryev A, 1998, Cell Res, V8, P81	50	175	181	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					664	672		10.1038/nn1441	http://dx.doi.org/10.1038/nn1441			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834420				2022-12-28	WOS:000228895100028
J	Loewenstein, Y; Mahon, S; Chadderton, P; Kitamura, K; Sompolinsky, H; Yarom, Y; Hausser, MH				Loewenstein, Y; Mahon, S; Chadderton, P; Kitamura, K; Sompolinsky, H; Yarom, Y; Hausser, MH			Bistability of cerebellar Purkinje cells modulated by sensory stimulation	NATURE NEUROSCIENCE			English	Article							CLIMBING FIBER AFFERENTS; ELECTRO-PHYSIOLOGICAL PROPERTIES; IN-VIVO; PREFRONTAL CORTEX; CORTICAL ACTIVITY; FIRING PATTERNS; MOSSY FIBER; NEURONS; DENDRITES; MODEL	A persistent change in neuronal activity after brief stimuli is a common feature of many neuronal microcircuits. This persistent activity can be sustained by ongoing reverberant network activity or by the intrinsic biophysical properties of individual cells. Here we demonstrate that rat and guinea pig cerebellar Purkinje cells in vivo show bistability of membrane potential and spike output on the time scale of seconds. The transition between membrane potential states can be bidirectionally triggered by the same brief current pulses. We also show that sensory activation of the climbing fiber input can switch Purkinje cells between the two states. The intrinsic nature of Purkinje cell bistability and its control by sensory input can be explained by a simple biophysical model. Purkinje cell bistability may have a key role in the short-term processing and storage of sensory information in the cerebellar cortex.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); University of London; University College London; University of London; University College London	Loewenstein, Y (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	yonatanl@mit.edu; s.mahon@ucl.ac.uk	Mahon, Severine/E-7195-2017; mahon, severine/AAG-9225-2021; Hausser, Michael/AAW-6827-2020; Sompolinsky, Haim/ABB-8398-2021; Kitamura, Kazuo/F-3379-2013	mahon, severine/0000-0001-8339-9034; Hausser, Michael/0000-0002-2673-8957; Kitamura, Kazuo/0000-0002-8956-4122; Chadderton, Paul/0000-0002-6276-1011				ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BAUSWEIN E, 1984, PFLUG ARCH EUR J PHY, V402, P292, DOI 10.1007/BF00585512; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BROOKHART JM, 1950, J NEUROPHYSIOL, V13, P465, DOI 10.1152/jn.1950.13.6.465; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHANG W, 1993, BRAIN RES, V614, P335, DOI 10.1016/0006-8993(93)91052-T; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P962, DOI 10.1152/jn.1981.45.5.962; EDGLEY SA, 1988, J PHYSIOL-LONDON, V401, P399, DOI 10.1113/jphysiol.1988.sp017169; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Genet S, 2002, J NEUROPHYSIOL, V88, P2430, DOI 10.1152/jn.00839.2001; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Hirata Y, 2000, PROG BRAIN RES, V124, P221; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V402, P731, DOI 10.1113/jphysiol.1988.sp017231; ITO M, 1984, CEREBELLIUM NEURAL C; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832, DOI 10.1152/jn.1998.80.2.832; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MCCARLEY RW, 1972, ELECTROEN CLIN NEURO, V33, P471, DOI 10.1016/0013-4694(72)90211-8; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; MIDTGAARD J, 1993, J NEUROPHYSIOL, V70, P2455, DOI 10.1152/jn.1993.70.6.2455; NACIMIENTO RC, 1969, NEUROBIOLOGY CEREBEL, P373; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; RAWSON JA, 1981, NEUROSCI LETT, V25, P131, DOI 10.1016/0304-3940(81)90320-7; RAWSON JA, 1981, NEUROSCI LETT, V25, P125, DOI 10.1016/0304-3940(81)90319-0; RINZEL J, 1998, METHODS NEURONAL MOD, P251; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; YUEN GL, 1995, BIOL CYBERN, V73, P375, DOI 10.1007/BF00199473	48	237	240	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					202	211		10.1038/nn1393	http://dx.doi.org/10.1038/nn1393			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665875				2022-12-28	WOS:000226638200020
J	Schoenemann, PT; Sheehan, MJ; Glotzer, LD				Schoenemann, PT; Sheehan, MJ; Glotzer, LD			Prefrontal white matter volume is disproportionately larger in humans than in other primates	NATURE NEUROSCIENCE			English	Article							BRAIN SIZE; FRONTAL-CORTEX; COMPARATIVE PERSPECTIVE; SEX-DIFFERENCES; MR-IMAGES; EVOLUTION; LANGUAGE; STEREOLOGY; NEOCORTEX; MAMMALS	Determining how the human brain differs from nonhuman primate brains is central to understanding human behavioral evolution. There is currently dispute over whether the prefrontal cortex, which mediates evolutionarily interesting behaviors, has increased disproportionately. Using magnetic resonance imaging brain scans from 11 primate species, we measured gray, white and total volumes for both prefrontal and the entire cerebrum on each specimen (n = 46). In relative terms, prefrontal white matter shows the largest difference between human and nonhuman, whereas gray matter shows no significant difference. This suggests that connectional elaboration (as gauged by white matter volume) played a key role in human brain evolution.	Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA	University of Pennsylvania	Schoenemann, PT (corresponding author), Univ Penn, Dept Anthropol, 3260 South St, Philadelphia, PA 19104 USA.	ptschoen@sas.upenn.edu	Sheehan, Michael/F-5612-2012	Sheehan, Michael/0000-0002-3949-7873				Aboitiz F, 1997, BRAIN RES REV, V25, P381, DOI 10.1016/S0165-0173(97)00053-2; ANKNEY CD, 1992, INTELLIGENCE, V16, P329; ARMSTRONG E, 1991, J HUM EVOL, V20, P341, DOI 10.1016/0047-2484(91)90014-M; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; Changizi MA, 2001, BIOL CYBERN, V84, P207, DOI 10.1007/s004220000205; Damasio A.R., 1985, INT J CLIN NEUROPSYC, P339; Deacon T., 1997, SYMBOLIC SPECIES COE; DEBRUIN JPC, 1990, PROG BRAIN RES, V85, P485; Dunbar R., 1996, GROOMING GOSSIP EVOL; ELIAS H, 1971, PHYSIOL REV, V51, P158, DOI 10.1152/physrev.1971.51.1.158; Falk D, 1999, J HUM EVOL, V36, P233, DOI 10.1006/jhev.1998.0273; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HOFMAN MA, 1983, Q REV BIOL, V58, P495, DOI 10.1086/413544; HOLLOWAY RALPH L., 1968, BRAIN RES, V7, P121, DOI 10.1016/0006-8993(68)90094-2; Holloway Ralph L., 1995, P42; Holloway RL, 2002, AM J PHYS ANTHROPOL, V118, P399, DOI 10.1002/ajpa.10090; HOLLOWAY RL, 1992, J HUM EVOL, V22, P163, DOI 10.1016/S0047-2484(05)80005-3; Humphrey N., 1984, CONSCIOUSNESS REGAIN, P14, DOI DOI 10.1126/SCIENCE.860134; Jerison H.J., 1982, P77; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; McBride T, 1999, BRAIN BEHAV EVOLUT, V54, P159, DOI 10.1159/000006620; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Roberts N, 2000, BRIT J RADIOL, V73, P679, DOI 10.1259/bjr.73.871.11089458; Rumbaugh DM, 1996, JPN PSYCHOL RES, V38, P113, DOI 10.1111/j.1468-5884.1996.tb00016.x; SAVAGERUMBAUGH ES, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P86; Schoenemann PT, 2000, P NATL ACAD SCI USA, V97, P4932, DOI 10.1073/pnas.97.9.4932; Schoenemann PT, 1999, MIND MACH, V9, P309, DOI 10.1023/A:1008360020568; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; VONBONIN G, 1948, FRONT LOB P ASS RES; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	270	274	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					242	252		10.1038/nn1394	http://dx.doi.org/10.1038/nn1394			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	892GN	15665874				2022-12-28	WOS:000226638200025
J	Linkenhoker, BA; von der Ohe, CG; Knudsen, EI				Linkenhoker, BA; von der Ohe, CG; Knudsen, EI			Anatomical traces of juvenile learning in the auditory system of adult barn owls	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; SPACE MAP; OPTIC TECTUM; VISUAL CALIBRATION; NEURAL REPRESENTATION; INFERIOR COLLICULUS; LOCALIZATION; MIDBRAIN; TIME; SITE	Early experience plays a powerful role in shaping adult neural circuitry and behavior. In barn owls, early experience markedly influences sound localization. Juvenile owls that learn new, abnormal associations between auditory cues and locations in visual space as a result of abnormal visual experience can readapt to the same abnormal experience in adulthood, when plasticity is otherwise limited. Here we show that abnormal anatomical projections acquired during early abnormal sensory experience persist long after normal experience has been restored. These persistent projections are perfectly situated to provide a physical framework for subsequent readaptation in adulthood to the abnormal sensory conditions experienced in early life. Our results show that anatomical changes that support strong learned neural connections early in life can persist even after they are no longer functionally expressed. This maintenance of silenced neural circuitry that was once adaptive may represent an important mechanism by which the brain preserves a record of early experience.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Sci Bldg, Stanford, CA 94305 USA.	eknudsen@stanford.edu						Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hyde PS, 2002, NATURE, V415, P73, DOI 10.1038/415073a; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; Kuhl PK, 1998, DAHLEM WORK, P53; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; OLSEN JF, 1989, J NEUROSCI, V9, P2591; SOMOGYI P, 1982, J NEUROCYTOL, V11, P779, DOI 10.1007/BF01153519; Spitz R, 1946, PSYCHOANALYTIC STUDY, V2; TAKAHASHI TT, 1987, J NEUROSCI, V7, P1843; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	20	61	62	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					93	98		10.1038/nn1367	http://dx.doi.org/10.1038/nn1367			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608636				2022-12-28	WOS:000225967600021
J	Sharot, T; Delgado, MR; Phelps, EA				Sharot, T; Delgado, MR; Phelps, EA			How emotion enhances the feeling of remembering	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; EPISODIC MEMORY; HUMAN AMYGDALA; FLASHBULB MEMORIES; HIPPOCAMPUS; PARAHIPPOCAMPAL; EVENTS; RECOLLECTION; FAMILIARITY; RETRIEVAL	Studies examining memories of arousing 'real-life' events show that emotion heightens the feeling of remembering, without necessarily enhancing the objective accuracy of the memories. We measured brain activity associated with the feeling of remembering emotional and neutral photos. Subjects indicated whether recognition was accompanied by a recollection of details about the study episode ('remember') or not ('know'). 'Remember' judgments were boosted for emotional photos, but accuracy did not differ. For neutral photos, 'remember' judgments were related to enhanced activity in the parahippocampal cortex, previously related to recognition of visual details, which one might expect to supply the retrieval clues for a 'remember' judgment. In contrast, 'remember' judgments for emotional photos were associated with enhanced activity in the amygdala, suggesting that subjects rely on arousal and perceptual fluency to evaluate these memories. For the first time, we identify the neural mechanisms underlying the enhanced feeling of remembering for emotional events.	NYU, Dept Psychol, New York, NY 10003 USA	New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, Room 863,6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			NIMH NIH HHS [MH62104] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Arthurs OJ, 2003, CLIN NEUROPHYSIOL, V114, P1203, DOI 10.1016/S1388-2457(03)00080-4; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Duzel E, 2003, J NEUROSCI, V23, P9439; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Glascher J, 2003, J NEUROSCI, V23, P10274; Henson RNA, 1999, J NEUROSCI, V19, P3962; James W, 1890, PRINCIPLES PSYCHOL, V1; Kohler S, 2002, HIPPOCAMPUS, V12, P718, DOI 10.1002/hipo.10077; Lang J.P., 1999, A4 U FLOR CTR RES PS; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; NEISSER U, 1992, STUDIES FLASHBULB ME, V4, P9; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; WINOGRAD E, 1992, STUDIES FLASHBULB ME, V4; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028	31	306	319	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1376	1380		10.1038/nn1353	http://dx.doi.org/10.1038/nn1353			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	874MG	15558065				2022-12-28	WOS:000225353900019
J	Sisk, CL; Foster, DL				Sisk, CL; Foster, DL			The neural basis of puberty and adolescence	NATURE NEUROSCIENCE			English	Review							GONADOTROPIN-RELEASING-HORMONE; DOPAMINE-RECEPTOR OVERPRODUCTION; TESTOSTERONE NEGATIVE FEEDBACK; EPISODIC BURSTING ACTIVITY; EXCITATORY AMINO-ACIDS; PRIMARY VISUAL-CORTEX; MALE SYRIAN-HAMSTER; SEX-DIFFERENCES; GNRH NEURONS; MALE-RATS	The pubertal transition to adulthood involves both gonadal and behavioral maturation. A developmental clock, along with permissive signals that provide information on somatic growth, energy balance and season, time the awakening of gonadotropin releasing hormone (GnRH) neurons at the onset of puberty. High-frequency GnRH release results from disinhibition and activation of GnRH neurons at puberty onset, leading to gametogenesis and an increase in gonadal steroid hormone secretion. Steroid hormones, in turn, both remodel and activate neural circuits during adolescent brain development, leading to the development of sexual salience of sensory stimuli, sexual motivation, and expression of copulatory behaviors in specific social contexts. These influences of hormones on reproductive behavior depend in part on changes in the adolescent brain that occur independently of gonadal maturation. Reproductive maturity is therefore the product of developmentally timed, brain-driven and recurrent interactions between steroid hormones and the adolescent nervous system.	Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; Univ Michigan, Dept Obstet & Gynecol, Reprod Sci Program, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sisk, CL (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	sisk@msu.edu	Jansen, Heiko T./A-5770-2008; Sisk, Cheryl L/C-1199-2012	Jansen, Heiko T./0000-0003-0178-396X; 				Abraham IM, 2003, J NEUROSCI, V23, P5771; Andersen SL, 2000, NEUROSCI BIOBEHAV R, V24, P137, DOI 10.1016/S0149-7634(99)00044-5; Andersen SL, 1997, NEUROREPORT, V8, P1495, DOI 10.1097/00001756-199704140-00034; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andersen SL, 2002, PSYCHONEUROENDOCRINO, V27, P683, DOI 10.1016/S0306-4530(01)00069-5; BAUM MJ, 1972, J COMP PHYSIOL PSYCH, V78, P356, DOI 10.1037/h0032288; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; BRONSON FH, 1986, BIOL REV, V61, P157, DOI 10.1111/j.1469-185X.1986.tb00465.x; BRONSON FH, 1975, BIOL REPROD, V13, P94, DOI 10.1095/biolreprod13.1.94; Cheung CC, 2001, NEUROENDOCRINOLOGY, V74, P12, DOI 10.1159/000054666; Chung WCJ, 2002, J NEUROSCI, V22, P1027, DOI 10.1523/JNEUROSCI.22-03-01027.2002; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; EBLING FJP, 1989, EXPERIENTIA, V45, P946, DOI 10.1007/BF01953052; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Eichmann F, 1999, PHYSIOL BEHAV, V65, P785; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Eyigor O, 1997, NEUROENDOCRINOLOGY, V66, P122, DOI 10.1159/000127229; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; FLOODY OR, 1987, HORM BEHAV, V21, P17, DOI 10.1016/0018-506X(87)90027-4; FOSTER DL, 1988, REPROD NUTR DEV, V28, P349, DOI 10.1051/rnd:19880302; Foster DL, 2002, REPRODUCTION, P83; Foster DL, 1999, BIOL REPROD, V60, P205, DOI 10.1095/biolreprod60.2.205; FOSTER DL, 1980, PROBLEMS PEDIATRIC E, P193; Foster Douglas L., 1994, P411; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOLDSMITH PC, 1987, J COMP NEUROL, V257, P130, DOI 10.1002/cne.902570110; GOLDSTEIN LA, 1990, J NEUROSCI, V10, P935; Gore AC, 1996, J NEUROSCI, V16, P5281; Han SK, 2002, ENDOCRINOLOGY, V143, P1459, DOI 10.1210/en.143.4.1459; Han SK, 2004, ENDOCRINOLOGY, V145, P495, DOI 10.1210/en.2003-1333; Hebbard PC, 2003, EXP NEUROL, V182, P470, DOI 10.1016/S0014-4886(03)00119-5; Herdt G, 2000, ARCH SEX BEHAV, V29, P587, DOI 10.1023/A:1002006521067; Hull EM, 1999, BEHAV BRAIN RES, V105, P105, DOI 10.1016/S0166-4328(99)00086-8; Hull EM, 2002, HORMONES BRAIN BEHAV, P3, DOI DOI 10.1016/B978-012532104-4/50003-2; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; JENNES LJ, 2002, HORMONES BRAIN BEHAV, P51; JOHNSTON RE, 1979, BEHAV NEURAL BIOL, V25, P473, DOI 10.1016/S0163-1047(79)90242-5; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kelly MJ, 2003, ANN NY ACAD SCI, V1007, P6, DOI 10.1196/annals.1286.001; Kelly MJ, 2002, TRENDS ENDOCRIN MET, V13, P409, DOI 10.1016/S1043-2760(02)00698-7; Kim SJ, 1999, BIOL REPROD, V61, P599, DOI 10.1095/biolreprod61.3.599; Kuehl-Kovarik MC, 2002, J NEUROSCI, V22, P2313, DOI 10.1523/JNEUROSCI.22-06-02313.2002; Lee BJ, 2001, MOL CELL NEUROSCI, V17, P107, DOI 10.1006/mcne.2000.0933; Mann DR, 2002, SEMIN REPROD MED, V20, P93, DOI 10.1055/s-2002-32500; Meek LR, 1997, HORM BEHAV, V31, P75, DOI 10.1006/hbeh.1997.1371; Meisel Robert L., 1994, P3; Moenter SM, 2003, ANN NY ACAD SCI, V1007, P143, DOI 10.1196/annals.1286.014; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Nunez JL, 2002, J NEUROBIOL, V52, P312, DOI 10.1002/neu.10092; Nunez JL, 2000, DEV BRAIN RES, V125, P83, DOI 10.1016/S0165-3806(00)00126-7; Nunez JL, 2001, J COMP NEUROL, V436, P32; Ojeda SR, 1999, ENDOCRINOLOGY, V140, P3774, DOI 10.1210/en.140.8.3774; Ojeda SR, 2003, ANN MED, V35, P244, DOI 10.1080/07853890310005164; Ojeda SR, 2002, HORMONES BRAIN BEHAV, P589, DOI [10.1016/B978-012532104-4/50077-9, DOI 10.1016/B978-012532104-4/50077-9]; OJEDA SR, 1994, PHYSL REPRODUCTION, P452; OLSTER DH, 1989, BRAIN RES, V484, P168, DOI 10.1016/0006-8993(89)90359-4; Paredes RG, 1998, HORM BEHAV, V33, P48, DOI 10.1006/hbeh.1998.1435; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Peterson S. L., 1993, ENDOCR J, V1, P29; Pfaff Donald W., 1994, P107; Pfaus JG, 1999, CURR OPIN NEUROBIOL, V9, P751, DOI 10.1016/S0959-4388(99)00034-3; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; Plant TM, 2001, FRONT NEUROENDOCRIN, V22, P107, DOI 10.1006/frne.2001.0211; Plant Tony M., 1994, P453; PRIMUS RJ, 1990, HORM BEHAV, V24, P311, DOI 10.1016/0018-506X(90)90012-M; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; RAMIREZ VD, 1965, ENDOCRINOLOGY, V76, P412, DOI 10.1210/endo-76-3-412; RAPISARDA JJ, 1983, ENDOCRINOLOGY, V112, P1172, DOI 10.1210/endo-112-4-1172; RISSMAN EF, 1992, BIOL REPROD, V47, P473, DOI 10.1095/biolreprod47.3.473; Romeo RD, 2002, NEUROSCI BIOBEHAV R, V26, P381, DOI 10.1016/S0149-7634(02)00009-X; Romeo RD, 2001, BRAIN RES, V889, P71, DOI 10.1016/S0006-8993(00)03111-5; Romeo RD, 1998, HORM BEHAV, V34, P48, DOI 10.1006/hbeh.1998.1463; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; SCHNEIDER JE, 2002, HORMONES BRAIN BEHAV, P435, DOI DOI 10.1016/B978-012532104-4/50009-3; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; Schulz KM, 2003, BRAIN RES, V988, P139, DOI 10.1016/S0006-8993(03)03358-4; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Silverman Ann-Judith, 1994, P1683; SISK CL, 1987, BIOL REPROD, V37, P73, DOI 10.1095/biolreprod37.1.73; Sisk CL, 2003, ANN NY ACAD SCI, V1007, P189, DOI 10.1196/annals.1286.019; SISK CL, 1983, ENDOCRINOLOGY, V112, P1208, DOI 10.1210/endo-112-4-1208; SISK CL, 1992, J BIOL RHYTHM, V7, P329, DOI 10.1177/074873049200700406; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Turek Fred W., 1994, P487; Urbanski HF, 2001, TRENDS ENDOCRIN MET, V12, P428, DOI 10.1016/S1043-2760(01)00505-7; URBANSKI HF, 1987, ENDOCRINOLOGY, V121, P907, DOI 10.1210/endo-121-3-907; Wallen K, 2004, J SEX RES, V41, P101, DOI 10.1080/00224490409552218; Wallen K, 2001, HORM BEHAV, V40, P339, DOI 10.1006/hbeh.2001.1696; Wierman ME, 1997, MOL CELL BIOL, V17, P1652, DOI 10.1128/MCB.17.3.1652; Wilson M. E., 1992, SEXUAL DIFFERENTIATI, P275, DOI 10.1007/978-1-4899-2453-7_9; WINTER JSD, 1972, J CLIN ENDOCR METAB, V35, P561, DOI 10.1210/jcem-35-4-561; WITKIN JW, 1995, J NEUROENDOCRINOL, V7, P665, DOI 10.1111/j.1365-2826.1995.tb00807.x; WITKIN JW, 1995, NEUROSCIENCE, V64, P1145, DOI 10.1016/0306-4522(94)00432-5; Woo TU, 1997, NEUROSCIENCE, V80, P1149, DOI 10.1016/S0306-4522(97)00059-6; Wood R., 1995, NEUROBIOLOGICAL EFFE, P3; Wood RI, 2000, INT CONGR SER, V1202, P269; WOOD RI, 1992, NEUROENDOCRINOLOGY, V55, P427, DOI 10.1159/000126154; Woodley SK, 2003, HORM BEHAV, V44, P110, DOI 10.1016/S0018-506X(03)00126-0; WRAY S, 1986, NEUROENDOCRINOLOGY, V43, P93, DOI 10.1159/000124516	112	669	679	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1040	1047		10.1038/nn1326	http://dx.doi.org/10.1038/nn1326			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452575				2022-12-28	WOS:000224156900011
J	Herzig, MC; Winkler, DT; Burgermeister, P; Pfeifer, M; Kohler, E; Schmidt, SD; Danner, S; Abramowski, D; Sturchler-Pierrat, C; Burki, K; van Duinen, SG; Maat-Schieman, MLC; Staufenbiel, M; Mathews, PM; Jucker, M				Herzig, MC; Winkler, DT; Burgermeister, P; Pfeifer, M; Kohler, E; Schmidt, SD; Danner, S; Abramowski, D; Sturchler-Pierrat, C; Burki, K; van Duinen, SG; Maat-Schieman, MLC; Staufenbiel, M; Mathews, PM; Jucker, M			A beta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis	NATURE NEUROSCIENCE			English	Article							DUTCH-TYPE; PRECURSOR-PROTEIN; TRANSGENIC MICE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; MUTANT PRESENILINS; HCHWA-D; ANGIOPATHY; IMMUNIZATION; PEPTIDE	The E693Q mutation in the amyloid beta precursor protein (APP) leads to cerebral amyloid angiopathy (CAA), with recurrent cerebral hemorrhagic strokes and dementia. In contrast to Alzheimer disease ( AD), the brains of those affected by hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D) show few parenchymal amyloid plaques. We found that neuronal overexpression of human E693Q APP in mice (APPDutch mice) caused extensive CAA, smooth muscle cell degeneration, hemorrhages and neuroinflammation. In contrast, overexpression of human wild-type APP (APPwt mice) resulted in predominantly parenchymal amyloidosis, similar to that seen in AD. In APPDutch mice and HCHWA-D human brain, the ratio of the amyloid-beta40 peptide (Abeta40) to Abeta42 was significantly higher than that seen in APPwt mice or AD human brain. Genetically shifting the AbetaDutch40/AbetaDutch42 ratio toward AbetaDutch42 by crossing APPDutch mice with transgenic mice producing mutated presenilin-1 redistributed the amyloid pathology from the vasculature to the parenchyma. The understanding that different Abeta species can drive amyloid pathology in different cerebral compartments has implications for current anti-amyloid therapeutic strategies. This HCHWA-D mouse model is the first to develop robust CAA in the absence of parenchymal amyloid, highlighting the key role of neuronally produced Abeta to vascular amyloid pathology and emphasizing the differing roles of Abeta40 and Abeta42 in vascular and parenchymal amyloid pathology.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; NYU, Sch Med, Nathan Kline Inst, Orangeburg, NY 10962 USA; Novartis Inst Biomed Res, Nervous Syst Res, CH-4002 Basel, Switzerland; Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; Nathan Kline Institute for Psychiatric Research; New York University; Novartis; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Herzig, Martin/R-4601-2016; Schmidt, Stephen/B-5398-2012; Schmidt, Stephen/AAC-6967-2019	Herzig, Martin/0000-0002-0500-353X; Mathews, Paul/0000-0003-1742-7687				Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bornebroek M, 1996, BRAIN PATHOL, V6, P111, DOI 10.1111/j.1750-3639.1996.tb00793.x; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Castano EM, 1996, J BIOL CHEM, V271, P32185, DOI 10.1074/jbc.271.50.32185; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Das P, 2001, NEUROBIOL AGING, V22, P721, DOI 10.1016/S0197-4580(01)00245-7; De Jonghe C, 1999, NEUROBIOL DIS, V6, P280, DOI 10.1006/nbdi.1999.0247; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Greenberg SM, 1998, NEUROLOGY, V51, P690, DOI 10.1212/WNL.51.3.690; Greenberg SM, 2002, NEUROLOGY, V58, P1587, DOI 10.1212/WNL.58.11.1587; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnson D, 1997, EDN, V42, P94; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Koller MF, 2004, NEURODEGENER DIS, V1, P20, DOI 10.1159/000076666; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Maat-Schieman MLC, 2000, ACTA NEUROPATHOL, V99, P409, DOI 10.1007/s004010051143; MaatSchieman MLC, 1996, BRAIN PATHOL, V6, P115, DOI 10.1111/j.1750-3639.1996.tb00794.x; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Monro OR, 2002, NEUROBIOL AGING, V23, P405, DOI 10.1016/S0197-4580(01)00317-7; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Natte R, 1999, ACTA NEUROPATHOL, V98, P577, DOI 10.1007/s004010051121; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRELLI F, 1990, BIOCHEM BIOPH RES CO, V170, P301, DOI 10.1016/0006-291X(90)91274-V; Richards JG, 2003, J NEUROSCI, V23, P8989; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; WATTENDORFF AR, 1982, J NEUROL SCI, V55, P121, DOI 10.1016/0022-510X(82)90094-6; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	50	321	338	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					954	960		10.1038/nn1302	http://dx.doi.org/10.1038/nn1302			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15311281	Green Accepted			2022-12-28	WOS:000223546700014
J	Mirescu, C; Peters, JD; Gould, E				Mirescu, C; Peters, JD; Gould, E			Early life experience alters response of adult neurogenesis to stress	NATURE NEUROSCIENCE			English	Article							NEONATAL MATERNAL SEPARATION; GENERATED GRANULE CELLS; RAT DENTATE GYRUS; LONG-EVANS RATS; SYNAPTIC PLASTICITY; HIPPOCAMPAL VOLUME; NEGATIVE FEEDBACK; MAJOR DEPRESSION; MEDIAN-EMINENCE; PROLIFERATION	Maternal deprivation produces persistent abnormalities in behavioral and neuroendocrine functions associated with the hippocampus, a brain region that shows considerable structural change in response to experience throughout life. Here we show that adverse experience early in life affects the regulation of adult neurogenesis in the hippocampus. More specifically, a decrease in cell proliferation and immature neuron production are observed in the dentate gyrus of adult rats that are maternally separated as pups. Although maternally separated rats show normal basal levels of corticosterone, the suppression of cell proliferation in these rats can be reversed by lowering corticosterone below the control value. In addition, normal stress-induced suppression of cell proliferation and neurogenesis, despite normal activation of the hypothalamic pituitary adrenal (HPA) axis, is not observed in maternally separated rats. Our results suggest that early adverse experience inhibits structural plasticity via hypersensitivity to glucocorticoids and diminishes the ability of the hippocampus to respond to stress in adulthood.	Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA.	goulde@princeton.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059740, P50MH058922] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58922, MH59740] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANNERMAN DM, 2003, BEHAV NEUROSCI, V116, P884; Bremner JD, 2001, AM J PSYCHIAT, V158, P653, DOI 10.1176/appi.ajp.158.4.653; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; JANS JE, 1990, DEV PSYCHOBIOL, V23, P519, DOI 10.1002/dev.420230607; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; Lovic V, 2001, DEV PSYCHOBIOL, V39, P19, DOI 10.1002/dev.1024; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MAGARINOS AM, 1987, HORM METAB RES, V19, P105, DOI 10.1055/s-2007-1011753; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; SAPOLSKY RM, 1989, ENDOCRINOLOGY, V125, P2881, DOI 10.1210/endo-125-6-2881; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Viau V, 1996, J NEUROENDOCRINOL, V8, P1, DOI 10.1111/j.1365-2826.1996.tb00680.x; VIAU V, 1993, J NEUROSCI, V13, P1097; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A	44	470	489	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					841	846		10.1038/nn1290	http://dx.doi.org/10.1038/nn1290			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273691				2022-12-28	WOS:000222930800014
J	Brown, EN; Kass, RE; Mitra, PP				Brown, EN; Kass, RE; Mitra, PP			Multiple neural spike train data analysis: state-of-the-art and future challenges	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; FIRING PATTERNS; INFORMATION; POPULATION; QUANTIFICATION; CLASSIFICATION; RECONSTRUCTION; IDENTIFICATION; PREDICTION; DISCHARGE	Multiple electrodes are now a standard tool in neuroscience research that make it possible to study the simultaneous activity of several neurons in a given brain region or across different regions. The data from multi-electrode studies present important analysis challenges that must be resolved for optimal use of these neurophysiological measurements to answer questions about how the brain works. Here we review statistical methods for the analysis of multiple neural spike-train data and discuss future challenges for methodology research.	Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, Boston, MA 02114 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15208 USA; Ctr Neural Basis Cognit, Dept Stat, Pittsburgh, PA 15208 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cold Spring Harbor Laboratory	Brown, EN (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neurosci Stat Res Lab, Boston, MA 02114 USA.	brown@neurostat.mgh.harvard.edu		Mitra, Partha/0000-0001-8818-6804	NIDA NIH HHS [DA015664] Funding Source: Medline; NIMH NIH HHS [MH66410, MH62528, MH61637, MH64537, MH59733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059733, R01MH064537, R01MH062528, K02MH061637, R25MH066410] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdallahi LMOM, 2003, BIOL CYBERN, V89, P170, DOI 10.1007/s00422-003-0416-8; ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Aksay E, 2003, J NEUROSCI, V23, P10852; AMARASINGHAM A, 2002, TEMPORAL STRUCTURE N; [Anonymous], 1978, DEV STAT; Baker SN, 2001, NEURAL COMPUT, V13, P1351, DOI 10.1162/08997660152002889; Bar-Gad I, 2001, J NEUROSCI METH, V107, P1, DOI 10.1016/S0165-0270(01)00339-9; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; BERGER T, 2003, IEEE INF THEORY SOC, V53, P1; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brillinger D.R., 1981, TIME SERIES; BRILLINGER DR, 1992, J AM STAT ASSOC, V87, P260, DOI 10.2307/2290256; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown EN, 2001, P NATL ACAD SCI USA, V98, P12261, DOI 10.1073/pnas.201409398; Brown EN, 1998, J NEUROSCI, V18, P7411; CHORNOBOY ES, 1988, BIOL CYBERN, V59, P265, DOI 10.1007/BF00332915; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P, 2001, COMPUTATIONAL NEUROS; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gao Y, 2003, I IEEE EMBS C NEUR E, P189; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Grun S, 2002, NEURAL COMPUT, V14, P81, DOI 10.1162/089976602753284464; Gutig R, 2002, NEURAL COMPUT, V14, P121, DOI 10.1162/089976602753284473; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Ito H, 2000, NEURAL COMPUT, V12, P195, DOI 10.1162/089976600300015952; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Kass RE, 2001, NEURAL COMPUT, V13, P1713, DOI 10.1162/08997660152469314; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; Nguyen DP, 2003, NETWORK-COMP NEURAL, V14, P61, DOI 10.1088/0954-898X/14/1/304; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pawitan Y., 2001, ALL LIKELIHOOD STAT; Percival D.B., 2000, CA ST PR MA, V4; PERCIVAL DB, 2002, SPECTRAL ANAL PHYS A; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pipa G, 2003, NEUROCOMPUTING, V52-4, P31, DOI 10.1016/S0925-2312(02)00823-8; Qaqish BF, 2003, BIOMETRIKA, V90, P455, DOI 10.1093/biomet/90.2.455; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rieke F., 1997, SPIKES EXPLORING NEU; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHIKRI O, 2003, NEURAL COMPUT, V5, P1803; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Stuart L, 2002, BIOSYSTEMS, V67, P265, DOI 10.1016/S0303-2647(02)00084-9; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thomson D. J, 1991, ADV SPECTRUM ANAL AR, VI, P58; Victor JD, 2003, NETWORK-COMP NEURAL, V14, P1, DOI 10.1088/0954-898X/14/1/001; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wiener MC, 2003, J NEUROSCI, V23, P2394; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	65	570	586	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					456	461		10.1038/nn1228	http://dx.doi.org/10.1038/nn1228			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114358				2022-12-28	WOS:000221101300013
J	Grill-Spector, K; Knouf, N; Kanwisher, N				Grill-Spector, K; Knouf, N; Kanwisher, N			The fusiform face area subserves face perception, not generic within-category identification	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; HUMAN NEURAL SYSTEM; SELECTIVE ACTIVATION; FUNCTIONAL MRI; VISUAL-CORTEX; BRAIN-AREAS; RECOGNITION; OBJECTS; EXPERTISE; GYRUS	The function of the fusiform face area (FFA), a face-selective region in human extrastriate cortex, is a matter of active debate. Here we measured the correlation between FFA activity measured by functional magnetic resonance imaging (fMRI) and behavioral outcomes in perceptual tasks to determine the role of the FFA in the detection and within-category identification of faces and objects. Our data show that FFA activation is correlated on a trial-by-trial basis with both detecting the presence of faces and identifying specific faces. However, for most non-face objects (including cars seen by car experts), within-category identification performance was correlated with activation in other regions of the ventral occipitotemporal cortex, not the FFA. These results indicate that the FFA is involved in both detection and identification of faces, but that it has little involvement in within-category identification of non-face objects (including objects of expertise).	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT)	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall, Stanford, CA 94305 USA.	kalanit@psych.stanford.edu		Grill-Spector, Kalanit/0000-0002-5404-9606	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Andrews TJ, 2002, NEUROIMAGE, V17, P890, DOI 10.1006/nimg.2002.1243; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GRILLSPECTOR K, IN PRESS PSYCHOL SCI; GRILLSPECTOR K, 2003, ATTENTION PERFORM, V20, P169; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2004, VISUAL NEUROSCIENCES, P1179; KANWISHER N, 1998, COGNITION B, V68, P1; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCKONE E, IN PRESS MONKEY BRAI; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Thompson KG, 2000, VISION RES, V40, P1523, DOI 10.1016/S0042-6989(99)00250-3; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	49	677	683	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					555	562		10.1038/nn1224	http://dx.doi.org/10.1038/nn1224			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15077112				2022-12-28	WOS:000221101300034
J	Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB				Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB			Fast and slow parietal pathways mediate spatial attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTEX	Mechanisms of selective attention are vital for guiding human behavior. The parietal cortex has long been recognized as a neural substrate of spatial attention, but the unique role of distinct parietal subregions has remained unclear. Using single-pulse transcranial magnetic stimulation, we found that the angular gyrus of the right parietal cortex mediates spatial orienting during two distinct time periods after the onset of a behaviorally relevant event. The biphasic involvement of the angular gyrus suggests that both fast and slow visual pathways are necessary for orienting spatial attention.	Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia	University of Melbourne	Chambers, CD (corresponding author), Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia.	c.chambers@psych.unimelb.edu.au	Mattingley, Jason/J-1537-2014; Chambers, Chris/E-7827-2010	Mattingley, Jason/0000-0003-0929-9216; Payne, Jonathan/0000-0001-9565-3845; Chambers, Chris/0000-0001-6058-4114				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7	11	190	192	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					217	218		10.1038/nn1203	http://dx.doi.org/10.1038/nn1203			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14983182				2022-12-28	WOS:000189197900009
J	Sandberg, M; Kallstrom, M; Muhr, J				Sandberg, M; Kallstrom, M; Muhr, J			Sox21 promotes the progression of vertebrate neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURONAL DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MAMMALIAN-CELLS; NERVOUS-SYSTEM; STEM-CELLS; EXPRESSION; IDENTITY; PROTEIN; GENES; LOOP	The generation of neurons constitutes the foundation of nervous system development, yet the mechanisms underlying neurogenesis are not well established. The HMG-box transcription factors Sox1, Sox2 and Sox3 ( Sox1 - 3) have previously been shown to suppress neurogenesis by maintaining neural cells in an undifferentiated state. Here we report that another HMG-box protein, Sox21, has the opposite activity and promotes neuronal differentiation. Using genetic studies in the chick embryo, we found that Sox21 mediates this function by counteracting the activity of Sox1 - 3. Accordingly, the balance of Sox21 and Sox1 - 3 activities determines whether neural cells remain as progenitors or commit to differentiation. Proneural basic helix-loop-helix proteins are essential for the establishment of neuronal fates. We now show that proneural proteins promote neurogenesis by upregulating Sox21 expression. These data establish a key role for Sox21 in the progression of neuronal differentiation and indicate that an important role of proneural proteins is their capacity to upregulate the expression of Sox21.	Karolinska Inst, Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research	Muhr, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Box 240, SE-17177 Stockholm, Sweden.	jonas.muhr@licr.ki.se		Sandberg, Magnus/0000-0003-0809-0656				Bae SK, 2000, DEVELOPMENT, V127, P2933; Beranger F, 2000, J BIOL CHEM, V275, P16103, DOI 10.1074/jbc.275.21.16103; Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohba H, 2004, NEUROSCI LETT, V358, P157, DOI 10.1016/j.neulet.2004.01.026; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Smith ST, 1996, DEVELOPMENT, V122, P3141; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090	39	153	158	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					995	1001		10.1038/nn1493	http://dx.doi.org/10.1038/nn1493			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995704				2022-12-28	WOS:000230760200010
J	Morrone, MC; Ross, J; Burr, D				Morrone, MC; Ross, J; Burr, D			Saccadic eye movements cause compression of time as well as space	NATURE NEUROSCIENCE			English	Article							VISUAL-PERCEPTION; VOLUNTARY ACTION; PARIETAL CORTEX; REPRESENTATION; ATTENTION; DURATION; LOCALIZATION; SUPPRESSION; INTEGRATION; AWARENESS	There is now considerable evidence that space is compressed when stimuli are flashed shortly before or after the onset of a saccadic eye movement. Here we report that short intervals of time between two successive perisaccadic visual (but not auditory) stimuli are also underestimated, indicating a compression of perceived time. We were even more surprised that in a critical interval before saccades, perceived temporal order is consistently reversed. The very similar time courses of spatial and temporal compression suggest that both are mediated by a common neural mechanism, probably related to the predictive shifts that occur in receptive fields of many visual areas at the time of saccades.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University; University of Western Australia; University of Florence	Burr, D (corresponding author), CNR, Ist Neurosci, Via Moruzzi 1, I-56100 Pisa, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Burr DC, 1996, VISION RES, V36, P2069, DOI 10.1016/0042-6989(95)00282-0; Carpenter R.H.S., 1988, MOVEMENT EYES, Vsecond; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Enns JT, 1999, J GEN PSYCHOL, V126, P355, DOI 10.1080/00221309909595371; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LIBET B, 1979, BRAIN, V102, P193, DOI 10.1093/brain/102.1.193; MATIN L, 1972, HDB SENSORY PHYSIOLO, V7, P331; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Morrone MC, 1997, J NEUROSCI, V17, P7941; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Park J, 2003, VISION RES, V43, P1667, DOI 10.1016/S0042-6989(03)00217-7; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; RIDDER WH, 1993, VISION RES, V33, P1795, DOI 10.1016/0042-6989(93)90170-2; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; ROSS J, 1972, 4 U W AUSTR DEP PSYC; Santoro L, 2002, VISION RES, V42, P1361, DOI 10.1016/S0042-6989(02)00056-1; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	40	292	296	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					950	954		10.1038/nn1488	http://dx.doi.org/10.1038/nn1488			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965472				2022-12-28	WOS:000230137100023
J	Goto, Y; Grace, AA				Goto, Y; Grace, AA			Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior	NATURE NEUROSCIENCE			English	Article							SCHIZOPHRENIA; RECEPTOR; RAT; BINDING; SYSTEM; PATHOPHYSIOLOGY; HIPPOCAMPAL; PERFORMANCE; HYPOTHESIS; STRIATUM	Goal-directed behavior is believed to involve interactions of prefrontal cortical and limbic inputs in the nucleus accumbens (NAcc), and their modulation by mesolimbic dopamine (DA) seems to be of primary importance in NAcc function. Using in vivo electrophysiological recordings simultaneously with DA system manipulation in rats, we show that tonic and phasic DA release selectively modulates hippocampal and prefrontal cortical inputs through D1 and D2 receptors, respectively. In addition, we also found that D1 activation and D2 inactivation in the NAcc produced behaviorally selective effects ( learning versus set shifting of response strategy) that correspond to specific afferents. These results suggest that the dynamics of DA release regulate the balance between limbic and cortical drive through activation and inactivation of DA receptor subtypes in the accumbens, and this regulates goal-directed behavior.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat & Psychol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goto, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	goto@bns.pitt.edu		Grace, Anthony/0000-0003-1864-5504	NIMH NIH HHS [MH57440] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440, R01MH057440] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albertin SV, 2000, BEHAV BRAIN RES, V117, P173, DOI 10.1016/S0166-4328(00)00303-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Charara A, 2003, NEUROPSYCHOPHARMACOL, V28, P1412, DOI 10.1038/sj.npp.1300220; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CREESE I, 1983, ANNU REV NEUROSCI, V6, P43, DOI 10.1146/annurev.ne.06.030183.000355; Csernansky JG, 1998, SCHIZOPHRENIA BULL, V24, P231, DOI 10.1093/oxfordjournals.schbul.a033323; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Floresco SB, 1997, J NEUROSCI, V17, P1880; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 1999, PSYCHOBIOLOGY, V27, P277; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Grunder G, 2003, ARCH GEN PSYCHIAT, V60, P974, DOI 10.1001/archpsyc.60.10.974; HALL H, 1985, EUR J PHARMACOL, V111, P191, DOI 10.1016/0014-2999(85)90756-3; Humeau Y, 2002, J NEUROSCI, V22, P7968; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Phillips PEM, 2004, NAT NEUROSCI, V7, P199, DOI 10.1038/nn0304-199a; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; VOORN P, 1986, J COMP NEUROL, V251, P84, DOI 10.1002/cne.902510106; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495	34	434	440	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					805	812		10.1038/nn1471	http://dx.doi.org/10.1038/nn1471			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908948				2022-12-28	WOS:000229345300022
J	Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ				Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ			Isolation of neural stem cells from the postnatal cerebellum	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN-TUMORS; MOUSE CEREBELLUM; PRECURSOR CELLS; SONIC HEDGEHOG; WHITE-MATTER; IN-VITRO; CNS; NEURONS	The cerebellum is critical for motor coordination and cognitive function and is the target of transformation in medulloblastoma, the most common malignant brain tumor in children. Although the development of granule cells, the most abundant neurons in the cerebellum, has been studied in detail, the origins of other cerebellar neurons and glia remain poorly understood. Here we show that the murine postnatal cerebellum contains multipotent neural stem cells (NSCs). These cells can be prospectively isolated based on their expression of the NSC marker prominin-1 (CD133) and their lack of markers of neuronal and glial lineages (lin(-)). Purified prominin(+)lin(-) cells form self-renewing neurospheres and can differentiate into astrocytes, oligodendrocytes and neurons in vitro. Moreover, they can generate each of these lineages after transplantation into the cerebellum. Identification of cerebellar stem cells has important implications for the understanding of cerebellar development and the origins of medulloblastoma.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	Duke University; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wechsler-Reya, RJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	rw.reya@duke.edu	Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Johnson, Jane/F-8881-2010; Corbeil, Denis/A-6519-2010; Huttner, Wieland B./P-4080-2018	Corbeil, Denis/0000-0003-1181-3659; Read, Tracy-Ann/0000-0002-5436-1296; /0000-0002-8605-2746; Hartman, Jessica/0000-0003-1578-3389	NIMH NIH HHS [R01 MH067916, R01 MH067916-05, R01 MH067916-01A1, 1R01MH067916-01, R01 MH067916-03, R01 MH067916-04] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067916] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altman J, 1997, DEV CEREBELLAR SYSTE; AOKI E, 1986, NEUROSCI LETT, V68, P267, DOI 10.1016/0304-3940(86)90500-8; ARUGA J, 1994, J NEUROCHEM, V63, P1880; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cheng YH, 2001, J NEUROBIOL, V46, P220, DOI 10.1002/1097-4695(20010215)46:3<220::AID-NEU1004>3.0.CO;2-P; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; GAO WQ, 1994, DEVELOPMENT, V120, P1059; Geisert EE, 1996, J NEUROSCI, V16, P5478; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HAEGEL H, 1993, J CELL BIOL, V122, P1067, DOI 10.1083/jcb.122.5.1067; HALLONET MER, 1990, DEVELOPMENT, V108, P19; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Imura T, 2003, J NEUROSCI, V23, P2824; KATSETOS CD, 1995, ARCH PATHOL LAB MED, V119, P734; Kern JK, 2002, MED HYPOTHESES, V59, P255, DOI 10.1016/S0306-9877(02)00212-8; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MARTIN P, 1995, SCHIZOPHRENIA BULL, V21, P241, DOI 10.1093/schbul/21.2.241; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG RN, 1989, NEUROL CLIN, V7, P25, DOI 10.1016/S0733-8619(18)30826-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Shetty AK, 1998, J NEUROBIOL, V35, P395, DOI 10.1002/(SICI)1097-4695(19980615)35:4<395::AID-NEU7>3.0.CO;2-U; SIMMONS ML, 1992, J NEUROSCI RES, V31, P646, DOI 10.1002/jnr.490310408; Singh SK, 2003, CANCER RES, V63, P5821; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TUCKER RP, 1988, J NEUROSCI, V8, P4503; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	50	374	399	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					723	729		10.1038/nn1473	http://dx.doi.org/10.1038/nn1473			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908947	Green Accepted			2022-12-28	WOS:000229345300011
J	Chacron, MJ; Maler, L; Bastian, J				Chacron, MJ; Maler, L; Bastian, J			Electroreceptor neuron dynamics shape information transmission	NATURE NEUROSCIENCE			English	Article							ELECTRIC FISH; APTERONOTUS-ALBIFRONS; RECEPTIVE-FIELDS; SENSORY NEURONS; STRIATE CORTEX; BRAIN; ADAPTATION; MODULATION; STIMULI; MONKEY	The gymnotiform weakly electric fish Apteronotus leptorhynchus can capture prey using electrosensory cues that are dominated by low temporal frequencies. However, conventional tuning curves predict poor electroreceptor afferent responses to low-frequency stimuli. We compared conventional tuning curves with information tuning curves and found that the latter predicted substantially improved responses to these behaviorally relevant stimuli. Analysis of receptor afferent baseline activity showed that negative correlations reduced low-frequency noise levels, thereby increasing information transmission. Multiunit recordings from receptor afferents showed that this increased information transmission could persist at the population level. Finally, we verified that this increased low-frequency information is preserved in the spike trains of central neurons that receive receptor afferent input. Our results demonstrate that conventional tuning curves can be misleading when certain noise reduction strategies are used by the nervous system.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Oklahoma System; University of Oklahoma - Norman; University of Ottawa	Chacron, MJ (corresponding author), Univ Oklahoma, Dept Zool, 730 Van Vleet Oval, Norman, OK 73019 USA.	mauricejchacron@yahoo.ca		Chacron, Maurice/0000-0002-3032-452X	Canadian Institutes of Health Research [71094-1] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Bennett M.V.L., 1986, P157; Berry MJ, 1998, J NEUROSCI, V18, P2200; Bialek W., 1996, SPIKES EXPLORING NEU; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARR CE, 1990, J NEUROSCI, V10, P3227; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Cook EP, 2004, J NEUROSCI, V24, P7964, DOI 10.1523/JNEUROSCI.5102-03.2004; Dayan P, 2001, THEORETICAL NEUROSCI, P45; DEBOER E, 1968, IEEE T BIOMED ENG, V15, P159; EGGERMONT JJ, 1990, HEARING RES, V43, P181, DOI 10.1016/0378-5955(90)90227-G; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Gabbiani F., 1998, METHODS NEURONAL MOD, P313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Holden AV, 2004, NATURE, V428, P382, DOI 10.1038/428382a; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KLEMM WR, 1981, INT J NEUROSCI, V14, P15, DOI 10.3109/00207458108985812; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; Lebedev MA, 1996, EXP BRAIN RES, V111, P313; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; LOWEN SB, 1992, J ACOUST SOC AM, V92, P803, DOI 10.1121/1.403950; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nelson ME, 1997, J COMP PHYSIOL A, V181, P532, DOI 10.1007/s003590050137; Norsworthy S. R., 1996, DELTA SIGMA DATA CON; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; RISKEN H, 1996, FOKKERPLANCK EQUATIO, P43003; SHIN JH, 1993, INT J ELECTRON, V74, P359, DOI 10.1080/00207219308925840; Shin JH, 2001, NEURAL NETWORKS, V14, P907, DOI 10.1016/S0893-6080(01)00077-6; SHUMWAY CA, 1989, J NEUROSCI, V9, P4388; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P187, DOI 10.1196/annals.1298.020; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WANG XJ, 1995, HDB BRAIN THEORY NEU, P686; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323	45	97	97	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					673	678		10.1038/nn1433	http://dx.doi.org/10.1038/nn1433			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15806098	Green Accepted			2022-12-28	WOS:000228895100029
J	Lohmann, C; Finski, A; Bonhoeffer, T				Lohmann, C; Finski, A; Bonhoeffer, T			Local calcium transients regulate the spontaneous motility of dendritic filopodia	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPSE FORMATION; PYRAMIDAL NEURONS; GLUTAMATERGIC SYNAPSES; SPINE FORMATION; CA2+ RELEASE; IN-VITRO; GROWTH; CA1; SYNAPTOGENESIS	During development, dendrites, and in particular dendritic filopodia, undergo extensive structural remodeling, presumably to help establish synaptic contacts. Here, we investigated the role of calcium signaling in dendritic plasticity by simultaneously recording calcium dynamics and filopodial growth in rat hippocampal slice cultures. Local calcium transients occurred in dendritic filopodia and shafts, often at putative synaptic sites. These events were highly correlated with filopodial motility: comparatively rare when individual filopodia emerged from the dendrite, they became more frequent after filopodia started growing, finally causing them to halt. Accordingly, an experimental reduction of the frequency of local calcium transients elicited filopodial growth and, conversely, calcium uncaging reduced filopodial motility. Our observations suggest that low levels of local calcium transients facilitate filopodial outgrowth, whereas high levels inhibit the formation of filopodia and stabilize newly formed ones. This process may facilitate synapse formation and may serve as a homeostatic mechanism distributing synapses evenly along developing dendrites.	Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Max Planck Society	Lohmann, C (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Planegg Martinsried, Germany.	lohmann@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009; Lohmann, Christian/B-8003-2012	Bonhoeffer, Tobias/0000-0001-7897-6634; Lohmann, Christian/0000-0002-1780-2419				BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Capogna M, 2003, J NEUROSCI, V23, P4044; Ciccolini F, 2003, J NEUROSCI, V23, P103; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kang HJ, 2000, NEUROSCI LETT, V282, P141, DOI 10.1016/S0304-3940(00)00893-4; Kettunen P, 2002, J NEUROSCI METH, V119, P37, DOI 10.1016/S0165-0270(02)00154-1; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Meberg PJ, 1999, NEUROREPORT, V10, P639, DOI 10.1097/00001756-199902250-00036; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; O'Brien JA, 2001, J NEUROSCI METH, V112, P57, DOI 10.1016/S0165-0270(01)00457-5; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Schuster T, 2001, J NEUROBIOL, V49, P142, DOI 10.1002/neu.1071; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tyzio R, 1999, J NEUROSCI, V19, P10372; Veselovsky NS, 1996, PFLUG ARCH EUR J PHY, V432, P351, DOI 10.1007/s004240050143; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zhang SX, 2004, MOL CELL NEUROSCI, V25, P334, DOI 10.1016/j.mcn.2003.10.017; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	41	106	107	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					305	312		10.1038/nn1406	http://dx.doi.org/10.1038/nn1406			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711541				2022-12-28	WOS:000227354600015
J	Clark, BA; Monsivais, P; Branco, T; London, M; Hausser, MH				Clark, BA; Monsivais, P; Branco, T; London, M; Hausser, MH			The site of action potential initiation in cerebellar Purkinje neurons	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PROPAGATION	Knowledge of the site of action potential initiation is essential for understanding how synaptic input is converted into neuronal output. Previous studies have shown that the lowest-threshold site for initiation of action potentials is in the axon. Here we use recordings from visualized rat cerebellar Purkinje cell axons to localize the site of initiation to a well-defined anatomical structure: the first node of Ranvier, which normally forms at the first axonal branch point.	UCL, Dept Physiol, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Hausser, MH (corresponding author), UCL, Dept Physiol, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Clark, Beverley/C-1519-2008; Hausser, Michael/AAW-6827-2020; Branco, Tiago/C-1503-2008; London, Michael/B-4175-2010	Hausser, Michael/0000-0002-2673-8957; London, Michael/0000-0001-5137-1707; Monsivais, Pablo/0000-0002-7088-6674				ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; Gianola S, 2003, J NEUROSCI, V23, P4613; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	15	107	109	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					137	139		10.1038/nn1390	http://dx.doi.org/10.1038/nn1390			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665877				2022-12-28	WOS:000226638200008
J	Long, MA; Jutras, MJ; Connors, BW; Burwell, RD				Long, MA; Jutras, MJ; Connors, BW; Burwell, RD			Electrical synapses coordinate activity in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; NEURONAL-ACTIVITY; GAP-JUNCTIONS; SYNCHRONIZATION; TRANSMISSION; NETWORKS; TETRODOTOXIN; INTERNEURONS; CHANNELS	In the suprachiasmatic nucleus (SCN), the master circadian pacemaker, neurons show circadian variations in firing frequency. There is also considerable synchrony of spiking across SCN neurons on a scale of milliseconds, but the mechanisms are poorly understood. Using paired whole-cell recordings, we have found that many neurons in the rat SCN communicate via electrical synapses. Spontaneous spiking was often synchronized in pairs of electrically coupled neurons, and the degree of this synchrony could be predicted from the magnitude of coupling. In wild-type mice, as in rats, the SCN contained electrical synapses, but electrical synapses were absent in connexin36-knockout mice. The knockout mice also showed dampened circadian activity rhythms and a delayed onset of activity during transition to constant darkness. We suggest that electrical synapses in the SCN help to synchronize its spiking activity, and that such synchrony is necessary for normal circadian behavior.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Dept Psychol, Providence, RI 02912 USA	Brown University; Brown University	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	bwc@brown.edu	Connors, Barry/AAX-1975-2020; Burwell, Rebecca D/E-4970-2011	Connors, Barry/0000-0002-3739-3157; Burwell, Rebecca/0000-0002-2063-9616	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12500] Funding Source: Medline; NIMH NIH HHS [MH60284] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Brandstaetter R, 2004, P NATL ACAD SCI USA, V101, P5699, DOI 10.1073/pnas.0401378101; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; Chu ZG, 2003, J NEUROSCI, V23, P96; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Long MA, 2002, J NEUROSCI, V22, P10898; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; Shinohara K, 2001, NEUROSCI LETT, V309, P37, DOI 10.1016/S0304-3940(01)02022-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Srinivas M, 1999, J NEUROSCI, V19, P9848; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; VANDENPOL AN, 1986, NEUROSCIENCE, V17, P643, DOI 10.1016/0306-4522(86)90037-0; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	154	158	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					61	66		10.1038/nn1361	http://dx.doi.org/10.1038/nn1361			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580271				2022-12-28	WOS:000225967600016
J	Purushothaman, G; Bradley, DC				Purushothaman, G; Bradley, DC			Neural population code for fine perceptual decisions in area MT	NATURE NEUROSCIENCE			English	Article							SPATIAL-FREQUENCY DISCRIMINATION; SUPERIOR TEMPORAL SULCUS; VISUAL AREA; FUNCTIONAL-ORGANIZATION; NEURONS; ORIENTATION; DIRECTION; MOTION; RESPONSES; MONKEY	In the middle temporal (MT) area of primates, many motion-sensitive neurons with a wide range of preferred directions respond to a stimulus moving in a single direction. These neurons are involved in direction perception, but it is not clear how perceptual decisions are related to the population response. We recorded the activities of MT neurons in rhesus monkeys while they discriminated closely related directions, and examined the relationship between the activities of neurons tuned to different directions and the monkeys' choices. Perceptual decisions were significantly correlated with the activities of the highest-precision neurons but not with those of the lowest-precision neurons. The combined performance of the high-precision neurons matched the monkeys' behavior, whereas the ability to predict behavior based on the entire active population was poor. These results suggest that fine discrimination decisions are crucially dependent on the activities of the most informative neurons.	Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Bradley, DC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave,Green 320, Chicago, IL 60637 USA.	bradley@uchicago.edu			NATIONAL EYE INSTITUTE [R01EY013138] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; ASH R, 1965, INFORMATION THEORY; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Barlow Horace, 1995, P415; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DEVALOIS RL, 1967, J NEUROPHYSIOL, V30, P415, DOI 10.1152/jn.1967.30.3.415; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Erickson R P, 2001, Prog Brain Res, V130, P9, DOI 10.1016/S0079-6123(01)30003-1; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Green DM, 1966, SIGNAL DETECTION THE; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Liu J, 2003, J NEUROPHYSIOL, V89, P246, DOI 10.1152/jn.00097.2002; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Poggio T, 2000, SPATIAL VISION, V13, P287, DOI 10.1163/156856800741108; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; REGAN D, 1983, J OPT SOC AM, V73, P1684, DOI 10.1364/JOSA.73.001684; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; REZA FM, 1994, INTRO INFORMATION TH; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SEKULER R, 2002, STEVENS HDB EXPT PSY, V1, P121; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; VOGELS R, 1990, J NEUROSCI, V10, P3543; WATAMANIUK SNJ, 1989, VISION RES, V29, P47, DOI 10.1016/0042-6989(89)90173-9; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; WILSON HR, 1984, J OPT SOC AM A, V1, P1091, DOI 10.1364/JOSAA.1.001091; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	243	247	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					99	106		10.1038/nn1373	http://dx.doi.org/10.1038/nn1373			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608633				2022-12-28	WOS:000225967600022
J	Racz, B; Blanpied, TA; Ehlers, MD; Weinberg, RJ				Racz, B; Blanpied, TA; Ehlers, MD; Weinberg, RJ			Lateral organization of endocytic machinery in dendritic spines	NATURE NEUROSCIENCE			English	Article							SYNAPSES; AMPA; PLASTICITY; RECEPTORS; MEMBRANE	Postsynaptic membrane trafficking plays an important role in synaptic plasticity, but the organization of trafficking machinery within dendritic spines is poorly understood. We use immunocytochemical analysis of rat hippocampal neurons to show that proteins mediating endocytosis are systematically arrayed within dendritic spines, tangential to the synapse. Thus, previously unrecognized lateral domains of the spine organize endocytic protein machinery at sites removed from the postsynaptic density.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Rácz, Bence/J-4220-2019; Weinberg, Richard/AAC-1898-2020	Rácz, Bence/0000-0002-1933-5332; Blanpied, Thomas/0000-0003-4957-557X; Weinberg, Richard/0000-0001-9689-7278				Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; He Y, 2000, J COMP NEUROL, V418, P255; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211	15	158	167	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					917	918		10.1038/nn1303	http://dx.doi.org/10.1038/nn1303			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322548				2022-12-28	WOS:000223546700007
J	Li, W; DeVries, SH				Li, W; DeVries, SH			Separate blue and green cone networks in the mammalian retina	NATURE NEUROSCIENCE			English	Article							GAP-JUNCTIONAL PROTEIN; MACAQUE RETINA; PRIMATE RETINA; BIPOLAR CELLS; GANGLION-CELLS; SENSITIVE CONES; TURTLE PHOTORECEPTORS; SPECTRAL SENSITIVITY; KAINATE RECEPTORS; GROUND-SQUIRREL	The distinct absorbance spectra of the cone photopigments form the basis of color vision, but ultrastructural and physiological evidence shows that mammalian cones are electrically coupled. Coupling between cones of the same spectral type should average voltage noise in adjacent photoreceptors and improve the ability to resolve low-contrast spatial patterns. However, indiscriminate coupling between spectral types could compromise color vision by smearing chromatic information across channels. Here we show, by measuring the junctional conductance between green-green and blue-green cone pairs in slices from the dichromatic ground-squirrel retina, that green-green cone pairs are routinely coupled with an average conductance of 220 pS, whereas coupling is undetectable in blue-green cone pairs. Together with a lack of tracer coupling and the selective localization of connexin proteins, our results show that signals in blue and green cones are processed separately in the photoreceptor layer.	Northwestern Univ, Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Li, W (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, 303 E Chicago Ave,Tarry 5-715, Chicago, IL 60611 USA.	w-li2@northwestern.edu		Li, Wei/0000-0002-2897-649X	NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHNELT P, 1990, J COMP NEUROL, V293, P39, DOI 10.1002/cne.902930104; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DEMONASTERIO FM, 1981, SCIENCE, V213, P1278, DOI 10.1126/science.7268439; DETWILER PB, 1979, J PHYSIOL-LONDON, V291, P75, DOI 10.1113/jphysiol.1979.sp012801; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Feigenspan A, 2004, J NEUROSCI, V24, P3325, DOI 10.1523/JNEUROSCI.5598-03.2004; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Ghosh KK, 1997, J COMP NEUROL, V379, P211; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Herr S, 2003, J COMP NEUROL, V457, P185, DOI 10.1002/cne.10553; Hornstein EP, 2004, NAT NEUROSCI, V7, P745, DOI 10.1038/nn1274; Hsu A, 2000, J OPT SOC AM A, V17, P635, DOI 10.1364/JOSAA.17.000635; JACOBS GH, 1978, ANIM BEHAV, V26, P409, DOI 10.1016/0003-3472(78)90058-1; Kolb H, 1997, J COMP NEUROL, V386, P443, DOI 10.1002/(SICI)1096-9861(19970929)386:3<443::AID-CNE8>3.0.CO;2-1; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; LAMB TD, 1976, J PHYSIOL-LONDON, V263, P257, DOI 10.1113/jphysiol.1976.sp011631; Laughlin SB, 2002, CURR BIOL, V12, pR833, DOI 10.1016/S0960-9822(02)01345-3; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; McGinnis JF, 1997, J NEUROSCI RES, V50, P487, DOI 10.1002/(SICI)1097-4547(19971101)50:3<487::AID-JNR15>3.0.CO;2-3; Mills SL, 2000, J NEUROSCI, V20, P8629, DOI 10.1523/JNEUROSCI.20-22-08629.2000; Mills SL, 2001, J COMP NEUROL, V436, P336; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NUNN BJ, 1984, NATURE, V309, P264, DOI 10.1038/309264a0; OBrien J, 1996, MOL BIOL CELL, V7, P233, DOI 10.1091/mbc.7.2.233; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; SZEL A, 1988, J COMP NEUROL, V273, P593, DOI 10.1002/cne.902730413; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; WILLIAMS DR, 1981, VISION RES, V21, P1357, DOI 10.1016/0042-6989(81)90242-X; YANG G, 1994, J NEUROSCI, V14, P5267	51	65	66	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					751	756		10.1038/nn1275	http://dx.doi.org/10.1038/nn1275			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208635				2022-12-28	WOS:000222274400017
J	Schindler, I; Rice, NJ; McIntosh, RD; Rossetti, Y; Vighetto, A; Milner, AD				Schindler, I; Rice, NJ; McIntosh, RD; Rossetti, Y; Vighetto, A; Milner, AD			Automatic avoidance of obstacles is a dorsal stream function: evidence from optic ataxia	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; NEUROPSYCHOLOGY; MECHANISMS; HAND	When we reach out to pick something up, our arm is directed to the target by visuomotor networks in the cortical dorsal stream. However, our reach trajectories are influenced also by nontarget objects, which might be construed as potential obstacles. We tested two patients with bilateral dorsal-stream (parietal lesions, both of whom were impaired at pointing to visual stimuli (optic ataxia). We asked them to reach between two cylinders, which varied in location from trial to trial. We found that the patients' reaches remained invariant with changes in obstacle location. In a control task when they were asked to point midway between the two objects, however, their responses shifted in an orderly fashion. We conclude that the dorsal stream provides the visual guidance we automatically build into our movements to avoid potential obstacles, as well as that required to ensure arrival at the target.	Univ Durham, Wolfson Res Inst, Dept Psychol, Stockton On Tees TS17 6BH, England; Univ Lyon 1, INSERM, UMR 534, Bron, France; IFNL, INSERM, Lyon, France	Durham University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Milner, AD (corresponding author), Univ Durham, Wolfson Res Inst, Dept Psychol, Queens Campus, Stockton On Tees TS17 6BH, England.	a.d.milner@dur.ac.uk	Rossetti, Yves/H-3693-2017	Rossetti, Yves/0000-0001-8867-4496; McIntosh, Robert/0000-0002-7615-6699				Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Harvey M, 2001, BEHAV NEUROL, V13, P17; Himmelbach M, 2003, J COGNITIVE NEUROSCI, V15, P972, DOI 10.1162/089892903770007362; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; McIntosh RD, 2004, NEUROPSYCHOLOGIA, V42, P1107, DOI 10.1016/j.neuropsychologia.2003.11.023; McIntosh RD, 2004, P ROY SOC B-BIOL SCI, V271, P15, DOI 10.1098/rspb.2003.2545; McIntosh RD, 2001, BEHAV NEUROL, V13, P3; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 2003, PROG BRAIN RES, V144, P213, DOI 10.1016/S0079-6123(03)14401-5; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 1999, STUD PERCEPT ACTION, V5, P275; ROSSETTI Y, IN PRESS NEUROPSYCHO; Rossetti Y, 2003, BRADFORD BOOKS, P67; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409	24	115	116	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					779	784		10.1038/nn1273	http://dx.doi.org/10.1038/nn1273			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208633				2022-12-28	WOS:000222274400021
J	Choudhary, J; Grant, SGN				Choudhary, J; Grant, SGN			Proteomics in postgenomic neuroscience: the end of the beginning	NATURE NEUROSCIENCE			English	Article							TANDEM AFFINITY PURIFICATION; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; MULTIPROTEIN COMPLEXES; QUANTITATIVE-ANALYSIS; PROTEIN COMPLEXES; SYSTEMS BIOLOGY; YEAST PROTEOME; IDENTIFICATION; MOUSE	Proteomics is complementary to genomic approaches anchored in DNA and RNA. Global characterization of proteins is providing new insights into general biological structures as well as synapses, receptor complexes and other neuronal and glial features. Current challenges for proteomics of the nervous system include problems relating to sample preparation, brain complexity, limited databases and informatics tools. The combination of proteomics with other global functional genomic approaches at the levels of genome and transcriptome, together with network biology, will provide important bridges between genes, physiology and pathology.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Choudhary, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Choudhary, Jyoti/S-1232-2017	Choudhary, Jyoti/0000-0003-0881-5477; Grant, Seth/0000-0001-8732-8735				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; CASTELLUCCI VF, 1988, NEURON, V1, P321, DOI 10.1016/0896-6273(88)90080-3; Che FY, 2002, ANAL CHEM, V74, P3190, DOI 10.1021/ac015681a; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grant SGN, 2003, CURR OPIN NEUROBIOL, V13, P577, DOI 10.1016/j.conb.2003.09.016; Grant SGN, 2003, BEHAVIORAL GENETICS IN THE POSTGENOMIC ERA, P123, DOI 10.1037/10480-008; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Herbert BR, 2001, TRENDS BIOTECHNOL, V19, pS3, DOI 10.1016/S0167-7799(01)01796-6; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang CM, 2001, MOL BRAIN RES, V92, P181, DOI 10.1016/S0169-328X(01)00118-8; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, TRENDS NEUROSCI, V24, P259, DOI 10.1016/S0166-2236(00)01792-6; Husi H, 2002, NEUROSCIENCE DATABAS, P51; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Korolainen MA, 2002, ELECTROPHORESIS, V23, P3428, DOI 10.1002/1522-2683(200210)23:19<3428::AID-ELPS3428>3.0.CO;2-5; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Martin K, 2003, COMB CHEM HIGH T SCR, V6, P331; Maurer Martin H, 2003, Proteome Sci, V1, P4, DOI 10.1186/1477-5956-1-4; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mouledous L, 2003, PROTEOMICS, V3, P610, DOI 10.1002/pmic.200300398; Nedelkov D, 2003, TRENDS BIOTECHNOL, V21, P301, DOI 10.1016/S0167-7799(03)00141-0; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patterson SD, 2003, NAT GENET, V33, P311, DOI 10.1038/ng1106; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Raghothama C, 2003, TRENDS BIOTECHNOL, V21, P467, DOI 10.1016/j.tibtech.2003.09.009; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Romijn EP, 2003, J CHROMATOGR A, V1000, P589, DOI 10.1016/S0021-9673(03)00178-X; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schweitzer B, 2002, CURR OPIN BIOTECH, V13, P14, DOI 10.1016/S0958-1669(02)00278-1; Shevchenko A, 2002, MOL CELL PROTEOMICS, V1, P204, DOI 10.1074/mcp.M200005-MCP200; Soreghan BA, 2003, PHARM RES, V20, P1713, DOI 10.1023/B:PHAM.0000003366.25263.78; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	64	96	103	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					440	445		10.1038/nn1240	http://dx.doi.org/10.1038/nn1240			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114355				2022-12-28	WOS:000221101300010
J	Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA				Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA			Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse	NATURE NEUROSCIENCE			English	Article							GLUTAMATE TRANSPORTER EAAC1; CULTURED HIPPOCAMPAL-NEURONS; AMINO-ACID TRANSPORTER; NITRIC-OXIDE; DICARBOXYLIC AMINOACIDURIA; INTRACELLULAR GLUTATHIONE; CORTICAL-NEURONS; OXIDATIVE STRESS; CYSTEINE UPTAKE; IN-VITRO	Uptake of the neurotransmitter glutamate is effected primarily by transporters expressed on astrocytes, and downregulation of these transporters leads to seizures and neuronal death. Neurons also express a glutamate transporter, termed excitatory amino acid carrier-1 (EAAC1), but the physiological function of this transporter remains uncertain. Here we report that genetically EAAC1-null (Slc1a1(-/-)) mice have reduced neuronal glutathione levels and, with aging, develop brain atrophy and behavioral changes. EAAC1 can also rapidly transport cysteine, an obligate precursor for neuronal glutathione synthesis. Neurons in the hippocampal slices of EAAC1(-/-) mice were found to have reduced glutathione content, increased oxidant levels and increased susceptibility to oxidant injury. These changes were reversed by treating the EAAC1(-/-) mice with N-acetylcysteine, a membrane-permeable cysteine precursor. These findings suggest that EAAC1 is the primary route for neuronal cysteine uptake and that EAAC1 deficiency thereby leads to impaired neuronal glutathione metabolism, oxidative stress and age-dependent neurodegeneration.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Swanson, RA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ray@itsa.ucsf.edu	Liu, Jialing/A-8627-2012	Liu, Jialing/0000-0003-4420-4382; Aoyama, Koji/0000-0003-4752-9262; Swanson, Raymond/0000-0002-3664-5359				AOYAMA K, 2005, J CEREB BLOOD FLOW M, V25, P258; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Avshalumov MV, 2002, J NEUROPHYSIOL, V87, P2896, DOI 10.1152/jn.2002.87.6.2896; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Dringen R, 2001, J NEUROSCI RES, V66, P1003, DOI 10.1002/jnr.10042; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Grover LM, 1999, J NEUROPHYSIOL, V81, P2814, DOI 10.1152/jn.1999.81.6.2814; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Lantz RC, 2001, TOXICOL SCI, V60, P348, DOI 10.1093/toxsci/60.2.348; Mazor D, 1996, EUR J HAEMATOL, V57, P241; MEISTER A, 1986, J AM COLL NUTR, V5, P137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parsons JL, 2000, MUTAGENESIS, V15, P311, DOI 10.1093/mutage/15.4.311; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sato H, 2002, J NEUROSCI, V22, P8028; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3; Shashidharan P, 1997, BRAIN RES, V773, P139, DOI 10.1016/S0006-8993(97)00921-9; SMITH CP, 1994, GENOMICS, V20, P335, DOI 10.1006/geno.1994.1183; Suh SW, 2003, J NEUROSCI, V23, P10681; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Umansky V, 2000, J CELL BIOCHEM, V78, P578, DOI 10.1002/1097-4644(20000915)78:4<578::AID-JCB7>3.0.CO;2-A; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yang YX, 2004, J NEUROCHEM, V88, P1361, DOI 10.1046/j.1471-4159.2003.02279.x; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	50	361	377	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					119	126		10.1038/nn1609	http://dx.doi.org/10.1038/nn1609			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311588				2022-12-28	WOS:000234288000025
J	Lorenzetti, FD; Mozzachiodi, R; Baxter, DA; Byrne, JH				Lorenzetti, FD; Mozzachiodi, R; Baxter, DA; Byrne, JH			Classical and operant conditioning differentially modify the intrinsic properties of an identified neuron	NATURE NEUROSCIENCE			English	Article							IN-VITRO ANALOG; FUNCTIONAL DYNAMICS; APLYSIA; REWARD	A long-standing debate in neuroscience is whether classical and operant conditioning are mechanistically similar or distinct. The feeding behavior of Aplysia provides a model system suitable for addressing this question. Here we report that classical and operant conditioning of feeding behavior differentially modify the intrinsic excitability of neuron B51, a critical element for the expression of the feeding response, thus revealing that these two forms of associative learning differ at the cellular level.	Univ Texas, Sch Med, Dept Neurobiol & Anat, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77030 USA	University of Texas System	Byrne, JH (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77030 USA.	John.H.Byrne@uth.tmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058321] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 58321] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; GORMEZANO I, 1976, PAVLOVIAN J BIOL SCI, V11, P37; Lechner HA, 2000, J NEUROSCI, V20, P3369, DOI 10.1523/JNEUROSCI.20-09-03369.2000; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; Mozzachiodi R, 2003, LEARN MEMORY, V10, P478, DOI 10.1101/lm.65303; Nargeot R, 1999, J NEUROSCI, V19, P2261; Nargeot R, 1999, J NEUROSCI, V19, P2247; Pavlov I.P., 1927, CONDITIONED REFLEXES; PLUMMER MR, 1990, J NEUROPHYSIOL, V63, P539, DOI 10.1152/jn.1990.63.3.539; RAYMOND JL, 1992, NEURAL NETWORKS, V5, P789, DOI 10.1016/S0893-6080(05)80140-6; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	15	62	63	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					17	19		10.1038/nn1593	http://dx.doi.org/10.1038/nn1593			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311590				2022-12-28	WOS:000234288000010
J	Cheng, LP; Samad, OA; Xu, Y; Mizuguchi, R; Luo, P; Shirasawa, S; Goulding, M; Ma, QF				Cheng, LP; Samad, OA; Xu, Y; Mizuguchi, R; Luo, P; Shirasawa, S; Goulding, M; Ma, QF			Lbx1 and Tlx3 are opposing switches in determining GABAergic versus glutamatergic transmitter phenotypes	NATURE NEUROSCIENCE			English	Article							DORSAL SPINAL-CORD; GENE-EXPRESSION; PAIN MECHANISMS; HOMEOBOX GENES; NEURONS; SPECIFICATION; INTERNEURONS; CIRCUITS; GABA; RECEPTORS	Most neurons in vertebrates make a developmental choice between two principal neurotransmitter phenotypes (glutamatergic versus GABAergic). Here we show that the homeobox gene Lbx1 determines a GABAergic cell fate in the dorsal spinal cord at early embryonic stages. In Lbx1(-/-) mice, the presumptive GABAergic neurons are transformed into glutamatergic cells. Furthermore, overexpression of Lbx1 in the chick spinal cord is sufficient to induce GABAergic differentiation. Paradoxically, Lbx1 is also expressed in glutamatergic neurons. We previously reported that the homeobox genes Tlx1 and Tlx3 determine glutamatergic cell fate. Here we show that impaired glutamatergic differentiation, observed in Tlx3(-/-) mice, is restored in Tlx3(-/-) Lbx1(-/-) mice. These genetic studies suggest that Lbx1 expression defines a basal GABAergic differentiation state, and Tlx3 acts to antagonize Lbx1 to promote glutamatergic differentiation.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Salk Institute; National Center for Global Health & Medicine - Japan	Ma, QF (corresponding author), Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	Qiufu_ma@dfci.harvard.edu	samad, omar/K-1921-2012					Azkue JJ, 1998, BRAIN RES, V790, P74, DOI 10.1016/S0006-8993(98)00050-X; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dickenson AH, 2002, BRIT J ANAESTH, V88, P755, DOI 10.1093/bja/88.6.755; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kruger M, 2002, J NEUROCHEM, V82, P774, DOI 10.1046/j.1471-4159.2002.01078.x; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2003, J NEUROSCI, V23, P8752; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; SCHAFFNER AE, 1993, DEV BRAIN RES, V72, P265, DOI 10.1016/0165-3806(93)90192-D; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8	37	136	141	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1510	1515		10.1038/nn1569	http://dx.doi.org/10.1038/nn1569			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234809				2022-12-28	WOS:000232966600025
J	Hirai, H; Pang, Z; Bao, DH; Miyazaki, T; Li, LY; Miura, E; Parris, J; Rong, YQ; Watanabe, M; Yuzaki, M; Morgan, JI				Hirai, H; Pang, Z; Bao, DH; Miyazaki, T; Li, LY; Miura, E; Parris, J; Rong, YQ; Watanabe, M; Yuzaki, M; Morgan, JI			Cbln1 is essential for synaptic integrity and plasticity in the cerebellum	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; GLUTAMATE-RECEPTOR DELTA-2; GAMMA MUTANT MICE; PURKINJE-CELLS; MOTOR COORDINATION; MULTIPLE INNERVATION; PRECEREBELLIN; LACKING; GLUR-DELTA-2	Cbln1 is a cerebellum-specific protein of previously unknown function that is structurally related to the C1q and tumor necrosis factor families of proteins. We show that Cbln1 is a glycoprotein secreted from cerebellar granule cells that is essential for three processes in cerebellar Purkinje cells: the matching and maintenance of pre- and postsynaptic elements at parallel fiber-Purkinje cell synapses, the establishment of the proper pattern of climbing fiber-Purkinje cell innervation, and induction of long-term depression at parallel fiber-Purkinje cell synapses. Notably, the phenotype of cbln1-null mice mimics loss-of-function mutations in the orphan glutamate receptor, GluR delta 2, a gene selectively expressed in Purkinje neurons. Therefore, Cbln1 secreted from presynaptic granule cells may be a component of a transneuronal signaling pathway that controls synaptic structure and plasticity.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	St Jude Children's Research Hospital; Hokkaido University	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	myuzaki@sc.itc.keio.ac.jp; jim.morgan@stjude.org	Morgan, James/N-8104-2018; Watanabe, Masahiko/S-3614-2019; Morgan, James/GRO-2905-2022; WATANABE, Masahiko/A-4055-2012; Miyazaki, Taisuke/C-8685-2012; Hirai, Hirokazu/ABP-1143-2022; Yuzaki, Michisuke/K-5328-2013	Watanabe, Masahiko/0000-0001-5037-7138; Morgan, James/0000-0002-8920-1065; WATANABE, Masahiko/0000-0001-5037-7138; Yuzaki, Michisuke/0000-0002-5750-3544; Hirai, Hirokazu/0000-0002-0721-4293	NCI NIH HHS [CA 21765] Funding Source: Medline; NIEHS NIH HHS [ES10772] Funding Source: Medline; NINDS NIH HHS [NS040361, NS040749, NS042828] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040361, R01NS040749] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BENOIT P, 1984, DEV BRAIN RES, V14, P310, DOI 10.1016/0165-3806(84)90320-1; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KAVETY B, 1994, MOL BRAIN RES, V27, P152, DOI 10.1016/0169-328X(94)90196-1; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Matsumoto M, 2000, INORG REACT MECH, V2, P19; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; MORGAN JI, 1988, SYNAPSE, V2, P117, DOI 10.1002/syn.890020203; MUGNAINI E, 1988, SYNAPSE, V2, P125, DOI 10.1002/syn.890020204; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Pang Z, 2000, J NEUROSCI, V20, P6333, DOI 10.1523/JNEUROSCI.20-17-06333.2000; Rhyu IJ, 1999, NEUROSCIENCE, V90, P717, DOI 10.1016/S0306-4522(98)00518-1; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; SOTELO C, 1990, J EXP BIOL, V153, P225; URADE Y, 1991, P NATL ACAD SCI USA, V88, P1069, DOI 10.1073/pnas.88.3.1069; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1; ZIAI MR, 1988, J NEUROCHEM, V51, P1771, DOI 10.1111/j.1471-4159.1988.tb01158.x	33	225	236	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1534	1541		10.1038/nn1576	http://dx.doi.org/10.1038/nn1576			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234806				2022-12-28	WOS:000232966600028
J	Pollmann, S; Maertens, M				Pollmann, S; Maertens, M			Shift of activity from attention to motor-related brain areas during visual learning	NATURE NEUROSCIENCE			English	Article							MAGNETIC STIMULATION; CORTEX; FMRI	With practice, we become increasingly efficient at visual object comparisons. This may be due to the formation of a memory template that not only binds individual features together to create an object, but also links the object with an associated response. In a longitudinal fMRI study of object matching, evidence for this link between perception and action was observed as a shift of activation from visual-attentive processing areas along the posterior intraparietal sulcus to hand-sensory and motor-related areas.	Otto von Guericke Univ, Dept Expt Psychol, D-39016 Magdeburg, Germany; Univ Leipzig, Day Clin Cognit Neurol, D-04103 Leipzig, Germany; Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, D-04103 Leipzig, Germany	Otto von Guericke University; Leipzig University; Max Planck Society	Pollmann, S (corresponding author), Otto von Guericke Univ, Dept Expt Psychol, Postbox 4120, D-39016 Magdeburg, Germany.	stefan.pollmann@nat.uni-magdeburg.de	Pollmann, Stefan/D-1999-2013	Pollmann, Stefan/0000-0001-5840-5658				Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Maldjian JA, 1999, NEUROIMAGE, V10, P55, DOI 10.1006/nimg.1999.0448; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P245; Walsh V, 1998, NEUROPSYCHOLOGIA, V36, P45, DOI 10.1016/S0028-3932(97)00111-5; Weidner R, 2002, CEREB CORTEX, V12, P318, DOI 10.1093/cercor/12.3.318; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	14	21	21	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1494	1496		10.1038/nn1552	http://dx.doi.org/10.1038/nn1552			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16205718	Green Published			2022-12-28	WOS:000232966600021
J	Sternson, SM; Shepherd, GMG; Friedman, JM				Sternson, SM; Shepherd, GMG; Friedman, JM			Topographic mapping of VMH -> arcuate nucleus microcircuits and their reorganization by fasting	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL NUCLEUS; HYPOTHALAMIC CONTROL; NEUROPEPTIDE-Y; FOOD-INTAKE; NEURONS; LESIONS; LEPTIN; RAT; OBESITY; ORGANIZATION	In the hypothalamic arcuate nucleus ( ARC), pro-opiomelanocortin ( POMC) neurons inhibit feeding and neuropeptide-Y (NPY) neurons stimulate feeding. We tested whether neurons in the ventromedial hypothalamic nucleus (VMH), a known satiety center, activate anorexigenic neuronal pathways in the ARC by projecting either excitatory synaptic inputs to POMC neurons and/or inhibitory inputs to NPY neurons. Using laser scanning photostimulation in brain slices from transgenic mice, we found that POMC and NPY neurons, which are interspersed in the ARC, are nevertheless regulated by anatomically distinct synaptic inputs. POMC neurons received strong excitatory input from the medial VMH (mVMH), whereas NPY neurons did not and, instead, received weak inhibitory input only from within the ARC. The strength of the excitatory input from the mVMH to POMC neurons was diminished by fasting. These data identify a new molecularly defined circuit that is dynamically regulated by nutritional state in a manner consistent with the known role of the VMH as a satiety center.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu	Shepherd, Gordon/F-2679-2010	Sternson, Scott/0000-0002-0835-444X				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brivanlou IH, 2004, P NATL ACAD SCI USA, V101, P2560, DOI 10.1073/pnas.0308577100; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 2002, J NEUROCYTOL, V31, P231, DOI 10.1023/A:1024165824469; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Faletti AG, 1999, P NATL ACAD SCI USA, V96, P1722, DOI 10.1073/pnas.96.4.1722; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KENNEDY GC, 1950, PROC R SOC SER B-BIO, V137, P535, DOI 10.1098/rspb.1950.0065; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; ONO T, 1982, BRAIN RES, V232, P494, DOI 10.1016/0006-8993(82)90295-5; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SHIMIZU N, 1987, BRAIN RES, V416, P153, DOI 10.1016/0006-8993(87)91508-3; Slimko EM, 2002, J NEUROSCI, V22, P7373; STENGER J, 1991, PHYSIOL BEHAV, V50, P1209, DOI 10.1016/0031-9384(91)90584-B; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	35	228	236	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1356	1363		10.1038/nn1550	http://dx.doi.org/10.1038/nn1550			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172601				2022-12-28	WOS:000232145900020
J	Lamsa, K; Heeroma, JH; Kullmann, DM				Lamsa, K; Heeroma, JH; Kullmann, DM			Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; DENDRITIC SPINES; CA1 NEURONS; CELL; FORM; EXCITABILITY; MECHANISMS	Cortical information processing requires a delicate balance of excitatory and inhibitory signaling. How is this balance preserved during hippocampal memory encoding, which involves NMDA receptor-dependent long term potentiation (LTP)? This form of LTP occurs at synapses between pyramidal neurons but has not been detected in feed-forward inhibitory interneurons. We show that paired pre- and postsynaptic activity evokes pathway-specific LTP in half of rat stratum radiatum interneurons if cytoplasmic integrity is preserved. LTP occurs in aspiny feed-forward interneurons and propagates to pyramidal neurons as an enhancement of disynaptic inhibition. We also show that when LTP is restricted to synapses on pyramidal neurons, the temporal fidelity of synaptic integration and action potential generation in pyramidal cells is compromised. However, when LTP also occurs at synapses on feed-forward interneurons, temporal fidelity is preserved. We propose that Hebbian LTP at synapses driving disynaptic inhibition is necessary to maintain information processing without degradation during memory encoding.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Heeroma, Joost/AFI-8727-2022; Heeroma, Joost/C-1749-2008; Lamsa, Karri/T-2025-2019; Kullmann, Dimitri M/A-3162-2009; Heeroma, Joost/AAF-4310-2022	Kullmann, Dimitri M/0000-0001-6696-3545; Lamsa, Karri/0000-0002-4609-1337				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christie BR, 2000, HIPPOCAMPUS, V10, P673, DOI 10.1002/1098-1063(2000)10:6<673::AID-HIPO1005>3.0.CO;2-O; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gulyas AI, 1998, EUR J NEUROSCI, V10, P3813, DOI 10.1046/j.1460-9568.1998.00402.x; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hebb Donald O., 1949, ORG BEHAV; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sourdet V, 2003, J NEUROSCI, V23, P10238; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	42	129	131	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					916	924		10.1038/nn1486	http://dx.doi.org/10.1038/nn1486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937481				2022-12-28	WOS:000230137100019
J	Munzberg, H; Myers, MG				Munzberg, H; Myers, MG			Molecular and anatomical determinants of central leptin resistance	NATURE NEUROSCIENCE			English	Review							HYPOTHALAMIC ARCUATE NUCLEUS; TYROSINE PHOSPHORYLATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; SIGNAL TRANSDUCER; GENE-EXPRESSION; ENERGY-BALANCE; POMC NEURONS; RECEPTOR; ACTIVATION	The increasing incidence of obesity in developed nations is an ever-growing challenge to health care, promoting diabetes and other diseases. The hormone leptin, which is derived from adipose tissue, regulates feeding and energy expenditure. Most forms of obesity are associated with diminished responsiveness to the appetite-suppressing effects of leptin. Here we review the mechanisms by which leptin activates intracellular signals, the roles of these signals in leptin action in vivo, and mechanisms that may attenuate leptin signaling, limiting its action in obese individuals. We highlight data regarding the expression of SOCS3 (a potential mediator of leptin resistance) in the arcuate nucleus of the hypothalamus.	Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu	Muenzberg-Gruening, Heike/N-1978-2017					Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 2004, PEPTIDES, V25, P331, DOI 10.1016/j.peptides.2004.02.014; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1; Burcelin R, 1999, DIABETES, V48, P1264, DOI 10.2337/diabetes.48.6.1264; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Cheng N, 2002, MOL CANCER RES, V1, P2; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DUNN SL, 2004, MOL ENDOCRINOL; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; HOWARD JK, 2004, NAT MED; Hu LM, 1998, NEUROENDOCRINOLOGY, V68, P77, DOI 10.1159/000054353; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; KRISCH B, 1978, CELL TISSUE RES, V192, P327; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; MORI H, 2004, NAT MED; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; MUNZBERG H, 2004, ENDOCRINOLOGY; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Peruzzo B, 2000, EXP BRAIN RES, V132, P10, DOI 10.1007/s002219900289; Rothstein SI, 2002, BEHAV ECOL, V13, P1, DOI 10.1093/beheco/13.1.1; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; SASAKI A, 2000, J BIOL CHEM; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tups A, 2004, ENDOCRINOLOGY, V145, P1185, DOI 10.1210/en.2003-1382; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	64	384	404	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					566	570		10.1038/nn1454	http://dx.doi.org/10.1038/nn1454			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856064				2022-12-28	WOS:000228895100014
J	Prinz, AA; Bucher, D; Marder, E				Prinz, AA; Bucher, D; Marder, E			Similar network activity from disparate circuit parameters	NATURE NEUROSCIENCE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; UNDERLYING PATTERN GENERATION; ACTIVITY-DEPENDENT REGULATION; SELECTIVE INACTIVATION; IDENTIFIED NEURONS; DOPAMINE MODULATION; QUANTAL AMPLITUDE; PYLORIC NEURON; PHASE-SHIFTS; CURRENTS	It is often assumed that cellular and synaptic properties need to be regulated to specific values to allow a neuronal network to function properly. To determine how tightly neuronal properties and synaptic strengths need to be tuned to produce a given network output, we simulated more than 20 million versions of a three-cell model of the pyloric network of the crustacean stomatogastric ganglion using different combinations of synapse strengths and neuron properties. We found that virtually indistinguishable network activity can arise from widely disparate sets of underlying mechanisms, suggesting that there could be considerable animal-to-animal variability in many of the parameters that control network activity, and that many different combinations of synaptic strengths and intrinsic membrane properties can be consistent with appropriate network performance.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Prinz, AA (corresponding author), Brandeis Univ, Volen Ctr, Mail Stop 013,415 South St, Waltham, MA 02454 USA.	prinz@brandeis.edu	Prinz, Astrid/GPX-8509-2022	Bucher, Dirk/0000-0003-4144-2895	NIMH NIH HHS [MH-46742] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1998, METHODS NEURONAL MOD, P361; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BELL AJ, 1992, ADV NEURAL INFORMATI, P59; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Brezina V, 1996, SCIENCE, V273, P806, DOI 10.1126/science.273.5276.806; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dayan P, 2001, COMPUTATIONAL NEUROS; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; EISEN JS, 1982, J NEUROPHYSIOL, V48, P1392, DOI 10.1152/jn.1982.48.6.1392; FOSTER WR, 1993, J NEUROPHYSIOL, V70, P2502, DOI 10.1152/jn.1993.70.6.2502; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HARTLINE DK, 1979, BIOL CYBERN, V33, P209, DOI 10.1007/BF00337410; Hartline DK, 1987, CRUSTACEAN STOMATOGA, P75; Hong SJ, 1997, J NEUROPHYSIOL, V77, P76, DOI 10.1152/jn.1997.77.1.76; Huerta R, 2001, BIOL CYBERN, V84, pL1, DOI 10.1007/PL00007976; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; Liu Z, 1998, J NEUROSCI, V18, P2309; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; MAYNARD DM, 1972, ANN NY ACAD SCI, V193, P59, DOI 10.1111/j.1749-6632.1972.tb27823.x; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; Mutalik VK, 2004, FEBS LETT, V558, P79, DOI 10.1016/S0014-5793(04)00021-3; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Pulver SR, 2005, J NEUROBIOL, V62, P47, DOI 10.1002/neu.20066; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; SELVERSTON AI, 1980, J NEUROPHYSIOL, V44, P1102, DOI 10.1152/jn.1980.44.6.1102; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	50	603	609	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1345	1352		10.1038/nn1352	http://dx.doi.org/10.1038/nn1352			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558066				2022-12-28	WOS:000225353900015
J	Luders, E; Narr, KI; Thompson, PM; Rex, DE; Jancke, L; Steinmetz, H; Toga, AW				Luders, E; Narr, KI; Thompson, PM; Rex, DE; Jancke, L; Steinmetz, H; Toga, AW			Gender differences in cortical complexity	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; CEREBRAL-CORTEX; ATLASES; PATTERN; MATTER; WOMEN; GRAY	Cortical complexity, a measure that quantifies the spatial frequency of gyrification and fissuration of the brain surface, has not been thoroughly characterized with respect to gender differences in the human brain. Using a new three-dimensional (3D) analytic technique with magnetic resonance imaging, we found greater gyrification in women than men in frontal and parietal regions. Increased complexity implies more cortical surface area, which may offset gender differences in brain volume and account for behavioral gender differences.	Univ Calif Los Angeles, Sch Med, Lab Neuroimaging, Dept Neurol, Div Brain Mapping, Los Angeles, CA 90095 USA; Swiss Fed Inst Technol, Dept Neuropsychol, CH-8032 Zurich, Switzerland; Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Toga, AW (corresponding author), Univ Calif Los Angeles, Sch Med, Lab Neuroimaging, Dept Neurol, Div Brain Mapping, 710 Westwood Pl,4238 Reed, Los Angeles, CA 90095 USA.	toga@loni.ucla.edu	Jäncke, Lutz/C-3792-2009; Thompson, Paul M/C-4194-2018	Jäncke, Lutz/0000-0002-8115-4890; Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [R21RR19771, P41 RR013642, M01 RR000865] Funding Source: Medline; NIBIB NIH HHS [P01 EB001955, R21EB01561] Funding Source: Medline; NIMH NIH HHS [P20 MH065166, MH14584] Funding Source: Medline; NLM NIH HHS [R01 LM05639] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865, R21RR019771, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB001561, P01EB001955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014584, P20MH065166] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 1988, STAT POWER ANAL BEHA; Gur RC, 1999, J NEUROSCI, V19, P4065; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Thompson PM, 1996, J NEUROSCI, V16, P4261; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WITELSON SF, 1995, J NEUROSCI, V15, P3418; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	15	194	199	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					799	800		10.1038/nn1277	http://dx.doi.org/10.1038/nn1277			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15338563				2022-12-28	WOS:000222930800021
J	Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S				Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S			Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; NEURAL RESPONSES; HUMAN BRAIN; PROBABILISTIC REINFORCEMENT; SEROTONERGIC NEURONS; DECISION-MAKING; LESIONS; MOTOR	Evaluation of both immediate and future outcomes of one's actions is a critical requirement for intelligent behavior. Using functional magnetic resonance imaging (fMRI), we investigated brain mechanisms for reward prediction at different time scales in a Markov decision task. When human subjects learned actions on the basis of immediate rewards, significant activity was seen in the lateral orbitofrontal cortex and the striatum. When subjects learned to act in order to obtain large future rewards while incurring small immediate losses, the dorsolateral prefrontal cortex, inferior parietal cortex, dorsal raphe nucleus and cerebellum were also activated. Computational model-based regression analysis using the predicted future rewards and prediction errors estimated from subjects' performance data revealed graded maps of time scale within the insula and the striatum: ventroanterior regions were involved in predicting immediate rewards and dorsoposterior regions were involved in predicting future rewards. These results suggest differential involvement of the cortico-basal ganglia loops in reward prediction at different time scales.	Nara Inst Sci & Technol, Dept Bioinformat & Genom, Nara 6300101, Japan; ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Japan Sci & Techol Agcy, CREST, Kyoto 6190288, Japan; Hiroshima Univ, Dept Psychiat & Neurosci, Minami Ku, Hiroshima 7348551, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Hiroshima University	Doya, K (corresponding author), Nara Inst Sci & Technol, Dept Bioinformat & Genom, 8916-5 Takayama, Nara 6300101, Japan.	doya@atr.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820; Tanaka, Saori/0000-0002-7001-5051				Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Balleine BW, 2000, J NEUROSCI, V20, P8954; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Chikama M, 1997, J NEUROSCI, V17, P9686; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; HABER SN, 1995, J NEUROSCI, V15, P4851; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Houk JC, 1995, MODELS INFORMATION P, P249; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Martens LC, 2001, EUR J PAEDIATR DENT, V2, P21; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mijnster MJ, 1997, J COMP NEUROL, V389, P1; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pears A, 2003, J NEUROSCI, V23, P11189; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003	49	561	577	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					887	893		10.1038/nn1279	http://dx.doi.org/10.1038/nn1279			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235607				2022-12-28	WOS:000222930800020
J	Celikel, T; Szostak, VA; Feldman, DE				Celikel, T; Szostak, VA; Feldman, DE			Modulation of spike timing by sensory deprivation during induction of cortical map plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC MODIFICATION; VISUAL-CORTEX; RESPONSES; POTENTIATION; SPECIFICITY; NEURONS; MEMORY; LTP	Deprivation-induced plasticity of sensory cortical maps involves long-term potentiation (LTP) and depression (LTD) of cortical synapses, but how sensory deprivation triggers LTP and LTD in vivo is unknown. Here we tested whether spike timing-dependent forms of LTP and LTD are involved in this process. We measured spike trains from neurons in layer 4 (L4) and layers 2 and 3 (L2/3) of rat somatosensory cortex before and after acute whisker deprivation, a manipulation that induces whisker map plasticity involving LTD at L4-to-L2/3 (L4-L2/3) synapses. Whisker deprivation caused an immediate reversal of firing order for most L4 and L2/3 neurons and a substantial decorrelation of spike trains, changes known to drive timing-dependent LTD at L4-L2/3 synapses in vitro. In contrast, spike rate changed only modestly. Thus, whisker deprivation is likely to drive map plasticity by spike timing-dependent mechanisms.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dfeldman@ucsd.edu	Celikel, Tansu/P-4235-2018		NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NINDS NIH HHS [R01 NS046652-02, R01 NS046652, 1 R01 NS046652] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046652] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2003, J NEUROSCI, V23, P7940; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fregnac Y, 1999, J NEUROBIOL, V41, P69; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gerstein G., 1999, CRC METH NEUROSCI S, P157; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goldreich D, 1999, J NEUROPHYSIOL, V82, P1311, DOI 10.1152/jn.1999.82.3.1311; Hebb Donald O., 1949, ORG BEHAV; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huber KM, 1998, NEUROPHARMACOLOGY, V37, P571, DOI 10.1016/S0028-3908(98)00050-1; Kelly MK, 1999, J NEUROSCI, V19, P9117, DOI 10.1523/JNEUROSCI.19-20-09117.1999; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Schubert D, 2003, J NEUROSCI, V23, P2961; SIMONS DJ, 1979, BRAIN RES, V165, P327, DOI 10.1016/0006-8993(79)90564-X; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	136	138	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					534	541		10.1038/nn1222	http://dx.doi.org/10.1038/nn1222			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15064767	Green Accepted			2022-12-28	WOS:000221101300031
J	Mirnics, K; Pevsner, J				Mirnics, K; Pevsner, J			Progress in the use of microarray technology to study the neurobiology of disease	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS LESIONS; GENE-EXPRESSION PROFILE; ALZHEIMERS-DISEASE; CDNA MICROARRAY; UP-REGULATION; SUSCEPTIBILITY GENE; PREFRONTAL CORTEX; CLUSTER-ANALYSIS; DNA MICROARRAYS; BRAIN DISEASES	The diverse functions of the brain are mediated by neurons and glia whose phenotype is defined by a dynamically maintained set of gene transcripts, or 'transcriptome'. Large-scale analysis of gene expression in postmortem brain using microarray technology has the potential to elucidate molecular changes that occur in disease states. There are unique challenges associated with studies of postmortem brain, including limited sample sizes and variable clinical phenotypes that are typical of complex disorders. Nevertheless, recent microarray-based studies have implicated both individual dysregulated genes and abnormal patterns of gene expression in brain disorders.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; Kennedy Krieger Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine	Mirnics, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, E1453 Biomed Sci, Pittsburgh, PA 15261 USA.	karoly+@pitt.edu; pevsner@jhmi.edu	Mirnics, Karoly/E-6730-2010	Mirnics, Karoly/0000-0002-5521-0254				Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brooksbank C, 2003, NUCLEIC ACIDS RES, V31, P43, DOI 10.1093/nar/gkg066; Causton Helen C, 2003, Genome Biol, V4, P351, DOI 10.1186/gb-2003-4-12-351; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; FELL A, 2001, UC DAVIS MAGAZINE, V19; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; Hirose Y, 2003, CANCER GENET CYTOGEN, V142, P1, DOI 10.1016/S0165-4608(02)00791-4; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2001, J BIOMED SCI, V8, P28, DOI 10.1007/BF02255968; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; MIMMACK ML, IN PRESS BIOL PSYCHI; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Morris DW, 2004, AM J MED GENET B, V125B, P50, DOI 10.1002/ajmg.b.20109; Mufson EJ, 2002, NEUROCHEM RES, V27, P1035, DOI 10.1023/A:1020952704398; Mukasa A, 2002, ONCOGENE, V21, P3961, DOI 10.1038/sj.onc.1205495; Mycko MP, 2003, BRAIN, V126, P1048, DOI 10.1093/brain/awg107; Pasinetti GM, 2001, J NEUROSCI RES, V65, P471, DOI 10.1002/jnr.1176; Pickett J, 2001, J AUTISM DEV DISORD, V31, P521, DOI 10.1023/A:1013282524687; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vawter MP, 2002, SCHIZOPHR RES, V58, P11, DOI 10.1016/S0920-9964(01)00377-2; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Whitney LW, 1999, ANN NEUROL, V46, P425; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; Williams NM, 2004, BIOL PSYCHIAT, V55, P192, DOI 10.1016/j.biopsych.2003.11.002; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8	65	118	120	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					434	439		10.1038/nn1230	http://dx.doi.org/10.1038/nn1230			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114354				2022-12-28	WOS:000221101300009
J	Tecott, LH; Nestler, EJ				Tecott, LH; Nestler, EJ			Neurobehavioral assessment in the information age	NATURE NEUROSCIENCE			English	Article							ANIMAL-MODELS; MUTANT MICE; HIPPOCAMPAL FUNCTION; COCAINE-SEEKING; ANXIETY; RATS; DISEASE; MAZE	The elucidation of the human and mouse genomes provides new opportunities for exploring the genetic underpinnings of complex mammalian behaviors. This information also provides new windows into the pathophysiology and treatment of neuropsychiatric diseases. Optimal use of the rapidly escalating numbers of mouse lines engineered for these purposes is hindered, however, by practical and theoretical limitations of common behavioral analyses. New strategies combining automated behavioral monitoring and information technologies are currently under development in both academic and industrial settings. These hold promise, both for improving the throughput of mouse behavioral assessment and for providing new insights into the neurobiology of mammalian behavioral regulation.	Univ Calif San Francisco, Sch Med, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tecott, LH (corresponding author), Univ Calif San Francisco, Sch Med, Ctr Neurobiol & Psychiat, 401 Parnassus Ave, San Francisco, CA 94143 USA.	tecott@itsa.ucsf.edu						Ahmad-Annuar A, 2003, CURR OPIN NEUROL, V16, P451, DOI 10.1097/01.wco.0000084221.82329.29; Bates GP, 2003, CURR OPIN NEUROL, V16, P465, DOI 10.1097/01.wco.0000084223.82329.bb; Blanchard DC, 2003, EUR J PHARMACOL, V463, P97, DOI 10.1016/S0014-2999(03)01276-7; Blanchard RJ, 2003, PHYSIOL BEHAV, V79, P515, DOI 10.1016/S0031-9384(03)00157-4; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dell'Omo G, 2000, BEHAV BRAIN RES, V115, P1, DOI 10.1016/S0166-4328(00)00234-5; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Ferrel K, 1999, NETW COMPUT, V10, P22; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; GOULDING EH, 2002, APPETITE, V39, P78; Green A.R., 1985, NEUROPHARMACOLOGY SE, P326; Hunter AJ, 2000, HUM MOL GENET, V9, P893, DOI 10.1093/hmg/9.6.893; KAAKKOLA S, 1990, PHARMACOL TOXICOL, V67, P95, DOI 10.1111/j.1600-0773.1990.tb00792.x; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MCCLEARN GE, 1979, ALCOHOL CLIN EXP RES, V3, P255, DOI 10.1111/j.1530-0277.1979.tb05310.x; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Scott MR, 2000, ARCH VIROL, P113; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shekhar A, 2001, PSYCHOPHARMACOLOGY, V157, P327; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Tecott LH, 2003, AM J PSYCHIAT, V160, P646, DOI 10.1176/appi.ajp.160.4.646; van der Staay FJ, 2002, GENES BRAIN BEHAV, V1, P9, DOI 10.1046/j.1601-1848.2001.00007.x; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Vyssotski AL, 2002, HIPPOCAMPUS, V12, P27, DOI 10.1002/hipo.10002; Wehner JM, 1996, BEHAV GENET, V26, P301, DOI 10.1007/BF02359386; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Willner P., 1991, BEHAV MODELS PSYCHOP, P3; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5	43	139	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					462	466		10.1038/nn1225	http://dx.doi.org/10.1038/nn1225			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114359				2022-12-28	WOS:000221101300014
J	Hua, JYY; Smith, SJ				Hua, JYY; Smith, SJ			Neural activity and the dynamics of central nervous system development	NATURE NEUROSCIENCE			English	Review							LATERAL GENICULATE-NUCLEUS; DENDRITES IN-VIVO; SYNAPTIC PLASTICITY; PRESYNAPTIC TERMINALS; HIPPOCAMPAL-NEURONS; RECEPTOR ACTIVATION; RETINOTECTAL AXONS; ZEBRAFISH EMBRYOS; PROTEIN-SYNTHESIS; BRANCH DYNAMICS	Recent imaging studies show that the formation of neural connections in the central nervous system is a highly dynamic process. The iterative formation and elimination of synapses and neuronal branches result in the formation of a much larger number of trial connections than is maintained in the mature brain. Neural activity modulates development through biasing this process of formation and elimination, promoting the formation and stabilization of appropriate synaptic connections on the basis of functional activity patterns.	Stanford Univ, Beckman Ctr B141, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Beckman Ctr B141, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	sjsmith@stanford.edu						Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Collin C, 2001, EUR J NEUROSCI, V13, P1273, DOI 10.1046/j.0953-816x.2001.01500.x; CREPEL F, 1971, BRAIN RES, V35, P272, DOI 10.1016/0006-8993(71)90617-2; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Dailey ME, 1996, J NEUROSCI, V16, P2983; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gallo G, 1997, J NEUROSCI, V17, P5445; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Horch HW, 1999, NEURON, V23, P353; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JACKSON H, 1982, J NEUROSCI, V2, P1736; Johns DC, 1999, J NEUROSCI, V19, P1691; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ramon y Cajal S, 1899, TEXTURA SISTEMA NERV; Renteria RC, 1996, J NEUROBIOL, V29, P415; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WEISEL TN, 1982, NATURE, V299, P583; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	89	312	329	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					327	332		10.1038/nn1218	http://dx.doi.org/10.1038/nn1218			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15048120				2022-12-28	WOS:000220482500007
J	Song, MR; Ghosh, A				Song, MR; Ghosh, A			FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation	NATURE NEUROSCIENCE			English	Article							RAT CEREBRAL-CORTEX; HISTONE H3 METHYLATION; CENTRAL-NERVOUS-SYSTEM; RNA-POLYMERASE-II; STEM-CELLS; RECOMBINANT RETROVIRUS; DEVELOPMENTAL-CHANGES; X-INACTIVATION; METHYLTRANSFERASE; TRANSCRIPTION	The generation of distinct cell types during development depends on the competence of progenitor populations to differentiate along specific lineages. Here we investigate the mechanisms that regulate competence of rodent cortical progenitors to differentiate into astrocytes in response to ciliary neurotrophic factor (CNTF). We found that fibroblast growth factor 2 (FGF2), which by itself does not induce astrocyte-specific gene expression, regulates the ability of CNTF to induce expression of glial fibrillary acidic protein (GFAP). FGF2 facilitates access of the STAT/CBP (signal transducer and activator of transcription/CRE binding protein) complex to the GFAP promoter by inducing Lys4 methylation and suppressing Lys9 methylation of histone H3 at the STAT binding site. Histone methylation at this site is specific to the cell's state of differentiation. In progenitors, the promoter is bound by Lys9-methylated histones, and in astrocytes, it is bound by Lys4-methylated histones, indicating that astrocyte differentiation in vivo involves this switch in chromatin state. Our observations indicate that extracellular signals can regulate access of transcription factors to genomic promoters by local chromatin modification, and thereby regulate developmental competence.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	aghosh@ucsd.edu			NIAID NIH HHS [1P30AI42855] Funding Source: Medline; NINDS NIH HHS [NS36176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036176] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Viti J, 2003, J NEUROSCI, V23, P3385; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	39	197	204	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					229	235		10.1038/nn1192	http://dx.doi.org/10.1038/nn1192			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770186				2022-12-28	WOS:000189197900012
J	Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A				Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A			Multiple origins of Cajal-Retzius cells at the borders of the developing pallium	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA EXPRESSION; SPINAL-CORD; GANGLIONIC EMINENCE; NEURONAL MIGRATION; MARGINAL ZONE; HIPPOCAMPAL CONNECTIONS; MAMMALIAN TELENCEPHALON; HOMEOBOX GENE; MOUSE	Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin(+) Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin(+) neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin(+) cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.	Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France; Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute	Pierani, A (corresponding author), Ecole Normale Super, CNRS, UMR 8542, 46 Rue Ulm, F-75005 Paris, France.	pierani@biologie.ens.fr	Pierani, Alessandra/O-6136-2017; Vigneau, Sébastien/B-2842-2008	Pierani, Alessandra/0000-0002-4872-4791; Vigneau, Sebastien/0000-0002-9091-2067; Narboux-Neme, Nicolas/0000-0002-3791-7459; Bielle, Franck/0000-0001-6564-6388; Arber, Silvia/0000-0002-6261-250X				Aboitiz F, 2002, BRAZ J MED BIOL RES, V35, P1455, DOI 10.1590/S0100-879X2002001200006; Alcantara S, 1998, J NEUROSCI, V18, P7779; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Borrell V, 1999, J NEUROSCI, V19, P1345; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; LU SW, 1994, MECH DEVELOP, V47, P187, DOI 10.1016/0925-4773(94)90089-2; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 1998, J COMP NEUROL, V397, P493; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Yun K, 2001, DEVELOPMENT, V128, P193; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	48	325	332	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1002	1012		10.1038/nn1511	http://dx.doi.org/10.1038/nn1511			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16041369				2022-12-28	WOS:000230760200011
J	Yang, YP; Fischer, QS; Zhang, Y; Baumgartel, K; Mansuy, IM; Daw, NW				Yang, YP; Fischer, QS; Zhang, Y; Baumgartel, K; Mansuy, IM; Daw, NW			Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; LONG-TERM DEPRESSION; PROTEIN-KINASE-A; EXTRACELLULAR-MATRIX; ADENYLYL-CYCLASE; BINDING PROTEIN; PHOSPHATASE; RECEPTORS; INDUCTION; ADULT	Numerous protein kinases have been implicated in visual cortex plasticity, but the role of serine/threonine protein phosphatases has not yet been established. Calcineurin, the only known Ca2+/calmodulin-activated protein phosphatase in the brain, has been identified as a molecular constraint on synaptic plasticity in the hippocampus and on memory. Using transgenic mice overexpressing calcineurin inducibly in forebrain neurons, we now provide evidence that calcineurin is also involved in ocular dominance plasticity. A transient increase in calcineurin activity is found to prevent the shift of responsiveness in the visual cortex following monocular deprivation, and this effect is reversible. These results imply that the balance between protein kinases and phosphatases is critical for visual cortex plasticity.	Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Univ Connecticut, Dept Chem Engn, Storrs, CT 06269 USA; Univ Zurich, Fac Med, Brain Res Inst, Dept Biol,Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	Yale University; University of Connecticut; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Yang, YP (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 333 Cedar St, New Haven, CT 06520 USA.	yuyang@aecom.yu.edu	Mansuy, Isabelle M/N-3042-2015; Yang, Yupeng/G-5107-2018	Mansuy, Isabelle M/0000-0001-7785-5371; Yang, Yupeng/0000-0002-9473-9994; Fischer, Quentin/0000-0002-7803-1179	NATIONAL EYE INSTITUTE [R01EY000053] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY00053] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antoni FA, 1998, J NEUROSCI, V18, P9650; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Daw N, 2004, VISION RES, V44, P3377, DOI 10.1016/j.visres.2004.09.004; Daw NW, 1999, J NEUROPHYSIOL, V81, P204, DOI 10.1152/jn.1999.81.1.204; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fansa H, 2000, RESTOR NEUROL NEUROS, V16, P77; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; FUNAUCHI M, 1994, NEUROSCI RES, V19, P269, DOI 10.1016/0168-0102(94)90039-6; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gordon JA, 1996, J NEUROSCI, V16, P3274; GOTO S, 1993, NEUROSCI LETT, V149, P189, DOI 10.1016/0304-3940(93)90768-G; GOTO S, 1994, NEUROSCIENCE, V62, P695, DOI 10.1016/0306-4522(94)90470-7; GOTO S, 1993, EXP BRAIN RES, V96, P377; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hensch TK, 1998, J NEUROSCI, V18, P2108; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Iwai Y, 2003, J NEUROSCI, V23, P6695; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; POLLI JW, 1991, DEV BRAIN RES, V63, P105, DOI 10.1016/0165-3806(91)90071-P; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TORII N, 1995, NEUROSCI LETT, V185, P1, DOI 10.1016/0304-3940(94)11210-A; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	34	36	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					791	796		10.1038/nn1464	http://dx.doi.org/10.1038/nn1464			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880107				2022-12-28	WOS:000229345300020
J	Kamitani, Y; Tong, F				Kamitani, Y; Tong, F			Decoding the visual and subjective contents of the human brain	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; MONKEY STRIATE CORTEX; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE FIELDS; MOTION; AREAS; REPRESENTATIONS; SPECTROSCOPY; ORGANIZATION	The potential for human neuroimaging to read out the detailed contents of a person's mental state has yet to be fully explored. We investigated whether the perception of edge orientation, a fundamental visual feature, can be decoded from human brain activity measured with functional magnetic resonance imaging (fMRI). Using statistical algorithms to classify brain states, we found that ensemble fMRI signals in early visual areas could reliably predict on individual trials which of eight stimulus orientations the subject was seeing. Moreover, when subjects had to attend to one of two overlapping orthogonal gratings, feature-based attention strongly biased ensemble activity toward the attended orientation. These results demonstrate that fMRI activity patterns in early visual areas, including primary visual cortex (V1), contain detailed orientation information that can reliably predict subjective perception. Our approach provides a framework for the readout of fine-tuned representations in the human brain and their subjective contents.	ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto 6190288, Japan; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Kamitani, Y (corresponding author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	kmtn@atr.jp	Patanaik, Amiya/G-4336-2010		NEI NIH HHS [R01-EY14202, R01 EY014202] Funding Source: Medline; NIMH NIH HHS [P50 MH062196, P50-MH62196] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BAUER R, 1989, EXP BRAIN RES, V76, P503, DOI 10.1007/BF00248906; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KAHNEMAN D, 1970, PERCEPT PSYCHOPHYS, V8, P161, DOI 10.3758/BF03210195; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Koch Christof, 2004, QUEST CONSCIOUSNESS; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MINSKY LM, 1987, PERCEPTRONS EXPANDED; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; Vapnik V., 1998, STAT LEARNING THEORY; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wilson H. R., 1990, VISUAL PERCEPTION NE, P231, DOI DOI 10.1016/B978-0-12-657675-7.50016-8; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; ZEKI S, 1991, J NEUROSCI, V11, P641	40	1212	1234	7	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					679	685		10.1038/nn1444	http://dx.doi.org/10.1038/nn1444			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852014	Green Accepted			2022-12-28	WOS:000228895100030
J	Tagawa, Y; Kanold, PO; Majdan, M; Shatz, CJ				Tagawa, Y; Kanold, PO; Majdan, M; Shatz, CJ			Multiple periods of functional ocular dominance plasticity in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; POSTNATAL-DEVELOPMENT; NERVOUS-SYSTEM; COLUMNS; EYE; RETINOGENICULATE; PROJECTIONS; EXPRESSION; GENE; RAT	The precise period when experience shapes neural circuits in the mouse visual system is unknown. We used Arc induction to monitor the functional pattern of ipsilateral eye representation in cortex during normal development and after visual deprivation. After monocular deprivation during the critical period, Arc induction reflects ocular dominance (OD) shifts within the binocular zone. Arc induction also reports faithfully expected OD shifts in cat. Shifts towards the open eye and weakening of the deprived eye were seen in layer 4 after the critical period ends and also before it begins. These shifts include an unexpected spatial expansion of Arc induction into the monocular zone. However, this plasticity is not present in adult layer 6. Thus, functionally assessed OD can be altered in cortex by ocular imbalances substantially earlier and far later than expected.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu		Kanold, Patrick/0000-0002-7529-5435	NATIONAL EYE INSTITUTE [R01EY002858, F32EY013526] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY013526, F32 EY013526-01, R01 EY02858, F32 EY1352] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DRAGER UC, 1974, BRAIN RES, V82, P284, DOI 10.1016/0006-8993(74)90607-6; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hensch TK, 2003, NEUROSCI RES, V47, P17, DOI 10.1016/S0168-0102(03)00164-0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; KAGEYAMA GH, 1993, J COMP NEUROL, V335, P123, DOI 10.1002/cne.903350109; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Lein ES, 2000, J NEUROSCI, V20, P1470; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Liu X, 1996, Chin Med Sci J, V11, P93; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; PHAM TA, 2004, LEARN MEMORY, V11, P1; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2	43	186	193	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					380	388		10.1038/nn1410	http://dx.doi.org/10.1038/nn1410			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723060				2022-12-28	WOS:000227354600024
J	Crabbe, JC; Morris, RGM				Crabbe, JC; Morris, RGM			Festina lente: Late-night thoughts on high-throughput screening of mouse behavior	NATURE NEUROSCIENCE			English	Editorial Material							ETHANOL INTOXICATION; ALZHEIMERS-DISEASE; LOCOMOTOR BEHAVIOR; INBRED STRAINS; MICE; MEMORY; LABORATORIES; MODEL; TESTS; SEE	A recent perspective discussed high-throughput behavioral analysis using mice, giving the overall impression that this area is lagging behind in neuroscience and biomedical research. Not only are we more optimistic about the current state of the art in behavioral neuroscience and its promise, but we also have reservations about whether high-throughput analysis is always an appropriate goal for most behavioral studies. We argue that behavioral studies should be carried out with clear goals and more regard to the intellectual context in which they have developed. In addition, behavioral studies can be performed quite easily, but this does not ensure the required validity or reliability of the particular tests used. Finally, high throughput may not always be an appropriate goal. We discuss the role of automated data collection and unique data-mining algorithms, and the question of the ethological relevance of behavioral tests.	Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland Alcohol Res Ctr, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97239 USA; Univ Edinburgh, Div Neurosci, Cognit Neurosci Lab, Edinburgh EH8 9JZ, Midlothian, Scotland	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Edinburgh	Crabbe, JC (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland Alcohol Res Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	crabbe@ohsu.edu	Morris, Richard G M/C-9982-2013	MORRIS, Richard G M/0000-0001-8661-1520	NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Clayton Nicky S., 1995, Current Opinion in Neurobiology, V5, P149, DOI 10.1016/0959-4388(95)80020-4; Crabbe JC, 2003, J APPL PHYSIOL, V95, P1338, DOI 10.1152/japplphysiol.00132.2003; Crabbe JC, 2003, GENES BRAIN BEHAV, V2, P201, DOI 10.1034/j.1601-183X.2003.00023.x; CRABBE JC, IN PRESS NEUROSCI BI; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Galea LAM, 1996, J EXP BIOL, V199, P195; Gerlai R, 1996, TRENDS NEUROSCI, V19, P188; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Kafkafi N, 2003, BEHAV BRAIN RES, V142, P193, DOI 10.1016/S0166-4328(03)00003-2; Kafkafi N, 2003, BEHAV NEUROSCI, V117, P464, DOI 10.1037/0735-7044.117.3.464; KALE A, IN PRESS ALCOHOLISM; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Morris Richard G. M., 1992, Current Biology, V2, P511, DOI 10.1016/0960-9822(92)90001-Q; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Rustay NR, 2003, P NATL ACAD SCI USA, V100, P2917, DOI 10.1073/pnas.0437273100; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959	26	48	49	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1175	1179		10.1038/nn1343	http://dx.doi.org/10.1038/nn1343			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15508013				2022-12-28	WOS:000224749400006
J	Groc, L; Heine, M; Cognet, L; Brickley, K; Stephenson, FA; Lounis, B; Choquet, D				Groc, L; Heine, M; Cognet, L; Brickley, K; Stephenson, FA; Lounis, B; Choquet, D			Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; DIFFUSION	The basis for differences in activity-dependent trafficking of AMPA receptors (AMPARs) and NMDA receptors (NMDARs) remains unclear. Using single-molecule tracking, we found different lateral mobilities for AMPARs and NMDARs: changes in neuronal activity modified AMPAR but not NMDAR mobility, whereas protein kinase C activation modified both. Differences in mobility were mainly detected for extrasynaptic AMPARs, suggesting that receptor diffusion between synaptic and extrasynaptic domains is involved in plasticity processes.	Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; CNRS, UMR 5798, Talence, France; Univ London, Sch Pharm, London WC1N 1AX, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; University of London School of Pharmacy	Choquet, D (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Cognet, Laurent/F-4163-2011; Choquet, Daniel/E-4203-2013; Lounis, Brahim/I-7862-2016; Cognet, Laurent/M-4505-2019; Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022	Cognet, Laurent/0000-0002-3573-5387; Lounis, Brahim/0000-0001-7501-0236; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763				Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Chung HJ, 2000, J NEUROSCI, V20, P7258; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Racca C, 2000, J NEUROSCI, V20, P2512; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tovar KR, 2002, NEURON, V34, P253; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	13	306	321	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					695	696		10.1038/nn1270	http://dx.doi.org/10.1038/nn1270			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208630				2022-12-28	WOS:000222274400006
J	Benedetti, F; Colloca, L; Torre, E; Lanotte, M; Melcarne, A; Pesare, M; Bergamasco, B; Lopiano, L				Benedetti, F; Colloca, L; Torre, E; Lanotte, M; Melcarne, A; Pesare, M; Bergamasco, B; Lopiano, L			Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus	NATURE NEUROSCIENCE			English	Article							DOPAMINE RELEASE; GLOBUS-PALLIDUS; OPIOID SYSTEMS; EXPECTATION; STIMULATION; APOMORPHINE; ANALGESIA	Placebo administration is known to affect the brain both in pain and in Parkinson disease. Here we show that placebo treatment caused reduced activity in single neurons in the subthalamic nucleus of placebo-responsive Parkinsonian patients. These changes in activity were tightly correlated with clinical improvement; no decrease in activity occurred when the clinical placebo response was absent.	Univ Turin, Sch Med, Dept Neurosci, Clin & Appl Physiol Program, I-10125 Turin, Italy; Univ Turin, Sch Med, Dept Neurosci, Neurol Clin, I-10126 Turin, Italy; CTO Med Ctr, Div Neurosurg, I-10126 Turin, Italy; Maugeri Fdn, I-27100 Pavia, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Istituti Clinici Scientifici Maugeri IRCCS	Benedetti, F (corresponding author), Univ Turin, Sch Med, Dept Neurosci, Clin & Appl Physiol Program, Corso Raffaello 30, I-10125 Turin, Italy.	fabrizio.benedetti@unito.it	Lanotte, Michele M./I-2647-2012; Colloca, Luana/S-1389-2018	Lanotte, Michele M./0000-0002-4184-028X; Colloca, Luana/0000-0002-6503-4709				Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Benazzouz A, 2000, NEUROLOGY, V55, pS13; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 2003, CURR OPIN ANESTHESIO, V16, P515, DOI 10.1097/00001503-200310000-00012; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Levy R, 2001, J NEUROPHYSIOL, V86, P249, DOI 10.1152/jn.2001.86.1.249; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Stefani A, 2002, CLIN NEUROPHYSIOL, V113, P91, DOI 10.1016/S1388-2457(01)00683-6	15	220	224	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					587	588		10.1038/nn1250	http://dx.doi.org/10.1038/nn1250			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146189				2022-12-28	WOS:000221640300011
J	Anders, S; Birbaumer, N; Sadowski, B; Erb, M; Mader, I; Grodd, W; Lotze, M				Anders, S; Birbaumer, N; Sadowski, B; Erb, M; Mader, I; Grodd, W; Lotze, M			Parietal somatosensory association cortex mediates affective blindsight	NATURE NEUROSCIENCE			English	Article							AMYGDALA; EMOTION; FEAR; ACTIVATION; PATHWAY	To investigate the neural substrates underlying emotional feelings in the absence of a conscious stimulus percept, we presented a visual stimulus in the blind field of partially cortically blind patients and measured cortical activity (by functional magnetic resonance imaging, fMRI) before and after the stimulus had been paired with an aversive event. After pairing, self-reported negative emotional valence and blood oxygen level-dependent (BOLD) responses in somatosensory association areas were enhanced, whereby somatosensory activity predicted highly corresponding reported feelings and startle reflex amplitudes across subjects. Our data provide direct evidence that cortical activity representing physical emotional states governs emotional feelings.	Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; Univ Eye Hosp Tubingen, Dept Pathophysiol & Vis & Neuroophthalmol, D-72076 Tubingen, Germany; Univ Tubingen Hosp, Dept Neuroradiol, CNS, Sect Expt MR, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Anders, S (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Gartenstr 29, D-72074 Tubingen, Germany.	silke.anders@med.uni-tuebingen.de	Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956; Birbaumer, Niels/0000-0002-6786-5127; Erb, Michael/0000-0002-9311-4693				Adolphs R, 2000, J NEUROSCI, V20, P2683; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Hamm AO, 2003, BRAIN, V126, P267, DOI 10.1093/brain/awg037; HITCHCOCK JM, 1991, BEHAV NEUROSCI, V105, P826, DOI 10.1037/0735-7044.105.6.826; Kimmig H, 1999, EXP BRAIN RES, V126, P443, DOI 10.1007/s002210050751; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Linke R, 1999, J COMP NEUROL, V403, P158; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Weiskrantz L, 2003, BRAIN, V126, P265, DOI 10.1093/brain/awg023	15	57	57	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					339	340		10.1038/nn1213	http://dx.doi.org/10.1038/nn1213			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034586				2022-12-28	WOS:000220482500011
J	Luksch, H; Khanbabaie, R; Wessel, R				Luksch, H; Khanbabaie, R; Wessel, R			Synaptic dynamics mediate sensitivity to motion independent of stimulus details	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PIGEON TECTAL NEURONS; NON-FOURIER MOTION; OPTIC TECTUM; VISUAL-CORTEX; NUCLEUS ROTUNDUS; LARVAL ZEBRAFISH; NEURAL CODE; RESPONSES; PATTERNS	Humans and other animals generally perceive motion independently of the cues that define the moving object. To understand the underlying mechanisms of this generalization of stimulus attributes, we have examined the cellular properties of avian wide-field tectal neurons that are sensitive to a variety of moving stimuli but not to static stationary stimuli. This in vitro study showed phasic signal transfer at the retinotectal synapse and binary dendritic responses to synaptic inputs that interact in a mutually exclusive manner in the postsynaptic tectal neuron. A model of the tectal circuitry predicts that these two cellular properties mediate sensitivity to a wide range of dynamic spatiotemporal stimuli, including moving stimuli, but not to static stationary stimuli in a tectal neuron. The computation that is independent of stimulus detail is initiated by tectal neurons and is completed by rotundal neurons that integrate outputs from multiple tectal neurons in a directionally selective manner.	Washington Univ, Dept Phys, St Louis, MO 63130 USA; Rhein Westfal TH Aachen, Inst Biol 2, D-52074 Aachen, Germany	Washington University (WUSTL); RWTH Aachen University	Wessel, R (corresponding author), Washington Univ, Dept Phys, CB 1105, St Louis, MO 63130 USA.	rw@wuphys.wustl.edu		Luksch, Harald/0000-0002-9835-7715				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ALBRIGHT TD, 1993, VISUAL MOTION ITS RO, P177; Baker CL, 2001, PROG BRAIN RES, V134, P171; Carandini M, 2002, J NEUROSCI, V22, P10053; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; Chichilnisky EJ, 2003, J NEUROSCI, V23, P6681; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Croner LJ, 1999, NEURON, V24, P777, DOI 10.1016/S0896-6273(00)81026-0; Croner LJ, 1999, J NEUROSCI, V19, P3935; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1978, BRAIN RES, V151, P599, DOI 10.1016/0006-8993(78)91093-4; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; FROST BJ, 1993, VISUAL MOTION ITS RO, P159; Geesaman BJ, 1996, J NEUROSCI, V16, P4716; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; HARDY O, 1985, J COMP NEUROL, V233, P390, DOI 10.1002/cne.902330308; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; HUNT SP, 1975, J COMP NEUROL, V162, P433, DOI 10.1002/cne.901620403; JASSIK-GERSCHENFELD D, 1970, Brain Research, V24, P407, DOI 10.1016/0006-8993(70)90182-4; JASSIKGE.D, 1972, BRAIN RES, V40, P303, DOI 10.1016/0006-8993(72)90136-9; Karten HJ, 1997, J COMP NEUROL, V387, P449; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Luksch H, 2003, J CHEM NEUROANAT, V25, P185, DOI 10.1016/S0891-0618(03)00010-3; Luksch H, 1998, J COMP NEUROL, V396, P399; Luksch H, 2001, J NEUROSCI, V21, P6440, DOI 10.1523/JNEUROSCI.21-16-06440.2001; Marin G, 2003, J COMP NEUROL, V458, P361, DOI 10.1002/cne.10591; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nalbach Hans-Ortwin, 1993, P25; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OLAVARRIA JF, 1992, J NEUROPHYSIOL, V68, P164, DOI 10.1152/jn.1992.68.1.164; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Palanca BJA, 2003, J NEUROSCI, V23, P7647; REYZIN AM, 1981, NEURAL MECH BEHAV PI, P165; Rodieck R.W., 1998, 1 STEPS SEEING; Roeser T, 2003, J NEUROSCI, V23, P3726; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tabata T, 2002, J NEUROPHYSIOL, V87, P30, DOI 10.1152/jn.00179.2001; Tombol T., 1999, Neurobiology (Budapest), V7, P45; TROY JB, 1994, VISUAL NEUROSCI, V11, P111, DOI 10.1017/S0952523800011159; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; WILSON HR, 1994, CIBA F SYMP, V184, P227	50	29	29	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					380	388		10.1038/nn1204	http://dx.doi.org/10.1038/nn1204			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	14990932				2022-12-28	WOS:000220482500017
J	Bechara, A				Bechara, A			Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective	NATURE NEUROSCIENCE			English	Article							COCAINE-DEPENDENT PATIENTS; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; PERFORMANCE; ABUSERS; BRAIN; ADDICTION; INDIVIDUALS; INHIBITION; DEFICITS	Here I argue that addicted people become unable to make drug-use choices on the basis of long-term outcome, and I propose a neural framework that explains this myopia for future consequences. I suggest that addiction is the product of an imbalance between two separate, but interacting, neural systems that control decision making: an impulsive, amygdala system for signaling pain or pleasure of immediate prospects, and a reflective, prefrontal cortex system for signaling pain or pleasure of future prospects. After an individual learns social rules, the reflective system controls the impulsive system via several mechanisms. However, this control is not absolute; hyperactivity within the impulsive system can override the reflective system. I propose that drugs can trigger bottom-up, involuntary signals originating from the amygdala that modulate, bias or even hijack the goal-driven cognitive resources that are needed for the normal operation of the reflective system and for exercising the willpower to resist drugs.	Univ So Calif, Dept Psychol, Inst Neurol Study Emot & Creat, Los Angeles, CA 90089 USA	University of Southern California	Bechara, A (corresponding author), Univ So Calif, Dept Psychol, Inst Neurol Study Emot & Creat, Los Angeles, CA 90089 USA.	bechara@usc.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012487, R21DA016708, R01DA011779] Funding Source: NIH RePORTER; NIDA NIH HHS [DA16708, DA12487, DA11779] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bartzokis G, 1999, AM J NEURORADIOL, V20, P1628; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Crone EA, 2004, DEV PSYCHOL, V40, P1228, DOI 10.1037/0012-1649.40.6.1228; Damasio A.R., 2005, DESCARTES ERROR EMOT; de Arcos FA, 2005, DRUG ALCOHOL DEPEN, V78, P159, DOI 10.1016/j.drugalcdep.2004.10.010; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; ESLINGER PJ, 1999, ATTENTION MEMORY EXE, P420; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fishbein D, 2005, EXP CLIN PSYCHOPHARM, V13, P25, DOI 10.1037/1064-1297.13.1.25; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; Goldman D, 1998, ARCH GEN PSYCHIAT, V55, P964, DOI 10.1001/archpsyc.55.11.964; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Martin EM, 2003, BIOL PSYCHIAT, V53, p97S; Martin EM, 2003, NEUROPSYCHOLOGY, V17, P283, DOI 10.1037/0894-4105.17.2.283; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noel X, 2005, ADDICTION, V100, P1302, DOI 10.1111/j.1360-0443.2005.01125.x; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Ricaurte George A., 2003, Science (Washington D C), V301, P1479; Rogers RD, 2004, PSYCHOPHARMACOLOGY, V172, P157, DOI 10.1007/s00213-003-1641-5; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	1390	1432	5	253	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1458	1463		10.1038/nn1584	http://dx.doi.org/10.1038/nn1584			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251988				2022-12-28	WOS:000232966600016
J	Dackis, C; O'Brien, C				Dackis, C; O'Brien, C			Neurobiology of addiction: treatment and public policy ramifications	NATURE NEUROSCIENCE			English	Editorial Material							OPIOID RECEPTOR GENE; DOPAMINE-D-2 RECEPTORS; COCAINE DEPENDENCE; ALCOHOL DEPENDENCE; BETA-ENDORPHIN; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; SEEKING BEHAVIOR; CENTRAL SWEDEN; D2 RECEPTORS	In the United States, efforts to treat addiction are hampered by prejudice and a public view that treats it as a disorder of self-control, not a disease. We highlight select advances in addiction research that, if disseminated to the public, could reverse these misconceptions and facilitate changes in policy to improve treatment access and care delivery for this highly prevalent disease.	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Treatment Res Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Dackis, C (corresponding author), Univ Penn, Dept Psychiat, 3900 Chestnut St, Philadelphia, PA 19104 USA.	dackis@mail.med.upenn.edu						ALTSHULER HL, 1980, PHARMACOL BIOCHEM BE, V13, P233, DOI 10.1016/S0091-3057(80)80035-9; Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P417, DOI 10.1038/sj.npp.1300598; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; BELENKA S, 2005, EC BENEFITS DRUG TRE; Brody AL, 2004, PSYCHIAT RES-NEUROIM, V130, P269, DOI 10.1016/j.pscychresns.2003.12.006; Czoty PW, 2004, PSYCHOPHARMACOLOGY, V174, P381, DOI 10.1007/s00213-003-1752-z; Dackis C, 2003, ANN NY ACAD SCI, V1003, P328, DOI 10.1196/annals.1300.021; Dackis C. A., 2005, DRUG DISCOV TODAY, V2, P79; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; DACKIS CA, 2002, DIS NERV SYST, P431; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; GENAZZANI AR, 1982, J CLIN ENDOCR METAB, V55, P583, DOI 10.1210/jcem-55-3-583; Georges F, 2003, NEUROPSYCHOPHARMACOL, V28, P1140, DOI 10.1038/sj.npp.1300161; Gerrits MAFM, 2002, BRAIN RES, V924, P141, DOI 10.1016/S0006-8993(01)03105-5; Gianoulakis C, 1996, ARCH GEN PSYCHIAT, V53, P250; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Haney Margaret, 2004, Expert Rev Vaccines, V3, P11, DOI 10.1586/14760584.3.1.11; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; KALIVAS PW, 1990, SYNAPSE, V5, P48, DOI 10.1002/syn.890050104; Kish SJ, 2001, NEUROPSYCHOPHARMACOL, V24, P561, DOI 10.1016/S0893-133X(00)00209-8; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; MPCLELLAN AT, 2000, JAMA-J AM MED ASSOC, V284, P1689; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Rammes G, 2001, NEUROPHARMACOLOGY, V40, P749, DOI 10.1016/S0028-3908(01)00008-9; Reid MS, 1996, NEUROREPORT, V7, P1325, DOI 10.1097/00001756-199605170-00022; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSSETTI ZL, 1992, ANN NY ACAD SCI, V654, P513, DOI 10.1111/j.1749-6632.1992.tb26016.x; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; VESCOVI PP, 1992, ALCOHOL ALCOHOLISM, V27, P471; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735	50	161	164	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1431	1436		10.1038/nn1105-1431	http://dx.doi.org/10.1038/nn1105-1431			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251982				2022-12-28	WOS:000232966600010
J	Woolley, SMN; Fremouw, TE; Hsu, A; Theunissen, FE				Woolley, SMN; Fremouw, TE; Hsu, A; Theunissen, FE			Tuning for spectro-temporal modulations as a mechanism for auditory discrimination of natural sounds	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELDS; CONSPECIFIC SONG; ZEBRA FINCHES; NEURONS; CORTEX; RESPONSES; SPEECH; REPRESENTATION; MIDBRAIN; STIMULI	Vocal communicators discriminate conspecific vocalizations from other sounds and recognize the vocalizations of individuals. To identify neural mechanisms for the discrimination of such natural sounds, we compared the linear spectro-temporal tuning properties of auditory midbrain and forebrain neurons in zebra finches with the statistics of natural sounds, including song. Here, we demonstrate that ensembles of auditory neurons are tuned to auditory features that enhance the acoustic differences between classes of natural sounds, and among the songs of individual birds. Tuning specifically avoids the spectro-temporal modulations that are redundant across natural sounds and therefore provide little information; rather, it overlaps with the temporal modulations that differ most across sounds. By comparing the real tuning and a less selective model of spectro-temporal tuning, we found that the real modulation tuning increases the neural discrimination of different sounds. Additionally, auditory neurons discriminate among zebra finch song segments better than among synthetic sound segments.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Woolley, SMN (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sw2277@columbia.edu		Theunissen, Frederic/0000-0001-8980-0650	NIDCD NIH HHS [R01 DC009810] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009810] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSMANN PF, 1996, J ACOUST SOC AM, V10, P2680; Braaten RF, 1999, ANIM BEHAV, V58, P105, DOI 10.1006/anbe.1999.1134; Calhoun BM, 1998, EUR J NEUROSCI, V10, P926, DOI 10.1046/j.1460-9568.1998.00102.x; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MARLER P, 1977, SCIENCE, V198, P519, DOI 10.1126/science.198.4316.519; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; NARINS PM, 1980, BRAIN BEHAV EVOLUT, V17, P48, DOI 10.1159/000121790; POLLAK GD, 1981, J NEUROPHYSIOL, V46, P605, DOI 10.1152/jn.1981.46.3.605; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; ROSE G, 1983, SCIENCE, V219, P1087, DOI 10.1126/science.6600522; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Woolley SMN, 2005, J NEUROPHYSIOL, V94, P1143, DOI 10.1152/jn.01064.2004; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; Woolley SMN, 1999, J NEUROSCI, V19, P358, DOI 10.1523/JNEUROSCI.19-01-00358.1999	37	198	199	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1371	1379		10.1038/nn1536	http://dx.doi.org/10.1038/nn1536			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136039				2022-12-28	WOS:000232145900022
J	Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR				Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR			Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC NEURONS; DIVERSITY-SERIES; ADULT-MOUSE; CORTICAL INTERNEURONS; HOMEOBOX GENES; VISUAL-CORTEX; IN-VITRO; RAT; FOREBRAIN	Dlx homeodomain transcription factors are essential during embryonic development for the production of forebrain GABAergic interneurons. Here we show that Dlx1 is also required for regulating the functional longevity of cortical and hippocampal interneurons in the adult brain. We demonstrate preferential Dlx1 expression in a subset of cortical and hippocampal interneurons which, in postnatal Dlx1 mutants, show a time-dependent reduction in number. This reduction preferentially affects calretinin(+) ( bipolar cells) and somatostatin(+) subtypes ( for example, bitufted cells), whereas parvalbumin(+) subpopulations ( basket cells and chandelier cells) seem to be unaffected. Cell transplantation analysis demonstrates that interneuron loss reflects cell-autonomous functions of Dlx1. The decrease in the number of interneurons was associated with a reduction of GABA-mediated inhibitory postsynaptic current in neocortex and hippocampus in vitro and cortical dysrhythmia in vivo. Dlx1 mutant mice show generalized electrographic seizures and histological evidence of seizure-induced reorganization, linking the Dlx1 mutation to delayed-onset epilepsy associated with interneuron loss.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USA; Baylor Coll Med, Dept Neurol, Dev Neurogenet Lab, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine	Cobos, I (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA.	icobos@itsa.ucsf.edu; jlrr@itsa.ucsf.edu	calcagnotto, maria elisa/B-1645-2013; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020	calcagnotto, maria elisa/0000-0001-8196-0596; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Noebels, Jeffrey/0000-0002-2887-0839; Baraban, Scott/0000-0003-1975-9781; Cobos, Inma/0000-0002-2043-1890	NICHD NIH HHS [HD24064] Funding Source: Medline; NIMH NIH HHS [R01 MH49428, K05 MH065670] Funding Source: Medline; NINDS NIH HHS [NS 29709, R01 NS40272] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, K05MH065670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040272, R01NS029709] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cajal S.R., 1911, HISTOLOGY NERVOUS SY; Cobos I, 2005, J COMP NEUROL, V483, P292, DOI 10.1002/cne.20405; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2002, J COMP NEUROL, V443, P1, DOI 10.1002/cne.1425; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kobayashi M, 2003, J NEUROSCI, V23, P2440; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sussel L, 1999, DEVELOPMENT, V126, P3359; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yun K, 2002, DEVELOPMENT, V129, P5029	49	381	390	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1059	1068		10.1038/nn1499	http://dx.doi.org/10.1038/nn1499			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007083				2022-12-28	WOS:000230760200018
J	Avenanti, A; Bueti, D; Galati, G; Aglioti, SM				Avenanti, A; Bueti, D; Galati, G; Aglioti, SM			Transcranial magnetic stimulation highlights the sensorimotor side of empathy for pain	NATURE NEUROSCIENCE			English	Article							HUMAN MOTOR CORTEX; PHANTOM-LIMB PAIN; COIL ORIENTATION; NEURAL SYSTEMS; MODULATION; IMITATION; ACTIVATION; MECHANISMS; PREMOTOR; BRAIN	Pain is intimately linked with action systems that are involved in observational learning and imitation. Motor responses to one's own pain allow freezing or escape reactions and ultimately survival. Here we show that similar motor responses occur as a result of observation of painful events in others. We used transcranial magnetic stimulation to record changes in corticospinal motor representations of hand muscles of individuals observing needles penetrating hands or feet of a human model or noncorporeal objects. We found a reduction in amplitude of motor-evoked potentials that was specific to the muscle that subjects observed being pricked. This inhibition correlated with the observer's subjective rating of the sensory qualities of the pain attributed to the model and with sensory, but not emotional, state or trait empathy measures. The empathic inference about the sensory qualities of others' pain and their automatic embodiment in the observer's motor system may be crucial for the social learning of reactions to pain.	Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Univ G DAnnunzio, Dipartimento Sci Clin & Bioimmagini, I-66010 Chieti, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Via Marsi 78, I-00185 Rome, Italy.	salvatoremaria.aglioti@uniroma1.it	Avenanti, Alessio/K-5250-2012; Aglioti, Salvatore M/E-9829-2012; Galati, Gaspare/F-3277-2011; Bueti, Domenica/E-7627-2014	Avenanti, Alessio/0000-0003-1139-9996; Galati, Gaspare/0000-0002-0640-4247; Bueti, Domenica/0000-0001-6660-7241; Aglioti, Salvatore Maria/0000-0001-8175-7563				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Bonino S., 1998, EMPATIA PROCESSI CON; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Davis M., 1996, EMPATHY SOCIAL PSYCH; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; EISEN A, 1987, CAN J NEUROL SCI, V14, P501, DOI 10.1017/S0317167100037999; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; KIMURA J, 1993, ELECTRODIAGNOSIS DIS; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MAIANI G, 1985, PAIN, V22, P399, DOI 10.1016/0304-3959(85)90045-4; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Saitoh Y, 1999, LANCET, V353, P212, DOI 10.1016/S0140-6736(05)77223-8; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Urban PP, 2004, MUSCLE NERVE, V29, P663, DOI 10.1002/mus.20011; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Wittgenstein Ludwig, 1958, PHILOS INVESTIGATION	50	425	435	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					955	960		10.1038/nn1481	http://dx.doi.org/10.1038/nn1481			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937484				2022-12-28	WOS:000230137100024
J	Dunah, AW; Hueske, E; Wyszynski, M; Hoogenraad, CC; Jaworski, J; Pak, DT; Simonetta, A; Liu, GS; Sheng, M				Dunah, AW; Hueske, E; Wyszynski, M; Hoogenraad, CC; Jaworski, J; Pak, DT; Simonetta, A; Liu, GS; Sheng, M			LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses	NATURE NEUROSCIENCE			English	Article							CADHERIN-CATENIN COMPLEX; CELL-ADHESION; AMPA RECEPTORS; PTP-SIGMA; ALPHA-CATENIN; LIPRIN-ALPHA; RAT-BRAIN; ASSOCIATION; EXPRESSION; TRAFFICKING	Leukocyte common antigen - related (LAR) family receptor protein tyrosine phosphatases (LAR-RPTP) bind to liprin-alpha (SYD2) and are implicated in axon guidance. We report that LAR-RPTP is concentrated in mature synapses in cultured rat hippocampal neurons, and is important for the development and maintenance of excitatory synapses in hippocampal neurons. RNA interference (RNAi) knockdown of LAR or dominant-negative disruption of LAR function results in loss of excitatory synapses and dendritic spines, reduction of surface AMPA receptors, impairment of dendritic targeting of the cadherin - beta-catenin complex, and reduction in the amplitude and frequency of miniature excitatory postsynaptic currents (mEPSCs). Cadherin, beta-catenin and GluR2/3 are tyrosine phosphoproteins that coimmunoprecipitate with liprin-alpha and GRIP from rat brain extracts. We propose that the cadherin-beta-catenin complex is cotransported with AMPA receptors to synapses and dendritic spines by a mechanism that involves binding of liprin-alpha to LAR-RPTP and tyrosine dephosphorylation by LAR-RPTP.	MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sheng, M (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Hoogenraad, Casper/B-8866-2011	Hoogenraad, Casper/0000-0002-2666-0758; Sheng, Morgan/0000-0002-8703-5366; Jaworski, Jacek/0000-0001-8760-7865				Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; PULIDO R, 1995, J BIOL CHEM, V270, P6722, DOI 10.1074/jbc.270.12.6722; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Schaapveld RQJ, 1998, MECH DEVELOP, V77, P59, DOI 10.1016/S0925-4773(98)00119-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1994, J BIOL CHEM, V269, P23632; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WANG YH, 1995, J NEUROCHEM, V65, P176; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yagi T, 2000, GENE DEV, V14, P1169; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	50	189	193	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					458	467		10.1038/nn1416	http://dx.doi.org/10.1038/nn1416			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15750591				2022-12-28	WOS:000228040400016
J	Ji, YY; Pang, PT; Feng, LY; Lu, B				Ji, YY; Pang, PT; Feng, LY; Lu, B			Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; EXCITATORY SYNAPSES; POSTSYNAPTIC DENSITIES; SYNAPTIC-TRANSMISSION; SURFACE EXPRESSION; PRIMARY CULTURES; FULL-LENGTH; CAMP; POTENTIATION; RELEASE	Synaptic actions of brain-derived neurotrophic factor (BDNF) are 'gated' by cyclic AMP (cAMP), but the underlying molecular mechanisms remain unclear. Here we report that cAMP regulates BDNF function in mature hippocampal neurons by modulating the signaling and trafficking of its receptor TrkB. cAMP gated the TrkB tyrosine kinase with three characteristic features: BDNF-induced TrkB phosphorylation was attenuated by inhibitors of cAMP signaling, it was potentiated by cAMP analogs, and activation of the cAMP pathway alone had no effect. In addition, cAMP facilitated trafficking of TrkB to dendritic spines, possibly by promoting its interaction with synaptic scaffolding protein PSD-95. Norepinephrinergic and dopaminergic agonists, which elevate intracellular cAMP concentration, also enhanced TrkB phosphorylation and its translocation to spines. cAMP gated long-term modulation by BDNF of spine density, but not the number of primary dendrites. These results reveal a specific role of cAMP in controlling BDNF actions in the brain, and provide new insights into the molecular mechanism underlying cAMP gating.	NICHHD, NIH, Sect Neural Dev & Plast, Bethesda, MD 20892 USA; Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong	Lu, B (corresponding author), NICHHD, NIH, Sect Neural Dev & Plast, 35 Lincoln Dr, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brinton RD, 2000, EUR J PHARMACOL, V405, P73, DOI 10.1016/S0014-2999(00)00543-4; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Drake CT, 1999, J NEUROSCI, V19, P8009; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gaiddon C, 1996, J NEUROCHEM, V66, P2279; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hu BR, 1998, J NEUROSCI, V18, P625; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; LESSMANN V, 1994, NEUROREPORT, V6, P21; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; PAPA M, 1995, J NEUROSCI, V15, P1; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shimada A, 1998, J NEUROSCI, V18, P8559; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Takei N, 1997, J NEUROCHEM, V68, P370; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	237	251	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					164	172		10.1038/nn1381	http://dx.doi.org/10.1038/nn1381			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665879				2022-12-28	WOS:000226638200015
J	Morris, JA; Jordan, CL; Breedlove, SM				Morris, JA; Jordan, CL; Breedlove, SM			Sexual differentiation of the vertebrate nervous system	NATURE NEUROSCIENCE			English	Review							DIMORPHIC MOTOR NUCLEUS; CONGENITAL ADRENAL-HYPERPLASIA; MOSAIC ANDROGEN INSENSITIVITY; GENDER-ROLE BEHAVIOR; FINCH SONG SYSTEM; SPINAL-CORD; PREOPTIC AREA; SIBERIAN HAMSTER; MEDIAL AMYGDALA; TESTOSTERONE PROPIONATE	Understanding the mechanisms that give rise to sex differences in the behavior of nonhuman animals may contribute to the understanding of sex differences in humans. In vertebrate model systems, a single factor-the steroid hormone testosterone-accounts for most, and perhaps all, of the known sex differences in neural structure and behavior. Here we review some of the events triggered by testosterone that masculinize the developing and adult nervous system, promote male behaviors and suppress female behaviors. Testosterone often sculpts the developing nervous system by inhibiting or exacerbating cell death and/or by modulating the formation and elimination of synapses. Experience, too, can interact with testosterone to enhance or diminish its effects on the central nervous system. However, more work is needed to uncover the particular cells and specific genes on which testosterone acts to initiate these events.	Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University	Breedlove, SM (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	breedsm@msu.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Breedlove, S. Marc/0000-0003-4359-4315				Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROSCI, V22, P8586; [Anonymous], PHYSL REPRODUCTION, DOI DOI 10.1016/B978-012532104-4/50003-2; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Arnold AP, 1996, DEV NEUROSCI-BASEL, V18, P124, DOI 10.1159/000111400; Arnold AP, 1996, HORM BEHAV, V30, P495, DOI 10.1006/hbeh.1996.0053; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Berenbaum SA, 1999, HORM BEHAV, V35, P102, DOI 10.1006/hbeh.1998.1503; BREEDLOVE SM, 1981, BRAIN RES, V225, P297; BREEDLOVE SM, 1980, SCIENCE, V210, P564, DOI 10.1126/science.7423210; Brenowitz EA, 2002, P NATL ACAD SCI USA, V99, P12421, DOI 10.1073/pnas.192308799; CIHAK R, 1970, J ANAT, V106, P93; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; Cooke BM, 2002, J BIOL RHYTHM, V17, P147, DOI 10.1177/074873002129002438; Cooke BM, 2001, NEUROSCI LETT, V312, P9, DOI 10.1016/S0304-3940(01)02173-5; Cooke BM, 1999, P NATL ACAD SCI USA, V96, P7538, DOI 10.1073/pnas.96.13.7538; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DEJONGE FH, 1989, BRAIN RES BULL, V23, P483, DOI 10.1016/0361-9230(89)90194-9; DOHLER KD, 1984, BRAIN RES, V302, P291, DOI 10.1016/0006-8993(84)90242-7; FORGER NG, 1995, J NEUROBIOL, V28, P354, DOI 10.1002/neu.480280308; Forger NG, 1997, J NEUROSCI, V17, P9605; FORGER NG, 1992, HORM BEHAV, V26, P204, DOI 10.1016/0018-506X(92)90042-T; FORGER NG, 1993, J NEUROSCI, V13, P4720; Forger NG, 2003, J NEUROSCI, V23, P8854; FORGER NG, 1986, P NATL ACAD SCI USA, V83, P7527, DOI 10.1073/pnas.83.19.7527; Freeman LM, 1996, HORM BEHAV, V30, P424, DOI 10.1006/hbeh.1996.0047; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; GURNEY ME, 1981, J NEUROSCI, V1, P658; Hegstrom CD, 2002, J NEUROENDOCRINOL, V14, P368, DOI 10.1046/j.0007-1331.2002.00791.x; Hines M, 2004, J SEX RES, V41, P75, DOI 10.1080/00224490409552215; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Holmes MM, 2004, J COMP NEUROL, V471, P180, DOI 10.1002/cne.20027; Ibanez MA, 2001, J NEUROSCI, V21, P5652, DOI 10.1523/JNEUROSCI.21-15-05652.2001; KONISHI M, 1987, CIBA F SYMP, V126, P173; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Martin JT, 2004, HORM BEHAV, V45, P31, DOI 10.1016/j.yhbeh.2003.07.003; McFadden D, 1998, P NATL ACAD SCI USA, V95, P2709, DOI 10.1073/pnas.95.5.2709; MONEY J, 1968, JOHNS HOPKINS MED J, V123, P105; Monks DA, 1999, J NEUROSCI, V19, P5597; Morris J. A., 2003, Hormones and Behavior, V44, P65; NORDEEN EJ, 1985, SCIENCE, V229, P671, DOI 10.1126/science.4023706; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Park JJ, 1998, J NEUROBIOL, V34, P242, DOI 10.1002/(SICI)1097-4695(19980215)34:3<242::AID-NEU4>3.0.CO;2-2; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Rahman Q, 2003, BEHAV NEUROSCI, V117, P1096, DOI 10.1037/0735-7044.117.5.1096; Roselli CE, 2004, ENDOCRINOLOGY, V145, P478, DOI 10.1210/en.2003-1098; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Wagner CK, 2004, ENDOCRINOLOGY, V145, P1046, DOI 10.1210/en.2003-1219; Watson NV, 2001, J NEUROSCI, V21, P1062, DOI 10.1523/JNEUROSCI.21-03-01062.2001; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; Wilson JD, 1999, ENDOCR REV, V20, P726, DOI 10.1210/er.20.5.726; Wisniewski AB, 2000, J CLIN ENDOCR METAB, V85, P2664, DOI 10.1210/jc.85.8.2664; Xu J, 2001, J NEUROSCI, V21, P4366, DOI 10.1523/JNEUROSCI.21-12-04366.2001; YOUNG JK, 1982, BRAIN RES, V239, P233, DOI 10.1016/0006-8993(82)90844-7; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; ZHOU L, 1994, ENDOCRINOLOGY, V134, P2622, DOI 10.1210/en.134.6.2622; Zup SL, 2003, J NEUROSCI, V23, P2357	63	467	472	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1034	1039		10.1038/nn1325	http://dx.doi.org/10.1038/nn1325			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452574				2022-12-28	WOS:000224156900010
J	Young, LJ; Wang, ZX				Young, LJ; Wang, ZX			The neurobiology of pair bonding	NATURE NEUROSCIENCE			English	Review							VOLES MICROTUS-OCHROGASTER; FEMALE PRAIRIE VOLES; PARTNER-PREFERENCE FORMATION; VASOPRESSIN RECEPTOR; SEXUAL-BEHAVIOR; NUCLEUS-ACCUMBENS; SOCIAL RECOGNITION; MONOGAMOUS VOLE; LATERAL SEPTUM; ROMANTIC LOVE	A neurobiological model for pair-bond formation has emerged from studies in monogamous rodents. The neuropeptides oxytocin and vasopressin contribute to the processing of social cues necessary for individual recognition. Mesolimbic dopamine is involved in reinforcement and reward learning. Concurrent activation of neuropeptide and dopamine receptors in the reward centers of the brain during mating results in a conditioned partner preference, observed as a pair bond. Differential regulation of neuropeptide receptor expression may explain species differences in the ability to form pair bonds. These and other studies discussed here have intriguing implications for the neurobiology of social attachment in our own species.	Emory Univ, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	Emory University; Emory University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Young, LJ (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022					Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Aragona BJ, 2003, HORM BEHAV, V44, P37; Bales KL, 2003, BEHAV NEUROSCI, V117, P854, DOI 10.1037/0735-7044.117.4.854; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Becker JB, 2001, J NEUROSCI, V21, P3236, DOI 10.1523/JNEUROSCI.21-09-03236.2001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; CHRISTENSSON K, 1989, ACTA OBSTET GYN SCAN, V68, P205, DOI 10.3109/00016348909020990; Cushing BS, 2000, HORM BEHAV, V37, P49, DOI 10.1006/hbeh.1999.1558; DeVries AC, 2002, PSYCHONEUROENDOCRINO, V27, P705, DOI 10.1016/S0306-4530(01)00073-7; DEVRIES AC, 1995, P NATL ACAD SCI USA, V92, P7744, DOI 10.1073/pnas.92.17.7744; DeVries AC, 1996, P NATL ACAD SCI USA, V93, P11980, DOI 10.1073/pnas.93.21.11980; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FERRIS CF, 1984, SCIENCE, V224, P521, DOI 10.1126/science.6538700; Getz LL, 1996, AM SCI, V84, P56; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Holstege G, 2003, J NEUROSCI, V23, P9185; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; INSEL TR, 1995, PHYSIOL BEHAV, V57, P615, DOI 10.1016/0031-9384(94)00362-9; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; JENKINS JS, 1984, BRAIN RES, V291, P111, DOI 10.1016/0006-8993(84)90656-5; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT, P237; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; KENDRICK KM, 1986, NEUROENDOCRINOLOGY, V44, P149, DOI 10.1159/000124638; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; KLITENICK MA, 1992, NEUROSCIENCE, V50, P371, DOI 10.1016/0306-4522(92)90430-A; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; KOOB GF, 1988, ANN N Y ACAD SCI, V537, P216; Kovacs GL, 1998, PSYCHONEUROENDOCRINO, V23, P945; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; MELIS MR, 1989, NEUROSCI LETT, V98, P351, DOI 10.1016/0304-3940(89)90427-8; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; MURPHY MR, 1987, J CLIN ENDOCR METAB, V65, P738, DOI 10.1210/jcem-65-4-738; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; Pfaus JG, 2001, HORM BEHAV, V40, P291, DOI 10.1006/hbeh.2001.1686; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; PFISTER HP, 1989, INT J NEUROSCI, V45, P221, DOI 10.3109/00207458908986235; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Wang ZX, 1996, J COMP NEUROL, V366, P726; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; WANG ZX, 1996, ADV STUD BEHAV, V25, P361, DOI DOI 10.1016/S0065-3454(08)60338-1; WASSINK TH, 2004, MOL PSYCHIAT; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WILLIAMS JR, 1994, J NEUROENDOCRINOL, V6, P247, DOI 10.1111/j.1365-2826.1994.tb00579.x; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wolff JO, 2002, BEHAVIOUR, V139, P1147, DOI 10.1163/15685390260437308; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691	76	991	1003	4	343	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1048	1054		10.1038/nn1327	http://dx.doi.org/10.1038/nn1327			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452576				2022-12-28	WOS:000224156900012
J	Yi, DJ; Woodman, GF; Widders, D; Marois, R; Chun, MM				Yi, DJ; Woodman, GF; Widders, D; Marois, R; Chun, MM			Neural fate of ignored stimuli: dissociable effects of perceptual and working memory load	NATURE NEUROSCIENCE			English	Article							VISUAL-SEARCH; SELECTIVE ATTENTION; MECHANISMS; SYSTEM; CORTEX	Observers commonly experience functional blindness to unattended visual events, and this problem has fuelled an intense debate concerning the fate of unattended visual information in neural processing. Here we used functional magnetic resonance imaging ( fMRI) to demonstrate that the type of task that a human subject engages in determines the way in which ignored visual background stimuli are processed in parahippocampal cortex. Increasing the perceptual difficulty of a foveal target task attenuated processing of task-irrelevant background scenes, whereas increasing the number of objects held in working memory did not have this effect. These dissociable effects of perceptual and working memory load clarify how task-irrelevant, unattended stimuli are processed in category-selective areas in human ventral visual cortex.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Vanderbilt Univ, Dept Psychol, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA; Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Yale University; Vanderbilt University; Vanderbilt University	Chun, MM (corresponding author), Yale Univ, Dept Psychol, POB 208205,2 Hillhouse Ave, New Haven, CT 06520 USA.	marvin.chun@yale.edu		Chun, Marvin/0000-0003-1070-7993	NATIONAL EYE INSTITUTE [F32EY015043, R01EY014193] Funding Source: NIH RePORTER; NEI NIH HHS [EY014193, F32EY015043] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; EGER E, IN PRESS J NEUROPHYS; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gehring WJ, 2002, COGNITIVE BRAIN RES, V13, P267, DOI 10.1016/S0926-6410(01)00132-X; Goldstein B., 2001, BLACKWELL HDB PERCEP, P272; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Jiang YH, 2001, J EXP PSYCHOL HUMAN, V27, P895, DOI 10.1037//0096-1523.27.4.895; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P497, DOI 10.1037/0096-1523.9.4.497; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LAVIE N, IN PRESS J EXP PSYCH; Luck S. J., 2002, STEVENS HDB EXPT PSY, V1, P235; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; Pashler HE, 1998, PSYCHOL ATTENTION; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; TREISMAN AM, 1960, Q J EXP PSYCHOL, V12, P242, DOI 10.1080/17470216008416732; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339	42	169	172	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					992	996		10.1038/nn1294	http://dx.doi.org/10.1038/nn1294			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286791				2022-12-28	WOS:000223546700019
J	Hornstein, EP; Verweij, J; Schnapf, JL				Hornstein, EP; Verweij, J; Schnapf, JL			Electrical coupling between red and green cones in primate retina	NATURE NEUROSCIENCE			English	Article							MONKEY MACACA-FASCICULARIS; LATERAL GENICULATE-NUCLEUS; HUMAN COLOR-VISION; RECEPTIVE-FIELDS; GAP-JUNCTIONS; SPECTRAL SENSITIVITY; VISUAL PIGMENTS; PHOTORECEPTORS; CELLS; TURTLE	Color vision in humans and other Old World primates depends on differences in the absorption properties of three spectral types of cone photoreceptors. Primate cones are linked by gap junctions, but it is not known to what extent the various cone types are electrically coupled through these junctions. Here we show, by using a combination of dye labeling and electrical recordings in the retina of macaque monkeys, that neighboring red and green cones are homologously and heterologously coupled by nonrectifying gap junctions. This indiscriminate coupling blurs the differences between red- and green-cone signals. The average junctional conductance is about 650 pS. Our calculations indicate that coupling between red and green cones may cause a modest decrease in human color discrimination with a comparable increase in luminance discrimination.	Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hornstein, EP (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, 10 Kirkham St, San Francisco, CA 94143 USA.	ehorn@phy.ucsf.edu; schn@phy.ucsf.edu			NATIONAL EYE INSTITUTE [R01EY007642, T32EY007120] Funding Source: NIH RePORTER; NEI NIH HHS [EY07642, EY07001, EY07120] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bumsted K, 1997, J COMP NEUROL, V378, P117; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; Dacey DM, 2000, J OPT SOC AM A, V17, P589, DOI 10.1364/JOSAA.17.000589; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Deeb SS, 2000, J OPT SOC AM A, V17, P538, DOI 10.1364/JOSAA.17.000538; DETWILER PB, 1979, J PHYSIOL-LONDON, V291, P75, DOI 10.1113/jphysiol.1979.sp012801; DEVALOIS RL, 1974, VISION RES, V14, P53, DOI 10.1016/0042-6989(74)90116-3; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Hsu A, 2000, J OPT SOC AM A, V17, P635, DOI 10.1364/JOSAA.17.000635; Jahromi SS, 2002, J NEUROPHYSIOL, V88, P1893, DOI 10.1152/jn.2002.88.4.1893; Kolb H, 1997, J COMP NEUROL, V386, P443, DOI 10.1002/(SICI)1096-9861(19970929)386:3<443::AID-CNE8>3.0.CO;2-1; LAMB TD, 1976, J PHYSIOL-LONDON, V263, P257, DOI 10.1113/jphysiol.1976.sp011631; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Li W, 2004, NAT NEUROSCI, V7, P751, DOI 10.1038/nn1275; MACNICHOL EF, 1983, COLOUR VISION PHYSL, P13; MARIANI AP, 1984, INT REV CYTOL, V86, P285, DOI 10.1016/S0074-7696(08)60181-3; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; MOLLON JD, 1989, J EXP BIOL, V146, P21; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Reid RC, 2002, J NEUROSCI, V22, P6158; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Srinivas M, 1999, J NEUROSCI, V19, P9848; TESSIERLAVIGNE M, 1988, PROC R SOC SER B-BIO, V234, P171, DOI 10.1098/rspb.1988.0043; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; Verweij J, 2003, J NEUROSCI, V23, P10249; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656	44	60	61	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					745	750		10.1038/nn1274	http://dx.doi.org/10.1038/nn1274			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208634				2022-12-28	WOS:000222274400016
J	Kim, J; Alger, BE				Kim, J; Alger, BE			Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; ANANDAMIDE; NEURONS; ENZYME	In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization-induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.	Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Program Neurosci, 655 W Baltimore St, Baltimore, MD 21201 USA.	balger@umaryland.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014725] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA14725] Funding Source: Medline; NINDS NIH HHS [R01 NS30219] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fowler CJ, 1997, J PHARMACOL EXP THER, V283, P729; Goparaju SK, 1999, BIOCHEM PHARMACOL, V57, P417, DOI 10.1016/S0006-2952(98)00314-1; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	14	184	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					697	698		10.1038/nn1262	http://dx.doi.org/10.1038/nn1262			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184902				2022-12-28	WOS:000222274400007
J	Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD				Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD			Music, language and meaning: brain signatures of semantic processing	NATURE NEUROSCIENCE			English	Article							SENTENCES; WORD; FMRI; COMPREHENSION; COMMUNICATION; PERFORMANCE; EMOTIONS; CONTEXT	Semantics is a key feature of language, but whether or not music can activate brain mechanisms related to the processing of semantic meaning is not known. We compared processing of semantic meaning in language and music, investigating the semantic priming effect as indexed by behavioral measures and by the N400 component of the event-related brain potential (ERP) measured by electroencephalography (EEG). Human subjects were presented visually with target words after hearing either a spoken sentence or a musical excerpt. Target words that were semantically unrelated to prime sentences elicited a larger N400 than did target words that were preceded by semantically related sentences. In addition, target words that were preceded by semantically unrelated musical primes showed a similar N400 effect, as compared to target words preceded by related musical primes. The N400 priming effect did not differ between language and music with respect to time course, strength or neural generators. Our results indicate that both music and language can prime the meaning of a word, and that music can, as language, determine physiological indices of semantic processing.	Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany	Max Planck Society	Koelsch, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	koelsch@cns.mpg.de	Koelsch, Stefan/AAV-1556-2020; Schulze, Katrin/A-7385-2010; Sammler, Daniela/V-9044-2019	Sammler, Daniela/0000-0001-7458-0229				Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bernstein L, 1981, UNANSWERED QUESTION; Busnel RG, 1976, WHISTLED LANGUAGES; Cowan GM, 1948, LANGUAGE, V24, P280, DOI 10.2307/410362; Crystal D., 1995, CAMBRIDGE ENCY LANGU; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1998, LANGUAGE COMPREHENSI; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; JONES MR, 1992, COGNITIVE BASES MUSI; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Kellenbach ML, 2000, COGNITIVE BRAIN RES, V10, P67, DOI 10.1016/S0926-6410(00)00023-9; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Meyer L., 1956, EMOTION MEANING MUSI; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OSTERHOUT L, 1995, ELECTROPHYSIOLOGY MI, P192; Peirce, 1994, COLLECTED PAPERS CS; PINKER S, 1997, HOW MIND WORKS; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; RAFFMANN D, 1993, LANGUAGE MUSIC MIND; Seboek T., 1976, SPEECH SURROGATES DR; Swain J., 1997, MUSICAL LANGUAGES; Talairach J., 1988, COPLANAR STEREOTAXIC; Zbikowski Lawrence M., 2002, CONCEPTUALIZING MUSI	32	309	323	5	135	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					302	307		10.1038/nn1197	http://dx.doi.org/10.1038/nn1197			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	777UU	14983184				2022-12-28	WOS:000189197900021
J	Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T				Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T			Synaptic background activity controls spike transfer from thalamus to cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RELAY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; NEOCORTICAL NEURONS; VISUAL INFORMATION; PYRAMIDAL NEURONS; SENSORY INPUT; IN-VIVO; CAT; CELLS	Characterizing the responsiveness of thalamic neurons is crucial to understanding the flow of sensory information. Typically, thalamocortical neurons possess two distinct firing modes. At depolarized membrane potentials, thalamic cells fire single action potentials and faithfully relay synaptic inputs to the cortex. At hyperpolarized potentials, the activation of T-type calcium channels promotes burst firing, and the transfer is less accurate. Our results suggest that this duality no longer holds if synaptic background activity is taken into account. By injecting stochastic conductances into guinea-pig thalamocortical neurons in slices, we show that the transfer function of these neurons is strongly influenced by conductance noise. The combination of synaptic noise with intrinsic properties gives a global responsiveness that is more linear, mixing single-spike and burst responses at all membrane potentials. Because in thalamic neurons, background synaptic input originates mainly from cortex, these results support a determinant role of corticothalamic feedback during sensory information processing.	CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France; Univ Bordeaux 2, INSERM 358, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bal, T (corresponding author), CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France.	jakob.wolfart@unklinik-freiburg.de; thierry.bal@iaf.cnrs-gif.fr	Wolfart, Jakob/F-1698-2011	Wolfart, Jakob/0000-0003-0594-2112; Destexhe, Alain/0000-0001-7405-0455				Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 2002, PHILOS T ROY SOC B, V357, P1649, DOI 10.1098/rstb.2002.1154; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; KOCH C, 1987, NEUROSCIENCE, V23, P399, DOI 10.1016/0306-4522(87)90064-9; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Leresche N, 2004, J NEUROSCI, V24, P5592, DOI 10.1523/JNEUROSCI.1038-04.2004; Lewis JE, 1999, J COMP PHYSIOL A, V185, P373, DOI 10.1007/s003590050397; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Shu YS, 2003, J NEUROSCI, V23, P10388; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434; Steriade M, 1997, THALAMUS, VI; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; TROY JB, 1992, VISUAL NEUROSCI, V9, P535, DOI 10.1017/S0952523800001784; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	49	126	129	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1760	1767		10.1038/nn1591	http://dx.doi.org/10.1038/nn1591			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261132				2022-12-28	WOS:000233576200026
J	Cai, SQ; Hernandez, L; Wang, Y; Park, KH; Sesti, F				Cai, SQ; Hernandez, L; Wang, Y; Park, KH; Sesti, F			MPS-1 is a K+ channel beta-subunit and a serine/threonine kinase	NATURE NEUROSCIENCE			English	Article							MINK-RELATED PEPTIDES; LONG-QT SYNDROME; MYELIN BASIC-PROTEIN; I-KS CHANNELS; POTASSIUM CHANNEL; CAENORHABDITIS-ELEGANS; CARDIAC-ARRHYTHMIA; MEMBRANE-PROTEIN; ALPHA-KINASES; ION-CHANNEL	We report the first example of a K+ channel beta-subunit that is also a serine/threonine kinase. MPS-1 is a single-transmembrane domain protein that coassembles with voltage-gated K+ channel KVS-1 in the nervous system of the nematode Caenorhabditis elegans. Biochemical analysis shows that MPS-1 can phosphorylate KVS-1 and other substrates. Electrophysiological analysis in Chinese hamster ovary (CHO) cells demonstrates that MPS-1 activity leads to a significant decrease in the macroscopic current. Single-channel analysis and biotinylation assays indicate that MPS-1 reduces the macroscopic current by lowering the open probability of the channel. These data are consistent with a model that predicts that the MPS-1-dependent phosphorylation of KVS-1 sustains cell excitability by controlling K+ flux.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 683 Hoes Lane, Piscataway, NJ 08854 USA.	sestife@umdnj.edu	Park, Ki Ho/E-8921-2011; Park, Ki Ho/N-8153-2017; wang, yi/C-4312-2012; Hernandez, Leonardo H/A-5363-2013	Park, Ki Ho/0000-0002-6193-9826; Hernandez, Leonardo H/0000-0002-8570-5848	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM68581-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beeton CA, 2000, BIOCHEM J, V350, P353, DOI 10.1042/0264-6021:3500353; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Chen HJ, 2003, BIOPHYS J, V84, P3679, DOI 10.1016/S0006-3495(03)75097-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; DU P, 2005, PROTEIN EXPR PU 0607; Hwang IS, 1997, B KOREAN CHEM SOC, V18, P428; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; LAURINO JP, 1988, ARCH BIOCHEM BIOPHYS, V265, P8, DOI 10.1016/0003-9861(88)90365-7; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; MIYAMOTO E, 1974, J BIOL CHEM, V249, P2769; Park KH, 2005, J BIOL CHEM, V280, P21893, DOI 10.1074/jbc.M502732200; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Sakmann B., 1995, SINGLE CHANNEL RECOR; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sesti F, 2000, BIOPHYS J, V79, P1369, DOI 10.1016/S0006-3495(00)76389-2; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tai KK, 1998, NATURE, V391, P605, DOI 10.1038/35416; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TONKS NK, 1990, J BIOL CHEM, V265, P10674; WANG Y, 2004, RECENT RES DEV BIO 2, V3, P351; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	46	26	28	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1503	1509		10.1038/nn1557	http://dx.doi.org/10.1038/nn1557			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222231				2022-12-28	WOS:000232966600024
J	Chang, KT; Min, KT				Chang, KT; Min, KT			Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function	NATURE NEUROSCIENCE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; SUPEROXIDE PRODUCTION; INHIBITS CALCINEURIN; DSCR1 ADAPT78; MOUSE MODELS; PROTEIN; GENE; PHOSPHORYLATION	Mitochondrial dysfunction has emerged as a common theme that underlies numerous neurological disorders, including Down syndrome. Down syndrome cultures and tissues show mitochondrial damage such as impaired mitochondrial enzyme activities, defective mitochondrial DNA repairs and accumulation of toxic free radicals, but the cause of mitochondrial dysfunction remains elusive. Here we demonstrate that the Drosophila melanogaster homolog of human Down syndrome critical region gene 1 (DSCR1), nebula (also known as sarah, sra), has a crucial role in the maintenance of mitochondrial function and integrity. We report that nebula protein is located in the mitochondria. An alteration in the abundance of nebula affects mitochondrial enzyme activities, mitochondrial DNA content, and the number and size of mitochondria. Furthermore, nebula interacts with the ADP/ATP translocator and influences its activity. These results identify nebula/DSCR1 as a regulator of mitochondrial function and integrity and further suggest that an increased level of DSCR1 may contribute to the mitochondrial dysfunction seen in Down syndrome.	Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Min, KT (corresponding author), Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA.	mink@mail.nih.gov		min, kyung-tai/0000-0003-0983-4258	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002988] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arbuzova S, 2002, BIOESSAYS, V24, P681, DOI 10.1002/bies.10138; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Biousse V, 2002, J NEURO-OPHTHALMOL, V22, P279, DOI 10.1097/00041327-200212000-00005; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Capone G, 2002, LIFE SCI, V70, P2885, DOI 10.1016/S0024-3205(02)01538-2; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1; DUAN JM, 1989, CAN J PHYSIOL PHARM, V67, P704, DOI 10.1139/y89-114; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gajewski K, 2003, P NATL ACAD SCI USA, V100, P1040, DOI 10.1073/pnas.0337662100; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; Gardiner K, 2005, Cytogenet Genome Res, V108, P269, DOI 10.1159/000081518; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hodson Daniel, 2004, Br J Haematol, V125, P265, DOI 10.1046/j.1365-2141.2004.04733.x; HOMYK T, 1977, GENETICS, V87, P105; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kingsbury TJ, 2000, GENE DEV, V14, P1595; KLINGENBER M, 1985, ENZYMES BIOL MEMBRAN; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; PRINCE J, 1994, J NEURAL TRANSM-PARK, V8, P171, DOI 10.1007/BF02260938; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Strippoli P, 2000, GENOMICS, V64, P252, DOI 10.1006/geno.2000.6127; Sullivan KMC, 2002, GENETICS, V161, P183; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wong-Riley M, 1997, VISION RES, V37, P3593, DOI 10.1016/S0042-6989(96)00210-6; WU CF, 1983, J NEUROSCI, V3, P1888; Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004; Zhang YQ, 1999, GENETICS, V153, P891	50	69	72	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1577	1585		10.1038/nn1564	http://dx.doi.org/10.1038/nn1564			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222229				2022-12-28	WOS:000232966600033
J	Koob, GF; Le Moal, M				Koob, GF; Le Moal, M			Plasticity of reward neurocircuitry and the 'dark side' of drug addiction	NATURE NEUROSCIENCE			English	Editorial Material							DYSREGULATION; ALLOSTASIS; WITHDRAWAL; STRESS; DEPENDENCE; BEHAVIOR; ETHANOL; RELAPSE; SEEKING; BRAIN	Drug seeking is associated with activation of reward neural circuitry. Here we argue that drug addiction also involves a 'dark side'-a decrease in the function of normal reward-related neurocircuitry and persistent recruitment of anti-reward systems. Understanding the neuroplasticity of the dark side of this circuitry is the key to understanding vulnerability to addiction.	Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Univ Bordeaux 2, Lab Physiopathol Comportements, INSERM, U588, F-33076 Bordeaux, France	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Koob, GF (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	gkoob@scripps.edu	LE MOAL, Michel/B-5125-2008					Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Le Moal Michel, 1995, P283; MARTIN WR, 1968, ADDICT STATES, P206; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; See RE, 2003, ANN NY ACAD SCI, V985, P294; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shippenberg TS, 2002, NEUROPSYCHOPHARMACOL, P1381; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	22	644	657	2	65	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1442	1444		10.1038/nn1105-1442	http://dx.doi.org/10.1038/nn1105-1442			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251985				2022-12-28	WOS:000232966600013
J	Song, P; Yang, Y; Barnes-Davies, M; Bhattacharjee, A; Hamann, M; Forsythe, ID; Oliver, DL; Kaczmarek, LK				Song, P; Yang, Y; Barnes-Davies, M; Bhattacharjee, A; Hamann, M; Forsythe, ID; Oliver, DL; Kaczmarek, LK			Acoustic environment determines phosphorylation state of the Kv3.1 potassium channel in auditory neurons	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; CENTRAL-NERVOUS-SYSTEM; K+ CHANNEL; TRAPEZOID BODY; MEDIAL NUCLEUS; BRAIN-STEM; SUBCELLULAR-LOCALIZATION; PROTEIN-PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; INACTIVATION GATE	Sound localization by auditory brainstem nuclei relies on the detection of microsecond interaural differences in action potentials that encode sound volume and timing. Neurons in these nuclei express high amounts of the Kv3.1 potassium channel, which allows them to fire at high frequencies with short-duration action potentials. Using computational modeling, we show that high amounts of Kv3.1 current decrease the timing accuracy of action potentials but enable neurons to follow high-frequency stimuli. The Kv3.1b channel is regulated by protein kinase C (PKC), which decreases current amplitude. Here we show that in a quiet environment, Kv3.1b is basally phosphorylated in rat brainstem neurons but is rapidly dephosphorylated in response to high-frequency auditory or synaptic stimulation. Dephosphorylation of the channel produced an increase in Kv3.1 current, facilitating high-frequency spiking. Our results indicate that the intrinsic electrical properties of auditory neurons are rapidly modified to adjust to the ambient acoustic environment.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Leicester, MRC, Toxicol Unit, Cellular & Mol Neurosci Grp, Leicester LE1 9HN, Leics, England	Yale University; University of Connecticut; University of Leicester; University of Leicester	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	Oliver, Douglas L./AAZ-2011-2020; Hamann, Martine/P-8054-2014; Oliver, Douglas L/M-9275-2016	Oliver, Douglas L./0000-0002-1176-4001; Hamann, Martine/0000-0002-9142-6773; Oliver, Douglas L/0000-0002-1176-4001; Forsythe, Ian/0000-0001-8216-0419	NCRR NIH HHS [C06 RR13551] Funding Source: Medline; NIDCD NIH HHS [DC01919, DC00189] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antz C, 1999, NAT STRUCT BIOL, V6, P146; Atzori M, 2000, NAT NEUROSCI, V3, P791, DOI 10.1038/77693; AUGUSTINE CK, 1990, J GEN PHYSIOL, V95, P245, DOI 10.1085/jgp.95.2.245; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; Barnes-Davies M, 2004, EUR J NEUROSCI, V19, P325, DOI 10.1111/j.0953-816X.2003.03133.x; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brew HM, 1995, J NEUROSCI, V15, P8011; COHEN YE, 1994, HEARING RES, V81, P11, DOI 10.1016/0378-5955(94)90148-1; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; CRITZ SD, 1993, J NEUROCHEM, V60, P1175, DOI 10.1111/j.1471-4159.1993.tb03273.x; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Grothe B, 2000, MICROSC RES TECHNIQ, V51, P382, DOI 10.1002/1097-0029(20001115)51:4<382::AID-JEMT7>3.0.CO;2-7; Hamann M, 2003, EUR J NEUROSCI, V18, P2899, DOI 10.1111/j.1460-9568.2003.03017.x; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MORENO H, 1995, J NEUROSCI, V15, P5486; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; Parameshwaran S, 2001, J NEUROSCI, V21, P485, DOI 10.1523/JNEUROSCI.21-02-00485.2001; Parameshwaran-Iyer S, 2003, J NEUROBIOL, V55, P165, DOI 10.1002/neu.10198; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; Phillips DP, 2005, HEARING RES, V202, P188, DOI 10.1016/j.heares.2004.11.001; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; SANES DH, 1990, J NEUROSCI, V10, P3494; Satzler K, 2002, J NEUROSCI, V22, P10567; Sekirnjak C, 1997, BRAIN RES, V766, P173, DOI 10.1016/S0006-8993(97)00527-1; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; SOMMER I, 1993, EXP BRAIN RES, V95, P223; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; von Hehn CAA, 2004, J NEUROSCI, V24, P1936, DOI 10.1523/JNEUROSCI.4554-03.2004; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Wang LY, 1998, P NATL ACAD SCI USA, V95, P1882, DOI 10.1073/pnas.95.4.1882; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I	47	103	119	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1335	1342		10.1038/nn1533	http://dx.doi.org/10.1038/nn1533			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136041				2022-12-28	WOS:000232145900017
J	Adolphs, R; Tranel, D; Koenigs, M; Damasio, AR				Adolphs, R; Tranel, D; Koenigs, M; Damasio, AR			Preferring one taste over another without recognizing either	NATURE NEUROSCIENCE			English	Article							RECOGNITION; DAMAGE	Stimuli can be discriminated without being consciously perceived and can be preferred without being remembered. Here we report a subject with a previously unknown dissociation of abilities: a strong behavioral preference for the taste of sugar over saline, despite a complete failure of recognition. The pattern of brain damage responsible for the dissociation suggests that reliable behavioral choice among tastes can occur in the absence of the gustatory cortex necessary for taste recognition.	Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	University of Iowa; University of Iowa; California Institute of Technology	Adolphs, R (corresponding author), Univ Iowa, Dept Neurol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	radolphs@hss.caltech.edu	Damasio, Antonio/AAD-1342-2019	Koenigs, Michael/0000-0002-5799-4881; Tranel, Daniel/0000-0002-1338-1389	NIMH NIH HHS [MH067681] Funding Source: Medline; NINDS NIH HHS [P01 NS 19632] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P1281, DOI 10.1016/S0028-3932(03)00064-2; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P252, DOI 10.1001/archneur.1985.04060030070012; FLYNN FW, 1988, BEHAV NEUROSCI, V102, P934, DOI 10.1037/0735-7044.102.6.934; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; ROLLS ET, 1999, BRAIN EMOTION; Small DM, 1997, J NEUROSCI, V17, P5136; Steiner J E, 1973, Symp Oral Sens Percept, P254; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	11	28	30	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					860	861		10.1038/nn1489	http://dx.doi.org/10.1038/nn1489			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951808				2022-12-28	WOS:000230137100011
J	Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I				Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I			Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety	NATURE NEUROSCIENCE			English	Article							DELTA-SUBUNIT; NEUROACTIVE STEROIDS; ESTROUS-CYCLE; ANTICONVULSANT ACTIVITY; WITHDRAWAL PROPERTIES; LUTEAL-PHASE; PROGESTERONE; ETHANOL; MODEL; NEUROSTEROIDS	Disturbances of neuronal excitability changes during the ovarian cycle may elevate seizure frequency in women with catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD). The mechanisms underlying these changes are unknown, but they could result from the effects of fluctuations in progesterone-derived neurosteroids on the brain. Neurosteroids and some anxiolytics share an important site of action: tonic inhibition mediated by delta subunit - containing GABA(A) receptors (delta GABA(A)Rs). Here we demonstrate periodic alterations in specific GABA(A)R subunits during the estrous cycle in mice, causing cyclic changes of tonic inhibition in hippocampal neurons. In late diestrus (high-progesterone phase), enhanced expression of delta GABA(A)Rs increases tonic inhibition, and a reduced neuronal excitability is reflected by diminished seizure susceptibility and anxiety. Eliminating cycling of delta GABA(A)Rs by antisense RNA treatment or gene knockout prevents the lowering of excitability during diestrus. Our findings are consistent with possible deficiencies in regulatory mechanisms controlling normal cycling of delta GABA(A)Rs in individuals with catamenial epilepsy or PMDD.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	mody@ucla.edu		Stell, Brandon/0000-0003-1287-9211; Maguire, Jamie/0000-0002-4085-8605	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002808, T32NS007449, R01NS030549, R37NS030549] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30549, T32 NS07449, NS02808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agmo A, 1997, PSYCHOPHARMACOLOGY, V129, P372, DOI 10.1007/s002130050203; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Broadbent J, 1999, PSYCHOPHARMACOLOGY, V141, P197, DOI 10.1007/s002130050825; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Gulinello M, 2002, NEUROPHARMACOLOGY, V43, P701, DOI 10.1016/S0028-3908(02)00171-5; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog AG, 1999, NEUROLOGY, V52, P1917, DOI 10.1212/WNL.52.9.1917-a; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Jones A, 1997, J NEUROSCI, V17, P1350; Lancel M, 2001, AM J PHYSIOL-ENDOC M, V281, pE130, DOI 10.1152/ajpendo.2001.281.1.E130; MARTIN JV, 1995, LIFE SCI, V57, P1903, DOI 10.1016/0024-3205(95)02177-K; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Molina-Hernandez M, 2001, NEUROPSYCHOBIOLOGY, V43, P29, DOI 10.1159/000054862; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nyberg S, 2004, PSYCHONEUROENDOCRINO, V29, P767, DOI 10.1016/S0306-4530(03)00121-5; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Reddy DS, 2001, EPILEPSIA, V42, P328, DOI 10.1046/j.1528-1157.2001.10100.x; Reddy DS, 1999, PHARMACOL BIOCHEM BE, V62, P53, DOI 10.1016/S0091-3057(98)00126-9; Reddy DS, 2004, J PHARMACOL EXP THER, V310, P230, DOI 10.1124/jpet.104.065268; Reddy DS, 2001, EPILEPSIA, V42, P337, DOI 10.1046/j.1528-1157.2001.10200.x; Rogawski MA, 2003, ANN NEUROL, V53, P288, DOI 10.1002/ana.10534; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Shuman Sevie, 2003, Epilepsia, V44, P292; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Smith SS, 2004, ALCOHOL, V33, P41, DOI 10.1016/j.alcohol.2004.04.003; Smith SS, 2002, STEROIDS, V67, P519, DOI 10.1016/S0039-128X(01)00170-2; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	48	457	465	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					797	804		10.1038/nn1469	http://dx.doi.org/10.1038/nn1469			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895085				2022-12-28	WOS:000229345300021
J	Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB				Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB			LINGO-1 negatively regulates myelination by oligodendrocytes	NATURE NEUROSCIENCE			English	Article							RECEPTOR FAMILY-MEMBER; FYN TYROSINE KINASE; MORPHOLOGICAL-DIFFERENTIATION; SHEATH THICKNESS; NERVOUS-SYSTEM; SCHWANN-CELLS; ACTIVATION; EXPRESSION; NEUREGULIN; MOLECULES	The control of myelination by oligodendrocytes in the CNS is poorly understood. Here we show that LINGO-1 is an important negative regulator of this critical process. LINGO-1 is expressed in oligodendrocytes. Attenuation of its function by dominant-negative LINGO-1, LINGO-1 RNA-mediated interference (RNAi) or soluble human LINGO-1 (LINGO-1-Fc) leads to differentiation and increased myelination competence. Attenuation of LINGO-1 results in downregulation of RhoA activity, which has been implicated in oligodendrocyte differentiation. Conversely, overexpression of LINGO-1 leads to activation of RhoA and inhibition of oligodendrocyte differentiation and myelination. Treatment of oligodendrocyte and neuron cocultures with LINGO-1-Fc resulted in highly developed myelinated axons that have internodes and well-defined nodes of Ranvier. The contribution of LINGO-1 to myelination was verified in vivo through the analysis of LINGO-1 knockout mice. The ability to recapitulate CNS myelination in vitro using LINGO-1 antagonists and the in vivo effects seen in the LINGO-1 knockout indicate that LINGO-1 signaling may be critical for CNS myelination.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Biogen; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard Medical School; Cleveland Clinic Foundation	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Bhat RV, 1996, GLIA, V17, P169; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; FRIEDE RL, 1986, EXP NEUROL, V92, P234, DOI 10.1016/0014-4886(86)90137-8; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kiewe P, 2003, LEUKEMIA LYMPHOMA, V44, P1815, DOI 10.1080/1042819031000116625; KOLODNY EH, 1993, CURR OPIN NEUROL NEU, V6, P379; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Li C, 1998, J NEUROSCI RES, V51, P210, DOI 10.1002/(SICI)1097-4547(19980115)51:2<210::AID-JNR9>3.0.CO;2-G; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Partadiredja G, 2003, J NEUROCYTOL, V32, P1165, DOI 10.1023/B:NEUR.0000021910.65920.41; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salvati S, 2000, DEV NEUROSCI-BASEL, V22, P481, DOI 10.1159/000017479; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Villagra NT, 2004, NEUROBIOL DIS, V16, P158, DOI 10.1016/j.nbd.2004.02.005; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	33	471	517	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					745	751		10.1038/nn1460	http://dx.doi.org/10.1038/nn1460			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895088				2022-12-28	WOS:000229345300014
J	Faber, ESL; Delaney, AJ; Sah, P				Faber, ESL; Delaney, AJ; Sah, P			SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; ACTIVATED POTASSIUM CURRENTS; NMDA-RECEPTOR ACTIVATION; DENDRITIC SPINES; LESIONED MICE; HAIR-CELLS; IN-VITRO; CALCIUM	At glutamatergic synapses, calcium influx through NMDA receptors (NMDARs) is required for long-term potentiation (LTP); this is a proposed cellular mechanism underlying memory and learning. Here we show that in lateral amygdala pyramidal neurons, SK channels are also activated by calcium influx through synaptically activated NMDARs, resulting in depression of the synaptic potential. Thus, blockade of SK channels by apamin potentiates fast glutamatergic synaptic potentials. This potentiation is blocked by the NMDAR antagonist AP5 (D(-)-2-amino-5-phosphono-valeric acid) or by buffering cytosolic calcium with BAPTA. Blockade of SK channels greatly enhances LTP of cortical inputs to lateral amygdala pyramidal neurons. These results show that NMDARs and SK channels are colocalized at glutamatergic synapses in the lateral amygdala. Calcium influx through NMDARs activates SK channels and shunts the resultant excitatory postsynaptic potential. These results demonstrate a new role for SK channels as postsynaptic regulators of synaptic efficacy.	Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Sah, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	pankaj.sah@uq.edu.au	Delaney, Andrew/H-4238-2018; Sah, Pankaj/C-8175-2009	Delaney, Andrew/0000-0001-8972-4870; Sah, Pankaj/0000-0001-5063-1589; Faber, Luli/0000-0001-9015-9805				Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BELCADIABBASSI W, 1995, NEUROREPORT, V6, P1293, DOI 10.1097/00001756-199506090-00016; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cangiano L, 2002, J NEUROPHYSIOL, V88, P289, DOI 10.1152/jn.2002.88.1.289; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Ikonen S, 1999, EUR J PHARMACOL, V382, P151, DOI 10.1016/S0014-2999(99)00616-0; Ikonen S, 1998, EUR J PHARMACOL, V347, P13, DOI 10.1016/S0014-2999(98)00075-2; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Power JM, 2002, J NEUROSCI, V22, P3454; ROMEY G, 1984, J PHYSIOL-PARIS, V79, P259; Roncarati R, 2001, NEUROSCIENCE, V104, P253, DOI 10.1016/S0306-4522(01)00066-5; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sah P, 1996, J NEUROSCI, V16, P4537; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2002, J NEUROSCI, V22, P9698; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; van der Staay FJ, 1999, NEUROSCI BIOBEHAV R, V23, P1087, DOI 10.1016/S0149-7634(99)00043-3; Villalobos C, 2004, J NEUROSCI, V24, P3537, DOI 10.1523/JNEUROSCI.0380-04.2004; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yamada SI, 2004, J NEUROPHYSIOL, V91, P2322, DOI 10.1152/jn.01049.2003; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	45	189	192	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					635	641		10.1038/nn1450	http://dx.doi.org/10.1038/nn1450			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852010				2022-12-28	WOS:000228895100024
J	Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF			Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; MESSENGER-RNA; SCHIZOPHRENIA; EXPRESSION; SYSTEMS; CORTEX; MEMORY	Using multimodal neuroimaging in humans, we demonstrate specific interactions between prefrontal activity and midbrain dopaminergic synthesis. A common V(108/158)M substitution in the gene for catecholamine-O-methyltransferase (COMT), an important enzyme regulating prefrontal dopamine turnover, predicted reduced dopamine synthesis in midbrain and qualitatively affected the interaction with prefrontal cortex. These data implicate a dopaminergic tuning mechanism in prefrontal cortex and suggest a systems-level mechanism for cognitive and neuropsychiatric associations with COMT.	NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, 9000 Rockville Pike, Bethesda, MD 20892 USA.	andreasml@nih.gov	McInerney-Leo, Aideen M/D-8302-2016; McInerney-Leo, Aideen M/E-1788-2018; Meyer-Lindenberg, Andreas/H-1076-2011	McInerney-Leo, Aideen M/0000-0002-0059-5732; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002716, Z01MH002867, Z01MH002716, ZIAMH002717, Z01MH002717] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akil M, 2003, J NEUROSCI, V23, P2008; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MEADORWOODRUFF JH, 1994, P NATL ACAD SCI USA, V91, P8297, DOI 10.1073/pnas.91.17.8297; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	15	341	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					594	596		10.1038/nn1438	http://dx.doi.org/10.1038/nn1438			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15821730				2022-12-28	WOS:000228895100019
J	Tolias, AS; Keliris, GA; Smirnakis, SM; Logothetis, NK				Tolias, AS; Keliris, GA; Smirnakis, SM; Logothetis, NK			Neurons in macaque area V4 acquire directional tuning after adaptation to motion stimuli	NATURE NEUROSCIENCE			English	Article							VISUAL AREA; SELECTIVE ATTENTION; RHESUS-MONKEY; MT; CONNECTIONS; LESIONS; CORTEX	Neurons in area V4 of the macaque are generally not selective for direction of motion, as judged from their response to directional stimuli presented after a baseline condition devoid of movement. We used motion adaptation to investigate whether stimulation history influences direction-of-motion selectivity. We found that classically nondirectional V4 neurons develop direction-of-motion selectivity after adaptation, an observation that underscores the dynamic nature of functional cortical architecture.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Max Planck Society; Harvard University; Massachusetts General Hospital	Tolias, AS (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	andreas.tolias@tuebingen.mpg.de	Keliris, Georgios A/B-6692-2008; Logothetis, Nikos/U-9282-2019	Keliris, Georgios A/0000-0001-6732-1261; 				Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	15	104	104	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					591	593		10.1038/nn1446	http://dx.doi.org/10.1038/nn1446			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834417				2022-12-28	WOS:000228895100018
J	Sober, SJ; Sabes, PN				Sober, SJ; Sabes, PN			Flexible strategies for sensory integration during motor planning	NATURE NEUROSCIENCE			English	Article							PRISM ADAPTATION; INTERMANUAL TRANSFER; POSITION-INFORMATION; REACHING MOVEMENTS; PARIETAL CORTEX; ARM MOVEMENTS; VISION; SPACE; MODEL; REPRESENTATIONS	When planning target-directed reaching movements, human subjects combine visual and proprioceptive feedback to form two estimates of the arm's position: one to plan the reach direction, and another to convert that direction into a motor command. These position estimates are based on the same sensory signals but rely on different combinations of visual and proprioceptive input, suggesting that the brain weights sensory inputs differently depending on the computation being performed. Here we show that the relative weighting of vision and proprioception depends both on the sensory modality of the target and on the information content of the visual feedback, and that these factors affect the two stages of planning independently. The observed diversity of weightings demonstrates the flexibility of sensory integration and suggests a unifying principle by which the brain chooses sensory inputs so as to minimize errors arising from the transformation of sensory signals between coordinate frames.	Univ Calif San Francisco, Dept Physiol, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sabes, PN (corresponding author), Univ Calif San Francisco, Dept Physiol, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	sabes@phy.ucsf.edu	Sabes, Philip/B-9279-2008		NATIONAL EYE INSTITUTE [R01EY015679] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015679, R01 EY015679-01A2, R01 EY15679-01A2] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ATKESON CG, 1985, J NEUROSCI, V5, P2318; CHOE CS, 1974, J EXP PSYCHOL, V102, P1076, DOI 10.1037/h0036325; COHEN MM, 1973, PERCEPT MOTOR SKILL, V37, P599, DOI 10.2466/pms.1973.37.2.599; DIZIO P, 1995, J NEUROPHYSIOL, V74, P1787, DOI 10.1152/jn.1995.74.4.1787; Efron B., 1994, MONOGRAPHS STAT APPL; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GHAHRAMANI Z, 1995, THESIS MIT; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; Good P., 2013, PERMUTATION TESTS PR; Goodbody SJ, 1999, EXP BRAIN RES, V127, P213, DOI 10.1007/s002210050791; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jordan M. I., 1996, HDB PERCEPTION ACTIO; KALIL RE, 1966, PERCEPT MOTOR SKILL, V22, P123, DOI 10.2466/pms.1966.22.1.123; Kitazawa S, 1997, J NEUROSCI, V17, P1481; McIntyre J, 2000, NEURAL COMPUT, V12, P2823, DOI 10.1162/089976600300014746; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; TAUB E, 1973, SCIENCE, V180, P755, DOI 10.1126/science.180.4087.755; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WALLACE B, 1979, PERCEPT PSYCHOPHYS, V25, P133, DOI 10.3758/BF03198799; WARREN DH, 1978, J EXP PSYCHOL HUMAN, V4, P302, DOI 10.1037/0096-1523.4.2.302; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WELCH RB, 1979, PERCEPT PSYCHOPHYS, V25, P126, DOI 10.3758/BF03198798; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	33	319	324	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					490	497		10.1038/nn1427	http://dx.doi.org/10.1038/nn1427			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793578	Green Submitted, Green Accepted			2022-12-28	WOS:000228040400020
J	Shakiryanova, D; Tully, A; Hewes, RS; Deitcher, DL; Levitan, ES				Shakiryanova, D; Tully, A; Hewes, RS; Deitcher, DL; Levitan, ES			Activity-dependent liberation of synaptic neuropeptide vesicles	NATURE NEUROSCIENCE			English	Article							SECRETORY VESICLES; DROSOPHILA LARVAE; RELEASE; EXOCYTOSIS; TERMINALS; MOBILITY; TRANSPORT; CELLS; ULTRASTRUCTURE; FLUORESCENCE	Despite the importance of neuropeptide release, which is evoked by long bouts of action potential activity and which regulates behavior, peptidergic vesicle movement has not been examined in living nerve terminals. Previous in vitro studies have found that secretory vesicle motion at many sites of release is constitutive: Ca2+ does not affect the movement of small synaptic vesicles in nerve terminals or the movement of large dense core vesicles in growth cones and endocrine cells. However, in vivo imaging of a neuropeptide, atrial natriuretic factor, tagged with green fluorescent protein in larval Drosophila melanogaster neuromuscular junctions shows that peptidergic vesicle behavior in nerve terminals is sensitive to activity-induced Ca2+ influx. Specifically, peptidergic vesicles are immobile in resting synaptic boutons but become mobile after seconds of stimulation. Vesicle movement is undirected, occurs without the use of axonal transport motors or F-actin, and aids in the depletion of undocked neuropeptide vesicles. Peptidergic vesicle mobilization and post-tetanic potentiation of neuropeptide release are sustained for minutes.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Oklahoma, Dept Cell Biol, Norman, OK 73019 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Cornell University	Levitan, ES (corresponding author), Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA.	Levitan@server.pharm.pitt.edu	Deitcher, David/K-6538-2019	Hewes, Randall/0000-0002-7518-7215; Bulgari, Dinara/0000-0001-5352-6207; Deitcher, David/0000-0002-8512-8868	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Barclay JW, 2002, J COMP PHYSIOL A, V188, P71, DOI 10.1007/s00359-002-0279-9; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Brezina V, 2000, J NEUROSCI, V20, P6760, DOI 10.1523/JNEUROSCI.20-18-06760.2000; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; Henkel AW, 1996, J NEUROSCI, V16, P3960; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Husain QM, 2004, J NEUROBIOL, V59, P181, DOI 10.1002/neu.10309; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Levitan ES, 2004, METHODS, V33, P281, DOI 10.1016/j.ymeth.2004.01.001; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; Ng YK, 2002, J PHYSIOL-LONDON, V542, P395, DOI 10.1113/jphysiol.2002.021733; Ng YK, 2003, BIOPHYS J, V84, P4127, DOI 10.1016/S0006-3495(03)75137-6; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; PERRY SV, 1965, BIOCHEM J, V96, P224, DOI 10.1042/bj0960224; PFISTER KK, 1989, BIOCHEMISTRY-US, V28, P9006, DOI 10.1021/bi00449a008; Phelps KK, 1999, BIOCHEMISTRY-US, V38, P10750, DOI 10.1021/bi990706+; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; SEWARD EP, 1995, J NEUROSCI, V15, P3390; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; WHIM MD, 1989, P NATL ACAD SCI USA, V86, P9034, DOI 10.1073/pnas.86.22.9034; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zupanc GKH, 1996, MICRON, V27, P35, DOI 10.1016/0968-4328(95)00028-3	37	93	96	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					173	178		10.1038/nn1377	http://dx.doi.org/10.1038/nn1377			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643430				2022-12-28	WOS:000226638200016
J	Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H				Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H			Odorant receptor heterodimerization in the olfactory system of Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							DIMERIZATION; EXPRESSION; ANTENNA; MAP	Despite increasing knowledge about dimerization of G-protein-coupled receptors, nothing is known about dimerization in the largest subfamily, odorant receptors. Using a combination of biochemical and electrophysiological approaches, we demonstrate here that odorant receptors can dimerize. DOR83b, an odorant receptor that is ubiquitously expressed in olfactory neurons from Drosophila melanogaster and highly conserved among insect species, forms heterodimeric complexes with other odorant-receptor proteins, which strongly increases their functionality.	Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; Ruhr Univ Bochum, AG Sinnesphysiol, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Neuhaus, EM (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.	eva.neuhaus@rub.de	Dooley, Ruth/A-5480-2010; Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Elmore T, 2003, J NEUROSCI, V23, P9906; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998	15	242	266	2	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					15	17		10.1038/nn1371	http://dx.doi.org/10.1038/nn1371			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592462				2022-12-28	WOS:000225967600007
J	Pegna, AJ; Khateb, A; Lazeyras, F; Seghier, ML				Pegna, AJ; Khateb, A; Lazeyras, F; Seghier, ML			Discriminating emotional faces without primary visual cortices involves the right amygdala	NATURE NEUROSCIENCE			English	Article							BLINDSIGHT; RESPONSES; FIELD; FEAR	Destruction of the brain's primary visual areas leads to blindness of cortical origin. Here we report on a subject who, after bilateral destruction of his visual cortices and ensuing cortical blindness, could nevertheless correctly guess the type of emotional facial expression being displayed, but could not guess other types of emotional or non-emotional stimuli. Functional magnetic resonance imaging showed activation of the right amygdala during the unconscious processing of emotionally expressive faces.	Univ Wales Bangor, Sch Psychol, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; Univ Hosp Geneva, Dept Clin Neurosci & Dermatol, Neurol Clin, Neuropsychol Unit, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; Univ Med Ctr, Dept Fundamental Neurosci, Lab Neurol & Neuroimaging Cognit, CH-1211 Geneva 4, Switzerland	Bangor University; University of Geneva; University of Geneva; University of Geneva	Pegna, AJ (corresponding author), Univ Wales Bangor, Sch Psychol, Ctr Cognit Neurosci, Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	alan.pegna@hcuge.ch	Seghier, Mohamed/O-8634-2019; Khateb, Asaid/AAF-1609-2020; Pegna, A J/D-1297-2017; Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed/0000-0002-1146-8800; Khateb, Asaid/0000-0003-4639-1564; Pegna, A J/0000-0001-9920-9290; Seghier, Mohamed L/0000-0002-1146-8800				Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Ekman P., 1975, PICTURES FACIAL AFFE; Hamm AO, 2003, BRAIN, V126, P267, DOI 10.1093/brain/awg037; Holmes G, 1918, Br J Ophthalmol, V2, P353, DOI 10.1136/bjo.2.7.353; Lang P. J., 1999, INT AFFECTIVE PICTUR; MARZI CA, 1986, NEUROPSYCHOLOGIA, V24, P749, DOI 10.1016/0028-3932(86)90074-6; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 2001, DISORDERS VISUAL BEH, V4, P215; Wright CI, 2002, NEUROREPORT, V13, P785, DOI 10.1097/00001756-200205070-00010; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	15	212	215	0	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					24	25		10.1038/nn1364	http://dx.doi.org/10.1038/nn1364			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592466				2022-12-28	WOS:000225967600011
J	Zugaro, MB; Monconduit, LC; Buzsaki, G				Zugaro, MB; Monconduit, LC; Buzsaki, G			Spike phase precession persists after transient intrahippocampal perturbation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; PLACE CELLS; THETA OSCILLATIONS; MEMORY SEQUENCES; RAT HIPPOCAMPUS; TEMPORAL CODE; SPATIAL MAP; EXPERIENCE; DYNAMICS; MODEL	Oscillatory spike timing in the hippocampus is regarded as a temporal coding mechanism for space, but the underlying mechanisms are poorly understood. To contrast the predictions of the different models of phase precession, we transiently turned off neuronal discharges for up to 250 ms and reset the phase of theta oscillations by stimulating the commissural pathway in rats. After recovery from silence, phase precession continued. The phase of spikes for the first theta cycle after the perturbation was more advanced than the phase of spikes for the last theta cycle just before the perturbation. These findings indicate that phase advancement that emerges within hippocampal circuitry may be updated at the beginning of each theta cycle by extrahippocampal inputs.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	monconduit, lenaic/GYV-2004-2022	monconduit, lenaic/0000-0001-8856-3809; Zugaro, Michael/0000-0002-6199-2635; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH054671] Funding Source: Medline; NINDS NIH HHS [R01 NS034994, R01 NS043157] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Booth V, 2001, J NEUROPHYSIOL, V85, P2432, DOI 10.1152/jn.2001.85.6.2432; Bose A, 2001, HIPPOCAMPUS, V11, P204, DOI 10.1002/hipo.1038; Bose A, 2000, J COMPUT NEUROSCI, V9, P5, DOI 10.1023/A:1008976210366; BUZSAKI G, 1990, PROG BRAIN RES, V83, P257; BUZSAKI G, 1981, EXP BRAIN RES, V43, P429; BUZSAKI G, 1981, BRAIN RES, V225, P235, DOI 10.1016/0006-8993(81)90833-7; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DEADWYLER SA, 1975, EXP NEUROL, V49, P35, DOI 10.1016/0014-4886(75)90194-6; DOUGLAS RM, 1983, J COMP NEUROL, V219, P285, DOI 10.1002/cne.902190304; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Friedman HS, 1998, J NEUROSCI METH, V83, P185, DOI 10.1016/S0165-0270(98)00075-2; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magee JC, 2003, TRENDS NEUROSCI, V26, P14, DOI 10.1016/S0166-2236(02)00012-7; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sato N, 2003, NEURAL COMPUT, V15, P2379, DOI 10.1162/089976603322362400; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Yamaguchi Y, 2003, BIOL CYBERN, V89, P1, DOI 10.1007/s00422-003-0415-9	40	68	70	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					67	71		10.1038/nn1369	http://dx.doi.org/10.1038/nn1369			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592464	Green Accepted			2022-12-28	WOS:000225967600017
J	Series, P; Latham, PE; Pouget, A				Series, P; Latham, PE; Pouget, A			Tuning curve sharpening for orientation selectivity: coding efficiency and the impact of correlations	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; POPULATION CODE; INTEGRATION; MODEL; V1; INFORMATION; VARIABILITY; COMPUTATION; MECHANISMS; INVARIANT	Several studies have shown that the information conveyed by bell-shaped tuning curves increases as their width decreases, leading to the notion that sharpening of tuning curves improves population codes. This notion, however, is based on assumptions that the noise distribution is independent among neurons and independent of the tuning curve width. Here we reexamine these assumptions in networks of spiking neurons by using orientation selectivity as an example. We compare two principal classes of model: one in which the tuning curves are sharpened through cortical lateral interactions, and one in which they are not. We report that sharpening through lateral interactions does not improve population codes but, on the contrary, leads to a severe loss of information. In addition, the sharpening models generate complicated codes that rely extensively on pairwise correlations. Our study generates several experimental predictions that can be used to distinguish between these two classes of model.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Series, Peggy/0000-0002-8580-7975; Pouget, Alexandre/0000-0003-3054-6365	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH62447] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2003, J NEUROSCI, V23, P7630; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duda R. O., 1973, PATTERN CLASSIFICATI; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Green DM, 1966, SIGNAL DETECTION THE; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; Lee D, 1998, J NEUROSCI, V18, P1161; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Panzeri S, 2003, CEREB CORTEX, V13, P45, DOI 10.1093/cercor/13.1.45; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Rolls ET, 2003, J NEUROPHYSIOL, V89, P2810, DOI 10.1152/jn.01070.2002; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Spiridon M, 2001, NETWORK-COMP NEURAL, V12, P409, DOI 10.1088/0954-898X/12/4/301; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Troyer TW, 1998, J NEUROSCI, V18, P5908; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yoon H, 1999, ADV NEUR IN, V11, P167; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; Zucker SW, 1989, NEURAL COMPUT, V1, P68, DOI 10.1162/neco.1989.1.1.68	48	160	161	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1129	1135		10.1038/nn1321	http://dx.doi.org/10.1038/nn1321			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452579				2022-12-28	WOS:000224156900023
J	Maro, GS; Vermeren, M; Voiculescu, O; Melton, L; Cohen, J; Charnay, P; Topilko, P				Maro, GS; Vermeren, M; Voiculescu, O; Melton, L; Cohen, J; Charnay, P; Topilko, P			Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS	NATURE NEUROSCIENCE			English	Article							PERIPHERAL NERVOUS-SYSTEM; DORSAL-ROOT-GANGLIA; SPINAL-CORD; DEVELOPING HINDBRAIN; SENSORY NEURONS; EXIT POINTS; STEM-CELLS; EXPRESSION; SPECIFICATION; NEUROGENESIS	Boundary cap ( BC) cells are neural crest derivatives that form clusters at the surface of the neural tube, at entry and exit points of peripheral nerve roots. Using various knock-in alleles of the mouse gene Egr2 ( also known as Krox20), the expression of which, in trunk regions, is initially restricted to BC cells, we were able to trace BC cell progeny during development and analyze their fate. Trunk BC-derived cells migrated along peripheral axons and colonized spinal nerve roots and dorsal root ganglia (DRG). All Schwann cell precursors occupying the dorsal roots were derived from BC cells. In the DRG, BC-derived cells were the progenitors of both neurons, mainly nociceptive afferents, and satellite cells. These data indicate that BC cells constitute a source of peripheral nervous system (PNS) components that, after the major neural crest ventrolateral migratory stream, feeds a secondary wave of migration to the PNS.	Ecole Normale Super, INSERM, U368, F-75230 Paris 05, France; MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Charnay, P (corresponding author), Ecole Normale Super, INSERM, U368, 46 Rue Ulm, F-75230 Paris 05, France.	charnay@wotan.ens.fr	Voiculescu, Octavian/C-3543-2008; Voiculescu, Octavian/A-7571-2010	Voiculescu, Octavian/0000-0003-0714-1482; Charnay, Patrick/0000-0002-3847-6042; Melton, Lisa/0000-0002-6314-359X; Vermeren, Matthieu/0000-0003-3584-0387				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; ALTMAN J, 1982, ADV ANAT EMBRYOL CEL, V74, P1; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Golding JP, 1997, MOL CELL NEUROSCI, V9, P381, DOI 10.1006/mcne.1997.0647; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Le Douarin NM, 1999, NEURAL CREST, V2; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Meyer D, 1997, DEVELOPMENT, V124, P3575; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Morrison SJ, 2001, CURR OPIN CELL BIOL, V13, P666, DOI 10.1016/S0955-0674(00)00269-6; MU XJ, 1993, J NEUROSCI, V13, P4029; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rosario CM, 1997, DEVELOPMENT, V124, P4213; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SHARMA K, 1995, NEURON, V14, P143, DOI 10.1016/0896-6273(95)90248-1; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Sonnabend DH, 2001, J SHOULDER ELB SURG, V10, P109, DOI 10.1067/mse.2001.112882; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; WEIS J, 1991, J CELL BIOL, V113, P1385, DOI 10.1083/jcb.113.6.1385; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538	44	181	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					930	938		10.1038/nn1299	http://dx.doi.org/10.1038/nn1299			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322547				2022-12-28	WOS:000223546700011
J	Kohn, A; Movshon, JA				Kohn, A; Movshon, JA			Adaptation changes the direction tuning of macaque MT neurons	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; TEMPORAL VISUAL AREA; ORIENTATION SELECTIVITY; CORTICAL PLASTICITY; TRANSPARENT MOTION; SINGLE UNITS; V1 NEURONS; CORTEX; MONKEY; PERCEPTION	Prolonged exposure to a stimulus, called 'adaptation', reduces cortical responsiveness. Adaptation has been studied extensively in primary visual cortex (V1), where responsivity is usually reduced most when the adapting and test stimuli are well matched. Theories about the functional benefits of adaptation have relied on this specificity, but the resultant changes in neuronal tuning are of the wrong type to account for well-documented perceptual aftereffects. Here we have used moving sinusoidal gratings to study the effect of adaptation on the direction tuning of neurons in area MT in macaques. Responsivity in MT is maintained best in the adapted direction and is strongly reduced for nearby directions. Consequently, adaptation in the preferred direction reduces the direction-tuning bandwidth, whereas adaptation at near-preferred directions causes tuning to shift toward the adapted direction. This previously unknown effect of adaptation is consistent with perceptual aftereffects and indicates that different cortical regions may adjust to constant sensory input in distinct ways.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Kohn, A (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.	adamk@cns.nyu.edu			NEI NIH HHS [EY02017] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; BARLOW H, 1989, COMP NEUR S, P54; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHANDLER JP, 1969, BEHAV SCI, V14, P81; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Movshon A, 1985, PATTERN RECOGN, V54, P117; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Movshon JA, 1996, J NEUROSCI, V16, P7733; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Patterson R, 1996, VISION RES, V36, P1773, DOI 10.1016/0042-6989(95)00239-1; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; QIAN N, 1994, J NEUROSCI, V14, P7367; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1989, VISUAL NEUROSCI, V2, P609, DOI 10.1017/S0952523800003539; Schrater PR, 1998, VISION RES, V38, P3899, DOI 10.1016/S0042-6989(98)00088-1; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Sur M, 2002, CURR BIOL, V12, pR168, DOI 10.1016/S0960-9822(02)00733-9; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Thiele A, 2000, NEURON, V26, P715, DOI 10.1016/S0896-6273(00)81207-6; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wainwright MJ, 2002, NEURAL INF PROCESS S, P203; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	50	232	232	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					764	772		10.1038/nn1267	http://dx.doi.org/10.1038/nn1267			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195097				2022-12-28	WOS:000222274400019
J	Hamann, S; Herman, RA; Nolan, CL; Wallen, K				Hamann, S; Herman, RA; Nolan, CL; Wallen, K			Men and women differ in amygdala response to visual sexual stimuli	NATURE NEUROSCIENCE			English	Article							BRAIN ACTIVATION; REWARD VALUE; MOTIVATION; BEHAVIOR; MECHANISMS; AROUSAL; MEMORY	Men are generally more interested in and responsive to visual sexually arousing stimuli than are women. Here we used functional magnetic resonance imaging (fMRI) to show that the amygdala and hypothalamus are more strongly activated in men than in women when viewing identical sexual stimuli. This was true even when women reported greater arousal. Sex differences were specific to the sexual nature of the stimuli, were restricted primarily to limbic regions, and were larger in the left amygdala than the right amygdala. Men and women showed similar activation patterns across multiple brain regions, including ventral striatal regions involved in reward. Our findings indicate that the amygdala mediates sex differences in responsiveness to appetitive and biologically salient stimuli; the human amygdala may also mediate the reportedly greater role of visual stimuli in male sexual behavior, paralleling prior animal findings.	Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Hamann, S (corresponding author), Emory Univ, Dept Psychol, 532 N Kilgo Circle, Atlanta, GA 30322 USA.	shamann@emory.edu						Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Arana FS, 2003, J NEUROSCI, V23, P9632; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Baird AD, 2004, ANN NEUROL, V55, P87, DOI 10.1002/ana.10997; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; Davies A, 2001, OPT PHOTONICS NEWS, V12, P34, DOI 10.1364/OPN.12.2.000034; DOLAN RJ, 2000, SER AFFECTIVE SCI, P225; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; GALLAGHER M, 2001, AMYGDALA FUNCTIONAL, P311; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gur RC, 2000, BRAIN LANG, V74, P157, DOI 10.1006/brln.2000.2325; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Holstege G, 2003, J NEUROSCI, V23, P9185; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Rauch SL, 1999, PSYCHIAT RES-NEUROIM, V91, P1, DOI 10.1016/S0925-4927(99)00020-7; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Roselli CE, 2001, J COMP NEUROL, V439, P208, DOI 10.1002/cne.1343; Schmitt DP, 2003, J PERS SOC PSYCHOL, V85, P85, DOI 10.1037/0022-3514.85.1.85; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Symons D, 1979, EVOLUTION HUMAN SEXU; Talairach J., 1988, COPLANAR STEREOTAXIC	39	381	386	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					411	416		10.1038/nn1208	http://dx.doi.org/10.1038/nn1208			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004563				2022-12-28	WOS:000220482500021
J	Taylor-Clarke, M; Jacobsen, P; Haggard, P				Taylor-Clarke, M; Jacobsen, P; Haggard, P			Keeping the world a constant size: object constancy in human touch	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; PLASTICITY; VISION; CORTEX	The perceived size of objects touching different regions of skin varies across the body surface by much less than is predicted from variations in tactile receptor density. Here we show that altering the visual experience of the body alters perceived tactile distances. We propose that the brain attempts to preserve tactile size constancy by rescaling the primary, distorted body-surface representation into object-centered space according to visual experience of the body.	UCL, Inst Neurosci Cognit, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of Oxford	Taylor-Clarke, M (corresponding author), UCL, Inst Neurosci Cognit, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Jacobsen, Pamela/0000-0001-8847-7775; Haggard, Patrick/0000-0001-7798-793X				BORING EG, 1964, AM J PSYCHOL, V77, P494, DOI 10.2307/1421027; Calford MB, 2002, NEUROSCIENCE, V111, P709, DOI 10.1016/S0306-4522(02)00022-2; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; GREEN BG, 1982, PERCEPT PSYCHOPHYS, V31, P315, DOI 10.3758/BF03202654; Iriki A, 1996, NEUROREPORT, V7, P2325; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Marr D., 1982, VISION; PAILLARD J, 1983, ARCH NEUROL-CHICAGO, V40, P548, DOI 10.1001/archneur.1983.04050080048008; Penfield W., 1950, CEREBRAL CORTEX MAN; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; WEBER EH, 1978, SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195	15	146	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					219	220		10.1038/nn1199	http://dx.doi.org/10.1038/nn1199			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966526				2022-12-28	WOS:000189197900010
J	Xiao, MY; Wasling, P; Hanse, E; Gustafsson, B				Xiao, MY; Wasling, P; Hanse, E; Gustafsson, B			Creation of AMPA-silent synapses in the neonatal hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR TRAFFICKING; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; POSTSYNAPTIC EXPRESSION; GLUTAMATERGIC SYNAPSES; POSTNATAL-DEVELOPMENT; SYNAPTIC CONNECTIONS; DEVELOPMENTAL SWITCH; CA1 REGION	In the developing brain, many glutamate synapses have been found to transmit only NMDA receptor-mediated signaling, that is, they are AMPA-silent. This result has been taken to suggest that glutamate synapses are initially AMPA-silent when they are formed, and that AMPA signaling is acquired through activity-dependent synaptic plasticity. The present study on CA3-CA1 synapses in the hippocampus of the neonatal rat suggests that AMPA-silent synapses are created through a form of activity-dependent silencing of AMPA signaling. We found that AMPA signaling, but not NMDA signaling, could be very rapidly silenced by presynaptic electrical stimulation at frequencies commonly used to probe synaptic function (0.05-1 Hz). Although this AMPA silencing required a rise in postsynaptic Ca2+, it did not require activation of NMDA receptors, metabotropic glutamate receptors or voltage-gated calcium channels. The AMPA silencing, possibly explained by a removal of postsynaptic AMPA receptors, could subsequently be reversed by paired presynaptic and postsynaptic activity.	Univ Gothenburg, Inst Physiol & Pharmacol, Dept Physiol, S-40530 Gothenburg, Sweden	University of Gothenburg	Xiao, MY (corresponding author), Univ Gothenburg, Inst Physiol & Pharmacol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden.	xiao@physiol.gu.se	Hanse, Eric/B-4935-2009					Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Diabira D, 1999, EUR J NEUROSCI, V11, P4015, DOI 10.1046/j.1460-9568.1999.00831.x; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Groc L, 2003, NEUROSCIENCE, V121, P65, DOI 10.1016/S0306-4522(03)00366-X; Groc L, 2002, J NEUROSCI, V22, P5552; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1999, NATURE, V399, P111, DOI 10.1038/20089; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rumpel S, 1998, J NEUROSCI, V18, P8863; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850	47	92	95	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					236	243		10.1038/nn1196	http://dx.doi.org/10.1038/nn1196			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966524				2022-12-28	WOS:000189197900013
J	Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C				Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C			Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; GAMMA-HYDROXYBUTYRIC ACID; MUSCARINIC POTASSIUM CHANNEL; VENTRAL TEGMENTAL AREA; FUNCTIONAL EXPRESSION; MOLECULAR-PROPERTIES; INWARD RECTIFIER; SYNAPTIC INPUTS; DRUG-ADDICTION; BETA-GAMMA	The rewarding effect of drugs of abuse is mediated by activation of the mesolimbic dopamine system, which is inhibited by putative anti-craving compounds. Interestingly, different GABA(B) receptor agonists can exert similarly opposing effects on the reward pathway, but the cellular mechanisms involved are unknown. Here we found that the coupling efficacy (EC50) of G-protein-gated inwardly rectifying potassium (GIRK, Kir3) channels to GABA(B) receptor was much lower in dopamine neurons than in GABA neurons of the ventral tegmental area (VTA), depending on the differential expression of GIRK subunits. Consequently, in rodent VTA slices, a low concentration of the canonical agonist baclofen caused increased activity, whereas higher doses eventually inhibited dopamine neurons. At behaviorally relevant dosages, baclofen activated GIRK channels in both cell types, but the drug of abuse gamma-hydroxy-butyric acid (GHB) activated GIRK channels only in GABAergic neurons. Thus GABA(B) receptor agonists exert parallel cellular and behavioral effects due to the cell- specific expression of GIRK subunits.	Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Geneva, Neurol Clin, CH-1211 Geneva 4, Switzerland; Salk Inst Biol Studies, Peptide Biol Lab, San Diego, CA 92186 USA; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA	University of Geneva; University of Geneva; Salk Institute; Rockefeller University	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Slesinger@salk.edu; Christian.Luscher@medecine.unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Stoffel, Markus/0000-0003-1304-5817				Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Carter LP, 2003, J PHARMACOL EXP THER, V305, P668, DOI 10.1124/jpet.102.047860; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Feigenbaum JJ, 1996, INT J NEUROSCI, V88, P53, DOI 10.3109/00207459608999812; GALLIMBERTI L, 1989, LANCET, V2, P787; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Jeong SW, 2000, J NEUROSCI, V20, P4489, DOI 10.1523/JNEUROSCI.20-12-04489.2000; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Madden TE, 1998, J PHARMACOL EXP THER, V287, P261; Martellotta MC, 1998, EUR NEUROPSYCHOPHARM, V8, P293, DOI 10.1016/S0924-977X(97)00087-4; McFarland K, 2001, J NEUROSCI, V21, P8655; Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2000, J NEUROCHEM, V75, P1986, DOI 10.1046/j.1471-4159.2000.0751986.x; SUGITA S, 1992, NEUROSCI LETT, V134, P207, DOI 10.1016/0304-3940(92)90518-C; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wickman K, 2002, GENE, V284, P241, DOI 10.1016/S0378-1119(01)00884-8; 2002, MATINDALE COMPLETE D, P2496	50	267	273	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					153	159		10.1038/nn1181	http://dx.doi.org/10.1038/nn1181			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14745451				2022-12-28	WOS:000188468500013
J	Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW				Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW			ORL1 receptor-mediated internalization of N-type calcium channels	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; INTRATHECALLY ADMINISTERED NOCICEPTIN; ROOT GANGLION NEURONS; MU-OPIOID RECEPTORS; RAT SPINAL-CORD; ORPHANIN-FQ; MORPHINE-TOLERANCE; CA2+ CHANNELS; PERIPHERAL INFLAMMATION; NEUROPATHIC PAIN	The inhibition of N-type calcium channels by opioid receptor like receptor 1 (ORL1) is a key mechanism for controlling the transmission of nociceptive signals. We recently reported that signaling complexes consisting of ORL1 receptors and N-type channels mediate a tonic inhibition of calcium entry. Here we show that prolonged (similar to 30 min) exposure of ORL1 receptors to their agonist nociceptin triggers an internalization of these signaling complexes into vesicular compartments. This effect is dependent on protein kinase C activation, occurs selectively for N-type channels and cannot be observed with mu-opioid or angiotensin receptors. In expression systems and in rat dorsal root ganglion neurons, the nociceptin-mediated internalization of the channels is accompanied by a significant downregulation of calcium entry, which parallels the selective removal of N-type calcium channels from the plasma membrane. This may provide a new means for long-term regulation of calcium entry in the pain pathway.	Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; John P Robarts Res Inst, Cell Biol Res Grp, London, ON N6A 5K8, Canada; Univ UMI, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France; Univ UMII, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France	University of Calgary; Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Khosravani, Houman/X-2391-2019; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Dubel, Stefan/0000-0001-8811-7390; Zamponi, Gerald W./0000-0002-0644-9066				Abdulla FA, 1997, J NEUROSCI, V17, P8721; Abdulla FA, 1998, J NEUROSCI, V18, P9685; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Andoh T, 1997, NEUROREPORT, V8, P2793, DOI 10.1097/00001756-199708180-00028; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Becker JAJ, 1999, J BIOL CHEM, V274, P27513, DOI 10.1074/jbc.274.39.27513; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Borgland SL, 2001, J PHYSIOL-LONDON, V536, P35, DOI 10.1111/j.1469-7793.2001.t01-1-00035.x; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Connor M, 1998, J PHYSIOL-LONDON, V509, P47, DOI 10.1111/j.1469-7793.1998.047bo.x; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; DE WM, 1997, NATURE, V385, P446; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Hao JX, 1997, NEUROSCI LETT, V223, P49, DOI 10.1016/S0304-3940(97)13401-2; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; IKEDA SR, 1996, NATURE, V380, P258; Jhamandas KH, 1998, CAN J PHYSIOL PHARM, V76, P314, DOI 10.1139/cjpp-76-3-314; Jia YP, 1998, NEUROSCI LETT, V250, P21, DOI 10.1016/S0304-3940(98)00430-3; Knoflach F, 1996, J NEUROSCI, V16, P6657; Larsson KP, 2000, NEUROSCI LETT, V296, P121, DOI 10.1016/S0304-3940(00)01640-2; Lutfy K, 2003, J NEUROSCI, V23, P10331; Mandyam CD, 2002, J PHARMACOL EXP THER, V302, P502, DOI 10.1124/jpet.102.033159; Mills RH, 2004, J NEUROSCI, V24, P947, DOI 10.1523/JNEUROSCI.1366-03.2004; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Neal CR, 1999, J COMP NEUROL, V406, P503; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; Scott RH, 1997, NEUROPHARMACOLOGY, V36, P195, DOI 10.1016/S0028-3908(97)83783-5; Spampinato S, 2002, CELL MOL LIFE SCI, V59, P2172, DOI 10.1007/s000180200016; Spampinato S, 2001, NEUROREPORT, V12, P3159, DOI 10.1097/00001756-200110080-00035; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Sutton KG, 2002, BRIT J PHARMACOL, V135, P257, DOI 10.1038/sj.bjp.0704439; Toth PT, 1996, J NEUROSCI, V16, P4617; Ueda H, 2000, J NEUROSCI, V20, P7640; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wick M J, 1994, Brain Res Mol Brain Res, V27, P37; Yamamoto T, 1997, NEUROSCI LETT, V224, P107, DOI 10.1016/S0304-3940(97)13475-9; Yamamoto T, 1997, NEUROSCIENCE, V81, P249, DOI 10.1016/S0306-4522(97)00166-8; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848	49	127	135	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					31	40		10.1038/nn1605	http://dx.doi.org/10.1038/nn1605			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311589				2022-12-28	WOS:000234288000015
J	Ishikane, H; Gangi, M; Honda, S; Tachibana, M				Ishikane, H; Gangi, M; Honda, S; Tachibana, M			Synchronized retinal oscillations encode essential information for escape behavior in frogs	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LONG-RANGE SYNCHRONIZATION; LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; NEURONAL RESPONSES; NEURAL ASSEMBLIES; GABA RECEPTORS; INHIBITION; INTEGRATION; MODULATION	Synchronized oscillatory activity is generated among visual neurons in a manner that depends on certain key features of visual stimulation. Although this activity may be important for perceptual integration, its functional significance has yet to be explained. Here we find a very strong correlation between synchronized oscillatory activity in a class of frog retinal ganglion cells ( dimming detectors) and a well-known escape response, as shown by behavioral tests and multi-electrode recordings from isolated retinas. Escape behavior elicited by an expanding dark spot was suppressed and potentiated by intraocular injection of GABA(A) receptor and GABA(C) receptor antagonists, respectively. Changes in escape behavior correlated with antagonist-evoked changes in synchronized oscillatory activity but not with changes in the discharge rate of dimming detectors. These antagonists did not affect the expanding dark spot - induced responses in retinal ganglion cells other than dimming detectors. Thus, synchronized oscillations in the retina are likely to encode escape-related information in frogs.	Univ Tokyo, Dept Psychol, Grad Sch Human & Sociol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Tachibana, M (corresponding author), Univ Tokyo, Dept Psychol, Grad Sch Human & Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	Ltmasao@L.u-tokyo.ac.jp	Ishikane, Hiroshi/AAX-8462-2021	Ishikane, Hiroshi/0000-0003-1316-2255				Arai I, 2004, J NEUROPHYSIOL, V92, P715, DOI 10.1152/jn.00159.2004; BACKSTROM AC, 1978, MED BIOL, V56, P72; BONAVENTURE N, 1986, EUR J PHARMACOL, V121, P327, DOI 10.1016/0014-2999(86)90253-0; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Du JL, 2000, J NEUROPHYSIOL, V84, P666, DOI 10.1152/jn.2000.84.2.666; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grusser O J, 1972, Bibl Ophthalmol, V82, P260; Grusser O.-J, 1976, P297; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; King JG, 1999, BRAIN RES, V841, P20, DOI 10.1016/S0006-8993(99)01764-3; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Molotchnikoff S, 1996, BRAIN RES, V731, P91, DOI 10.1016/0006-8993(96)00468-4; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Vitanova L, 2001, VISION RES, V41, P691, DOI 10.1016/S0042-6989(00)00294-7; WALDECK RF, 1995, BRAIN BEHAV EVOLUT, V46, P84, DOI 10.1159/000113261; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Watanabe S, 2000, J NEUROPHYSIOL, V84, P1826, DOI 10.1152/jn.2000.84.4.1826; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	46	88	93	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1087	1095		10.1038/nn1497	http://dx.doi.org/10.1038/nn1497			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995702				2022-12-28	WOS:000230760200021
J	Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB				Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB			ATP mediates rapid microglial response to local brain injury in vivo	NATURE NEUROSCIENCE			English	Article							ASTROCYTES; CELLS; ACTIVATION; RELEASE; PROTEIN; EXPRESSION; MOTILITY	Parenchymal microglia are the principal immune cells of the brain. Time-lapse two-photon imaging of GFP-labeled microglia demonstrates that the fine termini of microglial processes are highly dynamic in the intact mouse cortex. Upon traumatic brain injury, microglial processes rapidly and autonomously converge on the site of injury without cell body movement, establishing a potential barrier between the healthy and injured tissue. This rapid chemotactic response can be mimicked by local injection of ATP and can be inhibited by the ATP-hydrolyzing enzyme apyrase or by blockers of G protein - coupled purinergic receptors and connexin channels, which are highly expressed in astrocytes. The baseline motility of microglial processes is also reduced significantly in the presence of apyrase and connexin channel inhibitors. Thus, extracellular ATP regulates microglial branch dynamics in the intact brain, and its release from the damaged tissue and surrounding astrocytes mediates a rapid microglial response towards injury.	NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Jung, Steffen/K-1409-2012; Grutzendler, Jaime/F-3691-2010; Dustin, Michael/AAM-4611-2020; Davalos, Dimitrios/G-8627-2011	Jung, Steffen/0000-0003-4290-5716; Davalos, Dimitrios/0000-0001-9038-6688; Yang, Guang/0000-0002-5739-9126; Zuo, Yi/0000-0001-9020-0003; Dustin, Michael/0000-0003-4983-6389				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; SMITH SJ, 1990, SYMP MED H, V23, P49; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	40	2524	2601	8	257	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					752	758		10.1038/nn1472	http://dx.doi.org/10.1038/nn1472			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895084				2022-12-28	WOS:000229345300015
J	Torborg, CL; Hansen, KA; Feller, MB				Torborg, CL; Hansen, KA; Feller, MB			High frequency, synchronized bursting drives eye-specific segregation of retinogeniculate projections	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; RETINAL WAVES; MAMMALIAN RETINA; BETA-2 SUBUNIT; MICE LACKING; FUNCTIONAL-DEVELOPMENT; CORRELATED ACTIVITY; GANGLION-CELLS; MOUSE RETINA	Blockade of retinal waves prevents the segregation of retinogeniculate afferents into eye-specific layers in the visual thalamus. However, the key features of retinal waves that drive this refinement are controversial. Some manipulations of retinal waves lead to normal eye-specific segregation but others do not. By comparing retinal spiking patterns in several mutant mice with differing levels of eye-specific segregation, we show that the presence of high-frequency bursts synchronized across neighboring retinal ganglion cells correlates with robust eye-specific segregation and that the presence of high levels of asynchronous spikes does not inhibit this segregation. These findings provide a possible resolution to previously described discrepancies regarding the role of retinal waves in retinogeniculate segregation.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Feller, MB (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfeller@ucsd.edu			NATIONAL EYE INSTITUTE [R01EY013528] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013528] Funding Source: Medline; NINDS NIH HHS [NS13528-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bansal A, 2000, J NEUROSCI, V20, P7672; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Buhl DL, 2003, J NEUROSCI, V23, P1013; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Demas J, 2003, J NEUROSCI, V23, P2851; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Long MA, 2002, J NEUROSCI, V22, P10898; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sohl G, 2000, BRAIN RES REV, V32, P138, DOI 10.1016/S0165-0173(99)00074-0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Zoli M, 1998, J NEUROSCI, V18, P4461	36	121	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					72	78		10.1038/nn1376	http://dx.doi.org/10.1038/nn1376			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608630	Green Accepted			2022-12-28	WOS:000225967600018
J	Vande Velde, C; Cleveland, DW				Vande Velde, C; Cleveland, DW			VEGF: multitasking in ALS	NATURE NEUROSCIENCE			English	Editorial Material							MOTOR-NEURON DEGENERATION; ENDOTHELIAL GROWTH-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; HYPOXIA-RESPONSE ELEMENT; CEREBRAL BLOOD-FLOW; PROLONGS SURVIVAL; MODEL; DELIVERY; MICE		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Vande Velde, C (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Velde, Christine Vande/AAB-8828-2020; Vande Velde, Christine/F-2721-2016	Vande Velde, Christine/0000-0001-5926-1529; Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [R37 NS027036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gros-Louis F, 2003, MUSCLE NERVE, V28, P774, DOI 10.1002/mus.10498; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kobari M, 1996, J NEUROL SCI, V144, P64, DOI 10.1016/S0022-510X(96)00151-7; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; WALDEMAR G, 1992, J NEUROL SCI, V107, P19, DOI 10.1016/0022-510X(92)90204-X; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223	15	21	22	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					5	7		10.1038/nn0105-5	http://dx.doi.org/10.1038/nn0105-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15622408				2022-12-28	WOS:000225967600002
J	Maffei, A; Nelson, SB; Turrigiano, GG				Maffei, A; Nelson, SB; Turrigiano, GG			Selective reconfiguration of layer 4 visual cortical circuitry by visual deprivation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; MONOCULAR DEPRIVATION; IMMUNOREACTIVE NEURONS; NEOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY; SENSORY EXPERIENCE; OCULAR DOMINANCE; NERVOUS-SYSTEM; CORTEX; INHIBITION	Visual deprivation during a developmental sensitive period markedly alters visual cortical response properties, but the changes in intracortical circuitry that underlie these effects are poorly understood. Here we use a slice preparation of rat primary visual cortex to show that 2 d of prior visual deprivation early in life increases the excitability of layer 4 circuitry. Slice recordings showed that spontaneous activity of layer 4 star pyramidal neurons increased 25-fold after 2 d of visual deprivation between postnatal days ( P) 15 and P17. This effect was mediated by increased net excitatory and decreased net inhibitory synaptic drive. Paired recordings showed that excitatory connections between star pyramidal neurons doubled in amplitude, whereas inhibitory connections decreased or increased depending on the interneuron class. These effects reversed when vision was restored. This dynamic adjustment of the excitation-inhibition balance may allow the networks within layer 4 to maintain stable levels of activity in the face of variable sensory input.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Maffei, Arianna/0000-0001-6755-8904; Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY014439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016455] Funding Source: NIH RePORTER; NEI NIH HHS [EY014439] Funding Source: Medline; NIDA NIH HHS [DA16455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DEUCHARS J, 1995, NEUROSCIENCE, V65, P935, DOI 10.1016/0306-4522(95)00020-J; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hajos F, 1997, NEUROSCI LETT, V228, P179, DOI 10.1016/S0304-3940(97)00399-6; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Morales B, 2002, J NEUROSCI, V22, P8084; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; PETERS A, 1988, J COMP NEUROL, V267, P409, DOI 10.1002/cne.902670310; REID SNM, 1991, BRAIN RES, V563, P293, DOI 10.1016/0006-8993(91)91549-G; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shao ZW, 1996, J NEUROSCI, V16, P7353; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VANSLUYTERS RC, 1978, J PHYSIOL-LONDON, V284, P1; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	50	305	311	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1353	1359		10.1038/nn1351	http://dx.doi.org/10.1038/nn1351			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543139				2022-12-28	WOS:000225353900016
J	Solecki, DJ; Model, L; Gaetz, J; Kapoor, TM; Hatten, ME				Solecki, DJ; Model, L; Gaetz, J; Kapoor, TM; Hatten, ME			Par6 alpha signaling controls glial-guided neuronal migration	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE NEURONS; CELL POLARITY; MICROTUBULE DYNAMICS; CYTOPLASMIC DYNEIN; MITOTIC SPINDLES; CAENORHABDITIS-ELEGANS; CEREBRAL-CORTEX; MAMMALIAN-CELLS; ANIMAL-CELLS; C-ELEGANS	Neuronal migrations along glial fibers provide a primary pathway for the formation of cortical laminae. To examine the mechanisms underlying glial-guided migration, we analyzed the dynamics of cytoskeletal and signaling components in living neurons. Migration involves the coordinated two-stroke movement of a perinuclear tubulin 'cage' and the centrosome, with the centrosome moving forward before nuclear translocation. Overexpression of mParalpha disrupts the perinuclear tubulin cage, retargets PKCzeta and gamma-tubulin away from the centrosome, and inhibits centrosomal motion and neuronal migration. Thus, we propose that during neuronal migration the centrosome acts to coordinate cytoskeletal dynamics in response to mParalpha-mediated signaling.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockefeller.edu	Solecki, David/N-8080-2018		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015429] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS15429-24A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Komuro H, 1998, J NEUROSCI, V18, P1478; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; WADSWORTH P, 1986, ANN NY ACAD SCI, V466, P580, DOI 10.1111/j.1749-6632.1986.tb38434.x; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	50	219	221	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1195	1203		10.1038/nn1332	http://dx.doi.org/10.1038/nn1332			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475953				2022-12-28	WOS:000224749400012
J	Newton, JR; Ellsworth, C; Miyakawa, T; Tonegawa, S; Sur, M				Newton, JR; Ellsworth, C; Miyakawa, T; Tonegawa, S; Sur, M			Acceleration of visually cued conditioned fear through the auditory pathway	NATURE NEUROSCIENCE			English	Article							MEDIAL GENICULATE-NUCLEUS; RETINAL PROJECTIONS; LATERAL AMYGDALA; CORTICAL REORGANIZATION; POTENTIATED STARTLE; STRIATE CORTEX; THALAMUS; RESPONSES; LESIONS; BRAIN	Defensive responses elicited by sensory experiences are critical for survival. Mice acquire a conditioned fear response rapidly to an auditory cue but slowly to a visual cue, a difference in learned behavior that is likely to be mediated by direct projections to the lateral amygdala from the auditory thalamus but mainly indirect ones from the visual thalamus. Here, we show that acquisition of visually cued conditioned fear is accelerated in 'rewired' mice that have retinal projections routed to the auditory thalamus. Visual stimuli induce expression of the immediate early gene Fos ( also known as c-fos) in the auditory thalamus and the lateral amygdala in rewired mice, similar to the way auditory stimuli do in control mice. Thus, the rewired auditory pathway conveys visual information and mediates rapid activity-dependent plasticity in central structures that influence learned behavior.	MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu	Miyakawa, Tsuyoshi/A-7741-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200	NATIONAL EYE INSTITUTE [F32EY013900, R01EY015068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY15068, F32EY13900, R01EY14134] Funding Source: Medline; NIMH NIH HHS [P50MH58880] Funding Source: Medline; NINDS NIH HHS [R01NS32925] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Angelucci A, 1998, J COMP NEUROL, V400, P417, DOI 10.1002/(SICI)1096-9861(19981026)400:3<417::AID-CNE10>3.0.CO;2-O; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Doron NN, 1999, J COMP NEUROL, V412, P383; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; FROST DO, 1985, NATURE, V317, P162, DOI 10.1038/317162a0; FROST DO, 1982, DEV BRAIN RES, V3, P627, DOI 10.1016/0165-3806(82)90058-X; Heldt S, 2000, BEHAV NEUROSCI, V114, P749, DOI 10.1037//0735-7044.114.4.719; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KALIL RE, 1975, BRAIN RES, V100, P690, DOI 10.1016/0006-8993(75)90171-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim SD, 1996, J EXP PSYCHOL ANIM B, V22, P87; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lyckman AW, 2001, J NEUROSCI, V21, P7684, DOI 10.1523/JNEUROSCI.21-19-07684.2001; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MITCHELL DE, 1988, J PHYSIOL-LONDON, V395, P639, DOI 10.1113/jphysiol.1988.sp016939; MITCHELL DE, 1991, PHILOS T R SOC B, V333, P51, DOI 10.1098/rstb.1991.0060; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Namura S, 1997, J COMP NEUROL, V384, P59; NEWTON JR, 2004, ENCY NEUROSCIENCE, V3; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1993, J COMP NEUROL, V334, P263, DOI 10.1002/cne.903340208; ROE AW, 1992, J NEUROSCI, V12, P3651; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCHNEIDER GE, 1973, BRAIN BEHAV EVOLUT, V8, P73, DOI 10.1159/000124348; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shi CJ, 2001, J NEUROSCI, V21, P9844, DOI 10.1523/JNEUROSCI.21-24-09844.2001; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305	43	31	33	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					968	973		10.1038/nn1306	http://dx.doi.org/10.1038/nn1306			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322551				2022-12-28	WOS:000223546700016
J	Hoglinger, GU; Rizk, P; Muriel, MP; Duyckaerts, C; Oertel, WH; Caille, I; Hirsch, EC				Hoglinger, GU; Rizk, P; Muriel, MP; Duyckaerts, C; Oertel, WH; Caille, I; Hirsch, EC			Dopamine depletion impairs precursor cell proliferation in Parkinson disease	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; ADULT-RAT HIPPOCAMPUS; SUBVENTRICULAR ZONE; DENTATE GYRUS; INCREASES NEUROGENESIS; MAMMALIAN BRAIN; OLFACTORY-BULB; SPATIAL MEMORY; NEURONS; HALOPERIDOL	Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France; Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; Hop La Pitie Salpetriere, Dept Neuropathol, F-75651 Paris, France; Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Philipps University Marburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Hoglinger, GU (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France.	gunter@ccr.jussieu.fr	Caillé, Isabelle/AAC-9575-2021; Hirsch, Etienne/AAC-7655-2019; Höglinger, Günter U/F-2388-2015	Hirsch, Etienne/0000-0003-4823-276X; Höglinger, Günter U/0000-0001-7587-6187; Caille, Isabelle/0000-0002-9054-2641				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BACKHOUSE B, 1982, NEUROPATH APPL NEURO, V8, P109, DOI 10.1111/j.1365-2990.1982.tb00266.x; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dawirs RR, 1998, J NEURAL TRANSM, V105, P317, DOI 10.1007/s007020050061; Diaz J, 1997, J NEUROSCI, V17, P4282; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Franklin BJ, 1996, MOUSE BRAIN STEREOTA; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoogland PV, 2003, NEUROPATH APPL NEURO, V29, P303, DOI 10.1046/j.1365-2990.2003.00459.x; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LIDOW MS, 1995, J COMP NEUROL, V360, P393, DOI 10.1002/cne.903600303; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Oertel WH, 2001, ADV NEUROL, V86, P373; Ohtani N, 2003, J NEUROSCI, V23, P2840; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pillon B, 1997, NEUROPSYCHOLOGIA, V35, P221, DOI 10.1016/S0028-3932(96)00091-7; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ridet JL, 2000, TRENDS NEUROSCI, V23, P58, DOI 10.1016/S0166-2236(99)01523-4; Riekkinen P, 1998, NEUROREPORT, V9, P1507, DOI 10.1097/00001756-199805110-00048; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scotto-Lomassese S, 2003, J NEUROSCI, V23, P9289; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wakade CG, 2002, J NEUROSCI RES, V69, P72, DOI 10.1002/jnr.10281; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	47	712	748	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					726	735		10.1038/nn1265	http://dx.doi.org/10.1038/nn1265			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195095				2022-12-28	WOS:000222274400014
J	Wang, HB; Ferguson, GD; Pineda, VV; Cundiff, PE; Storm, DR				Wang, HB; Ferguson, GD; Pineda, VV; Cundiff, PE; Storm, DR			Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; HIPPOCAMPAL CA1 REGION; SYNAPTIC PLASTICITY; MUTANT MICE; LATE-PHASE; MUSHROOM BODIES; PERFORANT PATH; CROSS-TALK; DROSOPHILA	Cyclic AMP is a positive regulator of synaptic plasticity and is required for several forms of hippocampus-dependent memory including recognition memory. The type I adenylyl cyclase, Adcy1 (also known as AC1), is crucial in memory formation because it couples Ca2+ to cyclic AMP increases in the hippocampus. Because Adcy1 is neurospecific, it is a potential pharmacological target for increasing cAMP specifically in the brain and for improving memory. We have generated transgenic mice that overexpress Adcy1 in the forebrain using the Camk2a (also known as alpha-CaMKII) promoter. These mice showed elevated long-term potentiation (LTP), increased memory for object recognition and slower rates of extinction for contextual memory. The increase in recognition memory and lower rates of contextual memory extinction may be due to enhanced extracellular signal-related kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling, which is elevated in mice that overexpress Adcy1.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, F31NS042475] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498, 1F31NS042475-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Cooke SF, 2003, CELL MOL LIFE SCI, V60, P1, DOI 10.1007/s000180300000; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gerlai R, 2002, HIPPOCAMPUS, V12, P657, DOI 10.1002/hipo.10101; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Koh MT, 2003, NEUROREPORT, V14, P405, DOI 10.1097/01.wnr.0000058519.74643.df; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vianna MR, 2003, NEUROBIOL LEARN MEM, V79, P199, DOI 10.1016/S1074-7427(03)00003-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weeber EJ, 2002, NEURON, V33, P845, DOI 10.1016/S0896-6273(02)00634-7; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	168	173	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					635	642		10.1038/nn1248	http://dx.doi.org/10.1038/nn1248			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133516				2022-12-28	WOS:000221640300018
J	Astafiev, SV; Stanley, CM; Shulman, GL; Corbetta, M				Astafiev, SV; Stanley, CM; Shulman, GL; Corbetta, M			Extrastriate body area in human occipital cortex responds to the performance of motor actions	NATURE NEUROSCIENCE			English	Article							NEURAL REPRESENTATION; SEPARATING PROCESSES; FUNCTIONAL MRI; VISUAL-CORTEX; EYE-MOVEMENTS; BRAIN; ACTIVATION; ATTENTION; NEURONS; ORGANIZATION	A region in human lateral occipital cortex (the 'extrastriate body area' or EBA) has been implicated in the perception of body parts. Here we report functional magnetic resonance imaging (fMRI) evidence that the EBA is strongly modulated by limb (arm, foot) movements to a visual target stimulus, even in the absence of visual feedback from the movement. Therefore, the EBA responds not only during the perception of other people's body parts, but also during goal-directed movements of the observer's body parts. In addition, both limb movements and saccades to a detected stimulus produced stronger signals than stimulus detection without motor movements ('covert detection') in the calcarine sulcus and lingual gyrus. These motor-related modulations cannot be explained by simple visual or attentional factors related to the target stimulus, and suggest a potentially widespread influence of actions on visual cortex.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Astafiev, Serguei/A-9734-2014	CORBETTA, MAURIZIO/0000-0001-8295-3304; Astafiev, Serguei/0000-0003-3736-7095; Martin, Christine/0000-0003-0407-945X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833] Funding Source: NIH RePORTER; NEI NIH HHS [EY00379, EY001248] Funding Source: Medline; NINDS NIH HHS [5P50NS06833] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Chelazzi L, 2000, NEW COGN NEUROSCI, P667; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coslett HB, 1998, BRAIN COGNITION, V37, P527, DOI 10.1006/brcg.1998.1011; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; EVARTS EV, 1981, CAN J PHYSIOL PHARM, V59, P757, DOI 10.1139/y81-112; Falchier A, 2002, J NEUROSCI, V22, P5749; FISCHER B, 1981, EXP BRAIN RES, V43, P69; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Macaluso E, 2002, NEURON, V34, P647, DOI 10.1016/S0896-6273(02)00678-5; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILLER EK, 1993, J NEUROSCI, V13, P1460; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nakamura K, 2000, J NEUROPHYSIOL, V84, P677, DOI 10.1152/jn.2000.84.2.677; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; PERRETT DI, 1989, J EXP BIOL, V146, P87; Porro CA, 1996, J NEUROSCI, V16, P7688; Rinaman W.C., 1996, STANDARD MATH TABLES, V569-668; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Shulman GL, 1999, J NEUROSCI, V19, P9480; SPELKE E, 1994, COGNITION, V50, P431, DOI 10.1016/0010-0277(94)90039-6; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Talairach J., 1988, COPLANAR STEREOTAXIC; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Tootell RBH, 2003, J NEUROSCI, V23, P3981; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3	45	443	450	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					542	548		10.1038/nn1241	http://dx.doi.org/10.1038/nn1241			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15107859				2022-12-28	WOS:000221101300032
J	Ning, K; Li, L; Liao, MX; Liu, BS; Mielke, JG; Chen, YH; Duan, Y; El-Hayek, YH; Wan, Q				Ning, K; Li, L; Liao, MX; Liu, BS; Mielke, JG; Chen, YH; Duan, Y; El-Hayek, YH; Wan, Q			Circadian regulation of GABA(A) receptor function by CKI epsilon-CKI delta in the rat suprachiasmatic nuclei	NATURE NEUROSCIENCE			English	Article							CASEIN KINASE-I; PHOSPHORYLATION; MODULATION; MUTATION; CHANNELS; SYSTEM	The type A GABA receptors are thought to mediate synchronization of clock cell activity within the suprachiasmatic nuclei (SCN). Here we report that casein kinases I epsilon and delta (CKIepsilon and CKIdelta), the crucial clock regulators, form a complex with GABA(A) receptors and inhibit the receptors' function within the SCN according to a circadian rhythm. These results indicate that circadian variation of the kinase-receptor association may mediate regulation of GABA(A) receptor function by CKIepsilon-CKIdelta in the SCN.	Univ Hlth Network, Toronto Western Res Inst, Div Cellular & Mol Biol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Wan, Q (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Cellular & Mol Biol, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	qi.wan@utoronto.ca	Ning, Ke/B-4561-2009	Ning, Ke/0000-0002-0771-1134				Brandon NJ, 2002, PHARMACOL THERAPEUT, V94, P113, DOI 10.1016/S0163-7258(02)00175-4; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Wan Q, 1999, NAT NEUROSCI, V2, P401, DOI 10.1038/8062; Wan Q, 1997, J NEUROSCI, V17, P5062; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	15	13	14	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					489	490		10.1038/nn1236	http://dx.doi.org/10.1038/nn1236			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097994				2022-12-28	WOS:000221101300021
J	Staal, RGW; Mosharov, EV; Sulzer, D				Staal, RGW; Mosharov, EV; Sulzer, D			Dopamine neurons release transmitter via a flickering fusion pore	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SYNAPTIC VESICLES; CHROMAFFIN CELLS; HORSE EOSINOPHILS; SUBSTANTIA-NIGRA; QUANTAL SIZE; SINGLE; EXOCYTOSIS; TRANSMISSION; MIDBRAIN	A key question in understanding mechanisms of neurotransmitter release is whether the fusion pore of a synaptic vesicle regulates the amount of transmitter released during exocytosis. We measured dopamine release from small synaptic vesicles of rat cultured ventral midbrain neurons using carbon fiber amperometry. Our data indicate that small synaptic vesicle fusion pores flicker either once or multiple times in rapid succession, with each flicker releasing similar to25-30% of vesicular dopamine. The incidence of events with multiple flickers was reciprocally regulated by phorbol esters and staurosporine. Thus, dopamine neurons regulate the amount of neurotransmitter released by small synaptic vesicles by controlling the number of fusion pore flickers per exocytotic event. This mode of exocytosis is a potential mechanism whereby neurons can rapidly reuse vesicles without undergoing the comparatively slow process of recycling.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, Black 305,650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu		Staal, Roland/0000-0002-2857-2241				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Berg H.C., 1983, RANDOM WALKS BIOL, P152; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bittner MA, 2000, BIOCHIMIE, V82, P447, DOI 10.1016/S0300-9084(00)00222-4; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN GY, 1995, J NEUROSCI, V15, P7747; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Colquhoun David, 1995, P483; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GIROD R, 1993, J PHYSIOL-LONDON, V471, P129, DOI 10.1113/jphysiol.1993.sp019894; Gonon F, 2000, PROG BRAIN RES, V125, P291; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; HARTMANN J, 1995, J PHYSIOL-LONDON, V483, P201, DOI 10.1113/jphysiol.1995.sp020578; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jeremic A, 2003, BIOPHYS J, V85, P2035, DOI 10.1016/S0006-3495(03)74631-1; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Levant B, 1997, PHARMACOL REV, V49, P231; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; NICHOLSON C, 1999, MONITORING MOL NEURO, V8, P71; Pickel VM, 1996, J NEUROCYTOL, V25, P843, DOI 10.1007/BF02284846; Pothos EN, 1998, J NEUROSCI, V18, P5575; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; RICE ME, 1994, EXP BRAIN RES, V100, P395, DOI 10.1007/BF02738400; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	48	227	231	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					341	346		10.1038/nn1205	http://dx.doi.org/10.1038/nn1205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	14990933				2022-12-28	WOS:000220482500012
J	Hoshi, E; Tremblay, L; Feger, J; Carras, PL; Strick, PL				Hoshi, E; Tremblay, L; Feger, J; Carras, PL; Strick, PL			The cerebellum communicates with the basal ganglia	NATURE NEUROSCIENCE			English	Article							CIRCUITS; MOTOR; THALAMUS; PRIMATE; SYSTEM; CORTEX	The cerebral cortex is interconnected with two major subcortical structures: the basal ganglia and the cerebellum. How and where cerebellar circuits interact with basal ganglia circuits has been a longstanding question. Using transneuronal transport of rabies virus in macaques, we found that a disynaptic pathway links an output stage of cerebellar processing, the dentate nucleus, with an input stage of basal ganglia processing, the striatum.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; Tamagawa Univ Res Inst, Tokyo 1948610, Japan; Hop La Pitie Salpetriere, INSERM, U679, F-75651 Paris, France; Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	strickp@pitt.edu	Tremblay, Leon/H-1559-2017	Tremblay, Leon/0000-0001-8370-6903	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS047126] Funding Source: NIH RePORTER; NCRR NIH HHS [RR018604] Funding Source: Medline; NIMH NIH HHS [MH56661] Funding Source: Medline; NINDS NIH HHS [NS047126] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dum RP, 2002, ANN NY ACAD SCI, V978, P289, DOI 10.1111/j.1749-6632.2002.tb07575.x; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Jones EG, 1985, THALAMUS; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Percheron G, 1996, BRAIN RES REV, V22, P93; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9	15	541	551	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1491	1493		10.1038/nn1544	http://dx.doi.org/10.1038/nn1544			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16205719				2022-12-28	WOS:000232966600020
J	Lovinger, DM; Crabbe, JC				Lovinger, DM; Crabbe, JC			Laboratory models of alcoholism: treatment target identification and insight into mechanisms	NATURE NEUROSCIENCE			English	Review							BINDING-PROTEIN LUSH; SEROTONIN TRANSPORTER; GABA(A) RECEPTORS; MOTOR IMPAIRMENT; GABAERGIC TRANSMISSION; ETHANOL CONCENTRATIONS; ANIMAL-MODELS; COMPLEX TRAIT; RAT LINES; GENE	Laboratory models, including animal tissues and live animals, have proven useful for discovery of molecular targets of alcohol action as well as for characterization of genetic and environmental factors that influence alcohol's neural actions. Here we consider strengths and weaknesses of laboratory models used in alcohol research and analyze the limitations of using animals to model a complex human disease. We describe targets for the neural actions of alcohol, and we review studies in which animal models were used to examine excessive alcohol drinking and to discover genes that may contribute to risk for alcoholism. Despite some limitations of the laboratory models used in alcohol research, these experimental approaches are likely to contribute to the development of new therapies for alcohol abuse and alcoholism.	NIAAA, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Portland Alcohol Res Ctr, Portland, OR USA; Dept Vet Affairs Med Ctr, Portland, OR USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA.	lovindav@mail.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012714, Z01AA000407, P50AA010760, P60AA010760, U01AA013519] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAAA NIH HHS [P60 AA010760, AA10760, AA12714, AA13519] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aguayo Luis G., 2002, Current Topics in Medicinal Chemistry, V2, P869, DOI 10.2174/1568026023393426; Anderson KG, 2005, J STUD ALCOHOL, V66, P323, DOI 10.15288/jsa.2005.66.323; Anguelova M, 2003, MOL PSYCHIATR, V8, P574, DOI 10.1038/sj.mp.4001328; Ariwodola OJ, 2004, J NEUROSCI, V24, P10679, DOI 10.1523/JNEUROSCI.1768-04.2004; Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Barr CS, 2004, P NATL ACAD SCI USA, V101, P12358, DOI 10.1073/pnas.0403763101; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Bergeson SE, 2003, MAMM GENOME, V14, P454, DOI 10.1007/s00335-002-2254-4; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; BROWMAN KE, 2000, PSYCHOPHARMACOLOGY 4; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Congeddu E, 2003, MOL BRAIN RES, V110, P289, DOI 10.1016/S0169-328X(02)00660-5; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Crabbe JC, 2004, PSYCHOPHARMACOLOGY, V174, P539, DOI 10.1007/s00213-003-1608-6; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; CRABBE JC, IN PRESS CELL BIOL A; Cronise K, 2005, PHARMACOL BIOCHEM BE, V81, P943, DOI 10.1016/j.pbb.2005.07.005; Cunningham CL, 2003, MOLECULAR BIOLOGY OF DRUG ADDICTION, P263; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DI MV, 2005, NAT NEUROSCI, V8, P585; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dwyer DS, 2000, CELL MOL LIFE SCI, V57, P265, DOI 10.1007/PL00000689; EGLI M, IN PRESS ADDICT BIOL; FALK JL, 1961, SCIENCE, V133, P195, DOI 10.1126/science.133.3447.195; Fehr C, 2002, J NEUROSCI, V22, P3730; FIDLER TL, IN PRESS ALCOHOL CLI; Finn DA, 2005, PSYCHOPHARMACOLOGY, V178, P471, DOI 10.1007/s00213-004-2039-8; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS255; Hitzemann R, 2004, ALCOHOL CLIN EXP RES, V28, P1437, DOI 10.1097/01.ALC.0000139827.86749.DA; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Hood HM, 2001, BEHAV GENET, V31, P93, DOI 10.1023/A:1010214026692; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hungund BL, 2004, ANN NY ACAD SCI, V1025, P515, DOI 10.1196/annals.1316.064; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Johnson BA, 2000, PSYCHOPHARMACOLOGY, V149, P327, DOI 10.1007/s002130000371; Kim MS, 1998, GENETICS, V150, P711; Kliethermes CL, 2005, NEUROSCI BIOBEHAV R, V28, P837, DOI 10.1016/j.neubiorev.2004.11.001; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Le Foll B, 2005, J PHARMACOL EXP THER, V312, P875, DOI 10.1124/jpet.104.077974; LIU Y, 2000, METHODS ALCOHOL RELA; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; LOPEZ MF, 2005, PSYCHOPHARMACOL 0707, DOI DOI 10.1007/S00213-005-0026-3; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lovinger DM, 1997, N-S ARCH PHARMACOL, V356, P267, DOI 10.1007/PL00005051; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Middaugh LD, 2003, ALCOHOL CLIN EXP RES, V27, P1892, DOI 10.1097/01.ALC.0000099264.36220.48; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Mittleman G, 2003, ALCOHOL CLIN EXP RES, V27, P918, DOI 10.1097/01.ALC.0000071930.48632.AE; Murphy JM, 2002, BEHAV GENET, V32, P363, DOI 10.1023/A:1020266306135; Nagy J, 2004, IDRUGS, V7, P339; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nie ZG, 2004, SCIENCE, V303, P1512, DOI 10.1126/science.1092550; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Radcliffe RA, 2004, BEHAV GENET, V34, P453, DOI 10.1023/B:BEGE.0000023650.32243.39; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rodd-Henricks ZA, 2001, ALCOHOL CLIN EXP RES, V25, P1140, DOI 10.1097/00000374-200108000-00008; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; SCHUCKIT MA, 1979, DRUG ALCOHOL ABUSE; Sharpe AL, 2005, ALCOHOL CLIN EXP RES, V29, P1419, DOI 10.1097/01.alc.0000174746.64499.83; Shirley RL, 2004, NAT NEUROSCI, V7, P699, DOI 10.1038/nn1271; Siggins GR, 2005, PHARMACOL THERAPEUT, V107, P80, DOI 10.1016/j.pharmthera.2005.01.006; SIMANTOV R, 1977, BIOCHEM SOC T, V5, P62; Soyka M, 2003, AM J ADDICTION, V12, pS69, DOI 10.1111/j.1521-0391.2003.tb00497.x; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Tabakoff B, 2003, J NEUROSCI, V23, P4491; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Thomas MP, 2000, NEUROPHARMACOLOGY, V39, P218, DOI 10.1016/S0028-3908(99)00107-0; Ueno S, 2001, ALCOHOL CLIN EXP RES, V25, p76S, DOI 10.1097/00000374-200105051-00014; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vivian JA, 2001, ALCOHOL CLIN EXP RES, V25, P1087, DOI 10.1097/00000374-200108000-00001; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Weiss F, 2001, ANN NY ACAD SCI, V937, P1, DOI 10.1111/j.1749-6632.2001.tb03556.x; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Yao LN, 2002, CELL, V109, P733, DOI 10.1016/S0092-8674(02)00763-8; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7	100	76	77	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1471	1480		10.1038/nn1581	http://dx.doi.org/10.1038/nn1581			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251990				2022-12-28	WOS:000232966600018
J	McKay, LC; Janczewski, WA; Feldman, JL				McKay, LC; Janczewski, WA; Feldman, JL			Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE SYSTEM ATROPHY; DISEASE	Ablation of preBotzinger complex (preBotC) neurons, critical for respiratory rhythm generation, resulted in a progressive, increasingly severe disruption of respiratory pattern, initially during sleep and then also during wakefulness in adult rats. Sleep-disordered breathing is highly prevalent in elderly humans and in some patients with neurodegenerative disease. We propose that sleep-disordered breathing results from loss of preBotC neurons and could underlie death during sleep in these populations.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	feldman@ucla.edu	feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412; McKay, Leanne/0000-0003-4012-1985	NHLBI NIH HHS [R01 HL070029, R01 HL070029-02, HL70029] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070029] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Alheid GF, 2002, J NEUROCYTOL, V31, P693, DOI 10.1023/A:1025799830302; Benarroch EE, 2003, BRAIN, V126, P2183, DOI 10.1093/brain/awg220; Berry RB, 1997, SLEEP, V20, P654, DOI 10.1093/sleep/20.8.654; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Ferguson KA, 1996, CHEST, V110, P664, DOI 10.1378/chest.110.3.664; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; KRIEGER J, 1983, SLEEP, V6, P108, DOI 10.1093/sleep/6.2.108; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; Maria B, 2003, RESP MED, V97, P1151, DOI 10.1016/S0954-6111(03)00188-4; MENDELSON WB, 1988, PHYSIOL BEHAV, V43, P229, DOI 10.1016/0031-9384(88)90243-0; MUNSCHAUER FE, 1990, NEUROLOGY, V40, P677, DOI 10.1212/WNL.40.4.677; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005	15	165	169	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1142	1144		10.1038/nn1517	http://dx.doi.org/10.1038/nn1517			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116455	Green Accepted			2022-12-28	WOS:000231483800011
J	Jia, SP; He, DZZ				Jia, SP; He, DZZ			Motility-associated hair-bundle motion in mammalian outer hair cells	NATURE NEUROSCIENCE			English	Article							GUINEA-PIG COCHLEA; BASILAR-MEMBRANE; MECHANOELECTRICAL TRANSDUCTION; RECEPTOR POTENTIALS; GERBIL HEMICOCHLEA; SOMATIC MOTILITY; ADAPTATION; MOVEMENTS; ORGAN; CORTI	Mammalian hearing owes its remarkable sensitivity and frequency selectivity to a local mechanical feedback process within the cochlea. Cochlear outer hair cells (OHCs) function as the key elements in the feedback loop in which the fast somatic motility of OHCs is thought to be the source of cochlear amplification. An alternative view is that amplification arises from active hair-bundle movement, similar to that seen in nonmammalian hair cells. We measured voltage-evoked hair-bundle motions in the gerbil cochlea to determine if such movements were also present in mammalian OHCs. The OHCs showed bundle movement with peak responses of up to 830 nm. The movement was insensitive to manipulations that would normally block mechanotransduction in the stereocilia, and it was absent in neonatal OHCs and prestin-knockout OHCs. These findings suggest that the bundle movement originated in somatic motility and that somatic motility has a central role in cochlear amplification in mammals.	Creighton Univ, Sch Med, Dept Biomed Sci, Hair Cell Biophys Lab, Omaha, NE 68175 USA	Creighton University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Hair Cell Biophys Lab, 2500 Calif Plaza, Omaha, NE 68175 USA.	hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [R01 DC004696, R21 DC 006039, R21 DC006039, R01 DC 006496] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006039, R01DC004696] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; Benser ME, 1996, J NEUROSCI, V16, P5629; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; De Boer E., 1996, COCHLEA, P8, DOI [10.1007/978-1-4612-0757-3_5, DOI 10.1007/978-1-4612-0757-3_5]; EVANS BN, 1993, P NATL ACAD SCI USA, V90, P8347, DOI 10.1073/pnas.90.18.8347; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; He DZZ, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P181, DOI 10.1142/9789812704931_0024; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; He DZZ, 1997, J NEUROSCI, V17, P3634; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KOSSL M, 1992, J NEUROSCI, V12, P1575; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1995, PFLUG ARCH EUR J PHY, V430, P745, DOI 10.1007/BF00386170; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; MCMULLEN TA, 1985, HEARING RES, V17, P127, DOI 10.1016/0378-5955(85)90016-4; Murugasu E, 1996, J NEUROSCI, V16, P325; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; REUTER G, 1992, HEARING RES, V60, P236, DOI 10.1016/0378-5955(92)90025-I; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Richter CP, 1998, J NEUROPHYSIOL, V79, P2255, DOI 10.1152/jn.1998.79.5.2255; RUSCH A, 1990, HEARING RES, V48, P247, DOI 10.1016/0378-5955(90)90065-W; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; Spector AA, 2003, J ACOUST SOC AM, V113, P453, DOI 10.1121/1.1526493; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Weitzel EK, 2003, J ACOUST SOC AM, V114, P1462, DOI 10.1121/1.1596172; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	56	60	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1028	1034		10.1038/nn1509	http://dx.doi.org/10.1038/nn1509			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16041370				2022-12-28	WOS:000230760200014
J	Marcaggi, P; Attwell, D				Marcaggi, P; Attwell, D			Endocannabinoid signaling depends on the spatial pattern of synapse activation	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; PARALLEL FIBER SYNAPSES; LONG-TERM DEPRESSION; RETROGRADE INHIBITION; ENDOGENOUS CANNABINOIDS; CURRENTS; TRANSPORTERS; RELEASE	The brain's endocannabinoid retrograde messenger system decreases presynaptic transmitter release, but its physiological function is uncertain. We show that endocannabinoid signaling is absent when spatially dispersed synapses are activated on rodent cerebellar Purkinje cells but that it reduces presynaptic glutamate release when nearby synapses are active. This switching of signaling according to the spatial pattern of activity is controlled by postsynaptic type I metabotropic glutamate receptors, which are activated disproportionately when glutamate spillover between synapses produces synaptic crosstalk. When spatially distributed synapses are activated, endocannabinoid inhibition of transmitter release can be rescued by inhibiting glutamate uptake to increase glutamate spillover. Endocannabinoid signaling initiated by type I metabotropic glutamate receptors is a homeostatic mechanism that detects synaptic crosstalk and downregulates glutamate release in order to promote synaptic independence.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Marcaggi, P (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	P.Marcaggi@ucl.ac.uk	Marcaggi, Païkan/GYU-1658-2022; Attwell, David/ABE-6750-2020; Marcaggi, Païkan/P-5855-2016	Marcaggi, Païkan/0000-0003-3575-8340	Wellcome Trust [017948, 075232] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Coutinho V, 2004, EUR J NEUROSCI, V20, P740, DOI 10.1111/j.1460-9568.2004.03533.x; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Levenes C, 2001, J PHYSIOL-LONDON, V537, P125, DOI 10.1111/j.1469-7793.2001.0125k.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Neale SA, 2001, NEUROPHARMACOLOGY, V41, P42, DOI 10.1016/S0028-3908(01)00046-6; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	25	88	89	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					776	781		10.1038/nn1458	http://dx.doi.org/10.1038/nn1458			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15864304	Green Accepted			2022-12-28	WOS:000229345300018
J	Silvanto, J; Cowey, A; Lavie, N; Walsh, V				Silvanto, J; Cowey, A; Lavie, N; Walsh, V			Striate cortex (V1) activity gates awareness of motion	NATURE NEUROSCIENCE			English	Article								A key question in understanding visual awareness is whether any single cortical area is indispensable. In a transcranial magnetic stimulation experiment, we show that observers' awareness of activity in extrastriate area V5 depends on the amount of activity in striate cortex (V1). From the timing and pattern of effects, we infer that back-projections from extrastriate cortex influence information content in V1, but it is V1 that determines whether that information reaches awareness.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of Oxford	Silvanto, J (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	juha.silvanto@ucl.ac.uk	Lavie, Nilli/A-3560-2010	Silvanto, Juha/0000-0001-6044-5296				Angelucci A, 2002, J NEUROSCI, V22, P8633; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; SILVANTO J, IN PRESS CEREB CORTE; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; Weiskrantz L., 1986, BLINDSIGHT CASE STUD	14	155	158	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					143	144		10.1038/nn1379	http://dx.doi.org/10.1038/nn1379			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643428				2022-12-28	WOS:000226638200010
J	Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC				Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC			Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; N-TERMINAL KINASE; SMALL GTPASES RAC; RHO-GTPASES; VERTEBRATE GASTRULATION; NEURONAL MORPHOGENESIS; TRANSDUCTION PATHWAY; ACTIN CYTOSKELETON; PYRAMIDAL NEURONS; BETA-CATENIN	Dendritic arborization is required for proper neuronal connectivity. Rho GTPases have been implicated in the regulation of dendrite development. However, the signaling pathways that impinge on these molecular switches remain poorly understood. Here we show that Wnt7b, which is expressed in the mouse hippocampus, increases dendritic branching in cultured hippocampal neurons. This effect is mimicked by the expression of Dishevelled (Dvl) and is blocked by Sfrp1, a secreted Wnt antagonist. Consistent with these findings, hippocampal neurons from mice lacking Dvl1 show reduced dendritic arborization. Activation of the canonical Wnt-Gsk3beta pathway does not affect dendritic development. In contrast, Wnt7b and Dvl activate Rac and JNK in hippocampal neurons. Dominant-negative Rac, dominant-negative JNK or inhibition of JNK blocks Dvl-mediated dendritic growth. These findings demonstrate a new function for the non-canonical Wnt pathway in dendrite development and identify Dvl as a regulator of Rho GTPases and JNK during dendritic morphogenesis.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Salinas, PC (corresponding author), UCL, Dept Anat & Dev Biol, Rockefeller Bldg,Univ St, London WC1E 6BT, England.	p.salinas@ucl.ac.uk		Salinas, Patricia C./0000-0002-5748-083X	NINDS NIH HHS [R01 NS073159] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Coffey ET, 2000, J NEUROSCI, V20, P7602; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paglini G, 1998, J NEUROSCI, V18, P9858; Penton A, 2002, GENETICS, V161, P747; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	50	372	379	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					34	42		10.1038/nn1374	http://dx.doi.org/10.1038/nn1374			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608632				2022-12-28	WOS:000225967600013
J	Woods, C; Montcouquiol, M; Kelley, MW				Woods, C; Montcouquiol, M; Kelley, MW			Math1 regulates development of the sensory epithelium in the mammalian cochlea	NATURE NEUROSCIENCE			English	Article							HAIR CELL-DIFFERENTIATION; INNER-EAR DEVELOPMENT; MIND-BOMB MUTANT; GAMMA-SECRETASE; ORGAN DEVELOPMENT; EXPRESSION; NOTCH; ZEBRAFISH; CORTI; PROTEINS	The transcription factor Math1 (encoded by the gene Atoh1, also called Math1) is required for the formation of mechanosensory hair cells in the inner ear; however, its specific molecular role is unknown. Here we show that absence of Math1 in mice results in a complete disruption of formation of the sensory epithelium of the cochlea, including the development of both hair cells and associated supporting cells. In addition, ectopic expression of Math1 in nonsensory regions of the cochlea is sufficient to induce the formation of sensory clusters that contain both hair cells and supporting cells. The formation of these clusters is dependent on inhibitory interactions mediated, most probably, through the Notch pathway, and on inductive interactions that recruit cells to develop as supporting cells through a pathway independent of Math1. These results show that Math1 functions in the developing cochlea to initiate both inductive and inhibitory signals that regulate the overall formation of the sensory epithelia.	NIDCD, Sect Dev Neurosci, NIH, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kelley, MW (corresponding author), NIDCD, Sect Dev Neurosci, NIH, Porter Neurosci Res Ctr, Bldg 35, Bethesda, MD 20892 USA.	kelleymt@nidcd.nih.gov	montcouquiol, mireille/L-6199-2017	montcouquiol, mireille/0000-0001-8739-6519	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000059, ZIADC000059] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adam J, 1998, DEVELOPMENT, V125, P4645; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bianchi LM, 1999, ANAT RECORD, V256, P64, DOI 10.1002/(SICI)1097-0185(19990901)256:1<64::AID-AR8>3.0.CO;2-H; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; CernudaCernuda R, 1996, MICROSC RES TECHNIQ, V34, P302, DOI 10.1002/(SICI)1097-0029(19960701)34:4<302::AID-JEMT3>3.0.CO;2-Q; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1991, CIBA F SYMP, V160, P103; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Haddon C, 1999, J NEUROCYTOL, V28, P837, DOI 10.1023/A:1007013904913; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Helms AW, 2000, DEVELOPMENT, V127, P1185; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kelley MW, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P137; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kimberly WT, 2003, J NEUROSCI RES, V74, P353, DOI 10.1002/jnr.10736; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lanford RJ, 2000, JARO-J ASSOC RES OTO, V1, P161, DOI 10.1007/sl01620010023; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Morsli H, 1998, J NEUROSCI, V18, P3327; Mueller KL, 2002, J NEUROSCI, V22, P9368; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; Picard Didier, 1994, Current Opinion in Biotechnology, V5, P511, DOI 10.1016/0958-1669(94)90066-3; Rau A, 1999, J COMP NEUROL, V405, P271; Riley BB, 1999, DEVELOPMENT, V126, P5669; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; Rubel E. W, 1978, HDB SENSORY PHYSL, VIX, P135; Shailam R, 1999, J NEUROCYTOL, V28, P809, DOI 10.1023/A:1007009803095; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zine A, 2000, DEVELOPMENT, V127, P3373; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	46	307	329	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1310	1318		10.1038/nn1349	http://dx.doi.org/10.1038/nn1349			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543141				2022-12-28	WOS:000225353900011
J	Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC				Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC			Bypassing V1: a direct geniculate input to area MT	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; MIDDLE TEMPORAL AREA; MACAQUE MONKEY; SUPERIOR COLLICULUS; STRIATE CORTEX; KONIOCELLULAR PATHWAY; RESPONSE PROPERTIES; INFERIOR PULVINAR; PRESTRIATE CORTEX; DIRECT PROJECTION	Thalamic nuclei are thought to funnel sensory information to the brain's primary cortical areas, which in turn transmit signals afresh to higher cortical areas. Here we describe a direct projection in the macaque monkey from the lateral geniculate nucleus (LGN) to the motion-selective middle temporal area (MT or V5), a cortical area not previously considered 'primary'. The constituent neurons are mostly koniocellular, send virtually no collateral axons to primary visual cortex (V1) and equal about 10% of the V1 population innervating MT. This pathway could explain the persistence of motion sensitivity in subjects following injury to V1, suggesting more generally that residual perception after damage in a primary area may arise from sparse thalamic input to 'secondary' cortical areas.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sincich, LC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Koret Way, San Francisco, CA 94143 USA.	sincich@itsa.ucsf.edu		Horton, Jonathan/0000-0002-3952-435X; Wohlgemuth, Melville/0000-0003-4779-4154				BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BENEVENTO LA, 1981, J COMP NEUROL, V203, P455, DOI 10.1002/cne.902030309; BENEVENTO LA, 1982, BRAIN RES, V252, P161, DOI 10.1016/0006-8993(82)90991-X; BULLIER J, 1983, EXP BRAIN RES, V53, P168; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Collins CE, 2003, J NEUROSCI, V23, P2251; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Cropper SJ, 1996, NATURE, V379, P72, DOI 10.1038/379072a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1981, PROC R SOC SER B-BIO, V213, P73, DOI 10.1098/rspb.1981.0054; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUMPHREY NK, 1967, NATURE, V215, P595, DOI 10.1038/215595a0; LYSAKOWSKI A, 1988, EXP BRAIN RES, V69, P651; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nowak LG, 1997, CEREBR CORT, V12, P205; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rodman HR, 2001, J COMP NEUROL, V431, P168, DOI 10.1002/1096-9861(20010305)431:2<168::AID-CNE1063>3.0.CO;2-N; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sorenson KM, 1999, NEUROREPORT, V10, P3295, DOI 10.1097/00001756-199911080-00009; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; Stepniewska I, 2000, VISUAL NEUROSCI, V17, P529, DOI 10.1017/S0952523800174048; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; UNGERLEIDER LG, 1979, J COMP NEUROL, V188, P347, DOI 10.1002/cne.901880302; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; YOSHIDA K, 1981, NEUROSCI LETT, V22, P103, DOI 10.1016/0304-3940(81)90071-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1969, BRAIN RES, V13, P197, DOI 10.1016/0006-8993(69)90282-0	50	348	350	2	43	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1123	1128		10.1038/nn1318	http://dx.doi.org/10.1038/nn1318			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378066				2022-12-28	WOS:000224156900022
J	Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL				Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL			Attentional modulation of human auditory cortex	NATURE NEUROSCIENCE			English	Article							INTERMODAL SELECTIVE ATTENTION; LEVEL-DEPENDENT REPRESENTATION; EVENT-RELATED FMRI; TONOTOPIC ORGANIZATION; VISUAL-CORTEX; NEURAL MECHANISMS; CORTICAL AREAS; STIMULI; FREQUENCY; MEMORY	Attention powerfully influences auditory perception, but little is understood about the mechanisms whereby attention sharpens responses to unattended sounds. We used high-resolution surface mapping techniques (using functional magnetic resonance imaging, fMRI) to examine activity in human auditory cortex during an intermodal selective attention task. Stimulus-dependent activations (SDAs), evoked by unattended sounds during demanding visual tasks, were maximal over mesial auditory cortex. They were tuned to sound frequency and location, and showed rapid adaptation to repeated sounds. Attention-related modulations (ARMs) were isolated as response enhancements that occurred when subjects performed pitch-discrimination tasks. In contrast to SDAs, ARMs were localized to lateral auditory cortex, showed broad frequency and location tuning, and increased in amplitude with sound repetition. The results suggest a functional dichotomy of auditory cortical fields: stimulus-determined mesial fields that faithfully transmit acoustic information, and attentionally labile lateral fields that analyze acoustic features of behaviorally relevant sounds.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; VANCHCS, Martinez, CA 95553 USA; Univ Calif Davis, Human Cognit Neurophysiol Lab, Martinez, CA USA; Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; INSERM, U280, Mental Proc & Brain Activat Lab, F-69424 Lyon 03, France; Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.	dlwoods@ucdavis.edu	Alho, Kimmo/G-2997-2013; Bertrand, Olivier/B-6165-2008; Petkov, Christopher/O-5318-2015	Alho, Kimmo/0000-0001-8563-2792; Bertrand, Olivier/0000-0003-0733-7979; Petkov, Christopher/0000-0002-4932-7907; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NIDCD NIH HHS [DC005814] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005814] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ALCAINI M, 1994, PSYCHOPHYSIOLOGY, V31, P611, DOI 10.1111/j.1469-8986.1994.tb02354.x; ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Gaab N, 2003, J COGNITIVE NEUROSCI, V15, P810, DOI 10.1162/089892903322370735; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Jancke L, 1999, COGNITIVE BRAIN RES, V8, P117, DOI 10.1016/S0926-6410(99)00012-9; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kosaki H, 1997, J COMP NEUROL, V386, P304; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; WOODS DL, 1980, SCIENCE, V207, P655, DOI 10.1126/science.7352278; Woods DL, 2001, J COGNITIVE NEUROSCI, V13, P492, DOI 10.1162/08989290152001916; WOODS DL, 1990, EVENT RELATED BRAIN, P178	50	256	257	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					658	663		10.1038/nn1256	http://dx.doi.org/10.1038/nn1256			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156150				2022-12-28	WOS:000221640300021
J	Rice, ME; Cragg, SJ				Rice, ME; Cragg, SJ			Nicotine amplifies reward-related dopamine signals in striatum	NATURE NEUROSCIENCE			English	Article							BETA-2 SUBUNIT; RELEASE; NEURONS; RAT	Reward-seeking behaviors depend critically on dopamine signaling-dopamine neurons encode reward-related information by switching from tonic to phasic (burst-like) activity. Using guinea pig brain slices, we show that nicotine, like cocaine and amphetamine, acts directly in striatum where it enhances dopamine release during phasic but not tonic activity. This amplification provides a mechanism for nicotine facilitation of reward-related dopamine signals, including responses to other primary reinforcers that govern nicotine dependence in smokers.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	University of Oxford; New York University	Cragg, SJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	cragg@pharm.ox.ac.uk		Rice, Margaret/0000-0003-1793-2798; Cragg, Stephanie/0000-0001-9677-2256				Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Cragg SJ, 2003, J NEUROSCI, V23, P4378; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Thomson AM, 2000, PROG NEUROBIOL, V62, P159, DOI 10.1016/S0301-0082(00)00008-3; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	15	403	406	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					583	584		10.1038/nn1244	http://dx.doi.org/10.1038/nn1244			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146188				2022-12-28	WOS:000221640300009
J	Heintz, N				Heintz, N			Gene expression nervous system atlas (GENSAT)	NATURE NEUROSCIENCE			English	Article									Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute	Heintz, N (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	heintz@rockvax.rockefeller.edu						Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033	1	214	218	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					483	483		10.1038/nn0504-483	http://dx.doi.org/10.1038/nn0504-483			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114362	Bronze			2022-12-28	WOS:000221101300017
J	van Schie, HT; Mars, RB; Coles, MGH; Bekkering, H				van Schie, HT; Mars, RB; Coles, MGH; Bekkering, H			Modulation of activity in medial frontal and motor cortices during error observation	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; NEURAL SYSTEM; HAND ACTIONS; MECHANISMS; REWARD; IMITATION; SELECTION; PSYCHOPHYSIOLOGY; DISSOCIATION	We used measures of the human event-related brain potential (ERP) to investigate the neural mechanisms underlying error processing during action observation. Participants took part in two conditions, a task execution condition and a task observation condition. We found that activity in both the medial frontal cortex and the motor cortices, as measured via the error-related negativity and the lateralized readiness potential, respectively, was modulated by the correctness of observed behavior. These data suggest that similar neural mechanisms are involved in monitoring one's own actions and the actions of others.	Univ Nijmegen, Nijmegen Inst Cognit & Informat, NL-6500 HE Nijmegen, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	van Schie, HT (corresponding author), Univ Nijmegen, Nijmegen Inst Cognit & Informat, Box 9104, NL-6500 HE Nijmegen, Netherlands.	h.vanschie@nici.kun.nl	van Schie, Hein T/D-2281-2010; Mars, Rogier/G-2312-2018; Mars, Rogier/GWZ-9665-2022; Bekkering, Harold/A-6357-2009	Mars, Rogier/0000-0001-6302-8631; 				Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Blandin Y, 2000, Q J EXP PSYCHOL-A, V53, P846, DOI 10.1080/027249800410571; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holroyd C., 2004, ERRORS CONFLICTS BRA, P211; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; HOLROYD CB, COGNITIVE NEUROSCIEN; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Leuthold H, 2002, BIOL PSYCHOL, V60, P173, DOI 10.1016/S0301-0511(02)00032-7; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Miller J, 1996, ACTA PSYCHOL, V94, P189, DOI 10.1016/0001-6918(95)00046-1; Miltner W., 2004, ERRORS CONFLICTS BRA, P124; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petrosini L, 2003, BRAIN RES REV, V42, P252, DOI 10.1016/S0165-0173(03)00176-0; Piaget J., 1962, PLAY DREAMS IMITATIO; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; SCHERG M, 1996, BESA BRAIN ELECT SOU; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x	40	327	329	2	35	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					549	554		10.1038/nn1239	http://dx.doi.org/10.1038/nn1239			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	816HP	15107858				2022-12-28	WOS:000221101300033
J	Sato, M; Umetsu, D; Murakami, S; Yasugi, T; Tabata, T				Sato, M; Umetsu, D; Murakami, S; Yasugi, T; Tabata, T			DWnt4 regulates the dorsoventral specificity of retinal projections in the Drosophila melanogaster visual system	NATURE NEUROSCIENCE			English	Article							AXON GUIDANCE; WINGLESS; WNT; EYE; MORPHOGENESIS; KINASE; GENES; PROTEINS; RECEPTOR; BRAIN	In Drosophila melanogaster, the axons of retinal photoreceptor cells extend to the first optic ganglion, the lamina, forming a topographic representation. Here we show that DWnt4, a secreted protein of the Wnt family, is the ventral cue for the lamina. In DWnt4 mutants, ventral retinal axons misprojected to the dorsal lamina. DWnt4 was normally expressed in the ventral half of the developing lamina and DWnt4 protein was detected along ventral retinal axons. Dfrizzled2 and dishevelled, respectively, encode a receptor and a signaling molecule required for Wnt signaling. Mutations in both genes caused DWnt4-like defects, and both genes were autonomously required in the retina, suggesting a direct role of DWnt4 in retinal axon guidance. In contrast, iroquois homeobox genes are the dorsal cues for the retina. Dorsal axons accumulated DWnt4 and misprojected to the ventral lamina in iroquois mutants; the phenotype was suppressed in iroquois Dfrizzled2 mutants, suggesting that iroquois may attenuate the competence of Dfrizzled2 to respond to DWnt4.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Morphogenesis, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Tabata, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Morphogenesis, Bunkyo Ku, Tokyo 1130032, Japan.	ttabata@iam.u-tokyo.ac.jp	Yasugi, Tetsuo/N-4913-2015	Sato, Makoto/0000-0002-7763-0751				Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Chen CM, 1999, DEVELOPMENT, V126, P5441; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; GRABA Y, 1995, DEVELOPMENT, V121, P209; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; KUNES S, 1993, J NEUROSCI, V13, P752; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Oh SW, 2003, GENETICS, V163, P195; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pai LM, 1997, DEVELOPMENT, V124, P2255; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Stowers RS, 1999, GENETICS, V152, P1631; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	41	68	74	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					67	75		10.1038/nn1604	http://dx.doi.org/10.1038/nn1604			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369482				2022-12-28	WOS:000234288000019
J	Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP				Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP			Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOLECULAR-WEIGHT COMPLEXES; B-LIKE IMMUNOREACTIVITY; BRAIN MICROGLIAL CELLS; MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; TRANSGENIC MICE; FAMILIAL ALS; SPINAL-CORD; MOUSE MODEL	Here we report that chromogranins, components of neurosecretory vesicles, interact with mutant forms of superoxide dismutase (SOD1) that are linked to amyotrophic lateral sclerosis (ALS), but not with wild-type SOD1. This interaction was confirmed by yeast two-hybrid screen and by co-immunoprecipitation assays using either lysates from Neuro2a cells coexpressing chromogranins and SOD1 mutants or lysates from spinal cord of ALS mice. Confocal and immunoelectron microscopy revealed a partial colocalization of mutant SOD1 with chromogranins in spinal cord of ALS mice. Mutant SOD1 was also found in immuno-isolated trans-Golgi network and in microsome preparations, suggesting that it can be secreted. Indeed we report evidence that chromogranins may act as chaperone-like proteins to promote secretion of SOD1 mutants. From these results, and our finding that extracellular mutant SOD1 can trigger microgliosis and neuronal death, we propose a new ALS pathogenic model based on the toxicity of secreted SOD1 mutants.	Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada; Univ Laval Robert Giffard, Dept Psychiat, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Laval University; Laval University; RIKEN	Julien, JP (corresponding author), Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	jean-pierre.julien@crchul.ulaval.ca	Nukina, Nobuyuki/GPP-6265-2022	Urushitani, Makoto/0000-0003-2773-9836				BOOJ S, 1989, NEUROSCIENCE, V30, P479, DOI 10.1016/0306-4522(89)90267-4; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Ciesielski-Treska J, 1998, J BIOL CHEM, V273, P14339, DOI 10.1074/jbc.273.23.14339; Ciesielski-Treska J, 2001, J BIOL CHEM, V276, P13113, DOI 10.1074/jbc.M009711200; Cimini V, 2002, HISTOCHEM CELL BIOL, V118, P163, DOI 10.1007/s00418-002-0429-8; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kato A, 2000, BRAIN RES, V852, P444, DOI 10.1016/S0006-8993(99)02229-5; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Li JY, 1999, EUR J NEUROSCI, V11, P528, DOI 10.1046/j.1460-9568.1999.00456.x; LI JY, 1992, J NEUROBIOL, V23, P1094, DOI 10.1002/neu.480230813; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Marksteiner J, 2000, ACTA NEUROPATHOL, V100, P205, DOI 10.1007/s004010000239; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Parkin ET, 1999, J NEUROCHEM, V72, P1534, DOI 10.1046/j.1471-4159.1999.721534.x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; SCHIFFER D, 1995, J NEUROL SCI, V129, P68, DOI 10.1016/0022-510X(95)00068-D; SHARPLESS N, 1992, VIROLOGY, V191, P813, DOI 10.1016/0042-6822(92)90257-P; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; Stieber A, 2004, J NEUROL SCI, V219, P45, DOI 10.1016/j.jns.2003.12.004; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 1996, NEUROSCIENCE, V72, P377, DOI 10.1016/0306-4522(96)83172-1; Taylor DL, 2003, J NEUROSCI, V23, P2150; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	47	318	342	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					108	118		10.1038/nn1603	http://dx.doi.org/10.1038/nn1603			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369483				2022-12-28	WOS:000234288000024
J	Voss, M; Ingram, JN; Haggard, P; Wolpert, DM				Voss, M; Ingram, JN; Haggard, P; Wolpert, DM			Sensorimotor attenuation by central motor command signals in the absence of movement	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; VOLUNTARY MOVEMENT; HUMAN BRAIN; STIMULATION; PERCEPTION; SUPPRESSION; DELAY; TIME	Voluntary actions typically produce suppression of afferent sensation from the moving body part. We used transcranial magnetic stimulation to delay the output of motor commands from the motor cortex during voluntary movement. We show attenuation of sensation during this delay, in the absence of movement. We conclude that sensory suppression mainly relies on central signals related to the preparation for movement and that these signals are upstream of primary motor cortex.	Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; Dept Psychol, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Voss, M (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	martin.voss@charite.de	Haggard, Patrick/A-5081-2010	Wolpert, Daniel/0000-0003-2011-2790; Voss, Martin/0000-0002-5221-4647; Haggard, Patrick/0000-0001-7798-793X	Wellcome Trust [077730] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; PALMER E, 1994, J PHYSIOL-LONDON, V481, P509, DOI 10.1113/jphysiol.1994.sp020459; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P230, DOI 10.1016/0168-5597(94)90045-0; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; SEYAL M, 1992, ELECTROEN CLIN NEURO, V85, P397, DOI 10.1016/0168-5597(92)90053-E; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464; Wasaka T, 2003, NEUROIMAGE, V20, P1830, DOI 10.1016/S1053-8119(03)00442-7; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Ziemann U, 1997, BRAIN RES, V744, P32, DOI 10.1016/S0006-8993(96)01062-1	15	151	151	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					26	27		10.1038/nn1592	http://dx.doi.org/10.1038/nn1592			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311591	Green Accepted			2022-12-28	WOS:000234288000013
J	Yoshimura, Y; Callaway, EM				Yoshimura, Y; Callaway, EM			Fine-scale specificity of cortical networks depends on inhibitory cell type and connectivity	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; INTRINSIC FIRING PATTERNS; RAT FRONTAL-CORTEX; PYRAMIDAL CELLS; LOCAL CIRCUITS; MACAQUE MONKEY; BARREL CORTEX; NEURONS; INTERNEURONS; NEOCORTEX	Excitatory cortical neurons form fine-scale networks of precisely interconnected neurons. Here we tested whether inhibitory cortical neurons in rat visual cortex might also be connected with fine-scale specificity. Using paired intracellular recordings and cross-correlation analyses of photostimulation-evoked synaptic currents, we found that fast-spiking interneurons preferentially connected to neighboring pyramids that provided them with reciprocal excitation. Furthermore, they shared common fine-scale excitatory input with neighboring pyramidal neurons only when the two cells were reciprocally connected, and not when there was no connection or a one-way, inhibitory-to-excitatory connection. Adapting inhibitory neurons shared little or no common input with neighboring pyramids, regardless of their direct connectivity. We conclude that inhibitory connections and also excitatory connections to inhibitory neurons can both be precise on a fine scale. Furthermore, fine-scale specificity depends on the type of inhibitory neuron and on direct connectivity between neighboring pyramidal-inhibitory neuron pairs.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Nagoya Univ, Environm Med Res Inst, Dept Visual Neurosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Salk Institute; Nagoya University	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Yoshimura, Yumiko/0000-0002-7526-4153	NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NEI NIH HHS [EY010742] Funding Source: Medline; NIMH NIH HHS [MH063912, R01 MH063912] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AGMON A, 1992, J NEUROSCI, V12, P319; Blatow M, 2005, J PHYSIOL-LONDON, V562, P99, DOI 10.1113/jphysiol.2004.078584; Briggs F, 2001, J NEUROSCI, V21, P3600, DOI 10.1523/JNEUROSCI.21-10-03600.2001; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Martin K. A. C., 1984, CEREB CORTEX, V2, P241; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; SHEPHERD GM, 2005, NAT NEUROSCI; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	40	263	265	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1552	1559		10.1038/nn1565	http://dx.doi.org/10.1038/nn1565			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222228				2022-12-28	WOS:000232966600030
J	Boyden, ES; Zhang, F; Bamberg, E; Nagel, G; Deisseroth, K				Boyden, ES; Zhang, F; Bamberg, E; Nagel, G; Deisseroth, K			Millisecond-timescale, genetically targeted optical control of neural activity	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; REMOTE-CONTROL; LASER PHOTOSTIMULATION; HIPPOCAMPAL-NEURONS; ION CHANNELS; MICROSTIMULATION; LIGHT; CHLAMYDOMONAS; CIRCUITS; DEPENDENCE	Temporally precise, noninvasive control of activity in well-defined neuronal populations is a long-sought goal of systems neuroscience. We adapted for this purpose the naturally occurring algal protein Channelrhodopsin-2, a rapidly gated light-sensitive cation channel, by using lentiviral gene delivery in combination with high-speed optical switching to photostimulate mammalian neurons. We demonstrate reliable, millisecond-timescale control of neuronal spiking, as well as control of excitatory and inhibitory synaptic transmission. This technology allows the use of light to alter neural processing at the level of single spikes and synaptic events, yielding a widely applicable tool for neuroscientists and biomedical engineers.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; Univ Frankfurt, Dept Biochem Chem & Pharmaceut, D-60439 Frankfurt, Germany; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Max Planck Society; Goethe University Frankfurt; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Macrae, Rhiannon/AAX-1536-2020	Nagel, Georg/0000-0001-8174-8712				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	30	3026	3201	47	759	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1263	1268		10.1038/nn1525	http://dx.doi.org/10.1038/nn1525			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116447				2022-12-28	WOS:000231483800028
J	Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B				Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B			Activation of p75(NTR) by proBDNF facilitates hippocampal long-term depression	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); ACTIVITY-DEPENDENT SECRETION; NERVE GROWTH-FACTOR; RAT DENTATE GYRUS; SIGNAL-TRANSDUCTION; SYNAPTIC PLASTICITY; AREA CA1; BDNF; MICE; NEURONS	Pro- and mature brain-derived neurotrophic factor (BDNF) activate two distinct receptors: p75 neurotrophin receptor (p75(NTR)) and TrkB. Mature BDNF facilitates hippocampal synaptic potentiation through TrkB. Here we report that proBDNF, by activating p75(NTR), facilitates hippocampal long-term depression (LTD). Electron microscopy showed that p75(NTR) localized in dendritic spines, in addition to afferent terminals, of CA1 neurons. Deletion of p75(NTR) in mice selectively impaired the NMDA receptor - dependent LTD, without affecting other forms of synaptic plasticity. p75(NTR-/-) mice also showed a decrease in the expression of NR2B, an NMDA receptor subunit uniquely involved in LTD. Activation of p75(NTR) by proBDNF enhanced NR2B-dependent LTD and NR2B-mediated synaptic currents. These results show a crucial role for proBDNF-p75(NTR) signaling in LTD and its potential mechanism, and together with the finding that mature BDNF promotes synaptic potentiation, suggest a bidirectional regulation of synaptic plasticity by proBDNF and mature BDNF.	NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; Cornell Univ, Weill Med coll, Dept Med, Div Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med coll, Dept Neurol & Neurosci, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; Cornell University	Lu, B (corresponding author), NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, 35 Lincoln Dr, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18974] Funding Source: Medline; NINDS NIH HHS [NS30658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; Dougherty KD, 1999, J NEUROSCI, V19, P10140; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Ikegaya Y, 2002, EUR J NEUROSCI, V16, P145, DOI 10.1046/j.1460-9568.2002.02051.x; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; LU B, IN PRESS NAT REV NEU; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peters A., 1991, FINE STRUCTURE NERVO; Peters I, 2001, WORLD LITERATURE TOD, V75, P404, DOI 10.2307/40156724; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Wright JW, 2004, BEHAV BRAIN RES, V153, P453, DOI 10.1016/j.bbr.2004.01.001; YAN Q, 1988, J NEUROSCI, V8, P3481	50	595	620	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1069	1077		10.1038/nn1510	http://dx.doi.org/10.1038/nn1510			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025106				2022-12-28	WOS:000230760200019
J	Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR				Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR			Reference frames for representing visual and tactile locations in parietal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL INTRAPARIETAL AREA; PRIMATE SUPERIOR COLLICULUS; EYE POSITION; RECEPTIVE-FIELDS; MACAQUE; NEURONS; RESPONSES; GAZE; SPACE; CONNECTIONS	The ventral intraparietal area (VIP) receives converging inputs from visual, somatosensory, auditory and vestibular systems that use diverse reference frames to encode sensory information. A key issue is how VIP combines those inputs together. We mapped the visual and tactile receptive fields of multimodal VIP neurons in macaque monkeys trained to gaze at three different stationary targets. Tactile receptive fields were found to be encoded into a single somatotopic, or head-centered, reference frame, whereas visual receptive fields were widely distributed between eye-to head-centered coordinates. These findings are inconsistent with a remapping of all sensory modalities in a common frame of reference. Instead, they support an alternative model of multisensory integration based on multidirectional sensory predictions (such as predicting the location of a visual stimulus given where it is felt on the skin and vice versa). This approach can also explain related findings in other multimodal areas.	CNRS, Inst Cognit Sci, F-69675 Bron, France; Catholic Univ Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Centre National de la Recherche Scientifique (CNRS); Universite Catholique Louvain; University of Rochester	Duhamel, JR (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	duhamel@isc.cnrs.fr	Duhamel, Jean-René/M-4723-2017	Duhamel, Jean-René/0000-0003-0210-1027; AVILLAC, Marie/0000-0002-1003-8251; Pouget, Alexandre/0000-0003-3054-6365				ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1999, NEUROREPORT, V10, P873, DOI 10.1097/00001756-199903170-00037; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GARDNER EP, 1984, ELECTROEN CLIN NEURO, V58, P537, DOI 10.1016/0013-4694(84)90044-0; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Graziano Michael S. A., 1995, P1021; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Neppi-Modona M, 2004, CURR BIOL, V14, P1174, DOI 10.1016/j.cub.2004.06.047; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	49	325	329	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					941	949		10.1038/nn1480	http://dx.doi.org/10.1038/nn1480			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951810				2022-12-28	WOS:000230137100022
J	Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR				Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR			5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression	NATURE NEUROSCIENCE			English	Article							SEROTONIN TRANSPORTER; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS; ANTERIOR CINGULATE; GLUCOSE-METABOLISM; MOOD DISORDERS; HUMAN BRAIN	Carriers of the short allele of a functional 5' promoter polymorphism of the serotonin transporter gene have increased anxiety-related temperamental traits, increased amygdala reactivity and elevated risk of depression. Here, we used multimodal neuroimaging in a large sample of healthy human subjects to elucidate neural mechanisms underlying this complex genetic association. Morphometrical analyses showed reduced gray matter volume in short-allele carriers in limbic regions critical for processing of negative emotion, particularly perigenual cingulate and amygdala. Functional analysis of those regions during perceptual processing of fearful stimuli demonstrated tight coupling as a feedback circuit implicated in the extinction of negative affect. Short-allele carriers showed relative uncoupling of this circuit. Furthermore, the magnitude of coupling inversely predicted almost 30% of variation in temperamental anxiety. These genotype-related alterations in anatomy and function of an amygdala-cingulate feedback circuit critical for emotion regulation implicate a developmental, systems- level mechanism underlying normal emotional reactivity and genetic susceptibility for depression.	NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Weinberger, DR (corresponding author), NIMH, Genes Cognit & Psychosis Program, NIH, 10 Ctr Dr 4S235, Bethesda, MD 20892 USA.	weinberd@intra.nimh.nih.gov	Hariri, Ahmad/D-5761-2011; Pezawas, Lukas/A-2367-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Pezawas, Lukas/0000-0002-1329-6352; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002734, ZIAMH002716, Z01MH002716, ZIAMH002734, Z01MH002867] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Keightley ML, 2003, NEUROIMAGE, V20, P2031, DOI 10.1016/j.neuroimage.2003.08.022; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Reif A, 2003, BEHAV BRAIN RES, V139, P1, DOI 10.1016/S0166-4328(02)00267-X; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Shirao N, 2005, BRIT J PSYCHIAT, V186, P48, DOI 10.1192/bjp.186.1.48; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wu JC, 2001, NEUROPSYCHOPHARMACOL, V25, pS74, DOI 10.1016/S0893-133X(01)00336-0	50	1477	1514	2	254	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					828	834		10.1038/nn1463	http://dx.doi.org/10.1038/nn1463			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880108				2022-12-28	WOS:000229345300025
J	Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K				Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K			Geometric and functional organization of cortical circuits	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; QUANTITATIVE-ANALYSIS; SOMATOSENSORY CORTEX; LAYER 4; RAT; PLASTICITY; CELLS; CONNECTIVITY; PROJECTION	Can neuronal morphology predict functional synaptic circuits? In the rat barrel cortex, 'barrels' and 'septa' delineate an orderly matrix of cortical columns. Using quantitative laser scanning photostimulation we measured the strength of excitatory projections from layer 4 (L4) and L5A to L2/3 pyramidal cells in barrel- and septum-related columns. From morphological reconstructions of excitatory neurons we computed the geometric circuit predicted by axodendritic overlap. Within most individual projections, functional inputs were predicted by geometry and a single scale factor, the synaptic strength per potential synapse. This factor, however, varied between projections and, in one case, even within a projection, up to 20-fold. Relationships between geometric overlap and synaptic strength thus depend on the laminar and columnar locations of both the pre- and postsynaptic neurons, even for neurons of the same type. A large plasticity potential appears to be incorporated into these circuits, allowing for functional 'tuning' with fixed axonal and dendritic arbor geometry.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Northeastern University; Northeastern University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010; Bureau, Ingrid/O-3941-2016	Bureau, Ingrid/0000-0001-9166-2250	NINDS NIH HHS [K25 NS047138] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS047138] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender KJ, 2003, J NEUROSCI, V23, P8759; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CAJAL SRY, 1891, CELLULE, V7, P125; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRACE AA, 1985, NEUROSCIENCE, V16, P461, DOI 10.1016/0306-4522(85)90018-1; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Ichinohe N, 2003, J NEUROSCI, V23, P1372, DOI 10.1523/JNEUROSCI.23-04-01372.2003; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kim U, 1999, J COMP NEUROL, V408, P489; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; REN JQ, 1992, EXP BRAIN RES, V92, P1; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SHEPHERD GMG, IN PRESS J NEUROSCI; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STAIGER JF, 2004, CEREB CORTEX; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; UTTLEY AM, 1955, PROC R SOC SER B-BIO, V144, P229, DOI 10.1098/rspb.1955.0054; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	182	187	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					782	790		10.1038/nn1447	http://dx.doi.org/10.1038/nn1447			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880111				2022-12-28	WOS:000229345300019
J	Welchman, AE; Deubelius, A; Conrad, V; Bulthoff, HH; Kourtzi, Z				Welchman, AE; Deubelius, A; Conrad, V; Bulthoff, HH; Kourtzi, Z			3D shape perception from combined depth cues in human visual cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; DISPARITY-SELECTIVE NEURONS; LATERAL OCCIPITAL COMPLEX; STRUCTURE-FROM-MOTION; SURFACE ORIENTATION; AREA MT; BINOCULAR DISPARITY; RELATIVE DISPARITY; CORTICAL-NEURONS; RESPONSES	Our perception of the world's three-dimensional (3D) structure is critical for object recognition, navigation and planning actions. To accomplish this, the brain combines different types of visual information about depth structure, but at present, the neural architecture mediating this combination remains largely unknown. Here, we report neuroimaging correlates of human 3D shape perception from the combination of two depth cues. We measured fMRI responses while observers judged the 3D structure of two sequentially presented images of slanted planes defined by binocular disparity and perspective. We compared the behavioral and fMRI responses evoked by changes in one or both of the depth cues. fMRI responses in extrastriate areas (hMT +/V5 and lateral occipital complex), rather than responses in early retinotopic areas, reflected differences in perceived 3D shape, suggesting 'combined-cue' representations in higher visual areas. These findings provide insight into the neural circuits engaged when the human brain combines different information sources for unified 3D visual perception.	Max Planck Inst Biol Cybernet, D-72012 Tubingen, Germany; Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Max Planck Society; University of Birmingham	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Postfach 2169, D-72012 Tubingen, Germany.	zoe.kourtzi@tuebingen.mpg.de	Welchman, Andrew/B-7542-2013; Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Welchman, Andrew/0000-0002-7559-3299; Bülthoff, Heinrich H/0000-0003-2568-0607; Kourtzi, Zoe/0000-0001-9441-7832				Albright T D, 1993, Rev Oculomot Res, V5, P177; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; BACKUS BT, 2002, ADV NEURAL INFORMATI, V14; Bakin JS, 2000, J NEUROSCI, V20, P8188; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Clark J.J., 1990, DATA FUSION SENSORY; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; ENRIGHT JT, 1987, PERCEPTION, V16, P731, DOI 10.1068/p160731; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nienborg H, 2004, J NEUROSCI, V24, P2065, DOI 10.1523/JNEUROSCI.3887-03.2004; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Palanca BJA, 2003, J NEUROSCI, V23, P7647; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Taira M, 2001, NEUROIMAGE, V14, P959, DOI 10.1006/nimg.2001.0895; Tanaka H, 2001, J NEUROPHYSIOL, V85, P735, DOI 10.1152/jn.2001.85.2.735; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, VISUAL NEUROSCI, V13, P797, DOI 10.1017/S095252380000866X; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; van Ee R, 2002, J VISION, V2, P597, DOI 10.1167/2.9.2; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; ZEKI S, 1991, J NEUROSCI, V11, P641	50	133	134	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					820	827		10.1038/nn1461	http://dx.doi.org/10.1038/nn1461			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15864303				2022-12-28	WOS:000229345300024
J	Horvath, TL				Horvath, TL			The hardship of obesity: a soft-wired hypothalamus	NATURE NEUROSCIENCE			English	Article							BODY-WEIGHT; RAT HYPOTHALAMUS; ARCUATE NUCLEUS; MELANOCORTIN RECEPTORS; HYPOCRETIN NEURONS; FEEDING-BEHAVIOR; LEPTIN RECEPTOR; ENERGY-BALANCE; POMC NEURONS; FOOD-INTAKE	Food intake and energy expenditure are determinants of metabolic phenotype and are regulated by the CNS. Although humans have a well-balanced homeostatic feedback loop, obesity and metabolic disorders are spreading rapidly and carry a heavy toll of morbidity and mortality. The past decade has witnessed major advances in the understanding of basic metabolic processes, the brain circuitry that determines appropriate and, but, inappropriate behavioral and humoral responses to changing metabolic cues remains largely ill defined. This review summarizes current knowledge of the brain anatomy that supports food intake and energy expenditure and discusses cellular mechanisms such as synaptic plasticity that may provide clues toward the development of successful central therapies to combat metabolic disorders, including obesity and diabetes.	Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06510 USA.	tamas.horvath@yale.edu			NCRR NIH HHS [RR-014451] Funding Source: Medline; NIDDK NIH HHS [DK-060711] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannon WB, 1912, AM J PHYSIOL, V29, P441, DOI 10.1152/ajplegacy.1912.29.5.441; Carlson A, 1916, CONTROL HUNGER HLTH; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cooke Sam F, 2005, Curr Opin Investig Drugs, V6, P25; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 2004, ANN INTERN MED, V141, P885, DOI 10.7326/0003-4819-141-11-200412070-00014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARCIASEGURA LM, 1986, BRAIN RES, V366, P131, DOI 10.1016/0006-8993(86)91287-4; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; MEZEY E, 1985, BRAIN RES, V328, P341, DOI 10.1016/0006-8993(85)91046-7; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLETIER G, 1977, AM J ANAT, V150, P201, DOI 10.1002/aja.1001500115; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PFAFF DW, 1994, RECENT PROG HORM RES, V49, P1; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SCHALLY AV, 1973, J REPROD FERTIL, P119; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shepherd G. M., 2004, SYNAPTIC ORG BRAIN; SHERRINGTON CS, 1900, TXB PHYSL, P920; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; THEODOSIS DT, 1984, NEUROSCIENCE, V11, P183, DOI 10.1016/0306-4522(84)90222-7; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	49	178	180	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					561	565		10.1038/nn1453	http://dx.doi.org/10.1038/nn1453			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856063				2022-12-28	WOS:000228895100013
J	Chan, DK; Hudspeth, AJ				Chan, DK; Hudspeth, AJ			Ca2+ current-driven nonlinear amplification by the mammalian cochlea in vitro	NATURE NEUROSCIENCE			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; MECHANOELECTRICAL-TRANSDUCTION CHANNELS; BASILAR-MEMBRANE; MECHANICAL RESPONSES; TECTORIAL MEMBRANE; BUNDLE MOVEMENTS; GERBIL COCHLEA; NERVE-FIBERS; ADAPTATION	An active process in the inner ear expends energy to enhance the sensitivity and frequency selectivity of hearing. Two mechanisms have been proposed to underlie this process in the mammalian cochlea: receptor potential-based electromotility and Ca2+-driven active hair-bundle motility. To link the phenomenology of the cochlear amplifier with these cellular mechanisms, we developed an in vitro cochlear preparation from Meriones unguiculatus that affords optical access to the sensory epithelium while mimicking its in vivo environment. Acoustic and electrical stimulation elicited microphonic potentials and electrically evoked hair-bundle movement, demonstrating intact forward and reverse mechanotransduction. The mechanical responses of hair bundles from inner hair cells revealed a characteristic resonance and a compressive nonlinearity diagnostic of the active process. Blocking transduction with amiloride abolished nonlinear amplification, whereas eliminating all but the Ca2+ component of the transduction current did not. These results suggest that the Ca2+ current drives the cochlear active process, and they support the hypothesis that active hair-bundle motility underlies cochlear amplification.	Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Lab Sensory Neurosci, 1230 York Ave, New York, NY 10021 USA.	hudspaj@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F32 DC000241, R01 DC000241-26, DC00241, R01 DC000241] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; COOPER NP, 1994, HEARING RES, V78, P221, DOI 10.1016/0378-5955(94)90028-0; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; DALLOS P, 1982, SCIENCE, V218, P582, DOI 10.1126/science.7123260; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; Holt JR, 1997, J NEUROSCI, V17, P8739; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; JORGENSEN F, 1988, J PHYSIOL-LONDON, V403, P577, DOI 10.1113/jphysiol.1988.sp017265; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KIM DO, 1986, HEARING RES, V22, P105, DOI 10.1016/0378-5955(86)90088-2; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; Magnasco MO, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058101; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Murugasu E, 1996, J NEUROSCI, V16, P325; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; OHLEMILLER KK, 1992, HEARING RES, V63, P79, DOI 10.1016/0378-5955(92)90076-Y; Overstreet EH, 2002, JARO-J ASSOC RES OTO, V3, P351, DOI 10.1007/s101620020023; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Ricci Anthony, 2003, J Am Acad Audiol, V14, P325; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Ulfendahl M, 1998, CURR OPIN NEUROBIOL, V8, P475, DOI 10.1016/S0959-4388(98)80034-2; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	47	176	187	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					149	155		10.1038/nn1385	http://dx.doi.org/10.1038/nn1385			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643426	Green Accepted			2022-12-28	WOS:000226638200013
J	Simsek-Duran, F; Linden, DJ; Lonart, G				Simsek-Duran, F; Linden, DJ; Lonart, G			Adapter protein 14-3-3 is required for a presynaptic form of LTP in the cerebellum	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NERVOUS-SYSTEM; PHOSPHORYLATION; RIM1-ALPHA; LEONARDO; KINASE	Long-term potentiation (LTP) of granule cell-Purkinje cell synapses in the mouse cerebellum requires phosphorylation by protein kinase A of the active-zone protein RIM1alpha at Ser413. Here, we show that the adapter protein 14-3-3 readily binds phosphorylated Ser413 in RIM1alpha, and that presynaptic transfection with a dominant-negative 14-3-3eta. mutant, or a RIM1alpha mutant with enhanced 14-3-3 binding, inhibits LTP. Thus, RIM1alpha phosphorylation triggers presynaptic LTP in part through recruitment of 14-3-3 to phospho-Ser413-RIM1alpha.	Eastern Virginia Med Sch, Dept Anat & Pathol, Norfolk, VA 23501 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Eastern Virginia Medical School; Johns Hopkins University	Lonart, G (corresponding author), Eastern Virginia Med Sch, Dept Anat & Pathol, Norfolk, VA 23501 USA.	lonartg@evms.edu		Simsek-Duran, Fatma/0000-0001-8653-764X	NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Linden DJ, 1999, J NEUROSCI, V19, P10221; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; ROTH D, 1995, FEBS LETT, V374, P77, DOI 10.1016/0014-5793(95)01080-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; WATANABE M, 1991, MOL BRAIN RES, V10, P151, DOI 10.1016/0169-328X(91)90105-7; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349	15	39	40	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1296	1298		10.1038/nn1348	http://dx.doi.org/10.1038/nn1348			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543142				2022-12-28	WOS:000225353900008
J	Sohn, MH; Goode, A; Koedinger, KR; Stenger, VA; Fissell, K; Carter, CS; Anderson, JR				Sohn, MH; Goode, A; Koedinger, KR; Stenger, VA; Fissell, K; Carter, CS; Anderson, JR			Behavioral equivalence, but not neural equivalence - neural evidence of alternative strategies in mathematical thinking	NATURE NEUROSCIENCE			English	Article							FMRI	In a functional magnetic resonance imaging study, we investigated how people solve mathematically equivalent problems presented in two alternative formats: verbal, story format or symbolic, equation format. Although representation format had no effect on behavior, anterior prefrontal activation was greater in the story condition and posterior parietal activation was greater in the equation condition. These results show that there exist alternative neural pathways that implement different and yet equally efficient problem-solving strategies.	Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Human Comp Interact Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Psychol, Pittsburgh, PA USA; Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis	Sohn, MH (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	mhsohn@gwu.edu			NIMH NIH HHS [MH64190] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH064190] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Koedinger KR, 2004, J LEARN SCI, V13, P129, DOI 10.1207/s15327809jls1302_1; MCCLOSKEY M, 1991, J EXP PSYCHOL LEARN, V17, P377, DOI 10.1037/0278-7393.17.3.377; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; NATHAN MJ, 1992, COGNITION INSTRUCT, V9, P329, DOI 10.1207/s1532690xci0904_2; Qin YL, 2003, P NATL ACAD SCI USA, V100, P4951, DOI 10.1073/pnas.0431053100; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733	11	44	44	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1193	1194		10.1038/nn1337	http://dx.doi.org/10.1038/nn1337			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475949	Green Published			2022-12-28	WOS:000224749400011
J	Bao, SW; Chang, EF; Woods, J; Merzenich, MM				Bao, SW; Chang, EF; Woods, J; Merzenich, MM			Temporal plasticity in the primary auditory cortex induced by operant perceptual learning	NATURE NEUROSCIENCE			English	Article							MODULATION TRANSFER-FUNCTIONS; IMPAIRED CHILDREN; RESPONSE PROPERTIES; MONGOLIAN GERBIL; NERVE FIBERS; REPRESENTATION; NEURONS; SPEECH; INFORMATION; TONES	Processing of rapidly successive acoustic stimuli can be markedly improved by sensory training. To investigate the cortical mechanisms underlying such temporal plasticity, we trained rats in a 'sound maze' in which navigation using only auditory cues led to a target location paired with food reward. In this task, the repetition rate of noise pulses increased as the distance between the rat and target location decreased. After training in the sound maze, neurons in the primary auditory cortex (A1) showed greater responses to high-rate noise pulses and stronger phase-locking of responses to the stimuli; they also showed shorter post-stimulation suppression and stronger rebound activation. These improved temporal dynamics transferred to trains of pure-tone pips. Control animals that received identical sound stimulation but were given free access to food showed the same results as naive rats. We conclude that this auditory perceptual learning results in improvements in temporal processing, which may be mediated by enhanced cortical response dynamics.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bao, SW (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	bao@phy.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-34835, NS-10414] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2003, J NEUROSCI, V23, P10765; Bao SW, 2003, P NATL ACAD SCI USA, V100, P1405, DOI 10.1073/pnas.0337527100; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Eggermont JJ, 1999, J NEUROSCI, V19, P2780; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Ji WQ, 2001, J NEUROPHYSIOL, V86, P211, DOI 10.1152/jn.2001.86.1.211; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Mardia KV, 2000, DIRECTIONAL STAT; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MERZENICH MM, 1999, PERVASIVE DEV DISORD, P365; Nagarajan S, 1999, P NATL ACAD SCI USA, V96, P6483, DOI 10.1073/pnas.96.11.6483; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; Ponton CW, 1999, SCAND AUDIOL, V28, P13; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shepherd RK, 1997, ACTA OTO-LARYNGOL, P28; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wright BA, 1997, NATURE, V387, P176, DOI 10.1038/387176a0	42	196	200	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					974	981		10.1038/nn1293	http://dx.doi.org/10.1038/nn1293			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286790				2022-12-28	WOS:000223546700017
J	Kaufer, D; Ogle, WO; Pincus, ZS; Clark, KL; Nicholas, AC; Dinkel, KM; Dumas, TC; Ferguson, D; Lee, AL; Winters, MA; Sapolsky, RM				Kaufer, D; Ogle, WO; Pincus, ZS; Clark, KL; Nicholas, AC; Dinkel, KM; Dumas, TC; Ferguson, D; Lee, AL; Winters, MA; Sapolsky, RM			Restructuring the neuronal stress response with anti-glucocorticoid gene delivery	NATURE NEUROSCIENCE			English	Article							RECEPTOR BETA ISOFORM; NEUROTROPHIC FACTOR; RAT-BRAIN; HIPPOCAMPAL DAMAGE; MESSENGER-RNA; KAINIC ACID; CELL-DEATH; CORTICOSTERONE; EXPRESSION; ESTROGEN	Glucocorticoids, the adrenal steroids released during stress, compromise the ability of neurons to survive neurological injury. In contrast, estrogen protects neurons against such injuries. We designed three genetic interventions to manipulate the actions of glucocorticoids, which reduced their deleterious effects in both in vitro and in vivo rat models. The most effective of these interventions created a chimeric receptor combining the ligand-binding domain of the glucocorticoid receptor and the DNA-binding domain of the estrogen receptor. Expression of this chimeric receptor reduced hippocampal lesion size after neurological damage by 63% and reversed the outcome of the stress response by rendering glucocorticoids protective rather than destructive. Our findings elucidate three principal steps in the neuronal stress-response pathway, all of which are amenable to therapeutic intervention.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Dept Biomed Informat, Stanford, CA 94305 USA; Leibniz Inst Neurobiol, Magdeburg, Germany; Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; Stanford Univ, Dept Infect Dis, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Leibniz Institut fur Neurobiologie (LIN); Stanford University; Stanford University	Kaufer, D (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	danielak@stanford.edu	Dumas, Theodore/G-5810-2012	Ferguson, Deveroux/0000-0001-9302-5992				Antonawich FJ, 1999, NEUROSCIENCE, V88, P319, DOI 10.1016/S0306-4522(98)00213-9; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Bamberger CM, 1997, J STEROID BIOCHEM, V60, P43, DOI 10.1016/S0960-0760(96)00167-7; Carlstedt-Duke J, 1999, TRENDS ENDOCRIN MET, V10, P339, DOI 10.1016/S1043-2760(99)00178-2; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; DEKLOET ER, 1993, J STEROID BIOCHEM, V47, P183; Dinkel K, 2003, J NEUROCHEM, V84, P705, DOI 10.1046/j.1471-4159.2003.01604.x; Fink SL, 1997, J NEUROCHEM, V68, P961; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Galea LAM, 1999, BRAIN RES, V821, P383, DOI 10.1016/S0006-8993(99)01100-2; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gibbs RB, 1999, BRAIN RES, V844, P20, DOI 10.1016/S0006-8993(99)01880-6; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Hansson AC, 2003, J NEUROSCI, V23, P6013, DOI 10.1523/JNEUROSCI.23-14-06013.2003; Inoue T, 1998, NEUROSCIENCE, V86, P723, DOI 10.1016/S0306-4522(98)00112-2; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Karin M, 2001, J ENDOCRINOL, V169, P447, DOI 10.1677/joe.0.1690447; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McEwen BS, 1995, VITAM HORM, V51, P371, DOI 10.1016/S0083-6729(08)61045-6; Molteni R, 2001, BRAIN RES REV, V37, P249, DOI 10.1016/S0165-0173(01)00128-X; Nishi M, 1999, EUR J NEUROSCI, V11, P1927, DOI 10.1046/j.1460-9568.1999.00616.x; Nitta A, 1999, J NEUROSCI RES, V57, P227, DOI 10.1002/(SICI)1097-4547(19990715)57:2<227::AID-JNR8>3.3.CO;2-5; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; Oakley RH, 1999, J BIOL CHEM, V274, P27857, DOI 10.1074/jbc.274.39.27857; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roy M, 2003, NEUROENDOCRINOLOGY, V77, P24, DOI 10.1159/000068337; SAPOLSKY RM, 1989, NEUROSCI LETT, V97, P157, DOI 10.1016/0304-3940(89)90156-0; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Sapolsky RM, 2003, NAT REV NEUROSCI, V4, P61, DOI 10.1038/nrn1006; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; STEIN BA, 1988, BRAIN RES, V473, P175, DOI 10.1016/0006-8993(88)90332-0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Vasudevan N, 2002, J NEUROENDOCRINOL, V14, P836, DOI 10.1046/j.1365-2826.2002.00853.x; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WHITENER EM, 1995, COMPUT HUM BEHAV, V11, P65, DOI 10.1016/0747-5632(94)00023-B; Yudt MR, 2003, MOL CELL BIOL, V23, P4319, DOI 10.1128/MCB.23.12.4319-4330.2003; Zhou JZ, 2000, BRAIN RES, V885, P182, DOI 10.1016/S0006-8993(00)02934-6	45	66	68	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					947	953		10.1038/nn1296	http://dx.doi.org/10.1038/nn1296			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15300253				2022-12-28	WOS:000223546700013
J	Thompson, JK; Peterson, MR; Freeman, RD				Thompson, JK; Peterson, MR; Freeman, RD			High-resolution neurometabolic coupling revealed by focal activation of visual neurons	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; INITIAL DIP; OXYGENATION; BRAIN; STIMULATION; CORTEX; FMRI; MRI	Functional magnetic resonance imaging is an important tool for measuring brain function noninvasively, but the vascular and metabolic changes on which its measurements are based are not fully understood. Here, we examined the relationship between these changes and neural activity on a fine spatial scale through simultaneous measurements of tissue oxygen and extracellular neural activity in the cat lateral geniculate nucleus. Our findings indicate that activity-dependent increases in cerebral blood flow and oxidative metabolism occur on different spatial scales, and that the ratio between the two depends on the size of the activated neural population.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NATIONAL EYE INSTITUTE [P30EY003176, R01EY001175] Funding Source: NIH RePORTER; NEI NIH HHS [EY03176, EY01175] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Lindauer U, 2002, INT CONGR SER, V1235, P137, DOI 10.1016/S0531-5131(02)00180-2; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; SANDERSON KJ, 1971, J COMP NEUROL, V143, P101, DOI 10.1002/cne.901430107; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	14	49	49	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					919	920		10.1038/nn1308	http://dx.doi.org/10.1038/nn1308			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322552				2022-12-28	WOS:000223546700008
J	Singer, JH; Lassova, L; Vardi, N; Diamond, JS				Singer, JH; Lassova, L; Vardi, N; Diamond, JS			Coordinated multivesicular release at a mammalian ribbon synapse	NATURE NEUROSCIENCE			English	Article							ROD BIPOLAR CELLS; AII AMACRINE CELLS; RABBIT RETINA; QUANTAL ANALYSIS; RAT RETINA; ASYNCHRONOUS RELEASE; EXCITATORY SYNAPSES; SIGNAL INTERNEURONS; TIME-COURSE; VESICLES	Traditional models of synaptic transmission hold that release sites within an active zone operate independently. Although the release of multiple vesicles (multivesicular release; MVR) from single active zones occurs at some central synapses, MVR is not thought to require coordination among release sites. Ribbon synapses seem to be optimized to release many vesicles over an extended period, but the dynamics of MVR at ribbon synapses is unknown. We examined MVR at a ribbon synapse in a retinal slice preparation using paired recordings from presynaptic rod bipolar and postsynaptic AII amacrine cells. When evoked release was highly desynchronized, discrete postsynaptic events were larger than quantal miniature excitatory postsynaptic currents (mEPSCs) but had the same time course. The amplitude of these multiquantal mEPSCs, which seem to arise from the essentially simultaneous release of multiple vesicles, was reduced by lowering release probability. The release synchrony reflected in these multivesicular events suggests that release within an active zone is coordinated during MVR.	NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania	Singer, JH (corresponding author), NINDS, Synapt Physiol Unit, NIH, MSC-4066,Bldg 26,Room 2C-09, Bethesda, MD 20892 USA.	singerj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL EYE INSTITUTE [R01EY000828, R01EY011105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS043365] Funding Source: NIH RePORTER; NEI NIH HHS [EY11105, EY00828] Funding Source: Medline; NINDS NIH HHS [K22 NS043365] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Auger C, 1998, J NEUROSCI, V18, P4532; Barlow H B, 1971, Vision Res, VSuppl 3, P87; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Cui JJ, 2003, J PHYSIOL-LONDON, V553, P895, DOI 10.1113/jphysiol.2003.052092; DELCASTILLO J, 1954, J PHYSL, V124, P157; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Koulen P, 1998, EUR J NEUROSCI, V10, P1446, DOI 10.1046/j.1460-9568.1998.00156.x; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Li W, 2002, J COMP NEUROL, V448, P230, DOI 10.1002/cne.10189; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Muresan V, 1999, J NEUROSCI, V19, P1027; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PROPST JW, 1987, J NEUROSCI, V7, P3654; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Singer JH, 2003, J NEUROSCI, V23, P10923; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STERLING P, 1988, J NEUROSCI, V8, P623; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; VANEY DI, 1991, J COMP NEUROL, V310, P154, DOI 10.1002/cne.903100203; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; YOUNG HM, 1991, J COMP NEUROL, V310, P139, DOI 10.1002/cne.903100202; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	47	161	161	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					826	833		10.1038/nn1280	http://dx.doi.org/10.1038/nn1280			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235608				2022-12-28	WOS:000222930800012
J	Insel, TR; Volkow, ND; Landis, SC; Li, TK; Battey, JF; Sieving, P				Insel, TR; Volkow, ND; Landis, SC; Li, TK; Battey, JF; Sieving, P			Limits to growth: why neuroscience needs large-scale science	NATURE NEUROSCIENCE			English	Editorial Material									NIMH, NIH, Bethesda, MD 20892 USA; NIDA, Bethesda, MD 20892 USA; NINDS, Bethesda, MD 20892 USA; NIAAA, Bethesda, MD USA; NEI, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Insel, TR (corresponding author), NIMH, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA.	insel@mail.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002926, Z01NS003004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000065, Z01DC000065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBERTS BM, 1984, CELL, V41, P337; Boguski MS, 2004, NAT NEUROSCI, V7, P429, DOI 10.1038/nn1232; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038	5	28	29	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					426	427		10.1038/nn0504-426	http://dx.doi.org/10.1038/nn0504-426			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114352	Green Published			2022-12-28	WOS:000221101300007
J	Hiramoto, M; Hiromi, Y				Hiramoto, M; Hiromi, Y			ROBO directs axon crossing of segmental boundaries by suppressing responsiveness to relocalized Netrin	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; DROSOPHILA DERAILED RECEPTOR; CNS MIDLINE; GENETIC-ANALYSIS; C-ELEGANS; CAENORHABDITIS-ELEGANS; COMMISSURAL AXONS; MOTOR AXONS; S-LAMININ; PROTEIN	Networks in the CNS consist of neural modules that are connected in a repetitive array. Whereas individual modules contain guidance information along which axons track within the unit, these guidance cues hinder axon extension across module boundaries. We investigated how axons solve this 'boundary problem' by analyzing the longitudinal connections of neuromeres in Drosophila melanogaster. The initial trajectory of the longitudinal axons is guided by Netrin, which is localized on commissural axons by its receptor, Frazzled. The Netrin cue on the commissure of the next segment can act as a barrier to longitudinal axons, inhibiting their extension and misguiding them contralaterally along the commissure. We show that, before reaching the segmental boundary, the longitudinal axons' responsiveness to Netrin presented on the commissure is suppressed by Roundabout (ROBO), through counteracting Gq signaling. The absence of suppression causes the robo phenotype: longitudinal axons project toward the midline, as if running around a roundabout (rotary).	Natl Inst Genet, Dept Dev Genet, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Soc Promot Sci, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Hiramoto, M (corresponding author), Natl Inst Genet, Dept Dev Genet, 1111 Yata, Shizuoka 4118540, Japan.	hiramoto@pb3.so-net.ne.jp; yhiromi@lab.nig.ac.jp						Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURROWS M, 1996, NEUROBIOLOGY INSECT, P12; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GOODMAN CS, 1993, DEV DROSOPHILA MELAN, P1171; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; JESSELL TM, 2000, PRINCIPLES NEURAL SC, P1021; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Saheki Y, 2005, BRAIN RES, V1055, P196, DOI 10.1016/j.brainres.2005.06.056; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	50	22	23	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					58	66		10.1038/nn1612	http://dx.doi.org/10.1038/nn1612			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341212				2022-12-28	WOS:000234288000018
J	Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL				Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL			Axons and dendrites originate from neuroepithelial-like processes of retinal bipolar cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; NEURONAL POLARITY; GANGLION-CELLS; MOUSE RETINA; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CHICK RETINA; LOCALIZATION; MGLUR6; DIFFERENTIATION	The cellular mechanisms underlying axogenesis and dendritogenesis are not completely understood. The axons and dendrites of retinal bipolar cells, which contact their synaptic partners within specific laminae in the inner and outer retina, provide a good system for exploring these issues. Using transgenic mice expressing enhanced green fluorescent protein (GFP) in a subset of bipolar cells, we determined that axonal and dendritic arbors of these interneurons develop directly from apical and basal processes attached to the outer and inner limiting membranes, respectively. Selective stabilization of processes contributed to stratification of axonal and dendritic arbors within the appropriate synaptic layer. This unusual mode of axogenesis and dendritogenesis from neuroepithelial-like processes may act to preserve neighbor-neighbor relationships in synaptic wiring between the outer and inner retina.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Pennsylvania	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wongr@pcg.wustl.edu			NEI NIH HHS [EY11105, EY10699] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010699, R01EY011105] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; CAJAL RY, 1960, STUDIES VERTEBRATE N; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Demas J, 2003, J NEUROSCI, V23, P2851; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kirby MA, 1996, PERSPECT DEV NEUROBI, V3, P177; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; LOHMANN C, 2005, IMAGING NEUROSCIENCE, P159; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10238, 10.1002/glia.10288]; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; QUESADA A, 1985, J MORPHOL, V184, P205, DOI 10.1002/jmor.1051840210; QUESADA A, 1981, ZBL VET MED C, V10, P328, DOI 10.1111/j.1439-0264.1981.tb00697.x; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; SNOW RL, 1994, NEUROSCIENCE, V58, P399, DOI 10.1016/0306-4522(94)90046-9; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Tehrani A, 2000, INVEST OPHTH VIS SCI, V41, P314; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	39	120	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					85	92		10.1038/nn1615	http://dx.doi.org/10.1038/nn1615			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341211				2022-12-28	WOS:000234288000021
J	Lee, HK; Min, SS; Gallagher, M; Kirkwood, A				Lee, HK; Min, SS; Gallagher, M; Kirkwood, A			NMDA receptor-independent long-term depression correlates with successful aging in rats	NATURE NEUROSCIENCE			English	Article							POTENTIATION; INDUCTION; PROTEIN; HIPPOCAMPUS; BRAIN	Some individuals maintain high cognitive functioning at older ages. Here we show that mechanisms for long-term depression differ in aged rodents that maintain cognitive performance compared to young adults. Our results imply that cognitive abilities may be sustained in aged individuals by a switch in synaptic plasticity mechanisms.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Gallagher, M (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	michela@jhu.edu; kirkwood@jhu.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG09973] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Norris CM, 1996, J NEUROSCI, V16, P5382; Reyes-Harde M, 1998, NEUROSCI LETT, V252, P155, DOI 10.1016/S0304-3940(98)00496-0; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845	14	101	102	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1657	1659		10.1038/nn1586	http://dx.doi.org/10.1038/nn1586			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286930				2022-12-28	WOS:000233576200011
J	Brown, SL; Joseph, J; Stopfer, M				Brown, SL; Joseph, J; Stopfer, M			Encoding a temporally structured stimulus with a temporally structured neural representation	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; LOCUST ANTENNAL LOBE; OLFACTORY SYSTEM; ODOR PLUMES; MANDUCA-SEXTA; PHEROMONE; RESPONSES; NEURONS; DISCRIMINATION; OSCILLATIONS	Sensory neural systems use spatiotemporal coding mechanisms to represent stimuli. These time-varying response patterns sometimes outlast the stimulus. Can the temporal structure of a stimulus interfere with, or even disrupt, the spatiotemporal structure of the neural representation? We investigated this potential confound in the locust olfactory system. When odors were presented in trains of nearly overlapping pulses, responses of first-order interneurons (projection neurons) changed reliably, and often markedly, with pulse position as responses to one pulse interfered with subsequent responses. However, using the responses of an ensemble of projection neurons, we could accurately classify the odorants as well as characterize the temporal properties of the stimulus. Further, we found that second-order follower neurons showed firing patterns consistent with the information in the projection-neuron ensemble. Thus, ensemble-based spatiotemporal coding could disambiguate complex and potentially confounding temporally structured sensory stimuli and thereby provide an invariant response to a stimulus presented in various ways.	NICHHD, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stopfer, M (corresponding author), NICHHD, US Natl Inst Hlth, Bldg 35,Room 3A-102, Bethesda, MD 20892 USA.	stopferm@mail.nih.gov		Stopfer, Mark/0000-0001-9200-1884	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008760] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Barrozo RB, 2002, J INSECT PHYSIOL, V48, P825, DOI 10.1016/S0022-1910(02)00109-9; Bau J, 2002, J INSECT PHYSIOL, V48, P433, DOI 10.1016/S0022-1910(02)00062-8; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Fontanini A, 2003, J NEUROSCI, V23, P7993; FUSTER JM, 1982, J NEUROSCI, V2, P361; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; HAMILTON KA, 1988, J NEUROPHYSIOL, V59, P1736, DOI 10.1152/jn.1988.59.6.1736; Heinbockel T, 1999, J COMP NEUROL, V409, P1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; JOLIFFE IT, 1986, PRINCIPLAL COMPONENT; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Justus KA, 2002, PHYSIOL ENTOMOL, V27, P67, DOI 10.1046/j.1365-3032.2002.00270.x; Laurent G, 1999, ENTOMOL EXP APPL, V91, P7, DOI 10.1023/A:1003606702127; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Lei H, 1999, J NEUROPHYSIOL, V81, P1113, DOI 10.1152/jn.1999.81.3.1113; Lemon WC, 1997, J EXP BIOL, V200, P1809; Lemon WC, 2000, BIOSYSTEMS, V58, P151, DOI 10.1016/S0303-2647(00)00118-0; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MARIONPOLL F, 1992, J COMP PHYSIOL A, V171, P505, DOI 10.1007/BF00194583; MCCLURKIN JW, 1991, SCIENCE, V253, P675, DOI 10.1126/science.1908118; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Nowotny T, 2003, J COMPUT NEUROSCI, V15, P271, DOI 10.1023/A:1025825111088; Okada J, 2004, J EXP BIOL, V207, P3693, DOI 10.1242/jeb.01201; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Willis MA, 2005, J EXP BIOL, V208, P721, DOI 10.1242/jeb.01418	49	113	114	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1568	1576		10.1038/nn1559	http://dx.doi.org/10.1038/nn1559			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222230				2022-12-28	WOS:000232966600032
J	Everitt, BJ; Robbins, TW				Everitt, BJ; Robbins, TW			Neural systems of reinforcement for drug addiction: from actions to habits to compulsion	NATURE NEUROSCIENCE			English	Review							NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING BEHAVIOR; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; ORBITOFRONTAL CORTEX; CONDITIONED REINFORCEMENT; 2ND-ORDER SCHEDULES; EXCITOTOXIC LESIONS; DORSAL STRIATUM; D-AMPHETAMINE	Drug addiction is increasingly viewed as the endpoint of a series of transitions from initial drug use-when a drug is voluntarily taken because it has reinforcing, often hedonic, effects-through loss of control over this behavior, such that it becomes habitual and ultimately compulsive. Here we discuss evidence that these transitions depend on interactions between pavlovian and instrumental learning processes. We hypothesize that the change from voluntary drug use to more habitual and compulsive drug use represents a transition at the neural level from prefrontal cortical to striatal control over drug seeking and drug taking behavior as well as a progression from ventral to more dorsal domains of the striatum, involving its dopaminergic innervation. These neural transitions may themselves depend on the neuroplasticity in both cortical and striatal structures that is induced by chronic self-administration of drugs.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, MRC Wellcome Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Everitt, BJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	bje10@cam.ac.uk	Robbins, Trevor W/A-7551-2008	Everitt, Barry/0000-0003-4431-6536; Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderson HL, 2000, PSYCHOPHARMACOLOGY, V153, P111, DOI 10.1007/s002130000527; Altman J, 1996, PSYCHOPHARMACOLOGY, V125, P285, DOI 10.1007/BF02246016; BARRETT JE, 1981, J PHARMACOL EXP THER, V218, P692; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Caine SB, 2001, BEHAV NEUROSCI, V115, P880, DOI 10.1037//0735-7044.115.4.880; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-9; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1998, J PSYCHOPHARMACOL, V12, P54, DOI 10.1177/026988119801200108; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2004, INT J NEUROPSYCHOPH, V7, pS15; Grimm JW, 2000, PSYCHOBIOLOGY, V28, P383; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Haber SN, 2000, J NEUROSCI, V20, P2369; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hutcheson DM, 2003, ANN NY ACAD SCI, V1003, P410, DOI 10.1196/annals.1300.038; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Ikemoto S, 2005, J NEUROSCI, V25, P5061, DOI 10.1523/JNEUROSCI.0892-05.2005; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; Jakes I., 1996, THEORETICAL APPROACH; Kadohisa M, 2004, NEUROSCIENCE, V127, P207, DOI 10.1016/j.neuroscience.2004.04.037; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kearns DN, 2004, LEARN BEHAV, V32, P463; Kelley AE, 2002, J NEUROSCI, V22, P3306; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Donnell P, 2003, EUR J NEUROSCI, V17, P429, DOI 10.1046/j.1460-9568.2003.02463.x; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pears A, 2003, J NEUROSCI, V23, P11189; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; Salloway S, 2001, FRONTAL LOBES NEUROP; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; See RE, 2001, PSYCHOPHARMACOLOGY, V154, P301, DOI 10.1007/s002130000636; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Stewart J., 1987, METHODS ASSESSING RE, P211; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Taylor JR, 1999, PSYCHOPHARMACOLOGY, V142, P31, DOI 10.1007/s002130050859; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WOLFFGRAMM J, 1995, BEHAV BRAIN RES, V70, P77, DOI 10.1016/0166-4328(95)00131-C; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	100	2552	2583	9	578	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1481	1489		10.1038/nn1579	http://dx.doi.org/10.1038/nn1579			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251991				2022-12-28	WOS:000232966600019
J	Burguiere, E; Arleo, A; Hojjati, MR; Elgersma, Y; De Zeeuw, CI; Berthoz, A; Rondi-Reig, L				Burguiere, E; Arleo, A; Hojjati, MR; Elgersma, Y; De Zeeuw, CI; Berthoz, A; Rondi-Reig, L			Spatial navigation impairment in mice lacking cerebellar LTD: a motor adaptation deficit?	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; KINASE-C INHIBITOR; PURKINJE-CELLS; COMPONENTS; EXPRESSION	L7-PKCl transgenic mice, which lack parallel fiber - Purkinje cell long-term depression (LTD), were tested with two different mazes to dissociate the relative importance of declarative and procedural components of spatial navigation. We show that L7-PKCI mice are deficient in acquisition of an adapted goal-oriented behavior, part of the procedural component of the task. This supports the hypothesis that cerebellar LTD may subserve a general sensorimotor adaptation process shared by motor and spatial learning functions.	Coll France, CNRS, Lab Physiol Percept & Act, UMR 7152, F-75005 Paris, France; Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Erasmus University Rotterdam; Erasmus MC	Rondi-Reig, L (corresponding author), Coll France, CNRS, Lab Physiol Percept & Act, UMR 7152, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	laure.rondi-reig@college-de-france.fr	Elgersma, Ype/F-5164-2013; Arleo, Angelo/N-9255-2019; Rondi-Reig, Laure/G-2816-2011; Burguière, Eric/K-9925-2019; Burguière, Eric/G-1114-2015; Rondi-Reig, Laure/M-6141-2016; Hojjati, Mohammad reza/B-9941-2013	Elgersma, Ype/0000-0002-3758-1297; Arleo, Angelo/0000-0002-1990-1971; Burguière, Eric/0000-0002-9690-5909; Hojjati, Mohammad reza/0000-0001-7889-2545; Rondi-Reig, Laure/0000-0003-1006-0501				De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; ITO M, 1993, REV NEUROL, V149, P596; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Leggio MG, 1999, EXP BRAIN RES, V127, P1, DOI 10.1007/s002210050768; Martin LA, 2003, EUR J NEUROSCI, V18, P2002, DOI 10.1046/j.1460-9568.2003.02921.x; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Rondi-Reig L, 2005, PROG BRAIN RES, V148, P201, DOI 10.1016/S0079-6123(04)48017-0; SCHENK F, 1985, EXP BRAIN RES, V58, P11; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thach WT, 1997, INT REV NEUROBIOL, V41, P599, DOI 10.1016/S0074-7742(08)60372-4; Thompson RF, 1997, INT REV NEUROBIOL, V41, P151, DOI 10.1016/S0074-7742(08)60351-7	15	64	67	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1292	1294		10.1038/nn1532	http://dx.doi.org/10.1038/nn1532			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136042	Green Submitted			2022-12-28	WOS:000232145900010
J	Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M				Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M			DNER acts as a neuron-specific Notch ligand during Bergmann glial development	NATURE NEUROSCIENCE			English	Article							MULTIPLE FUNCTIONAL ROLES; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; BRAIN-DEVELOPMENT; PROGENITOR CELLS; RECEPTOR; ACTIVATION; EXPRESSION; MIGRATION	Differentiation of CNS glia is regulated by Notch signaling through neuron-glia interaction. Here, we identified Delta/Notch-like EGF-related receptor (DNER), a neuron-specific transmembrane protein, as a previously unknown ligand of Notch during cellular morphogenesis of Bergmann glia in the mouse cerebellum. DNER binds to Notch1 at cell-cell contacts and activates Notch signaling in vitro. In the developing cerebellum, DNER is highly expressed in Purkinje cell dendrites, which are tightly associated with radial fibers of Bergmann glia expressing Notch. DNER specifically binds to Bergmann glia in culture and induces process extension by activating gamma-secretase- and Deltex-dependent Notch signaling. Inhibition of Deltex-dependent, but not RBP-J-dependent, Notch signaling in Bergmann glia suppresses formation and maturation of radial fibers in organotypic slice cultures. Additionally, deficiency of DNER retards the formation of radial fibers and results in abnormal arrangement of Bergmann glia. Thus, DNER mediates neuron-glia interaction and promotes morphological differentiation of Bergmann glia through Deltex-dependent Notch signaling.	RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama 3510198, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448585, Japan	RIKEN; Kyoto University; Japan Science & Technology Agency (JST); Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kengaku, M (corresponding author), RIKEN Brain Sci Inst, Lab Neural Cell Polar, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kengaku@brain.riken.jp		Eiraku, Mototsugu/0000-0002-9433-9085				ALTMAN J, 1997, DEV CEERBELLAR SYSTE; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; DE SB, 1999, NATURE, V398, P518; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; FISHER M, 1984, P NATL ACAD SCI-BIOL, V81, P4414, DOI 10.1073/pnas.81.14.4414; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawaji K, 2004, MOL CELL NEUROSCI, V25, P228, DOI 10.1016/j.mcn.2003.10.006; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; LORDKIPANIDZE T, 2005, GLIA; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Parks AL, 2000, DEVELOPMENT, V127, P1373; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanaka M, 2003, NEUROSCI LETT, V353, P87, DOI 10.1016/j.neulet.2003.08.080; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	50	170	175	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					873	880		10.1038/nn1492	http://dx.doi.org/10.1038/nn1492			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965470				2022-12-28	WOS:000230137100014
J	Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S				Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S			G beta gamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							G-PROTEIN MODULATION; BLOCK NEUROTRANSMITTER RELEASE; DEPENDENT CALCIUM CHANNELS; BOTULINUM NEUROTOXIN-A; TRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS; FUSION COMPLEX; GLUTAMATERGIC TRANSMISSION; ANGSTROM RESOLUTION; MEMBRANE-FUSION	Presynaptic inhibition mediated by G protein-coupled receptors may involve a direct interaction between G proteins and the vesicle fusion machinery. The molecular target of this pathway is unknown. We demonstrate that G beta gamma-mediated presynaptic inhibition in lamprey central synapses occurs downstream from voltage-gated Ca2+ channels. Using presynaptic microinjections of botulinum toxins (BoNTs) during paired recordings, we find that cleavage of synaptobrevin in unprimed vesicles leads to an eventual exhaustion of synaptic transmission but does not prevent G beta gamma-mediated inhibition. In contrast, cleavage of the C-terminal nine amino acids of the 25 kDa synaptosome-associated protein (SNAP-25) by BoNT A prevents G beta gamma-mediated inhibition. Moreover, a peptide containing the region of SNAP-25 cleaved by BoNT A blocks the G beta gamma inhibitory effect. Finally, removal of the last nine amino acids of the C-terminus of SNAP-25 weakens G beta gamma interactions with soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes. Thus, the C terminus of SNAP-25, which links synaptotagmin I to the SNARE complex, may represent a target of G beta gamma for presynaptic inhibition.	Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor, Chicago, IL 60607 USA.	heidi.hamm@mcmail.vanderbilt.edu; sta@uic.edu	Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246				AHNERTHILGER G, 1995, PROG NEUROBIOL, V46, P83, DOI 10.1016/0301-0082(95)00003-E; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Blanes-Mira C, 2003, BIOCHEM J, V375, P159, DOI 10.1042/BJ20030509; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BRODIN L, 1994, ADV SEC MESS PHOSPH, V29, P205; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; BRODIN L, 1986, NEUROSCI LETT, V67, P53, DOI 10.1016/0304-3940(86)90207-7; Bruns D, 1997, J NEUROSCI, V17, P1898; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOLPHIN AC, 1993, BIOCHEM SOC T, V21, P391, DOI 10.1042/bst0210391; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOLZ GG, 1989, J NEUROSCI, V9, P657; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; MULKEY RM, 1993, J PHYSIOL-LONDON, V462, P243, DOI 10.1113/jphysiol.1993.sp019553; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; PHILLIPS WJ, 1991, J BIOL CHEM, V266, P11017; Pinxteren JA, 1998, EMBO J, V17, P6210, DOI 10.1093/emboj/17.21.6210; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schibeci R, 1999, J MED ETHICS, V25, P335, DOI 10.1136/jme.25.4.335; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Schwartz EJ, 2005, J NEUROPHYSIOL, V93, P980, DOI 10.1152/jn.00669.2004; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Williamson LC, 1996, J BIOL CHEM, V271, P7694, DOI 10.1074/jbc.271.13.7694; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	50	129	133	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					597	605		10.1038/nn1439	http://dx.doi.org/10.1038/nn1439			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834421				2022-12-28	WOS:000228895100020
J	Lam, TKT; Schwartz, GJ; Rossetti, L				Lam, TKT; Schwartz, GJ; Rossetti, L			Hypothalamic sensing of fatty acids	NATURE NEUROSCIENCE			English	Review							ACTIVATED PROTEIN-KINASE; DECREASES FOOD-INTAKE; BODY-WEIGHT; SYNTHASE INHIBITOR; MALONYL-COA; GENE-EXPRESSION; INTRACEREBROVENTRICULAR INFUSION; LEPTIN ACTION; OBESE GENE; AMP-KINASE	Selective regions of the brain, including the hypothalamus, are capable of gathering information on the body's nutritional status in order to implement appropriate behavioral and metabolic responses to changes in fuel availability. This review focuses on direct metabolic signaling within the hypothalamus. There is growing evidence supporting the idea that fatty acid metabolism within discrete hypothalamic regions can function as a sensor for nutrient availability that can integrate multiple nutritional and hormonal signals.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048321, R37DK048321, R01DK045024, R01DK047208, P60DK020541, R29DK045024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, P01AG021654] Funding Source: NIH RePORTER; NIA NIH HHS [AG21654, T32-AG023475] Funding Source: Medline; NIDDK NIH HHS [DK48321, DK20541, DK45024, DK47208] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BEVERLY JL, 1991, AM J PHYSIOL, V261, pR339, DOI 10.1152/ajpregu.1991.261.2.R339; BRIEF DJ, 1984, BRAIN RES BULL, V12, P571, DOI 10.1016/0361-9230(84)90174-6; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Clegg DJ, 2002, DIABETES, V51, P3196, DOI 10.2337/diabetes.51.11.3196; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GOTO M, 1971, P SOC EXP BIOL MED, V136, P1294; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; KANAREK RB, 1978, PHARMACOL BIOCHEM BE, V8, P615, DOI 10.1016/0091-3057(78)90397-0; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Lavrentyev EN, 2004, BIOCHEM BIOPH RES CO, V315, P174, DOI 10.1016/j.bbrc.2004.01.040; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MACDONALD MJ, 1990, DIABETES, V39, P1461, DOI 10.2337/diabetes.39.12.1461; Makimura H, 2001, DIABETES, V50, P733, DOI 10.2337/diabetes.50.4.733; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; MAYER J, 1953, NEW ENGL J MED, V249, P13, DOI 10.1056/NEJM195307022490104; MAYER J, 1953, PHYSIOL REV, V33, P472, DOI 10.1152/physrev.1953.33.4.472; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; MILLER JC, 1987, J NEUROCHEM, V49, P1507, DOI 10.1111/j.1471-4159.1987.tb01021.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TP, 1994, HUM-COMPUT INTERACT, V9, P1, DOI 10.1207/s15327051hci0901_1; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Qi KM, 2002, CURR OPIN CLIN NUTR, V5, P133, DOI 10.1097/00075197-200203000-00003; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Rapoport SI, 1996, LIPIDS, V31, pS97, DOI 10.1007/BF02637059; Ravussin E, 1999, INT J OBESITY, V23, P37, DOI 10.1038/sj.ijo.0800793; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Ruderman NB, 1997, ANN NY ACAD SCI, V827, P221, DOI 10.1111/j.1749-6632.1997.tb51837.x; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; SMITH GP, 1969, AM J PHYSIOL, V217, P1083, DOI 10.1152/ajplegacy.1969.217.4.1083; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; VANITALLIE TB, 1953, J CLIN NUTR, V1, P208; WALLS EK, 1989, PHYSIOL BEHAV, V45, P1223, DOI 10.1016/0031-9384(89)90113-3; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Widdowson PS, 1997, DIABETES, V46, P1782, DOI 10.2337/diabetes.46.11.1782; WITT E, 1992, PROTEIN ENG, V5, P267, DOI 10.1093/protein/5.3.267; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	80	359	370	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					579	584		10.1038/nn1456	http://dx.doi.org/10.1038/nn1456			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856066				2022-12-28	WOS:000228895100016
J	Dalton, KM; Nacewicz, BM; Johnstone, T; Schaefer, HS; Gernsbacher, MA; Goldsmith, HH; Alexander, AL; Davidson, RJ				Dalton, KM; Nacewicz, BM; Johnstone, T; Schaefer, HS; Gernsbacher, MA; Goldsmith, HH; Alexander, AL; Davidson, RJ			Gaze fixation and the neural circuitry of face processing in autism	NATURE NEUROSCIENCE			English	Article							EARLY RECOGNITION; FUNCTIONAL MRI; INDIVIDUALS; CHILDREN; DISORDERS; AREA	Diminished gaze fixation is one of the core features of autism and has been proposed to be associated with abnormalities in the neural circuitry of affect. We tested this hypothesis in two separate studies using eye tracking while measuring functional brain activity during facial discrimination tasks in individuals with autism and in typically developing individuals. Activation in the fusiform gyrus and amygdala was strongly and positively correlated with the time spent fixating the eyes in the autistic group in both studies, suggesting that diminished gaze fixation may account for the fusiform hypoactivation to faces commonly reported in autism. In addition, variation in eye fixation within autistic individuals was strongly and positively associated with amygdala activation across both studies, suggesting a heightened emotional response associated with gaze fixation in autism.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Dalton, KM (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	kmdalton@wisc.edu; rjdavids@wisc.edu	Johnstone, Tom/C-5909-2011; Warfield, Simon/B-3352-2009	Johnstone, Tom/0000-0001-8635-8158; Warfield, Simon/0000-0002-7659-3880; Davidson, Richard/0000-0002-8506-4964; Gernsbacher, Morton Ann/0000-0003-0397-3329	NICHD NIH HHS [T32 HD007489, T32 HD07489, P30 HD003352, P30 HD03352] Funding Source: Medline; NIMH NIH HHS [R01 MH069793, U54MH066398, U54 MH066398] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, T32HD007489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069793, U54MH066398] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Ellis H, 1998, FACE MIND, P67; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; GEROGE N, 1999, NAT NEUROSCI, V2, P547; Glutting J., 2000, WIDE RANGE INTELLIGE; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 1997, J AUTISM DEV DISORD, V27, P385, DOI 10.1023/A:1025853321118; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lehmann C, 2004, NEUROIMAGE, V21, P75, DOI 10.1016/j.neuroimage.2003.08.038; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mundy P, 1994, UNDERSTANDING OTHER, P181; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Talairach J., 1988, COPLANAR STEREOTAXIC	23	1015	1036	8	241	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					519	526		10.1038/nn1421	http://dx.doi.org/10.1038/nn1421			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911XP	15750588	Green Accepted			2022-12-28	WOS:000228040400024
J	Grandjean, D; Sander, D; Pourtois, G; Schwartz, S; Seghier, ML; Scherer, KR; Vuilleumier, P				Grandjean, D; Sander, D; Pourtois, G; Schwartz, S; Seghier, ML; Scherer, KR; Vuilleumier, P			The voices of wrath: brain responses to angry prosody in meaningless speech	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; CORTEX; ATTENTION; EMOTION	We report two functional magnetic resonance imaging experiments showing enhanced responses in human middle superior temporal sulcus for angry relative to neutral prosody. This emotional enhancement was voice specific, unrelated to isolated acoustic amplitude or frequency cues in angry prosody, and distinct from any concomitant task-related attentional modulation. Attention and emotion seem to have separate effects on stimulus processing, reflecting a fundamental principle of human brain organization shared by voice and face perception.	Univ Geneva, Dept Psychol, Geneva Emot Res Grp, CH-1205 Geneva, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurosci, CH-1211 Geneva 4, Switzerland; Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; Univ Geneva, Dept Psychol, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Grandjean, D (corresponding author), Univ Geneva, Dept Psychol, Geneva Emot Res Grp, Bd Pont Arve 40, CH-1205 Geneva, Switzerland.	Didier.Grandjean@pse.unige.ch	Seghier, Mohamed/O-8634-2019; Vuilleumier, Patrik/AAJ-1839-2021; Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed/0000-0002-1146-8800; Vuilleumier, Patrik/0000-0002-8198-9214; Seghier, Mohamed L/0000-0002-1146-8800; Pourtois, Gilles/0000-0002-5109-2801; Sander, David/0000-0003-1266-9361; Grandjean, Didier/0000-0001-6125-4520; Schwartz, Sophie/0000-0001-7718-4053				Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2	12	331	335	0	39	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					145	146		10.1038/nn1392	http://dx.doi.org/10.1038/nn1392			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665880				2022-12-28	WOS:000226638200011
J	Wang, HX; Gerkin, RC; Nauen, DW; Bi, GQ				Wang, HX; Gerkin, RC; Nauen, DW; Bi, GQ			Coactivation and timing-dependent integration of synaptic potentiation and depression	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ASYMMETRIC HEBBIAN PLASTICITY; PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; PYRAMIDAL CELLS; MEMORY; CALMODULIN; LTP; TRANSMISSION	Neuronal synaptic connections can be potentiated or depressed by paired pre- and postsynaptic spikes, depending on the spike timing. We show that in cultured rat hippocampal neurons a calcium/calmodulin-dependent protein kinase II (CaMKII)-mediated potentiation process and a calcineurin-mediated depression process can be activated concomitantly by spike triplets or quadruplets. The integration of the two processes critically depends on their activation timing. Depression can cancel previously activated potentiation, whereas potentiation tends to override previously activated depression. The time window for potentiation to dominate is about 70 ms, beyond which the two processes cancel. These results indicate that the signaling machinery underlying spike timing-dependent plasticity (STDP) may be separated into functional modules that are sensitive to the spatiotemporal dynamics (rather than the amount) of calcium influx. The timing dependence of modular interaction provides a quantitative framework for understanding the temporal integration of STDP.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neurosci, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Med Scientist Training Program, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bi, GQ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	gqbi@pitt.edu	Gerkin, Richard/B-7683-2008; Bi, Guo-Qiang/E-5075-2013	nauen, david/0000-0002-2652-9944; Gerkin, Richard C/0000-0002-2940-3378; Bi, Guo-Qiang/0000-0001-8735-3818	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066962] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066962] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Berninger B, 2002, BIOESSAYS, V24, P212, DOI 10.1002/bies.10060; Bi GQ, 2002, BIOL CYBERN, V87, P319, DOI 10.1007/s00422-002-0349-7; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gutig R, 2003, J NEUROSCI, V23, P3697; Hebb Donald O., 1949, ORG BEHAV; Hopfield JJ, 2004, P NATL ACAD SCI USA, V101, P337, DOI 10.1073/pnas.2536316100; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Petersen JD, 2003, J NEUROSCI, V23, P11270; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; RUBIN JE, IN PRESS J NEUROPHYS; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Senn W, 2003, J COMPUT NEUROSCI, V14, P119, DOI 10.1023/A:1021935100586; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stevens CF, 1996, NATURE, V381, P471, DOI 10.1038/381471a0; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	50	200	206	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					187	193		10.1038/nn1387	http://dx.doi.org/10.1038/nn1387			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657596				2022-12-28	WOS:000226638200018
J	Vuilleumier, P; Richardson, MP; Armony, JL; Driver, J; Dolan, RJ				Vuilleumier, P; Richardson, MP; Armony, JL; Driver, J; Dolan, RJ			Distant influences of amygdala lesion on visual cortical activation during emotional face processing	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; FACIAL EXPRESSIONS; T2 RELAXATION; CORTEX; RECOGNITION; AROUSAL; PROJECTIONS; ATTENTION; NUCLEUS; MONKEYS	Emotional visual stimuli evoke enhanced responses in the visual cortex. To test whether this reflects modulatory influences from the amygdala on sensory processing, we used event-related functional magnetic resonance imaging (fMRI) in human patients with medial temporal lobe sclerosis. Twenty-six patients with lesions in the amygdala, the hippocampus or both, plus 13 matched healthy controls, were shown pictures of fearful or neutral faces in task-relevant or task-irrelevant positions on the display. All subjects showed increased fusiform cortex activation when the faces were in task-relevant positions. Both healthy individuals and those with hippocampal damage showed increased activation in the fusiform and occipital cortex when they were shown fearful faces, but this was not the case for individuals with damage to the amygdala, even though visual areas were structurally intact. The distant influence of the amygdala was also evidenced by the parametric relationship between amygdala damage and the level of emotional activation in the fusiform cortex. Our data show that combining the fMRI and lesion approaches can help reveal the source of functional modulatory influences between distant but interconnected brain regions.	Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurosci, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Inst Neurol, Dept Clin & Expt Epilepsy, Epilepsy Imaging Grp, London WC1N 3BG, England; McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of Geneva; University of Geneva; University of London; University College London; University of London; University College London; University of London; University College London; McGill University; University of London; University College London	Vuilleumier, P (corresponding author), Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland.	patrik.vuilleumier@medecine.unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Driver, Jon/A-4779-2010; Richardson, Mark P/E-5385-2010	Vuilleumier, Patrik/0000-0002-8198-9214; Richardson, Mark P/0000-0001-8925-3140; Dolan, Ray/0000-0001-9356-761X				Adam C, 1996, ACTA NEUROL SCAND, V94, P1, DOI 10.1111/j.1600-0404.1996.tb00031.x; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Armony JL, 1998, J NEUROSCI, V18, P2592; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartlett PA, 2002, J NEUROL NEUROSUR PS, V73, P753, DOI 10.1136/jnnp.73.6.753; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dringenberg HC, 2001, NEUROREPORT, V12, P2395, DOI 10.1097/00001756-200108080-00022; Ekman P., 1976, PICTURE FACIAL AFFEC; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Hamann SB, 1999, NEUROPSYCHOLOGIA, V37, P1135, DOI 10.1016/S0028-3932(99)00027-5; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; LeDoux J. E., 1996, EMOTIONAL BRAIN; Meletti S, 2003, NEUROLOGY, V60, P426, DOI 10.1212/WNL.60.3.426; Meunier M, 2002, EMOTION, V2, P147, DOI 10.1037//1528-3542.2.2.147; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Seeck M, 1999, EPILEPTIC DISORD, V1, P179; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; VanPaesschen W, 1996, NEUROLOGY, V47, P1021, DOI 10.1212/WNL.47.4.1021; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; VUILLEUMIER P, IN PRESS VISUAL COGN; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wieshmann UC, 1996, J NEUROL NEUROSUR PS, V61, P357, DOI 10.1136/jnnp.61.4.357; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wolf HK, 1997, ACTA NEUROPATHOL, V93, P606, DOI 10.1007/s004010050658	50	690	703	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1271	1278		10.1038/nn1341	http://dx.doi.org/10.1038/nn1341			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494727	Green Published			2022-12-28	WOS:000224749400021
J	Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K				Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K			Essential role of Ca2+-binding protein 4, a Ca(v)1.4 channel regulator, in photoreceptor synaptic function	NATURE NEUROSCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; SENSITIVE CALCIUM-CHANNEL; CA2+ CHANNELS; CA2+-DEPENDENT INACTIVATION; BIPOLAR CELLS; HIPPOCAMPAL-NEURONS; CONE PHOTORECEPTORS; PLEXIFORM LAYER; RIBBON SYNAPSE; RETINA	CaBP1-8 are neuronal Ca2+-binding proteins with similarity to calmodulin (CaM). Here we show that CaBP4 is specifically expressed in photoreceptors, where it is localized to synaptic terminals. The outer plexiform layer, which contains the photoreceptor synapses with secondary neurons, was thinner in the Cabp4(-/-) mice than in control mice. Cabp4(-/-) retinas also had ectopic synapses originating from rod bipolar and horizontal cells tha HJt extended into the outer nuclear layer. Responses of Cabp4(-/-) rod bipolars were reduced in sensitivity about 100-fold. Electroretinograms (ERGs) indicated a reduction in cone and rod synaptic function. The phenotype of Cabp4(-/-) mice shares similarities with that of incomplete congenital stationary night blindness (CSNB2) patients. CaBP4 directly associated with the C-terminal domain of the Ca(v)1.4 alpha(1)-subunit and shifted the activation of Ca(v)1.4 to hyperpolarized voltages in transfected cells. These observations indicate that CaBP4 is important for normal synaptic function, probably through regulation of Ca2+ influx and neurotransmitter release in photoreceptor synaptic terminals.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Emory University; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Haeseleer, F (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	fanfan@u.washington.edu; palczews@u.washington.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836; Lee, Amy/0000-0001-8021-0443	NATIONAL EYE INSTITUTE [R03EY014561, R01EY011850, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044922] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY014561, EY09339, R01 EY009339, P30 EY001730, R01 EY011850, EY11850, EY014561] Funding Source: Medline; NINDS NIH HHS [NS044922, R01 NS044922] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BARNES S, 2002, CALCIUM, V514, P465; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2001, INVEST OPHTH VIS SCI, V42, P3294; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Koulen P, 1998, J NEUROSCI, V18, P10136; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Seidenbecher CI, 2002, ADV EXP MED BIOL, V514, P451; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Zhang N, 2002, J NEUROSCI, V22, P7065; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	50	222	232	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1079	1087		10.1038/nn1320	http://dx.doi.org/10.1038/nn1320			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452577	Green Accepted			2022-12-28	WOS:000224156900017
J	Mooser, F; Bosking, WH; Fitzpatrick, D				Mooser, F; Bosking, WH; Fitzpatrick, D			A morphological basis for orientation tuning in primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; LOCAL CIRCUIT NEURONS; SHREW TUPAIA-GLIS; SIMPLE CELLS; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; TOPOGRAPHIC ORGANIZATION; HORIZONTAL CONNECTIONS; OCULAR DOMINANCE; THALAMIC INPUT	Feedforward connections are thought to be important in the generation of orientation-selective responses in visual cortex by establishing a bias in the sampling of information from regions of visual space that lie along a neuron's axis of preferred orientation. It remains unclear, however, which structural elements-dendrites or axons-are ultimately responsible for conveying this sampling bias. To explore this question, we have examined the spatial arrangement of feedforward axonal connections that link non-oriented neurons in layer 4 and orientation-selective neurons in layer 2/3 of visual cortex in the tree shrew. Target sites of labeled boutons in layer 2/3 resulting from focal injections of biocytin in layer 4 show an orientation-specific axial bias that is sufficient to confer orientation tuning to layer 2/3 neurons. We conclude that the anisotropic arrangement of axon terminals is the principal source of the orientation bias contributed by feedforward connections.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	fitzpat@neuro.duke.edu			NEI NIH HHS [EY06821] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmed B, 1997, J COMP NEUROL, V380, P230; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; FREUND TF, 1985, J COMP NEUROL, V242, P275, DOI 10.1002/cne.902420209; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1980, J COMP NEUROL, V192, P531, DOI 10.1002/cne.901920311; HUMPHREY AL, 1980, J COMP NEUROL, V192, P549, DOI 10.1002/cne.901920312; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; LUND JS, 1987, J COMP NEUROL, V257, P60, DOI 10.1002/cne.902570106; Martinez-Diaz JJ, 2002, TECTONOPHYSICS, V356, P291, DOI 10.1016/S0040-1951(02)00400-6; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Tucker TR, 2004, VISUAL NEUROSCIENCES, P733; Usrey WM, 1996, J NEUROSCI, V16, P1203; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	43	60	62	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					872	879		10.1038/nn1287	http://dx.doi.org/10.1038/nn1287			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258585				2022-12-28	WOS:000222930800018
J	Bradley, J; Bonigk, W; Yau, KW; Frings, S				Bradley, J; Bonigk, W; Yau, KW; Frings, S			Calmodulin permanently associates with rat olfactory CNG channels under native conditions	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNELS; CALCIUM-CALMODULIN; BETA-SUBUNIT; TERMINAL REGIONS; RECEPTOR NEURONS; ODOR ADAPTATION; CATION CHANNEL; ION CHANNELS; MODULATION; TRANSDUCTION	An important mechanism by which vertebrate olfactory sensory neurons rapidly adapt to odorants is feedback modulation of the Ca2+-permeable cyclic nucleotide-gated (CNG) transduction channels. Extensive heterologous studies of homomeric CNGA2 channels have led to a molecular model of channel modulation based on the binding of calcium-calmodulin to a site on the cytoplasmic amino terminus of CNGA2. Native rat olfactory CNG channels, however, are heteromeric complexes of three homologous but distinct subunits. Notably, in heteromeric channels, we found no role for CNGA2 in feedback modulation. Instead, an IQ-type calmodulin-binding site on CNGB1b and a similar but previously unidentified site on CNGA4 are necessary and sufficient. These sites seem to confer binding of Ca2+-free calmodulin (apocalmodulin), which is then poised to trigger inhibition of native channels in the presence of Ca2+.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Forschungszentrum Julich, Inst Biol Informat Proc, D-52425 Julich, Germany	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Helmholtz Association; Research Center Julich	Bradley, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	jbradley@jhu.edu; s.frings@zoo.uni-heidelberg.de		Bradley, Jonathan/0000-0002-6933-1153	NATIONAL EYE INSTITUTE [R37EY006837, R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15S1, R01 EY006837-17, R01 EY006837-16A1, R37 EY006837-15, R01 EY006837, R37 EY006837-14, R01 EY014596-01, R01 EY014596, R37 EY006837, R01 EY014596-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Frings S, 2001, CELL MOL LIFE SCI, V58, P510, DOI 10.1007/PL00000876; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kleene SJ, 1999, J NEUROPHYSIOL, V81, P2675, DOI 10.1152/jn.1999.81.6.2675; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LYNCH JW, 1994, J GEN PHYSIOL, V103, P87, DOI 10.1085/jgp.103.1.87; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Orsale M, 2003, FEBS LETT, V548, P11, DOI 10.1016/S0014-5793(03)00716-6; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Sencer S, 2001, J BIOL CHEM, V276, P38237; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zheng J, 2003, J NEUROSCI, V23, P8167; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200	31	88	95	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					705	710		10.1038/nn1266	http://dx.doi.org/10.1038/nn1266			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195096	Green Accepted			2022-12-28	WOS:000222274400011
J	Misonou, H; Mohapatra, DP; Park, EW; Leung, V; Zhen, DK; Misonou, K; Anderson, AE; Trimmer, JS				Misonou, H; Mohapatra, DP; Park, EW; Leung, V; Zhen, DK; Misonou, K; Anderson, AE; Trimmer, JS			Regulation of ion channel localization and phosphorylation by neuronal activity	NATURE NEUROSCIENCE			English	Article							KV2.1 K+ CHANNEL; NEOCORTICAL PYRAMIDAL NEURONS; GATED POTASSIUM CHANNELS; RAT HIPPOCAMPAL-NEURONS; MAMMALIAN BRAIN; ALPHA-SUBUNITS; RECEPTOR; IDENTIFICATION; ACTIVATION; BINDING	Voltage-dependent Kv2.1 K+ channels, which mediate delayed rectifier Kv currents (I-K), are expressed in large clusters on the somata and dendrites of principal pyramidal neurons, where they regulate neuronal excitability. Here we report activity-dependent changes in the localization and biophysical properties of Kv2.1. In the kainate model of continuous seizures in rat, we find a loss of Kv2.1 clustering in pyramidal neurons in vivo. Biochemical analysis of Kv2.1 in the brains of these rats shows a marked dephosphorylation of Kv2.1. In cultured rat hippocampal pyramidal neurons, glutamate stimulation rapidly causes dephosphorylation of Kv2.1, translocation of Kv2.1 from clusters to a more uniform localization, and a shift in the voltage-dependent activation of I-K. An influx of Ca2+ leading to calcineurin activation is both necessary and sufficient for these effects. Our finding that neuronal activity modifies the phosphorylation state, localization and function of Kv2.1 suggests an important link between excitatory neurotransmission and the intrinsic excitability of pyramidal neurons.	Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Baylor Coll Med, Cain Fdn Lab, Houston, TX 77030 USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine	Misonou, H (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	hmisono@ucdavis.edu	Durga, Mohapatra/B-3620-2008; Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Misono, Hiroaki/0000-0001-5892-1804	NINDS NIH HHS [NS39943, NS42225] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225, R01NS039943] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Colbert CM, 1999, J NEUROSCI, V19, P8163; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2004, NAT NEUROSCI, V7, P98, DOI 10.1038/nn0204-98; Kang J, 2000, J NEUROPHYSIOL, V83, P70, DOI 10.1152/jn.2000.83.1.70; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malin SA, 2002, J NEUROSCI, V22, P10094; Martina M, 1998, J NEUROSCI, V18, P8111; MISONOU H, IN PRESS CRIT REV BI; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Pal S, 2003, J NEUROSCI, V23, P4798; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; SHI GY, 1994, J BIOL CHEM, V269, P23204; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WESTON JE, 1981, SOLID STATE IONICS, V2, P347, DOI 10.1016/0167-2738(81)90038-2	40	328	341	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					711	718		10.1038/nn1260	http://dx.doi.org/10.1038/nn1260			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195093				2022-12-28	WOS:000222274400012
J	Tzounopoulos, T; Kim, Y; Oertel, D; Trussell, LO				Tzounopoulos, T; Kim, Y; Oertel, D; Trussell, LO			Cell-specific, spike timing-dependent plasticities in the dorsal cochlear nucleus	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; NEURONS; CARTWHEEL; EFFICACY; LOCALIZATION; COINCIDENCE; EXPRESSION; DEPRESSION; SYNAPSES	In the dorsal cochlear nucleus, long-term synaptic plasticity can be induced at the parallel fiber inputs that synapse onto both fusiform principal neurons and cartwheel feedforward inhibitory interneurons. Here we report that in mouse fusiform cells, spikes evoked 5 ms after parallel-fiber excitatory postsynaptic potentials (EPSPs) led to long-term potentiation (LTP), whereas spikes evoked 5 ms before EPSPs led to long-term depression (LTD) of the synapse. The EPSP-spike protocol led to LTD in cartwheel cells, but no synaptic changes resulted from the reverse sequence (spike-EPSP). Plasticity in fusiform and cartwheel cells therefore followed Hebbian and anti-Hebbian learning rules, respectively. Similarly, spikes generated by summing EPSPs from different groups of parallel fibers produced LTP in fusiform cells, and LTD in cartwheel cells. LTD could also be induced in glutamatergic inputs of cartwheel cells by pairing parallel-fiber EPSPs with depolarizing glycinergic PSPs from neighboring cartwheel cells. Thus, synaptic learning rules vary with the postsynaptic cell, and may require the interaction of different transmitter systems.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	Oregon Health & Science University; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison	Tzounopoulos, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	tzounopo@ohsu.edu	Kim, Yuil/AAA-1103-2020	Kim, Yuil/0000-0001-9271-7073; Oertel, Donata/0000-0001-8416-7470	NIDCD NIH HHS [R01 DC000176] Funding Source: Medline; NINDS NIH HHS [NS28901] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028901, R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000176] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bell CC, 2002, BRAIN BEHAV EVOLUT, V59, P312, DOI 10.1159/000063567; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BERREBI AS, 1991, ANAT EMBRYOL, V183, P427; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bilak SR, 1998, SYNAPSE, V28, P251; Chavas J, 2003, J NEUROSCI, V23, P2019; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Golding NL, 1997, J NEUROPHYSIOL, V78, P248, DOI 10.1152/jn.1997.78.1.248; Golding NL, 1996, J NEUROSCI, V16, P2208; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Molitor SC, 1999, J NEUROPHYSIOL, V81, P985, DOI 10.1152/jn.1999.81.3.985; Molitor SC, 2003, J NEUROPHYSIOL, V89, P2225, DOI 10.1152/jn.00709.2002; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Pouille F, 2000, J PHYSIOL-LONDON, V527, P265, DOI 10.1111/j.1469-7793.2000.00265.x; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; RYUGO DK, 1995, J COMP NEUROL, V358, P102, DOI 10.1002/cne.903580107; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Sutherland DP, 1998, BEHAV BRAIN RES, V97, P1, DOI 10.1016/S0166-4328(98)00008-4; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Veruki ML, 2002, J NEUROSCI, V22, P10558; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Young ED, 2002, SPR HDB AUD, V15, P160; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384	40	219	224	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					719	725		10.1038/nn1272	http://dx.doi.org/10.1038/nn1272			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208632				2022-12-28	WOS:000222274400013
J	Cheng, LP; Arata, A; Mizuguchi, R; Qian, Y; Karunaratne, A; Gray, PA; Arata, S; Shirasawa, S; Bouchard, M; Luo, P; Chen, CL; Busslinger, M; Goulding, M; Onimaru, H; Ma, QF				Cheng, LP; Arata, A; Mizuguchi, R; Qian, Y; Karunaratne, A; Gray, PA; Arata, S; Shirasawa, S; Bouchard, M; Luo, P; Chen, CL; Busslinger, M; Goulding, M; Onimaru, H; Ma, QF			Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates	NATURE NEUROSCIENCE			English	Article							DORSAL SPINAL-CORD; RESPIRATORY RHYTHM GENERATION; PRESYNAPTIC REGULATION; DEVELOPMENTAL SWITCH; SENSORY NEURONS; HOMEOBOX GENES; RAT; EXPRESSION; BRAIN; INTERNEURONS	Glutamatergic and GABAergic neurons mediate much of the excitatory and inhibitory neurotransmission, respectively, in the vertebrate nervous system. The process by which developing neurons select between these two cell fates is poorly understood. Here we show that the homeobox genes Tlx3 and Tlx1 determine excitatory over inhibitory cell fates in the mouse dorsal spinal cord. First, we found that Tlx3 was required for specification of, and expressed in, glutamatergic neurons. Both generic and region-specific glutamatergic markers, including VGLUT2 and the AMPA receptor Gria2, were absent in Tlx mutant dorsal horn. Second, spinal GABAergic markers were derepressed in Tlx mutants, including Pax2 that is necessary for GABAergic differentiation, Gad1/2 and Viaat that regulate GABA synthesis and transport, and the kainate receptors Grik2/3. Third, ectopic expression of Tlx3 was sufficient to suppress GABAergic differentiation and induce formation of glutamatergic neurons. Finally, excess GABA-mediated inhibition caused dysfunction of central respiratory circuits in Tlx3 mutant mice.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; RIKEN, Brain Sci Inst, Lab Memory & Learning, Wako, Saitama 3510198, Japan; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Showa Univ, Ctr Biotechnol, Tokyo 1428555, Japan; Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Res Inst Mol Pathol, A-1030 Vienna, Austria; Showa Univ, Sch Med, Dept Physiol, Tokyo 1428555, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; RIKEN; Salk Institute; Showa University; National Center for Global Health & Medicine - Japan; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Showa University	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	Qiufu_Ma@dfci.harvard.edu	Karunaratne, Asanka/B-5808-2008; Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Arata, Akiko/0000-0001-7418-8294; Bouchard, Maxime/0000-0002-7619-9680				Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Azkue JJ, 1998, BRAIN RES, V790, P74, DOI 10.1016/S0006-8993(98)00050-X; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bennett MR, 1999, NEUROCHEM INT, V35, P269, DOI 10.1016/S0197-0186(99)00068-6; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Blessing WW, 1997, LOWER BRAINSTEM BODY; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Dickenson AH, 2002, BRIT J ANAESTH, V88, P755, DOI 10.1093/bja/88.6.755; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fode C, 2000, GENE DEV, V14, P67; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kerchner GA, 2002, J NEUROSCI, V22, P8010; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Lu Y, 2003, J NEUROSCI, V23, P8752; MA W, 1992, J COMP NEUROL, V325, P271, DOI 10.1002/cne.903250210; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; SCHAFFNER AE, 1993, DEV BRAIN RES, V72, P265, DOI 10.1016/0165-3806(93)90192-D; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Spike RC, 1998, EUR J NEUROSCI, V10, P324, DOI 10.1046/j.1460-9568.1998.00048.x; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370	49	263	264	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					510	517		10.1038/nn1221	http://dx.doi.org/10.1038/nn1221			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15064766				2022-12-28	WOS:000221101300028
J	Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF				Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF			WebQTL: Rapid exploratory analysis of gene expression and genetic networks for brain and behavior	NATURE NEUROSCIENCE			English	Database Review							STRAINS		Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Genom & Bioinformat, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Chesler, EJ (corresponding author), Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.	echesler@utmem.edu	Chesler, Elissa/K-4641-2019; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; Williams, Robert W./0000-0001-8924-4447				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Fehr C, 2002, J NEUROSCI, V22, P3730; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Williams M, 2001, NUCL ENG INT, V46, P18	6	139	141	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					485	486		10.1038/nn0504-485	http://dx.doi.org/10.1038/nn0504-485			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114364				2022-12-28	WOS:000221101300019
J	Duguid, IC; Smart, TG				Duguid, IC; Smart, TG			Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses	NATURE NEUROSCIENCE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; ENDOGENOUS CANNABINOIDS; CLIMBING FIBER; RAT CEREBELLUM; CALCIUM STORES; REBOUND POTENTIATION; TRANSMITTER RELEASE; SYNAPTIC CURRENTS; INHIBITION; NEURONS	Synaptic inhibition is a vital component in the control of cell excitability within the brain. Here we report a newly identified form of inhibitory synaptic plasticity, termed depolarization-induced potentiation of inhibition, in rodents. This mechanism strongly potentiated synaptic transmission from interneurons to Purkinje cells after the termination of depolarization-induced suppression of inhibition. It was triggered by an elevation of Ca(2+) in Purkinje cells and the subsequent retrograde activation of presynaptic NMDA receptors. These glutamate receptors promoted the spontaneous release of Ca(2+) from presynaptic ryanodine-sensitive Ca(2+) stores. Thus, NMDA receptor-mediated facilitation of transmission at this synapse provides a regulatory mechanism that can dynamically alter the synaptic efficacy at inhibitory synapses.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Duguid, Ian/0000-0001-6966-2641	Medical Research Council [G9603438] Funding Source: Medline; MRC [G9603438] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Galante M, 2003, J NEUROSCI, V23, P11229; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Glitsch M, 1999, J NEUROSCI, V19, P511; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Ito M, 1984, CEREBELLUM NEURAL CO; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kim J, 2001, J NEUROSCI, V21, P9608, DOI 10.1523/JNEUROSCI.21-24-09608.2001; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; KUROBE N, 1992, J NEUROCHEM, V58, P128, DOI 10.1111/j.1471-4159.1992.tb09287.x; Levenes C, 2001, J PHYSIOL-LONDON, V537, P125, DOI 10.1111/j.1469-7793.2001.0125k.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PITLER TA, 1992, J NEUROSCI, V12, P4122; Pittman QJ, 2000, EXP PHYSIOL, V85, p139S, DOI 10.1111/j.1469-445X.2000.tb00017.x; Pouzat C, 1997, J NEUROSCI, V17, P9104; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; Stephens GJ, 2001, EUR J NEUROSCI, V13, P1902, DOI 10.1046/j.0953-816x.2001.01566.x; Strata P, 1997, PROG BRAIN RES, V114, P263; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	49	196	202	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					525	533		10.1038/nn1227	http://dx.doi.org/10.1038/nn1227			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097992				2022-12-28	WOS:000221101300030
J	van den Top, M; Lee, K; Whyment, AD; Blanks, AM; Spanswick, D				van den Top, M; Lee, K; Whyment, AD; Blanks, AM; Spanswick, D			Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus	NATURE NEUROSCIENCE			English	Article							VASOPRESSIN RELEASE; NEUROPEPTIDE-Y; FOOD-INTAKE; SATED RATS; GHRELIN; CHANNELS	The hypothalamic arcuate nucleus (ARC) integrates and responds to satiety and hunger signals and forms the origins of the central neural response to perturbations in energy balance. Here we show that rat ARC neurons containing neuropeptide Y (NPY) and agouti-related protein (AgRP), which are conditional pacemakers, are activated by orexigens and inhibited by the anorexigen leptin. We propose a neuron-specific signaling mechanism through which central and peripheral signals engage the central neural anabolic drive.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Spanswick, D (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.	D.C.Spanswick@warwick.ac.uk	Blanks, Andrew/J-6461-2012	Blanks, Andrew/0000-0003-1073-6081				BICKNELL RJ, 1981, NEUROENDOCRINOLOGY, V33, P295, DOI 10.1159/000123248; Burdakov D, 2003, J NEUROSCI, V23, P4951; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2003, ANNU REV MED, V54, P453, DOI 10.1146/annurev.med.54.101601.152403; Dube MG, 2000, PEPTIDES, V21, P1557, DOI 10.1016/S0196-9781(00)00311-9; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jain MR, 2000, REGUL PEPTIDES, V87, P19, DOI 10.1016/S0167-0115(99)00102-0; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Wang LX, 2002, NEUROSCI LETT, V325, P47; Yamanaka A, 2000, BRAIN RES, V859, P404, DOI 10.1016/S0006-8993(00)02043-6	15	330	333	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					493	494		10.1038/nn1226	http://dx.doi.org/10.1038/nn1226			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097991				2022-12-28	WOS:000221101300023
J	Van Horn, JD; Grafton, ST; Rockmore, D; Gazzaniga, MS				Van Horn, JD; Grafton, ST; Rockmore, D; Gazzaniga, MS			Sharing neuroimaging studies of human cognition	NATURE NEUROSCIENCE			English	Article							BRAIN; NEUROSCIENCE; DATABASES; REPRESENTATIONS; CHALLENGES; YOUNG	After more than a decade of collecting large neuroimaging datasets, neuroscientists are now working to archive these studies in publicly accessible databases. In particular, the fMRI Data Center (fMRIDC), a high-performance computing center managed by computer and brain scientists, seeks to catalogue and openly disseminate the data from published fMRI studies to the community. This repository enables experimental validation and allows researchers to combine and examine patterns of brain activity beyond that of any single study. As with some biological databases, early scientific, technical and sociological concerns hindered initial acceptance of the fMRIDC. However, with the continued growth of this and other neuroscience archives, researchers are recognizing the potential of such resources for identifying new knowledge about cognitive and neural activity. Thus, the field of neuroimaging is following the lead of biology and chemistry, mining its accumulating body of knowledge and moving toward a 'discovery science' of brain function.	Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA; Dartmouth Coll, MRI Data Ctr, Hanover, NH 03755 USA; Dartmouth Coll, Dept Math, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Van Horn, JD (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA.	John.D.Van.Horn@dartmouth.edu		Van Horn, John Darrell/0000-0003-1537-0816				Arbib MA, 2000, NEURAL NETWORKS, V13, P975, DOI 10.1016/S0893-6080(00)00070-8; Ascoli GA, 2001, ANAT EMBRYOL, V204, P283, DOI 10.1007/s004290100201; Beltrame F, 1999, IEEE Trans Inf Technol Biomed, V3, P239, DOI 10.1109/4233.788587; Benson DA, 2003, NUCLEIC ACIDS RES, V31, P23, DOI 10.1093/nar/gkg057; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Carney SL, 2003, DRUG DISCOV TODAY, V8, P436, DOI 10.1016/S1359-6446(03)02710-7; Collins FS, 2001, CANCER, V91, P221, DOI 10.1002/1097-0142(20010101)91:1+<221::AID-CNCR8>3.3.CO;2-0; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Cozzarelli NR, 2004, P NATL ACAD SCI USA, V101, P3721, DOI 10.1073/pnas.0400437101; Druzgal TJ, 2003, J COGNITIVE NEUROSCI, V15, P771, DOI 10.1162/089892903322370708; Foster I, 2003, SCI AM, V288, P78, DOI 10.1038/scientificamerican0403-78; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; GREICIUS MD, 2004, P NATL ACAD SCI 0315; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Insel TR, 2003, PLOS BIOL, V1, P9, DOI 10.1371/journal.pbio.0000017; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Kable JW, 2002, J COGNITIVE NEUROSCI, V14, P795, DOI 10.1162/08989290260138681; Koslow SH, 2000, NAT NEUROSCI, V3, P863, DOI 10.1038/78760; Koslow SH, 2002, NAT REV NEUROSCI, V3, P311, DOI 10.1038/nrn787; Liou M, 2003, J COGNITIVE NEUROSCI, V15, P935, DOI 10.1162/089892903770007326; Lloyd D, 2002, J COGNITIVE NEUROSCI, V14, P818, DOI 10.1162/089892902760191027; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P925, DOI 10.1162/089892903770007317; Mirsky JS, 1998, J NEUROSCI METH, V82, P105, DOI 10.1016/S0165-0270(98)00049-1; NOY NF, 2002, SMI20020926; OECH TR, 2003, SHARING PUBLICATION; Oliver Diane E, 2002, Pac Symp Biocomput, P65; PHELPS ME, 1977, ACTA NEUROL SCAND, V56, P446; Posner MI, 1998, CURR OPIN NEUROBIOL, V8, P175, DOI 10.1016/S0959-4388(98)80137-2; Raichle M E, 1975, Ciba Found Symp, P85; Ramnani Narender, 2002, Trends in Neurosciences, V25, P496, DOI 10.1016/S0166-2236(02)02227-0; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Roy C S, 1890, J Physiol, V11, P85; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Shepherd GM, 2002, J NEUROSCI, V22, P1497; Simpson JR, 2000, J COGNITIVE NEUROSCI, V12, P157, DOI 10.1162/089892900564019; Sussman JL, 1998, SCIENCE, V282, P1993; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Talairach I., 1988, COPLANAR STEREOTACTI; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; Toni I, 2002, J COGNITIVE NEUROSCI, V14, P769, DOI 10.1162/08989290260138663; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Horn J.D., 2002, PRACTICAL GUIDE NEUR, P221; Van Horn JD, 2001, PHILOS T R SOC B, V356, P1323, DOI 10.1098/rstb.2001.0916; VANHORN JD, IN PRESS DATABASING; Wlodawer A, 1998, SCIENCE, V279, P306; Yarmush ML, 2002, ANNU REV BIOMED ENG, V4, P349, DOI 10.1146/annurev.bioeng.4.020702.153443	58	58	58	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					473	481		10.1038/nn1231	http://dx.doi.org/10.1038/nn1231			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	816HP	15114361				2022-12-28	WOS:000221101300016
J	de Lafuente, V; Romo, R				de Lafuente, V; Romo, R			Neuronal correlates of subjective sensory experience	NATURE NEUROSCIENCE			English	Article							EARLY VISUAL-CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; PREMOTOR CORTEX; PSYCHOPHYSICAL PERFORMANCE; CORTICAL MICROSTIMULATION; SOMATOSENSORY CORTEX; NEURAL CODES; DISCRIMINATION; MACAQUE	When a near-threshold stimulus is presented, a sensory percept may or may not be produced. The unpredictable outcome of such perceptual judgment is believed to be determined by the activity of neurons in early sensory cortex. We analyzed the responses of neurons in primary somatosensory cortex, recorded while monkeys judged the presence or absence of threshold stimuli. We found that these responses did not covary with the monkeys' perceptual reports. In contrast, the activity of frontal lobe neurons did covary with trial-by-trial judgments. Further control and microstimulation experiments indicated that frontal lobe neurons are closely related to the monkeys' subjective experiences during sensory detection.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx	de la Fuente, Javier/GQP-6328-2022	de Lafuente, Victor/0000-0002-1047-1354; romo, ranulfo/0000-0003-3529-3635				Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	229	232	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1698	1703		10.1038/nn1587	http://dx.doi.org/10.1038/nn1587			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286929				2022-12-28	WOS:000233576200018
J	Nestler, EJ				Nestler, EJ			Is there a common molecular pathway for addiction?	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ELEMENT-BINDING PROTEIN; DRUG-ADDICTION; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; MEDIATED TRANSCRIPTION; NEUROTROPHIC FACTOR; DOPAMINE NEURONS; GENE-EXPRESSION; COCAINE-SEEKING	Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration. Some similar actions occur for natural rewards as well. Researchers are making progress in understanding the molecular and cellular basis of these common effects. A major goal for future research is to determine whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu						Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Bonci A, 1997, J NEUROSCI, V17, P796; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Constantinescu A, 2004, J BIOL CHEM, V279, P43321, DOI 10.1074/jbc.M406994200; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kelley AE, 2002, J NEUROSCI, V22, P3306; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kreek MJ, 2001, ANN NY ACAD SCI, V937, P27; Littleton J, 2003, AM J ADDICTION, V12, pS3, DOI 10.1111/j.1521-0391.2003.tb00492.x; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Walters CL, 2005, BRAIN RES, V1032, P193, DOI 10.1016/j.brainres.2004.11.013; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	913	947	1	125	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1445	1449		10.1038/nn1578	http://dx.doi.org/10.1038/nn1578			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251986				2022-12-28	WOS:000232966600014
J	Wunderlich, K; Schneider, KA; Kastner, S				Wunderlich, K; Schneider, KA; Kastner, S			Neural correlates of binocular rivalry in the human lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ALERT MACAQUE; MONKEY; CAT; PERCEPTION; ORGANIZATION; SUPPRESSION; ATTENTION; RESPONSES; DYNAMICS	When dissimilar images are presented to the two eyes, they compete for perceptual dominance so that only one image is visible at a time while the other one is suppressed. Neural correlates of such binocular rivalry have been found at multiple stages of visual processing, including striate and extrastriate visual cortex. However, little is known about the role of subcortical processing during binocular rivalry. Here we used fMRI to measure neural activity in the human LGN while subjects viewed contrast-modulated gratings presented dichoptically. Neural activity in the LGN correlated strongly with the subjects' reported percepts, such that activity increased when a high-contrast grating was perceived and decreased when a low-contrast grating was perceived. Our results provide evidence for a functional role of the LGN in binocular rivalry and suggest that the LGN, traditionally viewed as the gateway to the visual cortex, may be an early gatekeeper of visual awareness.	Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University	Kastner, S (corresponding author), Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.	skastner@princeton.edu		Kastner, Sabine/0000-0002-9742-965X; Schneider, Keith/0000-0001-7120-3380	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043, T32MH065214, P50MH062196] Funding Source: NIH RePORTER; NIMH NIH HHS [T32 MH065214, R01MH-64043, P50MH-62196, P50 MH062196, R01 MH064043] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cohen J, 2003, ANIM COGN, V6, P93, DOI 10.1007/s10071-003-0168-9; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Lehky SR, 1991, NEURAL COMPUT, V3, P44, DOI 10.1162/neco.1991.3.1.44; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Lehky SR, 1996, VISION RES, V36, P1225, DOI 10.1016/0042-6989(95)00232-4; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BRIT J PSYCHOL, V56, P1, DOI 10.1111/j.2044-8295.1965.tb00939.x; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; LUND JS, 1975, J COMP NEUROL, V159, P305, DOI 10.1002/cne.901590303; MARROCCO RT, 1979, BRAIN RES, V168, P633, DOI 10.1016/0006-8993(79)90319-6; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; PAPE HC, 1986, EXP BRAIN RES, V61, P265; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; RODIECK RW, 1979, EXP BRAIN RES, V35, P465; SANDERSON KJ, 1971, EXP BRAIN RES, V13, P178; SCHMIELAU F, 1977, BRAIN RES, V120, P354, DOI 10.1016/0006-8993(77)90914-3; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; SCHROEDER CE, 1990, BRAIN RES, V521, P303, DOI 10.1016/0006-8993(90)91556-V; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; SINGER W, 1970, BRAIN RES, V18, P165, DOI 10.1016/0006-8993(70)90463-4; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; VARELA FJ, 1987, EXP BRAIN RES, V66, P10	39	211	217	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1595	1602		10.1038/nn1554	http://dx.doi.org/10.1038/nn1554			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234812	Green Accepted			2022-12-28	WOS:000232966600035
J	Fang, F; He, S				Fang, F; He, S			Cortical responses to invisible objects in the human dorsal and ventral pathways	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; RECOGNITION; PERCEPTION; ACTIVATION; FMRI; SEPARATE; MOTION; AREAS	The primate visual system is believed to comprise two main pathways: a ventral pathway for conscious perception and a dorsal pathway that can process visual information and guide action without accompanying conscious knowledge. Evidence for this theory has come primarily from studies of neurological patients and animals. Using fMRI, we show here that even though observers are completely unaware of test object images owing to interocular suppression, their dorsal cortical areas demonstrate substantial activity for different types of visual objects, with stronger responses to images of tools than of human faces. This result also suggests that in binocular rivalry, substantial information in the suppressed eye can escape the interocular suppression and reach dorsal cortex.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu						Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Claeys KG, 2003, NEURON, V40, P631, DOI 10.1016/S0896-6273(03)00590-7; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HE S, 2005, BINOCULAR RIVALRY PE; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 2001, HDB FUNCTIONAL NEURO, P109; Kluver H, 1938, J PSYCHOL, V5, P33; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004	34	306	320	5	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1380	1385		10.1038/nn1537	http://dx.doi.org/10.1038/nn1537			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136038				2022-12-28	WOS:000232145900023
J	Liu, YB; Shi, J; Lu, CC; Wang, ZB; Lyuksyutova, AI; Song, XJ; Zou, YM				Liu, YB; Shi, J; Lu, CC; Wang, ZB; Lyuksyutova, AI; Song, XJ; Zou, YM			Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASE; AXON GUIDANCE; MOLECULE; L1	Guidance cues along the longitudinal axis of the CNS are poorly understood. Wnt proteins attract ascending somatosensory axons to project from the spinal cord to the brain. Here we show that Wnt proteins repel corticospinal tract (CST) axons in the opposite direction. Several Wnt genes were found to be expressed in the mouse spinal cord gray matter, cupping the dorsal funiculus, in an anterior-to-posterior decreasing gradient along the cervical and thoracic cord. Wnts repelled CST axons in collagen gel assays through a conserved high-affinity receptor, Ryk, which is expressed in CST axons. Neonatal spinal cord secretes diffusible repellent(s) in an anterior-posterior graded fashion, with anterior cord being stronger, and the repulsive activity was blocked by antibodies to Ryk (anti-Ryk). Intrathecal injection of anti-Ryk blocked the posterior growth of CST axons. Therefore, Wnt proteins may have a general role in anterior-posterior guidance of multiple classes of axons.	Univ Chicago, Dept Neurol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Parker Coll Res Inst, Dallas, TX 75229 USA	University of Chicago; University of Chicago; University of Chicago	Zou, YM (corresponding author), Univ Chicago, Dept Neurol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu	Liu, Yaobo/AFS-0502-2022; shi, jun/C-2389-2011	Liu, Yaobo/0000-0002-7663-5649; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Joosten EAJ, 1996, DEV BRAIN RES, V94, P99, DOI 10.1016/0165-3806(96)00017-X; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	17	209	219	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1151	1159		10.1038/nn1520	http://dx.doi.org/10.1038/nn1520			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116452				2022-12-28	WOS:000231483800014
J	DeLong, KA; Urbach, TP; Kutas, M				DeLong, KA; Urbach, TP; Kutas, M			Probabilistic word pre-activation during language comprehension inferred from electrical brain activity	NATURE NEUROSCIENCE			English	Article							INCREMENTAL INTERPRETATION; POTENTIALS; CONTEXT; INTEGRATION; INFORMATION; SENTENCES; HYPOTHESIS; EXPECTANCY; DISCOURSE; AGREEMENT	Despite the numerous examples of anticipatory cognitive processes at micro and macro levels in many animal species, the idea that anticipation of specific words plays an integral role in real-time language processing has been contentious. Here we exploited a phonological regularity of English indefinite articles ('an' precedes nouns beginning with vowel sounds, whereas 'a' precedes nouns beginning with consonant sounds) in combination with event-related brain potential recordings from the human scalp to show that readers' brains can pre-activate individual words in a graded fashion to a degree that can be estimated from the probability that each word is given as a continuation for a sentence fragment offline. These findings are evidence that readers use the words in a sentence ( as cues to their world knowledge) to estimate relative likelihoods for upcoming words.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	DeLong, KA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	kadelong@cogsci.ucsd.edu		Urbach, Thomas/0000-0001-7993-142X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008313] Funding Source: NIH RePORTER; NIA NIH HHS [AG08313] Funding Source: Medline; NICHD NIH HHS [HD22614] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; CARROLL J, 1978, HDB PERCEPTION, V7, P299; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; GUNTER TC, 1992, PSYCHOPHYSIOLOGY, V29, P38, DOI 10.1111/j.1469-8986.1992.tb02009.x; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; KING JW, 1995, CRL NEWSLETTER, V10, P1; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KLUENDER R, 1993, LANG COGNITIVE PROC, V8, P573, DOI 10.1080/01690969308407588; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P406; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; MARSLENWILSON WD, 1975, SCIENCE, V189, P226, DOI 10.1126/science.189.4198.226; MITCHELL DC, 1978, Q J EXP PSYCHOL, V30, P609, DOI 10.1080/14640747808400689; OREGAN K, 1979, PERCEPT PSYCHOPHYS, V25, P501, DOI 10.3758/BF03213829; PICKERING MJ, 1994, J PSYCHOLINGUIST RES, V23, P323, DOI 10.1007/BF02145045; Sedivy JC, 1999, COGNITION, V71, P109, DOI 10.1016/S0010-0277(99)00025-6; STANOVICH KE, 1979, MEM COGNITION, V7, P77, DOI 10.3758/BF03197588; Steedman Mark, 1989, LEXICAL REPRESENTATI, P463; Tanenhaus MK, 2000, J PSYCHOLINGUIST RES, V29, P557, DOI 10.1023/A:1026464108329; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Traxler MJ, 1997, Q J EXP PSYCHOL-A, V50, P481, DOI 10.1080/027249897391982; TYLER LK, 1977, J VERB LEARN VERB BE, V16, P683, DOI 10.1016/S0022-5371(77)80027-3; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wicha NYY, 2003, NEUROSCI LETT, V346, P165, DOI 10.1016/S0304-3940(03)00599-8	32	667	675	5	69	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1117	1121		10.1038/nn1504	http://dx.doi.org/10.1038/nn1504			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	16007080				2022-12-28	WOS:000230760200025
J	Legan, PK; Lukashkina, VA; Goodyear, RJ; Lukashkin, AN; Verhoeven, K; Van Camp, G; Russell, IJ; Richardson, GP				Legan, PK; Lukashkina, VA; Goodyear, RJ; Lukashkin, AN; Verhoeven, K; Van Camp, G; Russell, IJ; Richardson, GP			A deafness mutation isolates a second role for the tectorial membrane in hearing	NATURE NEUROSCIENCE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; OUTER HAIR-CELLS; RECEPTOR POTENTIALS; INNER-EAR; COCHLEAR; RESPONSES; ORGAN; ORGANIZATION; MECHANICS; AFFERENT	alpha-tectorin (encoded by Tecta) is a component of the tectorial membrane, an extracellular matrix of the cochlea. In humans, the Y1870C missense mutation in TECTA causes a 50- to 80-dB hearing loss. In transgenic mice with the Y1870C mutation in Tecta, the tectorial membrane's matrix structure is disrupted, and its adhesion zone is reduced in thickness. These abnormalities do not seriously influence the tectorial membrane's known role in ensuring that cochlear feedback is optimal, because the sensitivity and frequency tuning of the mechanical responses of the cochlea are little changed. However, neural thresholds are elevated, neural tuning is broadened, and a sharp decrease in sensitivity is seen at the tip of the neural tuning curve. Thus, using Tecta(Y1870C/+) mice, we have genetically isolated a second major role for the tectorial membrane in hearing: it enables the motion of the basilar membrane to optimally drive the inner hair cells at their best frequency.	Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; Univ Antwerp, Dept Biomed Sci, Ctr Med Genet, B-2610 Antwerp, Belgium	University of Sussex; University of Antwerp	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk; G.P.Richardson@sussex.ac.uk	Van Camp, Guy/F-3386-2013; Lukashkin, Andrei N/N-1447-2017	Van Camp, Guy/0000-0001-5105-9000; Lukashkin, Andrei N/0000-0003-4577-8716; Legan, P. Kevin/0000-0002-7403-6415; Russell, Ian/0000-0002-4915-2772; Lukashkina, Victoria/0000-0002-9154-8746	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; Aranyosi AJ, 2004, BIOPHYS J, V87, P3536, DOI 10.1529/biophysj.104.044404; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BROOKES AJ, 1993, TRANSGENIC RES, V2, P238, DOI 10.1007/BF01977354; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; DAVIS H, 1952, COLD SPRING HARB SYM, V17, P143, DOI 10.1101/SQB.1952.017.01.014; DAVIS H, 1957, LARYNGOSCOPE, V68, P359; Frolenkov GI, 1998, HEARING RES, V126, P67, DOI 10.1016/S0378-5955(98)00150-6; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; KLETSKY EJ, 1980, HEARING RES, V2, P549, DOI 10.1016/0378-5955(80)90092-1; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOSSL M, 1992, J NEUROSCI, V12, P1575; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lin T, 2000, J ACOUST SOC AM, V107, P2615, DOI 10.1121/1.428648; Lukashkin AN, 1998, J ACOUST SOC AM, V103, P973, DOI 10.1121/1.421214; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Lukashkin AN, 2002, J ACOUST SOC AM, V111, P2740, DOI 10.1121/1.1479151; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Mom T, 1999, HEARING RES, V133, P40, DOI 10.1016/S0378-5955(99)00056-8; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; PATUZZI RB, 1987, HEARING RES, V30, P83, DOI 10.1016/0378-5955(87)90186-9; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; ROBERTSON D, 1984, HEARING RES, V15, P113, DOI 10.1016/0378-5955(84)90042-X; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Russell IJ, 1999, J NEUROPHYSIOL, V82, P676, DOI 10.1152/jn.1999.82.2.676; RUSSELL IJ, 1983, J PHYSIOL-LONDON, V338, P179, DOI 10.1113/jphysiol.1983.sp014668; RUSSELL IJ, 1995, ADV HEARING RES, P125; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; Sellick P, 2003, HEARING RES, V176, P42, DOI 10.1016/S0378-5955(02)00716-5; SPOENDLIN H, 1985, AM J OTOLARYNG, V6, P453, DOI 10.1016/S0196-0709(85)80026-0; THALMANN I, 1987, LARYNGOSCOPE, V97, P357; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; ZWISLOCKI JJ, 1980, HEARING RES, V2, P171, DOI 10.1016/0378-5955(80)90055-6; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2	48	103	105	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1035	1042		10.1038/nn1496	http://dx.doi.org/10.1038/nn1496			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995703				2022-12-28	WOS:000230760200015
J	Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR				Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR			PI3 kinase signaling is required for retrieval and extinction of contextual memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEDIATED GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-SYNTHESIS; BEHAVIORAL SENSITIZATION; MOLECULAR MECHANISMS; INHIBITORY AVOIDANCE; GLUTAMATE RECEPTORS; DORSAL HIPPOCAMPUS; RAT HIPPOCAMPUS	Memory retrieval is a dynamic aspect of memory formation that can be studied separately from other stages of memory processing. Although several signal transduction pathways including ERK/MAP kinase have been implicated in memory retrieval, the underlying signaling events are poorly defined. Here we report that re-exposure of mice to context after contextual training stimulates the activity of phosphatidylinositol 3 kinase (PI3K) in the hippocampus. Inhibition of PI3K activity in the hippocampus in vivo blocked contextual memory retrieval and extinction. Inhibitors of PI3K signaling also blocked increases in ERK/MAP kinase activity associated with memory retrieval. This suggests that PI3K activation in the hippocampus is critical for memory retrieval and is required for activation of ERK/MAP kinase during retrieval.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, R01NS037056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS20498, NS37056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Athos J., 2001, CURRENT PROTOCOLS NE; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barros DM, 2004, NEUROSCIENCE, V126, P651, DOI 10.1016/j.neuroscience.2004.03.010; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Blum S, 1999, J NEUROSCI, V19, P3535; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chan D, 1998, NETW COMPUT, V9, P18; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Izquierdo LA, 2001, EUR J NEUROSCI, V13, P1464, DOI 10.1046/j.0953-816x.2001.01530.x; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Opazo P, 2003, J NEUROSCI, V23, P3679; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanna PP, 2002, J NEUROSCI, V22, P3359; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szapiro G, 2000, NEUROSCIENCE, V99, P1, DOI 10.1016/S0306-4522(00)00236-0; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	50	166	166	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					925	931		10.1038/nn1482	http://dx.doi.org/10.1038/nn1482			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937483				2022-12-28	WOS:000230137100020
J	Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY				Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY			An fMRI investigation of race-related amygdala activity in African-American and Caucasian-American individuals	NATURE NEUROSCIENCE			English	Article							NEURAL COMPONENTS; INHIBITION; STIMULI; SYSTEM	Functional magnetic resonance imaging ( fMRI) was used to examine the nature of amygdala sensitivity to race. Both African-American and Caucasian-American individuals showed greater amygdala activity to African-American targets than to Caucasian-American targets, suggesting that race-related amygdala activity may result from cultural learning rather than from the novelty of other races. Additionally, verbal encoding of African-American targets produced significantly less amygdala activity than perceptual encoding of African-American targets.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lieberman, MD (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall, Los Angeles, CA 90095 USA.	lieber@ucla.edu	Lieberman, Matthew/ABD-8197-2020; Jarcho, Johanna/N-8862-2017	Lieberman, Matthew/0000-0002-4447-7359; Jarcho, Johanna/0000-0001-9075-6968; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [RR08655, RR12169, RR13642] Funding Source: Medline; NIMH NIH HHS [MH66709] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066709] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2003, J PERS SOC PSYCHOL, V85, P639, DOI 10.1037/0022-3514.85.4.639; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	15	257	268	1	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					720	722		10.1038/nn1465	http://dx.doi.org/10.1038/nn1465			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880106				2022-12-28	WOS:000229345300010
J	Meier, JC; Henneberger, C; Melnick, I; Racca, C; Harvey, RJ; Heinemann, U; Schmieden, V; Grantyn, R				Meier, JC; Henneberger, C; Melnick, I; Racca, C; Harvey, RJ; Heinemann, U; Schmieden, V; Grantyn, R			RNA editing produces glycine receptor alpha 3(P185L), resulting in high agonist potency	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; SUPERIOR COLLICULUS; GABAERGIC SYNAPSES; DNA METHYLATION; SUBUNIT; ZEBULARINE; BRAIN; IDENTIFICATION; TRANSPORTERS	The function of supramedullary glycine receptors (GlyRs) is still unclear. Using Wistar rat collicular slices, we demonstrate GlyR-mediated inhibition of spike discharge elicited by low glycine ( 10 mu M). Searching for the molecular basis of this phenomenon, we identified a new GlyR isoform. GlyR alpha 3(P185L), a result of cytidine 554 deamination, confers high glycine sensitivity (EC50 similar to 5 mu M) to neurons and thereby promotes the generation of sustained chloride conductances associated with tonic inhibition. The level of GlyR alpha 3-C554U RNA editing is sensitive to experimentally induced brain lesion, inhibition of cytidine deamination by zebularine and inhibition of mRNA transcription by actinomycin D, but not to blockade of protein synthesis by cycloheximide. Conditional regulation of GlyR alpha 3(P185L) is thus likely to be part of a post-transcriptional adaptive mechanism in neurons with enhanced excitability.	Charite, Johannes Mueller Ctr Physiol, Dept Dev Physiol, D-10117 Berlin, Germany; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Charite, Johannes Mueller Ctr Physiol, Dept Cellular Neurophysiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Leeds; University of London; University College London; University of London School of Pharmacy; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meier, JC (corresponding author), Charite, Johannes Mueller Ctr Physiol, Dept Dev Physiol, D-10117 Berlin, Germany.	jochen.meier@charite.de	Harvey, Robert/D-3994-2016; Henneberger, Christian/C-1557-2008	Harvey, Robert/0000-0001-5956-6664; Henneberger, Christian/0000-0002-5391-7387; Meier, Jochen/0000-0001-5574-3336				BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breustedt J, 2004, EUR J NEUROSCI, V19, P1987, DOI 10.1111/j.1460-9568.2004.03266.x; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chattipakorn SC, 2003, J NEUROPHYSIOL, V89, P1339, DOI 10.1152/jn.00908.2002; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Danglot L, 2004, MOL CELL NEUROSCI, V27, P394, DOI 10.1016/j.mcn.2004.05.007; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Grantyn A, 2004, PROG BRAIN RES, V143, P423, DOI 10.1016/S0079-6123(03)43040-9; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Haverkamp S, 2003, J COMP NEUROL, V465, P524, DOI 10.1002/cne.10852; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Juttner R, 2001, EUR J NEUROSCI, V13, P2088, DOI 10.1046/j.0953-816x.2001.01587.x; Kennedy RT, 2002, J NEUROSCI METH, V114, P39, DOI 10.1016/S0165-0270(01)00506-4; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KUHSE J, 1990, J BIOL CHEM, V265, P22317; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Mangin JA, 2003, J PHYSIOL-LONDON, V553, P369, DOI 10.1113/jphysiol.2003.052142; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; Meier J, 2003, NEUROREPORT, V14, P1507, DOI 10.1097/00001756-200308060-00021; Meier J, 2003, MOL CELL NEUROSCI, V23, P600, DOI 10.1016/S1044-7431(03)00079-4; Meier J, 2002, MOL CELL NEUROSCI, V21, P324, DOI 10.1006/mcne.2002.1161; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mori M, 2002, J PHYSIOL-LONDON, V539, P191, DOI 10.1113/jphysiol.2001.013147; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Vannier C, 1997, INT REV CYTOL, V176, P201, DOI 10.1016/S0074-7696(08)61611-3; Vincenzetti S, 2000, PROTEIN ENG, V13, P791, DOI 10.1093/protein/13.11.791; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Whitehead KJ, 2001, BRAIN RES, V910, P192, DOI 10.1016/S0006-8993(01)02684-1; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	50	92	94	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					736	744		10.1038/nn1467	http://dx.doi.org/10.1038/nn1467			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895087				2022-12-28	WOS:000229345300013
J	Higuchi, M; Iwata, N; Matsuba, Y; Sato, K; Sasamoto, K; Saido, TC				Higuchi, M; Iwata, N; Matsuba, Y; Sato, K; Sasamoto, K; Saido, TC			F-19 and H-1 MRI detection of amyloid beta plaques in vivo	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; BRAIN; MICE; VISUALIZATION; DERIVATIVES; MICROSCOPY	Formation of senile plaques composed of amyloid beta peptide, a pathological hallmark of Alzheimer disease, in human brains precedes disease onset by many years. Noninvasive detection of such plaques could be critical in presymptomatic diagnosis and could contribute to early preventive treatment strategies. Using amyloid precursor protein (APP) transgenic mice as a model of amyloid beta amyloidosis, we demonstrate here that an intravenously administered F-19-containing amyloidophilic compound labels brain plaques and allows them to be visualized in living mice by magnetic resonance imaging ( MRI) using F-19 and H-1. Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. This approach could be used in longitudinal studies in mouse models of Alzheimer disease to search for biomarkers associated with amyloid beta pathology as well as to track disease course after treatment with candidate medications.	RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Dojin Labs, Mashiki, Kumamoto 8612202, Japan	RIKEN	Saido, TC (corresponding author), RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903				Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; GOEDERT M, 1997, MOL GENETIC BASIS NE; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kung MP, 2002, BRAIN RES, V956, P202, DOI 10.1016/S0006-8993(02)03436-4; Lee SP, 2004, MAGN RESON MED, V52, P538, DOI 10.1002/mrm.20196; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Okamura N, 2004, J NEUROSCI, V24, P2535, DOI 10.1523/JNEUROSCI.4456-03.2004; Poduslo JF, 2002, NEUROBIOL DIS, V11, P315, DOI 10.1006/nbdi.2002.0550; Saido TC, 2003, ABETA METABOLISM ALZ; Sair HI, 2004, NEURORADIOLOGY, V46, P93, DOI 10.1007/s00234-003-1034-9; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609; Wadghiri YZ, 2003, MAGN RESON MED, V50, P293, DOI 10.1002/mrm.10529; Zhang J, 2004, MAGN RESON MED, V51, P452, DOI 10.1002/mrm.10730; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	29	289	305	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					527	533		10.1038/nn1422	http://dx.doi.org/10.1038/nn1422			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768036				2022-12-28	WOS:000228040400025
J	Kurtzer, I; Herter, TM; Scott, SH				Kurtzer, I; Herter, TM; Scott, SH			Random change in cortical load representation suggests distinct control of posture and movement	NATURE NEUROSCIENCE			English	Article							EQUILIBRIUM-POINT CONTROL; PRIMARY MOTOR CORTEX; DIRECTIONAL ISOMETRIC FORCE; HUMAN ARM MOVEMENT; VOLUNTARY MOVEMENT; MECHANICAL LOADS; MUSCLE; TASK; NETWORKS; SHOULDER	Accurately maintaining a fixed limb posture and quickly moving between postures underlies both everyday skills, including holding and lifting a cup of coffee, and expert skills, such as an Olympic wrestler's holding and throwing an opponent. A fundamental question in limb motor control is whether the brain manages these contrasting goals of posture and movement through a single, robust control process or whether each engages a specialized control process. We addressed this question by examining how individual neurons in the primary motor cortex of macaque monkeys represent mechanical loads during posture and movement tasks. Notably, approximately half of the neurons that expressed load-related activity did so exclusively during either posture only or movement only. Further, those neurons with load-related activity during both tasks randomly switched their magnitude of response between tasks. These random changes in load representation suggest specialized control processes, one for posture and one for movement.	Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Botterell Hall, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca						Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Batschelet E., 1981, CIRCULAR STAT BIOL; Brooke JD, 1997, PROG NEUROBIOL, V51, P393, DOI 10.1016/S0301-0082(96)00061-5; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; Cabel DW, 2001, J NEUROPHYSIOL, V86, P2102, DOI 10.1152/jn.2001.86.4.2102; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FETZ EE, 1987, CIBA F SYMP, V132, P98; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GOMI H, 1993, NEURAL NETWORKS, V6, P485, DOI 10.1016/S0893-6080(05)80053-X; Gottlieb GL, 1997, J NEUROPHYSIOL, V78, P2985, DOI 10.1152/jn.1997.78.6.2985; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Gribble PL, 1998, J NEUROPHYSIOL, V79, P1409, DOI 10.1152/jn.1998.79.3.1409; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; Hepp-Reymond MC, 1999, EXP BRAIN RES, V128, P123, DOI 10.1007/s002210050827; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P461, DOI 10.1113/jphysiol.1969.sp008924; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kilner JM, 2000, J NEUROSCI, V20, P8838; KURTZER I, IN PRESS EXP BRAIN R; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; McAuley JH, 2003, PROG NEUROBIOL, V69, P27, DOI 10.1016/S0301-0082(03)00003-0; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; Shapiro MB, 2002, J NEUROPHYSIOL, V88, P1059, DOI 10.1152/jn.2002.88.2.1059; STEIN RB, 1988, TRENDS NEUROSCI, V11, P328, DOI 10.1016/0166-2236(88)90097-5; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	45	151	152	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					498	504		10.1038/nn1420	http://dx.doi.org/10.1038/nn1420			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768037				2022-12-28	WOS:000228040400021
J	Bourikas, D; Pekarik, V; Baeriswyl, T; Grunditz, A; Sadhu, R; Nardo, M; Stoeckli, ET				Bourikas, D; Pekarik, V; Baeriswyl, T; Grunditz, A; Sadhu, R; Nardo, M; Stoeckli, ET			Sonic hedgehog guides commissural axons along the longitudinal axis of the spinal cord	NATURE NEUROSCIENCE			English	Article							FLOOR-PLATE; NEURONAL IDENTITY; CHICK DEVELOPMENT; NEURAL-TUBE; IN-VIVO; GUIDANCE; GENE; SPECIFICATION; RECEPTOR; PROTEIN	Dorsal commissural axons in the developing spinal cord cross the floor plate, then turn rostrally and grow along the longitudinal axis, close to the floor plate. We used a subtractive hybridization approach to identify guidance cues responsible for the rostral turn in chicken embryos. One of the candidates was the morphogen Sonic hedgehog (Shh). Silencing of the gene SHH (which encodes Shh) by in ovo RNAi during commissural axon navigation demonstrated a repulsive role in post-commissural axon guidance. This effect of Shh was not mediated by Patched (Ptc) and Smoothened (Smo), the receptors that mediate effects of Shh in morphogenesis and commissural axon growth toward the floor plate. Rather, functional in vivo studies showed that the repulsive effect of Shh on postcommissural axons was mediated by Hedgehog interacting protein (Hip).	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Zurich; Friedrich Miescher Institute for Biomedical Research	Stoeckli, ET (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	esther.stoeckli@zool.unizh.ch	Pekarik, Vladimir/I-5816-2014	Pekarik, Vladimir/0000-0001-6362-9007; Stoeckli, Esther/0000-0002-8485-0648				Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bourikas D, 2003, OLIGONUCLEOTIDES, V13, P411, DOI 10.1089/154545703322617096; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GREENSPOON S, 1995, J NEUROSCI, V15, P5956; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Ladher RK, 2000, DEV BIOL, V218, P183, DOI 10.1006/dbio.1999.9586; Lee CS, 2000, DEVELOPMENT, V127, P109; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1999, DEVELOPMENT, V126, P3649; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Perrin FE, 2000, MICROSC RES TECHNIQ, V48, P25, DOI 10.1002/(SICI)1097-0029(20000101)48:1<25::AID-JEMT4>3.0.CO;2-F; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Stoeckli Esther T., 2003, P297; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trousse F, 2001, DEVELOPMENT, V128, P3927; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANSTRAATEN HWM, 1991, ANAT EMBRYOL, V184, P55; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	45	181	185	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					297	304		10.1038/nn1396	http://dx.doi.org/10.1038/nn1396			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746914				2022-12-28	WOS:000227354600014
J	Kilner, JM; Vargas, C; Duval, S; Blakemore, SJ; Sirigu, A				Kilner, JM; Vargas, C; Duval, S; Blakemore, SJ; Sirigu, A			Motor activation prior to observation of a predicted movement	NATURE NEUROSCIENCE			English	Article								Previous research has shown that some of the same motor regions are activated both when performing and when observing a movement. Here we demonstrate in human subjects that such motor activity also occurs prior to observing someone else's action. This suggests that the mere knowledge of an upcoming movement is sufficient to excite one's own motor system, enabling people to anticipate, rather than react to, others' actions.	CNRS, Inst Cognit Sci, F-69675 Bron, France; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Fed Rio de Janeiro, Inst Biophys, BR-21949900 Rio De Janeiro, Brazil; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	Centre National de la Recherche Scientifique (CNRS); University of London; University College London; Universidade Federal do Rio de Janeiro; University of London; University College London	Sirigu, A (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Sirigu, Angela/L-4683-2017; Kilner, James M/A-2040-2010; Blakemore, Sarah-Jayne/A-1792-2010; Vargas, Claudia D./A-1523-2016	Blakemore, Sarah-Jayne/0000-0002-1690-2805; Vargas, Claudia D./0000-0001-6202-3580; Kilner, James/0000-0002-6632-6797				Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239	10	290	291	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1299	1301		10.1038/nn1355	http://dx.doi.org/10.1038/nn1355			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558063				2022-12-28	WOS:000225353900009
J	Gilroy, LA; Blake, R				Gilroy, LA; Blake, R			Physics embedded in visual perception of three-dimensional shape from motion	NATURE NEUROSCIENCE			English	Article							STRUCTURE-FROM-MOTION; DEPTH; REPRESENTATION; OBJECTS; AREA	Visual perception, and by implication underlying neural events, can become unstable when optical information specifying objects is ambiguous. Here we report that one striking form of instability - - perceived three-dimensional structure-from-motion (SFM) - - can be stabilized when an otherwise ambiguous object appears within a context implying frictional interactions with another rotating object; violations of physical conditions specifying friction disrupt stabilization. Evidently, information about frictional interaction is embedded within neural mechanisms specifying SFM.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Gilroy, LA (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 301 Wilson Hall, Nashville, TN 37203 USA.	lee.gilroy@vanderbilt.edu			NATIONAL EYE INSTITUTE [R01EY007760] Funding Source: NIH RePORTER; NEI NIH HHS [EY07135, EY07760] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; EBY DW, 1989, PERCEPTION, V18, P427, DOI 10.1068/p180427; Grossmann JK, 2003, VISION RES, V43, P359, DOI 10.1016/S0042-6989(02)00480-7; Hock HS, 2003, PERCEPT PSYCHOPHYS, V65, P429, DOI 10.3758/BF03194574; Miles WR, 1931, AM J PSYCHOL, V43, P392, DOI 10.2307/1414610; NAWROT M, 1991, VISUAL NEUROSCI, V6, P219, DOI 10.1017/S0952523800006234; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880	15	26	26	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					921	922		10.1038/nn1297	http://dx.doi.org/10.1038/nn1297			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15300254				2022-12-28	WOS:000223546700009
J	Viard, P; Butcher, AJ; Halet, G; Davies, A; Nurnberg, B; Heblich, F; Dolphin, AC				Viard, P; Butcher, AJ; Halet, G; Davies, A; Nurnberg, B; Heblich, F; Dolphin, AC			PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-B; G-BETA-GAMMA; GROWTH-FACTOR-I; CA2+ CHANNELS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL-3-OH KINASE; SUBUNIT HETEROGENEITY; ENDOPLASMIC-RETICULUM; COUPLED RECEPTORS; ACTIVATION	Phosphatidylinositol 3-kinase (PI3K) has been shown to enhance native voltage-dependent calcium channel (Ca(v)) currents both in myocytes and in neurons; however, the mechanism(s) responsible for this regulation were not known. Here we show that PI3K promotes the translocation of GFP-tagged Ca(v) channels to the plasma membrane in both COS-7 cells and neurons. We show that the effect of PI3K is mediated by Akt/PKB and specifically requires Ca(v)beta(2) subunits. The mutations S574A and S574E in Ca(v)beta(2a) prevented and mimicked, respectively, the effect of PI3K/Akt-PKB, indicating that phosphorylation of Ser574 on Ca(v)beta(2a) is necessary and sufficient to promote Ca(v) channel trafficking.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England; Univ Dusseldorf Klinikum, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany	University of London; University College London; University of London; University College London; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Viard, P (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	p.viard@ucl.ac.uk	Dolphin, Annette C/F-7416-2010; halet, guillaume/C-7502-2009; Tuluc, Petronel/C-2527-2011	Dolphin, Annette C/0000-0003-4626-4856; Nurnberg, Bernd/0000-0002-5995-6555; Halet, Guillaume/0000-0002-6204-2105				Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Dolphin AC, 2002, RECEPTOR ION CHANNEL, pOxford; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; GRAY A, 1999, BIOCHEM J, V344, P29; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin DJ, 2002, NEUROPHARMACOLOGY, V42, P353, DOI 10.1016/S0028-3908(01)00181-2; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Stephens GJ, 1998, J PHYSIOL-LONDON, V509, P15, DOI 10.1111/j.1469-7793.1998.015bo.x; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	39	200	206	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					939	946		10.1038/nn1300	http://dx.doi.org/10.1038/nn1300			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15311280				2022-12-28	WOS:000223546700012
J	Williams, SR				Williams, SR			Spatial compartmentalization and functional impact of conductance in pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; IN-VIVO; COINCIDENCE DETECTION; CORTICAL-NEURONS; SYNAPSE LOCATION; DENDRITIC SPIKES; BASAL DENDRITES; INPUT; RAT; CELLS	Dendritic spikes signal synaptic integration at remote apical dendritic sites in neocortical pyramidal neurons in vitro. Do dendritic spikes have a salient signaling role under in vivo conditions, where neocortical pyramidal neurons are bombarded with synaptic input? In the present study, levels of synaptic conductance apparent during active network states in vivo were emulated in vitro. Pronounced enhancement of somatic or apical dendritic conductance was spatially compartmentalized and 'visible' over a dendritic length (similar to200 mum) on the order of half the voltage length constant, as predicted by passive cable models. The spatial compartmentalization of conductance allowed independent subthreshold synaptic integration at axo-somatic and apical dendritic sites. Furthermore, spikes generated at distal apical dendritic sites efficiently propagated to the axon to initiate action potentials under high synaptic conductance states. The dendritic arborization and voltage-activated channel complement of rat neocortical pyramidal neurons are therefore optimized to allow distributed processing under realistic conductance states.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Williams, SR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	srw@mrc-lmb.cam.ac.uk		Williams, Stephen/0000-0001-5352-7947				Ariav G, 2003, J NEUROSCI, V23, P7750; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Colbert CM, 1997, J NEUROSCI, V17, P6512; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; KOCH C, 1990, J NEUROSCI, V10, P1728; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1964, NEURAL THEORY MODELI, P73; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Rudolph M, 2003, J NEUROSCI, V23, P2466; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Waters J, 2003, J NEUROSCI, V23, P8558; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, J NEUROSCI, V23, P7358; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	46	96	104	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					961	967		10.1038/nn1305	http://dx.doi.org/10.1038/nn1305			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322550				2022-12-28	WOS:000223546700015
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Underlying principles of visual shape selectivity in posterior inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; OBJECT RECOGNITION; 3-DIMENSIONAL SHAPES; RECEPTIVE-FIELDS; TERM-MEMORY; AREA V4; MACAQUE; RESPONSES; VISION; FEATURES	Object perception depends on shape processing in the ventral visual pathway, which in monkeys culminates in inferotemporal cortex (IT). Here we provide a description of fundamental quantitative principles governing neural selectivity for complex shape in IT. By measuring responses to large, parametric sets of two-dimensional (2D) silhouette shapes, we found that neurons in posterior IT (Brodmann's areas TEO and posterior TE) integrate information about multiple contour elements (straight and curved edge fragments of the type represented in lower-level areas) using both linear and nonlinear mechanisms. This results in complex, distributed response patterns that cannot be characterized solely in terms of example stimuli. We explained these response patterns with tuning functions in multidimensional shape space and accurately predicted neural responses to the widely varying shapes in our stimulus set. Integration of contour element information in earlier stages of IT represents an important step in the transformation from low-level shape signals to complex object representation.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						ALBRIGHT TD, 1990, P INT C FUZZY LOGIC, V2, P375; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Carandini M, 1997, J NEUROSCI, V17, P8621; Conner CE, 1997, J NEUROSCI, V17, P3201; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Edelman S, 2003, COGNITIVE SCI, V27, P73, DOI 10.1207/s15516709cog2701_3; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kimia BB, 2003, J PHYSIOL-PARIS, V97, P155, DOI 10.1016/j.jphysparis.2003.09.003; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kovacs G, 2003, CEREB CORTEX, V13, P178, DOI 10.1093/cercor/13.2.178; LEYTON M, 1998, GENERATIVE THEORY SH; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mel BW, 2000, NEURAL COMPUT, V12, P731, DOI 10.1162/089976600300015574; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1; WOLFE JM, 1992, PERCEPTION, V21, P465, DOI 10.1068/p210465; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	50	250	252	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					880	886		10.1038/nn1278	http://dx.doi.org/10.1038/nn1278			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235606				2022-12-28	WOS:000222930800019
J	McLaughlin, J; Osterhout, L; Kim, A				McLaughlin, J; Osterhout, L; Kim, A			Neural correlates of second-language word learning: minimal instruction produces rapid change	NATURE NEUROSCIENCE			English	Article							POTENTIALS	Adult second-language (L2) learning is often claimed to be slow and laborious compared to native language (L1) acquisition, but little is known about the rate of L2 word learning. Here we report that adult second-language learners' brain activity, as measured by event-related potentials (ERPs), discriminated between L2 words and L2 'pseudowords' (word-like letter strings) after just 14 h of classroom instruction. This occurred even while the learners performed at chance levels when making overt L2 word-nonword judgments, indicating that the early acquisition of some aspects of a new language may be overlooked by current behavioral assessments.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McLaughlin, J (corresponding author), Univ Washington, Dept Psychol, Guthrie Hall,Box 351525, Seattle, WA 98195 USA.	giuditta@u.washington.edu			NIDCD NIH HHS [R01DC01947, P30DC04661, F32DC005756, R01 DC001947] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC001947, R01DC001947, F32DC005756] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BENTIN S, 1987, BRAIN LANG, V31, P308, DOI 10.1016/0093-934X(87)90077-0; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; GREEN RM, 1974, SIGNAL DETECTION THE; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; Miller J, 1996, PERCEPT PSYCHOPHYS, V58, P65, DOI 10.3758/BF03205476; Osterhout L, 1997, TRENDS COGN SCI, V1, P203, DOI 10.1016/S1364-6613(97)01073-5; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926	8	268	271	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					703	704		10.1038/nn1264	http://dx.doi.org/10.1038/nn1264			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195094				2022-12-28	WOS:000222274400010
J	Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C				Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C			Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens	NATURE NEUROSCIENCE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; MEDIATING MATING BEHAVIOR; CENTRAL NERVOUS-SYSTEM; TREATED MALE-RATS; SEXUAL-DIFFERENTIATION; FEMININE BEHAVIOR; MICE LACKING; GENE; VASOPRESSIN; ESTRADIOL	Two clearly opposing views exist on the function of alpha-fetoprotein ( AFP), a fetal plasma protein that binds estrogens with high affinity, in the sexual differentiation of the rodent brain. AFP has been proposed to either prevent the entry of estrogens or to actively transport estrogens into the developing female brain. The availability of Afp mutant mice ( Afp(-/-)) now finally allows us to resolve this longstanding controversy concerning the role of AFP in brain sexual differentiation, and thus to determine whether prenatal estrogens contribute to the development of the female brain. Here we show that the brain and behavior of female Afp(-/-) mice were masculinized and defeminized. However, when estrogen production was blocked by embryonic treatment with the aromatase inhibitor 1,4,6-androstatriene-3,17-dione, the feminine phenotype of these mice was rescued. These results clearly demonstrate that prenatal estrogens masculinize and defeminize the brain and that AFP protects the female brain from these effects of estrogens.	Univ Liege, Ctr Cellular & Mol Neurobiol, B-4000 Cointe Ougree, Belgium; Univ Libre Bruxelles, Inst Biol & Med Mol, Dev Biol Lab, B-6041 Gosselies, Belgium	University of Liege; Universite Libre de Bruxelles	Bakker, J (corresponding author), Univ Liege, Ctr Cellular & Mol Neurobiol, Ave Hop 1,B36, B-4000 Cointe Ougree, Belgium.	jbakker@ulg.ac.be			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER; NICHD NIH HHS [HD044897] Funding Source: Medline; NIMH NIH HHS [MH50388] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREWS GK, 1982, J BIOL CHEM, V257, P5148; AUSSEL C, 1978, J STEROID BIOCHEM, V9, P547, DOI 10.1016/0022-4731(78)90121-8; Bakker J, 2002, J NEUROSCI, V22, P9104; BAKKER J, 1993, BEHAV NEUROSCI, V107, P480, DOI 10.1037/0735-7044.107.3.480; BAUM MJ, 1979, NEUROSCI BIOBEHAV R, V3, P265, DOI 10.1016/0149-7634(79)90013-7; Bennett JA, 2002, P NATL ACAD SCI USA, V99, P2211, DOI 10.1073/pnas.251667098; BENNO RH, 1978, BRAIN RES, V142, P182; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DEMEES C, IN PRESS CELL MOL BI; DOHLER KD, 1984, PROG BRAIN RES, V61, P99; Dominguez-Salazar E, 2004, HORM BEHAV, V46, P482, DOI 10.1016/j.yhbeh.2004.05.006; FEDER HH, 1965, SCIENCE, V147, P306, DOI 10.1126/science.147.3655.306; Fitch RH, 1998, BEHAV BRAIN SCI, V21, P311, DOI 10.1017/S0140525X98001216; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; GERALL AA, 1973, J COMP PHYSIOL PSYCH, V82, P449, DOI 10.1037/h0034113; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; GRADY KL, 1965, J COMP PHYSIOL PSYCH, V59, P176, DOI 10.1037/h0021824; Han TM, 2003, J NEUROBIOL, V54, P502, DOI 10.1002/neu.10157; Lonstein JS, 1999, J NEUROENDOCRINOL, V11, P441; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MCCALL AL, 1981, J REPROD FERTIL, V61, P103, DOI 10.1530/jrf.0.0610103; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MCEWEN BS, 1975, BRAIN RES, V96, P400, DOI 10.1016/0006-8993(75)90755-6; MEIJSROE.HM, 1973, J ENDOCRINOL, V59, P295, DOI 10.1677/joe.0.0590295; Mesfin FB, 2000, BBA-MOL BASIS DIS, V1501, P33, DOI 10.1016/S0925-4439(00)00008-9; PETRA PH, 1991, J STEROID BIOCHEM, V40, P735, DOI 10.1016/0960-0760(91)90299-K; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Plumari L, 2002, J NEUROENDOCRINOL, V14, P971, DOI 10.1046/j.1365-2826.2002.00866.x; Quadros PS, 2002, J NEUROENDOCRINOL, V14, P761, DOI 10.1046/j.1365-2826.2002.00827.x; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; RAYNAUD JP, 1973, STEROIDS, V21, P249, DOI 10.1016/S0039-128X(73)80009-1; SCHACHTER BS, 1982, DEV BRAIN RES, V5, P93, DOI 10.1016/0165-3806(82)90116-X; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Tobet SA, 1997, CELL MOL NEUROBIOL, V17, P565, DOI 10.1023/A:1022529918810; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; TORANALLERAND CD, 1984, PROG BRAIN RES, V61, P63; TORANALLERAND CD, 1982, DEV BRAIN RES, V5, P213; Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; WHALEN RE, 1967, ANAT RECORD, V157, P173, DOI 10.1002/ar.1091570208; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335	44	216	220	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					220	226		10.1038/nn1624	http://dx.doi.org/10.1038/nn1624			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388309				2022-12-28	WOS:000234990100017
J	Naeini, RS; Witty, MF; Seguela, P; Bourque, CW				Naeini, RS; Witty, MF; Seguela, P; Bourque, CW			An N-terminal variant of Trpv1 channel is required for osmosensory transduction	NATURE NEUROSCIENCE			English	Article							RAT SUPRAOPTIC NEURONS; NONSELECTIVE CATION CHANNEL; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; MICE LACKING; VASOPRESSIN SECRETION; MAGNOCELLULAR NEURONS; OSMOTIC REGULATION; LAMINA TERMINALIS; BLOOD OSMOLALITY	Body fluid homeostasis requires the release of arginine-vasopressin (AVP, an antidiuretic hormone) from the neurohypophysis. This release is controlled by specific and highly sensitive 'osmoreceptors' in the hypothalamus. Indeed, AVP-releasing neurons in the supraoptic nucleus (SON) are directly osmosensitive, and this osmosensitivity is mediated by stretch-inhibited cation channels. However, the molecular nature of these channels remains unknown. Here we show that SON neurons express an N-terminal splice variant of the transient receptor potential vanilloid type-1 (Trpv1), also known as the capsaicin receptor, but not full-length Trpv1. Unlike their wild-type counterparts, SON neurons in Trpv1 knockout (Trpv1(-/-)) mice could not generate ruthenium red-sensitive increases in membrane conductance and depolarizing potentials in response to hyperosmotic stimulation. Moreover, Trpv1(-/-) mice showed a pronounced serum hyperosmolality under basal conditions and severely compromised AVP responses to osmotic stimulation in vivo. These results suggest that the Trpv1 gene may encode a central component of the osmoreceptor.	McGill Univ, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), McGill Univ, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	charles.bourque@mcgill.ca	Naeini, Reza Sharif/K-2402-2019	Naeini, Reza Sharif/0000-0001-8896-5306; Bourque, Charles/0000-0002-1594-742X				Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bourque CW, 1998, PROG BRAIN RES, V119, P59; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2000, NAT NEUROSCI, V3, P572, DOI 10.1038/75744; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grob M, 2004, J NEUROSCI, V24, P3974, DOI 10.1523/JNEUROSCI.3720-03.2004; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; Li Z, 1996, NEUROSCIENCE, V71, P133, DOI 10.1016/0306-4522(95)00434-3; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lu G, 2005, MOL PHARMACOL, V67, P1119, DOI 10.1124/mol.104.009852; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; NAGATOMO T, 1995, J PHYSIOL-LONDON, V485, P87, DOI 10.1113/jphysiol.1995.sp020714; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; Oliet SHR, 1996, NEURON, V16, P175, DOI 10.1016/S0896-6273(00)80034-3; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; ROBERTSON GL, 1976, KIDNEY INT, V10, P25, DOI 10.1038/ki.1976.76; ROBERTSON GL, 1976, J CLIN ENDOCR METAB, V42, P613, DOI 10.1210/jcem-42-4-613; SCHRIER RW, 1979, AM J PHYSIOL, V236, P321; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Shibuya I, 1998, J NEUROENDOCRINOL, V10, P759, DOI 10.1046/j.1365-2826.1998.00260.x; Ster J, 2005, J NEUROSCI, V25, P2267, DOI 10.1523/JNEUROSCI.4053-04.2005; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; VANDESANDE F, 1975, CELL TISSUE RES, V164, P153; Voisin DL, 2002, TRENDS NEUROSCI, V25, P199, DOI 10.1016/S0166-2236(02)02142-2; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wainwright A, 2004, J COMP NEUROL, V474, P24, DOI 10.1002/cne.20100; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582	48	235	246	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					93	98		10.1038/nn1614	http://dx.doi.org/10.1038/nn1614			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327782				2022-12-28	WOS:000234288000022
J	Shaham, Y; Hope, BT				Shaham, Y; Hope, BT			The role of neuroadaptations in relapse to drug seeking	NATURE NEUROSCIENCE			English	Editorial Material							MESOLIMBIC DOPAMINE SYSTEM; STRESS-INDUCED RELAPSE; COCAINE-SEEKING; NEUROTROPHIC FACTOR; ADDICTION; SENSITIZATION; WITHDRAWAL; INCUBATION; EXPRESSION; GLUTAMATE	One of the most difficult problems in treating addiction is not withdrawing addicts from drugs, but preventing relapse. Persistent neuroadaptations are thought to underlie aspects of addiction, including relapse. This commentary assesses the degree to which these neuroadaptations, primarily identified in preclinical studies on cocaine, induce relapse.	NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shaham, Y (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014; Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, Z01DA000434] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Berhow MT, 1996, J NEUROSCI, V16, P4707; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2003, J NEUROSCI, V23, P742; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Stewart J, 2004, NEBR SYM MOTIV, V50, P197; Vezina P, 2002, J NEUROSCI, V22, P4654, DOI 10.1523/JNEUROSCI.22-11-04654.2002; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; WISE RA, 1988, J ABNORM PSYCHOL, V97, P118, DOI 10.1037/0021-843X.97.2.118; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006	30	110	112	1	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1437	1439		10.1038/nn1105-1437	http://dx.doi.org/10.1038/nn1105-1437			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251983				2022-12-28	WOS:000232966600011
J	Carey, MR; Medina, JF; Lisberger, SG				Carey, MR; Medina, JF; Lisberger, SG			Instructive signals for motor learning from visual cortical area MT	NATURE NEUROSCIENCE			English	Article							PURSUIT EYE-MOVEMENTS; SYNAPTIC PLASTICITY; MACAQUE MONKEY; BASAL GANGLIA; SMOOTH; MICROSTIMULATION; MOTION; DIRECTION; NEURONS; CEREBELLUM	Sensory error signals have long been proposed to act as instructive signals to guide motor learning. Here we have exploited the temporal specificity of learning in smooth pursuit eye movements and the well-defined anatomical structure of the neural circuit for pursuit to identify a part of sensory cortex that provides instructive signals for motor learning in monkeys. We show that electrical microstimulation in the motion-sensitive middle temporal area (MT) of extrastriate visual cortex instructs learning in smooth eye movements in a way that closely mimics the learning instructed by real visual motion. We conclude that MT provides instructive signals for motor learning in smooth pursuit eye movements under natural conditions, suggesting a similar role for sensory cortices in many kinds of learned behaviors.	Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn Ctr Integrat Neurosci, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carey, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	megan_carey@hms.harvard.edu		Medina, Javier/0000-0001-8708-5315; Carey, Megan/0000-0002-4499-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [NS34835, P01 NS034835, P01 NS034835-09] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLEY K, 1975, BRAIN RES, V98, P582, DOI 10.1016/0006-8993(75)90375-3; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; BOMAN DK, 1992, VISION RES, V32, P675, DOI 10.1016/0042-6989(92)90184-K; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Carey MR, 2004, J NEUROPHYSIOL, V91, P623, DOI 10.1152/jn.00525.2003; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chou IH, 2004, J NEUROSCI, V24, P4124, DOI 10.1523/JNEUROSCI.0172-04.2004; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Distler C, 2002, J COMP NEUROL, V444, P144, DOI 10.1002/cne.10127; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Groh JM, 1997, J NEUROSCI, V17, P4312; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kahlon M, 1996, J NEUROSCI, V16, P7270; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Kodaka Y, 2004, J NEUROPHYSIOL, V91, P2474, DOI 10.1152/jn.01079.2003; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Raymond JL, 1998, J NEUROSCI, V18, P9112; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Tian JR, 1997, J NEUROSCI, V17, P9233; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	47	39	40	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					813	819		10.1038/nn1470	http://dx.doi.org/10.1038/nn1470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908949	Green Accepted			2022-12-28	WOS:000229345300023
J	Haynes, JD; Rees, G				Haynes, JD; Rees, G			Predicting the orientation of invisible stimuli from activity in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; CORTICAL ACTIVATION; BINOCULAR-RIVALRY; STRIATE CORTEX; FUNCTIONAL MRI; PERCEPTION; REPRESENTATIONS; AWARENESS; VISUALIZATION; ADAPTATION	Humans can experience aftereffects from oriented stimuli that are not consciously perceived, suggesting that such stimuli receive cortical processing. Determining the physiological substrate of such effects has proven elusive owing to the low spatial resolution of conventional human neuroimaging techniques compared to the size of orientation columns in visual cortex. Here we show that even at conventional resolutions it is possible to use fMRI to obtain a direct measure of orientation-selective processing in V1. We found that many parts of V1 show subtle but reproducible biases to oriented stimuli, and that we could accumulate this information across the whole of V1 using multivariate pattern recognition. Using this information, we could then successfully predict which one of two oriented stimuli a participant was viewing, even when masking rendered that stimulus invisible. Our findings show that conventional fMRI can be used to reveal feature-selective processing in human cortex, even for invisible stimuli.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Haynes, JD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 1998, NAT NEUROSCI, V1, P549, DOI 10.1038/2785; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DUDA OR, 2001, PATTERN CLASSIFICATI; Everitt B.S., 1991, APPL MULTIVARIATE DA; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Westheimer G, 2003, VISION RES, V43, P53, DOI 10.1016/S0042-6989(02)00398-X; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107	37	604	612	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					686	691		10.1038/nn1445	http://dx.doi.org/10.1038/nn1445			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852013				2022-12-28	WOS:000228895100031
J	Saher, G; Brugger, B; Lappe-Siefke, C; Mobius, W; Tozawa, R; Wehr, MC; Wieland, F; Ishibashi, S; Nave, KA				Saher, G; Brugger, B; Lappe-Siefke, C; Mobius, W; Tozawa, R; Wehr, MC; Wieland, F; Ishibashi, S; Nave, KA			High cholesterol level is essential for myelin membrane growth	NATURE NEUROSCIENCE			English	Article							PROTEOLIPID PROTEIN; SQUALENE SYNTHASE; EMBRYONIC LETHALITY; NERVOUS-SYSTEM; SONIC HEDGEHOG; BASIC-PROTEIN; CELL-SURFACE; SPINAL-CORD; MICE; EXPRESSION	Cholesterol in the mammalian brain is a risk factor for certain neurodegenerative diseases, raising the question of its normal function. In the mature brain, the highest cholesterol content is found in myelin. We therefore created mice that lack the ability to synthesize cholesterol in myelin-forming oligodendrocytes. Mutant oligodendrocytes survived, but CNS myelination was severely perturbed, and mutant mice showed ataxia and tremor. CNS myelination continued at a reduced rate for many months, and during this period, the cholesterol-deficient oligodendrocytes actively enriched cholesterol and assembled myelin with > 70% of the cholesterol content of wild-type myelin. This shows that cholesterol is an indispensable component of myelin membranes and that cholesterol availability in oligodendrocytes is a rate-limiting factor for brain maturation.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Univ Tokyo, Dept Metab Dis, Tokyo 1138655, Japan; Hertie Inst Multiple Sclerosis Res, D-37075 Gottingen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; University of Tokyo	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	nave@em.mpg.de	Wehr, Michael/J-7989-2019; Nave, Klaus-Armin/C-8883-2011; Taylor, Graham/A-4027-2012; Saher, Gesine/AAH-1826-2021	Wehr, Michael/0000-0003-1770-8323; Saher, Gesine/0000-0003-3507-9604; /0000-0002-2902-7165				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFUTE DL, 1992, J BIOL CHEM, V267, P18308; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Gallyas F, 1979, Neurol Res, V1, P203; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Gu PD, 1998, J BIOL CHEM, V273, P12515, DOI 10.1074/jbc.273.20.12515; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Huber AB, 2002, J NEUROSCI, V22, P3553; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; JOYNER AL, 1991, BIOESSAYS, V13, P649, DOI 10.1002/bies.950131206; Jung M, 1996, J NEUROSCI, V16, P7920; Jurevics H, 2003, J NEUROSCI RES, V71, P826, DOI 10.1002/jnr.10544; KIM SU, 1975, LAB INVEST, V32, P720; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Larocca JN, 2002, NEUROCHEM RES, V27, P1313, DOI 10.1023/A:1021667515030; Lazzarini R., 2003, MYELIN BIOL DISORDER; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; Michikawa M, 1999, J NEUROCHEM, V72, P2278, DOI 10.1046/j.1471-4159.1999.0722278.x; Morell P, 1996, NEUROCHEM RES, V21, P463, DOI 10.1007/BF02527711; NAVE KA, 2003, MYELIN BIOL DISORDER, V2, P1125; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Nwokoro NA, 2001, MOL GENET METAB, V74, P105, DOI 10.1006/mgme.2001.3226; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Peters A., 1991, FINE STRUCTURE NERVO; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Plonne D, 1999, ANAL BIOCHEM, V276, P88, DOI 10.1006/abio.1999.4311; POPKO B, 1987, CELL, V48, P713, DOI 10.1016/0092-8674(87)90249-2; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sandhoff R, 1999, J LIPID RES, V40, P126; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776	49	467	472	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					468	475		10.1038/nn1426	http://dx.doi.org/10.1038/nn1426			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793579				2022-12-28	WOS:000228040400017
J	Rolls, MM; Doe, CQ				Rolls, MM; Doe, CQ			Baz, Par-6 and aPKC are not required for axon or dendrite specification in Drosophila	NATURE NEUROSCIENCE			English	Article							NEURONAL POLARITY; MUSHROOM BODIES; CELL POLARITY; NEUROBLASTS; PROLIFERATION; COMPLEX	Par-3/Baz, Par-6, and aPKC are evolutionarily conserved regulators of cell polarity, and overexpression experiments implicate them as axon determinants in vertebrate hippocampal neurons. Here we examined their mutant and overexpression phenotypes in Drosophila melanogaster. We found that mutants neurons had normal axon and dendrite morphology and remodeled axons correctly in metamorphosis, and that overexpression did not affect axon or dendrite specification. Baz/Par-6/aPKC are therefore not essential for axon specification in Drosophila.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu	Rolls, Melissa/G-6402-2014	Rolls, Melissa/0000-0002-5021-4360				CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	11	58	59	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1293	1295		10.1038/nn1346	http://dx.doi.org/10.1038/nn1346			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543144				2022-12-28	WOS:000225353900007
J	Priebe, NJ; Mechler, F; Carandini, M; Ferster, D				Priebe, NJ; Mechler, F; Carandini, M; Ferster, D			The contribution of spike threshold to the dichotomy of cortical simple and complex cells	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; MONKEY STRIATE CORTEX; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; FREQUENCY-SELECTIVITY; SYNAPTIC INTEGRATION; CONTRAST INVARIANCE; IN-VIVO; AREA 17	The existence of two classes of cells, simple and complex, discovered by Hubel and Wiesel in 1962, is one of the fundamental features of cat primary visual cortex. A quantitative measure used to distinguish simple and complex cells is the ratio between modulated and unmodulated components of spike responses to drifting gratings, an index that forms a bimodal distribution. We have found that the modulation ratio, when derived from the subthreshold membrane potential instead of from spike rate, is unimodally distributed, but highly skewed. The distribution of the modulation ratio as derived from spike rate can, in turn, be predicted quantitatively by the nonlinear properties of spike threshold applied to the skewed distribution of the subthreshold modulation ratio. Threshold also increases the spatial segregation of ON and OFF regions of the receptive field, a defining attribute of simple cells. The distinction between simple and complex cells is therefore enhanced by threshold, much like the selectivity for stimulus features such as orientation and direction. In this case, however, a continuous distribution in the spatial organization of synaptic inputs is transformed into two distinct classes of cells.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY 10021 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Northwestern University; Cornell University; The Smith-Kettlewell Eye Research Institute	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.	ferster@northwestern.edu	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682	NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009314-10, R01 EY009314] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GLEZER VD, 1982, BIOL CYBERN, V43, P35, DOI 10.1007/BF00337286; GLEZER VD, 1980, BIOL CYBERN, V37, P195, DOI 10.1007/BF00337038; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MATA ML, IN PRESS J NEUROPHYS; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Sokal R.R., 2012, BIOMETRY; SPITZER H, 1988, PROG NEUROBIOL, V31, P285, DOI 10.1016/0301-0082(88)90016-0; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711	46	163	164	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1113	1122		10.1038/nn1310	http://dx.doi.org/10.1038/nn1310			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15338009	Green Accepted			2022-12-28	WOS:000224156900021
J	Petersen, PH; Zou, KY; Krauss, S; Zhong, WM				Petersen, PH; Zou, KY; Krauss, S; Zhong, WM			Continuing role for mouse Numb and Numbl in maintaining progenitor cells during cortical neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC DIVISION; NEURONAL DIFFERENTIATION; MAMMALIAN NUMB; NOTCH; FATES; FOREBRAIN; GENE; SPECIFICATION	Neural progenitor cells in the developing neocortex change over time to produce different neurons, a phenomenon that is also observed in other regions of the nervous system. Mouse Numb (also known as m-numb) and Numbl (also known as numblike or Nbl) are redundant but essential in maintaining virtually all progenitor cells during early neurogenesis. They do this by allowing cells to choose progenitor over neuronal fates. To determine whether their roles change as neurogenesis progresses, we conditionally ablated both genes in the embryonic dorsal forebrain after initial waves of neurogenesis. Here we report that these proteins continue to be required for progenitor-cell maintenance, contrary to recently reported findings. As occurs during early neurogenesis, the loss of Numb and Numbl causes premature progenitor-cell depletion and, consequently, a highly specific malformation of the neocortex and hippocampus. Because progenitor cells can proliferate without Numb and Numbl before neurogenesis, we propose that Numb-mediated asymmetric cell divisions, which diversify many cell fates in Drosophila melanogaster, represent a general mechanism in mammals for stem cells to balance self-renewal and differentiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Oslo, Natl Hosp, Sect Cellular & Genet Therapy, Inst Microbiol, Oslo, Norway	Yale University; University of Oslo; National Hospital Norway	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	, PeturHenry/H-1506-2011	Krauss, Stefan/0000-0001-6992-8091	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GU M, 1994, SCIENCE, V265, P103; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; VERDI JM, 1996, CURR BIOL, V6, P113; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	48	139	150	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					803	811		10.1038/nn1289	http://dx.doi.org/10.1038/nn1289			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273690				2022-12-28	WOS:000222930800009
J	Fujisaki, W; Shimojo, S; Kashino, M; Nishida, S				Fujisaki, W; Shimojo, S; Kashino, M; Nishida, S			Recalibration of audiovisual simultaneity	NATURE NEUROSCIENCE			English	Article							VISUAL-MOTION PERCEPTION; TEMPORAL-ORDER JUDGMENT; MULTISENSORY INTEGRATION; AUDITORY LOCALIZATION; SUPERIOR COLLICULUS; SOUND LOCALIZATION; TIME; ADAPTATION; PLASTICITY; VISION	To perceive the auditory and visual aspects of a physical event as occurring simultaneously, the brain must adjust for differences between the two modalities in both physical transmission time and sensory processing time. One possible strategy to overcome this difficulty is to adaptively recalibrate the simultaneity point from daily experience of audiovisual events. Here we report that after exposure to a fixed audiovisual time lag for several minutes, human participants showed shifts in their subjective simultaneity responses toward that particular lag. This 'lag adaptation' also altered the temporal tuning of an auditory-induced visual illusion, suggesting that adaptation occurred via changes in sensory processing, rather than as a result of a cognitive shift while making task responses. Our findings suggest that the brain attempts to adjust subjective simultaneity across different modalities by detecting and reducing time lags between inputs that likely arise from the same physical events.	NTT Corp, NTT Commun Sci Labs, Kanagawa 2430198, Japan; CALTECH, Div Biol, Pasadena, CA 91125 USA	Nippon Telegraph & Telephone Corporation; California Institute of Technology	Nishida, S (corresponding author), NTT Corp, NTT Commun Sci Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.	nishida@brl.ntt.co.jp	Fujisaki, Waka/N-6151-2016	Fujisaki, Waka/0000-0003-3844-5235				BARLOW H, 1989, COMP NEUR S, P54; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; BENNETT RG, 1985, VISION RES, V25, P565, DOI 10.1016/0042-6989(85)90161-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; CANON LK, 1970, J EXP PSYCHOL, V84, P141, DOI 10.1037/h0028925; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Cunningham DW, 2001, J VISION, V1, P88, DOI 10.1167/1.2.3; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Dolezal H., 1982, LIVING WORLD TRANSFO; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Foder J. A., 1983, MODULARITY MIND; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Mather G., 1998, MOTION AFTEREFFECT M; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Okada M, 2003, NEUROREPORT, V14, P261, DOI 10.1097/00001756-200302100-00021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poppel E., 1985, GRENZEN BEWUSSTSEINS; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Regan D., 1989, HUMAN BRAIN ELECTROP; Reichardt W, 1961, SENS COMMUN, P303; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; TAPPE T, 1994, PERCEPTION, V23, P335, DOI 10.1068/p230335; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; Zwiers MP, 2003, NAT NEUROSCI, V6, P175, DOI 10.1038/nn999	44	411	420	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					773	778		10.1038/nn1268	http://dx.doi.org/10.1038/nn1268			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195098				2022-12-28	WOS:000222274400020
J	Amateau, SK; McCarthy, MM				Amateau, SK; McCarthy, MM			Induction of PGE(2) by estradiol mediates developmental masculinization of sex behavior	NATURE NEUROSCIENCE			English	Article							SEXUALLY DIMORPHIC NUCLEUS; PREOPTIC AREA; CLINICAL PHARMACOKINETICS; DENDRITIC SPINES; ARCUATE NUCLEUS; BINDING PROTEIN; RECEPTOR-ALPHA; MALE-RATS; DIFFERENTIATION; BRAIN	Adult male sexual behavior in mammals requires the neuronal organizing effects of gonadal steroids during a sensitive perinatal period. During development, estradiol differentiates the rat preoptic area (POA), an essential brain region in the male copulatory circuit. Here we report that increases in prostaglandin-E-2 (PGE(2)), resulting from changes in cyclooxygenase-2 (COX-2) regulation induced by perinatal exposure to estradiol, are necessary and sufficient to organize the crucial neural substrate that mediates male sexual behavior. Briefly preventing prostaglandin synthesis in newborn males with the COX inhibitor indomethacin permanently downregulates markers of dendritic spines in the POA and severely impairs male sexual behavior. Developmental exposure to the COX inhibitor aspirin results in mild impairment of sexual behavior. Conversely, administration of PGE(2) to newborn females masculinizes the POA and leads to male sex behavior in adults, thereby highlighting the pathway of steroid-independent brain masculinization. Our findings show that PGE(2) functions as a downstream effector of estradiol to permanently masculinize the brain.	Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Amateau, SK (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	samat001@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	NICHD NIH HHS [U54 HD28934] Funding Source: Medline; NIMH NIH HHS [MH52716, MH12862] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH012862, R01MH052716, R29MH052716] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Amateau SK, 2002, J NEUROSCI, V22, P8586; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; Baum B.M., 2002, BEHAV ENDOCRINOLOGY, P153; BEACH FA, 1946, J EXP ZOOL, V101, P91, DOI 10.1002/jez.1401010107; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Calizo LH, 2000, J NEUROSCI, V20, P1589; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; Davis AM, 2000, BEHAV NEUROSCI, V114, P923, DOI 10.1037/0735-7044.114.5.923; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; DEWSBURY DA, 1969, ANIM BEHAV, V17, P217, DOI 10.1016/0003-3472(69)90004-9; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Feng PF, 2001, DEV BRAIN RES, V129, P107, DOI 10.1016/S0165-3806(01)00158-4; Forger NG, 1998, J NEUROSCI, V18, P8720; GEORGE FW, 1982, ENDOCRINOLOGY, V111, P522, DOI 10.1210/endo-111-2-522; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; GREEN GA, 2001, CLIN CORNERSTONE, V3, P5; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HELLEBERG L, 1981, CLIN PHARMACOKINET, V6, P245, DOI 10.2165/00003088-198106040-00001; Herrmann K, 1996, J COMP NEUROL, V375, P1; HOUTSMULLER EJ, 1994, PHYSIOL BEHAV, V56, P535, DOI 10.1016/0031-9384(94)90298-4; Hull EM, 2002, HORMONES BRAIN BEHAV, P3, DOI DOI 10.1016/B978-012532104-4/50003-2; LARRIVASAHD J, 1991, NEUROENDOCRINOLOGY, V54, P416, DOI 10.1159/000125923; LEVY G, 1978, PEDIATRICS, V62, P867; MALENKA RC, 1991, MOL NEUROBIOL, V5, P289, DOI 10.1007/BF02935552; MCMULLEN NT, 1981, AM J ANAT, V161, P323, DOI 10.1002/aja.1001610306; Meisel Robert L., 1994, P3; Mong JA, 1999, J NEUROSCI, V19, P1464; Mong JA, 2001, J COMP NEUROL, V432, P259, DOI 10.1002/cne.1101; Murphy AZ, 2001, J COMP NEUROL, V438, P191, DOI 10.1002/cne.1309; PEREZ J, 1990, BRAIN RES, V527, P116, DOI 10.1016/0006-8993(90)91068-R; PFAFF DW, 1966, J ENDOCRINOL, V36, P415, DOI 10.1677/joe.0.0360415; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Powell WS, 2003, BEHAV NEUROSCI, V117, P69, DOI 10.1037/0735-7044.117.1.69; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; Roselli CE, 2003, HORM BEHAV, V44, P146, DOI 10.1016/S0018-506X(03)00123-5; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Stephens DJ, 2000, BIOCHEM J, V345, P185, DOI 10.1042/0264-6021:3450185; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549	50	231	232	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					643	650		10.1038/nn1254	http://dx.doi.org/10.1038/nn1254			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156148				2022-12-28	WOS:000221640300019
J	Pattyn, A; Simplicio, N; van Doorninck, JH; Goridis, C; Guillemot, FO; Brunet, JF				Pattyn, A; Simplicio, N; van Doorninck, JH; Goridis, C; Guillemot, FO; Brunet, JF			Ascl1/Mash1 is required for the development of central serotonergic neurons	NATURE NEUROSCIENCE			English	Article							HOMEOBOX GENE PHOX2B; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; PRONEURAL GENES; MOTOR-NEURON; EXPRESSION; SPECIFICATION; IDENTITY; MASH1; PROGENITORS	The transcriptional control of the differentiation of central serotonergic (5-HT) neurons in vertebrates has recently come under scrutiny and has been shown to involve the homeobox genes Nkx2-2 and Lmx1b, the Ets-domain gene Pet1 (also known as Fev) and the zinc-finger gene Gata3. The basic helix-loop-helix (bHLH) gene Ascl1 (also known as Mash1) is coexpressed with Nkx2-2 in the neuroepithelial domain of the hindbrain, which gives rise to 5-HT neurons. Here we show in the mouse that Ascl1 is essential for the birth of 5-HT neurons, both as a proneural gene for the production of postmitotic neuronal precursors and as a determinant of the serotonergic phenotype for the parallel activation of Gata3, Lmx1b and Pet1. Thus Ascl1, which is essential for noradrenergic differentiation, is also a determinant of the serotonergic phenotype.	Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France; Natl Inst Med Res, London NW7 1AA, England; Erasmus MC, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); MRC National Institute for Medical Research; Erasmus University Rotterdam; Erasmus MC	Brunet, JF (corresponding author), Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France.	jfbrunet@biologie.ens.fr	Alexandre, Pattyn/ABF-1346-2020	Brunet, Jean-Francois/0000-0002-1985-6103; Pattyn, Alexandre/0000-0003-1215-1482				Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cau E, 1997, DEVELOPMENT, V124, P1611; Cheng LP, 2003, J NEUROSCI, V23, P9961; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KONIG N, 1988, J NEUROSCI RES, V20, P212, DOI 10.1002/jnr.490200210; Lanigan TM, 1998, J NEUROBIOL, V34, P126, DOI 10.1002/(SICI)1097-4695(19980205)34:2<126::AID-NEU3>3.0.CO;2-4; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Lo LC, 1998, DEVELOPMENT, V125, P609; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pata I, 1999, DEVELOPMENT, V126, P5523; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Shimamura K, 1995, DEVELOPMENT, V121, P3923; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Tiveron MC, 2003, DEV BIOL, V260, P46, DOI 10.1016/S0012-1606(03)00213-6; Tiveron MC, 1996, J NEUROSCI, V16, P7649; TORK I, 1990, ANN NY ACAD SCI, V600, P9; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; van Doorninck J H, 1999, J Neurosci, V19, pRC12	43	143	151	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					589	595		10.1038/nn1247	http://dx.doi.org/10.1038/nn1247			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133515				2022-12-28	WOS:000221640300012
J	Gilmour, D; Knaut, H; Maischein, HM; Nusslein-Volhard, C				Gilmour, D; Knaut, H; Maischein, HM; Nusslein-Volhard, C			Towing of sensory axons by their migrating target cells in vivo	NATURE NEUROSCIENCE			English	Article							CHEMOKINE RECEPTOR CXCR4; LATERAL-LINE; NERVOUS-SYSTEM; GROWTH CONES; ZEBRAFISH; GUIDANCE; SDF-1; PROTEIN	Many pathfinding axons must locate target fields that are themselves positioned by active migration. A hypothetical method for ensuring that these migrations are coordinated is towing, whereby the extension of axons is entirely dependent on the migration of their target cells. Here we combine genetics and time-lapse imaging in the zebrafish to show that towing by migrating cells is a bona fide mechanism for guiding pathfinding axons in vivo.	Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA	Max Planck Society; New York University	Gilmour, D (corresponding author), Max Planck Inst Entwicklungsbiol, Genet Abt, Spemannstr 35, D-72076 Tubingen, Germany.	darren.gilmour@tuebingen.mpg.de		Knaut, Holger/0000-0002-8399-8720; Gilmour, Darren/0000-0001-7613-090X				Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Becker T, 2001, MECH DEVELOP, V109, P37, DOI 10.1016/S0925-4773(01)00504-4; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Shoji W, 1998, DEVELOPMENT, V125, P1275; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WEISS P, 1941, GROWTH             S, V5, P163; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	15	97	97	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					491	492		10.1038/nn1235	http://dx.doi.org/10.1038/nn1235			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097993				2022-12-28	WOS:000221101300022
J	Martone, ME; Gupta, A; Ellisman, MH				Martone, ME; Gupta, A; Ellisman, MH			e-neuroscience: challenges and triumphs in integrating distributed data from molecules to brains	NATURE NEUROSCIENCE			English	Article							CELL-CENTERED DATABASE; SYSTEM; ATLAS; LOCALIZATION; INFORMATICS; FRAMEWORK; PROJECT; TOOLS; MODEL	Imaging, from magnetic resonance imaging (MRI) to localization of specific macromolecules by microscopies, has been one of the driving forces behind neuroinformatics efforts of the past decade. Many web-accessible resources have been created, ranging from simple data collections to highly structured databases. Although many challenges remain in adapting neuroscience to the new electronic forum envisioned by neuroinformatics proponents, these efforts have succeeded in formalizing the requirements for effective data sharing and data integration across multiple sources. In this perspective, we discuss the importance of spatial systems and ontologies for proper modeling of neuroscience data and their use in a large-scale data integration effort, the Biomedical Informatics Research Network (BIRN).	Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Martone, ME (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA.	mark@ncmir.ucsd.edu		Martone, Maryann/0000-0002-8406-3871	NCRR NIH HHS [RR08605-08S1, RR08605, RR04050, RR043050-S2] Funding Source: Medline; NIDA NIH HHS [DA016602] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016602] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bjaalie JG, 2002, NAT REV NEUROSCI, V3, P322, DOI 10.1038/nrn790; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Bowden DM, 2003, NEUROINFORMATICS, V1, P43, DOI 10.1385/NI:1:1:043; Brevik A, 2001, ANAT EMBRYOL, V204, P319, DOI 10.1007/s004290100202; Bug W, 2003, NEUROINFORMATICS, V1, P359, DOI 10.1385/NI:1:4:359; ECKMAN BA, 2003, BIOINFORMATICS MANAG, P35; Foster I, 2002, PHYS TODAY, V55, P42, DOI 10.1063/1.1461327; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Gardner D, 2001, PHILOS T ROY SOC B, V356, P1229, DOI 10.1098/rstb.2001.0911; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gupta A, 2003, NEURAL NETWORKS, V16, P1277, DOI 10.1016/j.neunet.2003.07.008; GUPTA A, 2000, P 12 INT C SCI STAT; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; Koslow SH, 2002, NAT REV NEUROSCI, V3, P311, DOI 10.1038/nrn787; Kotter R, 2001, PHILOS T ROY SOC B, V356, P1111, DOI 10.1098/rstb.2001.0902; Lacroix Z., 2003, MORGAN KAUFMANN SERI, P75; LUDAESCHER B, 2001, P 17 INT C DAT ENG I; Ludascher Bertram, 2003, BIOINFORMATICS MANAG, P335; MacKenzie-Graham A, 2003, NEUROINFORMATICS, V1, P397, DOI 10.1385/NI:1:4:397; Marenco L, 2003, J AM MED INFORM ASSN, V10, P444, DOI 10.1197/jamia.M1303; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Miller PL, 2001, J AM MED INFORM ASSN, V8, P34, DOI 10.1136/jamia.2001.0080034; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Peltier ST, 2003, J PARALLEL DISTR COM, V63, P539, DOI 10.1016/S0743-7315(03)00061-3; Shepherd GM, 1998, TRENDS NEUROSCI, V21, P460, DOI 10.1016/S0166-2236(98)01300-9; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443	32	83	83	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					467	472		10.1038/nn1229	http://dx.doi.org/10.1038/nn1229			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114360				2022-12-28	WOS:000221101300015
J	Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM				Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM			Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MENTAL-RETARDATION; SYNAPTIC PLASTICITY; MISSENSE MUTATION; DENDRITIC SPINES; ACTIN DYNAMICS; DOWN-SYNDROME; MEMORY LOSS; LIM-KINASE; DREBRIN	Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase ( PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid ( A beta) was directly involved in PAK signaling deficits and drebrin loss in A beta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher A beta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.	Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Ste Foy, PQ G1K 7P4, Canada; Educ & Clin Ctr, Sepulveda, CA 91343 USA; Osaka Univ, Sch Med, Div Psychiat & Behav Proteom, Dept Post Genom & Dis, Suita, Osaka 565, Japan; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Laval University; Laval University; Osaka University; University of California System; University of California Los Angeles	Cole, GM (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA.	gmcole@ucla.edu	Calon, Frederic/AAF-4390-2020; Morihara, Takashi/AAK-2709-2021	Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, R01AG013741, P60AG010415, R01AG016793, R01AG010685, P50AG016570, R01AG022080] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG 16570, R01 AG013741, P50 AG016570, P50 AG05142, AG16793, AG022080, AG10685, R01 AG010685, AG10415, R01 AG13741, P01 AG16570] Funding Source: Medline; NINDS NIH HHS [NS43946] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Gedeon AK, 2003, AM J MED GENET A, V120A, P509, DOI 10.1002/ajmg.a.20131; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; MA QL, 2005, IN PRESS J NEUROSCI, V83; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McPhie DL, 2003, J NEUROSCI, V23, P6914; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Ong WY, 2002, EXP BRAIN RES, V144, P189, DOI 10.1007/s00221-002-1016-x; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; TAKAI E, 1986, J IMMUNOL METHODS, V95, P23, DOI 10.1016/0022-1759(86)90313-3; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yang FS, 1998, AM J PATHOL, V152, P379; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	50	246	261	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					234	242		10.1038/nn1630	http://dx.doi.org/10.1038/nn1630			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415866				2022-12-28	WOS:000234990100019
J	Bermingham, JR; Shearin, H; Pennington, J; O'Moore, J; Jaegle, M; Driegen, S; van Zon, A; Darbas, A; Ozkaynak, E; Ryu, EJ; Milbrandt, J; Meijer, D				Bermingham, JR; Shearin, H; Pennington, J; O'Moore, J; Jaegle, M; Driegen, S; van Zon, A; Darbas, A; Ozkaynak, E; Ryu, EJ; Milbrandt, J; Meijer, D			The claw paw mutation reveals a role for Lgi4 in peripheral nerve development	NATURE NEUROSCIENCE			English	Article							DOMINANT PARTIAL EPILEPSY; SCHWANN-CELL MYELINATION; TEMPORAL-LOBE EPILEPSY; RICH REPEAT PROTEINS; AUDITORY FEATURES; DOMAIN; MOUSE; GENE; NEUREGULIN-1; EXPRESSION	Peripheral nerve development results from multiple cellular interactions between axons, Schwann cells and the surrounding mesenchymal tissue. The delayed axonal sorting and hypomyelination throughout the peripheral nervous system of claw paw (clp) mutant mice suggest that the clp gene product is critical for these interactions. Here we identify the clp mutation as a 225-bp insertion in the Lgi4 gene. Lgi4 encodes a secreted and glycosylated leucine-rich repeat protein and is expressed in Schwann cells. The clp mutation affects Lgi4 mRNA splicing, resulting in a mutant protein that is retained in the cell. Additionally, siRNA-mediated downregulation of Lgi4 in wild-type neuron-Schwann cell cocultures inhibits myelination, whereas exogenous Lgi4 restores myelination in clp/clp cultures. Thus, the abnormalities observed in clp mice are attributable to the loss of Lgi4 function, and they identify Lgi4 as a new component of Schwann cell signaling pathway(s) that controls axon segregation and myelin formation.	McLaughlin Res Inst, Great Falls, MT 59405 USA; Erasmus MC Univ Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Dept Psychiat, St Louis, MO 63110 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); Washington University (WUSTL)	Bermingham, JR (corresponding author), McLaughlin Res Inst, 1520 23rd St S, Great Falls, MT 59405 USA.	jrbjr@po.mri.montana.edu; d.meijer@erasmusmc.nl	Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745, R21NS049087, R01NS040751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40751, NS40745, R01 NS040751, NS049087] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHELOS JJ, 1993, J NEUROSCI RES, V35, P46, DOI 10.1002/jnr.490350107; Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berkovic SF, 2004, NEUROLOGY, V62, P1115, DOI 10.1212/01.WNL.0000118213.94650.81; Bermingham JR, 2002, J NEUROSCI, V22, P10217; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Darbas A, 2004, DEV BIOL, V272, P470, DOI 10.1016/j.ydbio.2004.05.017; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gherardi E, 2004, CURR OPIN STRUC BIOL, V14, P669, DOI 10.1016/j.sbi.2004.10.010; Ghislain J, 2002, DEVELOPMENT, V129, P155; Gu WL, 2004, NEUROGENETICS, V5, P41, DOI 10.1007/s10048-003-0158-8; Gu WL, 2002, FEBS LETT, V519, P71, DOI 10.1016/S0014-5793(02)02713-8; HART GW, 1979, J BIOL CHEM, V254, P9747; HENRY EW, 1991, J HERED, V82, P287, DOI 10.1093/oxfordjournals.jhered.a111088; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; JESSEN KR, 2004, MYELIN BIOL DISORDER, V1, P329; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Koszowski AG, 1998, J NEUROSCI, V18, P5859; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nagasawa K, 2001, CURR DRUG METAB, V2, P355, DOI 10.2174/1389200013338243; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; Pisano T, 2005, EPILEPSIA, V46, P118, DOI 10.1111/j.0013-9580.2005.26304.x; Runkel F, 2003, MAMM GENOME, V14, P665, DOI 10.1007/s00335-003-2282-z; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 2001, GLIAL CELL DEV, P223; Wegner M, 2000, GLIA, V29, P118, DOI 10.1002/(SICI)1098-1136(20000115)29:2<118::AID-GLIA4>3.0.CO;2-Q; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	50	77	79	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					76	84		10.1038/nn1598	http://dx.doi.org/10.1038/nn1598			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341215				2022-12-28	WOS:000234288000020
J	Makara, JK; Mor, M; Fegley, D; Szabo, SI; Kathuria, S; Astarita, G; Duranti, A; Tontini, A; Tarzia, G; Rivara, S; Freund, TF; Piomelli, D				Makara, JK; Mor, M; Fegley, D; Szabo, SI; Kathuria, S; Astarita, G; Duranti, A; Tontini, A; Tarzia, G; Rivara, S; Freund, TF; Piomelli, D			Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus	NATURE NEUROSCIENCE			English	Article							ENDOGENOUS CANNABINOIDS; SYNAPSES	The functions of 2-arachidonoylglycerol (2-AG), the most abundant endocannabinoid found in the brain, remain largely unknown. Here we show that two previously unknown inhibitors of monoacylglycerol lipase, a presynaptic enzyme that hydrolyzes 2-AG, increase 2-AG levels and enhance retrograde signaling from pyramidal neurons to GABAergic terminals in the hippocampus. These results establish a role for 2-AG in synaptic plasticity and point to monoacylglycerol lipase as a possible drug target.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Urbino, Inst Med Chem, I-61029 Urbino, Italy; Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; Univ Calif Irvine, Ctr Drug Discovery, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of Urbino; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Parma; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	freund@koki.hu; piomelli@uci.edu	Rivara, Silvia/K-8104-2017; Astarita, Giuseppe/AAD-1239-2019; Mor, Marco/D-2394-2009; Astarita, Giuseppe/N-7346-2014	Rivara, Silvia/0000-0001-8058-4250; Mor, Marco/0000-0003-0199-1849; Astarita, Giuseppe/0000-0001-6700-301X				Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; HODSON HF, 2000, Patent No. [0040247, 040247]; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Huang CC, 2002, MOL PHARMACOL, V61, P578, DOI 10.1124/mol.61.3.578; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; KRANTZ A, 1990, J MED CHEM, V33, P464, DOI 10.1021/jm00164a002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	14	180	189	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1139	1141		10.1038/nn1521	http://dx.doi.org/10.1038/nn1521			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116451	Green Submitted			2022-12-28	WOS:000231483800010
J	Oh, MC; Derkach, VA				Oh, MC; Derkach, VA			Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; PHOSPHORYLATION; CONDUCTANCE; SWITCH	GluR1 and GluR2 subunits compose AMPA receptors (AMPARs) in the mature hippocampus, and both the GluR1 subunit and Ca2+/calmodulin-dependent protein kinase II (CaMKII) are required for synaptic plasticity, memory and learning. Although GluR1 phosphorylation by CaMKII is preserved, the functional regulation of AMPARs by phosphorylation is lost in the presence of the GluR2 subunit. Our findings define a previously unknown, dominant role of the GluR2 subunit in signaling mediated by CaMKII at AMPARs.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Derkach, VA (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	derkachv@ohsu.edu			NINDS NIH HHS [NS47773, NS27037] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037, F30NS047773] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Schmitt WB, 2003, J NEUROSCI, V23, P3953; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985	15	86	98	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					853	854		10.1038/nn1476	http://dx.doi.org/10.1038/nn1476			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924137				2022-12-28	WOS:000230137100008
J	Chen, L; Feany, MB				Chen, L; Feany, MB			alpha-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease	NATURE NEUROSCIENCE			English	Article							COUPLED RECEPTOR KINASES; HUMAN BRAIN; PROTEIN; MUTATIONS; NEURODEGENERATION; LESIONS; GENE; TAU; SUPPRESSION; HUNTINGTIN	alpha-Synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies. These inclusion bodies are the characteristic pathologic lesions of Parkinson disease. Here we define the role of phosphorylation of Ser129 in alpha-synuclein toxicity and inclusion formation using a Drosophila model of Parkinson disease. Mutation of Ser129 to alanine to prevent phosphorylation completely suppresses dopaminergic neuronal loss produced by expression of human alpha-synuclein. In contrast, altering Ser129 to the negatively charged residue aspartate, to mimic phosphorylation, significantly enhances alpha-synuclein toxicity. The G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity. Blocking phosphorylation at Ser129 substantially increases aggregate formation. Thus Ser129 phosphorylation status is crucial in mediating alpha-synuclein neurotoxicity and inclusion formation. Because increased number of inclusion bodies correlates with reduced toxicity, inclusion bodies may protect neurons from alpha-synuclein toxicity.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970	NIA NIH HHS [AG88001] Funding Source: Medline; NINDS NIH HHS [NS41536] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041536] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Choi JY, 2002, BIOTECHNOL APPL BIOC, V36, P33, DOI 10.1042/BA20020004; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forloni G, 1996, CURR OPIN NEUROL, V9, P492, DOI 10.1097/00019052-199612000-00017; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, ANTIVIR RES, V53, P99, DOI 10.1016/S0166-3542(01)00196-6; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shulman JM, 2003, GENETICS, V165, P1233; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	43	486	504	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					657	663		10.1038/nn1443	http://dx.doi.org/10.1038/nn1443			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834418				2022-12-28	WOS:000228895100027
J	Baunez, C; Dias, C; Cador, M; Amalric, M				Baunez, C; Dias, C; Cador, M; Amalric, M			The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards	NATURE NEUROSCIENCE			English	Article							HIGH-FREQUENCY STIMULATION; PREFRONTAL CORTEX; BASAL GANGLIA; REACTION-TIME; ORBITOFRONTAL CORTEX; BILATERAL LESIONS; NEURONAL-ACTIVITY; SEEKING BEHAVIOR; VENTRAL STRIATUM; DOPAMINE	A challenge in treating drug addicts is preventing their pathological motivation for the drug without impairing their general affective state toward natural reinforcers. Here we have shown that discrete lesions of the subthalamic nucleus greatly decreased the motivation of rats for cocaine while increasing it for food reward. The subthalamic nucleus, a key structure controlling basal ganglia outputs, is therefore able to oppositely modulate the effect of 'natural' rewards and drugs of abuse on behavior. Modulating the activity of the subthalamic nucleus might prove to be a new target for the treatment of cocaine addiction.	Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, F-13402 Marseille, France; Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Baunez, C (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, F-13402 Marseille, France.	cbaunez@up.univ-mrs.fr	LE MOINE, Catherine/E-2671-2014; BAUNEZ, Christelle/B-2255-2008; Baunez, Christelle/J-6664-2019; Baunez, Christelle/L-9989-2019	Baunez, Christelle/0000-0002-4368-652X; Amalric, Marianne/0000-0002-9915-6763				Absher JR, 2000, NEUROPSY NEUROPSY BE, V13, P220; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; BAUNEZ C, 1995, J NEUROSCI, V15, P6531; Baunez C, 2002, J NEUROSCI, V22, P562, DOI 10.1523/JNEUROSCI.22-02-00562.2002; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 1999, PSYCHOPHARMACOLOGY, V141, P57, DOI 10.1007/s002130050806; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Carelli RM, 2000, J NEUROSCI, V20, P4255; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; DEPOORTERE RY, 1993, PHARMACOL BIOCHEM BE, V45, P539, DOI 10.1016/0091-3057(93)90503-L; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Krack P, 2001, BASAL GANGLIA AND THALAMUS IN HEALTH AND MOVEMENT DISORDERS, P333; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lorrain DS, 2000, BEHAV BRAIN RES, V107, P9, DOI 10.1016/S0166-4328(99)00109-6; Mallet L, 2002, LANCET, V360, P1302, DOI 10.1016/S0140-6736(02)11339-0; Maurice N, 1998, J NEUROSCI, V18, P9539; Maurice N, 1998, SYNAPSE, V29, P363, DOI 10.1002/(SICI)1098-2396(199808)29:4<363::AID-SYN8>3.0.CO;2-3; Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85; Phillips JM, 1999, EUR J NEUROSCI, V11, P1003, DOI 10.1046/j.1460-9568.1999.00509.x; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PONTIERI FE, 1995, EUR J PHARMACOL, V284, P205, DOI 10.1016/0014-2999(95)00441-M; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Trepanier LL, 2000, BRAIN COGNITION, V42, P324, DOI 10.1006/brcg.1999.1108; TRILLET M, 1995, REV NEUROL, V151, P416; Turner MS, 2001, J NEUROSCI, V21, P2820, DOI 10.1523/JNEUROSCI.21-08-02820.2001; Uslaner JM, 2003, EUR J NEUROSCI, V17, P2180, DOI 10.1046/j.1460-9568.2003.02638.x; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; WHITTIER JR, 1947, ARCH NEURO PSYCHIATR, V58, P672, DOI 10.1001/archneurpsyc.1947.02300350022002	50	164	167	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					484	489		10.1038/nn1429	http://dx.doi.org/10.1038/nn1429			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793577				2022-12-28	WOS:000228040400019
J	Piper, M; Salih, S; Weinl, C; Holt, CE; Harris, WA				Piper, M; Salih, S; Weinl, C; Holt, CE; Harris, WA			Endocytosis-dependent desensitization and protein synthesis-dependent resensitization in retinal growth cone adaptation	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA; SIGNAL-TRANSDUCTION; RECEPTOR INTERNALIZATION; CHEMOTROPIC RESPONSES; MEDIATED ENDOCYTOSIS; HUMAN-NEUTROPHILS; SEMAPHORIN-III; EPHRIN-AS; F-ACTIN; CULTURE	It has been proposed that growth cones navigating through gradients adapt to baseline concentrations of guidance cues. This adaptation process is poorly understood. Using the collapse assay, we show that adaptation in Xenopus laevis retinal growth cones to the guidance cues Sema3A or netrin-1 involves two processes: a fast, ligand-specific desensitization that occurs within 2 min of exposure and is dependent on endocytosis, and a slower, ligand-specific resensitization, which occurs within 5 min and is dependent upon protein synthesis. These two phases of adaptation allow retinal axons to adjust their range of sensitivity to specific guidance cues.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Harris, WA (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Holt, Christine Elizabeth/0000-0003-2829-121X; Salih, Saif/0000-0002-6877-6978	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bassell GJ, 1998, J NEUROSCI, V18, P251; Beaumont V, 1998, J BIOL CHEM, V273, P33174, DOI 10.1074/jbc.273.50.33174; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Jurney WM, 2002, J NEUROSCI, V22, P6019; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Sakurai T, 2002, P NATL ACAD SCI USA, V99, P10795, DOI 10.1073/pnas.162161499; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Smythies J, 2000, P ROY SOC B-BIOL SCI, V267, P1363, DOI 10.1098/rspb.2000.1151; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sotelo-Silveira JR, 2000, J NEUROSCI RES, V62, P65, DOI 10.1002/1097-4547(20001001)62:1<65::AID-JNR7>3.0.CO;2-Z; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taylor BL, 2004, J BACTERIOL, V186, P3671, DOI 10.1128/JB.186.12.3671-3673.2004; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	48	132	132	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					179	186		10.1038/nn1380	http://dx.doi.org/10.1038/nn1380			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643427	Green Accepted			2022-12-28	WOS:000226638200017
J	Anton, ES; Ghashghaei, HT; Weber, JL; McCann, C; Fischer, TM; Cheung, ID; Gassmann, M; Messing, A; Klein, R; Schwab, MH; Lloyd, KCK; Lai, C				Anton, ES; Ghashghaei, HT; Weber, JL; McCann, C; Fischer, TM; Cheung, ID; Gassmann, M; Messing, A; Klein, R; Schwab, MH; Lloyd, KCK; Lai, C			Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain	NATURE NEUROSCIENCE			English	Article							RADIAL GLIA; NEURONAL PRECURSORS; CHAIN-MIGRATION; CELL-MIGRATION; MICE LACKING; STEM-CELLS; NEUREGULIN; PROLIFERATION; EXPRESSION; BRAIN	Neural progenitor proliferation, differentiation and migration are continually active in the rostral migratory stream of the adult brain. Here, we show that the receptor tyrosine kinase ErbB4 is expressed prominently by the neuroblasts present in the subventricular zone and the rostral migratory stream. The neuregulins (NRG1-NRG3), which have been identified as ErbB4 ligands, are detected either in the stream or in adjacent regions. Mice deficient in ErbB4 expressed under the control of either the nestin or the hGFAP promoter have altered neuroblast chain organization and migration and deficits in the placement and differentiation of olfactory interneurons. These findings suggest that ErbB4 activation helps to regulate the organization of neural chains that form the rostral migratory stream and influences the differentiation of olfactory interneuronal precursors.	Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Basel, Biozentrum Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland; Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, Madison, WI 53705 USA; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute; University of Basel; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Max Planck Society; University of California System; University of California Davis	Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	anton@med.unc.edu	Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; Gassmann, Martin/0000-0001-6201-3032	NIMH NIH HHS [F32 MH071013-01A1, F32 MH071013-02, F32 MH071013] Funding Source: Medline; NINDS NIH HHS [P30NS045892, NS39411] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH071013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS039411] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Anton ES, 1997, DEVELOPMENT, V124, P3501; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chazal G, 2000, J NEUROSCI, V20, P1446; Chiu K, 1996, DEV BRAIN RES, V95, P28, DOI 10.1016/0165-3806(96)00055-7; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gregg C. T., 2001, S SOC EXP BIOL, V53, P1; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Murase S, 2002, J NEUROSCI, V22, P3568; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; YEE KT, 2001, ABSTR SOC NEUR; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	49	197	205	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1319	1328		10.1038/nn1345	http://dx.doi.org/10.1038/nn1345			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543145				2022-12-28	WOS:000225353900012
J	Page-McCaw, PS; Chung, SC; Muto, A; Roeser, T; Staub, W; Finger-Baier, KC; Korenbrot, JI; Baier, H				Page-McCaw, PS; Chung, SC; Muto, A; Roeser, T; Staub, W; Finger-Baier, KC; Korenbrot, JI; Baier, H			Retinal network adaptation to bright light requires tyrosinase	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; RETINOMOTOR MOVEMENTS; INTERPLEXIFORM CELLS; PIGMENT EPITHELIUM; DOPAMINE DEPLETION; BEHAVIORAL SCREEN; HORIZONTAL CELLS; EYE-MOVEMENTS; FISH RETINA; ZEBRAFISH	The visual system adjusts its sensitivity to a wide range of light intensities. We report here that mutation of the zebrafish sdy gene, which encodes tyrosinase, slows down the onset of adaptation to bright light. When fish larvae were challenged with periods of darkness during the day, the sdy mutants required nearly an hour to recover optokinetic behavior after return to bright light, whereas wild types recovered within minutes. This behavioral deficit was phenocopied in fully pigmented fish by inhibiting tyrosinase and thus does not depend on the absence of melanin pigment in sdy. Electroretinograms showed that the dark-adapted retinal network recovers sensitivity to a pulse of light more slowly in sdy mutants than in wild types. This failure is localized in the retinal neural network, postsynaptic to photoreceptors. We propose that retinal pigment epithelium ( which normally expresses tyrosinase) secretes a modulatory factor, possibly L-DOPA, which regulates light adaptation in the retinal circuitry.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.	hbaier@itsa.ucsf.edu	Muto, Akira/E-2580-2015	Muto, Akira/0000-0003-4276-1775; Page-McCaw, Patrick/0000-0002-4139-9770				BALL AK, 1993, VISUAL NEUROSCI, V10, P529, DOI 10.1017/S0952523800004740; Behrens UD, 2000, CELL TISSUE RES, V299, P299; Biehlmaier O, 2003, J NEUROBIOL, V56, P222, DOI 10.1002/neu.10243; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; CAHILL GM, 1991, J NEUROSCI, V11, P2959; DEARRY A, 1986, J NEUROCHEM, V46, P1006, DOI 10.1111/j.1471-4159.1986.tb00612.x; DJAMGOZ MBA, 1992, NEUROCHEM INT, V20, P139, DOI 10.1016/0197-0186(92)90166-O; DOUGLAS RH, 1992, VISUAL NEUROSCI, V9, P335, DOI 10.1017/S0952523800010749; DOWLING JE, 1975, SCIENCE, V188, P270, DOI 10.1126/science.804181; Easter SS, 1996, DEV BIOL, V180, P646; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Haffter P, 1996, DEV GENES EVOL, V206, P260, DOI 10.1007/s004270050051; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Inagaki H, 1998, PIGM CELL RES, V11, P283, DOI 10.1111/j.1600-0749.1998.tb00737.x; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kubrusly RCC, 2003, J NEUROCHEM, V86, P45, DOI 10.1046/j.1471-4159.2003.01813.x; Li L, 2000, J NEUROSCI, V20, P1893; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; LIN ZS, 1994, VISUAL NEUROSCI, V11, P683, DOI 10.1017/S0952523800002996; LIN ZS, 1994, VISUAL NEUROSCI, V11, P695, DOI 10.1017/S095252380000300X; Manglapus MK, 1999, J NEUROSCI, V19, P4132; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; Rios M, 1999, J NEUROSCI, V19, P3519; Roeser T, 2003, J NEUROSCI, V23, P3726; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; SALAS C, 1992, NEUROREPORT, V3, P131, DOI 10.1097/00001756-199202000-00002; Seeliger Mathias W., 2002, Documenta Ophthalmologica, V104, P57, DOI 10.1023/A:1014454927931; TYCHSEN L, 1989, ANN NEUROL, V25, P444, DOI 10.1002/ana.410250505; Van Epps HA, 2001, INVEST OPHTH VIS SCI, V42, P868; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F; WAGNER HJ, 1992, VISUAL NEUROSCI, V9, P345, DOI 10.1017/S0952523800010750; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WITKOVSKY P, 1990, VISUAL NEUROSCI, V5, P405, DOI 10.1017/S0952523800000493; Wu J, 2004, J NEUROPHYSIOL, V91, P1134, DOI 10.1152/jn.00958.2003; YANG XL, 1988, J NEUROSCI, V8, P2269; Yazulla S, 1996, VISION RES, V36, P4045, DOI 10.1016/S0042-6989(96)00128-9; Zaunreiter M, 1998, NEUROREPORT, V9, P1205, DOI 10.1097/00001756-199804200-00045	43	62	65	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1329	1336		10.1038/nn1344	http://dx.doi.org/10.1038/nn1344			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15516923				2022-12-28	WOS:000225353900013
J	Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF				Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF			Control of axonal branching and synapse formation by focal adhesion kinase	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; P190 RHOGAP; IN-VIVO; PROTEIN; GROWTH; CELLS; PHOSPHORYLATION; PLASTICITY; STABILITY	The formation of neuronal networks in the central nervous system (CNS) requires precise control of axonal branch development and stabilization. Here we show that cell-specific ablation of the murine gene Ptk2 (more commonly known as fak), encoding focal adhesion kinase (FAK), increases the number of axonal terminals and synapses formed by neurons in vivo. Consistent with this, fak mutant neurons also form greater numbers of axonal branches in culture because they have increased branch formation and reduced branch retraction. Expression of wild-type FAK, but not that of several FAK variants that prevent interactions with regulators of Rho family GTPases including the p190 Rho guanine nuclear exchange factor (p190RhoGEF), rescues the axonal arborization phenotype observed in fak mutant neurons. In addition, expression of a mutant p190RhoGEF that cannot associate with FAK results in a phenotype very similar to that of neurons lacking FAK. Thus, FAK functions as a negative regulator of axonal branching and synapse formation, and it seems to exert its actions, in part, through Rho family GTPases.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	brico@umh.es; lfr@cgl.ucsf.edu		Rico, Beatriz/0000-0002-0581-851X	NINDS NIH HHS [R01 NS019090-26, R01 NS019090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barry ST, 1996, CELL ADHES COMMUN, V4, P387, DOI 10.3109/15419069709004456; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Contestabile A, 2003, INT J DEV NEUROSCI, V21, P83, DOI 10.1016/S0736-5748(02)00126-0; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Garin N, 2002, J COMP NEUROL, V447, P210, DOI 10.1002/cne.10226; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; ILLC D, 1995, NATURE, V377, P539; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mandell JW, 1996, J NEUROSCI, V16, P5727; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ren XD, 2000, J CELL SCI, V113, P3673; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Seki T, 1998, J NEUROSCI, V18, P3757; Sorra KE, 1998, J COMP NEUROL, V398, P225; Taylor JM, 1999, J CELL SCI, V112, P231; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yang YC, 2003, J NEUROSCI, V23, P4072; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	50	143	145	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1059	1069		10.1038/nn1317	http://dx.doi.org/10.1038/nn1317			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378065	Green Accepted			2022-12-28	WOS:000224156900015
J	Matsumoto, K; Nishihara, S; Kamimura, M; Shiraishi, T; Otoguro, T; Uehara, M; Maeda, Y; Ogura, K; Lumsden, A; Ogura, T				Matsumoto, K; Nishihara, S; Kamimura, M; Shiraishi, T; Otoguro, T; Uehara, M; Maeda, Y; Ogura, K; Lumsden, A; Ogura, T			The prepattern transcription factor Irx2, a target of the FGF8/MAP kinase cascade, is involved in cerebellum formation	NATURE NEUROSCIENCE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; IROQUOIS HOMEOBOX GENES; ISTHMIC ORGANIZER; CHICK-EMBRYO; NEURAL PLATE; MID/HINDBRAIN ORGANIZER; INDUCED ANTAGONIST; XENOPUS HOMOLOG; OTX2 EXPRESSION; DROSOPHILA EYE	The cerebellum develops from the rhombic lip of the rostral hindbrain and is organized by fibroblast growth factor 8 (FGF8) expressed by the isthmus. Here we report characterization of Irx2, a member of the Iroquois (Iro) and Irx class of homeobox genes, that is expressed in the presumptive cerebellum. When Irx2 is misexpressed with Fgf8a in the chick midbrain, the midbrain develops into cerebellum in conjunction with repression of Otx2 and induction of Gbx2. During this event, signaling by the FGF8 and mitogen-activated protein (MAP) kinase cascade modulates the activity of Irx2 by phosphorylation. Our data identify a link between the isthmic organizer and Irx2, thereby shedding light on the roles of Iro and Irx genes, which are conserved in both vertebrates and invertebrates.	Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Sendai, Miyagi 9808575, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Tohoku University; Nara Institute of Science & Technology; University of London; King's College London	Ogura, T (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	ogura@idac.tohoku.ac.jp	Lumsden, Andrew/C-5146-2009					Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; Glavic A, 2002, DEVELOPMENT, V129, P1609; Glavic A, 2001, DEV DYNAM, V222, P368, DOI 10.1002/dvdy.1189; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Goriely A, 1999, MECH DEVELOP, V87, P203, DOI 10.1016/S0925-4773(99)00149-5; Hidalgo-Sanchez M, 1999, DEVELOPMENT, V126, P3191; Itoh M, 2002, DEVELOPMENT, V129, P2317; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Lebel M, 2003, MOL CELL BIOL, V23, P8216, DOI 10.1128/MCB.23.22.8216-8225.2003; Lee SMK, 1997, DEVELOPMENT, V124, P959; Leyns L, 1996, MECH DEVELOP, V59, P63, DOI 10.1016/0925-4773(96)00577-1; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Lin JC, 1998, J NEUROSCI, V18, P9342; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Liu AM, 1999, DEVELOPMENT, V126, P4827; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martinez S, 1999, DEVELOPMENT, V126, P1189; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogura K, 2001, CYTOGENET CELL GENET, V92, P320, DOI 10.1159/000056921; Ogura T, 2002, DIFFERENTIATION, V70, P163, DOI 10.1046/j.1432-0436.2002.700406.x; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; Peters T, 2000, GENOME RES, V10, P1453, DOI 10.1101/gr.144100; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Sato T, 2001, DEVELOPMENT, V128, P2461; Shamim H, 1998, MECH DEVELOP, V76, P157, DOI 10.1016/S0925-4773(98)00102-6; Shamim H, 1999, DEVELOPMENT, V126, P945; Shinya M, 2001, DEVELOPMENT, V128, P4153; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761	48	68	70	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					605	612		10.1038/nn1249	http://dx.doi.org/10.1038/nn1249			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133517				2022-12-28	WOS:000221640300014
J	Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L				Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L			The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis	NATURE NEUROSCIENCE			English	Article							RHO-ASSOCIATED KINASE; CEREBELLAR HYPOPLASIA; SYNAPTIC PLASTICITY; SMALL GTPASES; MORPHOLOGY; RECEPTOR; CALCIUM; ACTIN; HOMER; COMPLEX	Of 11 genes involved in nonspecific X-linked mental retardation (MRX), three encode regulators or effectors of the Rho GTPases, suggesting an important role for Rho signaling in cognitive function. It remains unknown, however, how mutations in Rho-linked genes lead to MRX. Here we report that oligophrenin-1, a Rho-GTPase activating protein that is absent in a family affected with MRX, is required for dendritic spine morphogenesis. Using RNA interference and antisense RNA approaches, we show that knock-down of oligophrenin-1 levels in CA1 neurons in rat hippocampal slices significantly decreases spine length. This phenotype can be recapitulated using an activated form of RhoA and rescued by inhibiting Rho-kinase, indicating that reduced oligophrenin-1 levels affect spine length by increasing RhoA and Rho-kinase activities. We further demonstrate an interaction between oligophrenin-1 and the postsynaptic adaptor protein Homer. Our findings provide the first insight into how mutations in a Rho-linked MRX gene may compromise neuronal function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.org		Cross, Justin/0000-0002-6356-057X				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FAGNI L, 2002, SCI STKE, V137, P1; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frints SGM, 2002, CLIN GENET, V62, P423, DOI 10.1034/j.1399-0004.2002.620601.x; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	50	233	244	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					364	372		10.1038/nn1210	http://dx.doi.org/10.1038/nn1210			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034583				2022-12-28	WOS:000220482500015
J	Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB				Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB			LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex	NATURE NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OUTGROWTH INHIBITOR; NEURITE OUTGROWTH; AXON REGENERATION; RHO GTPASES; GROWTH; PROTEINS; PROMOTES; GUIDANCE; BINDING	Axon regeneration in the adult CNS is prevented by inhibitors in myelin. These inhibitors seem to modulate RhoA activity by binding to a receptor complex comprising a ligand-binding subunit (the Nogo-66 receptor NgR1) and a signal transducing subunit (the neurotrophin receptor p75). However, in reconstituted non-neuronal systems, NgR1 and p75 together are unable to activate RhoA, suggesting that additional components of the receptor may exist. Here we describe LINGO-1, a nervous system-specific transmembrane protein that binds NgR1 and p75 and that is an additional functional component of the NgR1/p75 signaling complex. In non-neuronal cells, coexpression of human NgR1, p75 and LINGO-1 conferred responsiveness to oligodendrocyte myelin glycoprotein, as measured by RhoA activation. A dominant-negative human LINGO-1 construct attenuated myelin inhibition in transfected primary neuronal cultures. This effect on neurons was mimicked using an exogenously added human LINGO-1-Fc fusion protein. Together these observations suggest that LINGO-1 has an important role in CNS biology.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA	Biogen	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Sands, Bruce/R-7887-2019	Sands, Bruce/0000-0001-5762-5042				AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chauhan NB, 2003, NEUROCHEM INT, V43, P225, DOI 10.1016/S0197-0186(03)00006-8; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hunt D, 2002, J NEUROCYTOL, V31, P93, DOI 10.1023/A:1023941421781; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; KULAPANULA J, 2003, J CELL BIOL, V160, P963; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nguyen-Ba-Charvet KT, 2002, J PHYSIOL-PARIS, V96, P91, DOI 10.1016/S0928-4257(01)00084-5; Ono T, 2003, J NEUROSCI, V23, P5887; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Robinson LLL, 2003, J CLIN ENDOCR METAB, V88, P3943, DOI 10.1210/jc.2003-030196; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	38	640	717	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					221	228		10.1038/nn1188	http://dx.doi.org/10.1038/nn1188			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966521				2022-12-28	WOS:000189197900011
